<SEC-DOCUMENT>0001641172-25-009814.txt : 20250513
<SEC-HEADER>0001641172-25-009814.hdr.sgml : 20250513
<ACCEPTANCE-DATETIME>20250513061057
ACCESSION NUMBER:		0001641172-25-009814
CONFORMED SUBMISSION TYPE:	S-1/A
PUBLIC DOCUMENT COUNT:		12
FILED AS OF DATE:		20250513
DATE AS OF CHANGE:		20250513

FILER:

	COMPANY DATA:	
		COMPANY CONFORMED NAME:			Imunon, Inc.
		CENTRAL INDEX KEY:			0000749647
		STANDARD INDUSTRIAL CLASSIFICATION:	PHARMACEUTICAL PREPARATIONS [2834]
		ORGANIZATION NAME:           	03 Life Sciences
		EIN:				521256615
		STATE OF INCORPORATION:			DE
		FISCAL YEAR END:			1231

	FILING VALUES:
		FORM TYPE:		S-1/A
		SEC ACT:		1933 Act
		SEC FILE NUMBER:	333-286403
		FILM NUMBER:		25936985

	BUSINESS ADDRESS:	
		STREET 1:		997 LENOX DRIVE
		STREET 2:		SUITE 100
		CITY:			LAWRENCEVILLE
		STATE:			NJ
		ZIP:			08648
		BUSINESS PHONE:		(609) 896-9100

	MAIL ADDRESS:	
		STREET 1:		997 LENOX DRIVE
		STREET 2:		SUITE 100
		CITY:			LAWRENCEVILLE
		STATE:			NJ
		ZIP:			08648

	FORMER COMPANY:	
		FORMER CONFORMED NAME:	Celsion CORP
		DATE OF NAME CHANGE:	20071121

	FORMER COMPANY:	
		FORMER CONFORMED NAME:	CELSION CORP
		DATE OF NAME CHANGE:	19980515

	FORMER COMPANY:	
		FORMER CONFORMED NAME:	CHEUNG LABORATORIES INC
		DATE OF NAME CHANGE:	19920703
</SEC-HEADER>
<DOCUMENT>
<TYPE>S-1/A
<SEQUENCE>1
<FILENAME>forms-1a.htm
<DESCRIPTION>S-1/A
<TEXT>
<HTML>
<HEAD>
     <TITLE></TITLE>
</HEAD>
<BODY STYLE="font: 10pt Times New Roman, Times, Serif">

<P STYLE="font: 10pt Times New Roman, Times, Serif; text-align: center; margin-top: 0pt; margin-bottom: 0pt"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt"><B>&nbsp;</B></FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; text-align: center; margin-top: 0pt; margin-bottom: 0pt"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt"><B></B></FONT></P>

<P STYLE="text-align: center; font: 10pt Times New Roman, Times, Serif; margin-top: 0; margin-bottom: 0"><B>As filed with the Securities
and Exchange Commission on May 12, 2025</B></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: center"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt"><B>&nbsp;</B></FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: right"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt"><B>Registration
No. 333-286403 </B></FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: center"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt"><B>&nbsp;</B></FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: center"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt"><B></B></FONT></P>

<!-- Field: Rule-Page --><DIV STYLE="margin-top: 0pt; margin-bottom: 0pt; width: 100%"><DIV STYLE="font-size: 1pt; border-top: Black 4pt solid; border-bottom: Black 1pt solid">&nbsp;</DIV></DIV><!-- Field: /Rule-Page -->

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: center"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt"><B>&nbsp;</B></FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: center"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 18pt"><B>UNITED
STATES</B></FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: center"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 18pt"><B>SECURITIES
AND EXCHANGE COMMISSION</B></FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: center"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 12pt"><B>Washington,
D.C. 20549</B></FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: center"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: center"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt"></FONT></P>

<P STYLE="font: 18pt Times New Roman, Times, Serif; margin: 0; text-align: center"> <FONT STYLE="font-family: Times New Roman, Times, Serif"><B>Amendment
No. 1 to</B></FONT> </P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: center"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 18pt"><B>FORM
S-1</B></FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: center"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt"><B>REGISTRATION
STATEMENT UNDER THE SECURITIES ACT OF 1933</B></FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: center"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: center"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 18pt"><B>Imunon,
Inc.</B></FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: center"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">(Exact
name of registrant as specified in its charter)</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: center"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>

<TABLE CELLSPACING="0" CELLPADDING="0" STYLE="font: 10pt Times New Roman, Times, Serif; width: 100%; border-collapse: collapse">
  <TR STYLE="font: 10pt Times New Roman, Times, Serif">
    <TD STYLE="font: 10pt Times New Roman, Times, Serif; vertical-align: top; width: 32%; text-align: center"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt"><B>Delaware</B></FONT></TD>
    <TD STYLE="font: 10pt Times New Roman, Times, Serif; vertical-align: bottom; width: 2%; text-align: center"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></TD>
    <TD STYLE="font: 10pt Times New Roman, Times, Serif; width: 32%; text-align: center"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt"><B>2834</B></FONT></TD>
    <TD STYLE="font: 10pt Times New Roman, Times, Serif; width: 2%; text-align: center"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></TD>
    <TD STYLE="font: 10pt Times New Roman, Times, Serif; vertical-align: top; width: 32%; text-align: center"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt"><B>52-1256615</B></FONT></TD></TR>
  <TR STYLE="font: 10pt Times New Roman, Times, Serif">
    <TD STYLE="font: 10pt Times New Roman, Times, Serif; vertical-align: top"><P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: center"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">(State
    or other jurisdiction of</FONT></P>
    <P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: center"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">incorporation
    or organization)</FONT></P></TD>
    <TD STYLE="font: 10pt Times New Roman, Times, Serif; vertical-align: bottom; text-align: center"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></TD>
    <TD STYLE="font: 10pt Times New Roman, Times, Serif; vertical-align: bottom"><P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: center"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">(Primary
    Standard Industrial</FONT></P>
    <P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: center"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">Classification
    Code Number)</FONT></P></TD>
    <TD STYLE="font: 10pt Times New Roman, Times, Serif; text-align: center"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></TD>
    <TD STYLE="font: 10pt Times New Roman, Times, Serif; vertical-align: top"><P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: center"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">(I.R.S.
    Employer</FONT></P>
    <P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: center"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">Identification
    No.)</FONT></P></TD></TR>
  </TABLE>
<P STYLE="text-align: center; font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>

<P STYLE="text-align: center; font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt"><B>997 Lenox Drive, Suite 100</B></FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; text-align: center; margin-top: 0pt; margin-bottom: 0pt"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt"><B></B></FONT> <FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt"><B>Lawrenceville, NJ 08648</B></FONT> <FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt"><B></B></FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; text-align: center; margin-top: 0pt; margin-bottom: 0pt"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt"><B>(609) 896-9100</B></FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; text-align: center; margin-top: 0pt; margin-bottom: 0pt"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">(Address, including zip code, and telephone number, including area code, of registrant&rsquo;s principal executive offices)</FONT></P>


<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: center"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt"><B>&nbsp;</B></FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: center"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt"><B>Stacy
Lindborg</B></FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: center"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt"><B>President
and Chief Executive Officer</B></FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: center"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt"><B>Imunon,
Inc.</B></FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: center"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt"><B>997
Lenox Drive, Suite 100</B></FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: center"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt"><B>Lawrenceville,
NJ 08648</B></FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: center"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt"><B>(609)
896-9100</B></FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: center"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">(Name,
address, including zip code, and telephone number, including area code, of agent for service)</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: center"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: center"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt"><B><I>Copies
to:</I></B></FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: center"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>

<TABLE CELLSPACING="0" CELLPADDING="0" STYLE="font: 10pt Times New Roman, Times, Serif; width: 100%; border-collapse: collapse">
  <TR STYLE="font: 10pt Times New Roman, Times, Serif; vertical-align: top">
    <TD STYLE="font: 10pt Times New Roman, Times, Serif; width: 32%"><P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: center"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt"><B>Jurgita
    Ashley</B></FONT></P>
    <P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: center"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt"><B>Thompson
    Hine LLP</B></FONT></P>
    <P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: center"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt"><B>3900
    Key Center</B></FONT></P>
    <P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: center"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt"><B>127
    Public Square</B></FONT></P>
    <P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: center"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt"><B>Cleveland,
    OH 44114</B></FONT></P>
    <P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: center"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt"><B>(216)
    566-5500</B></FONT></P></TD>
    <TD STYLE="font: 10pt Times New Roman, Times, Serif; width: 2%; text-align: center"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></TD>
    <TD STYLE="font: 10pt Times New Roman, Times, Serif; width: 32%"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></TD>
    <TD STYLE="font: 10pt Times New Roman, Times, Serif; width: 2%; text-align: center"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></TD>
    <TD STYLE="font: 10pt Times New Roman, Times, Serif; width: 32%"><P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: center"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt"><B>Ron
    Ben-Bassat, Esq.</B></FONT></P>
    <P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: center"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt"><B>Eric
    Victorson, Esq.</B></FONT></P>
    <P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: center"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt"><B>Sullivan
    &amp; Worcester LLP</B></FONT></P>
    <P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: center"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt"><B></B></FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: center"><B>1251 Avenue of the Americas</B></P>
<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: center"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt"><B></B></FONT></P>
    <P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: center"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt"><B>New
    York, NY 10020</B></FONT></P>
    <P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: center"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt"><B>(212)
    660-3000</B></FONT></P></TD></TR>
  </TABLE>
<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: center"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt"><B><I>&nbsp;</I></B></FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt"><B>Approximate
date of commencement of proposed sale to the public:</B> As soon as practicable after the effective date of this registration statement.</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">If
any of the securities being registered on this Form are to be offered on a delayed or continuous basis pursuant to Rule 415 under the
Securities Act of 1933, check the following box. &#9746;</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">If
this Form is filed to register additional securities for an offering pursuant to Rule 462(b) under the Securities Act, check the following
box and list the Securities Act registration statement number of the earlier effective registration statement for the same offering.
&#9744;</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">If
this Form is a post-effective amendment filed pursuant to Rule 462(c) under the Securities Act, check the following box and list the
Securities Act registration statement number of the earlier effective registration statement for the same offering. &#9744;</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">If
this Form is a post-effective amendment filed pursuant to Rule 462(d) under the Securities Act, check the following box and list the
Securities Act registration statement number of the earlier effective registration statement for the same offering. &#9744;</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">Indicate
by check mark whether the registrant is a large accelerated filer, an accelerated filer, a non-accelerated filer, a smaller reporting
company, or an emerging growth company. See the definitions of &ldquo;large accelerated filer,&rdquo; &ldquo;accelerated filer,&rdquo;
&ldquo;smaller reporting company,&rdquo; and &ldquo;emerging growth company&rdquo; in Rule 12b-2 of the Exchange Act.</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>

<TABLE CELLSPACING="0" CELLPADDING="0" STYLE="font: 10pt Times New Roman, Times, Serif; width: 100%; border-collapse: collapse">
  <TR STYLE="font: 10pt Times New Roman, Times, Serif; vertical-align: top">
    <TD STYLE="font: 10pt Times New Roman, Times, Serif; width: 20%"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">Large
    accelerated filer</FONT></TD>
    <TD STYLE="font: 10pt Times New Roman, Times, Serif; width: 45%"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#9744;</FONT></TD>
    <TD STYLE="font: 10pt Times New Roman, Times, Serif; width: 25%"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">Accelerated
    filer</FONT></TD>
    <TD STYLE="font: 10pt Times New Roman, Times, Serif; width: 10%"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#9744;</FONT></TD></TR>
  <TR STYLE="font: 10pt Times New Roman, Times, Serif; vertical-align: top">
    <TD STYLE="font: 10pt Times New Roman, Times, Serif"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">Non-accelerated
    filer</FONT></TD>
    <TD STYLE="font: 10pt Times New Roman, Times, Serif"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#9746;</FONT></TD>
    <TD STYLE="font: 10pt Times New Roman, Times, Serif"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">Smaller
    reporting company</FONT></TD>
    <TD STYLE="font: 10pt Times New Roman, Times, Serif"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#9746;</FONT></TD></TR>
  <TR STYLE="font: 10pt Times New Roman, Times, Serif; vertical-align: top">
    <TD STYLE="font: 10pt Times New Roman, Times, Serif"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></TD>
    <TD STYLE="font: 10pt Times New Roman, Times, Serif"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></TD>
    <TD STYLE="font: 10pt Times New Roman, Times, Serif"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">Emerging
    growth company</FONT></TD>
    <TD STYLE="font: 10pt Times New Roman, Times, Serif"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#9744;</FONT></TD></TR>
  </TABLE>
<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">If
an emerging growth company, indicate by check mark if the registrant has elected not to use the extended transition period for complying
with any new or revised financial accounting standards provided pursuant to Section 7(a)(2)(B) of the Securities Act. &#9744;</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt"><B>&nbsp;</B></FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt"><B>The
registrant hereby amends this registration statement on such date or dates as may be necessary to delay its effective date until the
registrant shall file a further amendment that specifically states that this registration statement shall thereafter become effective
in accordance with Section 8(a) of the Securities Act or until the registration statement shall become effective on such date as the
Securities and Exchange Commission, acting pursuant to said Section 8(a), may determine.</B></FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt"></FONT></P>

<!-- Field: Rule-Page --><DIV STYLE="margin-top: 0pt; margin-bottom: 0pt; width: 100%"><DIV STYLE="font-size: 1pt; border-top: Black 1pt solid; border-bottom: Black 4pt solid">&nbsp;</DIV></DIV><!-- Field: /Rule-Page -->

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>


<!-- Field: Page; Sequence: 1 -->
    <DIV STYLE="margin-top: 0pt; margin-bottom: 6pt; border-bottom: Black 1pt solid"><TABLE CELLPADDING="0" CELLSPACING="0" STYLE="border-collapse: collapse; width: 100%; font-size: 10pt"><TR STYLE="vertical-align: top; text-align: left"><TD STYLE="width: 100%">&nbsp;</TD></TR></TABLE></DIV>
    <DIV STYLE="break-before: page; margin-top: 6pt; margin-bottom: 0pt"><P STYLE="margin: 0pt">&nbsp;</P></DIV>
    <!-- Field: /Page -->

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt"></FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt"></FONT></P>

<P STYLE="text-align: center; font: 10pt Times New Roman, Times, Serif; margin-top: 0; margin-bottom: 0"></P>
<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt"></FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt; color: Red"><B>The
information in this prospectus is not complete and may be changed. We may not sell these securities until the registration statement
filed with the Securities and Exchange Commission is effective. This prospectus is not an offer to sell these securities, and it is not
soliciting offers to buy these securities, in any state where the offer or sale of these securities is not permitted.</B></FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt; color: Red">&nbsp;</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: center"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt; color: Red"><B><I>SUBJECT
TO COMPLETION, DATED MAY 12, 2025</I></B></FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: center"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt; color: Red">&nbsp;</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: center"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt; color: Red"><B>PRELIMINARY
PROSPECTUS</B></FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: center"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt"><B>&nbsp;</B></FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; text-align: center"><IMG SRC="form_001.jpg" ALT=""></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: center"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt"><B>&nbsp;</B></FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: center"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 14pt"><B>IMUNON,
INC.</B></FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: center"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: center"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt"><B>UP
TO 15,000,000 SHARES OF COMMON STOCK</B></FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: center"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt"><B>UP
TO 15,000,000 COMMON WARRANTS TO PURCHASE 45,000,000 SHARES OF COMMON STOCK* </B></FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: center"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt"><B>UP
TO 15,000,000 PRE-FUNDED WARRANTS TO PURCHASE 15,000,000 SHARES OF COMMON STOCK</B></FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: center"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt"><B>UP
TO 45,000,000 SHARES OF COMMON STOCK UNDERLYING SUCH COMMON WARRANTS* </B></FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: center"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt"><B>UP
TO 15,000,000 SHARES OF COMMON STOCK UNDERLYING SUCH PRE-FUNDED WARRANTS</B></FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: center"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt"><B>&nbsp;</B></FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify; text-indent: 0.5in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">We
are offering on a reasonable best-efforts basis up to 15,000,000 shares of our common stock, par value $0.01 per share (&ldquo;<U>Common
Stock</U>&rdquo;), together with warrants to purchase up to 45,000,000 shares of our Common Stock based on an assumed public
offering price of $0.80 per share of Common Stock and accompanying warrant, which was the closing price of our Common Stock on
the Nasdaq Stock Market (&ldquo;<U>Nasdaq</U>&rdquo;) on May 9, 2025. Each share of Common Stock, or a pre-funded warrant in lieu
thereof, is being sold together with a common warrant to purchase one share of Common Stock. The shares of Common Stock, or pre-funded
warrants in lieu thereof, and common warrants are immediately separable and will be issued separately in this offering but must be
purchased together in this offering. This prospectus also relates to the shares of Common Stock issuable upon exercise of the pre-funded
warrants and the common warrants sold in this offering.</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify"> <FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT> </P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 0pt; text-align: justify; text-indent: 0.5in"> <FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">The
common warrants will be exercisable upon receipt of stockholder approval, including (i) such approval as may be required by the applicable
rules and regulations of Nasdaq from the stockholders of the Company and board of directors of the Company: (a) to consent to any adjustment
to the exercise price and/or number of shares of Common Stock underlying the common warrants in the event of an adjustment upon the Adjustment
Date (as defined below) pursuant to the terms of the common warrants, (b) to consent to any adjustment to the exercise price of the common
warrants in the event of a voluntary adjustment pursuant to the terms of the common warrants, and (c) to consent to the &ldquo;alternative
cashless exercise&rdquo; provision of the common warrants, in each case without regard to any limitations upon exercise of the common
warrants relating to Stockholder Approval (as defined below) and/or the provisions prohibiting adjustments in such common warrants above
the price set forth in clause (ii) of the definition of Floor Price (as defined below); and (ii) such approval as may be required from
the stockholders of the Company and board of directors of the Company as necessary to increase the available number of authorized shares
of Common Stock of the Company to a minimum of [&#9679;] million authorized shares (collectively, the &ldquo;<U>Stockholder Approval</U>&rdquo;).
&ldquo;Adjustment Date&rdquo; means the close of trading on the 11th trading day after the trading day on which we file
a Current Report on Form 8-K with the Securities and Exchange Commission (the &ldquo;SEC&rdquo;) giving public notice of Stockholder Approval. &ldquo;Floor Price&rdquo; means a price per share
equal to $0.16 (based on an assumed public offering price of $0.80 per share), which represents 20% of the public offering price per
share. We have agreed to hold a meeting to obtain Stockholder Approval as soon as practicable following the closing of this offering,
but no later than sixty (60) days following the closing of this offering, and further agreed to cause an additional stockholder meeting
to be held every ninety (90) days thereafter until such Stockholder Approval is obtained. We cannot assure you that we will be able to
obtain requisite Stockholder Approval.</FONT> </P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 0pt; text-align: justify; text-indent: 0.5in"> <FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT> </P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 0pt; text-align: justify; text-indent: 0.5in"> <FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">*Each
common warrant offered hereby will become exercisable beginning on the date on which we file a Current Report on Form 8-K with the SEC giving public notice
of Stockholder Approval  (the &ldquo;<U>Initial Exercise Date</U>&rdquo;) at an assumed exercise price per share of $1.60, equal to 200% of
the assumed combined public offering price per share of Common Stock and accompanying common warrant, and will expire two and one-half
(2.5) years after the Initial Exercise Date. Holders of the common warrants may effect an &ldquo;alternative cashless exercise&rdquo;
at any time while the common warrants are outstanding following the Initial Exercise Date. Under the alternative cashless exercise option,
a holder of a common warrant has the right to receive an aggregate number of shares equal to the product of (i) the aggregate number
of shares of Common Stock that would be issuable upon a cash exercise of the common warrant and (ii) 3.0. Accordingly, it is highly unlikely
that a holder of the common warrants would wish to pay an exercise price in cash to receive one share of Common Stock when they could
instead choose the alternative cashless exercise option and pay no cash to receive three shares of Common Stock. As a result, we will
likely not receive any additional funds and do not expect to receive any additional funds upon the exercise of the common warrants. In
addition, on the Adjustment Date, the exercise price of the common warrants will be reduced to the greater of the Floor Price and the
lowest daily dollar volume-weighted average price during the period beginning two full trading days prior to the Adjustment Date and
ending on the 10th trading day after the Adjustment Date. Upon any such resulting adjustment of the exercise price of the common warrants,
the number of shares of Common Stock issuable under the common warrants will be increased such that the aggregate exercise price of a
common warrant (adjusted for any exercises by a holder prior to this adjustment) will remain unchanged following such adjustment. As
a result, the aggregate number of shares of Common Stock underlying all of the common warrants may increase from 15,000,000 up to 150,000,000
(in each case, based on an assumed public offering price of $0.80 per share), assuming full adjustment of the exercise price to the Floor
Price and before giving effect to the &ldquo;alternative cashless exercise&rdquo; provision. Assuming full adjustment of the exercise
price to the Floor Price, the aggregate number of shares of Common Stock issuable upon the exercise of all of the common warrants pursuant
to the &ldquo;alternative cashless exercise&rdquo; provisions therein would be 450,000,000 (based on an assumed public offering price
of $0.80 per share). In the event that we are unable to obtain Stockholder Approval, the common warrants will not be exercisable and
therefore will have no value.</FONT> </P>
<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt; text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify; text-indent: 0.5in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">We
are also offering to certain purchasers whose purchase of shares of Common Stock in this offering would otherwise result in the purchaser,
together with its affiliates and certain related parties, beneficially owning more than 4.99% (or, at the election of the purchaser,
9.99%) of our outstanding Common Stock immediately following the consummation of this offering, the opportunity to purchase, if any such
purchaser so chooses, pre-funded warrants, in lieu of shares of Common Stock that would otherwise result in such purchaser&rsquo;s beneficial
ownership exceeding 4.99% (or, at the election of the purchaser, 9.99%) of our outstanding Common Stock. The public offering price of
each pre-funded warrant and accompanying common warrant will be equal to the price at which one share of Common Stock and accompanying
common warrant is sold to the public in this offering, minus $0.0001, and the exercise price of each pre-funded warrant will be $0.0001
per share. The pre-funded warrants will be immediately exercisable and may be exercised at any time until all of the pre-funded warrants
are exercised in full. The pre-funded warrants and common warrants are immediately separable and will be issued separately in this offering,
but must be purchased together in this offering. For each pre-funded warrant we sell, the number of shares of Common Stock we are offering
will be decreased on a one-for-one basis.</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify; text-indent: 0.5in">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify; text-indent: 0.5in"> <FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">Certain
of our existing securityholders have indicated interest in participating in this offering at the public offering price and on the same
terms as the other purchasers in this offering. However, we cannot guarantee if any of them will participate in this offering.</FONT> </P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify; text-indent: 0.5in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify; text-indent: 0.5in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt"></FONT></P>

<!-- Field: Page; Sequence: 2 -->
    <DIV STYLE="margin-top: 0pt; margin-bottom: 6pt; border-bottom: Black 1pt solid"><TABLE CELLPADDING="0" CELLSPACING="0" STYLE="border-collapse: collapse; width: 100%; font-size: 10pt"><TR STYLE="vertical-align: top; text-align: left"><TD STYLE="width: 100%">&nbsp;</TD></TR></TABLE></DIV>
    <DIV STYLE="break-before: page; margin-top: 6pt; margin-bottom: 0pt"><P STYLE="margin: 0pt">&nbsp;</P></DIV>
    <!-- Field: /Page -->

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify; text-indent: 0.5in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify; text-indent: 0.5in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">We
have engaged Brookline Capital Markets, a division of Arcadia Securities, LLC (&ldquo;<U>Brookline</U>&rdquo;), to act as our placement
agent (the &ldquo;<U>Placement Agent</U>&rdquo;), to use its reasonable best efforts to arrange for the sale of the securities
offered by this prospectus. The Placement Agent is not purchasing or selling any of the securities we are offering, and the Placement
Agent is not required to arrange the purchase or sale of any specific number or dollar amount of securities. We have agreed to
pay to the Placement Agent the Placement Agent fees set forth in the table below, which assumes that we sell all of the securities
offered by this prospectus.</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify; text-indent: 0.5in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify; text-indent: 0.5in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">We
refer to the Common Stock, common warrants and pre-funded warrants to be sold in this offering collectively as the &ldquo;securities.&rdquo;
The securities will be offered at a fixed price and are expected to be issued in a single closing. The offering will terminate on May
30, 2025, unless (i) the closing occurs prior thereto or (ii) we decide to terminate the offering prior thereto (which we may
do at any time in our discretion), except that the shares of Common Stock underlying the warrants and shares of Common Stock underlying
the pre-funded warrants will be offered on a continuous basis pursuant to Rule 415 under the Securities Act of 1933, as amended (the
&ldquo;<U>Securities Act</U>&rdquo;). Investors purchasing securities offered hereby will have the option to execute a securities purchase
agreement with us. We expect that the closing of the offering will occur one trading day after we price the securities offered hereby.
When we price the securities, we will simultaneously enter into securities purchase agreements relating to the offering with those investors
who so choose. The offering will settle delivery versus payment (&ldquo;<U>DVP</U>&rdquo;)/receipt versus payment (&ldquo;<U>RVP</U>&rdquo;).
That is, on the closing date, we will issue the shares of Common Stock directly to the account(s) at the Placement Agent identified
by each purchaser; upon receipt of such shares, the Placement Agent shall promptly electronically deliver such shares to the applicable
purchaser, and payment therefor shall be made by the Placement Agent (or its clearing firm) by wire transfer to us.</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify; text-indent: 0.5in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify; text-indent: 0.5in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">Since
we will deliver the securities to be issued in this offering upon our receipt of investor funds, we and the Placement Agent have
not made any arrangements to place investor funds in an escrow account or trust account. Because this is a best-efforts offering, the
Placement Agent does not have an obligation to purchase any securities, and, as a result, there is a possibility that we may not
be able to sell the securities. There is no minimum offering requirement as a condition of closing of this offering. Because there is
no minimum offering amount required as a condition to closing this offering, we may sell fewer than all of the securities offered hereby,
which may significantly reduce the amount of proceeds received by us, and investors in this offering will not receive a refund in the
event that we do not sell an amount of securities sufficient to pursue our business goals described in this prospectus. In addition,
because there is no escrow account and no minimum offering amount, investors could be in a position where they have invested in our company,
but we are unable to fulfill all of our contemplated objectives due to a lack of interest in this offering. Further, any proceeds from
the sale of securities offered by us will be available for our immediate use, despite uncertainty about whether we would be able to use
such funds to effectively implement our business plan. See the section entitled &ldquo;Risk Factors&rdquo; for more information.</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify; text-indent: 0.5in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify; text-indent: 0.5in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">Our
Common Stock is listed on the Nasdaq under the ticker symbol &ldquo;IMNN.&rdquo; On May 9, 2025, the last reported sale price
per share of our Common Stock on Nasdaq was $0.80 per share. The actual public offering price per share of Common Stock and accompanying
common warrant, and per pre-funded warrant and accompanying common warrant, will be determined between us, the Placement Agent
and the investors in this offering at the time of pricing and may be at a discount to the current market price for our Common Stock,
and the recent market price for our Common Stock used throughout this prospectus may not be indicative of the final offering price per
share of Common Stock and accompanying common warrant, and per pre-funded warrant and accompanying common warrant. There is no established
public trading market for the common warrants or the pre-funded warrants, and we do not expect such a market to develop. Without an active
trading market, the liquidity of the pre-funded warrants and the common warrants will be limited. In addition, we do not intend to list
the pre-funded warrants or the common warrants on Nasdaq, any other national securities exchange or any other trading system.</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify; text-indent: 0.5in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify; text-indent: 0.5in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">You
should read this prospectus, together with additional information described under the headings &ldquo;<I>Incorporation of Certain Information
by Reference</I>&rdquo; and &ldquo;<I>Where You Can Find More Information,</I>&rdquo; carefully before you invest in any of our securities.</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify; text-indent: 0.5in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt"><B>&nbsp;</B></FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify; text-indent: 0.5in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt"><B></B></FONT></P>

<!-- Field: Page; Sequence: 3 -->
    <DIV STYLE="margin-top: 0pt; margin-bottom: 6pt; border-bottom: Black 1pt solid"><TABLE CELLPADDING="0" CELLSPACING="0" STYLE="border-collapse: collapse; width: 100%; font-size: 10pt"><TR STYLE="vertical-align: top; text-align: left"><TD STYLE="width: 100%">&nbsp;</TD></TR></TABLE></DIV>
    <DIV STYLE="break-before: page; margin-top: 6pt; margin-bottom: 0pt"><P STYLE="margin: 0pt">&nbsp;</P></DIV>
    <!-- Field: /Page -->

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify; text-indent: 0.5in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt"><B>&nbsp;</B></FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify; text-indent: 0.5in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt"><B>Investing
in our securities involves a high degree of risk. You should only purchase shares if you can afford the loss of your investment. If we
fail to regain compliance with Nasdaq&rsquo;s continued listing requirements, which requires the closing bid price of our Common Stock
to be $1.00 per share or more for a minimum of ten (10) consecutive business days before May 27, 2025, Nasdaq may delist our Common Stock.
Nasdaq may also delist our Common Stock for public interest concerns resulting from the dilutive impact and terms of the common warrants
in this offering. Our independent registered public accountant has issued an audit opinion which includes a statement expressing
substantial doubt as to our ability to continue as a going concern. See &ldquo;<I><A HREF="#Aa_005">Risk Factors</A></I>&rdquo; on page
6 of this prospectus and the section entitled &ldquo;<I>Risk Factors</I>&rdquo; included in our most recent Annual Report on Form
10-K, as revised or supplemented by our subsequent Quarterly Reports on Form 10-Q, which are incorporated herein by reference, for a
discussion of information that you should consider before investing in our securities.</B></FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify; text-indent: 0.5in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify; text-indent: 0.5in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt"><B>Neither
the SEC nor any state securities commission has approved or disapproved of these securities or passed upon the adequacy or accuracy of
this prospectus. Any representation to the contrary is a criminal offense.</B></FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify; text-indent: 0.5in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>

<TABLE CELLSPACING="0" CELLPADDING="0" STYLE="font: 10pt Times New Roman, Times, Serif; width: 100%; border-collapse: collapse">
  <TR STYLE="font: 10pt Times New Roman, Times, Serif; vertical-align: bottom">
    <TD STYLE="font: 10pt Times New Roman, Times, Serif"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt"><B>&nbsp;</B></FONT></TD>
    <TD STYLE="font: 10pt Times New Roman, Times, Serif"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt"><B>&nbsp;</B></FONT></TD>
    <TD COLSPAN="2" STYLE="border-bottom: black 1pt solid; font: 10pt Times New Roman, Times, Serif; text-align: center"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt"><B>Per
    Share and<BR>
    Accompanying<BR>
    Common<BR>
    Warrant</B></FONT></TD>
    <TD STYLE="font: 10pt Times New Roman, Times, Serif"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt"><B>&nbsp;</B></FONT></TD>
    <TD STYLE="font: 10pt Times New Roman, Times, Serif"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt"><B>&nbsp;</B></FONT></TD>
    <TD COLSPAN="2" STYLE="border-bottom: black 1pt solid; font: 10pt Times New Roman, Times, Serif; text-align: center"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt"><B>Per
    Pre-Funded<BR>
    Warrant and<BR>
    Accompanying<BR>
    Common<BR>
    Warrant</B></FONT></TD>
    <TD STYLE="font: 10pt Times New Roman, Times, Serif"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt"><B>&nbsp;</B></FONT></TD>
    <TD STYLE="font: 10pt Times New Roman, Times, Serif"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt"><B>&nbsp;</B></FONT></TD>
    <TD COLSPAN="2" STYLE="border-bottom: black 1pt solid; font: 10pt Times New Roman, Times, Serif; text-align: center"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt"><B>Total</B></FONT></TD>
    <TD STYLE="font: 10pt Times New Roman, Times, Serif"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt"><B>&nbsp;</B></FONT></TD></TR>
  <TR STYLE="font: 10pt Times New Roman, Times, Serif; vertical-align: bottom; background-color: rgb(204,238,255)">
    <TD STYLE="font: 10pt Times New Roman, Times, Serif; width: 49%; text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">Public
    offering price<SUP>(1)</SUP></FONT></TD>
    <TD STYLE="font: 10pt Times New Roman, Times, Serif; width: 1%"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></TD>
    <TD STYLE="font: 10pt Times New Roman, Times, Serif; width: 1%"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">$</FONT></TD>
    <TD STYLE="font: 10pt Times New Roman, Times, Serif; width: 14%; text-align: right">&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;</TD>
    <TD STYLE="font: 10pt Times New Roman, Times, Serif; width: 1%"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></TD>
    <TD STYLE="font: 10pt Times New Roman, Times, Serif; width: 1%"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></TD>
    <TD STYLE="font: 10pt Times New Roman, Times, Serif; width: 1%"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">$</FONT></TD>
    <TD STYLE="font: 10pt Times New Roman, Times, Serif; width: 14%; text-align: right">&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;</TD>
    <TD STYLE="font: 10pt Times New Roman, Times, Serif; width: 1%"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></TD>
    <TD STYLE="font: 10pt Times New Roman, Times, Serif; width: 1%"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></TD>
    <TD STYLE="font: 10pt Times New Roman, Times, Serif; width: 1%"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">$</FONT></TD>
    <TD STYLE="font: 10pt Times New Roman, Times, Serif; width: 14%; text-align: right">&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;</TD>
    <TD STYLE="font: 10pt Times New Roman, Times, Serif; width: 1%"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></TD></TR>
  <TR STYLE="font: 10pt Times New Roman, Times, Serif; vertical-align: bottom; background-color: White">
    <TD STYLE="font: 10pt Times New Roman, Times, Serif; text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">Placement
    Agent fees<SUP>(2)</SUP></FONT></TD>
    <TD STYLE="font: 10pt Times New Roman, Times, Serif"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></TD>
    <TD STYLE="font: 10pt Times New Roman, Times, Serif"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">$</FONT></TD>
    <TD STYLE="font: 10pt Times New Roman, Times, Serif; text-align: right"><P STYLE="margin: 0">&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;</P><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt"></FONT></TD>
    <TD STYLE="font: 10pt Times New Roman, Times, Serif"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></TD>
    <TD STYLE="font: 10pt Times New Roman, Times, Serif"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></TD>
    <TD STYLE="font: 10pt Times New Roman, Times, Serif"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">$</FONT></TD>
    <TD STYLE="font: 10pt Times New Roman, Times, Serif; text-align: right"><P STYLE="margin: 0">&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;</P><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt"></FONT></TD>
    <TD STYLE="font: 10pt Times New Roman, Times, Serif"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></TD>
    <TD STYLE="font: 10pt Times New Roman, Times, Serif"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></TD>
    <TD STYLE="font: 10pt Times New Roman, Times, Serif"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">$</FONT></TD>
    <TD STYLE="font: 10pt Times New Roman, Times, Serif; text-align: right"><P STYLE="margin: 0">&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;</P><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt"></FONT></TD>
    <TD STYLE="font: 10pt Times New Roman, Times, Serif"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></TD></TR>
  <TR STYLE="font: 10pt Times New Roman, Times, Serif; vertical-align: bottom; background-color: rgb(204,238,255)">
    <TD STYLE="font: 10pt Times New Roman, Times, Serif; text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">Proceeds
    to us, before expenses<SUP>(3)</SUP></FONT></TD>
    <TD STYLE="font: 10pt Times New Roman, Times, Serif"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></TD>
    <TD STYLE="font: 10pt Times New Roman, Times, Serif"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">$</FONT></TD>
    <TD STYLE="font: 10pt Times New Roman, Times, Serif; text-align: right"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;</FONT></TD>
    <TD STYLE="font: 10pt Times New Roman, Times, Serif"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></TD>
    <TD STYLE="font: 10pt Times New Roman, Times, Serif"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></TD>
    <TD STYLE="font: 10pt Times New Roman, Times, Serif"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">$</FONT></TD>
    <TD STYLE="font: 10pt Times New Roman, Times, Serif; text-align: right"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;</FONT></TD>
    <TD STYLE="font: 10pt Times New Roman, Times, Serif"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></TD>
    <TD STYLE="font: 10pt Times New Roman, Times, Serif"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></TD>
    <TD STYLE="font: 10pt Times New Roman, Times, Serif"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">$</FONT></TD>
    <TD STYLE="font: 10pt Times New Roman, Times, Serif; text-align: right"><P STYLE="margin: 0">&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;</P><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt"></FONT></TD>
    <TD STYLE="font: 10pt Times New Roman, Times, Serif"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></TD></TR>
  </TABLE>
<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>

<TABLE CELLSPACING="0" CELLPADDING="0" STYLE="font: 10pt Times New Roman, Times, Serif; width: 100%">
  <TR STYLE="font: 10pt Times New Roman, Times, Serif; vertical-align: top">
    <TD STYLE="font: 10pt Times New Roman, Times, Serif; width: .25in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></TD>
    <TD STYLE="font: 10pt Times New Roman, Times, Serif; width: .25in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">(1)</FONT></TD>
    <TD STYLE="font: 10pt Times New Roman, Times, Serif; text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">The
    combined public offering price is $&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;
    per share of Common Stock and accompanying common warrant (or $&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;
    per pre-funded warrant and accompanying common warrant). </FONT></TD></TR>
  </TABLE>
<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0.5in; text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>

<TABLE CELLSPACING="0" CELLPADDING="0" STYLE="font: 10pt Times New Roman, Times, Serif; width: 100%">
  <TR STYLE="font: 10pt Times New Roman, Times, Serif; vertical-align: top">
    <TD STYLE="font: 10pt Times New Roman, Times, Serif; width: .25in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></TD>
    <TD STYLE="font: 10pt Times New Roman, Times, Serif; width: .25in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">(2)</FONT></TD>
    <TD STYLE="font: 10pt Times New Roman, Times, Serif; text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">Represents
    a cash fee equal to seven percent (7.0%) of the aggregate purchase price paid by investors in this offering. We have also agreed
    to reimburse the Placement Agent for its accountable offering-related legal expenses in an amount up to $75,000 and
    $20,000 for non-accountable expenses. See &ldquo;<I>Plan of Distribution</I>&rdquo; for additional disclosure regarding compensation
    payable to the Placement Agent. </FONT></TD></TR>
  </TABLE>
<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0.5in; text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0.5in; text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">Because
there is no minimum number of securities or amount of proceeds required as a condition to closing this offering, the actual public offering
amount, Placement Agent fees, and proceeds to us, if any, are not presently determinable and may be substantially less than the total
maximum offering amounts set forth above. See &ldquo;<I>Plan of Distribution</I>&rdquo; for more information.</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0.5in; text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>

<TABLE CELLSPACING="0" CELLPADDING="0" STYLE="font: 10pt Times New Roman, Times, Serif; width: 100%">
  <TR STYLE="font: 10pt Times New Roman, Times, Serif; vertical-align: top">
    <TD STYLE="font: 10pt Times New Roman, Times, Serif; width: .25in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></TD>
    <TD STYLE="font: 10pt Times New Roman, Times, Serif; width: .25in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">(3)</FONT></TD>
    <TD STYLE="font: 10pt Times New Roman, Times, Serif; text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">Does
    not include proceeds from the exercise of the common warrants and/or pre-funded warrants in cash, if any.</FONT></TD></TR>
  </TABLE>
<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify; text-indent: 0.5in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">Delivery
of the securities is expected to be made on or about &nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;,
2025, subject to satisfaction of certain conditions.</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: center"> <FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt"><I>Sole
</I></FONT> <FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt"><I>Placement Agent</I></FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: center"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: center"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 14pt"><B>Brookline
Capital Markets</B></FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: center"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">a
division of Arcadia Securities, LLC</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: center"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: center"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">The
date of this prospectus is &nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;,
2025.</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: center"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>


<!-- Field: Page; Sequence: 4 -->
    <DIV STYLE="margin-top: 0pt; margin-bottom: 6pt; border-bottom: Black 1pt solid"><TABLE CELLPADDING="0" CELLSPACING="0" STYLE="border-collapse: collapse; width: 100%; font-size: 10pt"><TR STYLE="vertical-align: top; text-align: left"><TD STYLE="width: 100%">&nbsp;</TD></TR></TABLE></DIV>
    <DIV STYLE="break-before: page; margin-top: 6pt; margin-bottom: 0pt"><P STYLE="margin: 0pt">&nbsp;</P></DIV>
    <!-- Field: /Page -->

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: center">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: center"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt"><B>TABLE
OF CONTENTS</B></FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: center"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>



<TABLE CELLPADDING="0" CELLSPACING="0" STYLE="font: 10pt Times New Roman, Times, Serif; width: 100%">
  <TR STYLE="font: 10pt Times New Roman, Times, Serif; text-align: left; vertical-align: bottom; background-color: rgb(204,238,255)">
    <TD STYLE="font: 10pt Times New Roman, Times, Serif; text-align: left"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt"><A HREF="#Aa_001">CAUTIONARY NOTICE REGARDING FORWARD-LOOKING STATEMENTS</A></FONT></TD>
    <TD STYLE="font: 10pt Times New Roman, Times, Serif; width: 0.5in; text-align: right"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">1</FONT></TD></TR>
  <TR STYLE="font: 10pt Times New Roman, Times, Serif; text-align: left; vertical-align: bottom; background-color: White">
    <TD STYLE="font: 10pt Times New Roman, Times, Serif; text-align: left"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt"><A HREF="#Aa_002">ABOUT THIS PROSPECTUS</A></FONT></TD>
    <TD STYLE="font: 10pt Times New Roman, Times, Serif; text-align: right">2</TD></TR>
  <TR STYLE="font: 10pt Times New Roman, Times, Serif; text-align: left; vertical-align: bottom; background-color: rgb(204,238,255)">
    <TD STYLE="font: 10pt Times New Roman, Times, Serif; text-align: left"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt"><A HREF="#Aa_003">PROSPECTUS SUMMARY</A></FONT></TD>
    <TD STYLE="font: 10pt Times New Roman, Times, Serif; text-align: right">3</TD></TR>
  <TR STYLE="font: 10pt Times New Roman, Times, Serif; text-align: left; vertical-align: bottom; background-color: White">
    <TD STYLE="font: 10pt Times New Roman, Times, Serif; text-align: left"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt"><A HREF="#Aa_004">THE OFFERING</A></FONT></TD>
    <TD STYLE="font: 10pt Times New Roman, Times, Serif; text-align: right">4</TD></TR>
  <TR STYLE="font: 10pt Times New Roman, Times, Serif; text-align: left; vertical-align: bottom; background-color: rgb(204,238,255)">
    <TD STYLE="font: 10pt Times New Roman, Times, Serif; text-align: left"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt"><A HREF="#Aa_005">RISK FACTORS</A></FONT></TD>
    <TD STYLE="font: 10pt Times New Roman, Times, Serif; text-align: right">6</TD></TR>
  <TR STYLE="font: 10pt Times New Roman, Times, Serif; text-align: left; vertical-align: bottom; background-color: White">
    <TD STYLE="font: 10pt Times New Roman, Times, Serif; text-align: left"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt"><A HREF="#Aa_006">CAPITALIZATION</A></FONT></TD>
    <TD STYLE="font: 10pt Times New Roman, Times, Serif; text-align: right"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">10</FONT></TD></TR>
  <TR STYLE="font: 10pt Times New Roman, Times, Serif; text-align: left; vertical-align: bottom; background-color: rgb(204,238,255)">
    <TD STYLE="font: 10pt Times New Roman, Times, Serif; text-align: left"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt"><A HREF="#Aa_007">DILUTION</A></FONT></TD>
    <TD STYLE="font: 10pt Times New Roman, Times, Serif; text-align: right"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">11</FONT></TD></TR>
  <TR STYLE="font: 10pt Times New Roman, Times, Serif; text-align: left; vertical-align: bottom; background-color: White">
    <TD STYLE="font: 10pt Times New Roman, Times, Serif; text-align: left"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt"><A HREF="#Aa_008">USE OF PROCEEDS</A></FONT></TD>
    <TD STYLE="font: 10pt Times New Roman, Times, Serif; text-align: right"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">12</FONT></TD></TR>
  <TR STYLE="font: 10pt Times New Roman, Times, Serif; text-align: left; vertical-align: bottom; background-color: rgb(204,238,255)">
    <TD STYLE="font: 10pt Times New Roman, Times, Serif; text-align: left"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt"><A HREF="#Aa_009">DESCRIPTION OF CAPITAL STOCK</A></FONT></TD>
    <TD STYLE="font: 10pt Times New Roman, Times, Serif; text-align: right"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">13</FONT></TD></TR>
  <TR STYLE="font: 10pt Times New Roman, Times, Serif; text-align: left; vertical-align: bottom; background-color: White">
    <TD STYLE="font: 10pt Times New Roman, Times, Serif; text-align: left"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt"><A HREF="#Aa_010">DESCRIPTION OF SECURITIES WE ARE OFFERING</A></FONT></TD>
    <TD STYLE="font: 10pt Times New Roman, Times, Serif; text-align: right"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">18</FONT></TD></TR>
  <TR STYLE="font: 10pt Times New Roman, Times, Serif; text-align: left; vertical-align: bottom; background-color: rgb(204,238,255)">
    <TD STYLE="font: 10pt Times New Roman, Times, Serif; text-align: left"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt"><A HREF="#Aa_011">PLAN OF DISTRIBUTION</A></FONT></TD>
    <TD STYLE="font: 10pt Times New Roman, Times, Serif; text-align: right"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">21</FONT></TD></TR>
  <TR STYLE="font: 10pt Times New Roman, Times, Serif; text-align: left; vertical-align: bottom; background-color: White">
    <TD STYLE="font: 10pt Times New Roman, Times, Serif; text-align: left"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt"><A HREF="#Aa_012">MATERIAL UNITED STATES FEDERAL INCOME TAX CONSIDERATIONS</A></FONT></TD>
    <TD STYLE="font: 10pt Times New Roman, Times, Serif; text-align: right"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">24</FONT></TD></TR>
  <TR STYLE="font: 10pt Times New Roman, Times, Serif; text-align: left; vertical-align: bottom; background-color: rgb(204,238,255)">
    <TD STYLE="font: 10pt Times New Roman, Times, Serif; text-align: left"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt"><A HREF="#Aa_013">DIVIDEND POLICY</A></FONT></TD>
    <TD STYLE="font: 10pt Times New Roman, Times, Serif; text-align: right"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">28</FONT></TD></TR>
  <TR STYLE="font: 10pt Times New Roman, Times, Serif; text-align: left; vertical-align: bottom; background-color: White">
    <TD STYLE="font: 10pt Times New Roman, Times, Serif; text-align: left"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt"><A HREF="#Aa_014">LEGAL MATTERS</A></FONT></TD>
    <TD STYLE="font: 10pt Times New Roman, Times, Serif; text-align: right"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">29</FONT></TD></TR>
  <TR STYLE="font: 10pt Times New Roman, Times, Serif; text-align: left; vertical-align: bottom; background-color: rgb(204,238,255)">
    <TD STYLE="font: 10pt Times New Roman, Times, Serif; text-align: left"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt"><A HREF="#Aa_015">EXPERTS</A></FONT></TD>
    <TD STYLE="font: 10pt Times New Roman, Times, Serif; text-align: right"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">29</FONT></TD></TR>
  <TR STYLE="font: 10pt Times New Roman, Times, Serif; text-align: left; vertical-align: bottom; background-color: White">
    <TD STYLE="font: 10pt Times New Roman, Times, Serif; text-align: left"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt"><A HREF="#Aa_016">WHERE YOU CAN FIND MORE INFORMATION</A></FONT></TD>
    <TD STYLE="font: 10pt Times New Roman, Times, Serif; text-align: right"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">29</FONT></TD></TR>
  <TR STYLE="font: 10pt Times New Roman, Times, Serif; text-align: left; vertical-align: bottom; background-color: rgb(204,238,255)">
    <TD STYLE="font: 10pt Times New Roman, Times, Serif; text-align: left"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt"><A HREF="#Aa_017">INCORPORATION OF CERTAIN INFORMATION BY REFERENCE</A></FONT></TD>
    <TD STYLE="font: 10pt Times New Roman, Times, Serif; text-align: right"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">30</FONT></TD></TR>
</TABLE>
<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>


<!-- Field: Page; Sequence: 5; Options: NewSection; Value: 1 -->
    <DIV STYLE="margin-top: 0pt; margin-bottom: 6pt; border-bottom: Black 1pt solid"><TABLE CELLPADDING="0" CELLSPACING="0" STYLE="border-collapse: collapse; width: 100%; font-size: 10pt"><TR STYLE="vertical-align: top; text-align: left"><TD STYLE="text-align: center; width: 100%"><!-- Field: Sequence; Type: LowerRoman; Name: PageNo -->i<!-- Field: /Sequence --></TD></TR></TABLE></DIV>
    <DIV STYLE="break-before: page; margin-top: 6pt; margin-bottom: 0pt"><P STYLE="margin: 0pt">&nbsp;</P></DIV>
    <!-- Field: /Page -->

<P STYLE="font: bold 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: center"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>

<P STYLE="font: bold 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: center"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt"><A NAME="Aa_001"></A>CAUTIONARY
NOTICE REGARDING FORWARD-LOOKING STATEMENTS</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: center"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify; text-indent: 0.5in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">Certain
statements contained or incorporated by reference in this prospectus and in any related free writing prospectus may constitute forward-looking
statements within the meaning of the Private Securities Litigation Reform Act of 1995 and releases issued by the SEC and within the meaning
of Section 27A of the Securities Act, and Section 21E of the Securities Exchange Act of 1934, as amended (the &ldquo;<U>Exchange Act</U>&rdquo;).
Forward-looking statements may relate to such matters as anticipated financial performance, business prospects, technological developments,
product pipelines, clinical trials and research and development activities, the adequacy of capital reserves and anticipated operating
results and cash expenditures, current and potential collaborations, strategic alternatives and other aspects of our present and future
business operations and similar matters. These statements involve known and unknown risks, uncertainties and other factors, many of which
are outside of our control, that may cause our or our industry&rsquo;s actual results, levels of activity, performance or achievements
to be materially different from any future results, levels of activity, performance or achievements expressed or implied by such forward-looking
statements. Such statements include, without limitation:</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>

<TABLE CELLSPACING="0" CELLPADDING="0" STYLE="font: 10pt Times New Roman, Times, Serif; width: 100%">
  <TR STYLE="font: 10pt Times New Roman, Times, Serif; vertical-align: top">
    <TD STYLE="font: 10pt Times New Roman, Times, Serif; width: 0.5in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></TD>
    <TD STYLE="font: 10pt Times New Roman, Times, Serif; width: 0.25in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#9679;</FONT></TD>
    <TD STYLE="font: 10pt Times New Roman, Times, Serif; text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">any
    statements regarding future operations, plans, regulatory filings or approvals, including the plans and objectives of management
    for future operations or programs or proposed new products or services;</FONT></TD></TR>
  <TR STYLE="font: 10pt Times New Roman, Times, Serif; vertical-align: top">
    <TD STYLE="font: 10pt Times New Roman, Times, Serif"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></TD>
    <TD STYLE="font: 10pt Times New Roman, Times, Serif"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#9679;</FONT></TD>
    <TD STYLE="font: 10pt Times New Roman, Times, Serif; text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">any
    statements regarding the performance, or likely performance, or outcomes or economic benefit of any of our research and development
    activities, proposed or potential clinical trials or new drug filing strategies or timelines, including whether any of our clinical
    trials will be completed successfully within any specified time period or at all;</FONT></TD></TR>
  <TR STYLE="font: 10pt Times New Roman, Times, Serif; vertical-align: top">
    <TD STYLE="font: 10pt Times New Roman, Times, Serif"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></TD>
    <TD STYLE="font: 10pt Times New Roman, Times, Serif"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#9679;</FONT></TD>
    <TD STYLE="font: 10pt Times New Roman, Times, Serif; text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">any
    projections of earnings, cash resources, revenue, expense or other financial terms;</FONT></TD></TR>
  <TR STYLE="font: 10pt Times New Roman, Times, Serif; vertical-align: top">
    <TD STYLE="font: 10pt Times New Roman, Times, Serif"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></TD>
    <TD STYLE="font: 10pt Times New Roman, Times, Serif"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#9679;</FONT></TD>
    <TD STYLE="font: 10pt Times New Roman, Times, Serif; text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">any
    statements regarding the initiation, timing, progress and results of our research and development programs, preclinical studies,
    any clinical trials and Investigational New Drug application, New Drug Application and other regulatory submissions;</FONT></TD></TR>
  <TR STYLE="font: 10pt Times New Roman, Times, Serif; vertical-align: top">
    <TD STYLE="font: 10pt Times New Roman, Times, Serif"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></TD>
    <TD STYLE="font: 10pt Times New Roman, Times, Serif"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#9679;</FONT></TD>
    <TD STYLE="font: 10pt Times New Roman, Times, Serif; text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">any
    statements regarding cost and timing of development and testing, capital structure, financial condition, working capital needs and
    other financial items, including our ability to continue as a going concern;</FONT></TD></TR>
  <TR STYLE="font: 10pt Times New Roman, Times, Serif; vertical-align: top">
    <TD STYLE="font: 10pt Times New Roman, Times, Serif"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></TD>
    <TD STYLE="font: 10pt Times New Roman, Times, Serif"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#9679;</FONT></TD>
    <TD STYLE="font: 10pt Times New Roman, Times, Serif; text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">any
    statements regarding the implementation of our business model and integration of acquired technologies, assets or businesses and
    existing or future collaborations, mergers, acquisitions or other strategic transactions;</FONT></TD></TR>
  <TR STYLE="font: 10pt Times New Roman, Times, Serif; vertical-align: top">
    <TD STYLE="font: 10pt Times New Roman, Times, Serif"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></TD>
    <TD STYLE="font: 10pt Times New Roman, Times, Serif"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#9679;</FONT></TD>
    <TD STYLE="font: 10pt Times New Roman, Times, Serif; text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">any
    statements regarding approaches to medical treatment, any introduction of new products by others, any possible licenses or acquisitions
    of other technologies, assets or businesses, or possible actions by customers, suppliers, strategic partners, potential strategic
    partners, competitors or regulatory authorities;</FONT></TD></TR>
  <TR STYLE="font: 10pt Times New Roman, Times, Serif; vertical-align: top">
    <TD STYLE="font: 10pt Times New Roman, Times, Serif"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></TD>
    <TD STYLE="font: 10pt Times New Roman, Times, Serif"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#9679;</FONT></TD>
    <TD STYLE="font: 10pt Times New Roman, Times, Serif; text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">any
    statements regarding development or success of our collaboration arrangements or future payments that may come due to us under these
    arrangements;</FONT></TD></TR>
  <TR STYLE="font: 10pt Times New Roman, Times, Serif; vertical-align: top">
    <TD STYLE="font: 10pt Times New Roman, Times, Serif"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></TD>
    <TD STYLE="font: 10pt Times New Roman, Times, Serif"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#9679;</FONT></TD>
    <TD STYLE="font: 10pt Times New Roman, Times, Serif; text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">any
    statements regarding compliance with Nasdaq&rsquo;s listing standards and our ability to remain listed on Nasdaq; and</FONT></TD></TR>
  <TR STYLE="font: 10pt Times New Roman, Times, Serif; vertical-align: top">
    <TD STYLE="font: 10pt Times New Roman, Times, Serif"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></TD>
    <TD STYLE="font: 10pt Times New Roman, Times, Serif"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#9679;</FONT></TD>
    <TD STYLE="font: 10pt Times New Roman, Times, Serif; text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">any
    statements regarding future economic conditions or performance and any statement of assumptions underlying any of the foregoing.</FONT></TD></TR>
  </TABLE>
<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify; text-indent: 0.5in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify; text-indent: 0.5in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">In
some cases, you can identify forward-looking statements by terminology such as &ldquo;expect,&rdquo; &ldquo;anticipate,&rdquo; &ldquo;estimate,&rdquo;
&ldquo;continue,&rdquo; &ldquo;plan,&rdquo; &ldquo;believe,&rdquo; &ldquo;could,&rdquo; &ldquo;intend,&rdquo; &ldquo;predict,&rdquo;
&ldquo;project,&rdquo; &ldquo;may,&rdquo; &ldquo;should,&rdquo; &ldquo;will,&rdquo; &ldquo;would&rdquo; and words of similar import regarding
our expectations. Forward-looking statements are only predictions. Actual events or results may differ materially. Although we believe
that our expectations are based on reasonable assumptions within the bounds of our knowledge of our industry, business and operations,
we cannot guarantee that actual results will not differ materially from our expectations. In evaluating such forward-looking statements,
you should specifically consider various factors, including, but not limited to, the inherent uncertainty in the drug development process,
our ability to raise additional capital to fund our planned future operations and continue as a going concern, our ability to obtain
or maintain U.S. Food and Drug Administration and foreign regulatory approvals for our drug candidates, potential impact of the Russian
invasion of Ukraine and the unrest in the Middle East on our business, our ability to enroll patients in our clinical trials, risks relating
to third parties&rsquo; conduct of our clinical trials, risks relating to government, private health insurers and other third-party payers
coverage or reimbursement, risks relating to commercial potential of a drug candidate in development, changes in technologies for the
treatment of cancer, impact of development of competitive drug candidates by others, risks relating to intellectual property, volatility
in the market price of our Common Stock, potential inability to maintain compliance with Nasdaq listing rules and the impact of adverse
capital and credit market conditions. These and other risks and assumptions are outlined under &ldquo;<I>Risk Factors</I>&rdquo; contained
in this prospectus and any related free writing prospectus, and in our most recent Annual Report on Form 10-K, as revised or supplemented
by our subsequent Quarterly Reports on Form 10-Q, incorporated by reference into this prospectus, as well as any amendments thereto reflected
in subsequent filings with the SEC. The discussion of risks and uncertainties set forth in this prospectus or referenced in those filings
is not necessarily a complete or exhaustive list of all risks facing us at any particular point in time. We operate in a highly competitive,
highly regulated and rapidly changing environment, and our business is in a state of evolution. Therefore, it is likely that new risks
will emerge, and the nature and elements of existing risks will change. It is not possible for management to predict all such risk factors
or changes therein or to assess either the impact of all such risk factors on our business or the extent to which any individual risk
factor, combination of factors or new or altered factors may cause results to differ materially from those contained in any forward-looking
statement. Forward-looking statements represent our estimates and assumptions only as of the date such forward-looking statements are
made. You should carefully read this prospectus and any related free writing prospectus, together with the information incorporated herein
or therein by reference as described under the section titled &ldquo;<I>Incorporation of Certain Information by Reference,</I>&rdquo;
and with the understanding that our actual future results may materially differ from what we expect.</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify; text-indent: 0.5in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">Forward-looking
statements speak only as of the date they are made, and we assume no obligation to update any forward-looking statements publicly, or
to update the reasons why actual results could differ materially from those anticipated in any forward-looking statements, even if new
information becomes available, except as required by law.</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify; text-indent: 0.5in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>


<!-- Field: Page; Sequence: 6; Options: NewSection; Value: 1 -->
    <DIV STYLE="margin-top: 0pt; margin-bottom: 6pt; border-bottom: Black 1pt solid"><TABLE CELLPADDING="0" CELLSPACING="0" STYLE="border-collapse: collapse; width: 100%; font-size: 10pt"><TR STYLE="vertical-align: top; text-align: left"><TD STYLE="text-align: center; width: 100%"><!-- Field: Sequence; Type: Arabic; Name: PageNo -->1<!-- Field: /Sequence --></TD></TR></TABLE></DIV>
    <DIV STYLE="break-before: page; margin-top: 6pt; margin-bottom: 0pt"><P STYLE="margin: 0pt">&nbsp;</P></DIV>
    <!-- Field: /Page -->

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: center"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt"><B>&nbsp;</B></FONT></P>

<P STYLE="font: bold 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: center"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt"><A NAME="Aa_002"></A>ABOUT
THIS PROSPECTUS</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; text-align: center"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify; text-indent: 0.5in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">As
used in this prospectus, unless the context otherwise requires or indicates, references to &ldquo;the Company,&rdquo; &ldquo;we,&rdquo;
&ldquo;our,&rdquo; &ldquo;ourselves,&rdquo; and &ldquo;us&rdquo; refer to Imunon, Inc.</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify; text-indent: 0.5in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">You
should rely only on the information contained in this prospectus and any free writing prospectus prepared by us or on our behalf that
we have referred you to. Neither we nor the Placement Agent has authorized anyone to provide you with additional or different
information. If anyone provides you with additional, different, or inconsistent information, you should not rely on it. We and the Placement
Agent take no responsibility for, and can provide no assurance as to, the reliability of any other information that others may
give you. This prospectus is an offer to sell only the securities offered hereby and only under circumstances and in jurisdictions where
it is lawful to do so. We and the Placement Agent are not making an offer of these securities in any state, country, or other
jurisdiction where the offer is not permitted. You should not assume that the information in this prospectus or any free writing prospectus
is accurate as of any date other than the date of the applicable document regardless of its time of delivery or the time of any sales
of our securities. Our business, financial condition, results of operations and cash flows may have changed since the date of the applicable
document.</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify; text-indent: 0.5in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">This
prospectus describes the specific details regarding this offering and the terms and conditions of our securities being offered hereby
and the risks of investing in our securities. For additional information, please see the section entitled &ldquo;<I>Where You Can Find
More Information.</I>&rdquo;</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify; text-indent: 0.5in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">You
should not interpret the contents of this prospectus or any free writing prospectus to be legal, tax, business, or financial advice.
You should consult with your own advisors for that type of advice and consult with them about the legal, tax, business, financial, and
other issues that you should consider before investing in our securities.</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify; text-indent: 0.5in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify; text-indent: 0.5in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">Unless
otherwise indicated, information contained in this prospectus concerning our industry and the markets in which we operate, including
our general expectations and market position, and market opportunity, is based on information from our own management estimates and research,
as well as from industry and general publications and research, surveys and studies conducted by third parties. Management estimates
are derived from publicly available information, our knowledge of our industry and assumptions based on such information and knowledge,
which we believe to be reasonable. Our management estimates have not been verified by any independent source, and we have not independently
verified any third-party information. In addition, assumptions and estimates of our and our industry&rsquo;s future performance are necessarily
subject to a high degree of uncertainty and risk due to a variety of factors, including those described in &ldquo;<I>Risk Factors</I>.&rdquo;
These and other factors could cause our future performance to differ materially from our assumptions and estimates. See &ldquo;<I>Cautionary
Notice Regarding Forward-Looking Statements</I>.&rdquo;</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify; text-indent: 0.5in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify; text-indent: 0.5in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">We
further note that the representations, warranties and covenants made by us in any agreement that is filed as an exhibit to the registration
statement of which this prospectus is a part were made solely for the benefit of the parties to such agreement, including, in some cases,
for the purpose of allocating risk among the parties to such agreements, and should not be deemed to be a representation, warranty or
covenant to you. Moreover, such representations, warranties or covenants were accurate only as of the date when made. Accordingly, such
representations, warranties and covenants should not be relied on as accurately representing the current state of our affairs.</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify; text-indent: 0.5in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">The
Company&rsquo;s brand and product names contained in this prospectus are trademarks, registered trademarks, or service marks of Imunon,
Inc. or its subsidiary in the United States (&ldquo;<U>U.S.</U>&rdquo;) and certain other countries.</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify; text-indent: 0.5in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">All
other trademarks, trade names and service marks appearing in this prospectus or the documents incorporated by reference herein are the
property of their respective owners. Use or display by us of other parties&rsquo; trademarks, trade dress or products is not intended
to and does not imply a relationship with, or endorsements or sponsorship of, us by the trademark or trade dress owner. Solely for convenience,
trademarks, tradenames and service marks referred to in this prospectus appear without the &reg; and &trade; symbols, but those references
are not intended to indicate, in any way, that we will not assert, to the fullest extent under applicable law, our rights or that the
applicable owner will not assert its rights, to these trademarks and trade names.</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>


<!-- Field: Page; Sequence: 7; Value: 1 -->
    <DIV STYLE="margin-top: 0pt; margin-bottom: 6pt; border-bottom: Black 1pt solid"><TABLE CELLPADDING="0" CELLSPACING="0" STYLE="border-collapse: collapse; width: 100%; font-size: 10pt"><TR STYLE="vertical-align: top; text-align: left"><TD STYLE="text-align: center; width: 100%"><!-- Field: Sequence; Type: Arabic; Name: PageNo -->2<!-- Field: /Sequence --></TD></TR></TABLE></DIV>
    <DIV STYLE="break-before: page; margin-top: 6pt; margin-bottom: 0pt"><P STYLE="margin: 0pt">&nbsp;</P></DIV>
    <!-- Field: /Page -->

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: center"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt"><B>&nbsp;</B></FONT></P>

<P STYLE="font: bold 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: center"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt"><A NAME="Aa_003"></A>PROSPECTUS
SUMMARY</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; text-align: center"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify; text-indent: 0.5in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt"><I>This
summary highlights certain information about us, this offering and selected information contained elsewhere in this prospectus. Because
this is only a summary, it does not contain all of the information that may be important to you or that you should consider before investing
in our securities. You should read the entire prospectus carefully, especially the information under &ldquo;Risk Factors&rdquo; set forth
in this prospectus and the information in the documents incorporated by reference into this prospectus. This prospectus contains forward-looking
statements, based on current expectations and related to future events and our future financial performance, that involve risks and uncertainties.
Our actual results may vary materially from those discussed in the forward-looking statements as a result of various factors, including,
without limitation, those set forth under &ldquo;Risk Factors&rdquo; in this prospectus and under similar captions in the documents incorporated
by reference into this prospectus. See &ldquo;Cautionary Notice Regarding Forward-Looking Statements.&rdquo;</I></FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt"><B>Business
Overview</B></FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt"><B>&nbsp;</B></FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify; text-indent: 0.5in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">Imunon
is a clinical-stage biotechnology company focused on advancing a portfolio of innovative treatments that harness the body&rsquo;s natural
mechanisms with the aim to generate safe, effective and durable responses across a broad array of human diseases, constituting a differentiating
approach from conventional therapies. Imunon is developing its non-viral DNA technology across its modalities. The first modality, TheraPlas&reg;,
is developed for the coding of proteins and cytokines in the treatment of solid tumors where an immunological approach is deemed promising.
The second modality, PlaCCine&reg;, is developed for the coding of viral antigens that can elicit a strong immunological response. This
technology may represent a promising platform for the development of vaccines in infectious diseases.</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify; text-indent: 0.5in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">The
Company&rsquo;s lead clinical program, IMNN-001, is a DNA-based immunotherapy for the localized treatment of advanced ovarian cancer
that has completed Phase II clinical development studies. IMNN-001 works by instructing the body to produce safe and durable levels
of powerful cancer-fighting molecules, such as interleukin-12 and interferon gamma, at the tumor site. Additionally, the Company has
entered into a first-in-human study of its COVID-19 booster vaccine (IMNN-101). We will continue to leverage these modalities and to
advance the technological frontier of plasmid DNA to better serve patients with difficult-to-treat conditions.</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify"><B>Recent Developments</B></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify; text-indent: 0.5in">On March 24,
2025, we issued a press release announcing finalization of our Phase 3 study design for IMNN-001, a treatment for women with newly
diagnosed advanced ovarian cancer, and that the U.S. Food and Drug Administration is aligned with the protocol for the Phase 3 pivotal trial, called OVATION 3, of our lead candidate IMNN-001.</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify; text-indent: 0.5in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify; text-indent: 0.5in"> <FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">On
May 12, 2025, the Company entered into an exchange agreement (the &ldquo;<U>Exchange Agreement</U>&rdquo;) with the holders (the &ldquo;Existing
<U>Warrant Holders</U>&rdquo;) of certain warrants of the Company (the &ldquo;<U>Existing Warrants</U>&rdquo;) issued on August 1, 2024,
which are exercisable for an aggregate of 5,000,000 shares of Common Stock. Pursuant to the terms of the Exchange Agreement, the Company
will issue to the Existing Warrant Holders an aggregate of 2,921,000 shares of Common Stock (the &ldquo;<U>Warrant Exchange Shares</U>&rdquo;),
on a one-for-one basis, in exchange for shares issuable under the Existing Warrants (the &ldquo;<U>Warrant Exchange</U>&rdquo;), in reliance
on an exemption from registration provided by Section 3(a)(9) of the Securities Act. The Warrant Exchange is expected to close on May
13, 2025. The number of Warrant Exchange Shares that will be issued pursuant to the Exchange Agreement will represent 19.98% of the shares
of Common Stock outstanding as of the date of the Exchange Agreement.</FONT> </P>
<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify; text-indent: 0.5in"></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt"><B>Corporate
Information</B></FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify; text-indent: 0.5in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">We
were founded in 1982 and are a Delaware corporation. Our principal executive offices are located at 997 Lenox Drive, Suite 100, Lawrenceville,
NJ 08648. Our telephone number is (609) 896-9100. Our website is <I>www.imunon.com</I>. The information contained on or that can be accessed
through our website is not incorporated by reference into this prospectus, and you should not consider information on our website to
be part of this prospectus or in deciding to purchase our Common Stock.</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify; text-indent: 0.5in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">We
are a &ldquo;smaller reporting company,&rdquo; meaning that the market value of our stock held by non-affiliates is less than $700 million
and our annual revenue was less than $100 million during our most recently completed fiscal year. We may continue to be a smaller reporting
company if either (i) the market value of our stock held by non-affiliates is less than $250 million or (ii) our annual revenue was less
than $100 million during the most recently completed fiscal year and the market value of our stock held by non-affiliates is less than
$700 million. For so long as we remain a smaller reporting company, we are permitted and intend to rely on exemptions from certain disclosure
and other requirements that are applicable to other public companies that are not smaller reporting companies.</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify; text-indent: 0.5in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>


<!-- Field: Page; Sequence: 8; Value: 1 -->
    <DIV STYLE="margin-top: 0pt; margin-bottom: 6pt; border-bottom: Black 1pt solid"><TABLE CELLPADDING="0" CELLSPACING="0" STYLE="border-collapse: collapse; width: 100%; font-size: 10pt"><TR STYLE="vertical-align: top; text-align: left"><TD STYLE="text-align: center; width: 100%"><!-- Field: Sequence; Type: Arabic; Name: PageNo -->3<!-- Field: /Sequence --></TD></TR></TABLE></DIV>
    <DIV STYLE="break-before: page; margin-top: 6pt; margin-bottom: 0pt"><P STYLE="margin: 0pt">&nbsp;</P></DIV>
    <!-- Field: /Page -->

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; text-align: center"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>

<P STYLE="font: bold 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: center"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt"><A NAME="Aa_004"></A>THE
OFFERING</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; text-align: center"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>

<TABLE CELLSPACING="0" CELLPADDING="0" STYLE="font: 10pt Times New Roman, Times, Serif; width: 100%; border-collapse: collapse">
  <TR STYLE="font: 10pt Times New Roman, Times, Serif; vertical-align: top">
    <TD STYLE="font: 10pt Times New Roman, Times, Serif; width: 34%"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt"><B>Common
    Stock offered by us in this offering </B></FONT></TD>
    <TD STYLE="font: 10pt Times New Roman, Times, Serif; width: 2%"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></TD>
    <TD STYLE="font: 10pt Times New Roman, Times, Serif; width: 64%; text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">Up
    to 15,000,000 shares of our Common Stock on a &ldquo;best efforts&rdquo; basis based on an assumed public
    offering price of $0.80 per share and accompanying common warrants, which was the closing price of our Common Stock
    as reported on Nasdaq on May 9, 2025.</FONT></TD></TR>
  <TR STYLE="font: 10pt Times New Roman, Times, Serif; vertical-align: top">
    <TD STYLE="font: 10pt Times New Roman, Times, Serif"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></TD>
    <TD STYLE="font: 10pt Times New Roman, Times, Serif"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></TD>
    <TD STYLE="font: 10pt Times New Roman, Times, Serif; text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></TD></TR>
  <TR STYLE="font: 10pt Times New Roman, Times, Serif; vertical-align: top">
    <TD STYLE="font: 10pt Times New Roman, Times, Serif"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt"><B>Pre-funded
    warrants offered by us in this offering</B></FONT></TD>
    <TD STYLE="font: 10pt Times New Roman, Times, Serif"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></TD>
    <TD STYLE="font: 10pt Times New Roman, Times, Serif"><P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">We
are also offering to each purchaser whose purchase of shares in this offering would otherwise result in the purchaser, together with
its affiliates and certain related parties, beneficially owning more than 4.99% (or, at the election of the purchaser, 9.99%) of our
outstanding Common Stock immediately following the consummation of this offering, the opportunity to purchase, if the purchaser so chooses,
pre-funded warrants (each pre-funded warrant to purchase one share of our Common Stock) in lieu of shares that would otherwise result
in the purchaser&rsquo;s beneficial ownership exceeding 4.99% of our outstanding Common Stock (or, at the election of the purchaser,
9.99%). The purchase price of each pre-funded warrant and accompanying common warrant will equal the price at which one share of Common
Stock and accompanying warrant are being sold to the public in this offering, minus $0.0001, and the exercise price of each pre-funded
warrant will be $0.0001 per share. The pre-funded warrants will be exercisable immediately and may be exercised at any time until all
of the pre-funded warrants are exercised in full. For each pre-funded warrant we sell, the number of shares of Common Stock we are offering
will be decreased on a one-for-one basis. This prospectus also relates to the offering of the shares of Common Stock issuable upon
exercise of the pre-funded warrants. For more information regarding the pre-funded warrants, you should carefully read the section titled
&ldquo;<I>Description of Securities We Are Offering</I>&rdquo; in this prospectus. </FONT></P></TD></TR>
<TR STYLE="font: 10pt Times New Roman, Times, Serif; vertical-align: top">
    <TD STYLE="font: 10pt Times New Roman, Times, Serif">&nbsp;</TD>
    <TD STYLE="font: 10pt Times New Roman, Times, Serif">&nbsp;</TD>
    <TD STYLE="font: 10pt Times New Roman, Times, Serif">&nbsp;</TD></TR>

<TR STYLE="vertical-align: top">
    <TD STYLE="font: 10pt Times New Roman, Times, Serif; text-align: justify; width: 34%"> <FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt"><B>Common
    warrants offered by us in this offering</B></FONT> </TD>
    <TD STYLE="font: 10pt Times New Roman, Times, Serif; width: 2%"> <FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT> </TD>
    <TD STYLE="font: 10pt Times New Roman, Times, Serif; text-align: justify; width: 64%"> <FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">We
    are issuing to purchasers of shares of our Common Stock and/or pre-funded warrants in this offering a common warrant to purchase
    one share of our Common Stock for each share and/or pre-funded warrant purchased in this offering. The shares of Common Stock or
    pre-funded warrants, respectively, and common warrants are immediately separable and will be issued separately in this offering,
    but must initially be purchased together in this offering. The common warrants are exercisable <FONT STYLE="background-color: white">beginning
    on the Initial Exercise Date</FONT>, have an assumed exercise price equal to $1.60, (equal to 200% of the assumed combined public
    offering price per share of Common Stock and accompanying common warrant), and will expire two and one-half (2.5) years after the
    Initial Exercise Date. Holders of the common warrants may effect an &ldquo;alternative cashless exercise&rdquo; at any time while
    the common warrants are outstanding following the Initial Exercise Date. Under the alternative cashless exercise option, a holder
    of a common warrant has the right to receive an aggregate number of shares of Common Stock equal to the product of (i) the aggregate
    number of shares of Common Stock that would be issuable upon a cash rather than a cashless exercise of the common warrant and (ii)
    3.0. Accordingly, it is highly unlikely that a holder of the common warrants would wish to pay an exercise price in cash to receive
    one share of Common Stock when they could instead choose the alternative cashless exercise option and pay no cash to receive three
    shares of Common Stock. As a result, we will likely not receive any additional funds and do not expect to receive any additional
    funds upon the exercise of the common warrants. In addition, on the Adjustment Date, the exercise price of the common warrants will
    be reduced to the greater of the Floor Price and the lowest daily dollar volume-weighted average price during the period beginning
    two full trading days prior to the Adjustment Date and ending on the 10th trading day after the Adjustment Date. Upon any such resulting
    adjustment of the exercise price of the common warrants, the number of shares of Common Stock issuable under the common warrants
    will be increased such that the aggregate exercise price of a common warrant (adjusted for any exercises by a holder prior to this
    adjustment) will remain unchanged following such adjustment. As a result, the aggregate number of shares of Common Stock underlying
    all of the common warrants may increase from 15,000,000 up to 150,000,000 (in each case, based on an assumed public offering price
    of $0.80 per share), assuming full adjustment of the exercise price to the Floor Price and before giving effect to the &ldquo;alternative
    cashless exercise&rdquo; provision. Assuming full adjustment of the exercise price to the Floor Price, the aggregate number of shares
    of Common Stock issuable upon the exercise of all of the common warrants pursuant to the &ldquo;alternative cashless exercise&rdquo;
    provisions therein would be 450,000,000 (based on an assumed public offering price of $0.80 per share). This prospectus also relates
    to the offering of the shares of Common Stock issuable upon exercise of the common warrants. For more information regarding the common
    warrants, you should carefully read the section titled &ldquo;<I>Description of Securities We Are Offering</I>&rdquo; in this prospectus.</FONT> </TD></TR>

<TR STYLE="font: 10pt Times New Roman, Times, Serif; vertical-align: top">
    <TD STYLE="font: 10pt Times New Roman, Times, Serif; width: 34%">&nbsp;</TD>
    <TD STYLE="font: 10pt Times New Roman, Times, Serif; width: 2%">&nbsp;</TD>
    <TD STYLE="font: 10pt Times New Roman, Times, Serif; width: 64%">&nbsp;</TD></TR>
  <TR STYLE="font: 10pt Times New Roman, Times, Serif; vertical-align: top">
    <TD STYLE="font: 10pt Times New Roman, Times, Serif"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt"><B>Reasonable
    best-efforts offering</B></FONT></TD>
    <TD STYLE="font: 10pt Times New Roman, Times, Serif"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></TD>
    <TD STYLE="font: 10pt Times New Roman, Times, Serif; text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">We
    have agreed to issue and sell the securities offered hereby to the purchasers through the Placement Agent. The Placement Agent
    is not required to buy or sell any specific number or dollar amount of the securities offered hereby, but will use its
    reasonable best efforts to solicit offers to purchase the securities offered by this prospectus. See &ldquo;<I>Plan of Distribution</I>&rdquo;
    beginning on page 21 of this prospectus.</FONT></TD></TR>
  <TR STYLE="font: 10pt Times New Roman, Times, Serif; vertical-align: top">
    <TD STYLE="font: 10pt Times New Roman, Times, Serif"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></TD>
    <TD STYLE="font: 10pt Times New Roman, Times, Serif"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></TD>
    <TD STYLE="font: 10pt Times New Roman, Times, Serif; text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></TD></TR>
  <TR STYLE="font: 10pt Times New Roman, Times, Serif; vertical-align: top">
    <TD STYLE="font: 10pt Times New Roman, Times, Serif"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt"><B>Common
    Stock to be outstanding after the offering</B></FONT></TD>
    <TD STYLE="font: 10pt Times New Roman, Times, Serif"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></TD>
    <TD STYLE="font: 10pt Times New Roman, Times, Serif; text-align: justify"> <FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">32,541,732
    </FONT> <FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">shares (assuming all of the securities we are
    offering under this prospectus are sold, and assuming no sale of pre-funded warrants, which, if sold, would reduce the number of
    shares of Common Stock that we are offering on a one-for-one basis, and no exercise of the common warrants issued in this offering).</FONT></TD></TR>
  <TR STYLE="font: 10pt Times New Roman, Times, Serif; vertical-align: top">
    <TD STYLE="font: 10pt Times New Roman, Times, Serif"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></TD>
    <TD STYLE="font: 10pt Times New Roman, Times, Serif"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></TD>
    <TD STYLE="font: 10pt Times New Roman, Times, Serif; text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></TD></TR>
  <TR STYLE="font: 10pt Times New Roman, Times, Serif">
    <TD STYLE="font: 10pt Times New Roman, Times, Serif; vertical-align: top"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt"><B>Use
of proceeds</B></FONT></TD>
    <TD STYLE="font: 10pt Times New Roman, Times, Serif"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></TD>
    <TD STYLE="font: 10pt Times New Roman, Times, Serif; vertical-align: bottom; text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">We
    expect to use the net proceeds from this offering for general corporate purposes, including the clinical development of our lead
    product candidate (IMNN-001), capital expenditures and working capital. See &ldquo;<I>Use of Proceeds</I>.&rdquo;</FONT></TD></TR>
</TABLE>

<P STYLE="margin: 0">&nbsp;</P>

<P STYLE="margin: 0"></P>

<!-- Field: Page; Sequence: 9; Value: 1 -->
    <DIV STYLE="margin-top: 0pt; margin-bottom: 6pt; border-bottom: Black 1pt solid"><TABLE CELLPADDING="0" CELLSPACING="0" STYLE="border-collapse: collapse; width: 100%; font-size: 10pt"><TR STYLE="vertical-align: top; text-align: left"><TD STYLE="text-align: center; width: 100%"><!-- Field: Sequence; Type: Arabic; Name: PageNo -->4<!-- Field: /Sequence --></TD></TR></TABLE></DIV>
    <DIV STYLE="break-before: page; margin-top: 6pt; margin-bottom: 0pt"><P STYLE="margin: 0pt">&nbsp;</P></DIV>
    <!-- Field: /Page -->

<P STYLE="margin: 0">&nbsp;</P>

<TABLE CELLSPACING="0" CELLPADDING="0" STYLE="font: 10pt Times New Roman, Times, Serif; width: 100%; border-collapse: collapse">
  <TR STYLE="font: 10pt Times New Roman, Times, Serif">
    <TD STYLE="font: 10pt Times New Roman, Times, Serif; vertical-align: top; width: 34%"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt"><B>Lock-Up
    Agreements </B></FONT></TD>
    <TD STYLE="font: 10pt Times New Roman, Times, Serif; width: 2%"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></TD>
    <TD STYLE="font: 10pt Times New Roman, Times, Serif; vertical-align: bottom; text-align: justify; width: 64%"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">Our
    directors and officers have agreed with the Placement Agent, subject to certain exceptions, not to sell, transfer or dispose
    of, directly or indirectly, any of our Common Stock or securities convertible into or exercisable or exchangeable for our Common
    Stock for a period of 45 days after the completion of this offering. See &ldquo;<I>Plan of Distribution</I>&rdquo; for more information.</FONT></TD></TR>
  <TR STYLE="font: 10pt Times New Roman, Times, Serif">
    <TD STYLE="font: 10pt Times New Roman, Times, Serif; vertical-align: top"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></TD>
    <TD STYLE="font: 10pt Times New Roman, Times, Serif"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></TD>
    <TD STYLE="font: 10pt Times New Roman, Times, Serif; vertical-align: bottom"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></TD></TR>
  <TR STYLE="font: 10pt Times New Roman, Times, Serif">
    <TD STYLE="font: 10pt Times New Roman, Times, Serif; vertical-align: top"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt"><B>Nasdaq
    Symbol</B></FONT></TD>
    <TD STYLE="font: 10pt Times New Roman, Times, Serif"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></TD>
    <TD STYLE="font: 10pt Times New Roman, Times, Serif; vertical-align: bottom; text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">Our
    Common Stock is listed on Nasdaq under the symbol &ldquo;IMNN.&rdquo;</FONT></TD></TR>
  <TR STYLE="font: 10pt Times New Roman, Times, Serif">
    <TD STYLE="font: 10pt Times New Roman, Times, Serif; vertical-align: top"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></TD>
    <TD STYLE="font: 10pt Times New Roman, Times, Serif"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></TD>
    <TD STYLE="font: 10pt Times New Roman, Times, Serif; vertical-align: bottom"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></TD></TR>
  <TR STYLE="font: 10pt Times New Roman, Times, Serif">
    <TD STYLE="font: 10pt Times New Roman, Times, Serif; vertical-align: top"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt"><B>Risk
    Factors</B></FONT></TD>
    <TD STYLE="font: 10pt Times New Roman, Times, Serif"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></TD>
    <TD STYLE="font: 10pt Times New Roman, Times, Serif; vertical-align: bottom; text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">Investing
    in our securities involves a high degree of risk. You should carefully review and consider the &ldquo;<I>Risk Factors</I>&rdquo;
    section of this prospectus and in the documents incorporated by reference in this prospectus for a discussion of factors to consider
    before deciding to invest in our securities.</FONT></TD></TR>
  </TABLE>
<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify; text-indent: 0.5in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">The
number of shares of our Common Stock outstanding is based on an aggregate of <FONT STYLE="background-color: white">17,541,732</FONT>
shares of our Common Stock outstanding as of May 9, 2025 (after giving effect to the Warrant Exchange), and excludes:</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify; text-indent: 0.5in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>

<TABLE CELLSPACING="0" CELLPADDING="0" STYLE="font: 10pt Times New Roman, Times, Serif; width: 100%">
  <TR STYLE="font: 10pt Times New Roman, Times, Serif; vertical-align: top">
    <TD STYLE="width: 0.5in"><FONT STYLE="font-family: Times New Roman, Times, Serif">&nbsp;</FONT></TD>
    <TD STYLE="font: 10pt Times New Roman, Times, Serif; width: 0.25in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#9679;</FONT></TD>
    <TD STYLE="font: 10pt Times New Roman, Times, Serif; text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">1,942,351
    shares of Common Stock issuable upon the exercise of outstanding stock options as of May 9, </FONT> <FONT STYLE="font-family: Times New Roman, Times, Serif">2025,
    having a weighted average exercise price of $1.79 per share;</FONT></TD></TR>
  <TR STYLE="font: 10pt Times New Roman, Times, Serif; vertical-align: top">
    <TD>&nbsp;</TD>
    <TD STYLE="font: 10pt Times New Roman, Times, Serif"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#9679;</FONT></TD>
    <TD STYLE="font: 10pt Times New Roman, Times, Serif; text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">39,700
    shares of Common Stock issuable upon the vesting of Common Stock awards as of May 9, 2025, having a weighted average grant
    date fair value of $0.99 per share;</FONT></TD></TR>
  <TR STYLE="font: 10pt Times New Roman, Times, Serif; vertical-align: top">
    <TD>&nbsp;</TD>
    <TD STYLE="font: 10pt Times New Roman, Times, Serif"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#9679;</FONT></TD>
    <TD STYLE="font: 10pt Times New Roman, Times, Serif; text-align: justify"> <FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">2,234,060</FONT> <FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">
    shares of Common Stock issuable upon the exercise of outstanding warrants as of May 9, 2025, having a weighted average exercise
    price of $3.19 per share (after giving effect to the Warrant Exchange); and</FONT></TD></TR>
  <TR STYLE="font: 10pt Times New Roman, Times, Serif; vertical-align: top">
    <TD>&nbsp;</TD>
    <TD STYLE="font: 10pt Times New Roman, Times, Serif"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#9679;</FONT></TD>
    <TD STYLE="font: 10pt Times New Roman, Times, Serif; text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">223,522</FONT><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">
    shares of Common Stock reserved for future issuance pursuant to our existing stock incentive plan.</FONT></TD></TR>
  </TABLE>
<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify; text-indent: 0.5in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">Except
as otherwise noted, the above information reflects and assumes no sale of pre-funded warrants in this offering, which, if sold, would
reduce the number of shares of Common Stock that we are offering on a one-for-one basis, no exercise of any common warrants issued in
this offering, and no exercise of outstanding stock options or warrants after May 9, 2025.</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify; text-indent: 0.5in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>


<!-- Field: Page; Sequence: 10; Value: 1 -->
    <DIV STYLE="margin-top: 0pt; margin-bottom: 6pt; border-bottom: Black 1pt solid"><TABLE CELLPADDING="0" CELLSPACING="0" STYLE="border-collapse: collapse; width: 100%; font-size: 10pt"><TR STYLE="vertical-align: top; text-align: left"><TD STYLE="text-align: center; width: 100%"><!-- Field: Sequence; Type: Arabic; Name: PageNo -->5<!-- Field: /Sequence --></TD></TR></TABLE></DIV>
    <DIV STYLE="break-before: page; margin-top: 6pt; margin-bottom: 0pt"><P STYLE="margin: 0pt">&nbsp;</P></DIV>
    <!-- Field: /Page -->

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: center"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt; text-transform: uppercase"><B>&nbsp;</B></FONT></P>

<P STYLE="font: bold 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: center"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt"><A NAME="Aa_005"></A>RISK
FACTORS</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: center"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt; text-transform: uppercase"><B>&nbsp;</B></FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify; text-indent: 0.5in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt"><I>In
evaluating the Company, its business and any investment in the Company, you should carefully consider the following information about
risks, together with the other information described in or incorporated by reference in this prospectus, before making an investment
in our securities, including the additional risk factors incorporated by reference from Item 1A of the Company&rsquo;s Annual Report
on Form 10-K for the fiscal year ended December 31, 2024, as filed with the SEC on February 27, 2025, any subsequent Quarterly Reports
on Form 10-Q or Current Reports on Form 8-K, and all other documents incorporated by reference into this prospectus (see &ldquo;Incorporation
of Certain Information by Reference&rdquo;). If any of the circumstances or events described below actually arises or occurs, our business,
results of operations, cash flows and financial condition could be harmed. In any such case, the market price of our Common Stock could
decline, and you may lose all or part of your investment.</I></FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt"><B>Risks
Related to this Offering and Our Securities</B></FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt"><B><I>Future
sales and issuances of our Common Stock or other securities might result in significant dilution and could cause the price of our Common
Stock to decline.</I></B></FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify; text-indent: 0.5in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">To
raise capital, we may sell Common Stock, convertible securities or other equity securities in one or more transactions, at prices and
in a manner we determine from time to time. The price per share at which we sell additional shares of our Common Stock, or securities
convertible or exchangeable into Common Stock, in future transactions may be higher or lower than the price per share paid by investors
in this offering, and investors purchasing shares or other securities in the future could have rights superior to existing stockholders.</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify; text-indent: 0.25in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify; text-indent: 0.5in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">We
cannot predict what effect, if any, sales of shares of our Common Stock in the public market or the availability of shares for sale will
have on the market price of our Common Stock. However, future sales of substantial amounts of our Common Stock in the public market,
including shares issued upon exercise of outstanding options or warrants, or the perception that such sales may occur, could adversely
affect the market price of our Common Stock.</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify; text-indent: 0.25in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt"><B><I>If
you purchase shares of our Common Stock in this offering, you will incur immediate and substantial dilution in the book value of your
shares.</I></B></FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify; text-indent: 0.5in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">Investors
purchasing our securities in this offering will pay a price per share that substantially exceeds the net tangible book value per share.
As a result, investors purchasing shares of our Common Stock in this offering will incur immediate dilution of $0.45 per share,
representing the difference between the assumed public offering price per share of Common Stock and accompanying common warrant and our
pro forma net tangible book value per share as of March 31, 2025. To the extent outstanding options or warrants
to purchase our Common Stock are exercised, new investors may incur further dilution. For more information on the dilution you may experience
as a result of investing in this offering, see the section of this prospectus entitled &ldquo;<I>Dilution</I>.&rdquo;</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify"> <FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt"><B><I>&nbsp;</I></B></FONT> </P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt; text-align: justify; background-color: white"> <FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt"><B><I>Stockholders
will likely suffer substantial dilution when certain provisions in the common warrants are utilized.</I></B></FONT> </P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt; text-align: justify; background-color: white"> <FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT> </P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt; text-align: justify; text-indent: 0.5in; background-color: white"> <FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">If
the common warrants are exercised by way of an alternative cashless exercise, assuming receipt of Stockholder Approval, such exercising
holder will receive an aggregate number of shares equal to the product of (i) the aggregate number of shares of Common Stock that would
be issuable upon a cash rather than a cashless exercise of the common warrant and (ii) 3.0. Accordingly, it is highly unlikely that a
holder of the common warrants would wish to pay an exercise price in cash to receive one share of Common Stock when they could instead
choose the alternative cashless exercise option and pay no cash to receive three shares of Common Stock. As a result, we will likely
not receive, and do not expect to receive, any additional funds upon the exercise of the common warrants. If the alternative cashless
exercise provision is utilized, our stockholders may suffer substantial dilution.</FONT> </P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt; text-align: justify; text-indent: 0.5in; background-color: white"> <FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT> </P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt; text-align: justify; text-indent: 0.5in; background-color: white"> <FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">On
the Adjustment Date, the exercise price of the common warrants will be reduced to the greater of the Floor Price and the lowest daily
dollar volume-weighted average price during the period beginning two full trading days prior to the Adjustment Date and ending on the
10th trading day after the Adjustment Date. Upon any such resulting adjustment of the exercise price of the common warrants, the number
of shares of Common Stock issuable under the common warrants will be increased such that the aggregate exercise price of a common warrant
(adjusted for any exercises by a holder prior to this adjustment) will remain unchanged following such adjustment. As a result, the aggregate
number of shares of Common Stock underlying all of the common warrants may increase from 15,000,000 up to 150,000,000 (in each case, based
on an assumed public offering price of $0.80 per share), assuming full adjustment of the exercise price to the Floor Price and before
giving effect to the &ldquo;alternative cashless exercise&rdquo; provision. Assuming full adjustment of the exercise price to the Floor
Price, the aggregate number of shares of Common Stock issuable upon the exercise of all of the common warrants pursuant to the &ldquo;alternative
cashless exercise&rdquo; provisions therein would be 450,000,000 (based on an assumed public offering price of $0.80 per share).</FONT> </P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt; text-align: justify; text-indent: 0.5in; background-color: white"> <FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT> </P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt; text-align: justify; text-indent: 0.5in; background-color: white"> <FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">When
the above provisions in the common warrants are utilized, our stockholders will most likely suffer substantial dilution.</FONT> </P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt; text-align: justify; text-indent: 0.5in; background-color: white"> <FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT> </P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt; background-color: white"> <FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt"><B><I>We
will likely not receive any additional funds upon the exercise of the common warrants.</I></B></FONT> </P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt; text-align: justify; background-color: white"> <FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT> </P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt; text-align: justify; text-indent: 0.5in; background-color: white"> <FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">The
common warrants may be exercised by way of an alternative cashless exercise, in which case the holder would not pay a cash purchase price
upon exercise, but instead would receive upon such exercise the number of shares of Common Stock equal to the product of (i) the aggregate
number of shares of Common Stock that would be issuable upon a cash exercise rather than a cashless exercise of the common warrant multiplied
by (ii) 3.0. Accordingly, it is highly unlikely that a holder of the common warrants would wish to pay an exercise price in cash to receive
one share of Common Stock when they could instead choose the alternative cashless exercise option and pay no cash to receive three shares
of Common Stock. As a result, we will likely not receive, and do not expect to receive, any additional funds upon the exercise of the
common warrants.</FONT> </P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt; text-align: justify; background-color: white"> <FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt"><B><I>&nbsp;</I></B></FONT> </P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt; text-align: justify; background-color: white"> <FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt"><B><I>The
exercisability of the common warrants is contingent upon us obtaining Stockholder Approval. If we do not obtain such Stockholder Approval,
the common warrants may never become exercisable.</I></B></FONT> </P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt; text-align: justify; background-color: white"> <FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT> </P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt; text-align: justify; text-indent: 0.5in; background-color: white"> <FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">The
common warrants are not immediately exercisable, as their exercisability is contingent upon us obtaining Stockholder Approval. The common
warrants will become exercisable on Initial Exercise Date (i.e., the date on which Stockholder Approval is received) and will expire
two and one-half (2.5) years after the Initial Exercise Date. We have agreed to hold a meeting to obtain Stockholder Approval as soon
as practicable following the closing of this offering, but no later than sixty (60) days following the closing of this offering, and
further agreed to cause an additional stockholder meeting to be held every ninety (90) days thereafter until such Stockholder Approval
is obtained. We cannot assure you that we will be able to obtain requisite Stockholder Approval. In the event that we cannot obtain Stockholder
Approval, the common warrants may never become exercisable. If we are unable to obtain Stockholder Approval, the common warrants will
have no value.</FONT> </P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-right: 0pt; margin-bottom: 0pt; text-align: left; background-color: white"> <FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT> </P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt"><B><I>Management
will have broad discretion as to the use of the proceeds from the offering and uses may not improve our financial condition or market
value.</I></B></FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify; text-indent: 0.5in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">Because
we have not designated the amount of net proceeds from the offering to be used for any particular purpose, our management will have broad
discretion as to the application of such net proceeds and could use them for purposes other than those contemplated hereby. Our management
may use the net proceeds for corporate purposes that may not improve our financial condition or market value.</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify; text-indent: 0.5in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt"><B><I>There
is no public market for the common warrants or pre-funded warrants being offered in this offering.</I></B></FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt"><B><I>&nbsp;</I></B></FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify; text-indent: 0.5in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">There
is no established public trading market for the common warrants or pre-funded warrants being offered in this offering, and we do not
expect a market to develop. In addition, we do not intend to apply to list the common warrants or pre-funded warrants on any securities
exchange or nationally recognized trading system, including Nasdaq. Without an active market, the liquidity of the common warrants and
pre-funded warrants will be limited.</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify; text-indent: 0.5in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify; text-indent: 0.5in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt"></FONT></P>

<!-- Field: Page; Sequence: 11; Value: 1 -->
    <DIV STYLE="margin-top: 0pt; margin-bottom: 6pt; border-bottom: Black 1pt solid"><TABLE CELLPADDING="0" CELLSPACING="0" STYLE="border-collapse: collapse; width: 100%; font-size: 10pt"><TR STYLE="vertical-align: top; text-align: left"><TD STYLE="text-align: center; width: 100%"><!-- Field: Sequence; Type: Arabic; Name: PageNo -->6<!-- Field: /Sequence --></TD></TR></TABLE></DIV>
    <DIV STYLE="break-before: page; margin-top: 6pt; margin-bottom: 0pt"><P STYLE="margin: 0pt">&nbsp;</P></DIV>
    <!-- Field: /Page -->

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify; text-indent: 0.5in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt"><B><I>Holders
of common warrants or pre-funded warrants purchased in this offering will have no rights as Common Stockholders until such holders exercise
their warrants or pre-funded warrants and acquire our Common Stock.</I></B></FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify; text-indent: 0.5in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify; text-indent: 0.5in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">Until
holders of common warrants or pre-funded warrants acquire shares of our Common Stock upon exercise thereof, holders of such warrants
will have no rights with respect to the shares of our Common Stock underlying such warrants. Upon exercise of the common warrants or
pre-funded warrants, the holders will be entitled to exercise the rights of a Common Stockholder only as to matters for which the record
date occurs after the exercise date.</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify; text-indent: 0.5in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; text-align: justify; margin: 0"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt"><B><I>The
common warrants and pre-funded warrants are speculative in nature, and the common warrants may not have any value. </I></B></FONT></P>
<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify; text-indent: 0.5in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify; text-indent: 0.5in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">The
common warrants and pre-funded warrants offered hereby do not confer any rights of Common Stock ownership on their holders, such as voting
rights, but rather merely represent the right to acquire shares of our Common Stock at a fixed price. Each common warrant offered
hereby will become exercisable beginning on the Initial Exercise Date at an assumed exercise price per share of $1.60,
equal to 200% of the assumed combined public offering price per share of Common Stock and accompanying common warrant (the
closing price of our Common Stock on Nasdaq on May 9, 2025), and will expire two and one-half (2.5) years after
the Initial Exercise Date. In the event that we are unable to obtain Stockholder Approval, the common warrants will not
be exercisable and therefore will have no value. There is no established public trading market for common warrants and pre-funded
warrants being offered in this offering, and we do not expect a market to develop. In addition, we do not intend to apply to list the
common warrants or pre-funded warrants on any securities exchange or nationally recognized trading system, including Nasdaq. Without
an active market, the liquidity of the common warrants and pre-funded warrants will be limited.</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt"><B><I>&nbsp;</I></B></FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt"><B><I>This
is a reasonable best-efforts offering, with no minimum amount of securities required to be sold, and we may sell fewer than all of the
securities offered hereby.</I></B></FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify; text-indent: 0.5in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">The
Placement Agent has agreed to use its reasonable best efforts to solicit offers to purchase the securities in this offering.
The Placement Agent has no obligation to buy any of the securities from us or to arrange for the purchase or sale of any specific
number or dollar amount of the securities. There is no required minimum number of securities that must be sold as a condition to completion
of this offering, and there can be no assurance that the offering contemplated hereby will ultimately be consummated. Even if we sell
securities offered hereby, because there is no minimum offering amount required as a condition to closing of this offering, the actual
offering amount is not presently determinable and may be substantially less than the maximum amount set forth on the cover page of this
prospectus. We may sell fewer than all of the securities offered hereby, which may significantly reduce the amount of proceeds received
by us. Thus, we may not raise the amount of capital we believe is required for our operations in the short-term and may need to raise
additional funds, which may not be available or available on terms acceptable to us.</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt"></FONT></P>

<!-- Field: Page; Sequence: 12; Value: 1 -->
    <DIV STYLE="margin-top: 0pt; margin-bottom: 6pt; border-bottom: Black 1pt solid"><TABLE CELLPADDING="0" CELLSPACING="0" STYLE="border-collapse: collapse; width: 100%; font-size: 10pt"><TR STYLE="vertical-align: top; text-align: left"><TD STYLE="text-align: center; width: 100%"><!-- Field: Sequence; Type: Arabic; Name: PageNo -->7<!-- Field: /Sequence --></TD></TR></TABLE></DIV>
    <DIV STYLE="break-before: page; margin-top: 6pt; margin-bottom: 0pt"><P STYLE="margin: 0pt">&nbsp;</P></DIV>
    <!-- Field: /Page -->

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt"><B><I>Because
there is no minimum required for the offering to close, investors in this offering will not receive a refund in the event that we do
not sell an amount of securities sufficient to pursue the business goals outlined in this prospectus.</I></B></FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify; text-indent: 0.5in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">We
have not specified a minimum offering amount nor have or will we establish an escrow account in connection with this offering. Because
there is no escrow account and no minimum offering amount, investors could be in a position where they have invested in our Company,
but we are unable to fulfill our objectives due to a lack of interest in this offering. Further, because there is no escrow account in
operation and no minimum investment amount, any proceeds from the sale of securities offered by us will be available for our immediate
use, despite uncertainty about whether we would be able to use such funds to effectively implement our business plan. Investor funds
will not be returned under any circumstances whether during or after the offering.</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify; text-indent: 0.5in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt"><B><I>This
offering may cause the trading price of our Common Stock to decrease.</I></B></FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify; text-indent: 0.5in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">The
price per share, together with the number of shares of Common Stock we issue if this offering is completed, may result in an immediate
decrease in the market price of our Common Stock. This decrease may continue after the completion of this offering.</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt"><B><I>Our
Common Stock may be delisted from Nasdaq if we fail to comply with continued listing standards.</I></B></FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify; text-indent: 0.5in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify; text-indent: 0.5in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">Our
Common Stock is currently traded on Nasdaq under the symbol &ldquo;IMNN.&rdquo; If we fail to comply with Nasdaq&rsquo;s continued listing
standards, we may be delisted and our Common Stock will trade, if at all, only on the over-the-counter market, such as the OTC Bulletin
Board or OTCQX market, and then only if one or more registered broker-dealer market makers comply with quotation requirements. In addition,
delisting of our Common Stock could depress our stock price, substantially limit liquidity of our Common Stock and materially adversely
affect our ability to raise capital on terms acceptable to us, or at all. Further, delisting of our Common Stock would likely result
in our Common Stock becoming a &ldquo;penny stock&rdquo; under the Exchange Act.</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify; text-indent: 0.5in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify; text-indent: 0.5in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">On
November 26, 2024, we received a notice from Nasdaq staff (the &ldquo;Staff&rdquo;) notifying us that, based upon the closing bid price
of our Common Stock, for the 30 consecutive business days prior to the notice, we no longer met the requirement to maintain a minimum
closing bid price of $1.00 per share, as set forth in Nasdaq Listing Rule 5550(a)(2). In accordance with Nasdaq Listing Rule 5810(c)(3)(A),
we were granted 180 calendar days, or until May 27, 2025, to regain compliance with the minimum bid price rule. To regain compliance,
the closing bid price of our Common Stock must be $1.00 per share or more for a minimum of 10 consecutive business days at any time before
May 27, 2025. If we do not regain compliance with Rule 5550(a)(2) by May 27, 2025, we may be eligible for an additional 180 calendar
day compliance period. To qualify, we will be required to meet the continued listing requirement for market value of publicly held shares
and all other Nasdaq initial listing standards, except the bid price requirement, and would need to provide written notice to Nasdaq
of our intention to cure the deficiency during the second compliance period. If it appears to the Staff that we will not be able to cure
the deficiency, or if we are otherwise not eligible, Nasdaq would notify us that our securities will be subject to delisting. In the
event of such notification, we may appeal the Staff&rsquo;s determination to delist our securities, but there can be no assurance the
Staff would grant our request for continued listing. </FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify; text-indent: 0.5in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify; text-indent: 0.5in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">If
our Common Stock were to be delisted by Nasdaq, it may be eligible for quotation on an over-the-counter quotation system or on the pink
sheets. Upon any such delisting, our Common Stock would become subject to the regulations of the SEC relating to the market for penny
stocks. A penny stock is any equity security not traded on a national securities exchange that has a market price of less than $5.00
per share. The regulations applicable to penny stocks may severely affect the market liquidity for our Common Stock and could limit the
ability of stockholders to sell securities in the secondary market. In such a case, an investor may find it more difficult to dispose
of or obtain accurate quotations as to the market value of our Common Stock, and there can be no assurance that our Common Stock will
be eligible for trading or quotation on any alternative exchanges or markets.</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify; text-indent: 0.5in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify; text-indent: 0.5in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt"></FONT></P>

<!-- Field: Page; Sequence: 13; Value: 1 -->
    <DIV STYLE="margin-top: 0pt; margin-bottom: 6pt; border-bottom: Black 1pt solid"><TABLE CELLPADDING="0" CELLSPACING="0" STYLE="border-collapse: collapse; width: 100%; font-size: 10pt"><TR STYLE="vertical-align: top; text-align: left"><TD STYLE="text-align: center; width: 100%"><!-- Field: Sequence; Type: Arabic; Name: PageNo -->8<!-- Field: /Sequence --></TD></TR></TABLE></DIV>
    <DIV STYLE="break-before: page; margin-top: 6pt; margin-bottom: 0pt"><P STYLE="margin: 0pt">&nbsp;</P></DIV>
    <!-- Field: /Page -->

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify; text-indent: 0.5in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify; text-indent: 0.5in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">Delisting
from Nasdaq could adversely affect our ability to raise additional financing through public or private sales of equity securities, would
significantly affect the ability of investors to trade our securities and would negatively affect the value and liquidity of our Common
Stock. Delisting could also have other negative results, including the potential loss of confidence by employees, the loss of institutional
investor interest and fewer business development opportunities.</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt"><B><I>&nbsp;</I></B></FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify; background-color: white"> <B><I>Nasdaq may delist
our Common Stock for public interest concerns.</I></B> </P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify; background-color: white"> &nbsp; </P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify; text-indent: 0.5in; background-color: white"> Because
of the highly dilutive nature of this offering and the high risk of our Common Stock falling back into noncompliance with the continuing
listing standards of Nasdaq, Nasdaq may delist our Common Stock for public interest concerns, even if we are able to regain compliance
for continued listing on Nasdaq under the minimum closing bid price requirement, as described in the risk factor above. We are aware
of public disclosures made by other Nasdaq-listed companies disclosing that such companies received notification letters from Nasdaq
indicating that Nasdaq determined to delist such companies as a result of public interest concerns arising from the issuance of warrants
with similar terms to, and similar potential dilutive impact as, the common warrants in this offering. </P>
<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify"> <FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt"><B><I>&nbsp;</I></B></FONT> </P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt"><B><I>We
will need to raise additional capital to fund our planned future operations, and we may be unable to secure such capital without significant
dilutive financing transactions, or at all. If we are not able to raise additional capital, we may not be able to complete the
development, testing and commercialization of our drug candidates and will not be able to continue as a going concern.</I></B></FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify; text-indent: 0.5in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify; text-indent: 0.5in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">We
have not generated significant revenue and have incurred significant net losses in each year since our inception. For the quarter
ended March 31, 2025 and the year ended December 31, 2024, we incurred a net loss of $4.1 million and $18.6 million, respectively,
and used $2.8 million and $18.9 million, respectively, to fund operations. As of March 31, 2025, we have incurred approximately $411
million of cumulative net losses. As of March 31, 2025 and December 31, 2024, we had cash and cash equivalents of $2.9
million and $5.9 million, respectively. </FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify; text-indent: 0.5in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify; text-indent: 0.5in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">We
have substantial future capital requirements, including to continue our research and development activities and advance our drug
candidates through various development stages, including the Phase 3 registrational trial of IMNN-001 in advanced ovarian cancer. We
are unable to estimate the duration and completion costs of our research and development projects or when, if ever, and to what extent
we will receive cash inflows from the commercialization and sale of a product. Our inability to complete any of our research and development
activities, preclinical studies or clinical trials in a timely manner or our failure to enter into collaborative agreements when appropriate
could significantly increase our capital requirements and could adversely impact our liquidity. While our estimated future capital requirements
are uncertain and could increase or decrease as a result of many factors, including the extent to which we choose to advance our research,
development activities, preclinical studies and clinical trials, or if we are in a position to pursue manufacturing or commercialization
activities, we will need significant additional capital to develop our drug candidates through development and clinical trials, obtain
regulatory approvals and manufacture and commercialize approved products, if any. We do not know whether we will be able to access additional
capital when needed or on terms favorable to us or our stockholders. Our inability to raise additional capital, or to do so on terms
reasonably acceptable to us, would jeopardize the future success of our business.</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify; text-indent: 0.5in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify; text-indent: 0.5in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">In
addition, our unaudited financial statements for the quarter ended March 31, 2025 and our audited financial statements for the
year ended December 31, 2024 were prepared under the assumption that we would continue as a going concern. However, we have concluded
that there is substantial doubt about our ability to continue as a going concern, therefore our independent registered public accounting
firm included a &ldquo;going concern&rdquo; explanatory paragraph in its report on our financial statements for the year ended December
31, 2024 included in our Annual Report on Form 10-K for the year ended December 31, 2024, indicating that, without additional sources
of funding, our cash at December 31, 2024 is not sufficient for us to operate as a going concern for a period of at least one year from
the date that the financial statements included in the Annual Report on Form 10-K for the year ended December 31, 2024 were issued. Management&rsquo;s
plans concerning these matters, including our need to raise additional capital, are described in the Quarterly Report on Form 10-Q
for the quarter ended March 31, 2025 and the Annual Report on Form 10-K for the year ended December 31, 2024, however, management
cannot assure you that its plans will be successful. If we cannot continue as a viable entity, our stockholders would likely lose most
or all of their investment in us.</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt"><B><I>Purchasers
who purchase our securities in this offering pursuant to a securities purchase agreement may have rights not available to purchasers
that purchase without the benefit of a securities purchase agreement.</I></B></FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify; text-indent: 0.5in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">In
addition to rights and remedies available to all purchasers in this offering under federal securities and state law, the purchasers that
enter into a securities purchase agreement will also be able to bring claims of breach of contract against us. The ability to pursue
a claim for breach of contract provides those investors with the means to enforce the covenants uniquely available to them under the
securities purchase agreement.</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt"><B><I>We
have never paid dividends on our capital stock, and we do not anticipate paying dividends in the foreseeable future.</I></B></FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify; text-indent: 0.5in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">We
have never paid dividends on any of our capital stock and currently intend to retain any future earnings to fund the growth of our business.
We may also enter into credit agreements or other borrowing arrangements in the future that will restrict our ability to declare or pay
cash dividends on our Common Stock. Any determination to pay dividends in the future will be at the discretion of our board of directors
and will depend on our financial condition, operating results, capital requirements, general business conditions and other factors that
our board of directors may deem relevant. As a result, capital appreciation, if any, of the securities will be the sole source of gain,
if any, for the foreseeable future.<BR STYLE="clear: both"></FONT></P>

<P STYLE="font: bold 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: center"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>

<P STYLE="font: bold 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: center"></P>

<!-- Field: Page; Sequence: 14; Value: 1 -->
    <DIV STYLE="margin-top: 0pt; margin-bottom: 6pt; border-bottom: Black 1pt solid"><TABLE CELLPADDING="0" CELLSPACING="0" STYLE="border-collapse: collapse; width: 100%; font-size: 10pt"><TR STYLE="vertical-align: top; text-align: left"><TD STYLE="text-align: center; width: 100%"><!-- Field: Sequence; Type: Arabic; Name: PageNo -->9<!-- Field: /Sequence --></TD></TR></TABLE></DIV>
    <DIV STYLE="break-before: page; margin-top: 6pt; margin-bottom: 0pt"><P STYLE="margin: 0pt">&nbsp;</P></DIV>
    <!-- Field: /Page -->

<P STYLE="font: bold 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: center"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>

<P STYLE="font: bold 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: center"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt"><A NAME="Aa_006"></A>CAPITALIZATION</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: center"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt; text-transform: uppercase"><B>&nbsp;</B></FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify; text-indent: 0.5in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">The
following table sets forth our consolidated cash and cash equivalents and capitalization as of March 31, 2025: </FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify; text-indent: 0.5in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>

<TABLE CELLSPACING="0" CELLPADDING="0" STYLE="font: 10pt Times New Roman, Times, Serif; background-color: white; width: 100%">
  <TR STYLE="font: 10pt Times New Roman, Times, Serif; vertical-align: top">
    <TD STYLE="font: 10pt Times New Roman, Times, Serif; width: 0.5in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></TD>
    <TD STYLE="font: 10pt Times New Roman, Times, Serif; width: 0.25in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#9679;</FONT></TD>
    <TD STYLE="font: 10pt Times New Roman, Times, Serif; text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">on
    an actual basis; </FONT></TD></TR>
  <TR STYLE="font: 10pt Times New Roman, Times, Serif; vertical-align: top">
    <TD STYLE="font: 10pt Times New Roman, Times, Serif">&nbsp;</TD>
    <TD STYLE="font: 10pt Times New Roman, Times, Serif"> &#9679; </TD>
    <TD STYLE="font: 10pt Times New Roman, Times, Serif; text-align: justify"> on a pro forma basis to give effect to the Warrant Exchange;
    and </TD></TR>
  <TR STYLE="font: 10pt Times New Roman, Times, Serif; vertical-align: top">
    <TD STYLE="font: 10pt Times New Roman, Times, Serif"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></TD>
    <TD STYLE="font: 10pt Times New Roman, Times, Serif"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#9679;</FONT></TD>
    <TD STYLE="font: 10pt Times New Roman, Times, Serif; text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">on
    a pro forma as adjusted basis to give further effect to the sale of 15,000,000 shares of Common Stock and accompanying
    common warrants in the offering at an assumed public offering price of $0.80 per share of Common Stock and accompanying warrant
    (which was the closing price of our Common Stock on Nasdaq on May 9, 2025), after deducting Placement Agent fees and
    estimated offering expenses payable by us, and assuming no sale of any pre-funded warrants in this offering and no exercise of the
    common warrants issued in connection with this offering.</FONT></TD></TR>
  </TABLE>
<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify; text-indent: 0.5in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify; text-indent: 0.5in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">You
should read the following table in conjunction with the sections entitled &ldquo;<I>Use of Proceeds</I>&rdquo; included elsewhere in
this prospectus and &ldquo;<I>Management&rsquo;s Discussion and Analysis of Financial Condition and Results of Operations</I>&rdquo;
and our consolidated financial statements and related notes included in our Annual Report on Form 10-K for the year ended December 31,
2024 and our Quarterly Report on Form 10-Q for the quarter ended March 31, 2025, each of which is incorporated herein by reference.</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify; text-indent: 0.5in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify; text-indent: 0.5in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt"></FONT></P>

<TABLE CELLPADDING="0" CELLSPACING="0" STYLE="border-collapse: collapse; width: 100%; font: 10pt Times New Roman, Times, Serif">
  <TR STYLE="vertical-align: bottom">
    <TD>&nbsp;</TD><TD STYLE="font-weight: bold; padding-bottom: 1pt">&nbsp;</TD>
    <TD COLSPAN="2" STYLE="font-weight: bold; text-align: center; border-bottom: Black 1pt solid">Actual</TD><TD STYLE="padding-bottom: 1pt; font-weight: bold">&nbsp;</TD><TD STYLE="font-weight: bold; padding-bottom: 1pt">&nbsp;</TD>
    <TD COLSPAN="2" STYLE="font-weight: bold; text-align: center; border-bottom: Black 1pt solid"> Pro Forma </TD><TD STYLE="padding-bottom: 1pt; font-weight: bold">&nbsp;</TD><TD STYLE="font-weight: bold; padding-bottom: 1pt">&nbsp;</TD>
    <TD COLSPAN="2" STYLE="font-weight: bold; text-align: center; border-bottom: Black 1pt solid"> Pro Forma As<BR> Adjusted</TD><TD STYLE="padding-bottom: 1pt; font-weight: bold">&nbsp;</TD></TR>
  <TR STYLE="vertical-align: bottom">
    <TD>&nbsp;</TD><TD STYLE="font-weight: bold">&nbsp;</TD>
    <TD COLSPAN="2" STYLE="font-weight: bold; text-align: center">(unaudited)</TD><TD STYLE="font-weight: bold">&nbsp;</TD><TD STYLE="font-weight: bold">&nbsp;</TD>
    <TD COLSPAN="2" STYLE="font-weight: bold; text-align: center"> (unaudited) </TD><TD STYLE="font-weight: bold">&nbsp;</TD><TD STYLE="font-weight: bold">&nbsp;</TD>
    <TD COLSPAN="2" STYLE="font-weight: bold; text-align: center">(unaudited)</TD><TD STYLE="font-weight: bold">&nbsp;</TD></TR>
  <TR STYLE="vertical-align: bottom; background-color: rgb(204,238,255)">
    <TD STYLE="width: 46%; text-align: left; padding-bottom: 2.5pt">Cash and cash equivalents</TD><TD STYLE="width: 2%; padding-bottom: 2.5pt">&nbsp;</TD>
    <TD STYLE="width: 1%; border-bottom: Black 2.5pt double; text-align: left">$</TD><TD STYLE="width: 14%; border-bottom: Black 2.5pt double; text-align: right">2,871,756</TD><TD STYLE="width: 1%; padding-bottom: 2.5pt; text-align: left">&nbsp;</TD><TD STYLE="width: 2%; padding-bottom: 2.5pt">&nbsp;</TD>
    <TD STYLE="width: 1%; border-bottom: Black 2.5pt double; text-align: left"> $ </TD><TD STYLE="width: 14%; border-bottom: Black 2.5pt double; text-align: right"> 2,871,756 </TD><TD STYLE="width: 1%; padding-bottom: 2.5pt; text-align: left">&nbsp;</TD><TD STYLE="width: 2%; padding-bottom: 2.5pt">&nbsp;</TD>
    <TD STYLE="width: 1%; border-bottom: Black 2.5pt double; text-align: left">$</TD><TD STYLE="width: 14%; border-bottom: Black 2.5pt double; text-align: right">13,752,107</TD><TD STYLE="width: 1%; padding-bottom: 2.5pt; text-align: left">&nbsp;</TD></TR>
  <TR STYLE="vertical-align: bottom; background-color: White">
    <TD STYLE="text-align: left">Stockholders&rsquo; equity:</TD><TD>&nbsp;</TD>
    <TD STYLE="text-align: left">&nbsp;</TD><TD STYLE="text-align: right">&nbsp;</TD><TD STYLE="text-align: left">&nbsp;</TD><TD>&nbsp;</TD>
    <TD STYLE="text-align: left">&nbsp;</TD><TD STYLE="text-align: right">&nbsp;</TD><TD STYLE="text-align: left">&nbsp;</TD><TD>&nbsp;</TD>
    <TD STYLE="text-align: left">&nbsp;</TD><TD STYLE="text-align: right">&nbsp;</TD><TD STYLE="text-align: left">&nbsp;</TD></TR>
  <TR STYLE="vertical-align: bottom; background-color: rgb(204,238,255)">
    <TD STYLE="padding-left: 10pt">Preferred stock, par value $0.01 per share; 100,000 shares authorized; 0 shares issued and outstanding</TD><TD>&nbsp;</TD>
    <TD STYLE="text-align: left">&nbsp;</TD><TD STYLE="text-align: right">&mdash;</TD><TD STYLE="text-align: left">&nbsp;</TD><TD>&nbsp;</TD>
    <TD STYLE="text-align: left">&nbsp;</TD><TD STYLE="text-align: right"> &mdash; </TD><TD STYLE="text-align: left">&nbsp;</TD><TD>&nbsp;</TD>
    <TD STYLE="text-align: left">&nbsp;</TD><TD STYLE="text-align: right">&mdash;</TD><TD STYLE="text-align: left">&nbsp;</TD></TR>
  <TR STYLE="vertical-align: bottom; background-color: White">
    <TD STYLE="text-align: left; padding-bottom: 1pt; padding-left: 10pt">Common stock, par value $0.01 per share; 112,500,000 shares
    authorized, 14,620,732 shares issued and outstanding, actual, 17,541,732 shares issued and outstanding, pro forma, 32,541,732
    shares issued and outstanding, pro forma as adjusted</TD><TD STYLE="padding-bottom: 1pt">&nbsp;</TD>
    <TD STYLE="padding-bottom: 1pt; text-align: left">&nbsp;</TD><TD STYLE="padding-bottom: 1pt; text-align: right"> 146,207 </TD><TD STYLE="padding-bottom: 1pt; text-align: left">&nbsp;</TD><TD STYLE="padding-bottom: 1pt">&nbsp;</TD>
    <TD STYLE="padding-bottom: 1pt; text-align: left">&nbsp;</TD><TD STYLE="padding-bottom: 1pt; text-align: right"> 175,417 </TD><TD STYLE="padding-bottom: 1pt; text-align: left">&nbsp;</TD><TD STYLE="padding-bottom: 1pt">&nbsp;</TD>
    <TD STYLE="padding-bottom: 1pt; text-align: left">&nbsp;</TD><TD STYLE="padding-bottom: 1pt; text-align: right"> 325,417 </TD><TD STYLE="padding-bottom: 1pt; text-align: left">&nbsp;</TD></TR>
  <TR STYLE="vertical-align: bottom; background-color: rgb(204,238,255)">
    <TD STYLE="text-align: left; padding-left: 10pt">Additional paid-in capital</TD><TD>&nbsp;</TD>
    <TD STYLE="text-align: left">&nbsp;</TD><TD STYLE="text-align: right"> 411,296,548 </TD><TD STYLE="text-align: left">&nbsp;</TD><TD>&nbsp;</TD>
    <TD STYLE="text-align: left">&nbsp;</TD><TD STYLE="text-align: right"> 411,267,338 </TD><TD STYLE="text-align: left">&nbsp;</TD><TD>&nbsp;</TD>
    <TD STYLE="text-align: left">&nbsp;</TD><TD STYLE="text-align: right"> 421,997,689 </TD><TD STYLE="text-align: left">&nbsp;</TD></TR>
  <TR STYLE="vertical-align: bottom; background-color: White">
    <TD STYLE="text-align: left; padding-left: 10pt">Accumulated deficit</TD><TD>&nbsp;</TD>
    <TD STYLE="text-align: left">&nbsp;</TD><TD STYLE="text-align: right"> (410,905,539 </TD><TD STYLE="text-align: left"> ) </TD><TD>&nbsp;</TD>
    <TD STYLE="text-align: left">&nbsp;</TD><TD STYLE="text-align: right"> (410,905,539 </TD><TD STYLE="text-align: left"> ) </TD><TD>&nbsp;</TD>
    <TD STYLE="text-align: left">&nbsp;</TD><TD STYLE="text-align: right"> (410,905,539 </TD><TD STYLE="text-align: left">)</TD></TR>
  <TR STYLE="vertical-align: bottom; background-color: rgb(204,238,255)">
    <TD STYLE="text-align: left; padding-left: 10pt">Accumulated other comprehensive income</TD><TD>&nbsp;</TD>
    <TD STYLE="text-align: left">&nbsp;</TD><TD STYLE="text-align: right">&mdash;</TD><TD STYLE="text-align: left">&nbsp;</TD><TD>&nbsp;</TD>
    <TD STYLE="text-align: left">&nbsp;</TD><TD STYLE="text-align: right"> &mdash; </TD><TD STYLE="text-align: left">&nbsp;</TD><TD>&nbsp;</TD>
    <TD STYLE="text-align: left">&nbsp;</TD><TD STYLE="text-align: right">&mdash;</TD><TD STYLE="text-align: left">&nbsp;</TD></TR>
  <TR STYLE="vertical-align: bottom; background-color: White">
    <TD STYLE="text-align: left; padding-bottom: 1pt; padding-left: 10pt">Treasury stock</TD><TD STYLE="padding-bottom: 1pt">&nbsp;</TD>
    <TD STYLE="border-bottom: Black 1pt solid; text-align: left">&nbsp;</TD><TD STYLE="border-bottom: Black 1pt solid; text-align: right">(85,188</TD><TD STYLE="padding-bottom: 1pt; text-align: left">)</TD><TD STYLE="padding-bottom: 1pt">&nbsp;</TD>
    <TD STYLE="border-bottom: Black 1pt solid; text-align: left">&nbsp;</TD><TD STYLE="border-bottom: Black 1pt solid; text-align: right">(85,188</TD><TD STYLE="padding-bottom: 1pt; text-align: left">)</TD><TD STYLE="padding-bottom: 1pt">&nbsp;</TD>
    <TD STYLE="border-bottom: Black 1pt solid; text-align: left">&nbsp;</TD><TD STYLE="border-bottom: Black 1pt solid; text-align: right">(85,188</TD><TD STYLE="padding-bottom: 1pt; text-align: left">)</TD></TR>
  <TR STYLE="vertical-align: bottom; background-color: rgb(204,238,255)">
    <TD STYLE="text-align: left; padding-bottom: 1pt">Total stockholders&rsquo; equity</TD><TD STYLE="padding-bottom: 1pt">&nbsp;</TD>
    <TD STYLE="border-bottom: Black 1pt solid; text-align: left">$</TD><TD STYLE="border-bottom: Black 1pt solid; text-align: right"> 452,028 </TD><TD STYLE="padding-bottom: 1pt; text-align: left">&nbsp;</TD><TD STYLE="padding-bottom: 1pt">&nbsp;</TD>
    <TD STYLE="border-bottom: Black 1pt solid; text-align: left"> $ </TD><TD STYLE="border-bottom: Black 1pt solid; text-align: right"> 452,028 </TD><TD STYLE="padding-bottom: 1pt; text-align: left">&nbsp;</TD><TD STYLE="padding-bottom: 1pt">&nbsp;</TD>
    <TD STYLE="border-bottom: Black 1pt solid; text-align: left">$</TD><TD STYLE="border-bottom: Black 1pt solid; text-align: right"> 11,332,379 </TD><TD STYLE="padding-bottom: 1pt; text-align: left">&nbsp;</TD></TR>
  <TR STYLE="vertical-align: bottom; background-color: White">
    <TD STYLE="font-weight: bold; text-align: left; padding-bottom: 1pt">Total capitalization</TD><TD STYLE="padding-bottom: 1pt">&nbsp;</TD>
    <TD STYLE="border-bottom: Black 1pt solid; text-align: left">$</TD><TD STYLE="border-bottom: Black 1pt solid; text-align: right"> 452,028 </TD><TD STYLE="padding-bottom: 1pt; text-align: left">&nbsp;</TD><TD STYLE="padding-bottom: 1pt">&nbsp;</TD>
    <TD STYLE="border-bottom: Black 1pt solid; text-align: left"> $ </TD><TD STYLE="border-bottom: Black 1pt solid; text-align: right"> 452,028 </TD><TD STYLE="padding-bottom: 1pt; text-align: left">&nbsp;</TD><TD STYLE="padding-bottom: 1pt">&nbsp;</TD>
    <TD STYLE="border-bottom: Black 1pt solid; text-align: left">$</TD><TD STYLE="border-bottom: Black 1pt solid; text-align: right"> 11,332,379 </TD><TD STYLE="padding-bottom: 1pt; text-align: left">&nbsp;</TD></TR>
  </TABLE>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify; text-indent: 0.5in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt"></FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify; text-indent: 0.5in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify; text-indent: 0.5in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt"></FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify; text-indent: 0.5in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt"></FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify; text-indent: 0.5in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">A
$0.10 increase (decrease) in the assumed combined public offering price per share of Common Stock and common warrants of $0.80
would increase (decrease) the pro forma as adjusted amount of additional paid-in capital, total stockholders&rsquo; equity and
total capitalization by approximately $1.4 million ($1.4 million), assuming that the number of shares of Common Stock offered
by us, as set forth on the cover page of this prospectus, remains the same and after deducting estimated Placement Agent fees and estimated
offering expenses payable by us and assuming no exercise of common warrants or sale of pre-funded warrants. An increase (decrease) of
1,000,000 in the number of shares of Common Stock and accompanying common warrants offered by us would increase (decrease) the pro
forma as adjusted amount of additional paid-in capital, total stockholders&rsquo; equity and total capitalization by approximately
$0.7 million ($0.7 million), assuming no change in the public offering price per share of Common Stock and accompanying
common warrant, and after deducting estimated Placement Agent fees and estimated offering expenses payable by us.</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify; text-indent: 0.5in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify"> The discussion and table above are
based on 14,620,732 shares outstanding as of March 31, 2025 and excludes the following:</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>

<TABLE CELLSPACING="0" CELLPADDING="0" STYLE="font: 10pt Times New Roman, Times, Serif; width: 100%">
  <TR STYLE="font: 10pt Times New Roman, Times, Serif; vertical-align: top">
    <TD STYLE="font: 10pt Times New Roman, Times, Serif; width: 0.5in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></TD>
    <TD STYLE="font: 10pt Times New Roman, Times, Serif; width: 0.25in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#9679;</FONT></TD>
    <TD STYLE="font: 10pt Times New Roman, Times, Serif; text-align: justify"> <FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">1,942,351
    </FONT> <FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">shares of Common Stock issuable upon the exercise
    of outstanding stock options as of March 31, 2025, having a weighted average exercise price of $1.78 per share;</FONT></TD></TR>
  <TR STYLE="font: 10pt Times New Roman, Times, Serif; vertical-align: top">
    <TD STYLE="font: 10pt Times New Roman, Times, Serif"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></TD>
    <TD STYLE="font: 10pt Times New Roman, Times, Serif"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#9679;</FONT></TD>
    <TD STYLE="font: 10pt Times New Roman, Times, Serif; text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">39,700
    shares of Common Stock issuable upon the vesting of Common Stock awards as of March 31, 2025, having a weighted average
    grant date fair value of $0.99 per share;</FONT></TD></TR>
  <TR STYLE="font: 10pt Times New Roman, Times, Serif; vertical-align: top">
    <TD STYLE="font: 10pt Times New Roman, Times, Serif"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></TD>
    <TD STYLE="font: 10pt Times New Roman, Times, Serif"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#9679;</FONT></TD>
    <TD STYLE="font: 10pt Times New Roman, Times, Serif; text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">5,155,060
    shares of Common Stock issuable upon the exercise of outstanding warrants as of March 31, 2025, having a weighted average
    exercise price of $2.51 per share; and</FONT></TD></TR>
  <TR STYLE="font: 10pt Times New Roman, Times, Serif; vertical-align: top">
    <TD STYLE="font: 10pt Times New Roman, Times, Serif"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></TD>
    <TD STYLE="font: 10pt Times New Roman, Times, Serif"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#9679;</FONT></TD>
    <TD STYLE="font: 10pt Times New Roman, Times, Serif; text-align: justify"> <FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">223,522
    </FONT> <FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">shares of Common Stock reserved for future issuance
    pursuant to our existing stock incentive plan.</FONT></TD></TR>
  </TABLE>
<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt; text-transform: uppercase"><B>&nbsp;</B></FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify; text-indent: 0.5in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">The
information discussed above is illustrative only and will adjust based on the actual public offering price and other terms of this offering
determined at pricing.</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt; text-transform: uppercase"><B>&nbsp;</B></FONT></P>


<!-- Field: Page; Sequence: 15; Value: 1 -->
    <DIV STYLE="margin-top: 0pt; margin-bottom: 6pt; border-bottom: Black 1pt solid"><TABLE CELLPADDING="0" CELLSPACING="0" STYLE="border-collapse: collapse; width: 100%; font-size: 10pt"><TR STYLE="vertical-align: top; text-align: left"><TD STYLE="text-align: center; width: 100%"><!-- Field: Sequence; Type: Arabic; Name: PageNo -->10<!-- Field: /Sequence --></TD></TR></TABLE></DIV>
    <DIV STYLE="break-before: page; margin-top: 6pt; margin-bottom: 0pt"><P STYLE="margin: 0pt">&nbsp;</P></DIV>
    <!-- Field: /Page -->

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: center"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt; text-transform: uppercase"><B>&nbsp;</B></FONT></P>

<P STYLE="font: bold 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: center"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt"><A NAME="Aa_007"></A>DILUTION</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: center"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt; text-transform: uppercase"><B>&nbsp;</B></FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify; text-indent: 0.5in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">If
you purchase securities in this offering, assuming no sale of any pre-funded warrants and no exercise of the common warrants issued in
connection with this offering, your ownership interest will be immediately diluted to the extent of the difference between the combined
public offering price per share of our Common Stock and accompanying warrant in this offering and the pro forma as adjusted net
tangible book value per share of our Common Stock immediately after giving effect to this offering.</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify; text-indent: 0.5in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify; text-indent: 0.5in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">Our
net tangible book value as of March 31, 2025 was approximately $0.5 million, or approximately $0.03 per share
of our Common Stock. Our net tangible book value is the amount of our total tangible assets minus total liabilities. Net tangible book
value per share as of March 31, 2025 is our net tangible book value divided by the number of shares of Common Stock outstanding
as of March 31, 2025. </FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify; text-indent: 0.5in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify; text-indent: 0.5in"></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify; text-indent: 0.5in; background-color: white"> <FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">Our
pro forma net tangible book value as of March 31, 2025 was $0.5 million, or approximately $0.02 per share of Common Stock. Pro forma
net tangible book value per share represents our net tangible book value (as described above) divided by the number of shares of Common
Stock outstanding as of March 31, 2025, after giving effect to the Warrant Exchange.</FONT> </P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify; text-indent: 0.5in; background-color: white"></P>
<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify; text-indent: 0.5in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt"></FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify; text-indent: 0.5in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify; text-indent: 0.5in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">After
giving further effect to the sale of the maximum number of securities offered hereby, or 15,000,000 shares of Common Stock
(assuming no sale of any pre-funded warrants and no exercise of the common warrants) in this offering at an assumed combined public offering
price of $0.80 per share of Common Stock and accompanying common warrant (the last reported sale price of our Common Stock on
Nasdaq on May 9, 2025), and after deducting estimated Placement Agent fees and estimated offering expenses payable by us, our
pro forma as adjusted net tangible book value as of March 31, 2025 would have been approximately $11.3 million,
or approximately $0.35 per share of Common Stock. This amount represents an immediate increase in pro forma as adjusted
net tangible book value of $0.33 per share of Common Stock to our existing stockholders and an immediate dilution of $0.45
per share of Common Stock to investors participating in this offering. We determine dilution per share of Common Stock to investors participating
in this offering by subtracting pro forma as adjusted net tangible book value per share of Common Stock after giving effect to
this offering from the combined public offering price per share of Common Stock and accompanying common warrant paid by investors participating
in this offering.</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify; text-indent: 0.5in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>

<TABLE CELLSPACING="0" CELLPADDING="0" STYLE="font: 10pt Times New Roman, Times, Serif; width: 93%; border-collapse: collapse; margin-left: 0.5in">
  <TR STYLE="font: 10pt Times New Roman, Times, Serif; vertical-align: bottom; background-color: rgb(204,238,255)">
    <TD STYLE="font: 10pt Times New Roman, Times, Serif; width: 60%"> <FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">Assumed
    combined</FONT> <FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt"> public offering price per share of
    Common Stock and accompanying common warrant</FONT></TD>
    <TD STYLE="font: 10pt Times New Roman, Times, Serif; width: 2%"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></TD>
    <TD STYLE="font: 10pt Times New Roman, Times, Serif; width: 1%"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></TD>
    <TD STYLE="font: 10pt Times New Roman, Times, Serif; width: 16%; text-align: right"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></TD>
    <TD STYLE="width: 1%">&nbsp;</TD>
    <TD STYLE="font: 10pt Times New Roman, Times, Serif; width: 2%; text-align: left"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></TD>
    <TD STYLE="font: 10pt Times New Roman, Times, Serif; width: 1%"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">$</FONT></TD>
    <TD STYLE="text-align: right; font: 10pt Times New Roman, Times, Serif; width: 16%"><P STYLE="margin: 0"> 0.80 </P><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt"></FONT></TD>
    <TD STYLE="width: 1%">&nbsp;</TD></TR>
  <TR STYLE="font: 10pt Times New Roman, Times, Serif; vertical-align: bottom; background-color: White">
    <TD STYLE="font: 10pt Times New Roman, Times, Serif"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">Historical
    net tangible book value per share as of March 31, 2025 </FONT></TD>
    <TD STYLE="font: 10pt Times New Roman, Times, Serif"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></TD>
    <TD STYLE="font: 10pt Times New Roman, Times, Serif"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">$</FONT></TD>
    <TD STYLE="font: 10pt Times New Roman, Times, Serif; text-align: right"> <FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">0.03</FONT> </TD>
    <TD>&nbsp;</TD>
    <TD STYLE="font: 10pt Times New Roman, Times, Serif; text-align: left"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></TD>
    <TD STYLE="font: 10pt Times New Roman, Times, Serif; text-align: right"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></TD>
    <TD STYLE="text-align: right; font: 10pt Times New Roman, Times, Serif"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></TD>
    <TD>&nbsp;</TD></TR>
  <TR STYLE="vertical-align: bottom; background-color: rgb(204,238,255)">
    <TD STYLE="font-size: 10pt; text-align: left; padding-bottom: 1pt"> Increase (decrease) per share attributable to the pro forma
    adjustments described above </TD><TD STYLE="font-size: 10pt; padding-bottom: 1pt">&nbsp;</TD>
    <TD STYLE="border-bottom: Black 1pt solid; font-size: 10pt; text-align: left"> &nbsp; </TD><TD STYLE="border-bottom: Black 1pt solid; font-size: 10pt; text-align: right"> (0.01 </TD><TD STYLE="padding-bottom: 1pt; font-size: 10pt; text-align: left"> ) </TD><TD STYLE="padding-bottom: 1pt">&nbsp;</TD>
    <TD STYLE="padding-bottom: 1pt; text-align: left">&nbsp;</TD><TD STYLE="padding-bottom: 1pt; text-align: right"></TD><TD STYLE="padding-bottom: 1pt; text-align: left">&nbsp;</TD></TR>
<TR STYLE="vertical-align: bottom; background-color: White">
    <TD STYLE="font-size: 10pt; text-align: left"> Pro forma net tangible book value per share as of March 31, 2025 before giving effect
    to this offering </TD><TD STYLE="font-size: 10pt">&nbsp;</TD>
    <TD STYLE="font-size: 10pt; text-align: left">&nbsp;</TD><TD STYLE="font-size: 10pt; text-align: right"> 0.02 </TD><TD STYLE="font-size: 10pt; text-align: left">&nbsp;</TD><TD>&nbsp;</TD>
    <TD STYLE="text-align: left">&nbsp;</TD><TD STYLE="text-align: right"></TD><TD STYLE="text-align: left">&nbsp;</TD></TR>
<TR STYLE="font: 10pt Times New Roman, Times, Serif; vertical-align: bottom; background-color: rgb(204,238,255)">
    <TD STYLE="font: 10pt Times New Roman, Times, Serif"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">Increase
    in pro forma net tangible book value per share attributable to this offering</FONT></TD>
    <TD STYLE="font: 10pt Times New Roman, Times, Serif"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></TD>
    <TD STYLE="font: 10pt Times New Roman, Times, Serif"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">$</FONT></TD>
    <TD STYLE="font: 10pt Times New Roman, Times, Serif; text-align: right"><P STYLE="margin: 0"> 0.33 </P><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt"></FONT></TD>
    <TD>&nbsp;</TD>
    <TD STYLE="font: 10pt Times New Roman, Times, Serif; text-align: left"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></TD>
    <TD STYLE="font: 10pt Times New Roman, Times, Serif; text-align: right"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></TD>
    <TD STYLE="text-align: right; font: 10pt Times New Roman, Times, Serif"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></TD>
    <TD>&nbsp;</TD></TR>
  <TR STYLE="font: 10pt Times New Roman, Times, Serif; vertical-align: bottom; background-color: White">
    <TD STYLE="font: 10pt Times New Roman, Times, Serif"> <FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">Pro
    forma as</FONT> <FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt"> adjusted tangible book value per share,
    after giving effect to this offering</FONT></TD>
    <TD STYLE="font: 10pt Times New Roman, Times, Serif"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></TD>
    <TD STYLE="font: 10pt Times New Roman, Times, Serif"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></TD>
    <TD STYLE="font: 10pt Times New Roman, Times, Serif; text-align: right"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></TD>
    <TD>&nbsp;</TD>
    <TD STYLE="font: 10pt Times New Roman, Times, Serif; text-align: left"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></TD>
    <TD STYLE="border-bottom: Black 1pt solid; font: 10pt Times New Roman, Times, Serif"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">$</FONT></TD>
    <TD STYLE="text-align: right; border-bottom: Black 1pt solid; font: 10pt Times New Roman, Times, Serif"> 0.35 </TD>
    <TD>&nbsp;</TD></TR>
  <TR STYLE="font: 10pt Times New Roman, Times, Serif; vertical-align: bottom; background-color: rgb(204,238,255)">
    <TD STYLE="padding-bottom: 2.5pt; font: 10pt Times New Roman, Times, Serif"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">Dilution
    per share to investors in this offering</FONT></TD>
    <TD STYLE="padding-bottom: 2.5pt; font: 10pt Times New Roman, Times, Serif"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></TD>
    <TD STYLE="padding-bottom: 2.5pt; font: 10pt Times New Roman, Times, Serif"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></TD>
    <TD STYLE="padding-bottom: 2.5pt; font: 10pt Times New Roman, Times, Serif; text-align: right"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></TD>
    <TD STYLE="padding-bottom: 2.5pt">&nbsp;</TD>
    <TD STYLE="padding-bottom: 2.5pt; font: 10pt Times New Roman, Times, Serif; text-align: left"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></TD>
    <TD STYLE="border-bottom: Black 2.5pt double; font: 10pt Times New Roman, Times, Serif"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">$</FONT></TD>
    <TD STYLE="border-bottom: Black 2.5pt double; text-align: right; font: 10pt Times New Roman, Times, Serif"> 0.45 </TD>
    <TD STYLE="padding-bottom: 2.5pt">&nbsp;</TD></TR>
  </TABLE>
<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify; text-indent: 0.5in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt"></FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify; text-indent: 0.5in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt"></FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify; text-indent: 0.5in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt"></FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify; text-indent: 0.5in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify; text-indent: 0.5in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">A
$0.10 increase (decrease) in the assumed combined public offering price per share of Common Stock and common warrants of $0.80
would increase (decrease) the pro forma as adjusted net tangible book value by approximately $0.06 ($0.06) per share and
the dilution to new investors by $0.51 ($0.39) per share, assuming that the number of shares of Common Stock offered by us, as
set forth on the cover page of this prospectus, remains the same and after deducting estimated Placement Agent fees and estimated offering
expenses payable by us and assuming no exercise of common warrants or sale of pre-funded warrants. An increase (decrease) of 1,000,000
in the number of shares of Common Stock and accompanying common warrants offered by us would increase (decrease) the pro forma
as adjusted net tangible book value by approximately $(0.01) ($0.03) per share and the dilution to new investors by $0.44
($0.48) per share, assuming no change in the combined public offering price per share of Common Stock and accompanying common warrant,
and after deducting estimated Placement Agent fees and estimated offering expenses payable by us and assuming no exercise of common warrants
or sale of pre-funded warrants.</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify; text-indent: 0.5in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify; text-indent: 0.5in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">The
number of shares of our Common Stock outstanding is based on an aggregate of 14,620,732 shares of our Common Stock outstanding
as of March 31, 2025 and excludes:</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify; text-indent: 0.5in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>

<TABLE CELLSPACING="0" CELLPADDING="0" STYLE="font: 10pt Times New Roman, Times, Serif; width: 100%; border-collapse: collapse">
  <TR STYLE="font: 10pt Times New Roman, Times, Serif; vertical-align: top">
    <TD STYLE="width: 0.5in">&nbsp;</TD>
    <TD STYLE="font: 10pt Times New Roman, Times, Serif; width: 0.25in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#9679;</FONT></TD>
    <TD STYLE="font: 10pt Times New Roman, Times, Serif; text-align: justify"> <FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">1,942,352
    </FONT> <FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">shares of Common Stock issuable upon the exercise
    of outstanding stock options as of March 31, 2025, having a weighted average exercise price of $1.78 per share;</FONT></TD></TR>
  <TR STYLE="font: 10pt Times New Roman, Times, Serif; vertical-align: top">
    <TD>&nbsp;</TD>
    <TD STYLE="font: 10pt Times New Roman, Times, Serif"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#9679;</FONT></TD>
    <TD STYLE="font: 10pt Times New Roman, Times, Serif; text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">39,700
    shares of Common Stock issuable upon the vesting of Common Stock awards as of March 31, 2025, having a weighted average
    grant date fair value of $0.99 per share;</FONT></TD></TR>
  <TR STYLE="font: 10pt Times New Roman, Times, Serif; vertical-align: top">
    <TD>&nbsp;</TD>
    <TD STYLE="font: 10pt Times New Roman, Times, Serif"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#9679;</FONT></TD>
    <TD STYLE="font: 10pt Times New Roman, Times, Serif; text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">5,155,060
    shares of Common Stock issuable upon the exercise of outstanding warrants as of March 31, 2025, having a weighted average
    exercise price of $2.51 per share; and</FONT></TD></TR>
  <TR STYLE="font: 10pt Times New Roman, Times, Serif; vertical-align: top">
    <TD>&nbsp;</TD>
    <TD STYLE="font: 10pt Times New Roman, Times, Serif"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#9679;</FONT></TD>
    <TD STYLE="font: 10pt Times New Roman, Times, Serif; text-align: justify"> <FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">223,522
    </FONT> <FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">shares of Common Stock reserved for future issuance
    pursuant to our existing stock incentive plan.</FONT></TD></TR>
  </TABLE>
<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify; text-indent: 0.5in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify; text-indent: 0.5in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">To
the extent that any outstanding stock options or warrants are exercised, new stock options are issued under our stock incentive plans,
or we otherwise issue additional shares of Common Stock or securities convertible into or exercisable for Common Stock in the future,
at a price less than the public offering price, there will be further dilution to new investors.</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify; text-indent: 0.5in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify; text-indent: 0.5in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">The
information discussed above is illustrative only and will adjust based on the actual public offering price and other terms of this offering
determined at pricing. Except as indicated otherwise, the discussion and table above assume no exercise of common warrants offered hereby
and no sale of pre-funded warrants, which, if sold, would reduce the number of shares of Common Stock that we are offering on a one-for-one
basis. The foregoing discussion and table also does not take into account any &ldquo;alternative cashless exercises&rdquo; of the
common warrants, pursuant to which a holder of a common warrant has the right to receive an aggregate number of shares equal to the product
of (i) the aggregate number of shares of Common Stock that would be issuable upon a cash rather than a cashless exercise of the common
warrant and (ii) 3.0. </FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify; text-indent: 0.5in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>


<!-- Field: Page; Sequence: 16; Value: 1 -->
    <DIV STYLE="margin-top: 0pt; margin-bottom: 6pt; border-bottom: Black 1pt solid"><TABLE CELLPADDING="0" CELLSPACING="0" STYLE="border-collapse: collapse; width: 100%; font-size: 10pt"><TR STYLE="vertical-align: top; text-align: left"><TD STYLE="text-align: center; width: 100%"><!-- Field: Sequence; Type: Arabic; Name: PageNo -->11<!-- Field: /Sequence --></TD></TR></TABLE></DIV>
    <DIV STYLE="break-before: page; margin-top: 6pt; margin-bottom: 0pt"><P STYLE="margin: 0pt">&nbsp;</P></DIV>
    <!-- Field: /Page -->

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: center"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt"><B>&nbsp;</B></FONT></P>

<P STYLE="font: bold 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: center"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt"><A NAME="Aa_008"></A>USE
OF PROCEEDS</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: center"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify; text-indent: 0.5in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">We
estimate that we will receive net proceeds from this offering of approximately $10.9 million (assuming the sale of the maximum
number of securities offered hereby), based upon an assumed public offering price of $0.80 per share of Common Stock and accompanying
common warrant (which is the last reported sale price of our Common Stock on Nasdaq on May 9, 2025), after deducting the estimated
Placement Agent fees and estimated offering expenses payable by us and assuming no issuance of any pre-funded warrants and no exercise
of the common warrants. However, because this is a reasonable best-efforts offering with no minimum number of securities or amount of
proceeds as a condition to closing, the actual offering amount, Placement Agent fees, and net proceeds to us are not presently determinable
and may be substantially less than the maximum amounts set forth on the cover page of this prospectus, and we may not sell all or any
of the securities we are offering. As a result, we may receive significantly less in net proceeds. Based on the assumed offering price
set forth above, we estimate that our net proceeds from the sale of 75%, 50%, and 25% of the securities offered in this offering would
be approximately $8.1 million, $5.3 million, and $2.5 million, respectively, after deducting the estimated Placement
Agent fees and estimated offering expenses payable by us, and assuming no issuance of any pre-funded warrants and assuming no exercise
of the common warrants. These estimates exclude the proceeds, if any, from the exercise of common warrants offered hereby. We
will only receive additional proceeds from the exercise of the common warrants we are selling in this offering if Stockholder Approval
is obtained and such common warrants are exercised for cash. However, the common warrants may be exercised by way
of an &ldquo;alternative cashless exercise,&rdquo; meaning that the holder thereof may not pay a cash purchase price upon exercise, but
instead would receive upon such exercise three shares of our Common Stock for every common warrant they exercise. Accordingly, if Stockholder
Approval is obtained and the common warrants are exercisable, we will likely not receive any additional funds upon the exercise of common
warrants. </FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify; text-indent: 0.5in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">Each
$0.10 increase (decrease) in the assumed public offering price of $0.80 per share of Common Stock and accompanying common warrant
would increase (decrease) our net proceeds from this offering by approximately $1.4 million ($1.4 million), assuming that
the number of shares of Common Stock offered by us remains the same, and after deducting estimated Placement Agent fees and estimated
offering expenses payable by us. An increase (decrease) of 1,000,000 in the number of shares of Common Stock and accompanying common
warrants offered by us would increase (decrease) our net proceeds from this offering by approximately $0.7 million ($0.7
million), assuming no change in the public offering price per share of Common Stock and accompanying common warrant, and after deducting
estimated Placement Agent fees and estimated offering expenses payable by us.</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify; text-indent: 0.5in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">We
intend to use the net proceeds of this offering for general corporate purposes, including the clinical development of our lead product
candidate (IMNN-001), capital expenditures and working capital.</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify; text-indent: 0.5in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">Our
expected use of net proceeds from the offering represents our current intentions based upon our present plans and business condition.
Investors are cautioned, however, that expenditures may vary substantially from these uses. Investors will be relying on the judgment
of our management, who will have broad discretion regarding the application of the proceeds of this offering. The amounts and timing
of our actual expenditures will depend upon numerous factors, including the amount of cash necessary to run our operations, the amount
of competition and other operational factors. Pending the uses described above, we may invest the net proceeds from this offering in
short-and intermediate-term, interest-bearing obligations, investment-grade instruments, demand deposits, certificates of deposit or
direct or guaranteed obligations of the U.S. government.</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify; text-indent: 0.5in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>


<!-- Field: Page; Sequence: 17; Value: 1 -->
    <DIV STYLE="margin-top: 0pt; margin-bottom: 6pt; border-bottom: Black 1pt solid"><TABLE CELLPADDING="0" CELLSPACING="0" STYLE="border-collapse: collapse; width: 100%; font-size: 10pt"><TR STYLE="vertical-align: top; text-align: left"><TD STYLE="text-align: center; width: 100%"><!-- Field: Sequence; Type: Arabic; Name: PageNo -->12<!-- Field: /Sequence --></TD></TR></TABLE></DIV>
    <DIV STYLE="break-before: page; margin-top: 6pt; margin-bottom: 0pt"><P STYLE="margin: 0pt">&nbsp;</P></DIV>
    <!-- Field: /Page -->

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: center"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt"><B>&nbsp;</B></FONT></P>

<P STYLE="font: bold 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: center"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt"><A NAME="Aa_009"></A>DESCRIPTION
OF CAPITAL STOCK</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify; text-indent: 0.5in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">The
following summary of the general terms and provisions of our capital stock does not purport to be complete and is subject to, and qualified
in its entirety by, reference to our Amended and Restated Certificate of Incorporation (&ldquo;<U>Certificate of Incorporation</U>&rdquo;)
and our Amended and Restated Bylaws (&ldquo;<U>Bylaws</U>&rdquo;), each of which is incorporated by reference as an exhibit to our most
recent Annual Report filed with the SEC, and applicable provisions of the Delaware General Corporation Law (the &ldquo;<U>DGCL</U>&rdquo;).
The summaries below do not purport to be complete statements of the relevant provisions of the Certificate of Incorporation, the Bylaws
or the DGCL.</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt"><B>Authorized
Capital Stock</B></FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify; text-indent: 0.5in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">Our
authorized capital stock consists of 112,500,000 shares of Common Stock, par value $0.01 per share and 100,000 shares of preferred stock,
par value $0.01 per share, all of which preferred stock is undesignated. In connection with this offering, we intend to seek Stockholder
Approval to, among other things, increase the authorized shares of Common Stock. </FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt"><B>Common
Stock</B></FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify; text-indent: 0.5in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">Holders
of Common Stock are entitled to one vote for each share held of record on all matters submitted to a vote of stockholders and do not
have cumulative voting rights. Subject to any preferential rights of any outstanding preferred stock, holders of Common Stock are entitled
to receive ratably such dividends, if any, as may be declared from time to time by our board of directors out of funds legally available
therefor. In the event of a dissolution, liquidation or winding-up of the Company, holders of Common Stock are entitled to share ratably
in all assets remaining after payment of liabilities and any preferential rights of any outstanding preferred stock.</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify; text-indent: 0.5in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">Holders
of Common Stock have no preemptive or conversion rights or other subscription rights. There are no redemption or sinking fund provisions
applicable to our Common Stock. All outstanding shares of Common Stock are fully paid and non-assessable. The rights, preferences and
privileges of the holders of Common Stock are subject to, and may be adversely affected by, the rights of the holders of shares of any
series of preferred stock which may be designated and issued in the future.</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify; text-indent: 0.5in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">Our
Common Stock is listed on Nasdaq under the symbol &ldquo;IMNN.&rdquo;</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify; text-indent: 0.5in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt"><B>Transfer
Agent and Registrar</B></FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify; text-indent: 0.5in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">The
transfer agent and registrar for our Common Stock is Equiniti Trust Company, LLC. Equiniti Trust Company, LLC is located at 6201 15<SUP>th
</SUP>Avenue, Brooklyn, NY 11219. Their telephone number is (888) 999-0032.</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify; text-indent: 0.5in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt"><B>Preferred
Stock</B></FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt"><B><I>Undesignated
Preferred Stock</I></B></FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify; text-indent: 0.5in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">Pursuant
to our Certificate of Incorporation, our board of directors has the authority, without further action by the stockholders (unless such
stockholder action is required by applicable law or Nasdaq rules), to designate and issue shares of preferred stock in one or more series,
to establish from time to time the number of shares to be included in each such series, to fix the designations, powers (including voting),
privileges, preferences and relative participating, optional or other rights, if any, of the shares of each such series and the qualifications,
limitations or restrictions thereof and to increase or decrease the number of shares of any such series, but not below the number of
shares of such series then outstanding.</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify; text-indent: 0.5in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">We
will fix the designations, powers (including voting), privileges, preferences and relative participating, optional or other rights, if
any, of the preferred stock of each series, as well as the qualifications, limitations or restrictions thereof, in the certificate of
designation relating to that series. The certificate of designation will describe the terms of the series of preferred stock. This description
will include:</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>

<TABLE CELLSPACING="0" CELLPADDING="0" STYLE="font: 10pt Times New Roman, Times, Serif; width: 100%; border-collapse: collapse">
  <TR STYLE="font: 10pt Times New Roman, Times, Serif">
    <TD STYLE="font: 10pt Times New Roman, Times, Serif; width: 0.5in; text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></TD>
    <TD STYLE="font: 10pt Times New Roman, Times, Serif; width: 0.25in; text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#9679;</FONT></TD>
    <TD STYLE="font: 10pt Times New Roman, Times, Serif; text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">the
    title and stated value;</FONT></TD></TR>
  <TR STYLE="font: 10pt Times New Roman, Times, Serif">
    <TD STYLE="font: 10pt Times New Roman, Times, Serif; text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></TD>
    <TD STYLE="font: 10pt Times New Roman, Times, Serif; text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></TD>
    <TD STYLE="font: 10pt Times New Roman, Times, Serif; text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></TD></TR>
  <TR STYLE="font: 10pt Times New Roman, Times, Serif">
    <TD STYLE="font: 10pt Times New Roman, Times, Serif; text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></TD>
    <TD STYLE="font: 10pt Times New Roman, Times, Serif; text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#9679;</FONT></TD>
    <TD STYLE="font: 10pt Times New Roman, Times, Serif; text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">the
    number of shares we are offering;</FONT></TD></TR>
</TABLE>

<P STYLE="margin: 0">&nbsp;</P>

<P STYLE="margin: 0"></P>

<!-- Field: Page; Sequence: 18; Value: 1 -->
    <DIV STYLE="margin-top: 0pt; margin-bottom: 6pt; border-bottom: Black 1pt solid"><TABLE CELLPADDING="0" CELLSPACING="0" STYLE="border-collapse: collapse; width: 100%; font-size: 10pt"><TR STYLE="vertical-align: top; text-align: left"><TD STYLE="text-align: center; width: 100%"><!-- Field: Sequence; Type: Arabic; Name: PageNo -->13<!-- Field: /Sequence --></TD></TR></TABLE></DIV>
    <DIV STYLE="break-before: page; margin-top: 6pt; margin-bottom: 0pt"><P STYLE="margin: 0pt">&nbsp;</P></DIV>
    <!-- Field: /Page -->

<P STYLE="margin: 0">&nbsp;</P>

<TABLE CELLSPACING="0" CELLPADDING="0" STYLE="font: 10pt Times New Roman, Times, Serif; width: 100%; border-collapse: collapse">
  <TR STYLE="font: 10pt Times New Roman, Times, Serif">
    <TD STYLE="font: 10pt Times New Roman, Times, Serif; text-align: justify; width: 0.5in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></TD>
    <TD STYLE="font: 10pt Times New Roman, Times, Serif; text-align: justify; width: 0.25in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#9679;</FONT></TD>
    <TD STYLE="font: 10pt Times New Roman, Times, Serif; text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">the
    liquidation preference per share;</FONT></TD></TR>
  <TR STYLE="font: 10pt Times New Roman, Times, Serif">
    <TD STYLE="font: 10pt Times New Roman, Times, Serif; text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></TD>
    <TD STYLE="font: 10pt Times New Roman, Times, Serif; text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></TD>
    <TD STYLE="font: 10pt Times New Roman, Times, Serif; text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></TD></TR>
  <TR STYLE="font: 10pt Times New Roman, Times, Serif">
    <TD STYLE="font: 10pt Times New Roman, Times, Serif; text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></TD>
    <TD STYLE="font: 10pt Times New Roman, Times, Serif; text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#9679;</FONT></TD>
    <TD STYLE="font: 10pt Times New Roman, Times, Serif; text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">the
    purchase price;</FONT></TD></TR>
  <TR STYLE="font: 10pt Times New Roman, Times, Serif">
    <TD STYLE="font: 10pt Times New Roman, Times, Serif; text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></TD>
    <TD STYLE="font: 10pt Times New Roman, Times, Serif; text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></TD>
    <TD STYLE="font: 10pt Times New Roman, Times, Serif; text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></TD></TR>
  <TR STYLE="font: 10pt Times New Roman, Times, Serif">
    <TD STYLE="font: 10pt Times New Roman, Times, Serif; text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></TD>
    <TD STYLE="font: 10pt Times New Roman, Times, Serif; text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#9679;</FONT></TD>
    <TD STYLE="font: 10pt Times New Roman, Times, Serif; text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">the
    dividend rate, period and payment date and method of calculation for dividends;</FONT></TD></TR>
  <TR STYLE="font: 10pt Times New Roman, Times, Serif">
    <TD STYLE="font: 10pt Times New Roman, Times, Serif; text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></TD>
    <TD STYLE="font: 10pt Times New Roman, Times, Serif; text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></TD>
    <TD STYLE="font: 10pt Times New Roman, Times, Serif; text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></TD></TR>
  <TR STYLE="font: 10pt Times New Roman, Times, Serif">
    <TD STYLE="font: 10pt Times New Roman, Times, Serif; text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></TD>
    <TD STYLE="font: 10pt Times New Roman, Times, Serif; text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#9679;</FONT></TD>
    <TD STYLE="font: 10pt Times New Roman, Times, Serif; text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">whether
    dividends will be cumulative or non-cumulative and, if cumulative, the date from which dividends will accumulate;</FONT></TD></TR>
  <TR STYLE="font: 10pt Times New Roman, Times, Serif">
    <TD STYLE="font: 10pt Times New Roman, Times, Serif; text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></TD>
    <TD STYLE="font: 10pt Times New Roman, Times, Serif; text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></TD>
    <TD STYLE="font: 10pt Times New Roman, Times, Serif; text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></TD></TR>
  <TR STYLE="font: 10pt Times New Roman, Times, Serif">
    <TD STYLE="font: 10pt Times New Roman, Times, Serif; text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></TD>
    <TD STYLE="font: 10pt Times New Roman, Times, Serif; text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#9679;</FONT></TD>
    <TD STYLE="font: 10pt Times New Roman, Times, Serif; text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">the
    procedures for any auction or remarketing, if any;</FONT></TD></TR>
  <TR STYLE="font: 10pt Times New Roman, Times, Serif">
    <TD STYLE="font: 10pt Times New Roman, Times, Serif; text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></TD>
    <TD STYLE="font: 10pt Times New Roman, Times, Serif; text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></TD>
    <TD STYLE="font: 10pt Times New Roman, Times, Serif; text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></TD></TR>
  <TR STYLE="font: 10pt Times New Roman, Times, Serif">
    <TD STYLE="font: 10pt Times New Roman, Times, Serif; text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></TD>
    <TD STYLE="font: 10pt Times New Roman, Times, Serif; text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#9679;</FONT></TD>
    <TD STYLE="font: 10pt Times New Roman, Times, Serif; text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">the
    provisions for a sinking fund, if any;</FONT></TD></TR>
  <TR STYLE="font: 10pt Times New Roman, Times, Serif">
    <TD STYLE="font: 10pt Times New Roman, Times, Serif; text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></TD>
    <TD STYLE="font: 10pt Times New Roman, Times, Serif; text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></TD>
    <TD STYLE="font: 10pt Times New Roman, Times, Serif; text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></TD></TR>
  <TR STYLE="font: 10pt Times New Roman, Times, Serif">
    <TD STYLE="font: 10pt Times New Roman, Times, Serif; text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></TD>
    <TD STYLE="font: 10pt Times New Roman, Times, Serif; text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#9679;</FONT></TD>
    <TD STYLE="font: 10pt Times New Roman, Times, Serif; text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">the
    provisions for redemption or repurchase, if applicable, and any restrictions on our ability to exercise those redemption and repurchase
    rights;</FONT></TD></TR>
  <TR STYLE="font: 10pt Times New Roman, Times, Serif">
    <TD STYLE="font: 10pt Times New Roman, Times, Serif; text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></TD>
    <TD STYLE="font: 10pt Times New Roman, Times, Serif; text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></TD>
    <TD STYLE="font: 10pt Times New Roman, Times, Serif; text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></TD></TR>
  <TR STYLE="font: 10pt Times New Roman, Times, Serif">
    <TD STYLE="font: 10pt Times New Roman, Times, Serif; text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></TD>
    <TD STYLE="font: 10pt Times New Roman, Times, Serif; text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#9679;</FONT></TD>
    <TD STYLE="font: 10pt Times New Roman, Times, Serif; text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">any
    listing of the preferred stock on any securities exchange or market;</FONT></TD></TR>
  <TR STYLE="font: 10pt Times New Roman, Times, Serif">
    <TD STYLE="font: 10pt Times New Roman, Times, Serif; text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></TD>
    <TD STYLE="font: 10pt Times New Roman, Times, Serif; text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></TD>
    <TD STYLE="font: 10pt Times New Roman, Times, Serif; text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></TD></TR>
  <TR STYLE="font: 10pt Times New Roman, Times, Serif; vertical-align: top">
    <TD STYLE="font: 10pt Times New Roman, Times, Serif; text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></TD>
    <TD STYLE="font: 10pt Times New Roman, Times, Serif; text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#9679;</FONT></TD>
    <TD STYLE="font: 10pt Times New Roman, Times, Serif; text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">whether
    the preferred stock will be convertible into or exchangeable for other securities and, if applicable, the conversion price, or how
    it will be calculated, and the conversion period;</FONT></TD></TR>
  <TR STYLE="font: 10pt Times New Roman, Times, Serif; vertical-align: top">
    <TD STYLE="font: 10pt Times New Roman, Times, Serif; text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></TD>
    <TD STYLE="font: 10pt Times New Roman, Times, Serif; text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></TD>
    <TD STYLE="font: 10pt Times New Roman, Times, Serif; text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></TD></TR>
  <TR STYLE="font: 10pt Times New Roman, Times, Serif; vertical-align: top">
    <TD STYLE="font: 10pt Times New Roman, Times, Serif; text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></TD>
    <TD STYLE="font: 10pt Times New Roman, Times, Serif; text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#9679;</FONT></TD>
    <TD STYLE="font: 10pt Times New Roman, Times, Serif; text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">voting
    rights, if any, of the preferred stock;</FONT></TD></TR>
  <TR STYLE="font: 10pt Times New Roman, Times, Serif; vertical-align: top">
    <TD STYLE="font: 10pt Times New Roman, Times, Serif; text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></TD>
    <TD STYLE="font: 10pt Times New Roman, Times, Serif; text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></TD>
    <TD STYLE="font: 10pt Times New Roman, Times, Serif; text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></TD></TR>
  <TR STYLE="font: 10pt Times New Roman, Times, Serif; vertical-align: top">
    <TD STYLE="font: 10pt Times New Roman, Times, Serif; text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></TD>
    <TD STYLE="font: 10pt Times New Roman, Times, Serif; text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#9679;</FONT></TD>
    <TD STYLE="font: 10pt Times New Roman, Times, Serif; text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">preemptive
    rights, if any;</FONT></TD></TR>
  <TR STYLE="font: 10pt Times New Roman, Times, Serif; vertical-align: top">
    <TD STYLE="font: 10pt Times New Roman, Times, Serif; text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></TD>
    <TD STYLE="font: 10pt Times New Roman, Times, Serif; text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></TD>
    <TD STYLE="font: 10pt Times New Roman, Times, Serif; text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></TD></TR>
  <TR STYLE="font: 10pt Times New Roman, Times, Serif; vertical-align: top">
    <TD STYLE="font: 10pt Times New Roman, Times, Serif; text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></TD>
    <TD STYLE="font: 10pt Times New Roman, Times, Serif; text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#9679;</FONT></TD>
    <TD STYLE="font: 10pt Times New Roman, Times, Serif; text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">restrictions
    on transfer, sale or other assignment, if any;</FONT></TD></TR>
  <TR STYLE="font: 10pt Times New Roman, Times, Serif; vertical-align: top">
    <TD STYLE="font: 10pt Times New Roman, Times, Serif; text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></TD>
    <TD STYLE="font: 10pt Times New Roman, Times, Serif; text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></TD>
    <TD STYLE="font: 10pt Times New Roman, Times, Serif; text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></TD></TR>
  <TR STYLE="font: 10pt Times New Roman, Times, Serif; vertical-align: top">
    <TD STYLE="font: 10pt Times New Roman, Times, Serif; text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></TD>
    <TD STYLE="font: 10pt Times New Roman, Times, Serif; text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#9679;</FONT></TD>
    <TD STYLE="font: 10pt Times New Roman, Times, Serif; text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">liability
    as to further calls or to assessment by the Company, if any;</FONT></TD></TR>
  <TR STYLE="font: 10pt Times New Roman, Times, Serif; vertical-align: top">
    <TD STYLE="font: 10pt Times New Roman, Times, Serif; text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></TD>
    <TD STYLE="font: 10pt Times New Roman, Times, Serif; text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></TD>
    <TD STYLE="font: 10pt Times New Roman, Times, Serif; text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></TD></TR>
  <TR STYLE="font: 10pt Times New Roman, Times, Serif; vertical-align: top">
    <TD STYLE="font: 10pt Times New Roman, Times, Serif; text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></TD>
    <TD STYLE="font: 10pt Times New Roman, Times, Serif; text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#9679;</FONT></TD>
    <TD STYLE="font: 10pt Times New Roman, Times, Serif; text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">a
    discussion of any material U.S. federal income tax considerations applicable to the preferred stock;</FONT></TD></TR>
  <TR STYLE="font: 10pt Times New Roman, Times, Serif; vertical-align: top">
    <TD STYLE="font: 10pt Times New Roman, Times, Serif; text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></TD>
    <TD STYLE="font: 10pt Times New Roman, Times, Serif; text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></TD>
    <TD STYLE="font: 10pt Times New Roman, Times, Serif; text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></TD></TR>
  <TR STYLE="font: 10pt Times New Roman, Times, Serif; vertical-align: top">
    <TD STYLE="font: 10pt Times New Roman, Times, Serif; text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></TD>
    <TD STYLE="font: 10pt Times New Roman, Times, Serif; text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#9679;</FONT></TD>
    <TD STYLE="font: 10pt Times New Roman, Times, Serif; text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">the
    relative ranking and preferences of the preferred stock as to dividend rights and rights if we liquidate, dissolve or wind up our
    affairs;</FONT></TD></TR>
  <TR STYLE="font: 10pt Times New Roman, Times, Serif; vertical-align: top">
    <TD STYLE="font: 10pt Times New Roman, Times, Serif; text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></TD>
    <TD STYLE="font: 10pt Times New Roman, Times, Serif; text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></TD>
    <TD STYLE="font: 10pt Times New Roman, Times, Serif; text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></TD></TR>
  <TR STYLE="font: 10pt Times New Roman, Times, Serif; vertical-align: top">
    <TD STYLE="font: 10pt Times New Roman, Times, Serif; text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></TD>
    <TD STYLE="font: 10pt Times New Roman, Times, Serif; text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#9679;</FONT></TD>
    <TD STYLE="font: 10pt Times New Roman, Times, Serif; text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">any
    limitations on the issuance of any class or series of preferred stock ranking senior to or on a parity with the series of preferred
    stock as to dividend rights and rights if we liquidate, dissolve or wind up our affairs; and</FONT></TD></TR>
  <TR STYLE="font: 10pt Times New Roman, Times, Serif; vertical-align: top">
    <TD STYLE="font: 10pt Times New Roman, Times, Serif; text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></TD>
    <TD STYLE="font: 10pt Times New Roman, Times, Serif; text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></TD>
    <TD STYLE="font: 10pt Times New Roman, Times, Serif; text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></TD></TR>
  <TR STYLE="font: 10pt Times New Roman, Times, Serif; vertical-align: top">
    <TD STYLE="font: 10pt Times New Roman, Times, Serif; text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></TD>
    <TD STYLE="font: 10pt Times New Roman, Times, Serif; text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#9679;</FONT></TD>
    <TD STYLE="font: 10pt Times New Roman, Times, Serif; text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">any
    other specific terms, preferences, rights or limitations of, or restrictions on, the preferred stock.</FONT></TD></TR>
  </TABLE>
<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify; text-indent: 0.5in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">The
DGCL provides that the holders of preferred stock will have the right to vote separately as a class or, in some cases, as a series on
an amendment to our Certificate of Incorporation if the amendment would change the par value or, unless our Certificate of Incorporation
provides otherwise, the number of authorized shares of the class or the powers, preferences or special rights of the class or series
so as to adversely affect the class or series, as the case may be. This right is in addition to any voting rights that may be provided
in the applicable certificate of designation.</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify; text-indent: 0.5in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">Our
board of directors may authorize the issuance of preferred stock with voting or conversion rights that could adversely affect the voting
power or other rights of the holders of our Common Stock or other securities. Preferred stock could be issued quickly with terms designed
to delay or prevent a change in control of our Company or make removal of management more difficult. Additionally, the issuance of preferred
stock may have the effect of decreasing the market price of our Common Stock.</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify; text-indent: 0.5in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify; text-indent: 0.5in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt"></FONT></P>

<!-- Field: Page; Sequence: 19; Value: 1 -->
    <DIV STYLE="margin-top: 0pt; margin-bottom: 6pt; border-bottom: Black 1pt solid"><TABLE CELLPADDING="0" CELLSPACING="0" STYLE="border-collapse: collapse; width: 100%; font-size: 10pt"><TR STYLE="vertical-align: top; text-align: left"><TD STYLE="text-align: center; width: 100%"><!-- Field: Sequence; Type: Arabic; Name: PageNo -->14<!-- Field: /Sequence --></TD></TR></TABLE></DIV>
    <DIV STYLE="break-before: page; margin-top: 6pt; margin-bottom: 0pt"><P STYLE="margin: 0pt">&nbsp;</P></DIV>
    <!-- Field: /Page -->

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify; text-indent: 0.5in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt"><B>Anti-Takeover
Considerations and Special Provisions of Our Certificate of Incorporation, Our Bylaws and the Delaware General Corporation Law</B></FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt"><B><I>Certificate
of Incorporation and Bylaws</I></B></FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify; text-indent: 0.5in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">A
number of provisions of our Certificate of Incorporation and Bylaws concern matters of corporate governance and the rights of our stockholders.
Provisions that grant our board of directors the ability to issue shares of preferred stock and to set the voting rights, preferences
and other terms thereof may discourage takeover attempts that are not first approved by our board of directors, including takeovers that
may be considered by some stockholders to be in their best interests, such as those attempts that might result in a premium over the
market price for the shares held by stockholders. Certain provisions could delay or impede the removal of incumbent directors even if
such removal would be beneficial to our stockholders, such as the classification of our board of directors and the lack of cumulative
voting.</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify; text-indent: 0.5in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">Since
our board of directors has the power to retain and discharge our officers, these provisions could also make it more difficult for existing
stockholders or another party to effect a change in management.</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify; text-indent: 0.5in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">These
provisions may have the effect of deterring hostile takeovers or delaying changes in our control or in our management. These provisions
are intended to enhance the likelihood of continued stability in the composition of our board of directors and in the policies they implement
and to discourage certain types of transactions that may involve an actual or threatened change of our control. These provisions are
designed to reduce our vulnerability to an unsolicited acquisition proposal. The provisions also are intended to discourage certain tactics
that may be used in proxy fights. However, such provisions could have the effect of discouraging others from making tender offers for
our shares and, as a consequence, they also may inhibit fluctuations in the market price of our shares that could result from actual
or rumored takeover attempts.</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify; text-indent: 0.5in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">These
provisions also could discourage or make more difficult a merger, tender offer or proxy contest, even if they could be favorable to the
interests of stockholders and could potentially depress the market price of our Common Stock. Our board of directors believes that these
provisions are appropriate to protect our interests and the interests of our stockholders.</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt"><B><I>Classification
of Board; No Cumulative Voting</I></B></FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify; text-indent: 0.5in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">Our
Certificate of Incorporation and Bylaws provide for our board of directors to be divided into three classes, with staggered three-year
terms. Only one class of directors is elected at each annual meeting of our stockholders, with the other classes continuing for the remainder
of their respective three-year terms. Because our stockholders do not have cumulative voting rights, our stockholders representing a
majority of the shares of Common Stock outstanding will be able to elect all of our directors due to be elected at each annual meeting
of our stockholders.</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt"><B><I>Meetings
of and Actions by Stockholders</I></B></FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify; text-indent: 0.5in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">Our
Bylaws provide that annual meetings of our stockholders may take place at the time and place designated by our board of directors. A
special meeting of our stockholders may be called at any time by our board of directors, the chairman of our board of directors or the
president. Our Bylaws provide that (i) our board of directors can fix separate record dates for determining stockholders entitled to
receive notice of a stockholder meeting and for determining stockholders entitled to vote at the meeting; (ii) we may hold a stockholder
meeting by means of remote communications; (iii) any stockholder seeking to have the stockholders authorize or take corporate action
by written consent shall, by written notice to the secretary of the Company, request that the board of directors fix a record date, and
that the board of directors shall adopt a resolution fixing the record date in all events within ten calendar days after a request is
received; and (iv) a written consent of stockholders shall not be effective unless a written consent signed by a sufficient number of
stockholders to take such action is received by us within 60 calendar days of the earliest dated written consent received.</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt"></FONT></P>

<!-- Field: Page; Sequence: 20; Value: 1 -->
    <DIV STYLE="margin-top: 0pt; margin-bottom: 6pt; border-bottom: Black 1pt solid"><TABLE CELLPADDING="0" CELLSPACING="0" STYLE="border-collapse: collapse; width: 100%; font-size: 10pt"><TR STYLE="vertical-align: top; text-align: left"><TD STYLE="text-align: center; width: 100%"><!-- Field: Sequence; Type: Arabic; Name: PageNo -->15<!-- Field: /Sequence --></TD></TR></TABLE></DIV>
    <DIV STYLE="break-before: page; margin-top: 6pt; margin-bottom: 0pt"><P STYLE="margin: 0pt">&nbsp;</P></DIV>
    <!-- Field: /Page -->

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt"><B><I>Advance
Notice Requirements for Stockholder Proposals and Director Nominations</I></B></FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify; text-indent: 0.5in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">Our
Bylaws provide that stockholders seeking to bring business before an annual meeting of stockholders or to nominate candidates for election
as directors at an annual meeting of stockholders must provide timely notice in writing. To be timely, a stockholder&rsquo;s notice must
be delivered to, or mailed and received by, the secretary of the Company at our principal executive offices not later than the close
of business on the 90th calendar day, nor earlier than the close of business on the 120th calendar day in advance of the date specified
in the Company&rsquo;s proxy statement released to stockholders in connection with the previous year&rsquo;s annual meeting of stockholders.
If the date of the annual meeting is more than 30 calendar days before or after such anniversary date, notice by the stockholder to be
timely must be so not earlier than the close of business on the 120th calendar day in advance of such date of annual meeting and not
later than the close of business on the later of the 90th calendar day in advance of such date of annual meeting or the tenth calendar
day following the date on which public announcement of the date of the meeting is made. In no event shall the public announcement of
an adjournment or postponement of an annual meeting commence a new time period (or extend any time period) for the giving of an advance
notice by any stockholder. Any stockholder that proposes director nominations or other business must be a stockholder of record at the
time the advance notice is delivered by such stockholder to us and entitled to vote at the meeting. Our Bylaws also specify requirements
as to the form and content of a stockholder&rsquo;s notice. These provisions may preclude stockholders from bringing matters before an
annual meeting of stockholders or from making nominations for the election of directors at an annual meeting of stockholders. Unless
otherwise required by law, any director nomination or other business shall not be made or transacted if the stockholder (or a qualified
representative of the stockholder) does not appear at the meeting to present the director nominee or other proposed business.</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt"><B><I>Filling
of Board Vacancies</I></B></FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify; text-indent: 0.5in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">Our
Certificate of Incorporation and Bylaws provide that the authorized size of our board of directors shall be determined by the board of
directors by board resolution from time to time and that our board of directors has the exclusive power to fill any vacancies and newly
created directorships resulting from any increase in the authorized number of directors and the stockholders do not have the power to
fill such vacancies. Vacancies in our board of directors and newly created directorships resulting from any increase in the authorized
number of directors on our board of directors may be filled by a majority of the directors remaining in office, even though that number
may be less than a quorum of our board of directors, or by a sole remaining director. A director so elected to fill a vacancy shall serve
for the remaining term of the predecessor he or she replaced and until his or her successor is elected and has qualified, or until his
or her earlier resignation, removal or death.</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt"><B><I>Amendment
of the Certificate of Incorporation</I></B></FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify; text-indent: 0.5in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">Our
Certificate of Incorporation may be amended, altered, changed or repealed at a meeting of our stockholders entitled to vote thereon by
the affirmative vote of a majority of the outstanding stock entitled to vote thereon and a majority of the outstanding stock of each
class entitled to vote thereon as a class, in the manner prescribed by the DGCL.</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt"><B><I>Amendment
of the Bylaws</I></B></FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify; text-indent: 0.5in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">Our
Bylaws may be amended or repealed, or new Bylaws may be adopted, by either our board of directors or the affirmative vote of at least
66 2/3 percent of the voting power of our outstanding shares of capital stock.</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt"><B><I>Section
203 of the Delaware General Corporation Law</I></B></FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify; text-indent: 0.5in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">We
are subject to Section 203 of the DGCL, which prohibits a Delaware corporation from engaging in any business combination with any interested
stockholder for a period of three years after the date that such stockholder became an interested stockholder, with the following exceptions:</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>

<TABLE CELLSPACING="0" CELLPADDING="0" STYLE="font: 10pt Times New Roman, Times, Serif; width: 100%; border-collapse: collapse">
  <TR STYLE="font: 10pt Times New Roman, Times, Serif; vertical-align: top">
    <TD STYLE="font: 10pt Times New Roman, Times, Serif; width: 0.5in; text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></TD>
    <TD STYLE="font: 10pt Times New Roman, Times, Serif; width: 0.25in; text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#9679;</FONT></TD>
    <TD STYLE="font: 10pt Times New Roman, Times, Serif; text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">before
    such date, the board of directors of the corporation approved either the business combination or the transaction that resulted in
    the stockholder becoming an interested stockholder;</FONT></TD></TR>
</TABLE>

<P STYLE="margin: 0">&nbsp;</P>

<P STYLE="margin: 0"></P>

<!-- Field: Page; Sequence: 21; Value: 1 -->
    <DIV STYLE="margin-top: 0pt; margin-bottom: 6pt; border-bottom: Black 1pt solid"><TABLE CELLPADDING="0" CELLSPACING="0" STYLE="border-collapse: collapse; width: 100%; font-size: 10pt"><TR STYLE="vertical-align: top; text-align: left"><TD STYLE="text-align: center; width: 100%"><!-- Field: Sequence; Type: Arabic; Name: PageNo -->16<!-- Field: /Sequence --></TD></TR></TABLE></DIV>
    <DIV STYLE="break-before: page; margin-top: 6pt; margin-bottom: 0pt"><P STYLE="margin: 0pt">&nbsp;</P></DIV>
    <!-- Field: /Page -->

<P STYLE="margin: 0">&nbsp;</P>

<TABLE CELLSPACING="0" CELLPADDING="0" STYLE="font: 10pt Times New Roman, Times, Serif; width: 100%; border-collapse: collapse">
  <TR STYLE="font: 10pt Times New Roman, Times, Serif; vertical-align: top">
    <TD STYLE="font: 10pt Times New Roman, Times, Serif; text-align: justify; width: 0.5in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></TD>
    <TD STYLE="font: 10pt Times New Roman, Times, Serif; text-align: justify; width: 0.25in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#9679;</FONT></TD>
    <TD STYLE="font: 10pt Times New Roman, Times, Serif; text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">upon
    completion of the transaction that resulted in the stockholder becoming an interested stockholder, the interested stockholder owned
    at least 85 percent of the voting stock of the corporation outstanding at the time the transaction began, excluding for purposes
    of determining the voting stock outstanding (but not the outstanding voting stock owned by the interested stockholder) those shares
    owned (i) by persons who are directors and also officers and (ii) pursuant to employee stock plans in which employee participants
    do not have the right to determine confidentially whether shares held subject to the plan will be tendered in a tender or exchange
    offer; and</FONT></TD></TR>
  <TR STYLE="font: 10pt Times New Roman, Times, Serif; vertical-align: top">
    <TD STYLE="font: 10pt Times New Roman, Times, Serif; text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></TD>
    <TD STYLE="font: 10pt Times New Roman, Times, Serif; text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></TD>
    <TD STYLE="font: 10pt Times New Roman, Times, Serif; text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></TD></TR>
  <TR STYLE="font: 10pt Times New Roman, Times, Serif; vertical-align: top">
    <TD STYLE="font: 10pt Times New Roman, Times, Serif; text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></TD>
    <TD STYLE="font: 10pt Times New Roman, Times, Serif; text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#9679;</FONT></TD>
    <TD STYLE="font: 10pt Times New Roman, Times, Serif; text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">on
    or after such date, the business combination is approved by the board of directors and authorized at an annual or special meeting
    of the stockholders, and not by written consent, by the affirmative vote of at least 66 2/3 percent of the outstanding voting stock
    that is not owned by the interested stockholder.</FONT></TD></TR>
  </TABLE>
<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify; text-indent: 0.5in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">In
general, Section 203 defines a business combination to include the following:</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>

<TABLE CELLSPACING="0" CELLPADDING="0" STYLE="font: 10pt Times New Roman, Times, Serif; width: 100%; border-collapse: collapse">
  <TR STYLE="font: 10pt Times New Roman, Times, Serif; vertical-align: top">
    <TD STYLE="font: 10pt Times New Roman, Times, Serif; width: 0.5in; text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></TD>
    <TD STYLE="font: 10pt Times New Roman, Times, Serif; width: 0.25in; text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#9679;</FONT></TD>
    <TD STYLE="font: 10pt Times New Roman, Times, Serif; text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">any
    merger or consolidation involving the corporation and the interested stockholder;</FONT></TD></TR>
  <TR STYLE="font: 10pt Times New Roman, Times, Serif; vertical-align: top">
    <TD STYLE="font: 10pt Times New Roman, Times, Serif; text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></TD>
    <TD STYLE="font: 10pt Times New Roman, Times, Serif; text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></TD>
    <TD STYLE="font: 10pt Times New Roman, Times, Serif; text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></TD></TR>
  <TR STYLE="font: 10pt Times New Roman, Times, Serif; vertical-align: top">
    <TD STYLE="font: 10pt Times New Roman, Times, Serif; text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></TD>
    <TD STYLE="font: 10pt Times New Roman, Times, Serif; text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#9679;</FONT></TD>
    <TD STYLE="font: 10pt Times New Roman, Times, Serif; text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">any
    sale, lease, transfer, pledge or other disposition of ten percent or more of the assets of the corporation to or with the interested
    stockholder;</FONT></TD></TR>
  <TR STYLE="font: 10pt Times New Roman, Times, Serif; vertical-align: top">
    <TD STYLE="font: 10pt Times New Roman, Times, Serif; text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></TD>
    <TD STYLE="font: 10pt Times New Roman, Times, Serif; text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></TD>
    <TD STYLE="font: 10pt Times New Roman, Times, Serif; text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></TD></TR>
  <TR STYLE="font: 10pt Times New Roman, Times, Serif; vertical-align: top">
    <TD STYLE="font: 10pt Times New Roman, Times, Serif; text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></TD>
    <TD STYLE="font: 10pt Times New Roman, Times, Serif; text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#9679;</FONT></TD>
    <TD STYLE="font: 10pt Times New Roman, Times, Serif; text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">subject
    to certain exceptions, any transaction that results in the issuance or transfer by the corporation of any stock of the corporation
    to the interested stockholder;</FONT></TD></TR>
  <TR STYLE="font: 10pt Times New Roman, Times, Serif; vertical-align: top">
    <TD STYLE="font: 10pt Times New Roman, Times, Serif; text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></TD>
    <TD STYLE="font: 10pt Times New Roman, Times, Serif; text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></TD>
    <TD STYLE="font: 10pt Times New Roman, Times, Serif; text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></TD></TR>
  <TR STYLE="font: 10pt Times New Roman, Times, Serif; vertical-align: top">
    <TD STYLE="font: 10pt Times New Roman, Times, Serif; text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></TD>
    <TD STYLE="font: 10pt Times New Roman, Times, Serif; text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#9679;</FONT></TD>
    <TD STYLE="font: 10pt Times New Roman, Times, Serif; text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">any
    transaction involving the corporation that has the effect of increasing the proportionate share of the stock or any class or series
    of the corporation beneficially owned by the interested stockholder; and</FONT></TD></TR>
  <TR STYLE="font: 10pt Times New Roman, Times, Serif; vertical-align: top">
    <TD STYLE="font: 10pt Times New Roman, Times, Serif; text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></TD>
    <TD STYLE="font: 10pt Times New Roman, Times, Serif; text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></TD>
    <TD STYLE="font: 10pt Times New Roman, Times, Serif; text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></TD></TR>
  <TR STYLE="font: 10pt Times New Roman, Times, Serif; vertical-align: top">
    <TD STYLE="font: 10pt Times New Roman, Times, Serif; text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></TD>
    <TD STYLE="font: 10pt Times New Roman, Times, Serif; text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#9679;</FONT></TD>
    <TD STYLE="font: 10pt Times New Roman, Times, Serif; text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">the
    receipt by the interested stockholder of the benefit of any loss, advances, guarantees, pledges or other financial benefits by or
    through the corporation.</FONT></TD></TR>
  </TABLE>
<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify; text-indent: 0.5in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">In
general, Section 203 of the DGCL defines an &ldquo;interested stockholder&rdquo; as an entity or person who, together with the entity&rsquo;s
or person&rsquo;s affiliates and associates, beneficially owns, or is an affiliate of the corporation and within three years prior to
the time of determination of interested stockholder status did own, 15 percent or more of the outstanding voting stock of the corporation.</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify; text-indent: 0.5in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">A
Delaware corporation may &ldquo;opt out&rdquo; of these provisions with an express provision in its Certificate of Incorporation. We
have not opted out of these provisions, which may as a result, discourage or prevent mergers or other takeover or change of control attempts
of us.</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify; text-indent: 0.5in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>


<!-- Field: Page; Sequence: 22; Value: 1 -->
    <DIV STYLE="margin-top: 0pt; margin-bottom: 6pt; border-bottom: Black 1pt solid"><TABLE CELLPADDING="0" CELLSPACING="0" STYLE="border-collapse: collapse; width: 100%; font-size: 10pt"><TR STYLE="vertical-align: top; text-align: left"><TD STYLE="text-align: center; width: 100%"><!-- Field: Sequence; Type: Arabic; Name: PageNo -->17<!-- Field: /Sequence --></TD></TR></TABLE></DIV>
    <DIV STYLE="break-before: page; margin-top: 6pt; margin-bottom: 0pt"><P STYLE="margin: 0pt">&nbsp;</P></DIV>
    <!-- Field: /Page -->

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: center"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt"><B>&nbsp;</B></FONT></P>

<P STYLE="font: bold 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; text-align: center"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt"><A NAME="Aa_010"></A>DESCRIPTION
OF SECURITIES WE ARE OFFERING</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: center"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt"><B>&nbsp;</B></FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify; text-indent: 0.5in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">We
are offering shares of our Common Stock or pre-funded warrants in lieu of shares of Common Stock along with common warrants to purchase
shares of our Common Stock. For each pre-funded warrant we sell, the number of shares of Common Stock we are offering will be
decreased on a one-for-one basis. Each share of Common Stock or pre-funded warrant is being sold together with a common warrant to purchase
one share of Common Stock. The shares of Common Stock or pre-funded warrants and accompanying common warrants will be issued separately.
We are also registering the shares of Common Stock issuable from time to time upon exercise of the pre-funded warrants and common warrants
offered hereby.</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt"><B><I>Common
Stock</I></B></FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt"><B><I>&nbsp;</I></B></FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify; text-indent: 0.5in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">See
the description above under &ldquo;<I>Description of Capital Stock&mdash;Common Stock</I>.&rdquo;</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt"><B><I>Pre-Funded
Warrants</I></B></FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt"><I>&nbsp;</I></FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify; text-indent: 0.5in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">The
following summary of certain terms and provisions of pre-funded warrants that are being offered hereby is not complete and is subject
to, and qualified in its entirety by, the provisions of the pre-funded warrant, the form of which is filed as an exhibit to the registration
statement of which this prospectus forms a part. Prospective investors should carefully review the terms and provisions of the form of
pre-funded warrant for a complete description of the terms and conditions of the pre-funded warrants.</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify; text-indent: 20pt"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt"><I>Duration
and Exercise Price</I></FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify; text-indent: 20pt"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify; text-indent: 0.5in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">The
term &ldquo;pre-funded&rdquo; refers to the fact that the purchase price of each pre-funded warrant, at closing, will equal the price
per share at which shares of our Common Stock and accompanying common warrants are being sold to the public in this offering, minus $0.0001,
and the initial exercise price of each pre-funded warrant offered hereby will equal $0.0001 per share of Common Stock. The pre-funded
warrants will be immediately exercisable and may be exercised at any time until the pre-funded warrants are exercised in full. The exercise
price and number of shares of Common Stock issuable upon exercise is subject to appropriate adjustment in the event of stock dividends,
stock splits, reorganizations or similar events affecting our shares of Common Stock and the exercise price. Subject to the rules and
regulations of the applicable trading market, we may at any time during the term of the pre-funded warrant, subject to the prior written
consent of the holders of a majority of the shares issuable upon exercise of the pre-funded warrants, reduce the then current
exercise price to any amount and for any period of time deemed appropriate by our board of directors. The pre-funded warrants will be
issued separately from the common warrants.</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt"><I>Exercisability</I></FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify; text-indent: 20pt"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify; text-indent: 0.5in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">The
pre-funded warrants will be exercisable, at the option of each holder, in whole or in part, by delivering to us a duly executed exercise
notice accompanied by payment in full for the number of shares of our Common Stock purchased upon such exercise (except in the case of
a cashless exercise as discussed below). A holder (together with its affiliates) may not exercise any portion of the pre-funded warrant
to the extent that the holder would own more than 4.99% (or, at the election of the holder, 9.99%) of the outstanding Common Stock
immediately after exercise (the &ldquo;<U>Beneficial Ownership Limitation</U>&rdquo;), except that upon at least 61 days&rsquo; prior
notice from the holder to us, the holder may increase the Beneficial Ownership Limitation to a percentage not to exceed 9.99%. No fractional
shares of Common Stock will be issued in connection with the exercise of a pre-funded warrant. In lieu of fractional shares, we will
either pay the holder an amount in cash equal to the fractional amount multiplied by the exercise price or round up to the
next whole share of Common Stock.</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt"><I>Cashless
Exercise</I></FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify; text-indent: 20pt"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify; text-indent: 0.5in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">If,
at the time a holder exercises its pre-funded warrants, a registration statement registering the issuance of the shares of Common Stock
underlying the pre-funded warrants under the Securities Act is not then effective or available for the issuance of such shares, then
in lieu of making the cash payment otherwise contemplated to be made to us upon such exercise in payment of the aggregate exercise price,
the holder may elect instead to receive upon such exercise (either in whole or in part) the net number of shares of Common Stock determined
according to a formula set forth in the pre-funded warrants.</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify; text-indent: 20pt"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify; text-indent: 20pt"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt"></FONT></P>

<!-- Field: Page; Sequence: 23; Value: 1 -->
    <DIV STYLE="margin-top: 0pt; margin-bottom: 6pt; border-bottom: Black 1pt solid"><TABLE CELLPADDING="0" CELLSPACING="0" STYLE="border-collapse: collapse; width: 100%; font-size: 10pt"><TR STYLE="vertical-align: top; text-align: left"><TD STYLE="text-align: center; width: 100%"><!-- Field: Sequence; Type: Arabic; Name: PageNo -->18<!-- Field: /Sequence --></TD></TR></TABLE></DIV>
    <DIV STYLE="break-before: page; margin-top: 6pt; margin-bottom: 0pt"><P STYLE="margin: 0pt">&nbsp;</P></DIV>
    <!-- Field: /Page -->

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify; text-indent: 20pt"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt"><I>Fundamental
Transaction</I></FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify; text-indent: 0.5in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">In
the event of a fundamental transaction, as described in the pre-funded warrants and generally including any merger or consolidation of
the Company or the sale of all or substantially all of the Company&rsquo;s capital stock or assets, the holders of the pre-funded warrants
will be entitled to receive upon exercise of the pre-funded warrants the kind and amount of securities, cash or other property that the
holders would have received had they exercised the pre-funded warrants immediately prior to such fundamental transaction.</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify; text-indent: 20pt"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt"><I>Transferability</I></FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify; text-indent: 0.5in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">Subject
to applicable laws, a pre-funded warrant may be transferred at the option of the holder upon surrender of the pre-funded warrant to us
together with the appropriate instruments of transfer and funds sufficient to pay any transfer taxes payable upon such transfer.</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify; text-indent: 20pt"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt"><I>Trading
Market</I></FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt"><I>&nbsp;</I></FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify; text-indent: 0.5in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">There
is no trading market available for the pre-funded warrants on any securities exchange or nationally recognized trading system, and we
do not expect a trading market to develop. We do not intend to list the pre-funded warrants on any securities exchange or nationally
recognized trading market. Without a trading market, the liquidity of pre-funded warrants will be extremely limited. The shares of Common
Stock issuable upon exercise of the pre-funded warrants are currently traded on Nasdaq.</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify; text-indent: 0.5in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt"><I>Exchange
Listing</I></FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify; text-indent: 0.5in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">We
do not intend to list the pre-funded warrants on any securities exchange or nationally recognized trading system.</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify; text-indent: 20pt"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt"><I>Rights
as a Stockholder</I></FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify; text-indent: 0.5in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">Except
as otherwise provided in the pre-funded warrants or by virtue of such holder&rsquo;s ownership of shares of our Common Stock, the holders
of the pre-funded warrants do not have the rights or privileges of holders of our Common Stock, including any voting rights, until they
exercise their pre-funded warrants. The pre-funded warrants will provide that holders have the right to participate in distributions
or dividends paid on Common Stock.</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify; text-indent: 20pt"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt"><B><I>Common
Warrants</I></B></FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt"><B><I>&nbsp;</I></B></FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify; text-indent: 0.5in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">The
following summary of certain terms and provisions of the common warrants that are being offered hereby is not complete and is subject
to, and qualified in its entirety by, the provisions of the common warrants, the form of which is filed as an exhibit to the registration
statement of which this prospectus forms a part. Prospective investors should carefully review the terms and provisions of the form of
common warrant for a complete description of the terms and conditions of the common warrants. The common warrants will be issued separately
from the Common Stock and pre-funded warrants, and may be transferred separately immediately thereafter. A common warrant to purchase
one share of our Common Stock will be issued for every one share of Common Stock (or pre-funded warrants, as applicable) purchased in
this offering. </FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify; text-indent: 0.5in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify; text-indent: 0.5in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt"><I>Duration
and Exercise Price</I></FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify; text-indent: 0.5in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt"><I>&nbsp;</I></FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify; text-indent: 0.5in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">Each <FONT STYLE="background-color: white">common
warrant offered hereby will have an initial exercise price per share equal to the combined public offering price per share of Common
Stock and accompanying common warrant, which is assumed here to be </FONT> $1.60 per share <FONT STYLE="background-color: white">(200%
of</FONT> the closing price of our Common Stock on Nasdaq on May 9, 2025). The common warrants will be exercisable
beginning on the Initial Exercise Date <FONT>(i.e., the date on which we file a Current Report on
Form 8-K with the SEC giving public notice of Stockholder Approval) </FONT> and will expire two and one-half (2.5) years after the
Initial Exercise Date. The exercise price of the common warrants and the number of shares underlying the common warrants
are subject to adjustment, including in the following instances: </FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify; text-indent: 0.5in"> <FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT> </P>

<TABLE CELLPADDING="0" CELLSPACING="0" STYLE="width: 100%; font: 10pt Times New Roman, Times, Serif; margin-top: 0; margin-bottom: 0"><TR STYLE="font: 10pt Times New Roman, Times, Serif; vertical-align: top">
<TD STYLE="font: 10pt Times New Roman, Times, Serif; width: 0.5in"></TD><TD STYLE="font: 10pt Times New Roman, Times, Serif; width: 0.25in"> <FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#9679;</FONT> </TD><TD STYLE="font: 10pt Times New Roman, Times, Serif; text-align: justify"> <FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt"><I>Recapitalization
                                            and Other Events</I>: The exercise prices of the common warrants and number of shares underlying
                                            the common warrants are subject to adjustment for stock splits, dividends, combinations,
                                            recapitalization and similar events.</FONT> </TD></TR></TABLE>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0 0 0 0.75in; text-align: justify"> <FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT> </P>

<TABLE CELLPADDING="0" CELLSPACING="0" STYLE="width: 100%; font: 10pt Times New Roman, Times, Serif; margin-top: 0; margin-bottom: 0"><TR STYLE="font: 10pt Times New Roman, Times, Serif; vertical-align: top">
<TD STYLE="font: 10pt Times New Roman, Times, Serif; width: 0.5in"></TD><TD STYLE="font: 10pt Times New Roman, Times, Serif; width: 0.25in"> <FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#9679;</FONT> </TD><TD STYLE="font: 10pt Times New Roman, Times, Serif; text-align: justify"> <FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt"><I>Adjustment
                                            at the &ldquo;Adjustment Date&rdquo;</I>: On the Adjustment Date (as defined below), the
                                            exercise price of the common warrants will be reduced (but in no event increased) to the
                                            greater of (i) the Floor Price (as defined below) and (ii) the lowest daily dollar volume-weighted
                                            average price during the period beginning two full trading days prior to the Adjustment Date
                                            and ending on the 10th trading day after the Adjustment Date. Upon any such resulting adjustment
                                            of the exercise price of the common warrants, the number of shares of Common Stock issuable
                                            under the common warrants will be increased such that the aggregate exercise price of a common
                                            warrant (adjusted for any exercises by a holder prior to this adjustment) will remain unchanged
                                            following such adjustment. No adjustment in connection with an Adjustment Date or otherwise
                                            may result in an adjustment of the exercise price to a price less than the Floor Price. As
                                            a result, the aggregate number of shares of Common Stock underlying all of the common warrants
                                            may increase from 15,000,000 up to 150,000,000 (in each case, based on an assumed public offering
                                            price of $0.80 per share), assuming full adjustment of the exercise price to the Floor Price
                                            and before giving effect to the &ldquo;alternative cashless exercise&rdquo; provision. Assuming
                                            full adjustment of the exercise price to the Floor Price, the aggregate number of shares
                                            of Common Stock issuable upon the exercise of all of the common warrants pursuant to the
                                            &ldquo;alternative cashless exercise&rdquo; provisions therein would be 450,000,000 (based
                                            on an assumed public offering price of $0.80 per share). </FONT> </TD></TR><TR STYLE="font: 10pt Times New Roman, Times, Serif; vertical-align: top">
<TD STYLE="font: 10pt Times New Roman, Times, Serif">&nbsp;</TD><TD STYLE="font: 10pt Times New Roman, Times, Serif">&nbsp;</TD><TD STYLE="font: 10pt Times New Roman, Times, Serif; text-align: justify">&nbsp;</TD></TR>
                                                                                                                          <TR STYLE="font: 10pt Times New Roman, Times, Serif; vertical-align: top">
<TD STYLE="font: 10pt Times New Roman, Times, Serif">&nbsp;</TD><TD STYLE="font: 10pt Times New Roman, Times, Serif"> &#9679; </TD><TD STYLE="font: 10pt Times New Roman, Times, Serif; text-align: justify"><P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0"> <FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt"><I>Adjustments
                                            for Reverse Splits and Share Combination Events:</I> If at any time during the term of the
                                            common warrants there occurs any stock split, reverse stock split, stock dividend, stock
                                            combination recapitalization or other similar transaction involving our Common Stock (each,
                                            a &ldquo;<U>Share Combination Event</U>&rdquo;, and such date on which the Share Combination
                                            Event is effected, the &ldquo;<U>Share Combination Event Date</U>&rdquo;) and the lowest
                                            daily dollar volume-weighted average price per share of our Common Stock during the period
                                            commencing on the trading day immediately following the applicable Share Combination Event
                                            Date and ending on the fifth trading day immediately following the applicable Share Combination
                                            Event Date (the &ldquo;<U>Event Market Price</U>&rdquo;) (provided if the Share Combination
                                            Event is effective prior to the opening of trading on the market on which shares of our Common
                                            Stock are then traded, then, commencing on the Share Combination Event Date and ending on
                                            the fourth trading day immediately following the applicable Share Combination Event Date
                                            (such period, the &ldquo;<U>Share Combination Adjustment Period</U>&rdquo;)) is less than
                                            the exercise price then in effect (after giving effect to the adjustment for such event),
                                            then, at the close of trading on the last day of the Share Combination Adjustment Period,
                                            the exercise price then in effect on such fifth trading day will be reduced (but in no event
                                            increased) to the Event Market Price and the number of shares of Common Stock issuable upon
                                            exercise of a common warrant (such resulting number, the &ldquo;<U>Share Combination Issuable
                                            Shares</U>&rdquo;) will be increased such that the aggregate exercise price, after taking
                                            into account the decrease in the exercise price, will be equal to the aggregate exercise
                                            price on the date of issuance of the common warrants for the remaining shares of Common Stock
                                            then issuable pursuant to the common warrant; provided, however, that in no event will the
                                            Event Market Price be lower than the Floor Price; and provided further that notwithstanding
                                            the foregoing, if one or more Share Combination Events occurred prior to Stockholder Approval
                                            being obtained and the reduction of the exercise price was limited by clause (i) of the definition
                                            of Floor Price, once Stockholder Approval is obtained, the Exercise Price will automatically
                                            be reduced to equal the greater of (x) the lowest Event Market Price with respect to any
                                            Share Combination Event that occurred prior to Stockholder Approval being obtained, and (y)
                                            the price determined by reference to clause (ii) of the definition of Floor Price. If one
                                            or more Share Combination Events occurs prior to Stockholder Approval being obtained and
                                            the reduction of the exercise price to the Event Market Price, once Stockholder Approval
                                            is obtained, the exercise price will automatically be reduced to the lowest Event Market
                                            Price with respect to any Share Combination Event that occurred prior to Stockholder Approval
                                            being obtained and the Share Combination Issuable Shares will automatically be adjusted to
                                            equal the highest such number with respect to any Share Combination Event that occurred prior
                                            to Stockholder Approval being obtained, provided that in no event will the exercise price
                                            be reduced below the Floor Price. As a result, the aggregate number of shares of Common Stock
                                            underlying all of the common warrants may increase from 15,000,000 up to 150,000,000 (in
                                            each case, based on an assumed public offering price of $0.80 per share), assuming full adjustment
                                            of the exercise price to the Floor Price and before giving effect to the &ldquo;alternative
                                            cashless exercise&rdquo; provision. Assuming full adjustment of the exercise price to the
                                            Floor Price, the aggregate number of shares of Common Stock issuable upon the exercise of
                                            all of the common warrants pursuant to the &ldquo;alternative cashless exercise&rdquo; provisions
                                            therein would be 450,000,000 (based on an assumed public offering price of $0.80 per share).</FONT> </P></TD></TR>
                                                                                                                          </TABLE>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify"> <FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT> </P>

<TABLE CELLPADDING="0" CELLSPACING="0" STYLE="width: 100%; font: 10pt Times New Roman, Times, Serif; margin-top: 0; margin-bottom: 0"><TR STYLE="font: 10pt Times New Roman, Times, Serif; vertical-align: top">
<TD STYLE="font: 10pt Times New Roman, Times, Serif; width: 0.5in"></TD><TD STYLE="font: 10pt Times New Roman, Times, Serif; width: 0.25in"> <FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#9679;</FONT> </TD><TD STYLE="font: 10pt Times New Roman, Times, Serif; text-align: justify"> <FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt"><I>Voluntary
                                            Adjustment of Exercise Price</I>: </FONT> <FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">Subject
                                            to the rules and regulations of Nasdaq, the Company may at any time during the term
                                            of the common warrants, with the prior written consent of the holders of the common
                                            warrants representing at least a majority of the shares of Common Stock then underlying
                                            the common warrants, reduce the then current exercise price of the common warrants
                                            to any amount and for any period of time deemed appropriate by the board of directors
                                            of the Company. </FONT></TD></TR></TABLE>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify; text-indent: 0.5in"> <FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT> </P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify; text-indent: 0.5in"> <FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&ldquo;<U>Adjustment
Date</U>&rdquo; means the close of trading on the 11th trading day after the trading day during which the Company files a Current Report
on Form 8-K with the SEC giving public notice of Stockholder Approval.</FONT> </P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify; text-indent: 0.5in"> <FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT> </P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify; text-indent: 0.5in"> <FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&ldquo;<U>Floor
Price</U>&rdquo; means a price per share equal to $0.16 (based on an assumed public offering price of $0.80 per share), which represents
20% of the public offering price per share.</FONT> </P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify; text-indent: 0.5in"> <FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT> </P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify; text-indent: 0.5in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt"></FONT></P>

<!-- Field: Page; Sequence: 24; Value: 1 -->
    <DIV STYLE="margin-top: 0pt; margin-bottom: 6pt; border-bottom: Black 1pt solid"><TABLE CELLPADDING="0" CELLSPACING="0" STYLE="border-collapse: collapse; width: 100%; font-size: 10pt"><TR STYLE="vertical-align: top; text-align: left"><TD STYLE="text-align: center; width: 100%"><!-- Field: Sequence; Type: Arabic; Name: PageNo -->19<!-- Field: /Sequence --></TD></TR></TABLE></DIV>
    <DIV STYLE="break-before: page; margin-top: 6pt; margin-bottom: 0pt"><P STYLE="margin: 0pt">&nbsp;</P></DIV>
    <!-- Field: /Page -->

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify; text-indent: 0.5in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify; text-indent: 0.5in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt"><I>Exercisability</I></FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify; text-indent: 0.5in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt"><I>&nbsp;</I></FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify; text-indent: 0.5in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">The
<FONT>common warrants will be exercisable beginning on the Initial Exercise Date, at the option of each
holder, in whole or in part, by delivering a duly executed exercise notice accompanied by payment in full for the number of shares of
our Common Stock purchased upon such exercise (except in the case of a cashless exercise as discussed below). A holder (together
with its affiliates) may not exercise any portion of the common warrant to the extent that the holder would own more than 4.99% (or,
at the election of the holder, 9.99%) of the outstanding Common Stock immediately after exercise, except that upon at least 61 days&rsquo;
prior notice from the holder to us, the holder may increase or decrease the Beneficial Ownership Limitation to a percentage not to exceed
9.99%. No fractional shares of Common Stock will be issued in connection with the exercise of a common warrant. In lieu of fractional
shares, we will round down to the next whole share of Common Stock. The common warrants will expire two and one-half (2.5)
years after the Initial Exercise Date.</FONT></FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify; text-indent: 0.5in">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify; text-indent: 0.5in"><I>Cashless Exercise
<FONT STYLE="background-color: white">and Alternative Cashless Exercise</FONT> </I></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify; text-indent: 0.5in">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify; text-indent: 0.5in">If, at the time
a holder exercises its common warrants, a registration statement registering the issuance of the shares of Common Stock underlying the
common warrants under the Securities Act is not then effective or available for the issuance of such shares, then in lieu of making the
cash payment otherwise contemplated to be made to us upon such exercise in payment of the aggregate exercise price, the holder may elect
instead to receive upon such exercise (either in whole or in part) the net number of shares of Common Stock determined according to a
formula set forth in the common warrants.</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify; text-indent: 0.5in"> &nbsp; </P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt; text-align: justify; text-indent: 0.5in"> <FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">Holders
may also effect an &ldquo;alternative cashless exercise&rdquo; at any time while the common warrants are outstanding following the Initial
Exercise Date. Under the alternative cashless exercise option, a holder of a common warrant has the right to receive an aggregate number
of shares equal to the product of (i) the aggregate number of shares of Common Stock that would be issuable upon a cash rather than a
cashless exercise of the common warrant and (ii) 3.0. Accordingly, it is highly unlikely that a holder of the common warrants would wish
to pay an exercise price in cash to receive one share of Common Stock when they could instead choose the alternative cashless exercise
option and pay no cash to receive three shares of Common Stock. As a result, we will likely not receive, and do not expect to receive,
any additional funds upon the exercise of the common warrants.</FONT> </P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt; text-align: justify; text-indent: 0.5in"> <FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT> </P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt; text-align: justify; text-indent: 0.5in"> <FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt; background-color: white"><I>Stockholder
Approval</I></FONT> </P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt; text-align: justify"> <FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT> </P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt; text-align: justify; text-indent: 0.5in"> <FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">The
exercisability of the common warrants will be available only upon receipt of Stockholder Approval, including such stockholder approval
as may be required by the applicable rules and regulations of Nasdaq, including, but not limited to, with respect to (i) such approval
as may be required by the applicable rules and regulations of Nasdaq from the stockholders of the Company and board of directors of the
Company: (a) to consent to any adjustment to the exercise price and/or number of shares of Common Stock underlying the common warrants
in the event of an adjustment upon the Adjustment Date (as defined below) pursuant to the terms of the common warrants, (b) to consent
to any adjustment to the exercise price of the common warrants in the event of a voluntary adjustment pursuant to the terms of the common
warrants, and (c) to consent to the &ldquo;alternative cashless exercise&rdquo; provision of the common warrants, in each case without
regard to any limitations upon exercise of the common warrants relating to Stockholder Approval (as defined below) and/or the provisions
prohibiting adjustments in such common warrants above the price set forth in clause (ii) of the definition of Floor Price (as defined
below); and (ii) such approval as may be required from the stockholders of the Company and board of directors of the Company as necessary
to increase the available number of authorized shares of Common Stock of the Company to a minimum of [&#9679;] million authorized shares.
We have agreed to hold a meeting to obtain Stockholder Approval as soon as practicable following the closing of this offering, but no
later than sixty (60) days following the closing of this offering, and further agreed to cause an additional stockholder meeting to be
held every ninety (90) days thereafter until such Stockholder Approval is obtained. We cannot assure you that we will be able to obtain
requisite Stockholder Approval. In the event that we are unable to obtain Stockholder Approval, the common warrants will not be exercisable
and therefore will have no value.</FONT> </P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt; text-align: justify; text-indent: 0.5in"> <FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT> </P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify; text-indent: 0.5in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt"><I>Fundamental
Transaction</I></FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify; text-indent: 0.5in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt"><I>&nbsp;</I></FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify; text-indent: 0.5in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">In
the event of a fundamental transaction, as described in the common warrants and generally including merger or consolidation of the
Company or the sale of all or substantially all of the Company&rsquo;s capital stock or assets, the holders of the common warrants
will be entitled to receive upon exercise of the common warrants the kind and amount of securities, cash or other property that the
holders would have received had they exercised the common warrants immediately prior to such fundamental transaction. Notwithstanding
the foregoing, in the event of a fundamental transaction, the holders of common warrants have the right to require the Company or a
successor entity to purchase the common warrants from the holder for an amount of consideration equal to the Black Scholes Value (as
defined in the common warrants) of the remaining unexercised portion of the common warrants concurrently with or within 30 days
following the consummation of a fundamental transaction.</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify; text-indent: 0.5in">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify; text-indent: 0.5in">However, <FONT>in
the event of a fundamental transaction which is not in the Company&rsquo;s control, including a fundamental transaction not approved
by the Company&rsquo;s board of directors, the holders of the common warrants will only be entitled to receive from the Company or its
successor entity, as of the date of consummation of such fundamental transaction, the same type or form of consideration (and in the
same proportion), at the Black Scholes Value of the unexercised portion of the common warrants, that is being offered and paid to the
holders of the Company&rsquo;s Common Stock in connection with the fundamental transaction, whether that consideration is in the form
of cash, stock or any combination of cash and stock, or whether the holders of the Company&rsquo;s Common Stock are given the choice
to receive alternative forms of consideration in connection with the fundamental transaction. If holders of the Company&rsquo;s Common
Stock are not offered or paid any consideration in a fundamental transaction, such holders of the Company&rsquo;s Common Stock will be
deemed to have received shares of the successor entity in such fundamental transaction, and holders of the common warrants will receive
shares of the successor entity in the amount of the Black Scholes Value.</FONT></P>
<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify; text-indent: 0.5in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify; text-indent: 0.5in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt"><I>Transferability</I></FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify; text-indent: 0.5in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt"><I>&nbsp;</I></FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify; text-indent: 0.5in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">Subject
to applicable laws, a common warrant may be transferred at the option of the holder upon surrender of the common warrant together with
the appropriate instruments of transfer and funds sufficient to pay any transfer taxes payable upon such transfer.</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify; text-indent: 0.5in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify; text-indent: 0.5in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt"><I>Trading
Market</I></FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify; text-indent: 0.5in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt"><I>&nbsp;</I></FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify; text-indent: 0.5in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">There
is no trading market available for the common warrants on any securities exchange or nationally recognized trading system, and we do
not expect a trading market to develop. We do not intend to list the common warrants on any securities exchange or nationally recognized
trading market. Without a trading market, the liquidity of the common warrants will be extremely limited. The shares of Common Stock
issuable upon exercise of the common warrants are currently traded on Nasdaq.</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify; text-indent: 0.5in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify; text-indent: 0.5in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt"><I>Exchange
Listing</I></FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify; text-indent: 0.5in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt"><I>&nbsp;</I></FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify; text-indent: 0.5in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">We
do not intend to list the common warrants on any securities exchange or nationally recognized trading system.</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify; text-indent: 0.5in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify; text-indent: 0.5in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt"><I>Right
as a Stockholder</I></FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify; text-indent: 0.5in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt"><I>&nbsp;</I></FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify; text-indent: 0.5in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">Except
as otherwise provided in the common warrants or by virtue of such holder&rsquo;s ownership of shares of our Common Stock, the holders
of the common warrants do not have the rights or privileges of holders of our Common Stock, including any voting rights, until they exercise
their common warrants. The common warrants will provide that holders have the right to participate in distributions or dividends paid
on Common Stock.</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify; text-indent: 0.5in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify; text-indent: 0.5in"> <FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt"><I>Purchase
Rights</I></FONT> </P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify; text-indent: 0.5in"> <FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT> </P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify; text-indent: 0.5in"> <FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">If
we grant, issue or sell any options, convertible securities, or rights to purchase stock, warrants, securities or other property on a
pro rata basis to the record holders of our Common Stock (such rights, the &ldquo;<U>Purchase Rights</U>&rdquo;), then each holder of
a common warrant will be entitled to participate in the offering of Purchase Rights as if the holder of a common warrant were a holder
of our Common Stock. The amount of Purchase Rights that a holder of a common warrant could acquire would be the amount of Purchase Rights
the holder could have acquired if the holder of a common warrant had held the number of shares of Common Stock acquirable upon complete
exercise of their common warrant immediately before the date on which a record date is taken for the grant, issuance or sale of such
Purchase Rights, or, if no such record is taken, the date as of which the record holders of our Common Stock is determined for the grant,
issue or sale of such Purchase Rights. The number of shares issuable to common warrant holders in excess of the Beneficial Ownership
Limitation will be held in abeyance until such time as the issuance would be in compliance with such limitation.</FONT> </P>
<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify; text-indent: 0.5in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>


<!-- Field: Page; Sequence: 25; Value: 1 -->
    <DIV STYLE="margin-top: 0pt; margin-bottom: 6pt; border-bottom: Black 1pt solid"><TABLE CELLPADDING="0" CELLSPACING="0" STYLE="border-collapse: collapse; width: 100%; font-size: 10pt"><TR STYLE="vertical-align: top; text-align: left"><TD STYLE="text-align: center; width: 100%"><!-- Field: Sequence; Type: Arabic; Name: PageNo -->20<!-- Field: /Sequence --></TD></TR></TABLE></DIV>
    <DIV STYLE="break-before: page; margin-top: 6pt; margin-bottom: 0pt"><P STYLE="margin: 0pt">&nbsp;</P></DIV>
    <!-- Field: /Page -->

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; text-align: center"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt"><B>&nbsp;</B></FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; text-align: center"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt"><B><A NAME="Aa_011"></A>PLAN
OF DISTRIBUTION</B></FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify; text-indent: 0.5in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">Brookline
has agreed to act as our Placement Agent in connection with this offering subject to the terms and conditions of the placement
agency agreement dated &nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;,
2025. The placement agency agreement provides that the Placement Agent obligations are subject to conditions contained in the placement
agency agreement. The Placement Agent is not purchasing or selling any such securities, nor is it required to arrange for
the purchase and sale of any specific number or dollar amount of such securities, other than to use its &ldquo;reasonable best
efforts&rdquo; to arrange for the sale of such securities by us. Therefore, we may not sell all of the shares of Common Stock, pre-funded
warrants and common warrants being offered. The terms of this offering are subject to market conditions and negotiations between us,
the Placement Agent and prospective investors. The securities will be offered at a fixed price and are expected to be issued in
a single closing. The offering will terminate on May 30, 2025, unless (i) the closing occurs prior thereto or (ii) we decide to
terminate the offering prior thereto (which we may do at any time in our discretion), <FONT STYLE="background-color: white">except that
the shares of Common Stock underlying the warrants and shares of Common Stock underlying the pre-funded warrants will be offered on a
continuous basis pursuant to Rule 415 under the Securities Act</FONT>. We will enter into a securities purchase agreement directly with
certain investors, at the investor&rsquo;s option, who purchase our securities in this offering. Investors who do not enter into a securities
purchase agreement shall rely solely on this prospectus in connection with the purchase of our securities in this offering.</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify; text-indent: 0.5in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify; text-indent: 0.5in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">This
is a best-efforts offering, and there is no minimum offering amount required as a condition to the closing of this offering. The actual
amount of gross proceeds, if any, in this offering could vary substantially from the gross proceeds from the sale of the maximum amount
of securities being offered in this prospectus. The Placement Agent may retain sub-agents and selected dealers in connection with
this offering.</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 74.5pt; text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify; text-indent: 0.5in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">We
will deliver the securities being issued to the investors upon receipt of investor funds for the purchase of the securities offered pursuant
to this prospectus. We expect to deliver the securities being offered pursuant to this prospectus DVP/RVP on or about one trading day
after we price the securities being offered hereby. When we price the securities, we will simultaneously enter into securities purchase
agreements relating to the offering with those investors who so choose. Since we will deliver the securities to be issued in this offering
upon our receipt of investor funds, we and the Placement Agent have not made any arrangements to place investor funds in an escrow
account or trust account.</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify; text-indent: 0.5in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify; text-indent: 0.5in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">We
have agreed to indemnify the Placement Agent against specified liabilities, including liabilities under the Securities Act, and
to contribute to payments the Placement Agent may be required to make in respect thereof.</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify; text-indent: 0.5in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt"><B>Determination
of Offering Price and Warrant Exercise Price</B></FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify; text-indent: 0.5in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">The
actual offering price of the securities we are offering, and the exercise price of the common warrants and pre-funded warrants that we
are offering, were negotiated between us, the Placement Agent and the investors in the offering based on the trading of our shares
of Common Stock prior to the offering, among other things. Other factors considered in determining the public offering price of the securities
we are offering, as well as the exercise price of the common warrants that we are offering, include our history and prospects, the stage
of development of our business, our business plans for the future and the extent to which they have been implemented, an assessment of
our management, the general conditions of the securities markets at the time of the offering and such other factors as were deemed relevant.</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify; text-indent: 0.5in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt"><B>Fees
and Expenses</B></FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt"><B>&nbsp;</B></FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify; text-indent: 0.5in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">We
have agreed to pay the Placement Agent an aggregate fee equal to 7.0% of the purchase price paid by all purchasers in the offering.
In addition, we have agreed to reimburse the Placement Agent in an amount up to $75,000 for its accountable offering-related
legal expenses and for non-accountable expenses of up to $20,000. We estimate the total expenses of this offering paid or payable by
us, exclusive of the Placement Agent fee, will be approximately $0.3 million.</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify; text-indent: 0.5in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify; text-indent: 0.5in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt"></FONT></P>

<!-- Field: Page; Sequence: 26; Value: 1 -->
    <DIV STYLE="margin-top: 0pt; margin-bottom: 6pt; border-bottom: Black 1pt solid"><TABLE CELLPADDING="0" CELLSPACING="0" STYLE="border-collapse: collapse; width: 100%; font-size: 10pt"><TR STYLE="vertical-align: top; text-align: left"><TD STYLE="text-align: center; width: 100%"><!-- Field: Sequence; Type: Arabic; Name: PageNo -->21<!-- Field: /Sequence --></TD></TR></TABLE></DIV>
    <DIV STYLE="break-before: page; margin-top: 6pt; margin-bottom: 0pt"><P STYLE="margin: 0pt">&nbsp;</P></DIV>
    <!-- Field: /Page -->

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify; text-indent: 0.5in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify; text-indent: 0.5in"> <FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">Pursuant
to a side letter between the Placement Agent and A.G.P./Alliance Global Partners (&ldquo;A.G.P.&rdquo;), dated April 30, 2025, A.G.P.
agreed to be a financial advisor for the offering. In connection with the services provided by A.G.P., the Placement Agent and A.G.P.
agreed to split gross cash received in connection with the offering and the cash or warrants received pursuant to any right to participate
in any subsequent financing or securities offering of the Company as a lead, sole, or joint underwriter, financial advisor or placement
agent or pursuant to any tail provision that either A.G.P. or the Placement Agent may have with the Company.</FONT> </P>
<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify; text-indent: 0.5in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify; text-indent: 0.5in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">The
following table shows the per share price and total cash fees to be paid to the Placement Agent in connection with the sale of
the Common Stock and shares of Common Stock underlying the pre-funded warrants pursuant to this prospectus.</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify; text-indent: 0.45in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>

<TABLE CELLPADDING="0" CELLSPACING="0" STYLE="font: 10pt Times New Roman, Times, Serif; border-collapse: collapse; width: 100%">
  <TR STYLE="font: 10pt Times New Roman, Times, Serif; vertical-align: bottom">
    <TD STYLE="font: 10pt Times New Roman, Times, Serif; text-align: center">&nbsp;</TD><TD STYLE="font: 10pt Times New Roman, Times, Serif; padding-bottom: 1pt">&nbsp;</TD>
    <TD COLSPAN="2" STYLE="font: 10pt Times New Roman, Times, Serif; text-align: center; border-bottom: Black 1pt solid"><P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: center"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt"><B>Per Share of</B></FONT></P> <P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: center"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt"><B>Common Stock</B></FONT></P> <P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: center"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt"><B>and
                                            Common </B></FONT><B>Warrant</B></P></TD><TD STYLE="font: 10pt Times New Roman, Times, Serif; padding-bottom: 1pt">&nbsp;</TD><TD STYLE="font: 10pt Times New Roman, Times, Serif; padding-bottom: 1pt">&nbsp;</TD>
    <TD COLSPAN="2" STYLE="font: 10pt Times New Roman, Times, Serif; text-align: center; border-bottom: Black 1pt solid"><P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: center"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt"><B>Per Pre-Funded</B></FONT></P> <P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: center"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt"><B>Warrant and</B></FONT></P> <P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: center"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt"><B>Common Warrant</B></FONT></P></TD><TD STYLE="font: 10pt Times New Roman, Times, Serif; padding-bottom: 1pt">&nbsp;</TD><TD STYLE="font: bold 10pt Times New Roman, Times, Serif; padding-bottom: 1pt">&nbsp;</TD>
    <TD COLSPAN="2" STYLE="font: bold 10pt Times New Roman, Times, Serif; text-align: center; border-bottom: Black 1pt solid">Total</TD><TD STYLE="font: bold 10pt Times New Roman, Times, Serif; padding-bottom: 1pt">&nbsp;</TD></TR>
  <TR STYLE="font: 10pt Times New Roman, Times, Serif; vertical-align: bottom; background-color: rgb(204,238,255)">
    <TD STYLE="font: 10pt Times New Roman, Times, Serif; width: 38%">Offering price (1)</TD><TD STYLE="font: 10pt Times New Roman, Times, Serif; width: 2%">&nbsp;</TD>
    <TD STYLE="font: 10pt Times New Roman, Times, Serif; width: 1%; text-align: left">$</TD><TD STYLE="font: 10pt Times New Roman, Times, Serif; width: 18%; text-align: right">&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;</TD><TD STYLE="font: 10pt Times New Roman, Times, Serif; width: 1%; text-align: left">&nbsp;</TD><TD STYLE="font: 10pt Times New Roman, Times, Serif; width: 2%">&nbsp;</TD>
    <TD STYLE="font: 10pt Times New Roman, Times, Serif; width: 1%; text-align: left">$</TD><TD STYLE="font: 10pt Times New Roman, Times, Serif; width: 18%; text-align: right">&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;</TD><TD STYLE="font: 10pt Times New Roman, Times, Serif; width: 1%; text-align: left">&nbsp;</TD><TD STYLE="font: 10pt Times New Roman, Times, Serif; width: 2%">&nbsp;</TD>
    <TD STYLE="font: 10pt Times New Roman, Times, Serif; width: 1%; text-align: left">$</TD><TD STYLE="font: 10pt Times New Roman, Times, Serif; width: 14%; text-align: right">&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0"></P></TD><TD STYLE="font: 10pt Times New Roman, Times, Serif; width: 1%; text-align: left">&nbsp;</TD></TR>
  <TR STYLE="font: 10pt Times New Roman, Times, Serif; vertical-align: bottom; background-color: White">
    <TD STYLE="font: 10pt Times New Roman, Times, Serif; text-align: left; padding-bottom: 1pt">Placement Agent fees (2)</TD><TD STYLE="font: 10pt Times New Roman, Times, Serif; padding-bottom: 1pt">&nbsp;</TD>
    <TD STYLE="font: 10pt Times New Roman, Times, Serif; border-bottom: Black 1pt solid; text-align: left">$</TD><TD STYLE="font: 10pt Times New Roman, Times, Serif; border-bottom: Black 1pt solid; text-align: right"><P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0">&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;</P></TD><TD STYLE="font: 10pt Times New Roman, Times, Serif; padding-bottom: 1pt; text-align: left">&nbsp;</TD><TD STYLE="font: 10pt Times New Roman, Times, Serif; padding-bottom: 1pt">&nbsp;</TD>
    <TD STYLE="font: 10pt Times New Roman, Times, Serif; border-bottom: Black 1pt solid; text-align: left">$</TD><TD STYLE="font: 10pt Times New Roman, Times, Serif; border-bottom: Black 1pt solid; text-align: right"><P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0">&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;</P></TD><TD STYLE="font: 10pt Times New Roman, Times, Serif; padding-bottom: 1pt; text-align: left">&nbsp;</TD><TD STYLE="font: 10pt Times New Roman, Times, Serif; padding-bottom: 1pt">&nbsp;</TD>
    <TD STYLE="font: 10pt Times New Roman, Times, Serif; border-bottom: Black 1pt solid; text-align: left">$</TD><TD STYLE="font: 10pt Times New Roman, Times, Serif; border-bottom: Black 1pt solid; text-align: right">&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;</TD><TD STYLE="font: 10pt Times New Roman, Times, Serif; padding-bottom: 1pt; text-align: left">&nbsp;</TD></TR>
  <TR STYLE="font: 10pt Times New Roman, Times, Serif; vertical-align: bottom; background-color: rgb(204,238,255)">
    <TD STYLE="font: 10pt Times New Roman, Times, Serif; text-align: left; padding-bottom: 2.5pt">Proceeds, before expenses, to us (3)</TD><TD STYLE="font: 10pt Times New Roman, Times, Serif; padding-bottom: 2.5pt">&nbsp;</TD>
    <TD STYLE="font: 10pt Times New Roman, Times, Serif; border-bottom: Black 2.5pt double; text-align: left">$</TD><TD STYLE="font: 10pt Times New Roman, Times, Serif; border-bottom: Black 2.5pt double; text-align: right"><P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0">&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;</P></TD><TD STYLE="font: 10pt Times New Roman, Times, Serif; padding-bottom: 2.5pt; text-align: left">&nbsp;</TD><TD STYLE="font: 10pt Times New Roman, Times, Serif; padding-bottom: 2.5pt">&nbsp;</TD>
    <TD STYLE="font: 10pt Times New Roman, Times, Serif; border-bottom: Black 2.5pt double; text-align: left">$</TD><TD STYLE="font: 10pt Times New Roman, Times, Serif; border-bottom: Black 2.5pt double; text-align: right"><P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0">&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;</P></TD><TD STYLE="font: 10pt Times New Roman, Times, Serif; padding-bottom: 2.5pt; text-align: left">&nbsp;</TD><TD STYLE="font: 10pt Times New Roman, Times, Serif; padding-bottom: 2.5pt">&nbsp;</TD>
    <TD STYLE="font: 10pt Times New Roman, Times, Serif; border-bottom: Black 2.5pt double; text-align: left">$</TD><TD STYLE="font: 10pt Times New Roman, Times, Serif; border-bottom: Black 2.5pt double; text-align: right">&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;</TD><TD STYLE="font: 10pt Times New Roman, Times, Serif; padding-bottom: 2.5pt; text-align: left">&nbsp;</TD></TR>
  </TABLE>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 20pt"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>

<TABLE CELLSPACING="0" CELLPADDING="0" STYLE="font: 10pt Times New Roman, Times, Serif; width: 100%; border-collapse: collapse">
  <TR STYLE="font: 10pt Times New Roman, Times, Serif; vertical-align: top">
    <TD STYLE="font: 10pt Times New Roman, Times, Serif; width: .25in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></TD>
    <TD STYLE="font: 10pt Times New Roman, Times, Serif; width: .25in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">(1)</FONT></TD>
    <TD STYLE="font: 10pt Times New Roman, Times, Serif; text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">The
    combined public offering price is $&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp; per
    share of Common Stock and accompanying common warrant (or $&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;     per pre-funded warrant and accompanying common warrant).</FONT></TD></TR>
  <TR STYLE="font: 10pt Times New Roman, Times, Serif; vertical-align: top">
    <TD STYLE="font: 10pt Times New Roman, Times, Serif"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></TD>
    <TD STYLE="font: 10pt Times New Roman, Times, Serif"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">(2)</FONT></TD>
    <TD STYLE="font: 10pt Times New Roman, Times, Serif; text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">Represents
    a cash fee equal to seven percent (7.0%) of the aggregate purchase price paid by investors in this offering. We have also agreed
    to reimburse the Placement Agent for their accountable offering-related legal expenses in an amount up to $75,000 and for
    non-accountable expenses of up to $20,000.</FONT></TD></TR>
  <TR STYLE="font: 10pt Times New Roman, Times, Serif; vertical-align: top">
    <TD STYLE="font: 10pt Times New Roman, Times, Serif"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></TD>
    <TD STYLE="font: 10pt Times New Roman, Times, Serif"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">(3)</FONT></TD>
    <TD STYLE="font: 10pt Times New Roman, Times, Serif; text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">Does
    not include proceeds from the exercise of the common warrants and/or pre-funded warrants in cash, if any.</FONT></TD></TR>
  </TABLE>
<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt"><B>Indemnification</B></FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify; text-indent: 0.5in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">We
have agreed to indemnify the Placement Agent and other specified persons against certain liabilities, including liabilities under
the Securities Act and liabilities arising from breaches of representations and warranties contained in the underwriting agreement, or
to contribute to payments that the Placement Agent may be required to make in respect of those liabilities.</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt"><B>Lock-up
Agreements</B></FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify; text-indent: 0.45in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify; text-indent: 0.5in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">Our
directors and executive officers have entered into lock-up agreements. Under these agreements, these individuals have agreed, subject
to specified exceptions, not to sell or transfer any shares of Common Stock or securities convertible into, or exchangeable or exercisable
for, our shares of Common Stock during a period ending 45 days after the date of this prospectus, without first obtaining the written
consent of the Placement Agent. Specifically, these individuals have agreed, in part, not to:</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify; text-indent: 0.45in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>

<TABLE CELLSPACING="0" CELLPADDING="0" STYLE="font: 10pt Times New Roman, Times, Serif; width: 100%; border-collapse: collapse">
  <TR STYLE="font: 10pt Times New Roman, Times, Serif; vertical-align: top">
    <TD STYLE="font: 10pt Times New Roman, Times, Serif; width: 0.5in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></TD>
    <TD STYLE="font: 10pt Times New Roman, Times, Serif; width: 0.25in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#9679;</FONT></TD>
    <TD STYLE="font: 10pt Times New Roman, Times, Serif; text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">offer,
    pledge, sell, contract to sell, sell any option or contract to purchase, purchase any option or contract to sell, grant any option,
    right or warrant to purchase, lend, or otherwise transfer or dispose of (or enter into any transaction or device that is designed
    to, or could be expected to, result in the transfer or disposition by any person at any time in the future of), any shares of capital
    stock of the Company or any securities convertible into or exercisable or exchangeable for shares of capital stock of the Company;</FONT></TD></TR>
  </TABLE>
<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>

<TABLE CELLSPACING="0" CELLPADDING="0" STYLE="font: 10pt Times New Roman, Times, Serif; width: 100%; border-collapse: collapse">
  <TR STYLE="font: 10pt Times New Roman, Times, Serif; vertical-align: top">
    <TD STYLE="font: 10pt Times New Roman, Times, Serif; width: 0.5in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></TD>
    <TD STYLE="font: 10pt Times New Roman, Times, Serif; width: 0.25in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#9679;</FONT></TD>
    <TD STYLE="font: 10pt Times New Roman, Times, Serif; text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">make
    any demand for or exercise any right or cause to be filed a registration statement, including any amendments thereto, with respect
    to the registration of any of our securities; or</FONT></TD></TR>
  </TABLE>
<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>

<TABLE CELLSPACING="0" CELLPADDING="0" STYLE="font: 10pt Times New Roman, Times, Serif; width: 100%; border-collapse: collapse">
  <TR STYLE="font: 10pt Times New Roman, Times, Serif; vertical-align: top">
    <TD STYLE="font: 10pt Times New Roman, Times, Serif; width: 0.5in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></TD>
    <TD STYLE="font: 10pt Times New Roman, Times, Serif; width: 0.25in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#9679;</FONT></TD>
    <TD STYLE="font: 10pt Times New Roman, Times, Serif; text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">enter
    into any swap or other arrangement that transfers to another, in whole or in part, any of the economic consequences of ownership
    of capital stock of the Company.</FONT></TD></TR>
  </TABLE>
<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify; text-indent: 0.45in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify; text-indent: 0.5in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">Notwithstanding
these limitations, these shares of Common Stock may be transferred under limited circumstances, including, without limitation, by gift,
will or intestate succession.</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt"></FONT>&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify; text-indent: 0.5in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">In
addition, we have agreed that, subject to certain exceptions, we will not conduct any issuances of our Common Stock for a period of forty-five
(45) days following closing of this offering. Furthermore, we are also prohibited from entering into any agreement to issue Common Stock
or Common Stock Equivalents involving a Variable Rate Transaction (as each such term is defined in the placement agency agreement),
subject to certain exceptions, for ninety (90) days after the closing of this offering. A Variable Rate Transaction will not include
a new at-the-market offering of the Company&rsquo;s Common Stock, and sales under any such at-the-market offering may commence
starting on the date that is thirty (30) days after the date the Company files a Current Report on Form 8-K giving public notice of
receipt of Stockholder Approval. </FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify"></P>

<!-- Field: Page; Sequence: 27; Value: 1 -->
    <DIV STYLE="margin-top: 0pt; margin-bottom: 6pt; border-bottom: Black 1pt solid"><TABLE CELLPADDING="0" CELLSPACING="0" STYLE="border-collapse: collapse; width: 100%; font-size: 10pt"><TR STYLE="vertical-align: top; text-align: left"><TD STYLE="text-align: center; width: 100%"><!-- Field: Sequence; Type: Arabic; Name: PageNo -->22<!-- Field: /Sequence --></TD></TR></TABLE></DIV>
    <DIV STYLE="break-before: page; margin-top: 6pt; margin-bottom: 0pt"><P STYLE="margin: 0pt">&nbsp;</P></DIV>
    <!-- Field: /Page -->

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt"><B>Regulation
M</B></FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify; text-indent: 0.5in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">The
Placement Agent may be deemed to be an underwriter within the meaning of Section 2(a)(11) of the Securities Act, and any
commissions received by it and any profit realized on the resale of the securities sold by it while acting as principal
might be deemed to be underwriting discounts or commissions under the Securities Act. As an underwriter, the Placement Agent
would be required to comply with the requirements of the Securities Act and the Exchange Act, including, without limitation, Rule
10b-5 and Regulation M under the Exchange Act. These rules and regulations may limit the timing of purchases and sales of our securities
by the Placement Agent acting as principal. Under these rules and regulations, the Placement Agent (i) may not engage in
any stabilization activity in connection with our securities and (ii) may not bid for or purchase any of our securities or attempt to
induce any person to purchase any of our securities, other than as permitted under the Exchange Act, until it has completed its
participation in the distribution.</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt"><B>Discretionary
Accounts</B></FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify; text-indent: 0.5in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">The
Placement Agent does not intend to confirm sales of the securities offered hereby to any accounts over which it has discretionary
authority.</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt"><B>Other
Activities and Relationships</B></FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify; text-indent: 0.5in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">The
Placement Agent and certain of its affiliates are full service financial institutions engaged in various activities, which
may include securities trading, commercial and investment banking, financial advisory, investment management, investment research, principal
investment, hedging, financing and brokerage activities. The Placement Agent and certain of its affiliates have, from time
to time, performed, and may in the future perform, various commercial and investment banking and financial advisory services for us and
our affiliates, for which they received or will receive customary fees and expenses.</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify; text-indent: 0.5in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">In
the ordinary course of their various business activities, the Placement Agent and certain of its affiliates may make or
hold a broad array of investments and actively trade debt and equity securities (or related derivative securities) and financial instruments
(including bank loans) for their own account and for the accounts of their customers, and such investment and securities activities may
involve securities and/or instruments issued by us and our affiliates. If the Placement Agent or its affiliates have a lending
relationship with us, they routinely hedge their credit exposure to us consistent with their customary risk management policies. The
Placement Agent and its affiliates may hedge such exposure by entering into transactions that consist of either the purchase
of credit default swaps or the creation of short positions in our securities or the securities of our affiliates, including potentially
the Common Stock offered hereby. Any such short positions could adversely affect future trading prices of the Common Stock offered hereby.
The Placement Agent and certain of its affiliates may also communicate independent investment recommendations, market color
or trading ideas and/or publish or express independent research views in respect of such securities or instruments and may at any time
hold, or recommend to clients that they acquire, long and/or short positions in such securities and instruments.</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt"></FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify; text-indent: 0.5in">On July 30, 2024, we entered
into a securities purchase agreement with certain institutional and other accredited investors, pursuant to which we issued and sold
5,000,000 shares of our Common Stock in a registered direct offering and warrants to purchase 5,000,000 shares of Common Stock in a concurrent
private placement, for a combined purchase price of $2.00 per share of Common Stock and accompanying warrant. The closing of the private
placement took place on August 1, 2024 and we received total gross proceeds of $10.0 million. Brookline acted as co-placement agent and
H.C. Wainwright &amp; Co., LLC acted as the lead placement agent, for the registered direct offering and concurrent private placement.
The placement agents were entitled to fees equal to 7.0% of the gross proceeds from the registered direct offering and concurrent private
placement.</P>
<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt"></FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify; text-indent: 0.5in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">As
stated above, the Placement Agent and its affiliates have and may in the future provide, from time to time, investment banking
and financial advisory services to us in the ordinary course of business, for which they may receive customary fees and commissions.</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify; text-indent: 0.5in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">The
foregoing does not purport to be a complete statement of the terms and conditions of the placement agency agreement or the securities
purchase agreement entered into in connection with this offering, copies of which have been filed as exhibits to the registration statement
of which this prospectus is a part. See <I>&ldquo;Where You Can Find More Information.&rdquo;</I></FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt"><B>Listing</B></FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify; text-indent: 0.5in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">Our
Common Stock on is listed Nasdaq under the symbol &ldquo;IMNN.&rdquo;</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>



<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt"></FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt"><B>Offer
Restrictions Outside the United States</B></FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify; text-indent: 0.5in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify; text-indent: 0.5in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">Other
than in the United States, no action has been taken by us or the Placement Agent that would permit a public offering of the securities
offered by this prospectus in any jurisdiction where action for that purpose is required. The securities offered by this prospectus may
not be offered or sold, directly or indirectly, nor may this prospectus or any other offering material or advertisements in connection
with the offer and sale of any such securities be distributed or published in any jurisdiction, except under circumstances that will
result in compliance with the applicable rules and regulations of that jurisdiction. Persons into whose possession this prospectus comes
are advised to inform themselves about and to observe any restrictions relating to the offering and the distribution of this prospectus.
This prospectus does not constitute an offer to sell or a solicitation of an offer to buy any securities offered by this prospectus in
any jurisdiction in which such an offer or a solicitation is unlawful.</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify; text-indent: 0.5in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>


<!-- Field: Page; Sequence: 28; Value: 1 -->
    <DIV STYLE="margin-top: 0pt; margin-bottom: 6pt; border-bottom: Black 1pt solid"><TABLE CELLPADDING="0" CELLSPACING="0" STYLE="border-collapse: collapse; width: 100%; font-size: 10pt"><TR STYLE="vertical-align: top; text-align: left"><TD STYLE="text-align: center; width: 100%"><!-- Field: Sequence; Type: Arabic; Name: PageNo -->23<!-- Field: /Sequence --></TD></TR></TABLE></DIV>
    <DIV STYLE="break-before: page; margin-top: 6pt; margin-bottom: 0pt"><P STYLE="margin: 0pt">&nbsp;</P></DIV>
    <!-- Field: /Page -->

<P STYLE="font: bold 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: center"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>

<P STYLE="font: bold 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: center"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt"><A NAME="Aa_012"></A>MATERIAL
UNITED STATES FEDERAL INCOME TAX CONSIDERATIONS</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: center"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt"><B>&nbsp;</B></FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify; text-indent: 0.5in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">The
following is a summary of the material U.S. federal income tax consequences of the acquisition, ownership and disposition of our Common
Stock, and the acquisition, ownership, exercise, expiration or disposition of the common warrants and pre-funded warrants, but does not
purport to be a complete analysis of all the potential tax considerations relating thereto. This summary is based upon the provisions
of the Internal Revenue Code of 1986, as amended (the &ldquo;<U>Code</U>&rdquo;), Treasury Regulations promulgated thereunder, administrative
rulings and judicial decisions, all as of the date hereof. These authorities may be changed or subject to differing interpretations,
possibly with retroactive effect, so as to result in U.S. federal income tax consequences different from those set forth below. We have
not sought and will not seek any ruling from the Internal Revenue Service (the &ldquo;<U>IRS</U>&rdquo;) with respect to the statements
made and the conclusions reached in the following summary, and there can be no assurance that the IRS or a court will agree with such
statements and conclusions.</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify; text-indent: 0.5in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify; text-indent: 0.5in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">This
summary also does not address the tax considerations arising under the laws of any U.S. state or local or any non-U.S. jurisdiction,
estate or gift tax, the 3.8% Medicare tax on net investment income or any alternative minimum tax consequences. In addition, this discussion
does not address tax considerations applicable to a holder&rsquo;s particular circumstances or to a holder that may be subject to special
tax rules, including, without limitation:</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify; text-indent: 0.5in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>

<TABLE CELLSPACING="0" CELLPADDING="0" STYLE="font: 10pt Times New Roman, Times, Serif; width: 100%; border-collapse: collapse">
  <TR STYLE="font: 10pt Times New Roman, Times, Serif; vertical-align: top">
    <TD STYLE="text-align: justify; font: 10pt Times New Roman, Times, Serif; width: 0.5in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></TD>
    <TD STYLE="text-align: justify; font: 10pt Times New Roman, Times, Serif; width: 0.25in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#9679;</FONT></TD>
    <TD STYLE="font: 10pt Times New Roman, Times, Serif; text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">banks,
    insurance companies or other financial institutions;</FONT></TD></TR>
  <TR STYLE="font: 10pt Times New Roman, Times, Serif; vertical-align: top">
    <TD STYLE="text-align: justify; font: 10pt Times New Roman, Times, Serif"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></TD>
    <TD STYLE="text-align: justify; font: 10pt Times New Roman, Times, Serif"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></TD>
    <TD STYLE="font: 10pt Times New Roman, Times, Serif; text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></TD></TR>
  <TR STYLE="font: 10pt Times New Roman, Times, Serif; vertical-align: top">
    <TD STYLE="text-align: justify; font: 10pt Times New Roman, Times, Serif"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></TD>
    <TD STYLE="text-align: justify; font: 10pt Times New Roman, Times, Serif"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#9679;</FONT></TD>
    <TD STYLE="font: 10pt Times New Roman, Times, Serif; text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">tax-exempt
    or government organizations;</FONT></TD></TR>
  <TR STYLE="font: 10pt Times New Roman, Times, Serif; vertical-align: top">
    <TD STYLE="text-align: justify; font: 10pt Times New Roman, Times, Serif"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></TD>
    <TD STYLE="text-align: justify; font: 10pt Times New Roman, Times, Serif"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></TD>
    <TD STYLE="font: 10pt Times New Roman, Times, Serif; text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></TD></TR>
  <TR STYLE="font: 10pt Times New Roman, Times, Serif; vertical-align: top">
    <TD STYLE="text-align: justify; font: 10pt Times New Roman, Times, Serif"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></TD>
    <TD STYLE="text-align: justify; font: 10pt Times New Roman, Times, Serif"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#9679;</FONT></TD>
    <TD STYLE="font: 10pt Times New Roman, Times, Serif; text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">brokers
    or dealers in securities or currencies;</FONT></TD></TR>
  <TR STYLE="font: 10pt Times New Roman, Times, Serif; vertical-align: top">
    <TD STYLE="text-align: justify; font: 10pt Times New Roman, Times, Serif"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></TD>
    <TD STYLE="text-align: justify; font: 10pt Times New Roman, Times, Serif"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></TD>
    <TD STYLE="font: 10pt Times New Roman, Times, Serif; text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></TD></TR>
  <TR STYLE="font: 10pt Times New Roman, Times, Serif; vertical-align: top">
    <TD STYLE="text-align: justify; font: 10pt Times New Roman, Times, Serif"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></TD>
    <TD STYLE="text-align: justify; font: 10pt Times New Roman, Times, Serif"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#9679;</FONT></TD>
    <TD STYLE="font: 10pt Times New Roman, Times, Serif; text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">traders
    in securities that elect to use a mark-to-market method of accounting for their securities holdings;</FONT></TD></TR>
  <TR STYLE="font: 10pt Times New Roman, Times, Serif; vertical-align: top">
    <TD STYLE="text-align: justify; font: 10pt Times New Roman, Times, Serif"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></TD>
    <TD STYLE="text-align: justify; font: 10pt Times New Roman, Times, Serif"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></TD>
    <TD STYLE="font: 10pt Times New Roman, Times, Serif; text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></TD></TR>
  <TR STYLE="font: 10pt Times New Roman, Times, Serif; vertical-align: top">
    <TD STYLE="text-align: justify; font: 10pt Times New Roman, Times, Serif"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></TD>
    <TD STYLE="text-align: justify; font: 10pt Times New Roman, Times, Serif"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#9679;</FONT></TD>
    <TD STYLE="font: 10pt Times New Roman, Times, Serif; text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">persons
    that own, or are deemed to own, more than five percent of our capital stock;</FONT></TD></TR>
  <TR STYLE="font: 10pt Times New Roman, Times, Serif; vertical-align: top">
    <TD STYLE="text-align: justify; font: 10pt Times New Roman, Times, Serif"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></TD>
    <TD STYLE="text-align: justify; font: 10pt Times New Roman, Times, Serif"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></TD>
    <TD STYLE="font: 10pt Times New Roman, Times, Serif; text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></TD></TR>
  <TR STYLE="font: 10pt Times New Roman, Times, Serif; vertical-align: top">
    <TD STYLE="text-align: justify; font: 10pt Times New Roman, Times, Serif"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></TD>
    <TD STYLE="text-align: justify; font: 10pt Times New Roman, Times, Serif"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#9679;</FONT></TD>
    <TD STYLE="font: 10pt Times New Roman, Times, Serif; text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">certain
    U.S. expatriates (such as former citizens or former long-term residents of the United States);</FONT></TD></TR>
  <TR STYLE="font: 10pt Times New Roman, Times, Serif; vertical-align: top">
    <TD STYLE="text-align: justify; font: 10pt Times New Roman, Times, Serif"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></TD>
    <TD STYLE="text-align: justify; font: 10pt Times New Roman, Times, Serif"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></TD>
    <TD STYLE="font: 10pt Times New Roman, Times, Serif; text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></TD></TR>
  <TR STYLE="font: 10pt Times New Roman, Times, Serif; vertical-align: top">
    <TD STYLE="text-align: justify; font: 10pt Times New Roman, Times, Serif"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></TD>
    <TD STYLE="text-align: justify; font: 10pt Times New Roman, Times, Serif"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#9679;</FONT></TD>
    <TD STYLE="font: 10pt Times New Roman, Times, Serif; text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">persons
    who hold our Common Stock, pre-funded warrants or common warrants as a position in a hedging transaction, &ldquo;straddle,&rdquo;
    &ldquo;conversion transaction,&rdquo; synthetic security, other integrated investment, or other risk reduction transaction;</FONT></TD></TR>
  <TR STYLE="font: 10pt Times New Roman, Times, Serif; vertical-align: top">
    <TD STYLE="text-align: justify; font: 10pt Times New Roman, Times, Serif"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></TD>
    <TD STYLE="text-align: justify; font: 10pt Times New Roman, Times, Serif"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></TD>
    <TD STYLE="font: 10pt Times New Roman, Times, Serif; text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></TD></TR>
  <TR STYLE="font: 10pt Times New Roman, Times, Serif; vertical-align: top">
    <TD STYLE="text-align: justify; font: 10pt Times New Roman, Times, Serif"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></TD>
    <TD STYLE="text-align: justify; font: 10pt Times New Roman, Times, Serif"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#9679;</FONT></TD>
    <TD STYLE="font: 10pt Times New Roman, Times, Serif; text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">persons
    who do not hold our Common Stock, pre-funded warrants and common warrants as a capital asset within the meaning of Section 1221 of
    the Code (generally, for investment purposes);</FONT></TD></TR>
  <TR STYLE="font: 10pt Times New Roman, Times, Serif; vertical-align: top">
    <TD STYLE="text-align: justify; font: 10pt Times New Roman, Times, Serif"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></TD>
    <TD STYLE="text-align: justify; font: 10pt Times New Roman, Times, Serif"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></TD>
    <TD STYLE="font: 10pt Times New Roman, Times, Serif; text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></TD></TR>
  <TR STYLE="font: 10pt Times New Roman, Times, Serif; vertical-align: top">
    <TD STYLE="text-align: justify; font: 10pt Times New Roman, Times, Serif"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></TD>
    <TD STYLE="text-align: justify; font: 10pt Times New Roman, Times, Serif"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#9679;</FONT></TD>
    <TD STYLE="font: 10pt Times New Roman, Times, Serif; text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">persons
    deemed to sell our Common Stock, pre-funded warrants or common warrants under the constructive sale provisions of the Code;</FONT></TD></TR>
  <TR STYLE="font: 10pt Times New Roman, Times, Serif; vertical-align: top">
    <TD STYLE="text-align: justify; font: 10pt Times New Roman, Times, Serif"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></TD>
    <TD STYLE="text-align: justify; font: 10pt Times New Roman, Times, Serif"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></TD>
    <TD STYLE="font: 10pt Times New Roman, Times, Serif; text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></TD></TR>
  <TR STYLE="font: 10pt Times New Roman, Times, Serif; vertical-align: top">
    <TD STYLE="text-align: justify; font: 10pt Times New Roman, Times, Serif"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></TD>
    <TD STYLE="text-align: justify; font: 10pt Times New Roman, Times, Serif"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#9679;</FONT></TD>
    <TD STYLE="font: 10pt Times New Roman, Times, Serif; text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">pension
    plans;</FONT></TD></TR>
  <TR STYLE="font: 10pt Times New Roman, Times, Serif; vertical-align: top">
    <TD STYLE="text-align: justify; font: 10pt Times New Roman, Times, Serif"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></TD>
    <TD STYLE="text-align: justify; font: 10pt Times New Roman, Times, Serif"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></TD>
    <TD STYLE="font: 10pt Times New Roman, Times, Serif; text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></TD></TR>
  <TR STYLE="font: 10pt Times New Roman, Times, Serif; vertical-align: top">
    <TD STYLE="text-align: justify; font: 10pt Times New Roman, Times, Serif"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></TD>
    <TD STYLE="text-align: justify; font: 10pt Times New Roman, Times, Serif"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#9679;</FONT></TD>
    <TD STYLE="font: 10pt Times New Roman, Times, Serif; text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">partnerships,
    S corporations, or other entities or arrangements treated as partnerships for U.S. federal income tax purposes, or investors in any
    such entities;</FONT></TD></TR>
  <TR STYLE="font: 10pt Times New Roman, Times, Serif; vertical-align: top">
    <TD STYLE="text-align: justify; font: 10pt Times New Roman, Times, Serif"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></TD>
    <TD STYLE="text-align: justify; font: 10pt Times New Roman, Times, Serif"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></TD>
    <TD STYLE="font: 10pt Times New Roman, Times, Serif; text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></TD></TR>
  <TR STYLE="font: 10pt Times New Roman, Times, Serif; vertical-align: top">
    <TD STYLE="text-align: justify; font: 10pt Times New Roman, Times, Serif"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></TD>
    <TD STYLE="text-align: justify; font: 10pt Times New Roman, Times, Serif"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#9679;</FONT></TD>
    <TD STYLE="font: 10pt Times New Roman, Times, Serif; text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">regulated
    investment companies or real estate investment trusts;</FONT></TD></TR>
  <TR STYLE="font: 10pt Times New Roman, Times, Serif; vertical-align: top">
    <TD STYLE="text-align: justify; font: 10pt Times New Roman, Times, Serif"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></TD>
    <TD STYLE="text-align: justify; font: 10pt Times New Roman, Times, Serif"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></TD>
    <TD STYLE="font: 10pt Times New Roman, Times, Serif; text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></TD></TR>
  <TR STYLE="font: 10pt Times New Roman, Times, Serif; vertical-align: top">
    <TD STYLE="text-align: justify; font: 10pt Times New Roman, Times, Serif"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></TD>
    <TD STYLE="text-align: justify; font: 10pt Times New Roman, Times, Serif"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#9679;</FONT></TD>
    <TD STYLE="font: 10pt Times New Roman, Times, Serif; text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">persons
    for whom our stock constitutes &ldquo;qualified small business stock&rdquo; within the meaning of Section 1202 of the Code;</FONT></TD></TR>
  <TR STYLE="font: 10pt Times New Roman, Times, Serif; vertical-align: top">
    <TD STYLE="text-align: justify; font: 10pt Times New Roman, Times, Serif"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></TD>
    <TD STYLE="text-align: justify; font: 10pt Times New Roman, Times, Serif"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></TD>
    <TD STYLE="font: 10pt Times New Roman, Times, Serif; text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></TD></TR>
  <TR STYLE="font: 10pt Times New Roman, Times, Serif; vertical-align: top">
    <TD STYLE="text-align: justify; font: 10pt Times New Roman, Times, Serif"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></TD>
    <TD STYLE="text-align: justify; font: 10pt Times New Roman, Times, Serif"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#9679;</FONT></TD>
    <TD STYLE="font: 10pt Times New Roman, Times, Serif; text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">integral
    parts or controlled entities of foreign sovereigns;</FONT></TD></TR>
  <TR STYLE="font: 10pt Times New Roman, Times, Serif; vertical-align: top">
    <TD STYLE="text-align: justify; font: 10pt Times New Roman, Times, Serif"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></TD>
    <TD STYLE="text-align: justify; font: 10pt Times New Roman, Times, Serif"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></TD>
    <TD STYLE="font: 10pt Times New Roman, Times, Serif; text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></TD></TR>
  <TR STYLE="font: 10pt Times New Roman, Times, Serif; vertical-align: top">
    <TD STYLE="text-align: justify; font: 10pt Times New Roman, Times, Serif"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></TD>
    <TD STYLE="text-align: justify; font: 10pt Times New Roman, Times, Serif"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#9679;</FONT></TD>
    <TD STYLE="font: 10pt Times New Roman, Times, Serif; text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">controlled
    foreign corporations;</FONT></TD></TR>
  <TR STYLE="font: 10pt Times New Roman, Times, Serif; vertical-align: top">
    <TD STYLE="text-align: justify; font: 10pt Times New Roman, Times, Serif"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></TD>
    <TD STYLE="text-align: justify; font: 10pt Times New Roman, Times, Serif"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></TD>
    <TD STYLE="font: 10pt Times New Roman, Times, Serif; text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></TD></TR>
  <TR STYLE="font: 10pt Times New Roman, Times, Serif; vertical-align: top">
    <TD STYLE="text-align: justify; font: 10pt Times New Roman, Times, Serif"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></TD>
    <TD STYLE="text-align: justify; font: 10pt Times New Roman, Times, Serif"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#9679;</FONT></TD>
    <TD STYLE="font: 10pt Times New Roman, Times, Serif; text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">passive
    foreign investment companies and corporations that accumulate earnings to avoid U.S. federal income tax; </FONT></TD></TR>
</TABLE>

<P STYLE="margin: 0">&nbsp;</P>

<P STYLE="margin: 0"></P>

<!-- Field: Page; Sequence: 29; Value: 1 -->
    <DIV STYLE="margin-top: 0pt; margin-bottom: 6pt; border-bottom: Black 1pt solid"><TABLE CELLPADDING="0" CELLSPACING="0" STYLE="border-collapse: collapse; width: 100%; font-size: 10pt"><TR STYLE="vertical-align: top; text-align: left"><TD STYLE="text-align: center; width: 100%"><!-- Field: Sequence; Type: Arabic; Name: PageNo -->24<!-- Field: /Sequence --></TD></TR></TABLE></DIV>
    <DIV STYLE="break-before: page; margin-top: 6pt; margin-bottom: 0pt"><P STYLE="margin: 0pt">&nbsp;</P></DIV>
    <!-- Field: /Page -->

<P STYLE="margin: 0">&nbsp;</P>

<TABLE CELLSPACING="0" CELLPADDING="0" STYLE="font: 10pt Times New Roman, Times, Serif; width: 100%; border-collapse: collapse">
  <TR STYLE="font: 10pt Times New Roman, Times, Serif; vertical-align: top">
    <TD STYLE="text-align: justify; font: 10pt Times New Roman, Times, Serif; width: 0.5in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></TD>
    <TD STYLE="text-align: justify; font: 10pt Times New Roman, Times, Serif; width: 0.25in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#9679;</FONT></TD>
    <TD STYLE="font: 10pt Times New Roman, Times, Serif; text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">persons
    that acquire our Common Stock, pre-funded warrants or common warrants as compensation for services; or</FONT></TD></TR>
  <TR STYLE="font: 10pt Times New Roman, Times, Serif; vertical-align: top">
    <TD STYLE="text-align: justify; font: 10pt Times New Roman, Times, Serif"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></TD>
    <TD STYLE="text-align: justify; font: 10pt Times New Roman, Times, Serif"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></TD>
    <TD STYLE="font: 10pt Times New Roman, Times, Serif; text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></TD></TR>
  <TR STYLE="font: 10pt Times New Roman, Times, Serif; vertical-align: top">
    <TD STYLE="text-align: justify; font: 10pt Times New Roman, Times, Serif"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></TD>
    <TD STYLE="text-align: justify; font: 10pt Times New Roman, Times, Serif"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#9679;</FONT></TD>
    <TD STYLE="font: 10pt Times New Roman, Times, Serif; text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">a
    Non-U.S. Holder (as defined below under &ldquo;&mdash;<I>Definition of a U.S. Holder</I>.&rdquo;</FONT></TD></TR>
  </TABLE>
<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0.5in; text-align: justify; text-indent: -0.25in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify; text-indent: 0.5in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">In
addition, if a partnership, including any entity or arrangement classified as a partnership for U.S. federal income tax purposes, holds
our Common Stock, pre-funded warrants or common warrants, the tax treatment of a partner generally will depend on the status of the partner,
the activities of the partnership, and certain determinations made at the partner level. Accordingly, partnerships that hold our Common
Stock, pre-funded warrants or common warrants, and partners in such partnerships, should consult their tax advisors regarding the U.S.
federal income tax consequences to them of the acquisition, ownership, and disposition of our Common Stock, and the acquisition, ownership,
exercise, expiration, and disposition of the pre-funded warrants and common warrants.</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify; text-indent: 0.5in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify; text-indent: 0.5in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">You
are urged to consult your tax advisor with respect to the application of the U.S. federal income tax laws to your particular situation,
as well as any tax consequences of the acquisition, ownership and disposition of our Common Stock, and the acquisition, ownership, exercise,
expiration, and disposition of the pre-funded warrants and common warrants arising under the U.S. federal estate or gift tax rules or
under the laws of any U.S. state or local or any non-U.S. or other taxing jurisdiction or under any applicable tax treaty.</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify; text-indent: 0.5in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt"><B>Definition
of a U.S. Holder</B></FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt"><B>&nbsp;</B></FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify; text-indent: 0.5in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">For
purposes of this summary, a &ldquo;U.S. Holder&rdquo; is any beneficial owner of our Common Stock, pre-funded warrants or common warrants
that is a &ldquo;U.S. person,&rdquo; and is not a partnership, or an entity treated as a partnership or disregarded from its owner, each
for U.S. federal income tax purposes. A U.S. person is any person that, for U.S. federal income tax purposes, is or is treated as any
of the following:</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify; text-indent: 0.5in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>

<TABLE CELLSPACING="0" CELLPADDING="0" STYLE="font: 10pt Times New Roman, Times, Serif; width: 100%; border-collapse: collapse">
  <TR STYLE="font: 10pt Times New Roman, Times, Serif; vertical-align: top">
    <TD STYLE="font: 10pt Times New Roman, Times, Serif; width: 0.5in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></TD>
    <TD STYLE="font: 10pt Times New Roman, Times, Serif; width: 0.25in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#9679;</FONT></TD>
    <TD STYLE="font: 10pt Times New Roman, Times, Serif; text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">an
    individual who is a citizen or resident of the United States;</FONT></TD></TR>
  </TABLE>
<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0.5in; text-align: justify; text-indent: -0.25in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>

<TABLE CELLSPACING="0" CELLPADDING="0" STYLE="font: 10pt Times New Roman, Times, Serif; width: 100%; border-collapse: collapse">
  <TR STYLE="font: 10pt Times New Roman, Times, Serif; vertical-align: top">
    <TD STYLE="font: 10pt Times New Roman, Times, Serif; width: 0.5in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></TD>
    <TD STYLE="font: 10pt Times New Roman, Times, Serif; width: 0.25in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#9679;</FONT></TD>
    <TD STYLE="font: 10pt Times New Roman, Times, Serif; text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">a
    corporation (or other entity taxable as a corporation for U.S. federal income tax purposes) created or organized under the laws of
    the United States, any state thereof, or the District of Columbia;</FONT></TD></TR>
  </TABLE>
<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0.5in; text-align: justify; text-indent: -0.25in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>

<TABLE CELLSPACING="0" CELLPADDING="0" STYLE="font: 10pt Times New Roman, Times, Serif; width: 100%; border-collapse: collapse">
  <TR STYLE="font: 10pt Times New Roman, Times, Serif; vertical-align: top">
    <TD STYLE="font: 10pt Times New Roman, Times, Serif; width: 0.5in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></TD>
    <TD STYLE="font: 10pt Times New Roman, Times, Serif; width: 0.25in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#9679;</FONT></TD>
    <TD STYLE="font: 10pt Times New Roman, Times, Serif; text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">an
    estate, the income of which is subject to U.S. federal income tax regardless of its source; or</FONT></TD></TR>
  </TABLE>
<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0.5in; text-align: justify; text-indent: -0.25in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>

<TABLE CELLSPACING="0" CELLPADDING="0" STYLE="font: 10pt Times New Roman, Times, Serif; width: 100%; border-collapse: collapse">
  <TR STYLE="font: 10pt Times New Roman, Times, Serif; vertical-align: top">
    <TD STYLE="font: 10pt Times New Roman, Times, Serif; width: 0.5in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></TD>
    <TD STYLE="font: 10pt Times New Roman, Times, Serif; width: 0.25in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#9679;</FONT></TD>
    <TD STYLE="font: 10pt Times New Roman, Times, Serif; text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">a
    trust that (1) is subject to the primary supervision of a U.S. court and the control of one or more U.S. persons (within the meaning
    of Section 7701(a)(30) of the Code), or (2) has a valid election in effect to be treated as a U.S. person for U.S. federal income
    tax purposes.</FONT></TD></TR>
  </TABLE>
<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0.5in; text-align: justify; text-indent: -0.25in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify; text-indent: 0.5in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">For
purposes of this summary, a &ldquo;Non-U.S. Holder&rdquo; is any beneficial owner of our Common Stock, pre-funded warrants or common
warrants that is neither a U.S. Holder nor a partnership, or other entity treated as a partnership or disregarded from its owner, each
for U.S. federal income tax purposes.</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify; text-indent: 0.5in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt"><B>Treatment
of Pre-funded Warrants</B></FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify; text-indent: 0.5in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">Although
it is not entirely free from doubt, a pre-funded warrant should be treated as a share of our Common Stock for U.S. federal income tax
purposes and a holder of pre-funded warrants should generally be taxed in the same manner as a holder of Common Stock, as described below.
Accordingly, no gain or loss should be recognized upon the exercise of a pre-funded warrant and, upon exercise, the holding period of
a pre-funded warrant should carry over to the share of Common Stock received. Similarly, the tax basis of the pre-funded warrant should
carry over to the share of Common Stock received upon exercise, increased by the exercise price of $0.0001. However, our characterization
of a pre-funded warrant is not binding on the IRS, and the IRS may treat the pre-funded warrants as warrants to acquire Common Stock
and, if so, the amount and character of a holder&rsquo;s gain with respect to an investment in a pre-funded warrant could change. Each
holder should consult his, her or its own tax advisor regarding the risks associated with the acquisition of pre-funded warrants pursuant
to this offering (including potential alternative characterizations). The balance of this discussion generally assumes that the characterization
described above is respected for U.S. federal income tax purposes and the discussion below, to the extent it pertains to shares of our
Common Stock, is generally intended also to pertain to pre-funded warrants.</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify; text-indent: 0.5in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify; text-indent: 0.5in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt"></FONT></P>

<!-- Field: Page; Sequence: 30; Value: 1 -->
    <DIV STYLE="margin-top: 0pt; margin-bottom: 6pt; border-bottom: Black 1pt solid"><TABLE CELLPADDING="0" CELLSPACING="0" STYLE="border-collapse: collapse; width: 100%; font-size: 10pt"><TR STYLE="vertical-align: top; text-align: left"><TD STYLE="text-align: center; width: 100%"><!-- Field: Sequence; Type: Arabic; Name: PageNo -->25<!-- Field: /Sequence --></TD></TR></TABLE></DIV>
    <DIV STYLE="break-before: page; margin-top: 6pt; margin-bottom: 0pt"><P STYLE="margin: 0pt">&nbsp;</P></DIV>
    <!-- Field: /Page -->

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify; text-indent: 0.5in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt"><B>Allocation
of Purchase Price for Investment Units</B></FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt"><B>&nbsp;</B></FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify; text-indent: 0.5in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">Each
pre-funded warrant will be sold as a unit with a common warrant and each share of Common Stock will be sold as a unit with a common warrant,
and each of the items is referred to as a component of a unit. For U.S. federal income tax purposes, each unit consisting of the pre-funded
warrants and common warrants in one case, and the Common Stock and common warrants in the other, should each be treated as an &ldquo;investment
unit&rdquo; consisting of one share of Common Stock (see discussion above under the section titled &ldquo;&mdash;<I>Treatment of Pre-funded
Warrants</I>&rdquo; regarding a pre-funded warrant being treated as a share of our Common Stock for U.S. federal income tax purposes)
and one common warrant to acquire one share of our Common Stock. The purchase price for each investment unit should be allocated between
the two components in proportion to their relative fair market values at the time the unit is purchased by the holder. This allocation
of the purchase price for each unit will establish the holder&rsquo;s initial tax basis for U.S. federal income tax purposes in the components
included in each unit; the pre-funded warrants and common warrants in one case, and the Common Stock and common warrants in the other.
Each holder should consult his, her or its own tax advisor regarding the allocation of the purchase price for a unit.</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify; text-indent: 0.5in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt"><B>Tax
Consequences to U.S. Holders</B></FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt"><B>&nbsp;</B></FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt"><B><I>Distributions
on Common Stock</I></B></FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt"><B><I>&nbsp;</I></B></FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify; text-indent: 0.5in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">As
discussed in &ldquo;<I>Dividend Policy</I>,&rdquo; we do not currently expect to make distributions on our Common Stock. In the event
that we do make distributions of cash or other property, distributions paid on Common Stock, other than certain pro rata distributions
of Common Stock, will be treated as a dividend for U.S. federal income tax purposes to the extent paid out of our current or accumulated
earnings and profits (as determined under U.S. federal income tax principles) and will be includible in income by the U.S. Holder and,
except as described below with respect to dividends paid to certain non-corporate U.S. Holders, taxable as ordinary income when received.
Distributions in excess of our current and accumulated earnings and profits will constitute a return of capital that is applied against
and reduces, but not below zero, a U.S. Holder&rsquo;s adjusted tax basis in our Common Stock. Any remaining excess will be treated as
a capital gain realized on the sale or exchange of our Common Stock as described below under the section titled &ldquo;&mdash;Sale or
Other Disposition of Common Stock or Common Warrants.&rdquo; Subject to applicable limitations, dividends paid to certain non-corporate
U.S. Holders may be eligible for taxation as &ldquo;qualified dividend income&rdquo; and therefore may be taxable at rates applicable
to long-term capital gains. U.S. Holders should consult their tax advisers regarding the availability of the reduced tax rate on dividends
in their particular circumstances. Dividends received by a corporate U.S. Holder will be eligible for the dividends-received deduction
if the U.S. Holder meets certain holding period and other applicable requirements.</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify; text-indent: 0.5in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt"><B><I>Constructive
Dividends on Common Warrants or Pre-Funded Warrants</I></B></FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify; text-indent: 0.5in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">Under
Section 305 of the Code, an adjustment to the number of shares of Common Stock that will be issued on the exercise of the common warrants
or the pre-funded warrants, or an adjustment to the exercise price of the common warrants or the pre-funded warrants, may be treated
as a constructive distribution to a U.S. Holder of the common warrants or pre-funded warrants if, and to the extent that, such adjustment
has the effect of increasing such U.S. Holder&rsquo;s proportionate interest in our &ldquo;earnings and profits&rdquo; or assets, depending
on the circumstances of such adjustment (for example, if such adjustment is to compensate for a distribution of cash or other property
to our stockholders). Adjustments to the exercise price of a common warrant or pre-funded warrant made pursuant to a bona fide reasonable
adjustment formula that has the effect of preventing dilution of the interest of the holders of such warrants should generally not result
in a constructive distribution. Any constructive distributions would generally be subject to the tax treatment described above under
&ldquo;<I>&mdash; Distributions on Common Stock</I>&rdquo; whether or not there is an actual distribution of cash or other property to
the holders of the common warrants or pre-funded warrants. U.S. Holders should consult their tax advisors regarding the proper treatment
of any adjustments to the common warrants and pre-funded warrants and any distributions with respect to such warrants.</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify; text-indent: 0.5in">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify; text-indent: 0.5in"></P>

<!-- Field: Page; Sequence: 31; Value: 1 -->
    <DIV STYLE="margin-top: 0pt; margin-bottom: 6pt; border-bottom: Black 1pt solid"><TABLE CELLPADDING="0" CELLSPACING="0" STYLE="border-collapse: collapse; width: 100%; font-size: 10pt"><TR STYLE="vertical-align: top; text-align: left"><TD STYLE="text-align: center; width: 100%"><!-- Field: Sequence; Type: Arabic; Name: PageNo -->26<!-- Field: /Sequence --></TD></TR></TABLE></DIV>
    <DIV STYLE="break-before: page; margin-top: 6pt; margin-bottom: 0pt"><P STYLE="margin: 0pt">&nbsp;</P></DIV>
    <!-- Field: /Page -->

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify; text-indent: 0.5in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt"><B><I>Sale
or Other Disposition of Common Stock or Common Warrants</I></B></FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt"><B><I>&nbsp;</I></B></FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify; text-indent: 0.5in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">For
U.S. federal income tax purposes, gain or loss realized on the sale or other disposition (other than a redemption treated as a distribution
which will be taxed as described above under &ldquo;&mdash;<I>Distributions on Common Stock</I>&rdquo;) of Common Stock (see discussion
above under the section titled &ldquo;&mdash;<I>Treatment of Pre-funded Warrants</I>&rdquo; regarding a pre-funded warrant being treated
as a share of our Common Stock for U.S. federal income tax purposes) or common warrants (other than by exercise) will be capital gain
or loss and will be long-term capital gain or loss if the U.S. Holder held the Common Stock or common warrants for more than one year.
The amount of the gain or loss will equal the difference between the amount realized and the U.S. Holder&rsquo;s adjusted tax basis in
the Common Stock or common warrants disposed of. Long-term capital gains recognized by non-corporate U.S. Holders will be subject to
reduced tax rates. The deductibility of capital losses is subject to limitations. U.S. Holders who realize losses with respect to a disposition
of our Common Stock or common warrants should consult their own tax advisors regarding the tax treatment of such losses.</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify; text-indent: 0.5in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt"><B><I>Exercise
or Expiration of Common Warrants or Pre-Funded Warrants</I></B></FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt"><B><I>&nbsp;</I></B></FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify; text-indent: 0.5in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">In
general, a U.S. Holder will not be required to recognize income, gain or loss upon the exercise of a common warrant or pre-funded warrant
by payment of the exercise price, except to the extent of cash paid in lieu of a fractional share (which fractional share is generally
treated as received and then exchanged for cash). A U.S. Holder&rsquo;s tax basis in a share of Common Stock received upon exercise will
be equal to the sum of (1) the U.S. Holder&rsquo;s tax basis in the common warrant or pre-funded warrant (except to the extent of any
tax basis allocated to a fractional share for which a cash payment is received) and (2) the exercise price of the common warrant or pre-funded
warrant.</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify; text-indent: 0.5in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify; text-indent: 0.5in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">A
U.S. Holder&rsquo;s holding period in the Common Stock received upon exercise of a common warrant will generally commence on the day
after such U.S. Holder exercises the common warrant. Assuming a pre-funded warrant is treated as our Common Stock, a U.S. Holder&rsquo;s
holding period in the stock received upon exercise of a pre-funded warrant will generally include such holder&rsquo;s holding period
in the pre-funded warrant exchanged therefor.</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify; text-indent: 0.5in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify; text-indent: 0.5in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">No
discussion is provided herein regarding the U.S. federal income tax treatment on the exercise of a common warrant or a pre-funded warrant
on a cashless basis, and U.S. Holders are urged to consult their tax advisors as to the exercise of a warrant on a cashless basis.</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify; text-indent: 0.5in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify; text-indent: 0.5in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">If
a common warrant expires without being exercised, a U.S. Holder will recognize a capital loss in an amount equal to such U.S. Holder&rsquo;s
tax basis in the common warrant. This loss will be long-term capital loss if, at the time of the expiration, the U.S. Holder&rsquo;s
holding period in the common warrant is more than one year. The deductibility of capital losses is subject to limitations.</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify; text-indent: 0.5in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt"><B>Information
Reporting and Backup Withholding</B></FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt"><B>&nbsp;</B></FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify; text-indent: 0.5in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">Information
returns may be filed with the IRS in connection with distributions on Common Stock or constructive dividends on common warrants and pre-funded
warrants, and the proceeds of a sale or other disposition of Common Stock or pre-funded warrants or common warrants. A non-exempt U.S.
Holder may be subject to U.S. backup withholding on these payments if it fails to provide its taxpayer identification number to the withholding
agent and comply with certification procedures or otherwise establish an exemption from backup withholding, or if the U.S. Holder is
notified by the IRS that it has failed to report in full payments of interest and dividend income.</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify; text-indent: 0.5in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify; text-indent: 0.5in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">Backup
withholding is not an additional tax. The amount of any backup withholding from a payment generally will be allowed as a credit against
a U.S. Holder&rsquo;s U.S. federal income tax liability and may entitle the holder to a refund, provided that the required information
is timely furnished to the IRS.</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify; text-indent: 0.5in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify; text-indent: 0.5in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt"><B>THE
PRECEDING DISCUSSION OF U.S. FEDERAL TAX CONSIDERATIONS IS FOR GENERAL INFORMATION ONLY. IT IS NOT TAX ADVICE. EACH PROSPECTIVE INVESTOR
SHOULD CONSULT ITS TAX ADVISOR REGARDING THE PARTICULAR U.S. FEDERAL, STATE AND LOCAL AND NON-U.S. TAX CONSEQUENCES OF PURCHASING, HOLDING
AND DISPOSING OF OUR COMMON STOCK, PRE-FUNDED WARRANTS OR COMMON WARRANTS, INCLUDING THE CONSEQUENCES OF ANY PROPOSED CHANGE IN APPLICABLE
LAWS.</B></FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; text-align: center"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt"><B>&nbsp;</B></FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; text-align: center"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt"><B></B></FONT></P>

<!-- Field: Page; Sequence: 32; Value: 1 -->
    <DIV STYLE="margin-top: 0pt; margin-bottom: 6pt; border-bottom: Black 1pt solid"><TABLE CELLPADDING="0" CELLSPACING="0" STYLE="border-collapse: collapse; width: 100%; font-size: 10pt"><TR STYLE="vertical-align: top; text-align: left"><TD STYLE="text-align: center; width: 100%"><!-- Field: Sequence; Type: Arabic; Name: PageNo -->27<!-- Field: /Sequence --></TD></TR></TABLE></DIV>
    <DIV STYLE="break-before: page; margin-top: 6pt; margin-bottom: 0pt"><P STYLE="margin: 0pt">&nbsp;</P></DIV>
    <!-- Field: /Page -->

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; text-align: center"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt"><B>&nbsp;<BR STYLE="clear: both">
</B></FONT></P>

<P STYLE="font: bold 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: center"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt"><A NAME="Aa_013"></A>DIVIDEND
POLICY</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: center"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt"><B>&nbsp;</B></FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify; text-indent: 0.5in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">We
have never declared or paid any cash dividends on our Common Stock and we do not currently intend to pay any cash dividends on our Common
Stock in the foreseeable future. We expect to retain all available funds and future earnings, if any, to fund the development and growth
of our business. Any future determination to pay dividends, if any, on our Common Stock will be at the discretion of our board of directors
and will depend on, among other factors, the terms of any outstanding preferred stock, our results of operations, financial condition,
capital requirements and contractual restrictions.</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify; text-indent: 0.5in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify; text-indent: 0.5in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt"></FONT></P>

<!-- Field: Page; Sequence: 33; Value: 1 -->
    <DIV STYLE="margin-top: 0pt; margin-bottom: 6pt; border-bottom: Black 1pt solid"><TABLE CELLPADDING="0" CELLSPACING="0" STYLE="border-collapse: collapse; width: 100%; font-size: 10pt"><TR STYLE="vertical-align: top; text-align: left"><TD STYLE="text-align: center; width: 100%"><!-- Field: Sequence; Type: Arabic; Name: PageNo -->28<!-- Field: /Sequence --></TD></TR></TABLE></DIV>
    <DIV STYLE="break-before: page; margin-top: 6pt; margin-bottom: 0pt"><P STYLE="margin: 0pt">&nbsp;</P></DIV>
    <!-- Field: /Page -->

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify; text-indent: 0.5in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify; text-indent: 0.5in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt"></FONT></P>

<P STYLE="font: bold 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: center"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt"><A NAME="Aa_014"></A>LEGAL
MATTERS</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: center"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify; text-indent: 0.5in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">The
validity of the securities being offered hereby will be passed upon by Thompson Hine LLP. The Placement <FONT STYLE="background-color: white">Agent
is</FONT> being represented by Sullivan &amp; Worcester LLP, New York, New York, in connection with this offering.</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>

<P STYLE="font: bold 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: center"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt"><A NAME="Aa_015"></A>EXPERTS</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: center"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify; text-indent: 0.5in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">The
financial statements incorporated in this prospectus by reference to our Annual Report on Form&#8239;10-K for the year ended December
31, 2024 have been so incorporated in reliance on the report of WithumSmith+Brown, PC, an independent registered public accounting firm,
which report includes an explanatory paragraph about the existence of substantial doubt concerning the Company&rsquo;s ability to continue
as a going concern, given on the authority of said firm as experts in auditing and accounting.</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify; text-indent: 0.5in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>

<P STYLE="font: bold 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: center"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt"><A NAME="Aa_016"></A>WHERE
YOU CAN FIND MORE INFORMATION</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: center"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify; text-indent: 0.5in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">We
file reports, proxy statements and other information with the SEC. The SEC maintains a website that contains reports, proxy and information
statements and other information about issuers, such as us, who file electronically with the SEC. The address of that website is <I>http://www.sec.gov</I>.</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify; text-indent: 0.5in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">Our
web site address is <I>http://www.imunon.com</I>. There we make available free of charge, on or through the investor relations section
of our website, annual reports on Form 10-K, quarterly reports on Form 10-Q, current reports on Form 8-K and amendments to those reports
filed pursuant to Section 13(a) or 15(d) of the Exchange Act as soon as reasonably practicable after we electronically file such material
with the SEC. The information on our web site, however, is not, and should not be deemed to be, a part of this prospectus. All website
addresses in this prospectus are intended to be inactive textual references only.</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify; text-indent: 0.5in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">This
prospectus is part of a registration statement we filed with the SEC. This prospectus does not contain all of the information set forth
in the registration statement and the exhibits to the registration statement. The registration statement, its exhibits and the documents
incorporated by reference in this prospectus and their exhibits, all contain information that is material to the offering of the securities
hereby. Whenever a reference is made in this prospectus to any of our contracts or other documents, the reference may not be complete.
You should refer to the exhibits that are a part of the registration statement in order to review a copy of the contract or documents.
The full registration statement and exhibits may be obtained from the SEC or us, as provided below. You may inspect a copy of the registration
statement through the SEC&rsquo;s website, as provided above.</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>


<!-- Field: Page; Sequence: 34; Value: 1 -->
    <DIV STYLE="margin-top: 0pt; margin-bottom: 6pt; border-bottom: Black 1pt solid"><TABLE CELLPADDING="0" CELLSPACING="0" STYLE="border-collapse: collapse; width: 100%; font-size: 10pt"><TR STYLE="vertical-align: top; text-align: left"><TD STYLE="text-align: center; width: 100%"><!-- Field: Sequence; Type: Arabic; Name: PageNo -->29<!-- Field: /Sequence --></TD></TR></TABLE></DIV>
    <DIV STYLE="break-before: page; margin-top: 6pt; margin-bottom: 0pt"><P STYLE="margin: 0pt">&nbsp;</P></DIV>
    <!-- Field: /Page -->

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>

<P STYLE="font: bold 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: center"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt"><A NAME="Aa_017"></A>INCORPORATION
OF CERTAIN INFORMATION BY REFERENCE</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: center"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify; text-indent: 0.5in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">The
SEC&rsquo;s rules allow us to &ldquo;incorporate by reference&rdquo; information into this prospectus, which means that we can disclose
important information to you by referring you to another document filed separately with the SEC. The information incorporated by reference
is deemed to be part of this prospectus, and subsequent information that we file with the SEC will automatically update and supersede
that information.</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify; text-indent: 0.5in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">We
incorporate by reference into this prospectus and the registration statement of which this prospectus is a part the information or documents
listed below (except in each case the information contained in such document to the extent &ldquo;furnished&rdquo; and not &ldquo;filed&rdquo;)
that we have filed with the SEC:</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>

<TABLE CELLSPACING="0" CELLPADDING="0" STYLE="font: 10pt Times New Roman, Times, Serif; width: 100%; border-collapse: collapse">
  <TR STYLE="font: 10pt Times New Roman, Times, Serif; vertical-align: top">
    <TD STYLE="font: 10pt Times New Roman, Times, Serif; width: 48px; text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></TD>
    <TD STYLE="font: 10pt Times New Roman, Times, Serif; width: .25in; text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt"><B>&#9679;</B></FONT></TD>
    <TD STYLE="font: 10pt Times New Roman, Times, Serif; text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">Our
    <A HREF="https://www.sec.gov/Archives/edgar/data/749647/000149315225008460/form10-k.htm" STYLE="-sec-extract: exhibit">Annual Report on Form 10-K for the fiscal year ended December 31, 2024</A> filed on February 27, 2025;</FONT></TD></TR>
  <TR STYLE="font: 10pt Times New Roman, Times, Serif; vertical-align: top">
    <TD STYLE="font: 10pt Times New Roman, Times, Serif; text-align: justify">&nbsp;</TD>
    <TD STYLE="font: 10pt Times New Roman, Times, Serif; text-align: justify">&nbsp;</TD>
    <TD STYLE="font: 10pt Times New Roman, Times, Serif; text-align: justify">&nbsp;</TD></TR>
  <TR STYLE="font: 10pt Times New Roman, Times, Serif; vertical-align: top">
    <TD STYLE="font: 10pt Times New Roman, Times, Serif; text-align: justify"> &nbsp; </TD>
    <TD STYLE="font: 10pt Times New Roman, Times, Serif; text-align: justify"> &#9679; </TD>
    <TD STYLE="font: 10pt Times New Roman, Times, Serif; text-align: justify"> Our Quarterly Report on <A HREF="https://www.sec.gov/Archives/edgar/data/749647/000164117225009572/form10-q.htm" STYLE="-sec-extract: exhibit">Form 10-Q</A> for the quarter ended
    March 31, 2025 filed on May 12, 2025; </TD></TR>
  <TR STYLE="font: 10pt Times New Roman, Times, Serif; vertical-align: top">
    <TD STYLE="font: 10pt Times New Roman, Times, Serif; text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></TD>
    <TD STYLE="font: 10pt Times New Roman, Times, Serif; text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></TD>
    <TD STYLE="font: 10pt Times New Roman, Times, Serif; text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></TD></TR>
  <TR STYLE="font: 10pt Times New Roman, Times, Serif; vertical-align: top">
    <TD STYLE="font: 10pt Times New Roman, Times, Serif; text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></TD>
    <TD STYLE="font: 10pt Times New Roman, Times, Serif; text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt"><B>&#9679;</B></FONT></TD>
    <TD STYLE="text-align: justify; font: 10pt Times New Roman, Times, Serif"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">Our
    Current <FONT STYLE="background-color: white">Reports</FONT> on Form 8-K filed with the SEC on <A HREF="https://www.sec.gov/Archives/edgar/data/749647/000149315225005536/form8-k.htm" STYLE="-sec-extract: exhibit">February
    10, 2025</A>,</FONT> <FONT STYLE="background-color: white"><A HREF="https://www.sec.gov/Archives/edgar/data/749647/000164117225000207/form8-k.htm" STYLE="-sec-extract: exhibit">March
    24, 2025</A>,</FONT> and May 12, 2025 excluding any information furnished in such reports under Item 2.02, Item 7.01 or Item
    9.01; and</TD></TR>
  <TR STYLE="font: 10pt Times New Roman, Times, Serif; vertical-align: top">
    <TD STYLE="font: 10pt Times New Roman, Times, Serif; text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></TD>
    <TD STYLE="font: 10pt Times New Roman, Times, Serif; text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></TD>
    <TD STYLE="font: 10pt Times New Roman, Times, Serif; text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></TD></TR>
  <TR STYLE="font: 10pt Times New Roman, Times, Serif; vertical-align: top">
    <TD STYLE="font: 10pt Times New Roman, Times, Serif; text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></TD>
    <TD STYLE="font: 10pt Times New Roman, Times, Serif; text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt"><B>&#9679;</B></FONT></TD>
    <TD STYLE="font: 10pt Times New Roman, Times, Serif; text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">Description
    of Securities of the Company, incorporated herein by reference to <A HREF="https://www.sec.gov/Archives/edgar/data/749647/000149315225008460/ex4-7.htm" STYLE="-sec-extract: exhibit">Exhibit 4.7</A> to the Annual Report on Form 10-K of the Company for
    the fiscal year ended December 31, 2024. </FONT></TD></TR>
  </TABLE>
<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify; text-indent: 0.5in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">In
addition, all documents subsequently filed by us pursuant to Sections 13(a), 13(c), 14 or 15(d) of the Exchange Act, prior to the termination
of the offering (excluding any information furnished rather than filed), shall be deemed to be incorporated by reference into this prospectus.</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify; text-indent: 0.5in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify; text-indent: 0.5in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">Any
statement contained in this prospectus or in a document incorporated or deemed to be incorporated by reference into this prospectus will
be deemed to be modified or superseded for purposes hereof to the extent that a statement contained in this prospectus or any other subsequently
filed document that is deemed to be incorporated by reference into this prospectus modifies or supersedes the statement. Any statement
so modified or superseded will not be deemed, except as so modified or superseded, to constitute a part of this prospectus.</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify; text-indent: 0.5in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">You
may request a free copy of any of the documents incorporated by reference in this prospectus (other than exhibits, unless they are specifically
incorporated by reference in the documents) by writing or telephoning us at the following address:</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; text-align: center"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: center"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">Imunon,
Inc.</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; text-align: center"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">997
Lenox Drive, Suite 100</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: center"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">Lawrenceville,
NJ 08648</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; text-align: center"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">(609)
896-9100</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; text-align: center"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify; text-indent: 0.5in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">Exhibits
to the filings will not be sent, however, unless those exhibits have specifically been incorporated by reference in this prospectus.</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; text-align: center"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify; text-indent: 0.5in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">The
documents incorporated by reference may be accessed at our website: <I>http://www.imunon.com</I>.</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt"><B>&nbsp;</B></FONT></P>


<!-- Field: Page; Sequence: 35; Value: 1 -->
    <DIV STYLE="margin-top: 0pt; margin-bottom: 6pt; border-bottom: Black 1pt solid"><TABLE CELLPADDING="0" CELLSPACING="0" STYLE="border-collapse: collapse; width: 100%; font-size: 10pt"><TR STYLE="vertical-align: top; text-align: left"><TD STYLE="text-align: center; width: 100%"><!-- Field: Sequence; Type: Arabic; Name: PageNo -->30<!-- Field: /Sequence --></TD></TR></TABLE></DIV>
    <DIV STYLE="break-before: page; margin-top: 6pt; margin-bottom: 0pt"><P STYLE="margin: 0pt">&nbsp;</P></DIV>
    <!-- Field: /Page -->

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: center">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: center">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: center">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: center">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: center"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: center"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt"><IMG SRC="form_001.jpg" ALT=""></FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: center"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: center"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt"><B>Up
to 15,000,000 Shares of Common Stock</B></FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: center"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt"><B>Up
to 15,000,000 Common Warrants to Purchase 45,000,000 Shares of Common Stock</B></FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: center"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt"><B>Up
to 15,000,000 Pre-Funded Warrants to Purchase 15,000,000 Shares of Common Stock</B></FONT></P>

<P STYLE="text-indent: 20pt; font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: center"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt"><B>Up
to 45,000,000 Shares of Common Stock Underlying such Common Warrants</B></FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: center"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt"><B>Up
to 15,000,000 Shares of Common Stock Underlying Such Pre-Funded Warrants</B></FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: center"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: center"><FONT STYLE="font: small-caps 10pt Times New Roman, Times, Serif"><B>Preliminary
Prospectus</B></FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: center"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: center"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: center"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: center">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: center">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: center">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: center">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: center">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: center"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: center"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: center"> <FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt"><I>Sole
</I></FONT> <FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt"><I>Placement Agent</I></FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: center"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: center"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 14pt"><B>Brookline
Capital Markets</B></FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: center"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">a
division of Arcadia Securities, LLC</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: center"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: center"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt"><B>&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;,
</B></FONT><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt"><B>2025</B></FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: center"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>


<!-- Field: Page; Sequence: 36 -->
    <DIV STYLE="margin-top: 0pt; margin-bottom: 6pt; border-bottom: Black 1pt solid"><TABLE CELLPADDING="0" CELLSPACING="0" STYLE="border-collapse: collapse; width: 100%; font-size: 10pt"><TR STYLE="vertical-align: top; text-align: left"><TD STYLE="width: 100%">&nbsp;</TD></TR></TABLE></DIV>
    <DIV STYLE="break-before: page; margin-top: 6pt; margin-bottom: 0pt"><P STYLE="margin: 0pt">&nbsp;</P></DIV>
    <!-- Field: /Page -->

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: center">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: center"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt"><B>PART
II</B></FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: center"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt"><B>INFORMATION
NOT REQUIRED IN PROSPECTUS</B></FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: center"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt"><B>Item
13. Other Expenses of Issuance and Distribution.</B></FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify; text-indent: 0.5in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">The
following table sets forth the expenses to be incurred in connection with the offering described in this registration statement, all
of which will be paid by the Company. All amounts are estimates except for the SEC registration fee and the Financial Industry Authority,
Inc. (FINRA) filing fee:</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>

<TABLE CELLSPACING="0" CELLPADDING="0" STYLE="font: 10pt Times New Roman, Times, Serif; width: 100%; border-collapse: collapse">
  <TR STYLE="font: 10pt Times New Roman, Times, Serif; vertical-align: bottom; background-color: rgb(204,238,255)">
    <TD STYLE="font: 10pt Times New Roman, Times, Serif; width: 80%"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">SEC
    registration fee</FONT></TD>
    <TD STYLE="font: 10pt Times New Roman, Times, Serif; width: 2%"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></TD>
    <TD STYLE="font: 10pt Times New Roman, Times, Serif; width: 1%"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">$</FONT></TD>
    <TD STYLE="font: 10pt Times New Roman, Times, Serif; width: 16%; text-align: right"> <FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">7,349</FONT> </TD>
    <TD STYLE="font: 10pt Times New Roman, Times, Serif; width: 1%"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></TD></TR>
  <TR STYLE="font: 10pt Times New Roman, Times, Serif; vertical-align: bottom; background-color: White">
    <TD STYLE="font: 10pt Times New Roman, Times, Serif"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">FINRA
    filing fee</FONT></TD>
    <TD STYLE="font: 10pt Times New Roman, Times, Serif"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></TD>
    <TD STYLE="font: 10pt Times New Roman, Times, Serif"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></TD>
    <TD STYLE="font: 10pt Times New Roman, Times, Serif; text-align: right"> <FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">2,300</FONT> </TD>
    <TD STYLE="font: 10pt Times New Roman, Times, Serif"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></TD></TR>
  <TR STYLE="font: 10pt Times New Roman, Times, Serif; vertical-align: bottom; background-color: rgb(204,238,255)">
    <TD STYLE="font: 10pt Times New Roman, Times, Serif"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">Legal
    fees and expenses</FONT></TD>
    <TD STYLE="font: 10pt Times New Roman, Times, Serif"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></TD>
    <TD STYLE="font: 10pt Times New Roman, Times, Serif"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></TD>
    <TD STYLE="font: 10pt Times New Roman, Times, Serif; text-align: right"> <FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">200,000</FONT> </TD>
    <TD STYLE="font: 10pt Times New Roman, Times, Serif"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></TD></TR>
  <TR STYLE="font: 10pt Times New Roman, Times, Serif; vertical-align: bottom; background-color: White">
    <TD STYLE="font: 10pt Times New Roman, Times, Serif"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">Accounting
    fees and expenses</FONT></TD>
    <TD STYLE="font: 10pt Times New Roman, Times, Serif"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></TD>
    <TD STYLE="font: 10pt Times New Roman, Times, Serif"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></TD>
    <TD STYLE="font: 10pt Times New Roman, Times, Serif; text-align: right"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">25,000</FONT></TD>
    <TD STYLE="font: 10pt Times New Roman, Times, Serif"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></TD></TR>
  <TR STYLE="font: 10pt Times New Roman, Times, Serif; vertical-align: bottom; background-color: rgb(204,238,255)">
    <TD STYLE="font: 10pt Times New Roman, Times, Serif"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">Printing
    and related expenses</FONT></TD>
    <TD STYLE="font: 10pt Times New Roman, Times, Serif"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></TD>
    <TD STYLE="font: 10pt Times New Roman, Times, Serif"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></TD>
    <TD STYLE="font: 10pt Times New Roman, Times, Serif; text-align: right"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">10,000</FONT></TD>
    <TD STYLE="font: 10pt Times New Roman, Times, Serif"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></TD></TR>
  <TR STYLE="font: 10pt Times New Roman, Times, Serif; vertical-align: bottom; background-color: White">
    <TD STYLE="font: 10pt Times New Roman, Times, Serif"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">Miscellaneous</FONT></TD>
    <TD STYLE="font: 10pt Times New Roman, Times, Serif"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></TD>
    <TD STYLE="border-bottom: black 1pt solid; font: 10pt Times New Roman, Times, Serif"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></TD>
    <TD STYLE="border-bottom: black 1pt solid; font: 10pt Times New Roman, Times, Serif; text-align: right"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">35,000</FONT></TD>
    <TD STYLE="font: 10pt Times New Roman, Times, Serif"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></TD></TR>
  <TR STYLE="font: 10pt Times New Roman, Times, Serif; vertical-align: bottom; background-color: rgb(204,238,255)">
    <TD STYLE="font: 10pt Times New Roman, Times, Serif"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt"><B>Total
    expenses</B></FONT></TD>
    <TD STYLE="font: 10pt Times New Roman, Times, Serif"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt"><B>&nbsp;</B></FONT></TD>
    <TD STYLE="border-bottom: black 2.25pt double; font: 10pt Times New Roman, Times, Serif"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt"><B>$</B></FONT></TD>
    <TD STYLE="border-bottom: black 2.25pt double; font: 10pt Times New Roman, Times, Serif; text-align: right"> <FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt"><B>279,649</B></FONT> </TD>
    <TD STYLE="font: 10pt Times New Roman, Times, Serif"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt"><B>&nbsp;</B></FONT></TD></TR>
  </TABLE>
<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt"><B>&nbsp;</B></FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt"><B>Item
14. Indemnification of Directors and Officers.</B></FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify; text-indent: 0.5in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">The
Company is incorporated under the laws of the State of Delaware. Our Bylaws provide that we shall, to the maximum extent and in the manner
permitted by the DGCL, indemnify each of our directors and officers against expenses (including attorneys&rsquo; fees), judgments, fines,
settlements and other amounts actually and reasonably incurred in connection with any proceeding, arising by reason of the fact that
such person is or was an agent of the Company; provided, however, that the Company may modify the extent of such indemnification by individual
contracts with its directors and executive officers and, provided, further, that the Company shall not be required to indemnify any director
or officer in connection with any proceeding (or part thereof) initiated by such person unless (i) such indemnification is expressly
required to be made by law, (ii) the proceeding was authorized in advance by our board of directors, (iii) such indemnification is provided
by the Company, in its sole discretion, pursuant to the powers vested in the corporation under the DGCL or (iv) such indemnification
is required to be made pursuant to an individual contract.</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify; text-indent: 0.5in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">The
DGCL provides that a Delaware corporation has the power generally to indemnify its current and former directors, officers, employees
and other agents (each, a &ldquo;<U>corporation agent</U>&rdquo;) against expenses and liabilities, including amounts paid in settlement,
in connection with any proceeding involving such person by reason of his being a corporation agent, other than a proceeding by or in
the right of the corporation, if such person acted in good faith and in a manner such person reasonably believed to be in or not opposed
to the best interests of the corporation and, with respect to any criminal proceeding, such person had no reasonable cause to believe
such person&rsquo;s conduct was unlawful.</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify; text-indent: 0.5in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">In
the case of an action brought by or in the right of the corporation, indemnification of a corporation agent is permitted if such person
acted in good faith and in a manner such person reasonably believed to be in or not opposed to the best interests of the corporation.
However, no indemnification is permitted in respect of any claim, issue or matter as to which such person shall have been adjudged to
be liable to the corporation, unless and only to the extent that the court in which such proceeding was brought shall determine upon
application that despite the adjudication of liability, but in view of all the circumstances of the case, such person is fairly and reasonably
entitled to such indemnification.</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify; text-indent: 0.5in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">To
the extent that a corporation agent has been successful on the merits or otherwise in the defense of such proceeding, whether or not
by or in the right of the corporation, or in the defense of any claim, issue or matter therein, the corporation is required to indemnify
such person for expenses in connection therewith. Under the DGCL, the corporation may advance expenses incurred by a corporation agent
in connection with a proceeding, provided that the corporation agent undertakes to repay such amount if it shall ultimately be determined
that such person is not entitled to indemnification. Our Bylaws require us to advance expenses to any director or officer entitled to
indemnification, provided that such person undertakes to repay the advancement if it is determined in a final judicial decision from
which there is no appeal that such person is not entitled to indemnification.</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt"></FONT></P>

<!-- Field: Page; Sequence: 37; Options: NewSection; Value: 1 -->
    <DIV STYLE="margin-top: 0pt; margin-bottom: 6pt; border-bottom: Black 1pt solid"><TABLE CELLPADDING="0" CELLSPACING="0" STYLE="border-collapse: collapse; width: 100%; font-size: 10pt"><TR STYLE="vertical-align: top; text-align: left"><TD STYLE="text-align: center; width: 100%">II-<!-- Field: Sequence; Type: Arabic; Name: PageNo -->1<!-- Field: /Sequence --></TD></TR></TABLE></DIV>
    <DIV STYLE="break-before: page; margin-top: 6pt; margin-bottom: 0pt"><P STYLE="margin: 0pt">&nbsp;</P></DIV>
    <!-- Field: /Page -->

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify; text-indent: 0.5in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">The
power to indemnify and advance the expenses under the DGCL does not exclude other rights to which a corporation agent may be entitled
to under our Certificate of Incorporation, Bylaws, agreement, vote of stockholders or disinterested directors or otherwise. Insofar as
indemnification for liabilities arising under the Securities Act may be permitted to directors, officers or persons controlling the Company
pursuant to the foregoing provisions, we have been informed that, in the opinion of the SEC, such indemnification is against public policy
as expressed in the Securities Act and is therefore unenforceable.</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify; text-indent: 0.5in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">Our
Bylaws permit us to secure insurance on behalf of our directors, officers, employees and agents for any expense, liability or loss incurred
in such capacities, whether or not the Company would have the power to indemnify such person against such liability under the provisions
of the DGCL. We maintain general liability insurance that covers certain liabilities of our directors and officers arising out of claims
based on acts or omissions in their capacities as directors or officers.</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify; text-indent: 0.5in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">The
purpose of these provisions is to assist us in retaining qualified individuals to serve as our directors, officers, employees and agents
by limiting their exposure to personal liability for serving as such.</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt"><B>&nbsp;</B></FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt"><B>Item
15. Recent Sales of Unregistered Securities.</B></FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify; text-indent: 0.5in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">On
July 30, 2024, we entered into a securities purchase agreement with certain institutional and other accredited investors, pursuant to
which we issued and sold 5,000,000 shares of our Common Stock in a registered direct offering and warrants to purchase 5,000,000
shares of Common Stock in a concurrent private placement, for a combined purchase price of $2.00 per share of Common Stock
and accompanying warrant. The closing of the private placement took place on August 1, 2024 and we received total gross proceeds of $10.0
million. H.C. Wainwright &amp; Co., LLC acted as the lead placement agent, and Brookline Capital Markets, a division of Arcadia Securities,
LLC, acted as co-placement agent for the registered direct offering and concurrent private placement. The placement agents were entitled
to fees equal to 7.0% of the gross proceeds from the registered direct offering and concurrent private placement. The sales and issuances
of securities in the transaction were not registered under the Securities Act in reliance upon the exemption from registration provided
by Section 4(a)(2) thereof or Regulation D promulgated thereunder. The recipients of the securities in each of these transactions represented
their intentions to acquire the securities for investment only and not with a view to or for sale in connection with any distribution
thereof, and appropriate legends were placed upon the stock certificates issued in these transactions. All recipients had adequate access,
through their relationships with us, to information about us.</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify; text-indent: 0.5in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">On December 7, 2023, we granted (i) an option to purchase 80,000 shares of the Common Stock with an exercise price of $0.88 per share
and (ii) a restricted stock award of 20,000 restricted shares to Dr. S&eacute;bastien Hazard, our then-Executive Vice President and Chief
Medical Officer, as an &ldquo;inducement&rdquo; grant pursuant to Rule 5635(c)(4) of the Nasdaq Listing Rules. On October 7, 2024, we
granted: (i) an inducement stock option to purchase 60,000 shares of the Common Stock with an exercise price of $1.02 per share to one
individual hired by the Company during the fourth quarter of 2024 and (ii) an inducement stock option to purchase 50,000 shares of the
Common Stock with an exercise price of $1.02 per share to Susan Eylward, our General Counsel, in each case as an &ldquo;inducement&rdquo;
grant pursuant to Rule 5635(c)(4) of the Nasdaq Listing Rules. On February 18, 2025, we granted an inducement stock option to purchase
100,000 shares of Common Stock with an exercise price of $0.862 to Dr. Douglas Faller, our Chief Medical Officer, as an &ldquo;inducement&rdquo;
grant pursuant to Rule 5635(c)(4) of the Nasdaq Listing Rules. The grants of these awards were exempt from registration under the Securities
Act, pursuant to Section 4(a)(2) thereof as a transaction by an issuer not involving a public offering.</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify; text-indent: 0.5in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify; text-indent: 0.5in"></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify; text-indent: 0.5in"> <FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">On
May 12, 2025, the Company entered into an exchange agreement (the &ldquo;<U>Exchange Agreement</U>&rdquo;) with the holders (the &ldquo;Existing
<U>Warrant Holders</U>&rdquo;) of certain warrants of the Company (the &ldquo;<U>Existing Warrants</U>&rdquo;) issued on August 1, 2024,
which are exercisable for an aggregate of 5,000,000 shares of Common Stock. Pursuant to the terms of the Exchange Agreement, the Company
will issue to the Existing Warrant Holders an aggregate of 2,921,000 shares of Common Stock (the &ldquo;<U>Warrant Exchange Shares</U>&rdquo;),
on a one-for-one basis, in exchange for shares issuable under the Existing Warrants (the &ldquo;<U>Warrant Exchange</U>&rdquo;). The
Warrant Exchange is expected to close on May 13, 2025. The number of Warrant Exchange Shares that will be issued pursuant to the Exchange
Agreement will represent 19.98% of the shares of Common Stock outstanding as of the date of the Exchange Agreement. The Warrant Exchange
will be completed, and the Warrant Exchange Shares will be issued in reliance on, the exemption from registration provided by Section
3(a)(9) of the Securities Act, on the basis that (a) the Warrant Exchange Shares are being issued in exchange for other outstanding securities
of the Company; (b) there will be no additional consideration delivered by the Existing Warrant Holders in connection with the Warrant
Exchange; and (c) there were no commissions or other remuneration paid by the Company in connection with the Warrant Exchange.</FONT> </P>
<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify; text-indent: 0.5in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt"></FONT></P>
<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt"></FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt"><B>Item
16. Exhibits and Financial Statement Schedules.</B></FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">(a)
The exhibits set forth below have been or are being filed herewith and are numbered in accordance with Item 601 of Regulation S-K.</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt"></FONT></P>

<!-- Field: Page; Sequence: 38; Value: 1 -->
    <DIV STYLE="margin-top: 0pt; margin-bottom: 6pt; border-bottom: Black 1pt solid"><TABLE CELLPADDING="0" CELLSPACING="0" STYLE="border-collapse: collapse; width: 100%; font-size: 10pt"><TR STYLE="vertical-align: top; text-align: left"><TD STYLE="text-align: center; width: 100%">II-<!-- Field: Sequence; Type: Arabic; Name: PageNo -->2<!-- Field: /Sequence --></TD></TR></TABLE></DIV>
    <DIV STYLE="break-before: page; margin-top: 6pt; margin-bottom: 0pt"><P STYLE="margin: 0pt">&nbsp;</P></DIV>
    <!-- Field: /Page -->

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">(b)
Financial statement schedules have been omitted, as the information required to be set forth therein is included in the consolidated
financial statements or notes thereto incorporated by reference into the prospectus forming part of this registration statement.</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>

<TABLE CELLSPACING="0" CELLPADDING="0" STYLE="font: 10pt Times New Roman, Times, Serif; width: 100%; border-collapse: collapse">
  <TR STYLE="font: 10pt Times New Roman, Times, Serif; vertical-align: bottom">
    <TD STYLE="border-bottom: black 1pt solid; font: 10pt Times New Roman, Times, Serif; text-align: center; width: 0.75in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt"><B>EXHIBIT
    NO.</B></FONT></TD>
    <TD STYLE="width: 0.1in">&nbsp;</TD>
    <TD STYLE="border-bottom: black 1pt solid; font: 10pt Times New Roman, Times, Serif"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt"><B>DESCRIPTION</B></FONT></TD></TR>
  <TR STYLE="font: 10pt Times New Roman, Times, Serif; vertical-align: top">
    <TD STYLE="font: 10pt Times New Roman, Times, Serif; text-align: center"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></TD>
    <TD>&nbsp;</TD>
    <TD STYLE="font: 10pt Times New Roman, Times, Serif; text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></TD></TR>
  <TR STYLE="font: 10pt Times New Roman, Times, Serif; vertical-align: top">
    <TD STYLE="font: 10pt Times New Roman, Times, Serif; text-align: center"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">1.1+</FONT></TD>
    <TD>&nbsp;</TD>
    <TD STYLE="font: 10pt Times New Roman, Times, Serif; text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt"><A HREF="ex1-1.htm">Form of Placement Agency Agreement.</A></FONT></TD></TR>
  <TR STYLE="font: 10pt Times New Roman, Times, Serif; vertical-align: top">
    <TD STYLE="font: 10pt Times New Roman, Times, Serif; text-align: center"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></TD>
    <TD>&nbsp;</TD>
    <TD STYLE="font: 10pt Times New Roman, Times, Serif; text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></TD></TR>
  <TR STYLE="font: 10pt Times New Roman, Times, Serif; vertical-align: top">
    <TD STYLE="font: 10pt Times New Roman, Times, Serif; text-align: center"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">2.1*</FONT></TD>
    <TD>&nbsp;</TD>
    <TD STYLE="font: 10pt Times New Roman, Times, Serif; text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt"><A HREF="https://www.sec.gov/Archives/edgar/data/749647/000143774914014489/ex2-1.htm" STYLE="-sec-extract: exhibit">Asset Purchase Agreement dated as of June 6, 2014, by and between Imunon, Inc. and EGEN, Inc., incorporated herein by reference to Exhibit 2.1 to the Quarterly Report on Form 10-Q of the Company for the quarter ended June 30, 2014 (SEC File No. 001-15911).</A></FONT></TD></TR>
  <TR STYLE="font: 10pt Times New Roman, Times, Serif; vertical-align: top">
    <TD STYLE="font: 10pt Times New Roman, Times, Serif; text-align: center"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></TD>
    <TD>&nbsp;</TD>
    <TD STYLE="font: 10pt Times New Roman, Times, Serif; text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></TD></TR>
  <TR STYLE="font: 10pt Times New Roman, Times, Serif; vertical-align: top">
    <TD STYLE="font: 10pt Times New Roman, Times, Serif; text-align: center"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">2.2</FONT></TD>
    <TD>&nbsp;</TD>
    <TD STYLE="font: 10pt Times New Roman, Times, Serif; text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt"><A HREF="https://www.sec.gov/Archives/edgar/data/749647/000149315219004381/ex10-1.htm" STYLE="-sec-extract: exhibit">Amendment to Asset Purchase Agreement between Celsion Corporation and EGWU, Inc., dated March 28, 2019 incorporated herein by reference to Exhibit 10.1 to the Current Report on Form 8-K of the Company filed on April 1, 2019 (SEC File No. 001-15911).</A></FONT></TD></TR>
  <TR STYLE="font: 10pt Times New Roman, Times, Serif; vertical-align: top">
    <TD STYLE="font: 10pt Times New Roman, Times, Serif; text-align: center"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></TD>
    <TD>&nbsp;</TD>
    <TD STYLE="font: 10pt Times New Roman, Times, Serif; text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></TD></TR>
  <TR STYLE="font: 10pt Times New Roman, Times, Serif; vertical-align: top">
    <TD STYLE="font: 10pt Times New Roman, Times, Serif; text-align: center"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">3.1</FONT></TD>
    <TD>&nbsp;</TD>
    <TD STYLE="font: 10pt Times New Roman, Times, Serif; text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt"><A HREF="https://www.sec.gov/Archives/edgar/data/749647/000149315223008888/ex3-1.htm" STYLE="-sec-extract: exhibit">Amended and Restated Certificate of Incorporation of Imunon, dated March 24, 2023, incorporated herein by reference to Exhibit 3.1 to the Current Report on Form 8-K of the Company filed on March 24, 2023 (SEC File No. 001-15911).</A></FONT></TD></TR>
  <TR STYLE="font: 10pt Times New Roman, Times, Serif; vertical-align: top">
    <TD STYLE="font: 10pt Times New Roman, Times, Serif; text-align: center"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></TD>
    <TD>&nbsp;</TD>
    <TD STYLE="font: 10pt Times New Roman, Times, Serif; text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></TD></TR>
  <TR STYLE="font: 10pt Times New Roman, Times, Serif; vertical-align: top">
    <TD STYLE="font: 10pt Times New Roman, Times, Serif; text-align: center"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">3.2</FONT></TD>
    <TD>&nbsp;</TD>
    <TD STYLE="font: 10pt Times New Roman, Times, Serif; text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt"><A HREF="https://www.sec.gov/Archives/edgar/data/749647/000149315224010195/ex3-1.htm" STYLE="-sec-extract: exhibit">Amended and Restated Bylaws of the Company, effective on March 15, 2024, incorporated by reference to Exhibit 3.1 to the Current Report on Form 8-K of the Company, filed on March 18, 2024 (SEC File No. 001-15911).</A></FONT></TD></TR>
  <TR STYLE="font: 10pt Times New Roman, Times, Serif; vertical-align: top">
    <TD STYLE="font: 10pt Times New Roman, Times, Serif; text-align: center"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></TD>
    <TD>&nbsp;</TD>
    <TD STYLE="font: 10pt Times New Roman, Times, Serif; text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></TD></TR>
  <TR STYLE="font: 10pt Times New Roman, Times, Serif; vertical-align: top">
    <TD STYLE="font: 10pt Times New Roman, Times, Serif; text-align: center"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">4.1</FONT></TD>
    <TD>&nbsp;</TD>
    <TD STYLE="font: 10pt Times New Roman, Times, Serif; text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt"><A HREF="https://www.sec.gov/Archives/edgar/data/749647/000143774917017965/ex_98287.htm" STYLE="-sec-extract: exhibit">Form of Representative&rsquo;s Common Stock Purchase Warrant, incorporated herein by reference to Exhibit 4.2 to the Current Report on Form 8-K of the Company, filed on October 31, 2017 (SEC File No. 001-15911).</A></FONT></TD></TR>
  <TR STYLE="font: 10pt Times New Roman, Times, Serif; vertical-align: top">
    <TD STYLE="font: 10pt Times New Roman, Times, Serif; text-align: center"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></TD>
    <TD>&nbsp;</TD>
    <TD STYLE="font: 10pt Times New Roman, Times, Serif; text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></TD></TR>
  <TR STYLE="font: 10pt Times New Roman, Times, Serif; vertical-align: top">
    <TD STYLE="font: 10pt Times New Roman, Times, Serif; text-align: center"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">4.2</FONT></TD>
    <TD>&nbsp;</TD>
    <TD STYLE="font: 10pt Times New Roman, Times, Serif; text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt"><A HREF="https://www.sec.gov/Archives/edgar/data/749647/000143774917012481/ex4-4.htm" STYLE="-sec-extract: exhibit">Form of Placement Agent Common Stock Purchase Warrant incorporated herein by reference to Exhibit 4.4 to the Current Report on Form 8-K of the Company, filed on July 11, 2017 (SEC File No. 001-15911).</A></FONT></TD></TR>
  <TR STYLE="font: 10pt Times New Roman, Times, Serif; vertical-align: top">
    <TD STYLE="font: 10pt Times New Roman, Times, Serif; text-align: center"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></TD>
    <TD>&nbsp;</TD>
    <TD STYLE="font: 10pt Times New Roman, Times, Serif; text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></TD></TR>
  <TR STYLE="font: 10pt Times New Roman, Times, Serif; vertical-align: top">
    <TD STYLE="font: 10pt Times New Roman, Times, Serif; text-align: center"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">4.3</FONT></TD>
    <TD>&nbsp;</TD>
    <TD STYLE="font: 10pt Times New Roman, Times, Serif; text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt"><A HREF="https://www.sec.gov/Archives/edgar/data/749647/000149315220017312/ex4-1.htm" STYLE="-sec-extract: exhibit">Form of Amended and Restated Warrant (issued under First Amendment of Venture Loan and Security Agreement, dated as of August 1, 2020, by and among Imunon, Inc., Horizon Funding I, LLC, Horizon Funding Trust 2019-1, and Horizon Technology Finance Corporation, as Collateral Agent), incorporated herein by reference to Exhibit 4.1 to the Current Report on Form 8-K of the Company, filed on September 4, 2020 (SEC File No. 001-15911).</A></FONT></TD></TR>
  <TR STYLE="font: 10pt Times New Roman, Times, Serif; vertical-align: top">
    <TD STYLE="font: 10pt Times New Roman, Times, Serif; text-align: center"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></TD>
    <TD>&nbsp;</TD>
    <TD STYLE="font: 10pt Times New Roman, Times, Serif; text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></TD></TR>
  <TR STYLE="font: 10pt Times New Roman, Times, Serif; vertical-align: top">
    <TD STYLE="font: 10pt Times New Roman, Times, Serif; text-align: center"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">4.4</FONT></TD>
    <TD>&nbsp;</TD>
    <TD STYLE="font: 10pt Times New Roman, Times, Serif; text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt"><A HREF="https://www.sec.gov/Archives/edgar/data/749647/000149315220003910/ex4-1.htm" STYLE="-sec-extract: exhibit">Form of Exchange Warrant, incorporated herein by reference to Exhibit 4.1 to the Current Report on Form 8-K of the Company, filed on March 13, 2020 (SEC File No. 001-15911).</A></FONT></TD></TR>
  <TR STYLE="font: 10pt Times New Roman, Times, Serif; vertical-align: top">
    <TD STYLE="font: 10pt Times New Roman, Times, Serif; text-align: center"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></TD>
    <TD>&nbsp;</TD>
    <TD STYLE="font: 10pt Times New Roman, Times, Serif; text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></TD></TR>
  <TR STYLE="font: 10pt Times New Roman, Times, Serif; vertical-align: top">
    <TD STYLE="font: 10pt Times New Roman, Times, Serif; text-align: center"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">4.5</FONT></TD>
    <TD>&nbsp;</TD>
    <TD STYLE="font: 10pt Times New Roman, Times, Serif; text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt"><A HREF="https://www.sec.gov/Archives/edgar/data/749647/000149315219007214/ex4-1.htm" STYLE="-sec-extract: exhibit">Warrant to purchase Shares of Common Stock of Celsion Corporation between Celsion Corporation and EGWU, Inc., dated March 28, 2019, incorporated herein by reference to Exhibit 4.1 to the Quarterly Report on Form 10-Q of the Company for the quarter ended March 31, 2019 (SEC File No. 001-15911).</A></FONT></TD></TR>
  <TR STYLE="font: 10pt Times New Roman, Times, Serif; vertical-align: top">
    <TD STYLE="font: 10pt Times New Roman, Times, Serif; text-align: center"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></TD>
    <TD>&nbsp;</TD>
    <TD STYLE="font: 10pt Times New Roman, Times, Serif; text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></TD></TR>
  <TR STYLE="font: 10pt Times New Roman, Times, Serif; vertical-align: top">
    <TD STYLE="font: 10pt Times New Roman, Times, Serif; text-align: center"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">4.6</FONT></TD>
    <TD>&nbsp;</TD>
    <TD STYLE="font: 10pt Times New Roman, Times, Serif; text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt"><A HREF="https://www.sec.gov/Archives/edgar/data/749647/000149315224029697/ex4-1.htm" STYLE="-sec-extract: exhibit">Form of Warrant, incorporated by reference to Exhibit 4.1 to the Current Report on Form 8-K of the Company filed on July 31, 2024 (SEC File No. 001-15911).</A></FONT></TD></TR>
  <TR STYLE="font: 10pt Times New Roman, Times, Serif; vertical-align: top">
    <TD STYLE="font: 10pt Times New Roman, Times, Serif; text-align: center"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></TD>
    <TD>&nbsp;</TD>
    <TD STYLE="font: 10pt Times New Roman, Times, Serif; text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></TD></TR>
  <TR STYLE="font: 10pt Times New Roman, Times, Serif; vertical-align: top">
    <TD STYLE="font: 10pt Times New Roman, Times, Serif; text-align: center"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">4.7</FONT></TD>
    <TD>&nbsp;</TD>
    <TD STYLE="font: 10pt Times New Roman, Times, Serif; text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt"><A HREF="https://www.sec.gov/Archives/edgar/data/749647/000149315225008460/ex4-7.htm" STYLE="-sec-extract: exhibit">Description of Securities of the Registrant, incorporated by reference to Exhibit 4.7 to the Annual Report on Form 10-K of the Company for the year ended December 31, 2024 (SEC File No. 001-15911).</A></FONT></TD></TR>
  <TR STYLE="font: 10pt Times New Roman, Times, Serif; vertical-align: top">
    <TD STYLE="font: 10pt Times New Roman, Times, Serif; text-align: center"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></TD>
    <TD>&nbsp;</TD>
    <TD STYLE="font: 10pt Times New Roman, Times, Serif; text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></TD></TR>
  <TR STYLE="font: 10pt Times New Roman, Times, Serif; vertical-align: top">
    <TD STYLE="font: 10pt Times New Roman, Times, Serif; text-align: center"> <FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">4.8#</FONT> </TD>
    <TD>&nbsp;</TD>
    <TD STYLE="font: 10pt Times New Roman, Times, Serif; text-align: justify"><A HREF="https://www.sec.gov/Archives/edgar/data/749647/000164117225002783/ex4-8.htm" STYLE="-sec-extract: exhibit"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">Form of Pre-Funded Warrant.</FONT></A></TD></TR>
  <TR STYLE="font: 10pt Times New Roman, Times, Serif; vertical-align: top">
    <TD STYLE="font: 10pt Times New Roman, Times, Serif; text-align: center"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></TD>
    <TD>&nbsp;</TD>
    <TD STYLE="font: 10pt Times New Roman, Times, Serif; text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></TD></TR>
  <TR STYLE="font: 10pt Times New Roman, Times, Serif; vertical-align: top">
    <TD STYLE="font: 10pt Times New Roman, Times, Serif; text-align: center"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">4.9+</FONT></TD>
    <TD>&nbsp;</TD>
    <TD STYLE="font: 10pt Times New Roman, Times, Serif; text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt"><A HREF="ex4-9.htm">Form of Common Stock Purchase Warrant.</A></FONT></TD></TR>
  <TR STYLE="font: 10pt Times New Roman, Times, Serif; vertical-align: top">
    <TD STYLE="font: 10pt Times New Roman, Times, Serif; text-align: center"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></TD>
    <TD>&nbsp;</TD>
    <TD STYLE="font: 10pt Times New Roman, Times, Serif; text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></TD></TR>
  <TR STYLE="font: 10pt Times New Roman, Times, Serif; vertical-align: top">
    <TD STYLE="font: 10pt Times New Roman, Times, Serif; text-align: center"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">5.1+</FONT></TD>
    <TD>&nbsp;</TD>
    <TD STYLE="font: 10pt Times New Roman, Times, Serif; text-align: justify"><A HREF="ex5-1.htm"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">Opinion of Thompson Hine LLP.</FONT></A></TD></TR>
  <TR STYLE="font: 10pt Times New Roman, Times, Serif; vertical-align: top">
    <TD STYLE="font: 10pt Times New Roman, Times, Serif; text-align: center"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></TD>
    <TD>&nbsp;</TD>
    <TD STYLE="font: 10pt Times New Roman, Times, Serif; text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></TD></TR>
  <TR STYLE="font: 10pt Times New Roman, Times, Serif; vertical-align: top">
    <TD STYLE="font: 10pt Times New Roman, Times, Serif; text-align: center"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">10.1**</FONT></TD>
    <TD>&nbsp;</TD>
    <TD STYLE="font: 10pt Times New Roman, Times, Serif; text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt"><A HREF="https://www.sec.gov/Archives/edgar/data/749647/000143774917009400/ex10-1.htm" STYLE="-sec-extract: exhibit">Imunon, Inc. 2007 Stock Incentive Plan, as amended, incorporated herein by reference to Exhibit 10.1 to the Current Report on Form 8-K of the Company, filed on May 16, 2017 (SEC File No. 001-15911).</A></FONT></TD></TR>
  <TR STYLE="font: 10pt Times New Roman, Times, Serif; vertical-align: top">
    <TD STYLE="font: 10pt Times New Roman, Times, Serif; text-align: center"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></TD>
    <TD>&nbsp;</TD>
    <TD STYLE="font: 10pt Times New Roman, Times, Serif; text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></TD></TR>
  <TR STYLE="font: 10pt Times New Roman, Times, Serif; vertical-align: top">
    <TD STYLE="font: 10pt Times New Roman, Times, Serif; text-align: center"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">10.2</FONT></TD>
    <TD>&nbsp;</TD>
    <TD STYLE="font: 10pt Times New Roman, Times, Serif; text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt"><A HREF="https://www.sec.gov/Archives/edgar/data/749647/000143774917019215/ex_99691.htm" STYLE="-sec-extract: exhibit">Form Inducement Offer to Exercise Common Stock Purchase Warrants, incorporated herein by reference to Exhibit 10.3 to the Quarterly Report on Form 10-Q of the Company for the quarter ended September 30, 2017 (SEC File No. 001-15911).</A></FONT></TD></TR>
  <TR STYLE="font: 10pt Times New Roman, Times, Serif; vertical-align: top">
    <TD STYLE="font: 10pt Times New Roman, Times, Serif; text-align: center"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></TD>
    <TD>&nbsp;</TD>
    <TD STYLE="font: 10pt Times New Roman, Times, Serif; text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></TD></TR>
  <TR STYLE="font: 10pt Times New Roman, Times, Serif; vertical-align: top">
    <TD STYLE="font: 10pt Times New Roman, Times, Serif; text-align: center"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">10.3**</FONT></TD>
    <TD>&nbsp;</TD>
    <TD STYLE="font: 10pt Times New Roman, Times, Serif; text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt"><A HREF="https://www.sec.gov/Archives/edgar/data/749647/000143774918010040/ex_114605.htm" STYLE="-sec-extract: exhibit">Imunon, Inc. 2018 Stock Incentive Plan, incorporated by reference to Exhibit 10.1 to the Current Report on Form 8-K of the Company filed May 15, 2018 (SEC File No. 001-15911).</A></FONT></TD></TR>
</TABLE>

<P STYLE="margin: 0">&nbsp;</P>

<P STYLE="margin: 0"></P>

<!-- Field: Page; Sequence: 39; Value: 1 -->
    <DIV STYLE="margin-top: 0pt; margin-bottom: 6pt; border-bottom: Black 1pt solid"><TABLE CELLPADDING="0" CELLSPACING="0" STYLE="border-collapse: collapse; width: 100%; font-size: 10pt"><TR STYLE="vertical-align: top; text-align: left"><TD STYLE="text-align: center; width: 100%">II-<!-- Field: Sequence; Type: Arabic; Name: PageNo -->3<!-- Field: /Sequence --></TD></TR></TABLE></DIV>
    <DIV STYLE="break-before: page; margin-top: 6pt; margin-bottom: 0pt"><P STYLE="margin: 0pt">&nbsp;</P></DIV>
    <!-- Field: /Page -->

<P STYLE="margin: 0">&nbsp;</P>

<TABLE CELLSPACING="0" CELLPADDING="0" STYLE="font: 10pt Times New Roman, Times, Serif; width: 100%; border-collapse: collapse">
  <TR STYLE="font: 10pt Times New Roman, Times, Serif; vertical-align: top">
    <TD STYLE="font: 10pt Times New Roman, Times, Serif; text-align: center; width: 0.75in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">10.4**
    </FONT></TD>
    <TD STYLE="width: 0.1in">&nbsp;</TD>
    <TD STYLE="font: 10pt Times New Roman, Times, Serif; text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt"><A HREF="https://www.sec.gov/Archives/edgar/data/749647/000149315219007203/ex10-1.htm" STYLE="-sec-extract: exhibit">First Amendment to the Imunon, Inc. 2018 Stock Incentive Plan, incorporated by reference to Exhibit 10.1 to the Current Report on Form 8-K of the Company, filed on May 15, 2019 (SEC File No. 001-15911).</A></FONT></TD></TR>
  <TR STYLE="font: 10pt Times New Roman, Times, Serif; vertical-align: top">
    <TD STYLE="font: 10pt Times New Roman, Times, Serif; text-align: center"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></TD>
    <TD>&nbsp;</TD>
    <TD STYLE="font: 10pt Times New Roman, Times, Serif; text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></TD></TR>
  <TR STYLE="font: 10pt Times New Roman, Times, Serif; vertical-align: top">
    <TD STYLE="font: 10pt Times New Roman, Times, Serif; text-align: center"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">10.5**</FONT></TD>
    <TD>&nbsp;</TD>
    <TD STYLE="font: 10pt Times New Roman, Times, Serif; text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt"><A HREF="https://www.sec.gov/Archives/edgar/data/749647/000149315220011263/ex10-1.htm" STYLE="-sec-extract: exhibit">Second Amendment to the Imunon, Inc. 2018 Stock Incentive Plan, incorporated by reference to Exhibit 10.1 to the Current Report on Form 8-K of the Company, filed on June 16, 2020 (SEC File No. 001-15911).</A></FONT></TD></TR>
  <TR STYLE="font: 10pt Times New Roman, Times, Serif; vertical-align: top">
    <TD STYLE="font: 10pt Times New Roman, Times, Serif; text-align: center"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></TD>
    <TD>&nbsp;</TD>
    <TD STYLE="font: 10pt Times New Roman, Times, Serif; text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></TD></TR>
  <TR STYLE="font: 10pt Times New Roman, Times, Serif; vertical-align: top">
    <TD STYLE="font: 10pt Times New Roman, Times, Serif; text-align: center"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">10.6**</FONT></TD>
    <TD>&nbsp;</TD>
    <TD STYLE="font: 10pt Times New Roman, Times, Serif; text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt"><A HREF="https://www.sec.gov/Archives/edgar/data/749647/000149315221014023/ex10-1.htm" STYLE="-sec-extract: exhibit">Third Amendment to the Celsion Corporation 2018 Stock Incentive Plan, incorporated herein by reference to Exhibit 10.1 to the Current Report on Form 8-K of the Company, filed with the Commission on June 10, 2021 (SEC File No. 001-15911).</A></FONT></TD></TR>
  <TR STYLE="font: 10pt Times New Roman, Times, Serif; vertical-align: top">
    <TD STYLE="font: 10pt Times New Roman, Times, Serif; text-align: center"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></TD>
    <TD>&nbsp;</TD>
    <TD STYLE="font: 10pt Times New Roman, Times, Serif; text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></TD></TR>
  <TR STYLE="font: 10pt Times New Roman, Times, Serif; vertical-align: top">
    <TD STYLE="font: 10pt Times New Roman, Times, Serif; text-align: center"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">10.7**</FONT></TD>
    <TD>&nbsp;</TD>
    <TD STYLE="font: 10pt Times New Roman, Times, Serif; text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt"><A HREF="https://www.sec.gov/Archives/edgar/data/749647/000149315223021447/ex10-1.htm" STYLE="-sec-extract: exhibit">Imunon, Inc. 2018 Stock Incentive Plan, as amended as of June 14, 2023, incorporated herein by reference to Exhibit 10.1 to the Current Report on Form 8-K of the Company, filed with the Commission on June 15, 2023 (SEC File No. 001-15911).</A></FONT></TD></TR>
  <TR STYLE="font: 10pt Times New Roman, Times, Serif; vertical-align: top">
    <TD STYLE="font: 10pt Times New Roman, Times, Serif; text-align: center"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></TD>
    <TD>&nbsp;</TD>
    <TD STYLE="font: 10pt Times New Roman, Times, Serif; text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></TD></TR>
  <TR STYLE="font: 10pt Times New Roman, Times, Serif; vertical-align: top">
    <TD STYLE="font: 10pt Times New Roman, Times, Serif; text-align: center"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">10.8**</FONT></TD>
    <TD>&nbsp;</TD>
    <TD STYLE="font: 10pt Times New Roman, Times, Serif; text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt"><A HREF="https://www.sec.gov/Archives/edgar/data/749647/000149315224018795/ex10-1.htm" STYLE="-sec-extract: exhibit">Form of Incentive Stock Option Grant Agreement under the 2018 Stock Incentive Plan, incorporated herein by reference to Exhibit 10.1 to the Quarterly Report on Form 10-Q of the Company for the quarter ended March 31, 2024 (SEC File No. 001-15911).</A></FONT></TD></TR>
  <TR STYLE="font: 10pt Times New Roman, Times, Serif; vertical-align: top">
    <TD STYLE="font: 10pt Times New Roman, Times, Serif; text-align: center"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></TD>
    <TD>&nbsp;</TD>
    <TD STYLE="font: 10pt Times New Roman, Times, Serif; text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></TD></TR>
  <TR STYLE="font: 10pt Times New Roman, Times, Serif; vertical-align: top">
    <TD STYLE="font: 10pt Times New Roman, Times, Serif; text-align: center"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">10.9**</FONT></TD>
    <TD>&nbsp;</TD>
    <TD STYLE="font: 10pt Times New Roman, Times, Serif; text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt"><A HREF="https://www.sec.gov/Archives/edgar/data/749647/000149315224018795/ex10-2.htm" STYLE="-sec-extract: exhibit">Form of Restricted Stock Agreement under the 2018 Stock Incentive Plan, incorporated herein by reference to Exhibit 10.2 to the Quarterly Report on Form 10-Q of the Company for the quarter ended March 31, 2024 (SEC File No. 001-15911).</A></FONT></TD></TR>
  <TR STYLE="font: 10pt Times New Roman, Times, Serif; vertical-align: top">
    <TD STYLE="font: 10pt Times New Roman, Times, Serif; text-align: center"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></TD>
    <TD>&nbsp;</TD>
    <TD STYLE="font: 10pt Times New Roman, Times, Serif; text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></TD></TR>
  <TR STYLE="font: 10pt Times New Roman, Times, Serif; vertical-align: top">
    <TD STYLE="font: 10pt Times New Roman, Times, Serif; text-align: center"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">10.10**</FONT></TD>
    <TD>&nbsp;</TD>
    <TD STYLE="font: 10pt Times New Roman, Times, Serif; text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt"><A HREF="https://www.sec.gov/Archives/edgar/data/749647/000149315224034310/ex99-1.htm" STYLE="-sec-extract: exhibit">Form of Nonqualified Stock Option and Restricted Stock Grant Agreement for employment inducement awards, incorporated by reference to Exhibit 99.1 to the Company&rsquo;s Registration Statement on Form S-8 filed on August 29, 2024 (No. 333-281833).</A></FONT></TD></TR>
  <TR STYLE="font: 10pt Times New Roman, Times, Serif; vertical-align: top">
    <TD STYLE="font: 10pt Times New Roman, Times, Serif; text-align: center"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></TD>
    <TD>&nbsp;</TD>
    <TD STYLE="font: 10pt Times New Roman, Times, Serif; text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></TD></TR>
  <TR STYLE="font: 10pt Times New Roman, Times, Serif; vertical-align: top">
    <TD STYLE="font: 10pt Times New Roman, Times, Serif; text-align: center"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">10.11**</FONT></TD>
    <TD>&nbsp;</TD>
    <TD STYLE="font: 10pt Times New Roman, Times, Serif; text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt"><A HREF="https://www.sec.gov/Archives/edgar/data/749647/000074964710000024/offerletter.htm" STYLE="-sec-extract: exhibit">Employment Offer Letter, entered into on June 15, 2010, between the Company and Jeffrey W. Church, incorporated herein by reference to Exhibit 10.1 to the Current Report on Form 8-K of the Company filed on June 18, 2010 (SEC File No. 001-15911).</A></FONT></TD></TR>
  <TR STYLE="font: 10pt Times New Roman, Times, Serif; vertical-align: top">
    <TD STYLE="font: 10pt Times New Roman, Times, Serif; text-align: center"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></TD>
    <TD>&nbsp;</TD>
    <TD STYLE="font: 10pt Times New Roman, Times, Serif; text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></TD></TR>
  <TR STYLE="font: 10pt Times New Roman, Times, Serif; vertical-align: top">
    <TD STYLE="font: 10pt Times New Roman, Times, Serif; text-align: center"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">10.12**</FONT></TD>
    <TD>&nbsp;</TD>
    <TD STYLE="font: 10pt Times New Roman, Times, Serif; text-align: justify"><A HREF="https://www.sec.gov/Archives/edgar/data/749647/000143774915004805/ex10-27.htm" STYLE="-sec-extract: exhibit"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">Employment Offer Letter effective as of June 2, 2014, between the Company and Khursheed Anwer incorporated herein by reference to Exhibit 10.27 to the Annual Report of the Company for the year ended December 31, 2014 (SEC File No. 001-15911).</FONT></A></TD></TR>
  <TR STYLE="font: 10pt Times New Roman, Times, Serif; vertical-align: top">
    <TD STYLE="font: 10pt Times New Roman, Times, Serif; text-align: center"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></TD>
    <TD>&nbsp;</TD>
    <TD STYLE="font: 10pt Times New Roman, Times, Serif; text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></TD></TR>
  <TR STYLE="font: 10pt Times New Roman, Times, Serif; vertical-align: top">
    <TD STYLE="font: 10pt Times New Roman, Times, Serif; text-align: center"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">10.13**</FONT></TD>
    <TD>&nbsp;</TD>
    <TD STYLE="font: 10pt Times New Roman, Times, Serif; text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt"><A HREF="https://www.sec.gov/Archives/edgar/data/749647/000149315222019765/ex10-2.htm" STYLE="-sec-extract: exhibit">Employment Agreement between the Company and Michael H. Tardugno, effective as of July 18, 2022, incorporated herein by reference to Exhibit 10.2 to the Current Report on Form 8-K of the Company filed with the Commission on July 19, 2022 (SEC File No. 001-15911).</A></FONT></TD></TR>
  <TR STYLE="font: 10pt Times New Roman, Times, Serif; vertical-align: top">
    <TD STYLE="font: 10pt Times New Roman, Times, Serif; text-align: center"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></TD>
    <TD>&nbsp;</TD>
    <TD STYLE="font: 10pt Times New Roman, Times, Serif; text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></TD></TR>
  <TR STYLE="font: 10pt Times New Roman, Times, Serif; vertical-align: top">
    <TD STYLE="font: 10pt Times New Roman, Times, Serif; text-align: center"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">10.14**</FONT></TD>
    <TD>&nbsp;</TD>
    <TD STYLE="font: 10pt Times New Roman, Times, Serif; text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt"><A HREF="https://www.sec.gov/Archives/edgar/data/749647/000149315222019765/ex10-1.htm" STYLE="-sec-extract: exhibit">Employment Agreement between the Company Corporation and Corinne Le Goff, effective as of July 18, 2022 incorporated herein by reference to Exhibit 10.1 to the Current Report on Form 8-K of the Company filed with the Commission on July 19, 2022 (SEC File No. 001-15911).</A></FONT></TD></TR>
  <TR STYLE="font: 10pt Times New Roman, Times, Serif; vertical-align: top">
    <TD STYLE="font: 10pt Times New Roman, Times, Serif; text-align: center"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></TD>
    <TD>&nbsp;</TD>
    <TD STYLE="font: 10pt Times New Roman, Times, Serif; text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></TD></TR>
  <TR STYLE="font: 10pt Times New Roman, Times, Serif; vertical-align: top">
    <TD STYLE="font: 10pt Times New Roman, Times, Serif; text-align: center"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">10.15**</FONT></TD>
    <TD>&nbsp;</TD>
    <TD STYLE="font: 10pt Times New Roman, Times, Serif; text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt"><A HREF="https://www.sec.gov/Archives/edgar/data/749647/000143774916041670/ex10-1.htm" STYLE="-sec-extract: exhibit">Amended and Restated Change in Control Agreement dated as of September 6, 2016, by and between the Company and Michael H. Tardugno, incorporated herein by reference to Exhibit 10.1 to the Quarterly Report on Form 10-Q of the Company for the quarter ended September 30, 2016 (SEC File No. 001-15911).</A></FONT></TD></TR>
  <TR STYLE="font: 10pt Times New Roman, Times, Serif; vertical-align: top">
    <TD STYLE="font: 10pt Times New Roman, Times, Serif; text-align: center"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></TD>
    <TD>&nbsp;</TD>
    <TD STYLE="font: 10pt Times New Roman, Times, Serif; text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></TD></TR>
  <TR STYLE="font: 10pt Times New Roman, Times, Serif; vertical-align: top">
    <TD STYLE="font: 10pt Times New Roman, Times, Serif; text-align: center"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">10.16**</FONT></TD>
    <TD>&nbsp;</TD>
    <TD STYLE="font: 10pt Times New Roman, Times, Serif; text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt"><A HREF="https://www.sec.gov/Archives/edgar/data/749647/000149315224018166/ex10-1.htm" STYLE="-sec-extract: exhibit">Employment Agreement, dated as of May 3, 2024, between the Company and Stacy Lindborg, Ph.D., incorporated by reference to Exhibit 10.1 to the Current Report on Form 8-K of the Company filed on May 8, 2024 (SEC File No. 001-15911).</A></FONT></TD></TR>
</TABLE>

<P STYLE="margin: 0">&nbsp;</P>

<P STYLE="margin: 0"></P>

<!-- Field: Page; Sequence: 40; Value: 1 -->
    <DIV STYLE="margin-top: 0pt; margin-bottom: 6pt; border-bottom: Black 1pt solid"><TABLE CELLPADDING="0" CELLSPACING="0" STYLE="border-collapse: collapse; width: 100%; font-size: 10pt"><TR STYLE="vertical-align: top; text-align: left"><TD STYLE="text-align: center; width: 100%">II-<!-- Field: Sequence; Type: Arabic; Name: PageNo -->4<!-- Field: /Sequence --></TD></TR></TABLE></DIV>
    <DIV STYLE="break-before: page; margin-top: 6pt; margin-bottom: 0pt"><P STYLE="margin: 0pt">&nbsp;</P></DIV>
    <!-- Field: /Page -->

<P STYLE="margin: 0">&nbsp;</P>

<P STYLE="margin: 0"></P>

<TABLE CELLSPACING="0" CELLPADDING="0" STYLE="font: 10pt Times New Roman, Times, Serif; width: 100%; border-collapse: collapse">
  <TR STYLE="font: 10pt Times New Roman, Times, Serif; vertical-align: top">
    <TD STYLE="font: 10pt Times New Roman, Times, Serif; text-align: center; width: 0.75in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">10.17**</FONT></TD>
    <TD STYLE="width: 0.1in">&nbsp;</TD>
    <TD STYLE="font: 10pt Times New Roman, Times, Serif; text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt"><A HREF="https://www.sec.gov/Archives/edgar/data/749647/000149315224020543/ex10-1.htm" STYLE="-sec-extract: exhibit">Retirement and Consulting Agreement, dated May 17, 2024, between Imunon, Inc. and Jeffrey Church, incorporated by reference to Exhibit 10.1 to the Current Report on Form 8-K of the Company filed on May 20, 2024 (SEC File No. 001-15911).</A></FONT></TD></TR>
  <TR STYLE="font: 10pt Times New Roman, Times, Serif; vertical-align: top">
    <TD STYLE="font: 10pt Times New Roman, Times, Serif; text-align: center"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></TD>
    <TD>&nbsp;</TD>
    <TD STYLE="font: 10pt Times New Roman, Times, Serif; text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></TD></TR>
  <TR STYLE="font: 10pt Times New Roman, Times, Serif; vertical-align: top">
    <TD STYLE="font: 10pt Times New Roman, Times, Serif; text-align: center"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">10.18**</FONT></TD>
    <TD>&nbsp;</TD>
    <TD STYLE="font: 10pt Times New Roman, Times, Serif; text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt"><A HREF="https://www.sec.gov/Archives/edgar/data/749647/000149315224020543/ex10-2.htm" STYLE="-sec-extract: exhibit">Consulting Agreement, dated April 15, 2024, by and between Imunon, Inc. and Monomoy Advisors, LLC incorporated by reference to Exhibit 10.2 to the Current Report on Form 8-K of the Company filed on May 20, 2024 (SEC File No. 001-15911).</A></FONT></TD></TR>
  <TR STYLE="font: 10pt Times New Roman, Times, Serif; vertical-align: top">
    <TD STYLE="font: 10pt Times New Roman, Times, Serif; text-align: center"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></TD>
    <TD>&nbsp;</TD>
    <TD STYLE="font: 10pt Times New Roman, Times, Serif; text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></TD></TR>
  <TR STYLE="font: 10pt Times New Roman, Times, Serif; vertical-align: top">
    <TD STYLE="font: 10pt Times New Roman, Times, Serif; text-align: center"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">10.19**</FONT></TD>
    <TD>&nbsp;</TD>
    <TD STYLE="font: 10pt Times New Roman, Times, Serif; text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt"><A HREF="https://www.sec.gov/Archives/edgar/data/749647/000149315224039646/ex10-1.htm" STYLE="-sec-extract: exhibit">Offer Letter of Employment, dated October 2, 2024, between Imunon, Inc. and Susan Eylward, incorporated by reference to Exhibit 10.1 to the Current Report on Form 8-K of the Company filed on October 7, 2024 (SEC File No. 001-15911).</A></FONT></TD></TR>
  <TR STYLE="font: 10pt Times New Roman, Times, Serif; vertical-align: top">
    <TD STYLE="font: 10pt Times New Roman, Times, Serif; text-align: center"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></TD>
    <TD>&nbsp;</TD>
    <TD STYLE="font: 10pt Times New Roman, Times, Serif; text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></TD></TR>
  <TR STYLE="font: 10pt Times New Roman, Times, Serif; vertical-align: top">
    <TD STYLE="font: 10pt Times New Roman, Times, Serif; text-align: center"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">10.20**</FONT></TD>
    <TD>&nbsp;</TD>
    <TD STYLE="font: 10pt Times New Roman, Times, Serif; text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt"><A HREF="https://www.sec.gov/Archives/edgar/data/749647/000149315224043931/ex10-5.htm" STYLE="-sec-extract: exhibit">Separation Agreement, dated August 9, 2024 by and between the Company and S&eacute;bastien Hazard, M.D., incorporated by reference to Exhibit 10.5 to the Quarterly Report on Form 10-Q of the Company for the quarter ended September 30, 2024 (SEC file No. 001-15911).</A></FONT></TD></TR>
  <TR STYLE="font: 10pt Times New Roman, Times, Serif; vertical-align: top">
    <TD STYLE="font: 10pt Times New Roman, Times, Serif; text-align: center"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></TD>
    <TD>&nbsp;</TD>
    <TD STYLE="font: 10pt Times New Roman, Times, Serif; text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></TD></TR>
  <TR STYLE="font: 10pt Times New Roman, Times, Serif; vertical-align: top">
    <TD STYLE="font: 10pt Times New Roman, Times, Serif; text-align: center"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">10.21</FONT></TD>
    <TD>&nbsp;</TD>
    <TD STYLE="font: 10pt Times New Roman, Times, Serif; text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt"><A HREF="https://www.sec.gov/Archives/edgar/data/749647/000074964711000106/exhibit99_1.htm" STYLE="-sec-extract: exhibit">Lease Agreement, executed July 21, 2011, by and between Imunon, Inc. and Brandywine Operating Partnership, L.P., incorporated herein by reference to Exhibit 10.1 to the Current Report on Form 8-K of the Company filed on July 25, 2011 (SEC File No. 001-15911).</A></FONT></TD></TR>
  <TR STYLE="font: 10pt Times New Roman, Times, Serif; vertical-align: top">
    <TD STYLE="font: 10pt Times New Roman, Times, Serif; text-align: center"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></TD>
    <TD>&nbsp;</TD>
    <TD STYLE="font: 10pt Times New Roman, Times, Serif; text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></TD></TR>
  <TR STYLE="font: 10pt Times New Roman, Times, Serif; vertical-align: top">
    <TD STYLE="font: 10pt Times New Roman, Times, Serif; text-align: center"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">10.22</FONT></TD>
    <TD>&nbsp;</TD>
    <TD STYLE="font: 10pt Times New Roman, Times, Serif; text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt"><A HREF="https://www.sec.gov/Archives/edgar/data/749647/000143774917019215/ex_99690.htm" STYLE="-sec-extract: exhibit">First Amendment to Lease Agreement, executed April 20, 2017, by and between Imunon, Inc. and Lenox Drive Office Park, LLC, incorporated herein by reference to Exhibit 10.1 to the Current Report on Form 10-Q of the Company filed on November 14, 2017 (SEC File No. 001-15911).</A></FONT></TD></TR>
  <TR STYLE="font: 10pt Times New Roman, Times, Serif; vertical-align: top">
    <TD STYLE="font: 10pt Times New Roman, Times, Serif; text-align: center"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></TD>
    <TD>&nbsp;</TD>
    <TD STYLE="font: 10pt Times New Roman, Times, Serif; text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></TD></TR>
  <TR STYLE="font: 10pt Times New Roman, Times, Serif; vertical-align: top">
    <TD STYLE="font: 10pt Times New Roman, Times, Serif; text-align: center"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">10.23</FONT></TD>
    <TD>&nbsp;</TD>
    <TD STYLE="font: 10pt Times New Roman, Times, Serif; text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt"><A HREF="https://www.sec.gov/Archives/edgar/data/749647/000149315219007214/ex10-1.htm" STYLE="-sec-extract: exhibit">Second Amendment to Lease Agreement, dated January 9, 2019, by and between Celsion Corporation and Lenox Drive Office Park, LLC, successor in interest to Brandywine Operating Partnership, L.P., incorporated herein by reference to Exhibit 10-Q to the Current Report on Form 10-Q of the Company for the quarter ended March 31, 2019 (SEC File No. 001-15911).</A></FONT></TD></TR>
  <TR STYLE="font: 10pt Times New Roman, Times, Serif; vertical-align: top">
    <TD STYLE="font: 10pt Times New Roman, Times, Serif; text-align: center"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></TD>
    <TD>&nbsp;</TD>
    <TD STYLE="font: 10pt Times New Roman, Times, Serif; text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></TD></TR>
  <TR STYLE="font: 10pt Times New Roman, Times, Serif; vertical-align: top">
    <TD STYLE="font: 10pt Times New Roman, Times, Serif; text-align: center"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">10.24</FONT></TD>
    <TD>&nbsp;</TD>
    <TD STYLE="font: 10pt Times New Roman, Times, Serif; text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt"><A HREF="https://www.sec.gov/Archives/edgar/data/749647/000143774918009535/ex_113795.htm" STYLE="-sec-extract: exhibit">Lease Agreement dated January 15, 2018, by and between Imunon, Inc. and HudsonAlpha Institute of Biotechnology for office and lab space located in Huntsville, Alabama incorporated herein by reference to Exhibit 10.1 to the Quarterly Report on Form 10-Q of the Company for the quarter ended March 31, 2018 (SEC File No. 001-15911).</A></FONT></TD></TR>
  <TR STYLE="font: 10pt Times New Roman, Times, Serif; vertical-align: top">
    <TD STYLE="font: 10pt Times New Roman, Times, Serif; text-align: center"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></TD>
    <TD>&nbsp;</TD>
    <TD STYLE="font: 10pt Times New Roman, Times, Serif; text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></TD></TR>
  <TR STYLE="font: 10pt Times New Roman, Times, Serif; vertical-align: top">
    <TD STYLE="font: 10pt Times New Roman, Times, Serif; text-align: center"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">10.25</FONT></TD>
    <TD>&nbsp;</TD>
    <TD STYLE="font: 10pt Times New Roman, Times, Serif; text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt"><A HREF="https://www.sec.gov/Archives/edgar/data/749647/000149315220011263/ex10-2.htm" STYLE="-sec-extract: exhibit">Settlement Agreement and Release, by and between the plaintiff to the shareholder action captioned O&rsquo;Connor v. Braun, et al., N.J. Super., Dkt. No. MERC-00068-19, William J. O&rsquo;Connor, derivatively on behalf of Imunon, Inc. and individually on behalf of himself and all other similarly situated stockholders of Imunon, Inc. and defendants, incorporated herein by reference to Exhibit 10.2 to the Current Report on Form 8-K of the Company, filed on June 16, 2020 (SEC File No. 001-15911).</A></FONT></TD></TR>
  <TR STYLE="font: 10pt Times New Roman, Times, Serif; vertical-align: top">
    <TD STYLE="font: 10pt Times New Roman, Times, Serif; text-align: center"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></TD>
    <TD>&nbsp;</TD>
    <TD STYLE="font: 10pt Times New Roman, Times, Serif; text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></TD></TR>
  <TR STYLE="font: 10pt Times New Roman, Times, Serif; vertical-align: top">
    <TD STYLE="font: 10pt Times New Roman, Times, Serif; text-align: center"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">10.26</FONT></TD>
    <TD>&nbsp;</TD>
    <TD STYLE="font: 10pt Times New Roman, Times, Serif; text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt"><A HREF="https://www.sec.gov/Archives/edgar/data/749647/000149315220003910/ex10-1.htm" STYLE="-sec-extract: exhibit">Form of Exercise Agreement, incorporated by reference to Exhibit 10.1 to the Current Report on Form 8-K of the Company, filed on March 13, 2020 (SEC File No. 001-15911).</A></FONT></TD></TR>
  <TR STYLE="font: 10pt Times New Roman, Times, Serif; vertical-align: top">
    <TD STYLE="font: 10pt Times New Roman, Times, Serif; text-align: center"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></TD>
    <TD>&nbsp;</TD>
    <TD STYLE="font: 10pt Times New Roman, Times, Serif; text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></TD></TR>
  <TR STYLE="font: 10pt Times New Roman, Times, Serif; vertical-align: top">
    <TD STYLE="font: 10pt Times New Roman, Times, Serif; text-align: center"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">10.27</FONT></TD>
    <TD>&nbsp;</TD>
    <TD STYLE="font: 10pt Times New Roman, Times, Serif; text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt"><A HREF="https://www.sec.gov/Archives/edgar/data/749647/000149315222015061/ex10-1.htm" STYLE="-sec-extract: exhibit">At the Market Offering Agreement, dated May 25, 2022 by and between Celsion Corporation and H.C. Wainwright &amp; Co. LLC, incorporated by reference to Exhibit 10.1 to the Current Report on Form 8-K of the Company, filed on May 25, 2022, (SEC File NO. 001-15911).</A></FONT></TD></TR>
  <TR STYLE="font: 10pt Times New Roman, Times, Serif; vertical-align: top">
    <TD STYLE="font: 10pt Times New Roman, Times, Serif; text-align: center"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></TD>
    <TD>&nbsp;</TD>
    <TD STYLE="font: 10pt Times New Roman, Times, Serif; text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></TD></TR>
  <TR STYLE="font: 10pt Times New Roman, Times, Serif; vertical-align: top">
    <TD STYLE="font: 10pt Times New Roman, Times, Serif; text-align: center"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">10.28</FONT></TD>
    <TD>&nbsp;</TD>
    <TD STYLE="font: 10pt Times New Roman, Times, Serif; text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt"><A HREF="https://www.sec.gov/Archives/edgar/data/749647/000149315224019876/ex1-3.htm" STYLE="-sec-extract: exhibit">Amendment No. 1, dated May 15, 2024, to At the Market Offering Agreement, by and between Imunon, Inc. and H.C. Wainwright &amp; Co. LLC, incorporated by reference to Exhibit 1.3 to the Company&rsquo;s Registration Statement on Form S-3 (No. 333-279425) filed on May 15, 2024.</A></FONT></TD></TR>
  <TR STYLE="font: 10pt Times New Roman, Times, Serif; vertical-align: top">
    <TD STYLE="font: 10pt Times New Roman, Times, Serif; text-align: center"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></TD>
    <TD>&nbsp;</TD>
    <TD STYLE="font: 10pt Times New Roman, Times, Serif; text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></TD></TR>
  <TR STYLE="font: 10pt Times New Roman, Times, Serif; vertical-align: top">
    <TD STYLE="font: 10pt Times New Roman, Times, Serif; text-align: center"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">10.29</FONT></TD>
    <TD>&nbsp;</TD>
    <TD STYLE="font: 10pt Times New Roman, Times, Serif; text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt"><A HREF="https://www.sec.gov/Archives/edgar/data/749647/000149315224029697/ex10-1.htm" STYLE="-sec-extract: exhibit">Form of Securities Purchase Agreement, dated as of July 30, 2024, by and among the Company and each purchaser party thereto, incorporated by reference to Exhibit 10.1 to the Current Report on Form 8-K of the Company, filed on July 31, 2024 (SEC File No. 001-15911).</A></FONT></TD></TR>
  <TR STYLE="font: 10pt Times New Roman, Times, Serif; vertical-align: top">
    <TD STYLE="font: 10pt Times New Roman, Times, Serif; text-align: center"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></TD>
    <TD>&nbsp;</TD>
    <TD STYLE="font: 10pt Times New Roman, Times, Serif; text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></TD></TR>
  <TR STYLE="font: 10pt Times New Roman, Times, Serif; vertical-align: top">
    <TD STYLE="font: 10pt Times New Roman, Times, Serif; text-align: center"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">10.30+</FONT></TD>
    <TD>&nbsp;</TD>
    <TD STYLE="font: 10pt Times New Roman, Times, Serif; text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt"><A HREF="ex10-30.htm">Form of Securities Purchase Agreement.</A></FONT></TD></TR>
</TABLE>
<P STYLE="margin: 0">&nbsp;</P>

<P STYLE="margin: 0"></P>

<!-- Field: Page; Sequence: 41; Value: 1 -->
    <DIV STYLE="margin-top: 0pt; margin-bottom: 6pt; border-bottom: Black 1pt solid"><TABLE CELLPADDING="0" CELLSPACING="0" STYLE="border-collapse: collapse; width: 100%; font-size: 10pt"><TR STYLE="vertical-align: top; text-align: left"><TD STYLE="text-align: center; width: 100%">II-<!-- Field: Sequence; Type: Arabic; Name: PageNo -->5<!-- Field: /Sequence --></TD></TR></TABLE></DIV>
    <DIV STYLE="break-before: page; margin-top: 6pt; margin-bottom: 0pt"><P STYLE="margin: 0pt">&nbsp;</P></DIV>
    <!-- Field: /Page -->

<P STYLE="margin: 0">&nbsp;</P>

<TABLE CELLSPACING="0" CELLPADDING="0" STYLE="font: 10pt Times New Roman, Times, Serif; width: 100%; border-collapse: collapse">
  <TR STYLE="font: 10pt Times New Roman, Times, Serif; vertical-align: top">
    <TD STYLE="font: 10pt Times New Roman, Times, Serif; text-align: center"> <FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">10.31+</FONT> </TD>
    <TD>&nbsp;</TD>
    <TD STYLE="font: 10pt Times New Roman, Times, Serif; text-align: justify"> <A HREF="ex10-31.htm">Form of Exchange Agreement, dated May 12, 2025.</A> </TD></TR>
  <TR STYLE="font: 10pt Times New Roman, Times, Serif; vertical-align: top">
    <TD STYLE="font: 10pt Times New Roman, Times, Serif; text-align: center">&nbsp;</TD>
    <TD>&nbsp;</TD>
    <TD STYLE="font: 10pt Times New Roman, Times, Serif; text-align: justify">&nbsp;</TD></TR>
  <TR STYLE="font: 10pt Times New Roman, Times, Serif; vertical-align: top">
    <TD STYLE="font: 10pt Times New Roman, Times, Serif; text-align: center; width: 0.75in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">21.1</FONT></TD>
    <TD STYLE="width: 0.1in">&nbsp;</TD>
    <TD STYLE="font: 10pt Times New Roman, Times, Serif; text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt"><A HREF="https://www.sec.gov/Archives/edgar/data/749647/000149315225008460/ex21-1.htm" STYLE="-sec-extract: exhibit">Subsidiaries of Imunon, Inc., incorporated by reference to Exhibit 21.1 to the Annual Report on Form 10-K of the Company for the year ended December 31, 2024 (SEC File No. 001-15911).</A></FONT></TD></TR>
  <TR STYLE="font: 10pt Times New Roman, Times, Serif; vertical-align: top">
    <TD STYLE="font: 10pt Times New Roman, Times, Serif; text-align: center"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></TD>
    <TD>&nbsp;</TD>
    <TD STYLE="font: 10pt Times New Roman, Times, Serif; text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></TD></TR>
  <TR STYLE="font: 10pt Times New Roman, Times, Serif; vertical-align: top">
    <TD STYLE="font: 10pt Times New Roman, Times, Serif; text-align: center"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">23.1+</FONT></TD>
    <TD>&nbsp;</TD>
    <TD STYLE="font: 10pt Times New Roman, Times, Serif; text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt"><A HREF="ex23-1.htm">Consent of WithumSmith+Brown, PC, independent registered public accounting firm for the Company.</A></FONT></TD></TR>
  <TR STYLE="font: 10pt Times New Roman, Times, Serif; vertical-align: top">
    <TD STYLE="font: 10pt Times New Roman, Times, Serif; text-align: center"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></TD>
    <TD>&nbsp;</TD>
    <TD STYLE="font: 10pt Times New Roman, Times, Serif; text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></TD></TR>
  <TR STYLE="font: 10pt Times New Roman, Times, Serif; vertical-align: top">
    <TD STYLE="font: 10pt Times New Roman, Times, Serif; text-align: center"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">23.2+</FONT></TD>
    <TD>&nbsp;</TD>
    <TD STYLE="font: 10pt Times New Roman, Times, Serif; text-align: justify"><A HREF="ex5-1.htm"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">Consent of Thompson Hine LLP (included in Exhibit 5.1).</FONT></A></TD></TR>
  <TR STYLE="font: 10pt Times New Roman, Times, Serif; vertical-align: top">
    <TD STYLE="font: 10pt Times New Roman, Times, Serif; text-align: center"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></TD>
    <TD>&nbsp;</TD>
    <TD STYLE="font: 10pt Times New Roman, Times, Serif; text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></TD></TR>
  <TR STYLE="font: 10pt Times New Roman, Times, Serif; vertical-align: top">
    <TD STYLE="font: 10pt Times New Roman, Times, Serif; text-align: center"> <FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">24.1#</FONT> </TD>
    <TD>&nbsp;</TD>
    <TD STYLE="font: 10pt Times New Roman, Times, Serif; text-align: justify"><A HREF="https://www.sec.gov/Archives/edgar/data/749647/000164117225002783/forms-1.htm#Aa_018" STYLE="-sec-extract: exhibit"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">Power of Attorney.</FONT></A></TD></TR>
  <TR STYLE="font: 10pt Times New Roman, Times, Serif; vertical-align: top">
    <TD STYLE="font: 10pt Times New Roman, Times, Serif; text-align: center"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></TD>
    <TD>&nbsp;</TD>
    <TD STYLE="font: 10pt Times New Roman, Times, Serif; text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></TD></TR>
  <TR STYLE="font: 10pt Times New Roman, Times, Serif; vertical-align: top">
    <TD STYLE="font: 10pt Times New Roman, Times, Serif; text-align: center"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">107+</FONT></TD>
    <TD>&nbsp;</TD>
    <TD STYLE="font: 10pt Times New Roman, Times, Serif; text-align: justify"><A HREF="ex107.htm"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">Filing Fee Table.</FONT></A></TD></TR>
  </TABLE>
<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>

<TABLE CELLSPACING="0" CELLPADDING="0" STYLE="font: 10pt Times New Roman, Times, Serif; width: 100%; border-collapse: collapse">
  <TR STYLE="font: 10pt Times New Roman, Times, Serif; vertical-align: top">
    <TD STYLE="font: 10pt Times New Roman, Times, Serif; width: 0.5in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">*</FONT></TD>
    <TD STYLE="font: 10pt Times New Roman, Times, Serif; text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">Portions
    of this exhibit have been omitted pursuant to a request for confidential treatment under Rule 24b-2 of the Securities Exchange Act
    of 1934, amended, and the omitted material has been separately filed with the Securities and Exchange Commission.</FONT></TD></TR>
  <TR STYLE="font: 10pt Times New Roman, Times, Serif; vertical-align: top">
    <TD STYLE="font: 10pt Times New Roman, Times, Serif"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">**</FONT></TD>
    <TD STYLE="font: 10pt Times New Roman, Times, Serif; text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">Management
    contract or compensatory plan or arrangement.</FONT></TD></TR>
  <TR STYLE="font: 10pt Times New Roman, Times, Serif; vertical-align: top">
    <TD STYLE="font: 10pt Times New Roman, Times, Serif"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">+</FONT></TD>
    <TD STYLE="font: 10pt Times New Roman, Times, Serif; text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">Filed
    herewith.</FONT></TD></TR>
  <TR STYLE="font: 10pt Times New Roman, Times, Serif; vertical-align: top">
    <TD STYLE="font: 10pt Times New Roman, Times, Serif"> # </TD>
    <TD STYLE="font: 10pt Times New Roman, Times, Serif; text-align: justify"><P STYLE="margin: 0; font: 10pt Times New Roman, Times, Serif"> Previously
                                            filed. </P></TD></TR>
  </TABLE>
<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt"><B>Item
17. Undertakings.</B></FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify; text-indent: 0.5in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">The
undersigned registrant hereby undertakes:</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify; text-indent: 0.5in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">(1)
To file, during any period in which offers or sales are being made, a post-effective amendment to this registration statement:</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify; text-indent: 0.25in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0.5in; text-align: justify; text-indent: 0.5in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">(i)
To include any prospectus required by Section 10(a)(3) of the Securities Act;</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify; text-indent: 0.5in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0.5in; text-align: justify; text-indent: 0.5in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">(ii)
To reflect in the prospectus any facts or events arising after the effective date of the registration statement (or the most recent post-effective
amendment thereof) which, individually or in the aggregate, represent a fundamental change in the information set forth in the registration
statement. Notwithstanding the foregoing, any increase or decrease in volume of securities offered (if the total dollar value of securities
offered would not exceed that which was registered) and any deviation from the low or high end of the estimated maximum offering range
may be reflected in the form of prospectus filed with the SEC pursuant to Rule 424(b) if, in the aggregate, the changes in volume and
price represent no more than 20% change in the maximum aggregate offering price set forth in the &ldquo;Calculation of Registration Fee&rdquo;
table in the effective registration statement; and</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify; text-indent: 0.5in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0.5in; text-align: justify; text-indent: 0.5in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">(iii)
To include any material information with respect to the plan of distribution not previously disclosed in the registration statement or
any material change to such information in the registration statement;</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify; text-indent: 0.5in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify; text-indent: 0.5in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt"><I>provided,
however,</I> that paragraphs (1)(i), (1)(ii) and (1)(iii) above do not apply if the information required to be included in a post-effective
amendment by those paragraphs is contained in reports filed with or furnished to the SEC by the registrant pursuant to Section 13 or
Section 15(d) of the Exchange Act that are incorporated by reference in the registration statement.</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify; text-indent: 0.5in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify; text-indent: 0.5in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">(2)
That, for the purpose of determining any liability under the Securities Act, each such post-effective amendment shall be deemed to be
a new registration statement relating to the securities offered therein, and the offering of such securities at that time shall be deemed
to be the initial bona fide offering thereof.</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify; text-indent: 0.25in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify; text-indent: 0.5in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">(3)
To remove from registration by means of a post-effective amendment any of the securities being registered which remain unsold at the
termination of the offering.</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify; text-indent: 0.25in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify; text-indent: 0.25in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt"></FONT></P>

<!-- Field: Page; Sequence: 42; Value: 1 -->
    <DIV STYLE="margin-top: 0pt; margin-bottom: 6pt; border-bottom: Black 1pt solid"><TABLE CELLPADDING="0" CELLSPACING="0" STYLE="border-collapse: collapse; width: 100%; font-size: 10pt"><TR STYLE="vertical-align: top; text-align: left"><TD STYLE="text-align: center; width: 100%">II-<!-- Field: Sequence; Type: Arabic; Name: PageNo -->6<!-- Field: /Sequence --></TD></TR></TABLE></DIV>
    <DIV STYLE="break-before: page; margin-top: 6pt; margin-bottom: 0pt"><P STYLE="margin: 0pt">&nbsp;</P></DIV>
    <!-- Field: /Page -->

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify; text-indent: 0.25in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify; text-indent: 0.5in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">(4)
That, for the purpose of determining liability under the Securities Act to any purchaser, each prospectus filed pursuant to Rule 424(b)
as part of a registration statement relating to an offering, other than registration statements relying on Rule 430B or other than prospectuses
filed in reliance on Rule 430A, shall be deemed to be part of and included in the registration statement as of the date it is first used
after effectiveness; provided, however, that no statement made in a registration statement or prospectus that is part of the registration
statement or made in a document incorporated or deemed incorporated by reference into the registration statement or prospectus that is
part of the registration statement will, as to a purchaser with a time of contract of sale prior to such first use, supersede or modify
any statement that was made in the registration statement or prospectus that was part of the registration statement or made in any such
document immediately prior to such date of first use.</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify; text-indent: 0.25in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify; text-indent: 0.5in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">(5)
That, for the purpose of determining liability of the registrant under the Securities Act to any purchaser in the initial distribution
of the securities, the undersigned registrant undertakes that in a primary offering of securities of the undersigned registrant pursuant
to this registration statement, regardless of the underwriting method used to sell the securities to the purchaser, if the securities
are offered or sold to such purchaser by means of any of the following communications, the undersigned registrant will be a seller to
the purchaser and will be considered to offer or sell such securities to such purchaser:</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify; text-indent: 0.25in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>

<TABLE CELLSPACING="0" CELLPADDING="0" STYLE="font: 10pt Times New Roman, Times, Serif; width: 100%; border-collapse: collapse">
  <TR STYLE="font: 10pt Times New Roman, Times, Serif; vertical-align: top">
    <TD STYLE="width: 0.5in">&nbsp;</TD>
    <TD STYLE="font: 10pt Times New Roman, Times, Serif; width: 0.5in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">(i)</FONT></TD>
    <TD STYLE="font: 10pt Times New Roman, Times, Serif; text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">Any
    preliminary prospectus or prospectus of the undersigned registrant relating to the offering required to be filed pursuant to Rule
    424;</FONT></TD></TR>
  <TR STYLE="font: 10pt Times New Roman, Times, Serif; vertical-align: top">
    <TD>&nbsp;</TD>
    <TD STYLE="font: 10pt Times New Roman, Times, Serif"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></TD>
    <TD STYLE="font: 10pt Times New Roman, Times, Serif; text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></TD></TR>
  <TR STYLE="font: 10pt Times New Roman, Times, Serif; vertical-align: top">
    <TD>&nbsp;</TD>
    <TD STYLE="font: 10pt Times New Roman, Times, Serif"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">(ii)</FONT></TD>
    <TD STYLE="font: 10pt Times New Roman, Times, Serif; text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">Any
    free writing prospectus relating to the offering prepared by or on behalf of the undersigned registrant or used or referred to by
    the undersigned registrant;</FONT></TD></TR>
  <TR STYLE="font: 10pt Times New Roman, Times, Serif; vertical-align: top">
    <TD>&nbsp;</TD>
    <TD STYLE="font: 10pt Times New Roman, Times, Serif"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></TD>
    <TD STYLE="font: 10pt Times New Roman, Times, Serif; text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></TD></TR>
  <TR STYLE="font: 10pt Times New Roman, Times, Serif; vertical-align: top">
    <TD>&nbsp;</TD>
    <TD STYLE="font: 10pt Times New Roman, Times, Serif"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">(iii)</FONT></TD>
    <TD STYLE="font: 10pt Times New Roman, Times, Serif; text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">The
    portion of any other free writing prospectus relating to the offering containing material information about the undersigned registrant
    or its securities provided by or on behalf of the undersigned registrant; and</FONT></TD></TR>
  <TR STYLE="font: 10pt Times New Roman, Times, Serif; vertical-align: top">
    <TD>&nbsp;</TD>
    <TD STYLE="font: 10pt Times New Roman, Times, Serif"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></TD>
    <TD STYLE="font: 10pt Times New Roman, Times, Serif; text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></TD></TR>
  <TR STYLE="font: 10pt Times New Roman, Times, Serif; vertical-align: top">
    <TD>&nbsp;</TD>
    <TD STYLE="font: 10pt Times New Roman, Times, Serif"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">(iv)</FONT></TD>
    <TD STYLE="font: 10pt Times New Roman, Times, Serif; text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">Any
    other communication that is an offer in the offering made by the undersigned registrant to the purchaser.</FONT></TD></TR>
  </TABLE>
<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify; text-indent: 0.25in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify; text-indent: 0.5in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">(6)
The undersigned registrant hereby undertakes that, for purposes of determining any liability under the Securities Act, each filing of
the registrant&rsquo;s annual report pursuant to Section 13(a) or Section 15(d) of the Exchange Act (and, where applicable, each filing
of an employee benefit plan&rsquo;s annual report pursuant to Section 15(d) of the Exchange Act) that is incorporated by reference in
the registration statement shall be deemed to be a new registration statement relating to the securities offered therein, and the offering
of such securities at that time shall be deemed to be the initial bona fide offering thereof.</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify; text-indent: 0.5in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify; text-indent: 0.5in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">(7)
For purposes of determining any liability under the Securities Act of 1933, the information omitted from the form of prospectus filed
as part of this registration statement in reliance upon Rule 430A and contained in a form of prospectus filed by the registrant pursuant
to Rule 424(b)(1) or (4) or 497(h) under the Securities Act shall be deemed to be part of this registration statement as of the time
it was declared effective.</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify; text-indent: 0.5in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify; text-indent: 0.5in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">(8)
For the purpose of determining any liability under the Securities Act of 1933, each post-effective amendment that contains a form of
prospectus shall be deemed to be a new registration statement relating to the securities offered therein, and the offering of such securities
at that time shall be deemed to be the initial bona fide offering thereof.</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify; text-indent: 0.25in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify; text-indent: 0.5in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">Insofar
as indemnification for liabilities arising under the Securities Act may be permitted to directors, officers and controlling persons of
the registrant pursuant to the indemnification provisions described herein, or otherwise, the registrant has been advised that in the
opinion of the SEC such indemnification is against public policy as expressed in the Securities Act and is, therefore, unenforceable.
In the event that a claim for indemnification against such liabilities (other than the payment by the registrant of expenses incurred
or paid by a director, officer or controlling person of the registrant in the successful defense of any action, suit or proceeding) is
asserted by such director, officer or controlling person in connection with the securities being registered, the registrant will, unless
in the opinion of its counsel the matter has been settled by controlling precedent, submit to a court of appropriate jurisdiction the
question whether such indemnification by it is against public policy as expressed in the Securities Act and will be governed by the final
adjudication of such issue.</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify; text-indent: 0.5in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>


<!-- Field: Page; Sequence: 43; Value: 1 -->
    <DIV STYLE="margin-top: 0pt; margin-bottom: 6pt; border-bottom: Black 1pt solid"><TABLE CELLPADDING="0" CELLSPACING="0" STYLE="border-collapse: collapse; width: 100%; font-size: 10pt"><TR STYLE="vertical-align: top; text-align: left"><TD STYLE="text-align: center; width: 100%">II-<!-- Field: Sequence; Type: Arabic; Name: PageNo -->7<!-- Field: /Sequence --></TD></TR></TABLE></DIV>
    <DIV STYLE="break-before: page; margin-top: 6pt; margin-bottom: 0pt"><P STYLE="margin: 0pt">&nbsp;</P></DIV>
    <!-- Field: /Page -->

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: center"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt"><B>&nbsp;</B></FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: center"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt"><B>SIGNATURES</B></FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: center"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify; text-indent: 0.5in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">Pursuant
to the requirements of the Securities Act, the Registrant has duly caused this registration statement to be signed on its behalf by the
undersigned, thereunto duly authorized, in the City of Lawrenceville, State of New Jersey, on May 12, 2025.</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify; text-indent: 0.5in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>

<TABLE CELLSPACING="0" CELLPADDING="0" STYLE="font: 10pt Times New Roman, Times, Serif; width: 100%; border-collapse: collapse">
  <TR STYLE="font: 10pt Times New Roman, Times, Serif; vertical-align: top">
    <TD STYLE="font: 10pt Times New Roman, Times, Serif"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></TD>
    <TD COLSPAN="2" STYLE="font: 10pt Times New Roman, Times, Serif"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">IMUNON,
    INC.</FONT></TD></TR>
  <TR STYLE="font: 10pt Times New Roman, Times, Serif; vertical-align: top">
    <TD STYLE="font: 10pt Times New Roman, Times, Serif; width: 50%"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></TD>
    <TD STYLE="font: 10pt Times New Roman, Times, Serif; width: 3%"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></TD>
    <TD STYLE="font: 10pt Times New Roman, Times, Serif; width: 47%"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></TD></TR>
  <TR STYLE="font: 10pt Times New Roman, Times, Serif; vertical-align: top">
    <TD STYLE="font: 10pt Times New Roman, Times, Serif"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></TD>
    <TD STYLE="font: 10pt Times New Roman, Times, Serif"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">By:</FONT></TD>
    <TD STYLE="border-bottom: black 1pt solid; font: 10pt Times New Roman, Times, Serif"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt"><I>/s/
    Stacy R. Lindborg</I></FONT></TD></TR>
  <TR STYLE="font: 10pt Times New Roman, Times, Serif; vertical-align: top">
    <TD STYLE="font: 10pt Times New Roman, Times, Serif"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></TD>
    <TD STYLE="font: 10pt Times New Roman, Times, Serif"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></TD>
    <TD STYLE="font: 10pt Times New Roman, Times, Serif"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">Stacy
    R. Lindborg, Ph.D.</FONT></TD></TR>
  <TR STYLE="font: 10pt Times New Roman, Times, Serif; vertical-align: top">
    <TD STYLE="font: 10pt Times New Roman, Times, Serif"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></TD>
    <TD STYLE="font: 10pt Times New Roman, Times, Serif"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></TD>
    <TD STYLE="font: 10pt Times New Roman, Times, Serif"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">President
    and Chief Executive Officer</FONT></TD></TR>
  </TABLE>
<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: center">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify; text-indent: 0.5in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">Pursuant
to the requirements of the Securities Act, this registration statement has been signed by the following persons in the capacities and
on the dates indicated.</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>

<TABLE CELLSPACING="0" CELLPADDING="0" STYLE="font: 10pt Times New Roman, Times, Serif; width: 100%; border-collapse: collapse">
  <TR STYLE="font: 10pt Times New Roman, Times, Serif">
    <TD STYLE="border-bottom: black 1pt solid; font: 10pt Times New Roman, Times, Serif; vertical-align: bottom; width: 24%; text-align: center"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt"><B>Name</B></FONT></TD>
    <TD STYLE="font: 10pt Times New Roman, Times, Serif; width: 2%"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></TD>
    <TD STYLE="border-bottom: black 1pt solid; font: 10pt Times New Roman, Times, Serif; vertical-align: bottom; width: 48%; text-align: center"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt"><B>Position</B></FONT></TD>
    <TD STYLE="font: 10pt Times New Roman, Times, Serif; width: 2%"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></TD>
    <TD STYLE="border-bottom: black 1pt solid; font: 10pt Times New Roman, Times, Serif; vertical-align: bottom; width: 24%; text-align: center"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt"><B>Date</B></FONT></TD></TR>
  <TR STYLE="font: 10pt Times New Roman, Times, Serif">
    <TD STYLE="font: 10pt Times New Roman, Times, Serif; vertical-align: top"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></TD>
    <TD STYLE="font: 10pt Times New Roman, Times, Serif"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></TD>
    <TD STYLE="font: 10pt Times New Roman, Times, Serif; vertical-align: top; text-align: center"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></TD>
    <TD STYLE="font: 10pt Times New Roman, Times, Serif"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></TD>
    <TD STYLE="font: 10pt Times New Roman, Times, Serif; text-align: center"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></TD></TR>
  <TR STYLE="font: 10pt Times New Roman, Times, Serif">
    <TD STYLE="border-bottom: black 1pt solid; font: 10pt Times New Roman, Times, Serif; vertical-align: top"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt"><I>/s/
    Stacy R. Lindborg</I></FONT></TD>
    <TD STYLE="font: 10pt Times New Roman, Times, Serif"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></TD>
    <TD STYLE="font: 10pt Times New Roman, Times, Serif; vertical-align: top; text-align: center"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">President,
    Chief Executive Officer and</FONT></TD>
    <TD STYLE="font: 10pt Times New Roman, Times, Serif"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></TD>
    <TD STYLE="font: 10pt Times New Roman, Times, Serif; text-align: center"> <FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">May
    12,</FONT> <FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt"> 2025</FONT></TD></TR>
  <TR STYLE="font: 10pt Times New Roman, Times, Serif">
    <TD STYLE="font: 10pt Times New Roman, Times, Serif; vertical-align: top"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">Stacy
    R. Lindborg, Ph.D.</FONT></TD>
    <TD STYLE="font: 10pt Times New Roman, Times, Serif"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></TD>
    <TD STYLE="font: 10pt Times New Roman, Times, Serif; vertical-align: top; text-align: center"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">Director
    (Principal Executive Officer)</FONT></TD>
    <TD STYLE="font: 10pt Times New Roman, Times, Serif"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></TD>
    <TD STYLE="font: 10pt Times New Roman, Times, Serif; text-align: center"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></TD></TR>
  <TR STYLE="font: 10pt Times New Roman, Times, Serif">
    <TD STYLE="font: 10pt Times New Roman, Times, Serif"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></TD>
    <TD STYLE="font: 10pt Times New Roman, Times, Serif"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></TD>
    <TD STYLE="font: 10pt Times New Roman, Times, Serif; vertical-align: top; text-align: center"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></TD>
    <TD STYLE="font: 10pt Times New Roman, Times, Serif"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></TD>
    <TD STYLE="font: 10pt Times New Roman, Times, Serif; text-align: center"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></TD></TR>
  <TR STYLE="font: 10pt Times New Roman, Times, Serif">
    <TD STYLE="border-bottom: black 1pt solid; font: 10pt Times New Roman, Times, Serif; vertical-align: top"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt"><I>/s/
    David Gaiero</I></FONT></TD>
    <TD STYLE="font: 10pt Times New Roman, Times, Serif"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></TD>
    <TD STYLE="font: 10pt Times New Roman, Times, Serif; vertical-align: top; text-align: center"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">Chief
    Financial Officer </FONT></TD>
    <TD STYLE="font: 10pt Times New Roman, Times, Serif"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></TD>
    <TD STYLE="font: 10pt Times New Roman, Times, Serif; text-align: center"> <FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">May
    12,</FONT> <FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt"> 2025</FONT></TD></TR>
  <TR STYLE="font: 10pt Times New Roman, Times, Serif">
    <TD STYLE="font: 10pt Times New Roman, Times, Serif; vertical-align: top; text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">David
    Gaiero</FONT></TD>
    <TD STYLE="font: 10pt Times New Roman, Times, Serif"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></TD>
    <TD STYLE="font: 10pt Times New Roman, Times, Serif; vertical-align: top; text-align: center"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">(Principal
    Financial and Accounting Officer) </FONT></TD>
    <TD STYLE="font: 10pt Times New Roman, Times, Serif"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></TD>
    <TD STYLE="font: 10pt Times New Roman, Times, Serif; text-align: center"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></TD></TR>
  <TR STYLE="font: 10pt Times New Roman, Times, Serif">
    <TD STYLE="font: 10pt Times New Roman, Times, Serif; vertical-align: top; text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></TD>
    <TD STYLE="font: 10pt Times New Roman, Times, Serif"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></TD>
    <TD STYLE="font: 10pt Times New Roman, Times, Serif; vertical-align: top; text-align: center"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></TD>
    <TD STYLE="font: 10pt Times New Roman, Times, Serif"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></TD>
    <TD STYLE="font: 10pt Times New Roman, Times, Serif; text-align: center"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></TD></TR>
  <TR STYLE="font: 10pt Times New Roman, Times, Serif">
    <TD STYLE="text-align: center; border-bottom: black 1pt solid; font: 10pt Times New Roman, Times, Serif; vertical-align: bottom"> <FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">*</FONT> </TD>
    <TD STYLE="font: 10pt Times New Roman, Times, Serif"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></TD>
    <TD STYLE="font: 10pt Times New Roman, Times, Serif; vertical-align: top; text-align: center"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">Executive
    Chairman and Director</FONT></TD>
    <TD STYLE="font: 10pt Times New Roman, Times, Serif"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></TD>
    <TD STYLE="font: 10pt Times New Roman, Times, Serif; text-align: center"> <FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">May
    12,</FONT> <FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt"> 2025</FONT></TD></TR>
  <TR STYLE="font: 10pt Times New Roman, Times, Serif">
    <TD STYLE="font: 10pt Times New Roman, Times, Serif; vertical-align: top; text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">Michael
    H. Tardugno</FONT></TD>
    <TD STYLE="font: 10pt Times New Roman, Times, Serif"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></TD>
    <TD STYLE="font: 10pt Times New Roman, Times, Serif; vertical-align: top; text-align: center"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></TD>
    <TD STYLE="font: 10pt Times New Roman, Times, Serif"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></TD>
    <TD STYLE="font: 10pt Times New Roman, Times, Serif; text-align: center"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></TD></TR>
  <TR STYLE="font: 10pt Times New Roman, Times, Serif">
    <TD STYLE="font: 10pt Times New Roman, Times, Serif; vertical-align: top; text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></TD>
    <TD STYLE="font: 10pt Times New Roman, Times, Serif"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></TD>
    <TD STYLE="font: 10pt Times New Roman, Times, Serif; vertical-align: top; text-align: center"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></TD>
    <TD STYLE="font: 10pt Times New Roman, Times, Serif"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></TD>
    <TD STYLE="font: 10pt Times New Roman, Times, Serif; text-align: center"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></TD></TR>
  <TR STYLE="font: 10pt Times New Roman, Times, Serif">
    <TD STYLE="text-align: center; border-bottom: black 1pt solid; font: 10pt Times New Roman, Times, Serif; vertical-align: top"> <FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">*</FONT> </TD>
    <TD STYLE="font: 10pt Times New Roman, Times, Serif"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></TD>
    <TD STYLE="font: 10pt Times New Roman, Times, Serif; vertical-align: top; text-align: center"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">Director</FONT></TD>
    <TD STYLE="font: 10pt Times New Roman, Times, Serif"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></TD>
    <TD STYLE="font: 10pt Times New Roman, Times, Serif; text-align: center"> <FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">May
    12,</FONT> <FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt"> 2025</FONT></TD></TR>
  <TR STYLE="font: 10pt Times New Roman, Times, Serif">
    <TD STYLE="font: 10pt Times New Roman, Times, Serif; vertical-align: top; text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">Frederick
    J. Fritz</FONT></TD>
    <TD STYLE="font: 10pt Times New Roman, Times, Serif"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></TD>
    <TD STYLE="font: 10pt Times New Roman, Times, Serif; vertical-align: top; text-align: center"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></TD>
    <TD STYLE="font: 10pt Times New Roman, Times, Serif"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></TD>
    <TD STYLE="font: 10pt Times New Roman, Times, Serif; text-align: center"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></TD></TR>
  <TR STYLE="font: 10pt Times New Roman, Times, Serif">
    <TD STYLE="font: 10pt Times New Roman, Times, Serif; vertical-align: top"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></TD>
    <TD STYLE="font: 10pt Times New Roman, Times, Serif"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></TD>
    <TD STYLE="font: 10pt Times New Roman, Times, Serif; vertical-align: top; text-align: center"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></TD>
    <TD STYLE="font: 10pt Times New Roman, Times, Serif"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></TD>
    <TD STYLE="font: 10pt Times New Roman, Times, Serif; text-align: center"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></TD></TR>
  <TR STYLE="font: 10pt Times New Roman, Times, Serif">
    <TD STYLE="text-align: center; border-bottom: black 1pt solid; font: 10pt Times New Roman, Times, Serif; vertical-align: top"> <FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">*</FONT> </TD>
    <TD STYLE="font: 10pt Times New Roman, Times, Serif"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></TD>
    <TD STYLE="font: 10pt Times New Roman, Times, Serif; vertical-align: top; text-align: center"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">Director</FONT></TD>
    <TD STYLE="font: 10pt Times New Roman, Times, Serif"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></TD>
    <TD STYLE="font: 10pt Times New Roman, Times, Serif; text-align: center"> <FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">May
    12,</FONT> <FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt"> 2025</FONT></TD></TR>
  <TR STYLE="font: 10pt Times New Roman, Times, Serif">
    <TD STYLE="font: 10pt Times New Roman, Times, Serif; vertical-align: top; text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">James
    E. Dentzer</FONT></TD>
    <TD STYLE="font: 10pt Times New Roman, Times, Serif"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></TD>
    <TD STYLE="font: 10pt Times New Roman, Times, Serif; vertical-align: top; text-align: center"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></TD>
    <TD STYLE="font: 10pt Times New Roman, Times, Serif"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></TD>
    <TD STYLE="font: 10pt Times New Roman, Times, Serif; text-align: center"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></TD></TR>
  <TR STYLE="font: 10pt Times New Roman, Times, Serif">
    <TD STYLE="font: 10pt Times New Roman, Times, Serif; vertical-align: top"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></TD>
    <TD STYLE="font: 10pt Times New Roman, Times, Serif"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></TD>
    <TD STYLE="font: 10pt Times New Roman, Times, Serif; vertical-align: top; text-align: center"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></TD>
    <TD STYLE="font: 10pt Times New Roman, Times, Serif"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></TD>
    <TD STYLE="font: 10pt Times New Roman, Times, Serif; text-align: center"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></TD></TR>
  <TR STYLE="font: 10pt Times New Roman, Times, Serif">
    <TD STYLE="text-align: center; border-bottom: black 1pt solid; font: 10pt Times New Roman, Times, Serif; vertical-align: top"> <FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">*</FONT> </TD>
    <TD STYLE="font: 10pt Times New Roman, Times, Serif"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></TD>
    <TD STYLE="font: 10pt Times New Roman, Times, Serif; vertical-align: top; text-align: center"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">Director</FONT></TD>
    <TD STYLE="font: 10pt Times New Roman, Times, Serif"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></TD>
    <TD STYLE="font: 10pt Times New Roman, Times, Serif; text-align: center"> <FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">May
    12,</FONT> <FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt"> 2025</FONT></TD></TR>
  <TR STYLE="font: 10pt Times New Roman, Times, Serif">
    <TD STYLE="font: 10pt Times New Roman, Times, Serif; vertical-align: top; text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">Donald
    Braun, Ph.D.</FONT></TD>
    <TD STYLE="font: 10pt Times New Roman, Times, Serif"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></TD>
    <TD STYLE="font: 10pt Times New Roman, Times, Serif; vertical-align: top; text-align: center"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></TD>
    <TD STYLE="font: 10pt Times New Roman, Times, Serif"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></TD>
    <TD STYLE="font: 10pt Times New Roman, Times, Serif; text-align: center"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></TD></TR>
  <TR STYLE="font: 10pt Times New Roman, Times, Serif">
    <TD STYLE="font: 10pt Times New Roman, Times, Serif; vertical-align: top"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></TD>
    <TD STYLE="font: 10pt Times New Roman, Times, Serif"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></TD>
    <TD STYLE="font: 10pt Times New Roman, Times, Serif; vertical-align: top; text-align: center"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></TD>
    <TD STYLE="font: 10pt Times New Roman, Times, Serif"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></TD>
    <TD STYLE="font: 10pt Times New Roman, Times, Serif; text-align: center"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></TD></TR>
  <TR STYLE="font: 10pt Times New Roman, Times, Serif">
    <TD STYLE="text-align: center; border-bottom: black 1pt solid; font: 10pt Times New Roman, Times, Serif; vertical-align: top"> * </TD>
    <TD STYLE="font: 10pt Times New Roman, Times, Serif"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></TD>
    <TD STYLE="font: 10pt Times New Roman, Times, Serif; vertical-align: top; text-align: center"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">Director</FONT></TD>
    <TD STYLE="font: 10pt Times New Roman, Times, Serif"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></TD>
    <TD STYLE="font: 10pt Times New Roman, Times, Serif; text-align: center"> <FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">May
    12,</FONT> <FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt"> 2025</FONT></TD></TR>
  <TR STYLE="font: 10pt Times New Roman, Times, Serif">
    <TD STYLE="font: 10pt Times New Roman, Times, Serif; vertical-align: top; text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">Christine
    Pellizzari, J.D.</FONT></TD>
    <TD STYLE="font: 10pt Times New Roman, Times, Serif"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></TD>
    <TD STYLE="font: 10pt Times New Roman, Times, Serif; vertical-align: top; text-align: center"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></TD>
    <TD STYLE="font: 10pt Times New Roman, Times, Serif"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></TD>
    <TD STYLE="font: 10pt Times New Roman, Times, Serif; text-align: center"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></TD></TR>
  </TABLE>
<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt"></FONT></P>

<TABLE CELLSPACING="0" CELLPADDING="0" STYLE="width: 100%; font: 12pt Times New Roman, Times, Serif; border-collapse: collapse">
  <TR STYLE="vertical-align: top">
    <TD STYLE="font: 10pt Times New Roman, Times, Serif; width: 5%"> <FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">*
    By:</FONT> </TD>
    <TD STYLE="font: 10pt Times New Roman, Times, Serif; width: 45%; border-bottom: Black 1pt solid"> <FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt"><I>/s/
    Susan Eylward</I></FONT> </TD>
    <TD STYLE="font: 10pt Times New Roman, Times, Serif; width: 50%"> <FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT> </TD></TR>
  <TR STYLE="font: 10pt Times New Roman, Times, Serif; vertical-align: top">
    <TD STYLE="font: 10pt Times New Roman, Times, Serif"> <FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT> </TD>
    <TD STYLE="font: 10pt Times New Roman, Times, Serif"> <FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">Susan
    Eylward</FONT> </TD>
    <TD STYLE="font: 10pt Times New Roman, Times, Serif"> <FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT> </TD></TR>
  <TR STYLE="font: 10pt Times New Roman, Times, Serif; vertical-align: top">
    <TD STYLE="font: 10pt Times New Roman, Times, Serif"> <FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT> </TD>
    <TD STYLE="font: 10pt Times New Roman, Times, Serif"> <FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">Attorney-in-Fact</FONT> </TD>
    <TD STYLE="font: 10pt Times New Roman, Times, Serif"> <FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT> </TD></TR>
  <TR STYLE="font: 10pt Times New Roman, Times, Serif; vertical-align: top">
    <TD STYLE="font: 10pt Times New Roman, Times, Serif"> <FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT> </TD>
    <TD STYLE="font: 10pt Times New Roman, Times, Serif"> <FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">May
    12, 2025</FONT> </TD>
    <TD STYLE="font: 10pt Times New Roman, Times, Serif"> <FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT> </TD></TR>
  </TABLE>
<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt"></FONT></P>

<!-- Field: Page; Sequence: 44; Options: Last -->
    <DIV STYLE="margin-top: 0pt; margin-bottom: 6pt; border-bottom: Black 1pt solid"><TABLE CELLPADDING="0" CELLSPACING="0" STYLE="border-collapse: collapse; width: 100%; font-size: 10pt"><TR STYLE="vertical-align: top; text-align: left"><TD STYLE="text-align: center; width: 100%">II-<!-- Field: Sequence; Type: Arabic; Name: PageNo -->8<!-- Field: /Sequence --></TD></TR></TABLE></DIV>
    <!-- Field: /Page -->

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>

</BODY>
</HTML>
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>EX-1.1
<SEQUENCE>2
<FILENAME>ex1-1.htm
<DESCRIPTION>EX-1.1
<TEXT>
<HTML>
<HEAD>
     <TITLE></TITLE>
</HEAD>
<BODY STYLE="font: 10pt Times New Roman, Times, Serif">

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; margin-left: 0; text-align: right"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; margin-left: 0; text-align: right"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt"><B>Exhibit
1.1</B></FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; margin-left: 0; text-align: right"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; margin-left: 0; text-align: right"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">[___],
2025</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; margin-left: 0"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; margin-left: 0"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">Imunon,
Inc.</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; margin-left: 0"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">Attention:
Stacy R. Lindborg</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; margin-left: 0"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">997
Lenox Drive, Suite 100</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; margin-left: 0"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">Lawrenceville,
NJ 08648</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; margin-left: 0"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>

<TABLE CELLSPACING="0" CELLPADDING="0" STYLE="font-size: 10pt; width: 100%; border-collapse: collapse">
  <TR STYLE="vertical-align: top">
    <TD STYLE="font: 10pt Times New Roman, Times, Serif; width: 0.5in"><FONT STYLE="font-family: Times New Roman, Times, Serif">Re:</FONT></TD>
    <TD STYLE="font: 10pt Times New Roman, Times, Serif"><FONT STYLE="font-family: Times New Roman, Times, Serif"><U>Placement Agency
    Agreement</U></FONT></TD></TR>
  </TABLE>
<P STYLE="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; margin-left: 0"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; margin-left: 0"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">Dear
Dr. Lindborg:</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; margin-left: 0"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; margin-left: 0; text-align: justify; text-indent: 0.5in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">Subject
to the terms and conditions of this letter agreement (the &ldquo;<B>Agreement</B>&rdquo;) by and between Brookline Capital Markets, a
division of Arcadia Securities, LLC, as placement agent (the &ldquo;<B>Placement
Agent</B>&rdquo;), and Imunon, Inc., a Delaware corporation (the &ldquo;<B>Company</B>&rdquo;), the parties hereby agree that the Placement
Agent shall serve as the placement agent for the Company, on a &ldquo;reasonable best efforts&rdquo; basis, in connection with the
proposed offering (the &ldquo;<B>Placement</B>&rdquo;) of securities of the Company, consisting of: (i) shares of common stock, par value
$0.01 per share (&ldquo;<B>Common Stock</B>&rdquo;), (ii) pre-funded warrants to purchase Common Stock (the &ldquo;<B>Pre-Funded Warrants</B>&rdquo;),
and (iii) warrants to purchase Common Stock (the &ldquo;<B>Common Warrants</B>&rdquo; and collectively with the Pre-Funded Warrants,
the &ldquo;<B>Warrants</B>&rdquo;). The Common Stock and Warrants actually sold by the Placement Agent are referred to herein as the
&ldquo;<B>Placement Agent Securities</B>.&rdquo; The Placement Agent Securities and shares of Common Stock issuable upon the exercise
of the Warrants shall be offered and sold under the Company&rsquo;s registration statement on Form S-1 (File No. 286403), which was declared
effective by the Securities and Exchange Commission (the &ldquo;<B>Commission</B>&rdquo;) on [___], 2025. This agreement (this &ldquo;<B>Agreement</B>&rdquo;),
together with the other documents executed and delivered by the Company and/or the Purchasers (as defined below) in connection with the
Placement, including, without limitation, a securities purchase agreement (the &ldquo;<B>Purchase Agreement</B>&rdquo;), shall be collectively
referred to herein as the &ldquo;<B>Transaction Documents</B>.&rdquo; The terms of the Placement shall be mutually agreed upon by the
Company and the purchasers party to the Purchase Agreement (each, a &ldquo;<B>Purchaser</B>&rdquo; and collectively, the &ldquo;<B>Purchasers</B>&rdquo;),
and nothing herein constitutes that the Placement Agent would have the power or authority to bind the Company or any Purchaser, or an
obligation for the Company to issue any Placement Agent Securities or complete the Placement. The Company expressly acknowledges and
agrees that the Placement Agent&rsquo;s obligations hereunder are on a reasonable best-efforts basis only and that the execution of this
Agreement does not constitute a commitment by the Placement Agent to purchase the Placement Agent Securities and does not ensure the
successful placement of the Placement Agent Securities or any portion thereof or the success of the Placement Agent with respect to securing
any other financing on behalf of the Company. The Placement Agent may retain other brokers or dealers to act as sub-agents or selected
dealers on its behalf in connection with the Placement. Certain affiliates of the Placement Agent may participate in the Placement by
purchasing some of the Placement Agent Securities. The sale of Placement Agent Securities to any Purchaser will be evidenced by the Purchase
Agreement between the Company and such Purchaser, in a form reasonably acceptable to the Company and the Purchaser; provided, that, at
a Purchaser&rsquo;s option, Purchasers who do not enter into a securities purchase agreement shall rely solely on the Preliminary Prospectus
and the Prospectus in connection with the purchase of securities in the offering. Capitalized terms that are not otherwise defined herein
have the meanings given to such terms in the Purchase Agreement. Prior to the signing of any Purchase Agreement, officers of the Company
will be available to answer inquiries from prospective Purchasers.</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; margin-left: 0; text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; margin-left: 0; text-align: justify; text-indent: 0.5in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt"><U>SECTION
1. REPRESENTATIONS AND WARRANTIES OF THE COMPANY; COVENANTS OF THE COMPANY</U>.</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; margin-left: 0; text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>

<TABLE CELLSPACING="0" CELLPADDING="0" STYLE="font: 10pt Times New Roman, Times, Serif; width: 100%; border-collapse: collapse">
  <TR STYLE="font: 10pt Times New Roman, Times, Serif; vertical-align: top">
    <TD STYLE="width: 0.25in"><FONT STYLE="font-family: Times New Roman, Times, Serif">&nbsp;</FONT></TD>
    <TD STYLE="font: 10pt Times New Roman, Times, Serif; width: 0.25in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">A.</FONT></TD>
    <TD STYLE="font: 10pt Times New Roman, Times, Serif; text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt"><U>Representations
    of the Company</U>. With respect to the Placement Agent Securities, each of the representations and warranties (together with any
    related disclosure schedules thereto) and covenants made by the Company to the Purchasers in the Purchase Agreement in connection
    with the Placement, is hereby incorporated herein by reference into this Agreement (as though fully restated herein) and is, as of
    the date of this Agreement and as of the Closing Date, hereby made to, and in favor of, the Placement Agent. In addition to the
    foregoing, the Company represents and warrants that there are no affiliations with any Financial Industry Regulatory Authority (&ldquo;<B>FINRA</B>&rdquo;)
    member firm participating in the Placement among the Company&rsquo;s officers, directors or, to the knowledge of the Company, any
    five percent (5.0%) or greater stockholder of the Company.</FONT></TD></TR>
  </TABLE>
<P STYLE="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; margin-left: 0; text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>


<!-- Field: Page; Sequence: 1 -->
    <DIV STYLE="margin-bottom: 6pt; border-bottom: Black 1pt solid"><TABLE CELLPADDING="0" CELLSPACING="0" STYLE="border-collapse: collapse; width: 100%; font-size: 10pt"><TR STYLE="vertical-align: top; text-align: left"><TD STYLE="width: 100%">&nbsp;</TD></TR></TABLE></DIV>
    <DIV STYLE="break-before: page; margin-top: 6pt"><P STYLE="margin: 0pt">&nbsp;</P></DIV>
    <!-- Field: /Page -->

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; margin-left: 0"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>

<TABLE CELLSPACING="0" CELLPADDING="0" STYLE="font: 10pt Times New Roman, Times, Serif; width: 100%; border-collapse: collapse">
  <TR STYLE="font: 10pt Times New Roman, Times, Serif; vertical-align: top">
    <TD STYLE="width: 0.25in"><FONT STYLE="font-family: Times New Roman, Times, Serif">&nbsp;</FONT></TD>
    <TD STYLE="font: 10pt Times New Roman, Times, Serif; width: 0.25in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">B.</FONT></TD>
    <TD STYLE="font: 10pt Times New Roman, Times, Serif; text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt"><U>Covenants
    of the Company</U>. The Company covenants and agrees to continue to retain (i) a firm of Public Company Accounting Oversight Board
    independent registered public accountants for a period of at least two (2) years after the Closing Date and (ii) a reputable transfer
    agent for a period of two (2) years after the Closing Date, provided the Company is then subject to the reporting requirement of
    the Exchange Act (as defined below). Furthermore, for forty-five (45) days after the Closing Date, the Company shall not,
    without the prior written consent of the Placement Agent, (i) issue, enter into any agreement to issue or announce the issuance or
    proposed issuance of any shares of Common Stock or (ii) file any registration statement or amendment or supplement thereto, other
    than the Preliminary Prospectus, the Prospectus or a registration statement on Form S-8 in connection with any employee benefit plan;
    provided, however, the Company may enter into a new at-the-market sales agreement to implement an Exempt ATM Facility, and file
    any registration statement or any amendment or supplement thereto, with respect to the Exempt ATM Facility, and provided
    further that only beginning on the date that is thirty (30) days after the Stockholder Approval Notice Date, the Company may make
    sales of common stock pursuant to the Exempt ATM Facility. In addition, for ninety (90) days after the Closing Date, the
    Company shall not effect or enter into an agreement to effect any issuance of Common Stock or Common Stock Equivalents involving
    a Variable Rate Transaction (as defined in the Purchase Agreement), except such restriction shall not apply with respect to an Exempt
    Issuance. For the avoidance of doubt, a Variable Rate Transaction shall not include the Exempt ATM Facility, and that sales under
    the Exempt ATM Facility may commence on the date that is thirty (30) days after the Stockholder Approval Notice Date.</FONT></TD></TR>
  </TABLE>
<P STYLE="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; margin-left: 0.5in; text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; margin-left: 0; text-align: justify; text-indent: 0.5in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt"><U>SECTION
2. REPRESENTATIONS OF THE PLACEMENT AGENT</U>. The Placement Agent represents and warrants that it (i) is a member in good
standing of the FINRA, (ii) is a registered broker/dealer under the Securities Exchange Act of 1934, as amended (the &ldquo;<B>Exchange
Act</B>&rdquo;), (iii) is licensed as a broker/dealer under the laws of the United States of America, applicable to the offers and sales
of the Placement Agent Securities by the Placement Agent, (iv) is validly existing under the laws of its place of organization or incorporation,
and (v) has full power and authority to enter into and perform its obligations under this Agreement. Each Placement Agent will immediately
notify the Company in writing of any change in its status with respect to subsections (i) through (v) above. Each Placement Agent covenants
that it will use its reasonable best efforts to conduct the Placement hereunder in compliance with the provisions of this Agreement and
the requirements of applicable law.</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; margin-left: 0; text-align: justify; text-indent: 0.5in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; margin-left: 0; text-align: justify; text-indent: 0.5in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt"><U>SECTION
3. COMPENSATION</U>. In consideration of the services to be provided for hereunder, the Company shall pay to the Placement Agent and/or its respective
designees a cash fee of seven percent (7.0%) of the aggregate purchase price paid by any and all Purchasers at the Closing (the &ldquo;<B>Cash
Fee</B>&rdquo;).</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; margin-left: 0; text-align: justify; text-indent: 0.5in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; margin-left: 0; text-align: justify; text-indent: 0.5in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt"><U>SECTION
4. EXPENSES</U>. The Company agrees to pay all costs, fees and expenses incurred by the Company in connection with the performance of
its obligations hereunder and in connection with the transactions contemplated hereby, including, without limitation: (i) all expenses
incident to the issuance, delivery and qualification of the Placement Agent Securities (including all printing and engraving costs);
(ii) all fees and expenses of the transfer agent; (iii) all necessary issue, transfer and other stamp taxes in connection with the issuance
and sale of the Placement Agent Securities other than any transfer taxes payable upon the assignment of Warrants by their holders pursuant
to the terms of the Warrants; (iv) all fees and expenses of the Company&rsquo;s counsel, independent public or certified public accountants
and other advisors; (v) all costs and expenses incurred in connection with the preparation, printing, filing, shipping and distribution
of the Registration Statement (including financial statements, exhibits, schedules, consents and certificates of experts), the Preliminary
Prospectus and the Prospectus, and all amendments and supplements thereto, and this Agreement; (vi) all filing fees, reasonable attorneys&rsquo;
fees and expenses incurred by the Company in connection with qualifying or registering (or obtaining exemptions from the qualification
or registration of) all or any part of the Placement Agent Securities for offer and sale under the state securities or blue sky laws
or the securities laws of any other country; (vii) the fees and expenses associated with including the Placement Agent Securities on
the Trading Market; (viii) up to $75,000 for accountable expenses related to legal fees of counsel to the Placement Agents; and (ix)
non-accountable expenses, including IPREO software related expenses, background check expenses, tombstones and marketing related expenses,
including road show expenses, and any other non-accountable expenses incurred by the Placement Agent in connection with the Placement,
provided, however, that such reimbursement for non-accountable expenses shall not exceed $20,000. The Placement Agent reserves the right
to reduce any item of compensation or adjust the terms thereof as specified herein in the event that a determination shall be made by
FINRA to the effect that the Placement Agents&rsquo; aggregate compensation is in excess of FINRA Rules or that the terms thereof require
adjustment.</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; margin-left: 0; text-align: justify; text-indent: 0.5in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>


<!-- Field: Page; Sequence: 2; Options: NewSection; Value: 2 -->
    <DIV STYLE="margin-bottom: 6pt; border-bottom: Black 1pt solid"><TABLE CELLPADDING="0" CELLSPACING="0" STYLE="border-collapse: collapse; width: 100%; font-size: 10pt"><TR STYLE="vertical-align: top; text-align: left"><TD STYLE="text-align: center; width: 100%"><!-- Field: Sequence; Type: Arabic; Name: PageNo -->2<!-- Field: /Sequence --></TD></TR></TABLE></DIV>
    <DIV STYLE="break-before: page; margin-top: 6pt"><P STYLE="margin: 0pt">&nbsp;</P></DIV>
    <!-- Field: /Page -->

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; margin-left: 0"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; text-align: justify; text-indent: 0.5in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt"><U>SECTION
5. INDEMNIFICATION</U>.</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; margin-left: 0; text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>

<TABLE CELLSPACING="0" CELLPADDING="0" STYLE="font: 10pt Times New Roman, Times, Serif; width: 100%; border-collapse: collapse">
  <TR STYLE="font: 10pt Times New Roman, Times, Serif; vertical-align: top">
    <TD STYLE="width: 0.25in"><FONT STYLE="font-family: Times New Roman, Times, Serif">&nbsp;</FONT></TD>
    <TD STYLE="font: 10pt Times New Roman, Times, Serif; width: 0.25in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">A.</FONT></TD>
    <TD STYLE="font: 10pt Times New Roman, Times, Serif; text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">To
    the extent permitted by law, with respect to the Placement Agent Securities, the Company shall indemnify and hold harmless the Placement
    Agent and its affiliates, agents, stockholders, directors, officers, employees, members and controlling persons (within the meaning
    of Section 15 of the Securities Act or Section 20 of the Exchange Act) (each such entity or person, an &ldquo;<B>Indemnified Person</B>&rdquo;)
    from and against all claims, actions, suits, proceedings (including those of stockholders), damages, costs and liabilities (collectively,
    &ldquo;<B>Claims</B>&rdquo;), and shall reimburse each Indemnified Person for all reasonable fees and expenses (including the reasonable
    fees and expenses of counsel) (collectively, the &ldquo;<B>Expenses</B>&rdquo;) as they are incurred by an Indemnified Person in
    investigating, preparing, pursuing or defending any Claim that is caused by, arises out of, or is based upon (i) any untrue statements
    made or any statements omitted to be made in the Registration Statement, the Preliminary Prospectus or the Prospectus, or by any
    omission or alleged omission to state therein a material fact necessary to make the statements therein, in light of the circumstances
    under which they were made, not misleading (other than untrue statements or alleged untrue statements in, or omissions or alleged
    omissions from, information relating to an Indemnified Person furnished in writing by or on behalf of such Indemnified Person for
    use in the Registration Statement, Preliminary Prospectus or any Prospectus) or (ii) any other actions taken or omitted to be taken
    by the Company or any Indemnified Person in connection with this Agreement; provided, however, the Company will not be responsible
    for any Claims or Expenses of any Indemnified Person that are judicially determined to have resulted primarily from such Indemnified
    Person&rsquo;s (x) willful misconduct, violation of law or gross negligence in connection with any of the action, inaction or the
    services described herein, or (y) use of any offering materials or information concerning the Company in connection with the offer
    or sale of the Placement Agent Securities in the Placement, which were not authorized for such use by the Company and which use constitutes
    gross negligence, violation of law or willful misconduct.</FONT></TD></TR>
  <TR STYLE="font: 10pt Times New Roman, Times, Serif; vertical-align: top">
    <TD><FONT STYLE="font-family: Times New Roman, Times, Serif">&nbsp;</FONT></TD>
    <TD STYLE="font: 10pt Times New Roman, Times, Serif"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></TD>
    <TD STYLE="font: 10pt Times New Roman, Times, Serif; text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></TD></TR>
  <TR STYLE="font: 10pt Times New Roman, Times, Serif; vertical-align: top">
    <TD><FONT STYLE="font-family: Times New Roman, Times, Serif">&nbsp;</FONT></TD>
    <TD STYLE="font: 10pt Times New Roman, Times, Serif"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">B.</FONT></TD>
    <TD STYLE="font: 10pt Times New Roman, Times, Serif; text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">Promptly
    after receipt by the Placement Agent of notice of any Claim or the commencement of any action or proceeding with respect to which
    any Indemnified Person is entitled to indemnity hereunder, the Placement Agent will notify the Company in writing of such Claim
    or of the commencement of such action or proceeding, but failure to so notify the Company shall not relieve the Company from any
    obligation it may have hereunder, except and only to the extent such failure results in the forfeiture by the Company of substantial
    rights and defenses. If the Company so elects or is requested by the Placement Agent, the Company will assume the defense of such
    action or proceeding and will employ counsel reasonably satisfactory to the Placement Agent and will pay the fees and expenses of
    such counsel. Notwithstanding the preceding sentence, the Placement Agent will be entitled to employ its own counsel separate
    from counsel for the Company and from any other party in such action if counsel for the Placement Agent reasonably determine that
    they would be inappropriate under the applicable rules of professional responsibility for the same counsel to represent both the
    Company and the Placement Agent. In such event, the reasonable fees and disbursements of no more than one such separate counsel
    will be paid by the Company, in addition to fees of local counsel.</FONT></TD></TR>
  <TR STYLE="font: 10pt Times New Roman, Times, Serif; vertical-align: top">
    <TD><FONT STYLE="font-family: Times New Roman, Times, Serif">&nbsp;</FONT></TD>
    <TD STYLE="font: 10pt Times New Roman, Times, Serif"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></TD>
    <TD STYLE="font: 10pt Times New Roman, Times, Serif; text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></TD></TR>
  <TR STYLE="font: 10pt Times New Roman, Times, Serif; vertical-align: top">
    <TD><FONT STYLE="font-family: Times New Roman, Times, Serif">&nbsp;</FONT></TD>
    <TD STYLE="font: 10pt Times New Roman, Times, Serif"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">C.</FONT></TD>
    <TD STYLE="font: 10pt Times New Roman, Times, Serif; text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">The
    Company may not settle, compromise or consent to the entry of any judgment in any pending or threatened Claim, in which indemnification
    may be sought hereunder (whether or not any Indemnified Person is an actual or potential party thereto), without the prior written
    consent of the Placement Agent (which will not be unreasonably delayed or withheld) unless such settlement, compromise or consent
    provides for an unconditional and irrevocable release of each Indemnified Person from any and all liability arising out of such Claim.</FONT></TD></TR>
  <TR STYLE="font: 10pt Times New Roman, Times, Serif; vertical-align: top">
    <TD><FONT STYLE="font-family: Times New Roman, Times, Serif">&nbsp;</FONT></TD>
    <TD STYLE="font: 10pt Times New Roman, Times, Serif"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></TD>
    <TD STYLE="font: 10pt Times New Roman, Times, Serif; text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></TD></TR>
  <TR STYLE="font: 10pt Times New Roman, Times, Serif; vertical-align: top">
    <TD><FONT STYLE="font-family: Times New Roman, Times, Serif">&nbsp;</FONT></TD>
    <TD STYLE="font: 10pt Times New Roman, Times, Serif"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">D.</FONT></TD>
    <TD STYLE="font: 10pt Times New Roman, Times, Serif; text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">The
    Company agrees to notify the Placement Agent promptly of the assertion against either of them or any other person of any Claim or
    the commencement of any action or proceeding relating to a transaction contemplated by this Agreement.</FONT></TD></TR>
  </TABLE>
<P STYLE="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; margin-left: 0"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>


<!-- Field: Page; Sequence: 3; Value: 2 -->
    <DIV STYLE="margin-bottom: 6pt; border-bottom: Black 1pt solid"><TABLE CELLPADDING="0" CELLSPACING="0" STYLE="border-collapse: collapse; width: 100%; font-size: 10pt"><TR STYLE="vertical-align: top; text-align: left"><TD STYLE="text-align: center; width: 100%"><!-- Field: Sequence; Type: Arabic; Name: PageNo -->3<!-- Field: /Sequence --></TD></TR></TABLE></DIV>
    <DIV STYLE="break-before: page; margin-top: 6pt"><P STYLE="margin: 0pt">&nbsp;</P></DIV>
    <!-- Field: /Page -->

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; margin-left: 0"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>

<TABLE CELLSPACING="0" CELLPADDING="0" STYLE="font: 10pt Times New Roman, Times, Serif; width: 100%; border-collapse: collapse">
  <TR STYLE="font: 10pt Times New Roman, Times, Serif; vertical-align: top">
    <TD STYLE="width: 0.25in"><FONT STYLE="font-family: Times New Roman, Times, Serif">&nbsp;</FONT></TD>
    <TD STYLE="font: 10pt Times New Roman, Times, Serif; width: 0.25in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">E.</FONT></TD>
    <TD STYLE="font: 10pt Times New Roman, Times, Serif; text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">If
    for any reason the foregoing indemnity is unavailable to the Placement Agent or insufficient to hold the Placement Agent harmless,
    then the Company shall contribute to the amount paid or payable by the Placement Agent as a result of such Claim or Expenses in
    such proportion as is appropriate to reflect (a) the relative benefits to the Company on the one hand, and the Placement Agent on
    the other hand, in connection with the Placement, (b) the relative fault of the parties, and (c) other equitable considerations;
    provided, however, that in no event shall the amount to be contributed by the Placement Agent exceed the fees actually received
    by the Placement Agent under this Agreement. Notwithstanding the immediately preceding sentence, to the extent the exception to
    indemnification contemplated by Paragraph A of this Section applies with respect to the Placement Agent, the Company shall contribute
    to the amount paid or payable by the Placement Agent as a result of such Claim or Expenses in such proportion as is appropriate to
    reflect the relative fault of the Company, on the one hand, and the Placement Agent, on the other hand, in connection with the matters
    contemplated by the Agreement; provided, however, that in no event shall the amount to be contributed by the Placement Agent exceed
    the fees actually received by the Placement Agent under the Agreement. The Company agrees that for the purposes of this paragraph,
    the relative benefits to the Company and the Placement Agent of the contemplated transaction (whether or not such transaction is
    consummated) shall be deemed to be in the same proportion that the aggregate cash consideration payable (or contemplated to be payable)
    in such transaction bears to the fees paid or payable to the Placement Agent under the Agreement.</FONT></TD></TR>
  <TR STYLE="font: 10pt Times New Roman, Times, Serif; vertical-align: top">
    <TD><FONT STYLE="font-family: Times New Roman, Times, Serif">&nbsp;</FONT></TD>
    <TD STYLE="font: 10pt Times New Roman, Times, Serif"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></TD>
    <TD STYLE="font: 10pt Times New Roman, Times, Serif; text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></TD></TR>
  <TR STYLE="font: 10pt Times New Roman, Times, Serif; vertical-align: top">
    <TD><FONT STYLE="font-family: Times New Roman, Times, Serif">&nbsp;</FONT></TD>
    <TD STYLE="font: 10pt Times New Roman, Times, Serif"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">F.</FONT></TD>
    <TD STYLE="font: 10pt Times New Roman, Times, Serif; text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">These
    indemnification provisions shall remain in full force and effect whether or not the transaction contemplated by this Agreement is
    completed, survive the termination of this Agreement, and be in addition to any liability that the Company might otherwise have to
    any Indemnified Person.</FONT></TD></TR>
  </TABLE>
<P STYLE="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; margin-left: 0; text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; margin-left: 0; text-align: justify; text-indent: 0.5in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt"><U>SECTION
6. ENGAGEMENT TERM</U>. The Placement Agents&rsquo; engagement hereunder will be until the earlier of the Closing Date and May 30,
2025. The date of termination of this Agreement is referred to herein as the &ldquo;<B>Termination Date</B>.&rdquo; In the event,
however, in the course of the Placement Agents&rsquo; performance of due diligence they deem it necessary to terminate the engagement,
the Placement Agent may do so prior to the Termination Date. The Company may elect to terminate the engagement hereunder for any reason
prior to the Termination Date but will remain responsible for fees pursuant to Section 3 hereof with respect to the Placement Agent Securities,
if sold in the Placement. Notwithstanding anything to the contrary contained herein, the provisions concerning the Company&rsquo;s obligation
to pay any fees actually earned pursuant to Section 3 hereof and the provisions concerning confidentiality, indemnification and contribution
contained herein, as well as provisions in Sections 10 &ndash; 14 hereof will survive any expiration or termination of this Agreement.
If this Agreement is terminated prior to the completion of the Placement, all fees and expenses due to the Placement Agent as set forth
in Section 3 and Section 4 (except for the $20,000 non-accountable expense allowance) shall be paid by the Company to the Placement Agent
on or before the Termination Date (in the event such fees are earned or owed as of the Termination Date). The Placement Agent agrees
not to use any confidential information concerning the Company provided to the by the Company for any purposes other than those contemplated
under this Agreement.</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; margin-left: 0; text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; margin-left: 0; text-align: justify; text-indent: 0.5in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt"><U>SECTION
7. PLACEMENT AGENT INFORMATION</U>. The Company agrees that any information or advice rendered by the Placement Agent in connection
with this engagement is for the confidential use of the Company only in its evaluation of the Placement and, except as otherwise required
by law, the Company will not disclose or otherwise refer to the advice or information in any manner without the Placement Agents&rsquo;
prior written consent (which will not be unreasonably delayed or withheld).</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; margin-left: 0; text-align: justify; text-indent: 0.5in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; margin-left: 0pt; text-align: justify; text-indent: 0.5in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt"><U>SECTION
8. NO FIDUCIARY RELATIONSHIP</U>. This Agreement does not create, and shall not be construed as creating rights enforceable by any person
or entity not a party hereto, except those entitled hereto by virtue of the indemnification provisions hereof. The Company acknowledges
and agrees that the Placement Agent is not and shall not be construed as a fiduciary of the Company and shall have no duties or liabilities
to the equity holders or the creditors of the Company or any other person by virtue of this Agreement or the retention of the Placement
Agent hereunder, all of which are hereby expressly waived.</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; margin-left: 0; text-align: justify; text-indent: 31.5pt"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>


<!-- Field: Page; Sequence: 4; Value: 2 -->
    <DIV STYLE="margin-bottom: 6pt; border-bottom: Black 1pt solid"><TABLE CELLPADDING="0" CELLSPACING="0" STYLE="border-collapse: collapse; width: 100%; font-size: 10pt"><TR STYLE="vertical-align: top; text-align: left"><TD STYLE="text-align: center; width: 100%"><!-- Field: Sequence; Type: Arabic; Name: PageNo -->4<!-- Field: /Sequence --></TD></TR></TABLE></DIV>
    <DIV STYLE="break-before: page; margin-top: 6pt"><P STYLE="margin: 0pt">&nbsp;</P></DIV>
    <!-- Field: /Page -->

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; margin-left: 0"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt"><U>SECTION
9. CLOSING</U>. The obligations of the Placement Agent, and the closing of the sale of the Placement Agent Securities hereunder are
subject to the accuracy, when made and on the Closing Date, of the representations and warranties on the part of the Company contained
herein and in the Purchase Agreement, to the performance by the Company of its obligations hereunder, and to each of the following additional
terms and conditions, except as otherwise disclosed to and acknowledged and waived by the Placement Agents:</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>

<TABLE CELLSPACING="0" CELLPADDING="0" STYLE="font: 10pt Times New Roman, Times, Serif; width: 100%; border-collapse: collapse">
  <TR STYLE="font: 10pt Times New Roman, Times, Serif; vertical-align: top">
    <TD STYLE="width: 0.25in">&nbsp;</TD>
    <TD STYLE="font: 10pt Times New Roman, Times, Serif; width: 0.25in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">A.</FONT></TD>
    <TD STYLE="font: 10pt Times New Roman, Times, Serif; text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">All
    corporate proceedings and other legal matters incident to the authorization, form, execution, delivery and validity of each of this
    Agreement, the Placement Agent Securities, and all other legal matters relating to this Agreement and the transactions contemplated
    hereby with respect to the Placement Agent Securities shall be reasonably satisfactory in all material respects to the Placement
    Agent.</FONT></TD></TR>
  <TR STYLE="font: 10pt Times New Roman, Times, Serif; vertical-align: top">
    <TD>&nbsp;</TD>
    <TD STYLE="font: 10pt Times New Roman, Times, Serif"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></TD>
    <TD STYLE="font: 10pt Times New Roman, Times, Serif; text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></TD></TR>
  <TR STYLE="font: 10pt Times New Roman, Times, Serif; vertical-align: top">
    <TD>&nbsp;</TD>
    <TD STYLE="font: 10pt Times New Roman, Times, Serif"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">B.</FONT></TD>
    <TD STYLE="font: 10pt Times New Roman, Times, Serif; text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">The
    Placement Agent shall have received from Company Counsel such counsel&rsquo;s written opinion and negative assurance letter with
    respect to the Placement Agent Securities, addressed to the Placement Agent and dated as of the Closing Date, in form and substance
    reasonably satisfactory to the Placement Agent.</FONT></TD></TR>
  <TR STYLE="font: 10pt Times New Roman, Times, Serif; vertical-align: top">
    <TD>&nbsp;</TD>
    <TD STYLE="font: 10pt Times New Roman, Times, Serif"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></TD>
    <TD STYLE="font: 10pt Times New Roman, Times, Serif; text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></TD></TR>
  <TR STYLE="font: 10pt Times New Roman, Times, Serif; vertical-align: top">
    <TD>&nbsp;</TD>
    <TD STYLE="font: 10pt Times New Roman, Times, Serif"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">C.</FONT></TD>
    <TD STYLE="font: 10pt Times New Roman, Times, Serif; text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">The
    Placement Agent shall have received an executed Lock-Up Agreements from the Company&rsquo;s executive officers and directors.</FONT></TD></TR>
  <TR STYLE="font: 10pt Times New Roman, Times, Serif; vertical-align: top">
    <TD>&nbsp;</TD>
    <TD STYLE="font: 10pt Times New Roman, Times, Serif"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></TD>
    <TD STYLE="font: 10pt Times New Roman, Times, Serif; text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></TD></TR>
  <TR STYLE="font: 10pt Times New Roman, Times, Serif; vertical-align: top">
    <TD>&nbsp;</TD>
    <TD STYLE="font: 10pt Times New Roman, Times, Serif"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">D.</FONT></TD>
    <TD STYLE="font: 10pt Times New Roman, Times, Serif; text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">Shares
    of Common Stock sold in the Placement, including shares of Common Stock issuable upon the exercise of the Warrants, must be registered
    under the Exchange Act. The Company shall have taken no action designed to, or likely to have the effect of, terminating the registration
    of the Common Stock under the Exchange Act and shall use its commercially reasonable best efforts to avoid delisting or suspending
    from trading the Common Stock from the Trading Market or other applicable U.S. national exchange.</FONT></TD></TR>
  <TR STYLE="font: 10pt Times New Roman, Times, Serif; vertical-align: top">
    <TD>&nbsp;</TD>
    <TD STYLE="font: 10pt Times New Roman, Times, Serif"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></TD>
    <TD STYLE="font: 10pt Times New Roman, Times, Serif; text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></TD></TR>
  <TR STYLE="font: 10pt Times New Roman, Times, Serif; vertical-align: top">
    <TD>&nbsp;</TD>
    <TD STYLE="font: 10pt Times New Roman, Times, Serif"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">E.</FONT></TD>
    <TD STYLE="font: 10pt Times New Roman, Times, Serif; text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">No
    action shall have been taken and no statute, rule, regulation or order shall have been enacted, adopted or issued by any governmental
    agency or body which would, as of the Closing Date, prevent the issuance or sale of the Placement Agent Securities or materially
    and adversely affect or potentially and adversely affect the business or operations of the Company; and no injunction, restraining
    order or order of any other nature by any federal or state court of competent jurisdiction shall have been issued as of the Closing
    Date which would prevent the issuance or sale of the Placement Agent Securities or materially and adversely affect or potentially
    and adversely affect the business or operations of the Company.</FONT></TD></TR>
  <TR STYLE="font: 10pt Times New Roman, Times, Serif; vertical-align: top">
    <TD>&nbsp;</TD>
    <TD STYLE="font: 10pt Times New Roman, Times, Serif"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></TD>
    <TD STYLE="font: 10pt Times New Roman, Times, Serif; text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></TD></TR>
  <TR STYLE="font: 10pt Times New Roman, Times, Serif; vertical-align: top">
    <TD>&nbsp;</TD>
    <TD STYLE="font: 10pt Times New Roman, Times, Serif"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">F.</FONT></TD>
    <TD STYLE="font: 10pt Times New Roman, Times, Serif; text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">The
    Company shall have entered into a Purchase Agreement with each of the Purchasers who elect to purchase the Placement Agent Securities
    through the Purchase Agreement (and not by reliance on the Preliminary Prospectus or Prospectus), and such agreements shall be in
    full force and effect and shall contain representations, warranties and covenants of the Company as agreed upon between the Company
    and the Purchasers.</FONT></TD></TR>
  <TR STYLE="font: 10pt Times New Roman, Times, Serif; vertical-align: top">
    <TD>&nbsp;</TD>
    <TD STYLE="font: 10pt Times New Roman, Times, Serif"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></TD>
    <TD STYLE="font: 10pt Times New Roman, Times, Serif; text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></TD></TR>
  <TR STYLE="font: 10pt Times New Roman, Times, Serif; vertical-align: top">
    <TD>&nbsp;</TD>
    <TD STYLE="font: 10pt Times New Roman, Times, Serif"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">G.</FONT></TD>
    <TD STYLE="font: 10pt Times New Roman, Times, Serif; text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">FINRA
    shall have raised no objection to the fairness and reasonableness of the terms and arrangements of this Agreement. In addition, the
    Company shall, if requested by the Placement Agent, make or authorize Placement Agent&rsquo;s counsel to make on the Company&rsquo;s
    behalf, any filing with the FINRA Corporate Financing Department pursuant to FINRA Rule 5110 with respect to the Placement and pay
    all filing fees required in connection therewith.</FONT></TD></TR>
  <TR STYLE="font: 10pt Times New Roman, Times, Serif; vertical-align: top">
    <TD>&nbsp;</TD>
    <TD STYLE="font: 10pt Times New Roman, Times, Serif"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></TD>
    <TD STYLE="font: 10pt Times New Roman, Times, Serif; text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></TD></TR>
  <TR STYLE="font: 10pt Times New Roman, Times, Serif; vertical-align: top">
    <TD>&nbsp;</TD>
    <TD STYLE="font: 10pt Times New Roman, Times, Serif"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">H.</FONT></TD>
    <TD STYLE="font: 10pt Times New Roman, Times, Serif; text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">The
    Placement Agent shall have received a customary &ldquo;comfort&rdquo; letter from Withum Smith + Brown, PC.</FONT></TD></TR>
  <TR STYLE="font: 10pt Times New Roman, Times, Serif; vertical-align: top">
    <TD>&nbsp;</TD>
    <TD STYLE="font: 10pt Times New Roman, Times, Serif"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></TD>
    <TD STYLE="font: 10pt Times New Roman, Times, Serif; text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></TD></TR>
  <TR STYLE="font: 10pt Times New Roman, Times, Serif; vertical-align: top">
    <TD>&nbsp;</TD>
    <TD STYLE="font: 10pt Times New Roman, Times, Serif"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">I.</FONT></TD>
    <TD STYLE="font: 10pt Times New Roman, Times, Serif; text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">The
    Placement Agent shall have received customary certificates of the Company&rsquo;s executive officers, as to the accuracy of the
    representations and warranties contained in the Purchase Agreement, and a certificate of the Company&rsquo;s secretary certifying
    (i) that the Company&rsquo;s charter documents are true and complete, have not been modified and are in full force and effect; (ii)
    that the resolutions of the Company&rsquo;s Board of Directors relating to the Placement are in full force and effect and have not
    been modified; and (iii) as to the incumbency of the officers of the Company.</FONT></TD></TR>
  </TABLE>
<P STYLE="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; margin-left: 0; text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; margin-left: 0; text-align: justify; text-indent: 0.5in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">If
any of the conditions specified in this Section 9 shall not have been fulfilled when and as required by this Agreement, all obligations
of the Placement Agent hereunder may be cancelled by the Placement Agent at, or at any time prior to, the Closing Date. Notice of such
cancellation shall be given to the Company in writing or orally. Any such oral notice shall be confirmed promptly thereafter in writing.</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; margin-left: 0; text-align: justify; text-indent: 0.5in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>


<!-- Field: Page; Sequence: 5; Value: 2 -->
    <DIV STYLE="margin-bottom: 6pt; border-bottom: Black 1pt solid"><TABLE CELLPADDING="0" CELLSPACING="0" STYLE="border-collapse: collapse; width: 100%; font-size: 10pt"><TR STYLE="vertical-align: top; text-align: left"><TD STYLE="text-align: center; width: 100%"><!-- Field: Sequence; Type: Arabic; Name: PageNo -->5<!-- Field: /Sequence --></TD></TR></TABLE></DIV>
    <DIV STYLE="break-before: page; margin-top: 6pt"><P STYLE="margin: 0pt">&nbsp;</P></DIV>
    <!-- Field: /Page -->

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; margin-left: 0"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; margin-left: 0; text-align: justify; text-indent: 0.5in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt"><U>SECTION
10. GOVERNING LAW</U>. This Agreement will be governed by, and construed in accordance with, the laws of the State of New York applicable
to agreements made and to be performed entirely in such State, without regard to principles of conflicts of law. This Agreement may not
be assigned by either party without the prior written consent of the other party. This Agreement shall be binding upon and inure to the
benefit of the parties hereto, and their respective successors and permitted assigns. Any right to trial by jury with respect to any
dispute arising under this Agreement or any transaction or conduct in connection herewith is waived. Any dispute arising under this Agreement
may be brought into the courts of the State of New York or into the Federal Court located in New York, New York and, by execution and
delivery of this Agreement, the Company hereby accepts for itself and in respect of its property, generally and unconditionally, the
jurisdiction of aforesaid courts. Each party hereto hereby irrevocably waives personal service of process and consents to process being
served in any such suit, action or proceeding by delivering a copy thereof via overnight delivery (with evidence of delivery) to such
party at the address in effect for notices to it under this Agreement and agrees that such service shall constitute good and sufficient
service of process and notice thereof. Nothing contained herein shall be deemed to limit in any way any right to serve process in any
manner permitted by law. If either party shall commence an action or proceeding to enforce any provisions of this Agreement, then the
prevailing party in such action or proceeding shall be reimbursed by the other party for its attorney&rsquo;s fees and other costs and
expenses incurred with the investigation, preparation and prosecution of such action or proceeding.</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; margin-left: 0; text-align: justify; text-indent: 0.5in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; margin-left: 0; text-align: justify; text-indent: 0.5in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt"><U>SECTION
11. ENTIRE AGREEMENT/MISCELLANEOUS</U>. This Agreement embodies the entire agreement and understanding between the parties hereto, and
supersedes all prior agreements and understandings, relating to the subject matter hereof. If any provision of this Agreement is determined
to be invalid or unenforceable in any respect, such determination will not affect such provision in any other respect or any other provision
of this Agreement, which will remain in full force and effect. This Agreement may not be amended or otherwise modified or waived except
by an instrument in writing signed by both the Placement Agent and the Company. The representations, warranties, agreements and covenants
contained herein shall survive the Closing Date of the Placement and delivery of the Placement Agent Securities for the applicable statutes
of limitations. This Agreement may be executed in two or more counterparts, all of which when taken together shall be considered one
and the same agreement and shall become effective when counterparts have been signed by each party and delivered to the other party,
it being understood that both parties need not sign the same counterpart. In the event that any signature is delivered by facsimile transmission
or a .pdf format file, such signature shall create a valid and binding obligation of the party executing (or on whose behalf such signature
is executed) with the same force and effect as if such facsimile or .pdf signature page were an original thereof.</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; margin-left: 0; text-align: justify; text-indent: 0.5in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; margin-left: 0; text-align: justify; text-indent: 0.5in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt"><U>SECTION
12. NOTICES</U>. Any and all notices or other communications or deliveries required or permitted to be provided hereunder shall be in
writing and shall be deemed given and effective on the earliest of (a) the date of transmission, if such notice or communication is sent
to the email address specified on the signature pages attached hereto prior to 6:30 p.m. (New York City time) on a business day, (b)
the next business day after the date of transmission, if such notice or communication is sent to the email address on the signature pages
attached hereto on a day that is not a business day or later than 6:30 p.m. (New York City time) on any business day, (c) the third (3<SUP>rd</SUP>)
business day following the date of mailing, if sent by an internationally recognized air courier service, or (d) upon actual receipt
by the party to whom such notice is required to be given. The address for such notices and communications shall be as set forth on the
signature pages hereto.</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; margin-left: 0; text-align: justify; text-indent: 0.5in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; margin-left: 0; text-align: justify; text-indent: 0.5in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt"><U>SECTION
13. PRESS ANNOUNCEMENTS</U>. The Company agrees that the Placement Agent shall, on and after the Closing Date, have the right to reference
the Placement and the Placement Agents&rsquo; role in connection therewith in the Placement Agents&rsquo; marketing materials and on
its website and to place advertisements in financial and other newspapers and journals, in each case at its own expense.</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; margin-left: 0; text-align: justify; text-indent: 0.5in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; margin-left: 0; text-align: justify; text-indent: 0.5in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt"><U>SECTION
14. PAYMENTS</U>. All payments made or deemed to be made by the Company to the Placement Agent, its affiliates, stockholders, directors,
officers, employees, members and controlling persons (within the meaning of Section 15 of the Securities Act or Section 20 of the Exchange
Act) (each, a &ldquo;<B>Payee</B>&rdquo;), if any, will be made without withholding or deduction for or on account of any present or
future taxes, duties, assessments or governmental charges of whatever nature (other than taxes on net income or similar taxes) imposed
or levied by or on behalf of the United States or any political subdivision or any taxing authority thereof or therein unless the Company
is or becomes required by law to withhold or deduct such taxes, duties, assessments or other governmental charges. In such event, the
Company will pay such additional amounts as will result, after such withholding or deduction, in the receipt by the Payee of the amounts
that would otherwise have been receivable in respect thereof. For the avoidance of doubt, all sums payable, paid or deemed payable under
this Agreement shall be considered exclusive of value added tax, sales tax or other similar taxes which shall be borne by, paid, collected
and remitted by the Company in accordance with applicable law.</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; margin-left: 0; text-align: justify; text-indent: 0.5in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; margin-left: 0; text-align: justify; text-indent: 0.5in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">Please
confirm that the foregoing correctly sets forth our agreement by signing and returning to the Placement Agent the enclosed copy of this
Agreement.</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; margin-left: 0; text-align: center"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; margin-left: 0; text-align: center"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt"><I>[The
remainder of this page has been intentionally left blank.]</I></FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; margin-left: 0; text-align: center"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt"><I>&nbsp;</I></FONT></P>


<!-- Field: Page; Sequence: 6; Value: 2 -->
    <DIV STYLE="margin-bottom: 6pt; border-bottom: Black 1pt solid"><TABLE CELLPADDING="0" CELLSPACING="0" STYLE="border-collapse: collapse; width: 100%; font-size: 10pt"><TR STYLE="vertical-align: top; text-align: left"><TD STYLE="text-align: center; width: 100%"><!-- Field: Sequence; Type: Arabic; Name: PageNo -->6<!-- Field: /Sequence --></TD></TR></TABLE></DIV>
    <DIV STYLE="break-before: page; margin-top: 6pt"><P STYLE="margin: 0pt">&nbsp;</P></DIV>
    <!-- Field: /Page -->

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; margin-left: 0"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; margin-left: 0; text-align: justify; text-indent: 0.5in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">The
foregoing Agreement is hereby accepted and agreed to as of the date first written above.</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; margin-left: 0; text-align: justify; text-indent: 0.5in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; margin-left: 0"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt"></FONT></P>

<TABLE CELLSPACING="0" CELLPADDING="0" STYLE="font: 10pt Times New Roman, Times, Serif; width: 100%; border-collapse: collapse">
  <TR STYLE="font: 10pt Times New Roman, Times, Serif; vertical-align: top">
    <TD STYLE="font: 10pt Times New Roman, Times, Serif"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></TD>
    <TD COLSPAN="2" STYLE="font: 10pt Times New Roman, Times, Serif"><P STYLE="margin-top: 0; margin-bottom: 0"><FONT STYLE="font-family: Tmes New Roman, Times, Serif; font-size: 10pt"><B>BROOKLINE CAPITAL MARKETS</B></FONT></P>
                                                                     <P STYLE="margin-top: 0; margin-bottom: 0"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt"><B>A Division of Arcadia Securities, LLC </B></FONT></P></TD></TR>
  <TR STYLE="font: 10pt Times New Roman, Times, Serif; vertical-align: top">
    <TD STYLE="font: 10pt Times New Roman, Times, Serif; width: 50%"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp; </FONT></TD>
    <TD STYLE="font: 10pt Times New Roman, Times, Serif; width: 5%"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></TD>
    <TD STYLE="font: 10pt Times New Roman, Times, Serif; width: 45%"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp; </FONT></TD></TR>
  <TR STYLE="font: 10pt Times New Roman, Times, Serif; vertical-align: top">
    <TD STYLE="padding-bottom: 1pt; font: 10pt Times New Roman, Times, Serif"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></TD>
    <TD STYLE="padding-bottom: 1pt; font: 10pt Times New Roman, Times, Serif"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">By:
    </FONT></TD>
    <TD STYLE="border-bottom: Black 1pt solid; font: 10pt Times New Roman, Times, Serif"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;</FONT></TD></TR>
  <TR STYLE="font: 10pt Times New Roman, Times, Serif; vertical-align: top">
    <TD STYLE="font: 10pt Times New Roman, Times, Serif"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></TD>
    <TD STYLE="font: 10pt Times New Roman, Times, Serif"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">Name:
    </FONT></TD>
    <TD STYLE="font: 10pt Times New Roman, Times, Serif"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></TD></TR>
  <TR STYLE="font: 10pt Times New Roman, Times, Serif; vertical-align: top">
    <TD STYLE="font: 10pt Times New Roman, Times, Serif"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></TD>
    <TD STYLE="font: 10pt Times New Roman, Times, Serif"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">Title:
    </FONT></TD>
    <TD STYLE="font: 10pt Times New Roman, Times, Serif"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></TD></TR>
  </TABLE>
<P STYLE="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; margin-left: 0"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>

<TABLE CELLSPACING="0" CELLPADDING="0" STYLE="font: 10pt Times New Roman, Times, Serif; width: 100%; border-collapse: collapse">
  <TR STYLE="font: 10pt Times New Roman, Times, Serif; vertical-align: top">
    <TD STYLE="font: 10pt Times New Roman, Times, Serif; width: 50%"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></TD>
    <TD STYLE="font: 10pt Times New Roman, Times, Serif; width: 50%"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt"><U>Address
    for Notice</U>:</FONT></TD></TR>
  <TR STYLE="font: 10pt Times New Roman, Times, Serif; vertical-align: top">
    <TD STYLE="font: 10pt Times New Roman, Times, Serif"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></TD>
    <TD STYLE="font: 10pt Times New Roman, Times, Serif"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">600
    Lexington Avenue, 30th Floor</FONT></TD></TR>
  <TR STYLE="font: 10pt Times New Roman, Times, Serif; vertical-align: top">
    <TD STYLE="font: 10pt Times New Roman, Times, Serif"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></TD>
    <TD STYLE="font: 10pt Times New Roman, Times, Serif"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">New
    York, NY 10022</FONT></TD></TR>
  <TR STYLE="font: 10pt Times New Roman, Times, Serif; vertical-align: top">
    <TD STYLE="font: 10pt Times New Roman, Times, Serif"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></TD>
    <TD STYLE="font: 10pt Times New Roman, Times, Serif"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">Attn:
    [_]</FONT></TD></TR>
  <TR STYLE="font: 10pt Times New Roman, Times, Serif; vertical-align: top">
    <TD STYLE="font: 10pt Times New Roman, Times, Serif"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></TD>
    <TD STYLE="font: 10pt Times New Roman, Times, Serif"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">Email:
    [_]</FONT></TD></TR>
  </TABLE>
<P STYLE="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; margin-left: 0.5in; text-indent: -0.5in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>


<!-- Field: Page; Sequence: 7; Value: 2 -->
    <DIV STYLE="margin-bottom: 6pt; border-bottom: Black 1pt solid"><TABLE CELLPADDING="0" CELLSPACING="0" STYLE="border-collapse: collapse; width: 100%; font-size: 10pt"><TR STYLE="vertical-align: top; text-align: left"><TD STYLE="text-align: center; width: 100%"><!-- Field: Sequence; Type: Arabic; Name: PageNo -->7<!-- Field: /Sequence --></TD></TR></TABLE></DIV>
    <DIV STYLE="break-before: page; margin-top: 6pt"><P STYLE="margin: 0pt">&nbsp;</P></DIV>
    <!-- Field: /Page -->

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; margin-left: 0"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; margin-left: 0.5in; text-indent: -0.5in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">Accepted
and agreed to as of the date first written above:</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; margin-left: 0.5in; text-indent: -0.5in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>

<TABLE CELLSPACING="0" CELLPADDING="0" STYLE="font: 10pt Times New Roman, Times, Serif; width: 100%; border-collapse: collapse">
  <TR STYLE="font: 10pt Times New Roman, Times, Serif; vertical-align: top">
    <TD COLSPAN="3" STYLE="font: 10pt Times New Roman, Times, Serif"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt"><B>IMUNON,
    INC. </B></FONT></TD></TR>
  <TR STYLE="font: 10pt Times New Roman, Times, Serif; vertical-align: top">
    <TD STYLE="font: 10pt Times New Roman, Times, Serif; width: 5%"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></TD>
    <TD STYLE="font: 10pt Times New Roman, Times, Serif; width: 45%"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></TD>
    <TD STYLE="font: 10pt Times New Roman, Times, Serif; width: 50%"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></TD></TR>
  <TR STYLE="font: 10pt Times New Roman, Times, Serif; vertical-align: top">
    <TD STYLE="padding-bottom: 1pt; font: 10pt Times New Roman, Times, Serif"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">By:</FONT></TD>
    <TD STYLE="border-bottom: Black 1pt solid; font: 10pt Times New Roman, Times, Serif"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></TD>
    <TD STYLE="padding-bottom: 1pt; font: 10pt Times New Roman, Times, Serif"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></TD></TR>
  <TR STYLE="font: 10pt Times New Roman, Times, Serif; vertical-align: top">
    <TD STYLE="font: 10pt Times New Roman, Times, Serif"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">Name:</FONT></TD>
    <TD STYLE="font: 10pt Times New Roman, Times, Serif"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">Stacy
    R. Lindborg</FONT></TD>
    <TD STYLE="font: 10pt Times New Roman, Times, Serif"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></TD></TR>
  <TR STYLE="font: 10pt Times New Roman, Times, Serif; vertical-align: top">
    <TD STYLE="font: 10pt Times New Roman, Times, Serif"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">Title:</FONT></TD>
    <TD STYLE="font: 10pt Times New Roman, Times, Serif"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">President
    and Chief Executive Officer</FONT></TD>
    <TD STYLE="font: 10pt Times New Roman, Times, Serif"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></TD></TR>
  </TABLE>
<P STYLE="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; margin-left: 0"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>

<TABLE CELLSPACING="0" CELLPADDING="0" STYLE="font: 10pt Times New Roman, Times, Serif; width: 100%; border-collapse: collapse">
  <TR STYLE="font: 10pt Times New Roman, Times, Serif">
    <TD STYLE="font: 10pt Times New Roman, Times, Serif; vertical-align: bottom; width: 50%"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt"><U>Address
    for Notice</U>:</FONT></TD>
    <TD STYLE="font: 10pt Times New Roman, Times, Serif; vertical-align: top; width: 50%"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></TD></TR>
  <TR STYLE="font: 10pt Times New Roman, Times, Serif">
    <TD STYLE="font: 10pt Times New Roman, Times, Serif; vertical-align: bottom"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">997
    Lenox Drive, Suite 100</FONT></TD>
    <TD STYLE="font: 10pt Times New Roman, Times, Serif; vertical-align: top"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></TD></TR>
  <TR STYLE="font: 10pt Times New Roman, Times, Serif; vertical-align: top">
    <TD STYLE="font: 10pt Times New Roman, Times, Serif"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">Lawrenceville,
    NJ 08648</FONT></TD>
    <TD STYLE="font: 10pt Times New Roman, Times, Serif"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></TD></TR>
  <TR STYLE="font: 10pt Times New Roman, Times, Serif">
    <TD STYLE="font: 10pt Times New Roman, Times, Serif; vertical-align: bottom"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">Attn:
    Stacy R. Lindborg</FONT></TD>
    <TD STYLE="font: 10pt Times New Roman, Times, Serif; vertical-align: top"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></TD></TR>
  <TR STYLE="font: 10pt Times New Roman, Times, Serif">
    <TD STYLE="font: 10pt Times New Roman, Times, Serif; vertical-align: bottom"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">Email:
    [***]</FONT></TD>
    <TD STYLE="font: 10pt Times New Roman, Times, Serif; vertical-align: top"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></TD></TR>
  </TABLE>
<P STYLE="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; margin-left: 0; text-align: center"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt"><I>&nbsp;</I></FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; margin-left: 0; text-align: center"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt"><I>[Signature
Page to Placement Agent Agreement]</I></FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; margin-left: 0; text-align: center"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt"><I>&nbsp;</I></FONT></P>


<!-- Field: Page; Sequence: 8; Options: Last -->
    <DIV STYLE="margin-bottom: 6pt; border-bottom: Black 1pt solid"><TABLE CELLPADDING="0" CELLSPACING="0" STYLE="border-collapse: collapse; width: 100%; font-size: 10pt"><TR STYLE="vertical-align: top; text-align: left"><TD STYLE="text-align: center; width: 100%"><!-- Field: Sequence; Type: Arabic; Name: PageNo -->8<!-- Field: /Sequence --></TD></TR></TABLE></DIV>
    <!-- Field: /Page -->

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; margin-left: 0"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>

</BODY>
</HTML>
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>EX-4.9
<SEQUENCE>3
<FILENAME>ex4-9.htm
<DESCRIPTION>EX-4.9
<TEXT>
<HTML>
<HEAD>
     <TITLE></TITLE>
</HEAD>
<BODY STYLE="font: 10pt Times New Roman, Times, Serif">

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: right"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt"><B>&nbsp;</B></FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: right"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt"><B>Exhibit
4.9</B></FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: center"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: center"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt"><B>IMUNON,
INC.</B></FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: center"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt; font-variant: small-caps"><B>Warrant
To Purchase Common Stock</B></FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>

<TABLE CELLSPACING="0" CELLPADDING="0" STYLE="font: 10pt Times New Roman, Times, Serif; width: 100%; border-collapse: collapse">
  <TR STYLE="font: 10pt Times New Roman, Times, Serif; vertical-align: top">
    <TD STYLE="font: 10pt Times New Roman, Times, Serif; width: 49%"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">Warrant
    Shares: [&#9679;]</FONT></TD>
    <TD STYLE="font: 10pt Times New Roman, Times, Serif; width: 2%"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></TD>
    <TD STYLE="font: 10pt Times New Roman, Times, Serif; text-align: right; width: 49%"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">Issuance
    Date: [&#9679;], 2025</FONT></TD></TR>
  <TR STYLE="font: 10pt Times New Roman, Times, Serif; vertical-align: top">
    <TD STYLE="font: 10pt Times New Roman, Times, Serif"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></TD>
    <TD STYLE="font: 10pt Times New Roman, Times, Serif"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></TD>
    <TD STYLE="font: 10pt Times New Roman, Times, Serif; text-align: right"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">Initial
    Exercise Date: [&#9679;], 2025</FONT></TD></TR>
  </TABLE>
<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify; text-indent: 1in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify; text-indent: 0.5in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">Imunon,
Inc., a Delaware corporation (the &ldquo;<B>Company</B>&rdquo;), hereby certifies that, for good and valuable consideration, the receipt
and sufficiency of which are hereby acknowledged<FONT STYLE="text-transform: uppercase">, [&#9679;]</FONT>, the registered holder hereof
or its permitted assigns (the &ldquo;<B>Holder</B>&rdquo;), is entitled, subject to the terms set forth below, to purchase from the Company,
at the Exercise Price (as defined below) then in effect, at any time or times on or after the date of Stockholder Approval Notice, but
not after 11:59 p.m., New York time, on the Expiration Date, (as defined below), up to <FONT STYLE="text-transform: uppercase">[&#9679;]
</FONT>fully paid nonassessable shares of Common Stock, subject to adjustment as provided herein (the &ldquo;<B>Warrant Shares</B>&rdquo;).
Except as otherwise defined herein, capitalized terms in this Warrant to Purchase Common Stock (including any Warrants to Purchase Common
Stock issued in exchange, transfer or replacement hereof, this &ldquo;<B>Warrant</B>&rdquo;), shall have the meanings set forth in Section
17. This Warrant is one of the Warrants to purchase Common Stock issued pursuant to that certain Securities Purchase Agreement, dated
as of [&#9679;], 2025 (the &ldquo;<B>Subscription Date</B>&rdquo;), by and among the Company and the investors (the &ldquo;<B>Buyers</B>&rdquo;)
referred to therein (the &ldquo;<B>Securities Purchase Agreement</B>&rdquo;). Capitalized terms used herein and not otherwise defined
shall have the definitions ascribed to such terms in the Securities Purchase Agreement.</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify; text-indent: 1in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify; text-indent: 1in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">1.
<U>EXERCISE OF WARRANT.</U></FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify; text-indent: 1.5in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify; text-indent: 1in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">(a)
<U>Mechanics of Exercise</U>. Subject to the terms and conditions hereof (including, without limitation, the limitations set forth in
Section 1(g)), this Warrant may be exercised by the Holder at any time or times on or after the Stockholder Approval Notice Date, in
whole or in part, by delivery of a written notice (whether via electronic mail or otherwise), in the form attached hereto as <U>Exhibit
A</U> (the &ldquo;<B>Exercise Notice</B>&rdquo;), of the Holder&rsquo;s election to exercise this Warrant. Within one Business Day following
the date of delivery of the Exercise Notice, the Holder shall (A) make payment to the Company of an amount equal to the applicable Exercise
Price multiplied by the number of Warrant Shares as to which this Warrant is being exercised (the &ldquo;<B>Aggregate Exercise Price</B>&rdquo;)
in cash by wire transfer of immediately available funds or (B) if the provisions of Section 1(e) are applicable, by notifying the Company
that this Warrant is being exercised pursuant to a Cashless Exercise (including an &ldquo;alternative cashless exercise&rdquo;) (as such
terms are defined in Section 1(e)). The Holder shall not be required to deliver the original Warrant in order to effect an exercise hereunder,
nor shall any ink original signature or medallion guarantee (or other type of guarantee or notarization) with respect to any Exercise
Notice be required. Execution and delivery of the Exercise Notice with respect to less than all of the Warrant Shares shall have the
same effect as cancellation of the original Warrant and issuance of a new Warrant evidencing the right to purchase the remaining number
of Warrant Shares. On or before the Standard Settlement Period following the date on which the Company has received the Exercise Notice,
the Company shall transmit by electronic mail an acknowledgment of confirmation of receipt of the Exercise Notice to the Holder and the
Company&rsquo;s transfer agent (the &ldquo;<B>Transfer Agent</B>&rdquo;). On or before the third Trading Day, in each case,
following the date on which the Holder delivers the Exercise Notice to the Company, so long as the Holder delivers the Aggregate Exercise
Price (or notice of a Cashless Exercise or an alternative cashless exercise) on or prior to the Trading Day following the date on which
the Exercise Notice was delivered by the Holder (the &ldquo;<B>Share Delivery Date</B>&rdquo;) (provided that if the Aggregate Exercise
Price has not been delivered by such date, the Share Delivery Date shall be three (3) Trading Days after the Aggregate
Exercise Price (or notice of a Cashless Exercise or an alternative cashless exercise) is delivered), the Company shall (X) provided that
the Transfer Agent is participating in The Depository Trust Company (&ldquo;<B>DTC</B>&rdquo;) Fast Automated Securities Transfer Program,
credit such aggregate number of Warrant Shares to which the Holder is entitled pursuant to such exercise to the Holder&rsquo;s or its
designee&rsquo;s balance account with DTC through its Deposit / Withdrawal At Custodian system, or (Y) if the Transfer Agent is not participating
in the DTC Fast Automated Securities Transfer Program, deliver to the Holder, book entry statements evidencing the Warrant Shares, for
the number of Warrant Shares to which the Holder is entitled pursuant to such exercise. If the Company fails for any reason to deliver
to the Holder the Warrant Shares subject to an Exercise Notice by the Share Delivery Date, the Company shall pay to the Holder, in cash,
as liquidated damages and not as a penalty, for each $1,000 of Warrant Shares subject to such exercise (based on the Weighted Average
Price of the Common Stock on the date of the applicable Exercise Notice), $10 per Trading Day (increasing to $20 per Trading
Day on the third (3rd) Trading Day after the Warrant Share Delivery Date) for each Trading Day after such Share Delivery Date until such
Warrant Shares are delivered or Holder rescinds such exercise. The Company shall be responsible for all fees and expenses of the Transfer
Agent, any legal fees related to any legal opinion required by the Company or its Transfer Agent and all fees and expenses with respect
to the issuance of Warrant Shares via DTC, if any. The Company shall enter into a binding written agreement with the Transfer Agent in
a form satisfactory to the Holder which agreement shall require the Transfer Agent to process Exercise Notices delivered by the Holder
and issue the Warrant Shares by the Share Delivery Date without requiring the prior delivery of issuance instructions from the Company
or other action taken by the Company with respect to a particular exercise and issuance. Upon delivery of the Exercise Notice, the Holder
shall be deemed for all corporate purposes to have become the holder of record of the Warrant Shares with respect to which this Warrant
has been exercised, irrespective of the date such Warrant Shares are credited to the Holder&rsquo;s DTC account or the date of delivery
of the book entry statements evidencing such Warrant Shares, as the case may be. Partial exercises of this Warrant resulting in purchases
of a portion of the total number of Warrant Shares available hereunder shall have the effect of lowering the outstanding number of Warrant
Shares purchasable hereunder in an amount equal to the applicable number of Warrant Shares purchased. The Holder and the Company shall
maintain records showing the number of Warrant Shares purchased and the date of such purchases. No fractional Warrant Shares are to be
issued upon the exercise of this Warrant, but rather the number of Warrant Shares to be issued shall be rounded down to the nearest whole
number. Issuance of Warrant Shares shall be made without charge to the Holder for any issue or transfer tax or other incidental expense
in respect of the issuance of such Warrant Shares, all of which taxes and expenses shall be paid by the Company, and such Warrant Shares
shall be issued in the name of the Holder or in such name or names as may be directed by the Holder. The Company shall pay all Transfer
Agent fees required for same-day processing of any Notice of Exercise and all fees to the Depository Trust Company (or another established
clearing corporation performing similar functions) required for same-day electronic delivery of the Warrant Shares. The Company&rsquo;s
obligations to issue and deliver Warrant Shares in accordance with the terms and subject to the conditions hereof are absolute and unconditional,
irrespective of any action or inaction by the Holder to enforce the same, any waiver or consent with respect to any provision hereof,
the recovery of any judgment against any Person or any action to enforce the same, or any setoff, counterclaim, recoupment, limitation
or termination.</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify; text-indent: 1.5in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>


<!-- Field: Page; Sequence: 1 -->
    <DIV STYLE="margin-bottom: 6pt; border-bottom: Black 1pt solid"><TABLE CELLPADDING="0" CELLSPACING="0" STYLE="border-collapse: collapse; width: 100%; font-size: 10pt"><TR STYLE="vertical-align: top; text-align: left"><TD STYLE="width: 100%">&nbsp;</TD></TR></TABLE></DIV>
    <DIV STYLE="break-before: page; margin-top: 6pt"><P STYLE="margin: 0pt">&nbsp;</P></DIV>
    <!-- Field: /Page -->

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify; text-indent: 1in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">(b)
<U>Exercise Price</U>. For purposes of this Warrant, &ldquo;<B>Exercise Price</B>&rdquo; means $[&#9679;] per share, subject to adjustment
as provided herein.</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify; text-indent: 1.5in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify; text-indent: 1in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">(c)
<U>Rescission Rights</U>. If the Company fails to cause the Transfer Agent to transmit to the Holder the Warrant Shares pursuant to Section
1(a) by the Share Delivery Date, then the Holder will have the right to rescind such exercise.</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify; text-indent: 1.5in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify; text-indent: 1in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">(d)
<U>Company&rsquo;s Failure to Timely Deliver Securities</U>. In addition to any other rights available to the Holder, if the Company
shall fail to cause the Transfer Agent to transmit to the Holder on or prior to the Share Delivery Date, Warrant Shares pursuant to an
exercise notice delivered by the Holder and if after such date the Holder is required by its broker to purchase (in an open market transaction
or otherwise) or the Holder&rsquo;s brokerage firm otherwise purchases, Common Stock to deliver in satisfaction of a sale by the Holder
of the Warrant Shares which the Holder anticipated receiving upon such exercise (a &ldquo;<B>Buy-In</B>&rdquo;), then the Company shall,
within three (3) Trading Days after the Holder&rsquo;s request (a) pay in cash to the Holder the amount, if any, by which (x) the Holder&rsquo;s
total purchase price (including brokerage commissions or markups, if any) for the Common Stock so purchased exceeds (y) the amount obtained
by multiplying (1) the number of Warrant Shares that the Company was required to deliver to the Holder in connection with the exercise
at issue times (2) the price at which the sell order giving rise to such purchase obligation was executed, and (b) at the option of the
Holder, either reinstate the portion of the Warrant and equivalent number of Warrant Shares for which such exercise was not honored (in
which case such exercise shall be deemed rescinded) or deliver to the Holder the number of shares of Common Stock that would have been
issued had the Company timely complied with its exercise and delivery obligations hereunder. For example, if the Holder purchases Common
Stock having a total purchase price of $11,000 to cover a Buy-In with respect to an attempted exercise of Common Stock with an aggregate
sale price giving rise to such purchase obligation of $10,000, under clause (a) of the immediately preceding sentence the Company shall
be required to pay the Holder $1,000. The Holder shall provide the Company written notice indicating the amounts payable to the Holder
in respect of the Buy-In and evidence of the amount of such loss. Nothing herein shall limit the Holder&rsquo;s right to pursue any other
remedies available to it hereunder, at law or in equity, including, without limitation, a decree of specific performance and/or injunctive
relief with respect to the Company&rsquo;s failure to timely deliver shares of Common Stock upon the exercise of this Warrant as required
pursuant to the terms hereof.</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify; text-indent: 1in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">(e)
<U>Cashless Exercise</U>. If at the time of exercise hereof, after the Stockholder Approval Notice Date and on or before the Expiration
Date, there is no effective registration statement registering the issuance of the Warrant Shares to the Holder, or the prospectus contained
therein is not available for the issuance of the Warrant Shares to the Holder, then this Warrant may also be exercised, in whole or in
part, at such time by means of a &ldquo;Cashless Exercise&rdquo; in which the Holder shall be entitled to receive a number of Warrant
Shares equal to the quotient obtained by dividing [(A-B) (X)] by (A), where:</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify; text-indent: 1.5in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">For
purposes of the foregoing formula:</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 1.5in; text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>

<TABLE CELLSPACING="0" CELLPADDING="0" STYLE="font: 10pt Times New Roman, Times, Serif; width: 100%; border-collapse: collapse">
  <TR STYLE="font: 10pt Times New Roman, Times, Serif; vertical-align: top">
    <TD STYLE="font: 10pt Times New Roman, Times, Serif; width: 1in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></TD>
    <TD STYLE="font: 10pt Times New Roman, Times, Serif; width: 0.25in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">(A)</FONT></TD>
    <TD STYLE="font: 10pt Times New Roman, Times, Serif; width: 0.1in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">=</FONT></TD>
    <TD STYLE="font: 10pt Times New Roman, Times, Serif; text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">as
    applicable: (i) the VWAP on the Trading Day immediately preceding the date of the applicable Notice of Exercise if such Notice of
    Exercise is (1) both executed and delivered pursuant to Section 1(a) hereof on a day that is not a Trading Day or (2) both executed
    and delivered pursuant to Section 1(a) hereof on a Trading Day prior to the opening of &ldquo;regular trading hours&rdquo; (as defined
    in Rule 600(b) of Regulation NMS promulgated under the federal securities laws) on such Trading Day, (ii) at the option of the Holder,
    either (y) the VWAP on the Trading Day immediately preceding the date of the applicable Notice of Exercise or (z) the Bid Price of
    the Common Stock on the principal Trading Market as reported by Bloomberg as of the time of the Holder&rsquo;s execution of the applicable
    Notice of Exercise if such Notice of Exercise is executed during &ldquo;regular trading hours&rdquo; on a Trading Day and is delivered
    within two (2) hours thereafter (including until two (2) hours after the close of &ldquo;regular trading hours&rdquo; on a Trading
    Day) pursuant to Section 1(a) hereof or (iii) the VWAP on the date of the applicable Notice of Exercise if the date of such Notice
    of Exercise is a Trading Day and such Notice of Exercise is both executed and delivered pursuant to Section 1(a) hereof after the
    close of &ldquo;regular trading hours&rdquo; on such Trading Day;</FONT></TD></TR>
  <TR STYLE="font: 10pt Times New Roman, Times, Serif; vertical-align: top">
    <TD STYLE="font: 10pt Times New Roman, Times, Serif"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></TD>
    <TD STYLE="font: 10pt Times New Roman, Times, Serif"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></TD>
    <TD STYLE="font: 10pt Times New Roman, Times, Serif"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></TD>
    <TD STYLE="font: 10pt Times New Roman, Times, Serif"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></TD></TR>
  <TR STYLE="font: 10pt Times New Roman, Times, Serif; vertical-align: top">
    <TD STYLE="font: 10pt Times New Roman, Times, Serif"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></TD>
    <TD STYLE="font: 10pt Times New Roman, Times, Serif"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">(B)</FONT></TD>
    <TD STYLE="font: 10pt Times New Roman, Times, Serif"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">=</FONT></TD>
    <TD STYLE="font: 10pt Times New Roman, Times, Serif"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">the
    Exercise Price of this Warrant, as adjusted hereunder; and</FONT></TD></TR>
  <TR STYLE="font: 10pt Times New Roman, Times, Serif; vertical-align: top">
    <TD STYLE="font: 10pt Times New Roman, Times, Serif"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></TD>
    <TD STYLE="font: 10pt Times New Roman, Times, Serif"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></TD>
    <TD STYLE="font: 10pt Times New Roman, Times, Serif"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></TD>
    <TD STYLE="font: 10pt Times New Roman, Times, Serif"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></TD></TR>
  <TR STYLE="font: 10pt Times New Roman, Times, Serif; vertical-align: top">
    <TD STYLE="font: 10pt Times New Roman, Times, Serif"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></TD>
    <TD STYLE="font: 10pt Times New Roman, Times, Serif"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">(X)</FONT></TD>
    <TD STYLE="font: 10pt Times New Roman, Times, Serif"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">=</FONT></TD>
    <TD STYLE="font: 10pt Times New Roman, Times, Serif; text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">the
    number of Warrant Shares that would be issuable upon exercise of this Warrant in accordance with the terms of this Warrant if such
    exercise were by means of a cash exercise rather than a cashless exercise.</FONT></TD></TR>
  </TABLE>
<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify; text-indent: 1.5in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>


<!-- Field: Page; Sequence: 2; Options: NewSection; Value: 2 -->
    <DIV STYLE="margin-bottom: 6pt; border-bottom: Black 1pt solid"><TABLE CELLPADDING="0" CELLSPACING="0" STYLE="border-collapse: collapse; width: 100%; font-size: 10pt"><TR STYLE="vertical-align: top; text-align: left"><TD STYLE="text-align: center; width: 100%"><!-- Field: Sequence; Type: Arabic; Name: PageNo -->2<!-- Field: /Sequence --></TD></TR></TABLE></DIV>
    <DIV STYLE="break-before: page; margin-top: 6pt"><P STYLE="margin: 0pt">&nbsp;</P></DIV>
    <!-- Field: /Page -->

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify; text-indent: 1in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">Whether
or not an effective registration statement or prospectus is available, the Holder may also effect an &ldquo;alternative cashless exercise&rdquo;
at any time on or after the Stockholder Approval Notice Date and prior to the Expiration Date. In such event, the aggregate number of
Warrant Shares issuable in such alternative cashless exercise pursuant to any given Notice of Exercise electing to effect an alternative
cashless exercise shall equal the product of (i) the aggregate number of Warrant Shares that would be issuable upon exercise of this
Warrant if such exercise were by means of a cash exercise rather than a cashless exercise, multiplied by (ii) 3.0. Such number of aggregate
Warrant Shares issuable in such alternative cashless exercise shall be proportionally adjusted in the event of any stock split, dividend,
reclassification or any other adjustment provided in Section 2(c) hereof. Notwithstanding anything herein to the contrary, on the Expiration
Date, this Warrant shall be automatically exercised via alternative cashless exercise pursuant to this Section 1(e), provided that the
Stockholder Approval Notice Date shall have occurred.</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify; text-indent: 1.5in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify; text-indent: 1in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">If
Common Stock is issued pursuant to this Section 1(e), the Company hereby acknowledges and agrees that the Warrant Shares issued in a
Cashless Exercise or an alternative cashless exercise shall be deemed to have been acquired by the Holder, and the holding period for
the Warrant Shares shall be deemed to have commenced, on the date this Warrant was originally issued pursuant to the Securities Purchase
Agreement. The Company agrees not to take any position contrary to this Section 1(e).</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify; text-indent: 1.5in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify; text-indent: 1in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">(f)
<U>Disputes</U>. In the case of a dispute as to the determination of the Exercise Price or the arithmetic calculation of the Warrant
Shares, the Company shall promptly issue to the Holder the number of Warrant Shares that are not disputed and resolve such dispute in
accordance with Section 12.</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify; text-indent: 1.5in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify; text-indent: 1in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">(g)
<U>Beneficial Ownership Limitations on Exercises</U>. Notwithstanding anything to the contrary contained herein, the Company shall not
effect the exercise of any portion of this Warrant, and the Holder shall not have the right to exercise any portion of this Warrant,
pursuant to the terms and conditions of this Warrant and any such exercise shall be null and void and treated as if never made, to the
extent that after giving effect to such exercise, the Holder together with the other Attribution Parties collectively would beneficially
own in excess of [4.99%/9.99%] (the &ldquo;<B>Maximum Percentage</B>&rdquo;) of the number of shares of Common Stock outstanding immediately
after giving effect to such exercise. For purposes of the foregoing sentence, the aggregate number of shares of Common Stock beneficially
owned by the Holder and the other Attribution Parties shall include the number of shares of Common Stock held by the Holder and all other
Attribution Parties plus the number of shares of Common Stock issuable upon exercise of this Warrant with respect to which the determination
of such sentence is being made, but shall exclude the number of shares of Common Stock which would be issuable upon (A) exercise of the
remaining, unexercised portion of this Warrant beneficially owned by the Holder or any of the other Attribution Parties and (B) exercise
or conversion of the unexercised or unconverted portion of any other securities of the Company (including, without limitation, any convertible
notes or convertible preferred stock or warrants) and Pre-funded Warrants beneficially owned by the Holder or any other Attribution Party
subject to a limitation on conversion or exercise analogous to the limitation contained in this Section 1(g). For purposes of this Section
1(g), beneficial ownership shall be calculated in accordance with Section 13(d) of the Securities Exchange Act of 1934, as amended (the
&ldquo;<B>1934 Act</B>&rdquo;). For purposes of this Warrant, in determining the number of outstanding shares of Common Stock the Holder
may acquire upon the exercise of this Warrant without exceeding the Maximum Percentage, the Holder may rely on the number of outstanding
shares of Common Stock as reflected in (x) the Company&rsquo;s most recent Annual Report on Form 10-K, Quarterly Report on Form 10-Q,
Current Report on Form 8-K or other public filing with the Securities and Exchange Commission (the &ldquo;<B>SEC</B>&rdquo;), as the
case may be, (y) a more recent public announcement by the Company or (3) any other written notice by the Company or the Transfer Agent
setting forth the number of shares of Common Stock outstanding (the &ldquo;<B>Reported Outstanding Share Number</B>&rdquo;). If the Company
receives an Exercise Notice from the Holder at a time when the actual number of outstanding shares of Common Stock is less than the Reported
Outstanding Share Number, the Company shall (i) notify the Holder in writing of the number of shares of Common Stock then outstanding
and, to the extent that such Exercise Notice would otherwise cause the Holder&rsquo;s beneficial ownership, as determined pursuant to
this Section 1(g), to exceed the Maximum Percentage, the Holder must notify the Company of a reduced number of Warrant Shares to be purchased
pursuant to such Exercise Notice (the number of shares by which such purchase is reduced, the &ldquo;<B>Reduction Shares</B>&rdquo;)
and (ii) as soon as reasonably practicable, the Company shall return to the Holder any exercise price paid by the Holder for the Reduction
Shares. For any reason at any time, upon the written or oral request of the Holder, the Company shall within one (1) Trading Day confirm
orally and in writing or by electronic mail to the Holder the number of shares of Common Stock then outstanding. In any case, the number
of outstanding shares of Common Stock shall be determined after giving effect to the conversion or exercise of securities of the Company,
including this Warrant, by the Holder and any other Attribution Party since the date as of which the Reported Outstanding Share Number
was reported. In the event that the issuance of shares of Common Stock to the Holder upon exercise of this Warrant results in the Holder
and the other Attribution Parties being deemed to beneficially own, in the aggregate, more than the Maximum Percentage of the number
of outstanding shares of Common Stock (as determined under Section 13(d) of the 1934 Act), the number of shares so issued by which the
Holder&rsquo;s and the other Attribution Parties&rsquo; aggregate beneficial ownership exceeds the Maximum Percentage (the &ldquo;<B>Excess
Shares</B>&rdquo;) shall be deemed null and void and shall be cancelled ab initio, and the Holder shall not have the power to vote or
to transfer the Excess Shares. As soon as reasonably practicable after the issuance of the Excess Shares has been deemed null and void,
the Company shall return to the Holder the exercise price paid by the Holder for the Excess Shares. Upon delivery of a written notice
to the Company, the Holder may from time to time increase or decrease the Maximum Percentage to any other percentage not in excess of
9.99% as specified in such notice; provided that (i) any such increase in the Maximum Percentage will not be effective until the sixty-first
(61st) day after such notice is delivered to the Company and (ii) any such increase or decrease will apply only to the Holder and the
other Attribution Parties and not to any other holder of Warrants that is not an Attribution Party of the Holder. For purposes of clarity,
the Common Stock issuable pursuant to the terms of this Warrant in excess of the Maximum Percentage shall not be deemed to be beneficially
owned by the Holder for any purpose including for purposes of Section 13(d) or Rule 16a-1(a)(1) of the 1934 Act. <FONT STYLE="background-color: white">No
</FONT>prior inability to exercise this Warrant pursuant to this paragraph shall have any effect on the applicability of the provisions
of this paragraph with respect to any subsequent determination of exercisability. The provisions of this paragraph shall be construed
and implemented in a manner otherwise than in strict conformity with the terms of this Section 1(g) to the extent necessary to correct
this paragraph or any portion of this paragraph which may be defective or inconsistent with the intended beneficial ownership limitation
contained in this Section 1(g) or to make changes or supplements necessary or desirable to properly give effect to such limitation. The
limitation contained in this paragraph may not be waived and shall apply to a successor holder of this Warrant.</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify; text-indent: 1.5in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>


<!-- Field: Page; Sequence: 3; Value: 2 -->
    <DIV STYLE="margin-bottom: 6pt; border-bottom: Black 1pt solid"><TABLE CELLPADDING="0" CELLSPACING="0" STYLE="border-collapse: collapse; width: 100%; font-size: 10pt"><TR STYLE="vertical-align: top; text-align: left"><TD STYLE="text-align: center; width: 100%"><!-- Field: Sequence; Type: Arabic; Name: PageNo -->3<!-- Field: /Sequence --></TD></TR></TABLE></DIV>
    <DIV STYLE="break-before: page; margin-top: 6pt"><P STYLE="margin: 0pt">&nbsp;</P></DIV>
    <!-- Field: /Page -->

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify; text-indent: 1in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">(h)
<U>Insufficient Authorized Shares</U>. If at any time following receipt of the Stockholder Approval with respect to the Authorized Share
Increase, while this Warrant remains outstanding the Company does not have a sufficient number of authorized and unreserved shares of
Common Stock to satisfy its obligation to reserve for issuance upon exercise of this Warrant at least a number of shares of Common Stock
equal to 100% of the number of shares of Common Stock as shall from time to time be necessary to effect the exercise of all of the Warrants
then outstanding without regard to any limitation on exercise included herein and assuming that the shares underlying this Warrant are
adjusted based on an Adjustment Price equal to $[&#9679;] (as adjusted for stock splits, stock dividends, recapitalizations, reorganizations,
reclassification, combinations, reverse stock splits, or other similar events occurring after the Subscription Date) (the &ldquo;<B>Required
Reserve Amount</B>&rdquo; and the failure to have such sufficient number of authorized and unreserved Common Stock, an &ldquo;<B>Authorized
Share Failure</B>&rdquo;), then the Company shall immediately take all action necessary to increase the number of the Company&rsquo;s
shares of authorized Common Stock to an amount sufficient to allow the Company to reserve the Required Reserve Amount for this Warrant
then outstanding. Without limiting the generality of the foregoing sentence, as soon as practicable after the date of the occurrence
of an Authorized Share Failure, but in no event later than ninety (90) days after the occurrence of such Authorized Share Failure, the
Company shall hold a meeting of its shareholders for the approval of an increase in the number of authorized shares of Common Stock.
In connection with such meeting, the Company shall provide each shareholder with a proxy statement and shall use its best efforts to
solicit its shareholders&rsquo; approval of such increase in the number of authorized shares of Common Stock and to cause its board of
directors to recommend to the shareholders that they approve such proposal. Notwithstanding the foregoing, if any such time of an Authorized
Share Failure, the Company is able to obtain the approval of holders of a majority of the shares of Common Stock voting at any meeting
to approve the increase in the number of authorized shares of Common Stock, the Company may satisfy this obligation by obtaining such
approval. In the event that upon any exercise of this Warrant following receipt of the Stockholder Approval with respect to the Authorized
Share Increase, the Company does not have sufficient authorized shares to deliver in satisfaction of such exercise, then unless the Holder
elects to void such attempted exercise, the Holder may require the Company to pay to the Holder within three (3) Trading Days of the
applicable exercise, cash in an amount equal to the product of (i) the quotient determined by dividing (x) the number of Warrant Shares
that the Company is unable to deliver pursuant to this Section 1(h), by (y) the total number of Warrant Shares issuable upon exercise
of this Warrant (without regard to any limitations or restrictions on exercise of this Warrant) and (ii) the Black Scholes Value; provided,
that (x) references to &ldquo;the day immediately following the public announcement of the applicable Fundamental Transaction&rdquo;
in the definition of &ldquo;Black Scholes Value&rdquo; shall instead refer to &ldquo;the date the Holder exercises this Warrant and the
Company cannot deliver the required number of Warrant Shares because of an Authorized Share Failure&rdquo; and (y) clause (iii) of the
definition of &ldquo;Black Scholes Value&rdquo; shall instead refer to &ldquo;the underlying price per share used in such calculation
shall be the highest Weighted Average Price during the period beginning on the date of the applicable date of exercise and the date that
the Company makes the applicable cash payment.&rdquo; In the event that the Company does not have a sufficient number of shares of Common
Stock available to honor the exercise of Warrants following receipt of Stockholder Approval but prior to a subsequent increase in the
number of authorized shares of Common Stock, the Company shall allocate the available number of Warrant Shares on a pro rata basis among
all Holders exercising Warrants, until such time as the Company has a sufficient number of authorized shares of Common Stock to issue
all Warrant Shares in full.</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify; text-indent: 1in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">(i)
<U>Stockholder Approval</U>. As soon practicable as after the Issuance date, but in no event later than sixty (60) days after the Issuance
Date, the Company shall hold a meeting of its stockholders for the Stockholder Approval. In connection with such meeting, the Company
shall provide each stockholder with a proxy statement and shall use its best efforts to solicit its stockholders&rsquo; approval of the
Stockholder Approval and the board of directors of the Company shall recommend to the stockholders that the stockholders approve the
Stockholder Approval. Notwithstanding the foregoing, if at any time the Company is able to obtain the approval of holders of a majority
of the shares of Common Stock voting at any meeting to approve the increase in the number of authorized shares of Common Stock at or
above the number then required to allow the full exercise of the Warrants, the Company may satisfy this obligation by obtaining such
approval. If the Company fails to obtain Stockholder Approval at the meeting of its stockholders, the Company shall as soon practicable
after failure to obtain the Stockholder Approval, but in no event later than ninety (90) days after such failure, hold
a meeting of its stockholders for the Stockholder Approval. In connection with such meeting, the Company shall provide each stockholder
with a proxy statement and shall use its best efforts to solicit its stockholders&rsquo; approval of the Stockholder Approval and to
cause its board of directors to recommend to the stockholders that they approve such proposal.</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify; text-indent: 1in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>


<!-- Field: Page; Sequence: 4; Value: 2 -->
    <DIV STYLE="margin-bottom: 6pt; border-bottom: Black 1pt solid"><TABLE CELLPADDING="0" CELLSPACING="0" STYLE="border-collapse: collapse; width: 100%; font-size: 10pt"><TR STYLE="vertical-align: top; text-align: left"><TD STYLE="text-align: center; width: 100%"><!-- Field: Sequence; Type: Arabic; Name: PageNo -->4<!-- Field: /Sequence --></TD></TR></TABLE></DIV>
    <DIV STYLE="break-before: page; margin-top: 6pt"><P STYLE="margin: 0pt">&nbsp;</P></DIV>
    <!-- Field: /Page -->

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify; text-indent: 0.5in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">2.
<U>ADJUSTMENT OF EXERCISE PRICE AND NUMBER OF WARRANT SHARES</U>. The Exercise Price and the number of Warrant Shares shall be adjusted
from time to time as follows (provided that, notwithstanding anything herein to the contrary, any adjustment to the number of Warrants
Shares based on the aggregate Exercise Price shall be determined using the aggregate Exercise Price on the Closing Date other than pursuant
to a reduction in Warrant Shares as a result of the exercise of this Warrant by the Holder):</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify; text-indent: 1.5in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify; text-indent: 1in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">(a)
[<U>Reserved</U>].</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify; text-indent: 1.5in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify; text-indent: 1in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">(b)
<U>Voluntary Adjustment by Company.</U> Subject to the rules and regulations of the primary Principal Market, the Company may at any
time during the term of this Warrant, with the prior written consent of the Required Holders, reduce the then current Exercise Price
to any amount and for any period of time deemed appropriate by the Board of Directors of the Company.</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify; text-indent: 1.5in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify; text-indent: 1in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">(c)
<U>Adjustment Upon Subdivision or Combination of Common Stock</U>. If the Company at any time on or after the Subscription Date subdivides
(by any stock split, stock dividend, recapitalization or otherwise) one or more classes of its outstanding Common Stock into a greater
number of shares, the Exercise Price in effect immediately prior to such subdivision will be proportionately reduced and the number of
Warrant Shares will be proportionately increased. If the Company at any time on or after the Subscription Date combines (by combination,
reverse stock split or otherwise) one or more classes of its outstanding Common Stock into a smaller number of shares, the Exercise Price
in effect immediately prior to such combination will be proportionately increased and the number of Warrant Shares will be proportionately
decreased. Any adjustment under this Section 2(c) shall become effective at the close of business on the date the subdivision or combination
becomes effective.</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify; text-indent: 1.5in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify; text-indent: 1in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">(d)
<U>Adjustments</U>. On the Adjustment Date, the Exercise Price shall be reduced (but in no event increased) to the greater of (I) the
Floor Price and (II) the lowest Weighted Average Price during the Adjustment Period (each such price an &ldquo;<B>Adjustment Price</B>&rdquo;).
Upon any such adjustment of the Exercise Price pursuant to this Section 2(d), the number of Warrant Shares issuable hereunder shall be
increased such that the aggregate Exercise Price of this Warrant on the Issuance Date (adjusted for any Warrants exercised by the Holder
prior to such Adjustment Date for the Warrant Shares then outstanding) shall remain unchanged following such adjustment. Notwithstanding
the foregoing, if a Holder requests to exercise this Warrant in whole or in part on any given date prior to an Adjustment Date at any
time following Stockholder Approval Notice, solely with respect to such portion of this Warrant being exercised on such applicable exercise
date, (a) such applicable Adjustment Date shall be deemed to mean the exercise date, (b) such applicable Adjustment Period End Date shall
be deemed to have ended on the Trading Day immediately prior to such exercise and (c) the applicable Adjustment Price for such exercised
Warrants shall be calculated pursuant to this Section 2(d). For the avoidance of doubt, no adjustment to the Adjustment Price shall apply
to any Warrants exercised prior to any applicable Adjustment Period.</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify; text-indent: 1.5in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify; text-indent: 1in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">(e)
[Reserved].</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify; text-indent: 1.5in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>


<!-- Field: Page; Sequence: 5; Value: 2 -->
    <DIV STYLE="margin-bottom: 6pt; border-bottom: Black 1pt solid"><TABLE CELLPADDING="0" CELLSPACING="0" STYLE="border-collapse: collapse; width: 100%; font-size: 10pt"><TR STYLE="vertical-align: top; text-align: left"><TD STYLE="text-align: center; width: 100%"><!-- Field: Sequence; Type: Arabic; Name: PageNo -->5<!-- Field: /Sequence --></TD></TR></TABLE></DIV>
    <DIV STYLE="break-before: page; margin-top: 6pt"><P STYLE="margin: 0pt">&nbsp;</P></DIV>
    <!-- Field: /Page -->

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify; text-indent: 1in"> (f) Share Combination
Event Adjustment. In addition to the adjustments set forth in this Section 2, subject to Stockholder Approval, if at any time on or after
the Issuance Date there occurs any share split, reverse share split, share dividend, share combination recapitalization or other similar
transaction involving the Common Stock (each, a &ldquo;Share Combination Event&rdquo;, and such date on which the Share Combination Event
is effected, the &ldquo;Share Combination Event Date&rdquo;) and the lowest Weighted Average Price of the Common Stock during the period
commencing on the Trading Day immediately following the applicable Share Combination Event Date and ending on the fifth (5th) Trading
Day immediately following the applicable Share Combination Event Date (the &ldquo;Event Market Price&rdquo;) (provided if the Share Combination
Event is effective prior to the opening of trading on the Principal Market (or if the Common Stock no longer trades on the Principal
Market, on the primary Eligible Market on which the Common Stock then trades), then, commencing on the Share Combination Event Date and
ending on the fourth (4th) Trading Day immediately following the applicable Share Combination Event Date (such period, the &ldquo;Share
Combination Adjustment Period&rdquo;)) is less than the Exercise Price then in effect (after giving effect to the adjustment in clause
2(c) above), then, at the close of trading on the Principal Market (or if the Common Stock no longer trades on the Principal Market,
on the primary Eligible Market on which the Common Stock then trades) on the last day of the Share Combination Adjustment Period, the
Exercise Price then in effect on such 5th Trading Day shall be reduced (but in no event increased) to the Event Market Price and the
number of Warrant Shares issuable upon exercise of this Warrant hereunder (such resulting number, the &ldquo;Share Combination Issuable
Shares&rdquo;) shall be increased such that the aggregate Exercise Price payable hereunder, after taking into account the decrease in
the Exercise Price, shall be equal to the aggregate Exercise Price on the Issuance Date for the Warrant Shares then outstanding; provided,
however, that in no event shall the Event Market Price be lower than the Floor Price; and provided further that notwithstanding the foregoing,
if one or more Share Combination Events occurred prior to the Stockholder Approval being obtained and the reduction of the Exercise Price
was limited by clause (i) of the definition of Floor Price, once the Stockholder Approval is obtained, the Exercise Price will automatically
be reduced to equal the greater of (x) the lowest Event Market Price with respect to any Share Combination Event that occurred prior
to the Stockholder Approval being obtained, and (y) the price determined by reference to clause (ii) of the definition of Floor Price.
For the avoidance of doubt, if the adjustment in this Section 2(e) would otherwise result in an increase in the Exercise Price hereunder,
no adjustment shall be made, and if this Warrant is exercised, on any date on which the Holder delivers an Exercise Notice to the Company
(for purposes of this Section 2(e), an &ldquo;Exercise Date&rdquo;) during the Share Combination Adjustment Period, solely with respect
to such portion of this Warrant exercised on such applicable Exercise Date, such applicable Share Combination Adjustment Period shall
be deemed to have ended on, and include, the Trading Day immediately prior to such Exercise Date and the Event Market Price on such applicable
Exercise Date will be the lowest Weighted Average Price of the Common Stock immediately prior to the Share Combination Event Date and
ending on, and including the Trading Day immediately prior to such Exercise Date. Notwithstanding the foregoing, if one or more Share
Combination Events occurs prior to the Stockholder Approval being obtained and the reduction of the Exercise Price to the Event Market
Price, once the Stockholder Approval is obtained, the Exercise Price will automatically be reduced to the lowest Event Market Price with
respect to any Share Combination Event that occurred prior to the Stockholder Approval being obtained and the Share Combination Issuable
Shares will automatically be adjusted to equal the highest such number with respect to any Share Combination Event that occurred prior
to the Stockholder Approval being obtained, provided that in no event will the Exercise Price be reduced below the Floor Price. </P>

<P STYLE="font: 11pt Times New Roman, Times, Serif; margin: 0; text-align: justify; text-indent: 1in">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify; text-indent: 1in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">(g)
<U>Other Events</U>. If any event occurs of the type contemplated by the provisions of this Section 2 but not expressly provided for
by such provisions (including, without limitation, the granting of stock appreciation rights, phantom stock rights or other rights with
equity features), then the Company&rsquo;s Board of Directors will make an appropriate adjustment in the Exercise Price and the number
of Warrant Shares, as mutually determined by the Company&rsquo;s Board of Directors and the Required Holders, so as to protect the rights
of the Holder; <U>provided</U> that no such adjustment pursuant to this Section 2(g) will increase the Exercise Price or decrease the
number of Warrant Shares as otherwise determined pursuant to this Section 2.</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify; text-indent: 1in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify; text-indent: 0.5in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">3.
<U>RIGHTS UPON DISTRIBUTION OF ASSETS</U>. During such time as this Warrant is outstanding, if the Company shall declare or make any
dividend or other distribution of its assets (or rights to acquire its assets), other than under Sections 2(c) and 4(a) of this Warrant,
to all (or substantially all) of holders of shares of Common Stock, by way of return of capital or otherwise (including, without limitation,
any distribution of cash, stock or other securities, property or options by way of a dividend, spin off, reclassification, corporate
rearrangement, contingent value right, scheme of arrangement or other similar transaction) (a &ldquo;<B>Distribution</B>&rdquo;), at
any time after the issuance of this Warrant, then, in each such case, the Holder shall be entitled to participate in such Distribution
to the same extent that the Holder would have participated therein if the Holder had held the number of shares of Common Stock acquirable
upon complete exercise of this Warrant (without regard to any limitations on exercise hereof, including without limitation, the Maximum
Percentage) immediately before the date of which a record is taken for such Distribution, or, if no such record is taken, the date as
of which the record holders of shares of Common Stock are to be determined for the participation in such Distribution (<U>provided</U>,
<U>however</U>, that, to the extent that the Holder&rsquo;s right to participate in any such Distribution would result in the Holder
exceeding the Maximum Percentage, then the Holder shall not be entitled to participate in such Distribution to such extent (or in the
beneficial ownership of any shares of Common Stock as a result of such Distribution to such extent) and the portion of such Distribution
shall be held in abeyance for the benefit of the Holder until such time, if ever, as its right thereto would not result in the Holder
exceeding the Maximum Percentage). To the extent that this Warrant has not been partially or completely exercised at the time of such
Distribution, such portion of the Distribution shall be held in abeyance for the benefit of the Holder until the Holder has exercised
this Warrant.</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify; text-indent: 1in">&nbsp;</P>




<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify"></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify; text-indent: 0.5in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">4.
<U>PURCHASE RIGHTS; FUNDAMENTAL TRANSACTIONS</U>.</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify; text-indent: 1.5in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify; text-indent: 1in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">(a)
<U>Purchase Rights</U>. In addition to any adjustments pursuant to Section 2 above, if at any time the Company grants, issues or sells
any Options, Convertible Securities or rights to purchase stock, warrants, securities or other property pro rata to the record holders
of any class of Common Stock (the &ldquo;<B>Purchase Rights</B>&rdquo;), then the Holder will be entitled to acquire, upon the terms
applicable to such Purchase Rights, the aggregate Purchase Rights which the Holder could have acquired if the Holder had held the number
of shares of Common Stock acquirable upon complete exercise of this Warrant (without regard to any limitations or restrictions on exercise
of this Warrant, including without limitation, the Maximum Percentage) immediately before the date on which a record is taken for the
grant, issuance or sale of such Purchase Rights, or, if no such record is taken, the date as of which the record holders of Common Stock
is to be determined for the grant, issue or sale of such Purchase Rights (<U>provided</U>, <U>however</U>, that to the extent that the
Holder&rsquo;s right to participate in any such Purchase Right would result in the Holder and the other Attribution Parties exceeding
the Maximum Percentage, then the Holder shall not be entitled to participate in such Purchase Right to such extent (and shall not be
entitled to beneficial ownership of such Common Stock as a result of such Purchase Right (and beneficial ownership) to such extent) and
such Purchase Right to such extent shall be held in abeyance for the benefit of the Holder until such time or times as its right thereto
would not result in the Holder and the other Attribution Parties exceeding the Maximum Percentage, at which time or times the Holder
shall be granted such right (and any Purchase Right granted, issued or sold on such initial Purchase Right or on any subsequent Purchase
Right held similarly in abeyance) to the same extent as if there had been no such limitation).</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify; text-indent: 1.5in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify; text-indent: 1.5in"></P>

<!-- Field: Page; Sequence: 6; Value: 2 -->
    <DIV STYLE="margin-bottom: 6pt; border-bottom: Black 1pt solid"><TABLE CELLPADDING="0" CELLSPACING="0" STYLE="border-collapse: collapse; width: 100%; font-size: 10pt"><TR STYLE="vertical-align: top; text-align: left"><TD STYLE="text-align: center; width: 100%"><!-- Field: Sequence; Type: Arabic; Name: PageNo -->6<!-- Field: /Sequence --></TD></TR></TABLE></DIV>
    <DIV STYLE="break-before: page; margin-top: 6pt"><P STYLE="margin: 0pt">&nbsp;</P></DIV>
    <!-- Field: /Page -->

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify; text-indent: 1.5in">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify; text-indent: 1in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">(b)
<U>Fundamental Transactions</U>. If, at any time while this Warrant is outstanding, (i) the Company, directly or indirectly, in one or
more related transactions effects any merger or consolidation of the Company with or into another Person (other than for the purpose
of changing the Company&rsquo;s name and/or the jurisdiction of incorporation of the Company or a holding company for the Company), (ii)
the Company, directly or indirectly, effects any sale, lease, license, assignment, transfer, conveyance or other disposition of all or
substantially all of its assets, in one or a series of related transactions, (iii) any, direct or indirect, purchase offer, tender offer
or exchange offer (whether by the Company or another Person) is completed pursuant to which holders of Common Stock are permitted to
sell, tender or exchange their shares for other securities, cash or property and has been accepted by the holders of greater than 50%
of the voting power of the outstanding common and preferred stock of the Company, (iv) the Company, directly or indirectly, in one or
more related transactions effects any reclassification, reorganization or recapitalization of the Common Stock or any compulsory share
exchange pursuant to which the Common Stock is effectively converted into or exchanged for other securities, cash or property, or (v)
the Company, directly or indirectly, in one or more related transactions consummates a stock or share purchase agreement or other business
combination (including, without limitation, a reorganization, recapitalization, spin-off, merger or scheme of arrangement) with another
Person or group of Persons whereby such other Person or group acquires greater than 50% of the voting power of the outstanding common
and preferred stock of the Company (not including any shares of Common Stock held by the other Person or other Persons making or party
to, or associated or affiliated with the other Persons making or party to, such stock or share purchase agreement or other business combination)
(each a &ldquo;<U>Fundamental Transaction</U>&rdquo;), then, upon any subsequent exercise of this Warrant, the Holder shall have the
right to receive, for each Warrant Share that would have been issuable upon such exercise immediately prior to the occurrence of such
Fundamental Transaction, at the option of the Holder (without regard to any limitation in Section 1(g) on the exercise of this Warrant),
the number of shares of Common Stock of the successor or acquiring corporation or of the Company, if it is the surviving corporation,
and any additional consideration (together, the &ldquo;<U>Alternate Consideration</U>&rdquo;) receivable as a result of such Fundamental
Transaction by a holder of the number of shares of Common Stock for which this Warrant is exercisable immediately prior to such Fundamental
Transaction (without regard to any limitation in Section 1(g)). For purposes of any such exercise, the determination of the Exercise
Price shall be appropriately adjusted to apply to such Alternate Consideration based on the amount of Alternate Consideration issuable
in respect of one share of Common Stock in such Fundamental Transaction, and the Company shall apportion the Exercise Price among the
Alternate Consideration in a reasonable manner reflecting the relative value of any different components of the Alternate Consideration.
If holders of Common Stock are given any choice as to the securities, cash or property to be received in a Fundamental Transaction, then
the Holder shall be given the same choice as to the Alternate Consideration it receives upon any exercise of this Warrant following such
Fundamental Transaction. Notwithstanding anything to the contrary, in the event of a Fundamental Transaction, the Company or any Successor
Entity (as defined below) shall, at the Holder&rsquo;s option, exercisable at any time concurrently with, or within 30 days after, the
consummation of the Fundamental Transaction (or, if later, the date of the public announcement of the applicable Fundamental Transaction),
purchase this Warrant from the Holder by paying to the Holder an amount of consideration equal to the Black Scholes Value (as
defined below) of the remaining unexercised portion of this Warrant on the date of the consummation of such Fundamental Transaction;
<U>provided</U>, <U>however</U>, that, if the Fundamental Transaction is not within the Company&rsquo;s control, including not approved
by the Company&rsquo;s Board of Directors, the Holder shall only be entitled to receive from the Company or any Successor Entity as of
the date of the consummation of such Fundamental Transaction the same type or form of consideration (and in the same proportion), at
the Black Scholes Value of the unexercised portion of this Warrant, that is being offered and paid to the holders of Common Stock of
the Company in connection with the Fundamental Transaction, whether that consideration be in the form of cash, stock or any combination
thereof, or whether the holders of Common Stock are given the choice to receive from among alternative forms of consideration in connection
with the Fundamental Transaction; <U>provided</U>, <U>further</U>, that if holders of Common Stock of the Company are not offered or
paid any consideration in such Fundamental Transaction, such holders of Common Stock will be deemed to have received common stock of
the Successor Entity (which Successor Entity may be the Company following such Fundamental Transaction) in such Fundamental Transaction
and a Holder shall receive shares of the Successor Entity in the amount of the Black Scholes Value. &ldquo;<U>Black Scholes Value</U>&rdquo;
means the value of this Warrant based on the Black-Scholes Option Pricing Model obtained from the &ldquo;OV&rdquo; function on Bloomberg
determined as of the day of consummation of the applicable Fundamental Transaction for pricing purposes and reflecting (A) a risk-free
interest rate corresponding to the U.S. Treasury rate for a period equal to the time between the date of the public announcement of the
applicable contemplated Fundamental Transaction and the Termination Date, (B) an expected volatility equal to the 100 day volatility
as obtained from the HVT function on Bloomberg (determined utilizing a 365-day annualization factor) as of the Trading Day immediately
following the public announcement of the applicable Fundamental Transaction, (C) the underlying price per share used in such calculation
shall be the greater of (i) the sum of the price per share being offered in cash, if any, plus the value of any non-cash consideration,
if any, being offered in such Fundamental Transaction and (ii) the greater of (x) the last VWAP immediately prior to the public announcement
of such Fundamental Transaction and (y) the last VWAP immediately prior to the consummation of such Fundamental Transaction, (D)
a remaining option time equal to the time between the date of the public announcement of the applicable Fundamental Transaction and the
Termination Date and (E) a zero cost of borrow. In the event of a cash payment in connection with a Fundamental Transaction, the
payment of the Black Scholes Value will be made by wire transfer of immediately available funds within five Trading Days of the Holder&rsquo;s
election (or, if later, on the effective date of the Fundamental Transaction. The Company shall cause any successor entity
in a Fundamental Transaction in which the Company is not the survivor (the &ldquo;<U>Successor Entity</U>&rdquo;) to assume in writing
all of the obligations of the Company under this Warrant and the other Transaction Documents in accordance with the provisions of this
Section 4(b) pursuant to written agreements in form and substance reasonably satisfactory to the Holder and approved by the Holder (without
unreasonable delay) prior to such Fundamental Transaction and shall, at the option of the Holder, deliver to the Holder in exchange for
this Warrant a security of the Successor Entity evidenced by a written instrument substantially similar in form and substance to this
Warrant which is exercisable for a corresponding number of shares of capital stock of such Successor Entity (or its parent entity) equivalent
to the shares of Common Stock acquirable and receivable upon exercise of this Warrant (without regard to any limitations on the exercise
of this Warrant) prior to such Fundamental Transaction, and with an exercise price which applies the exercise price hereunder to such
shares of capital stock (but taking into account the relative value of the shares of Common Stock pursuant to such Fundamental Transaction
and the value of such shares of capital stock, such number of shares of capital stock and such exercise price being for the purpose of
protecting the economic value of this Warrant immediately prior to the consummation of such Fundamental Transaction), and which is reasonably
satisfactory in form and substance to the Holder. Upon the occurrence of any such Fundamental Transaction, the Successor Entity shall
be added to the term &ldquo;Company&rdquo; under this Warrant (so that from and after the occurrence or consummation of such Fundamental
Transaction, each and every provision of this Warrant and the other Transaction Documents referring to the &ldquo;Company&rdquo; shall
refer instead to each of the Company and the Successor Entity or Successor Entities, jointly and severally), and the Successor Entity
or Successor Entities, jointly and severally with the Company, may exercise every right and power of the Company prior thereto and the
Successor Entity or Successor Entities shall assume all of the obligations of the Company prior thereto under this Warrant and the other
Transaction Documents with the same effect as if the Company and such Successor Entity or Successor Entities, jointly and severally,
had been named as the Company herein.</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify; text-indent: 1in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>


<!-- Field: Page; Sequence: 7; Value: 2 -->
    <DIV STYLE="margin-bottom: 6pt; border-bottom: Black 1pt solid"><TABLE CELLPADDING="0" CELLSPACING="0" STYLE="border-collapse: collapse; width: 100%; font-size: 10pt"><TR STYLE="vertical-align: top; text-align: left"><TD STYLE="text-align: center; width: 100%"><!-- Field: Sequence; Type: Arabic; Name: PageNo -->7<!-- Field: /Sequence --></TD></TR></TABLE></DIV>
    <DIV STYLE="break-before: page; margin-top: 6pt"><P STYLE="margin: 0pt">&nbsp;</P></DIV>
    <!-- Field: /Page -->

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify; text-indent: 0.5in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">5.
<U>NON-CIRCUMVENTION</U>. The Company hereby covenants and agrees that the Company will not, by amendment of its articles of incorporation
or bylaws, or through any reorganization, transfer of assets, consolidation, merger, scheme of arrangement, dissolution, issue or sale
of securities, or any other voluntary action, avoid or seek to avoid the observance or performance of any of the terms of this Warrant,
and will at all times in good faith carry out all of the provisions of this Warrant and take all action as may be required to protect
the rights of the Holder. Without limiting the generality of the foregoing, the Company (i) shall not increase the par value of any Common
Stock receivable upon the exercise of this Warrant above the Exercise Price then in effect, (ii) shall take all such actions as may be
necessary or appropriate in order that the Company may validly and legally issue fully paid and nonassessable shares of Common Stock
upon the exercise of this Warrant, and (iii) following the Stockholder Approval Date, shall, so long as any of the Warrants are outstanding,
take all action necessary to reserve and keep available out of its authorized and unissued Common Stock, solely for the purpose of effecting
the exercise of the Warrants, 100% of the number of shares of Common Stock as shall from time to time be necessary to effect the exercise
of the Warrants then outstanding (without regard to any limitations on exercise).</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify; text-indent: 1in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify; text-indent: 0.5in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">6.
<U>WARRANT HOLDER NOT DEEMED A SHAREHOLDER</U>. Except as otherwise specifically provided herein including Section 3, the Holder, solely
in such Person&rsquo;s capacity as a holder of this Warrant, shall not be entitled to vote or receive dividends or be deemed the holder
of share capital of the Company for any purpose, nor shall anything contained in this Warrant be construed to confer upon the Holder,
solely in such Person&rsquo;s capacity as the Holder of this Warrant, any of the rights of a shareholder of the Company or any right
to vote, give or withhold consent to any corporate action (whether any reorganization, issue of stock, reclassification of stock, consolidation,
merger, conveyance or otherwise), receive notice of meetings, receive dividends or subscription rights, or otherwise, prior to the issuance
to the Holder of the Warrant Shares which such Person is then entitled to receive upon the due exercise of this Warrant. In addition,
nothing contained in this Warrant shall be construed as imposing any liabilities on the Holder to purchase any securities (upon exercise
of this Warrant or otherwise) or as a shareholder of the Company, whether such liabilities are asserted by the Company or by creditors
of the Company. Notwithstanding this Section 6, the Company shall provide the Holder with copies of the same notices and other information
given to the shareholders of the Company generally, contemporaneously with the giving thereof to the shareholders.</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify; text-indent: 1in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify; text-indent: 0.5in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">7.
<U>REISSUANCE OF WARRANTS</U>.</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify; text-indent: 1.5in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify; text-indent: 1in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">(a)
<U>Transfer of Warrant</U>. If this Warrant is to be transferred, the Holder shall surrender this Warrant to the Company, whereupon the
Company will forthwith issue and deliver upon the order of the Holder a new Warrant (in accordance with Section 7(d)), registered as
the Holder may request, representing the right to purchase the number of Warrant Shares being transferred by the Holder and, if less
than the total number of Warrant Shares then underlying this Warrant is being transferred, a new Warrant (in accordance with Section
7(d)) to the Holder representing the right to purchase the number of Warrant Shares not being transferred.</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify; text-indent: 1.5in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify; text-indent: 1in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">(b)
<U>Lost, Stolen or Mutilated Warrant</U>. Upon receipt by the Company of evidence reasonably satisfactory to the Company of the loss,
theft, destruction or mutilation of this Warrant, and, in the case of loss, theft or destruction, of any indemnification undertaking
by the Holder to the Company in customary form and, in the case of mutilation, upon surrender and cancellation of this Warrant, the Company
shall execute and deliver to the Holder a new Warrant (in accordance with Section 7(d)) representing the right to purchase the Warrant
Shares then underlying this Warrant.</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify; text-indent: 1.5in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify; text-indent: 1in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">(c)
<U>Exchangeable for Multiple Warrants</U>. This Warrant is exchangeable, upon the surrender hereof by the Holder at the principal office
of the Company, for a new Warrant or Warrants (in accordance with Section 7(d)) representing in the aggregate the right to purchase the
number of Warrant Shares then underlying this Warrant, and each such new Warrant will represent the right to purchase such portion of
such Warrant Shares as is designated by the Holder at the time of such surrender; <U>provided</U>, <U>however</U>, that no Warrants for
fractional Warrant Shares shall be given.</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify; text-indent: 1.5in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify; text-indent: 1in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">(d)
<U>Issuance of New Warrants</U>. Whenever the Company is required to issue a new Warrant pursuant to the terms of this Warrant, such
new Warrant (i) shall be of like tenor with this Warrant, (ii) shall represent, as indicated on the face of such new Warrant, the right
to purchase the Warrant Shares then underlying this Warrant (or in the case of a new Warrant being issued pursuant to Section 7(a) or
Section 7(c), the Warrant Shares designated by the Holder which, when added to the number of shares of Common Stock underlying the other
new Warrants issued in connection with such issuance, does not exceed the number of Warrant Shares then underlying this Warrant), (iii)
shall have an issuance date, as indicated on the face of such new Warrant which is the same as the Issuance Date, and (iv) shall have
the same rights and conditions as this Warrant.</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify; text-indent: 1in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify; text-indent: 0.5in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">8.
<U>NOTICES</U>. Whenever notice is required to be given under this Warrant, unless otherwise provided herein, such notice shall be given
in accordance with Section 5.4 of the Securities Purchase Agreement. The Company shall provide the Holder with prompt written notice
of all actions taken pursuant to this Warrant, including in reasonable detail a description of such action and the reason therefor. Without
limiting the generality of the foregoing, the Company will give written notice to the Holder (i) immediately upon any adjustment of the
Exercise Price, setting forth in reasonable detail, and certifying, the calculation of such adjustment and (ii) at least fifteen (15)
days prior to the date on which the Company closes its books or takes a record (A) with respect to any dividend or distribution upon
the Common Stock, (B) with respect to any grants, issuances or sales of any Options, Convertible Securities or rights to purchase stock,
warrants, securities or other property to holders of Common Stock or (C) for determining rights to vote with respect to any Fundamental
Transaction, dissolution or liquidation; <U>provided</U> in each case that such information shall be made known to the public prior to
or in conjunction with such notice being provided to the Holder. It is expressly understood and agreed that the time of exercise specified
by the Holder in each Exercise Notice shall be definitive and may not be disputed or challenged by the Company.</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify; text-indent: 1in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>


<!-- Field: Page; Sequence: 8; Value: 2 -->
    <DIV STYLE="margin-bottom: 6pt; border-bottom: Black 1pt solid"><TABLE CELLPADDING="0" CELLSPACING="0" STYLE="border-collapse: collapse; width: 100%; font-size: 10pt"><TR STYLE="vertical-align: top; text-align: left"><TD STYLE="text-align: center; width: 100%"><!-- Field: Sequence; Type: Arabic; Name: PageNo -->8<!-- Field: /Sequence --></TD></TR></TABLE></DIV>
    <DIV STYLE="break-before: page; margin-top: 6pt"><P STYLE="margin: 0pt">&nbsp;</P></DIV>
    <!-- Field: /Page -->

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify; text-indent: 0.5in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">9.
<U>AMENDMENT AND WAIVER</U>. Except as otherwise provided herein, the provisions of this Warrant may be amended or waived and the Company
may take any action herein prohibited, or omit to perform any act herein required to be performed by it, only if the Company has obtained
the written consent of the Holder.</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify; text-indent: 1in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify; text-indent: 0.5in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">10.
<U>GOVERNING LAW; JURISDICTION; JURY TRIAL</U>. This Warrant shall be governed by and construed and enforced in accordance with, and
all questions concerning the construction, validity, interpretation and performance of this Warrant shall be governed by, the internal
laws of the State of New York, without giving effect to any choice of law or conflict of law provision or rule (whether of the State
of New York or any other jurisdictions) that would cause the application of the laws of any jurisdictions other than the State of New
York. The Company hereby irrevocably submits to the exclusive jurisdiction of the state and federal courts sitting in The City of New
York, Borough of Manhattan, for the adjudication of any dispute hereunder or in connection herewith or with any transaction contemplated
hereby or discussed herein, and hereby irrevocably waives, and agrees not to assert in any suit, action or proceeding, any claim that
it is not personally subject to the jurisdiction of any such court, that such suit, action or proceeding is brought in an inconvenient
forum or that the venue of such suit, action or proceeding is improper. The Company hereby irrevocably waives personal service of process
and consents to process being served in any such suit, action or proceeding by mailing a copy thereof to the Company at the address set
forth on the signature page to the Securities Purchase Agreement and agrees that such service shall constitute good and sufficient service
of process and notice thereof. Nothing contained herein shall be deemed to limit in any way any right to serve process in any manner
permitted by law. Nothing contained herein shall be deemed or operate to preclude the Holder from bringing suit or taking other legal
action against the Company in any other jurisdiction to collect on the Company&rsquo;s obligations to the Holder, to realize on any collateral
or any other security for such obligations, or to enforce a judgment or other court ruling in favor of the Holder. <B>THE COMPANY HEREBY
IRREVOCABLY WAIVES ANY RIGHT IT MAY HAVE, AND AGREES NOT TO REQUEST, A JURY TRIAL FOR THE ADJUDICATION OF ANY DISPUTE HEREUNDER OR IN
CONNECTION WITH OR ARISING OUT OF THIS WARRANT OR ANY TRANSACTION CONTEMPLATED HEREBY.</B></FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify; text-indent: 1in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify; text-indent: 0.5in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">11.
<U>CONSTRUCTION; HEADINGS</U>. This Warrant shall be deemed to be jointly drafted by the Company and all the Buyers and shall not be
construed against any Person as the drafter hereof. The headings of this Warrant are for convenience of reference and shall not form
part of, or affect the interpretation of, this Warrant.</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify; text-indent: 1in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify; text-indent: 0.5in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">12.
<U>DISPUTE RESOLUTION</U>. In the case of a dispute as to the determination of the Exercise Price or the arithmetic calculation of the
Warrant Shares, the Company shall submit the disputed determinations or arithmetic calculations via facsimile or electronic mail within
two (2) Business Days of receipt of the Exercise Notice giving rise to such dispute, as the case may be, to the Holder. If the Holder
and the Company are unable to agree upon such determination or calculation of the Exercise Price or the Warrant Shares within three (3)
Business Days of such disputed determination or arithmetic calculation being submitted to the Holder, then the Company shall, within
two (2) Business Days submit via facsimile or electronic mail (a) the disputed determination of the Exercise Price to an independent,
reputable investment bank selected by the Company and approved by the Holder or (b) the disputed arithmetic calculation of the Warrant
Shares to the Company&rsquo;s independent, outside accountant. The Company shall cause at its expense the investment bank or the accountant,
as the case may be, to perform the determinations or calculations and notify the Company and the Holder of the results no later than
ten (10) Business Days from the time it receives the disputed determinations or calculations. Such investment bank&rsquo;s or accountant&rsquo;s
determination or calculation, as the case may be, shall be binding upon all parties absent demonstrable error.</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify; text-indent: 1in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>


<!-- Field: Page; Sequence: 9; Value: 2 -->
    <DIV STYLE="margin-bottom: 6pt; border-bottom: Black 1pt solid"><TABLE CELLPADDING="0" CELLSPACING="0" STYLE="border-collapse: collapse; width: 100%; font-size: 10pt"><TR STYLE="vertical-align: top; text-align: left"><TD STYLE="text-align: center; width: 100%"><!-- Field: Sequence; Type: Arabic; Name: PageNo -->9<!-- Field: /Sequence --></TD></TR></TABLE></DIV>
    <DIV STYLE="break-before: page; margin-top: 6pt"><P STYLE="margin: 0pt">&nbsp;</P></DIV>
    <!-- Field: /Page -->

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify; text-indent: 0.5in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">13.
<U>REMEDIES, OTHER OBLIGATIONS, BREACHES AND INJUNCTIVE RELIEF</U>. The remedies provided in this Warrant shall be cumulative and in
addition to all other remedies available under this Warrant and the other Transaction Documents, at law or in equity (including a decree
of specific performance and/or other injunctive relief), and nothing herein shall limit the right of the Holder to pursue actual damages
for any failure by the Company to comply with the terms of this Warrant. The Company acknowledges that a breach by it of its obligations
hereunder will cause irreparable harm to the Holder and that the remedy at law for any such breach may be inadequate. The Company therefore
agrees that, in the event of any such breach or threatened breach, the holder of this Warrant shall be entitled, in addition to all other
available remedies, to an injunction restraining any breach, without the necessity of showing economic loss and without any bond or other
security being required.</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify; text-indent: 1in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify; text-indent: 0.5in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">14.
<U>TRANSFER</U>. This Warrant and the Warrant Shares may be offered for sale, sold, transferred, pledged or assigned without the consent
of the Company, except as may otherwise be required by Section 4.1 of the Securities Purchase Agreement.</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify; text-indent: 1in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify; text-indent: 0.5in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">15.
<U>SEVERABILITY</U>. If any provision of this Warrant is prohibited by law or otherwise determined to be invalid or unenforceable by
a court of competent jurisdiction, the provision that would otherwise be prohibited, invalid or unenforceable shall be deemed amended
to apply to the broadest extent that it would be valid and enforceable, and the invalidity or unenforceability of such provision shall
not affect the validity of the remaining provisions of this Warrant so long as this Warrant as so modified continues to express, without
material change, the original intentions of the parties as to the subject matter hereof and the prohibited nature, invalidity or unenforceability
of the provision(s) in question does not substantially impair the respective expectations or reciprocal obligations of the parties or
the practical realization of the benefits that would otherwise be conferred upon the parties. The parties will endeavor in good faith
negotiations to replace the prohibited, invalid or unenforceable provision(s) with a valid provision(s), the effect of which comes as
close as possible to that of the prohibited, invalid or unenforceable provision(s).</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify; text-indent: 1in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify; text-indent: 0.5in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">16.
<U>DISCLOSURE</U>. Upon receipt or delivery by the Company of any notice in accordance with the terms of this Warrant, unless the Company
has in good faith determined that the matters relating to such notice do not constitute material, nonpublic information relating to the
Company or its Subsidiaries (as defined in the Securities Purchase Agreement), the Company shall contemporaneously with any such receipt
or delivery publicly disclose such material, nonpublic information on a Form 8-K or otherwise. In the event that the Company believes
that a notice contains material, nonpublic information relating to the Company or its Subsidiaries, the Company so shall indicate to
the Holder contemporaneously with delivery of such notice, and in the absence of any such indication, the Holder shall be allowed to
presume that all matters relating to such notice do not constitute material, nonpublic information relating to the Company or its Subsidiaries.</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify; text-indent: 1in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify; text-indent: 0.5in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">17.
<U>CERTAIN DEFINITIONS</U>. For purposes of this Warrant, the following terms shall have the following meanings:</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify; text-indent: 1.5in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify; text-indent: 1in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">(a)
&ldquo;<B>1933 Act</B>&rdquo; means the Securities Act of 1933, as amended.</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify; text-indent: 1.5in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify; text-indent: 1in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">(b)
&ldquo;<B>Adjustment Date</B>&rdquo; means the close of trading on the Trading Day immediately after the Adjustment Period End Date.</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify; text-indent: 1.5in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>


<!-- Field: Page; Sequence: 10; Value: 2 -->
    <DIV STYLE="margin-bottom: 6pt; border-bottom: Black 1pt solid"><TABLE CELLPADDING="0" CELLSPACING="0" STYLE="border-collapse: collapse; width: 100%; font-size: 10pt"><TR STYLE="vertical-align: top; text-align: left"><TD STYLE="text-align: center; width: 100%"><!-- Field: Sequence; Type: Arabic; Name: PageNo -->10<!-- Field: /Sequence --></TD></TR></TABLE></DIV>
    <DIV STYLE="break-before: page; margin-top: 6pt"><P STYLE="margin: 0pt">&nbsp;</P></DIV>
    <!-- Field: /Page -->

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify; text-indent: 1in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">(c)
&ldquo;<B>Adjustment Period</B>&rdquo; means the period commencing on the Adjustment Period Commencement Date and ending following the
close of trading on the Adjustment Period End Date.</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify; text-indent: 1.5in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify; text-indent: 1in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">(d)
&ldquo;<B>Adjustment Period Commencement Date</B>&rdquo; means the two full Trading Days immediately preceding the Stockholder Approval
Notice Date.</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify; text-indent: 1in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify; text-indent: 1in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">(e)
&ldquo;<B>Adjustment Period End Date</B>&rdquo; means the tenth (10th) Trading Day after the Stockholder Approval Notice Date.</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify; text-indent: 1.5in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify; text-indent: 1in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">(f)
&ldquo;<B>Affiliate</B>&rdquo; shall have the meaning ascribed to such term in Rule 405 of the 1933 Act.</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify; text-indent: 1.5in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify; text-indent: 1in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">(g)
&ldquo;<B>Attribution Parties</B>&rdquo; means, collectively, the following Persons: (i) any investment vehicle, including, any funds,
feeder funds or managed accounts, currently, or from time to time after the Issuance Date, directly or indirectly managed or advised
by the Holder&rsquo;s investment manager or any of its Affiliates or principals, (ii) any direct or indirect Affiliates of the Holder
or any of the foregoing, (iii) any Person acting or who could be deemed to be acting as a Group together with the Holder or any of the
foregoing and (iv) any other Persons whose beneficial ownership of the Common Stock would or could be aggregated with the Holder&rsquo;s
and the other Attribution Parties for purposes of Section 13(d) of the 1934 Act. For clarity, the purpose of the foregoing is to subject
collectively the Holder and all other Attribution Parties to the Maximum Percentage.</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify; text-indent: 1in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">(h)
&ldquo;<B>Bloomberg</B>&rdquo; means Bloomberg Financial Markets.</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify; text-indent: 1.5in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify; text-indent: 1in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">(i)
&ldquo;<B>Business Day</B>&rdquo; means any day other than Saturday, Sunday or other day on which commercial banks in The City of New
York are authorized or required by law to remain closed.</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify; text-indent: 1.5in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify; text-indent: 1in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">(j)
&ldquo;<B>Convertible Securities</B>&rdquo; means any stock or securities (other than Options) directly or indirectly convertible into
or exercisable or exchangeable for Common Stock.</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify; text-indent: 1.5in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify; text-indent: 1in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">(k)
<B>&ldquo;Common Stock&rdquo; </B>means (i) the Company&rsquo;s common stock, par value $0.01, and (ii) any share capital into which
such Common Stock shall have been changed or any share capital resulting from a reclassification, reorganization or reclassification
of such Common Stock.</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify; text-indent: 1.5in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify; text-indent: 1in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">(l)
&ldquo;<B>Eligible Market</B>&rdquo; means the Principal Market, the NYSE American, The Nasdaq Global Select Market, The Nasdaq Capital
Market, The New York Stock Exchange, Inc., the OTCQB or the OTCQX.</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify; text-indent: 1.5in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify; text-indent: 1in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">(m)
&ldquo;<B>Expiration Date</B>&rdquo; means two and one-half (2.5) years after the date that the Company obtains the Stockholder Approval.</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify; text-indent: 1.5in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify; text-indent: 1in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">(n)
<FONT STYLE="background-color: white">&ldquo;<B>Floor Price</B>&rdquo; means a price per share equal to $[&#9679;]<SUP>1</SUP>.</FONT></FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify; text-indent: 1.5in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify; text-indent: 1in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">(o)
&ldquo;<B>Group</B>&rdquo; means a &ldquo;group&rdquo; as that term is used in Section 13(d) of the 1934 Act and as defined in Rule 13d-5
thereunder.</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify; text-indent: 1.5in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify; text-indent: 1in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">(p)
&ldquo;<B>Options</B>&rdquo; means any rights, warrants or options to subscribe for or purchase (i) Common Stock or (ii) Convertible
Securities.</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt; text-align: justify; text-indent: 0pt"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>

<!-- Field: Rule-Page --><DIV STYLE="margin-top: 0pt; margin-bottom: 0pt; width: 25%"><DIV STYLE="font-size: 1pt; border-top: Black 1pt solid">&nbsp;</DIV></DIV><!-- Field: /Rule-Page -->

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt; text-align: justify; text-indent: 0pt"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt"></FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt; text-align: justify; text-indent: 0pt"><SUP>1</SUP> <FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">Insert
20% of the closing price immediately prior to signing the SPA</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt; text-align: justify; text-indent: 0pt"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>


<!-- Field: Page; Sequence: 11; Value: 2 -->
    <DIV STYLE="margin-bottom: 6pt; border-bottom: Black 1pt solid"><TABLE CELLPADDING="0" CELLSPACING="0" STYLE="border-collapse: collapse; width: 100%; font-size: 10pt"><TR STYLE="vertical-align: top; text-align: left"><TD STYLE="text-align: center; width: 100%"><!-- Field: Sequence; Type: Arabic; Name: PageNo -->11<!-- Field: /Sequence --></TD></TR></TABLE></DIV>
    <DIV STYLE="break-before: page; margin-top: 6pt"><P STYLE="margin: 0pt">&nbsp;</P></DIV>
    <!-- Field: /Page -->

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify; text-indent: 1in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">(q)
&ldquo;<B>Person</B>&rdquo; means an individual, a limited liability company, a partnership, a joint venture, a corporation, a trust,
an unincorporated organization, any other entity and a government or any department or agency thereof.</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify; text-indent: 1.5in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify; text-indent: 1in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">(r)
&ldquo;<B>Pre-funded Warrants</B>&rdquo; shall have the meaning ascribed to such term in the Securities Purchase Agreement.</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify; text-indent: 1.5in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify; text-indent: 1in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">(s)
&ldquo;<B>Principal Market</B>&rdquo; means the national securities exchange or other trading market on which the Common Stock is primarily
listed on and quoted for trading, which, as of the Issuance Date, is the Nasdaq Capital Market.</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify; text-indent: 1.5in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify; text-indent: 1in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">(t)
[Reserved].</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify; text-indent: 1.5in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify; text-indent: 1in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">(u)
[Reserved].</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify; text-indent: 1.5in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify; text-indent: 1in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">(v)
&ldquo;<B>Required Holders</B>&rdquo; means the holders of the Warrants representing at least a majority of the shares of Common Stock
underlying the Warrants then outstanding.</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify; text-indent: 1.5in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify; text-indent: 1in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">(w)
&ldquo;<B>Stockholder Approval</B>&rdquo; means (i) such approval as may be required by the applicable rules and regulations of The Nasdaq
Stock Market LLC (or any successor entity) from the shareholders of the Company and board of directors of the Company: (a) to consent
to any adjustment to the Exercise Price and/or number of shares of Common Stock underlying this Warrant and the Warrants in the event
of an adjustment upon the Adjustment Date pursuant to Section 2(d) hereof and under the Warrants, (b) to consent to any adjustment to
the Exercise Price of this Warrant and the Warrants in the event of a voluntary adjustment pursuant to Section 2(b) hereof and under
the Warrants, and (c) to consent to the &ldquo;alternative cashless exercise&rdquo; provision of this Warrant, in each case without regard
to any limitations upon exercise of the this Warrant relating to Stockholder Approval and/or the provisions prohibiting adjustments in
such Warrants above the price set forth in clause (ii) of the definition of Floor Price; and (ii) such approval as may be required from
the shareholders of the Company and board of directors of the Company as necessary to increase the available number of authorized shares
of Common Stock of the Company to a minimum of [&#9679;] million authorized shares (such increase, the &ldquo;<B>Authorized Share Increase</B>&rdquo;).</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify; text-indent: 1.5in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify; text-indent: 1in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">(x)
&ldquo;<B>Stockholder Approval Notice</B>&rdquo; means the time of public availability of the Current Report on Form 8-K filed by the
Company with the Securities and Exchange Commission giving public notice of the Stockholder Approval.</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify; text-indent: 1.5in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify; text-indent: 1in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">(y)
&ldquo;<B>Stockholder Approval Notice Date</B>&rdquo; means the Trading Day during which the Company files a Current Report on Form 8-K
with the Securities and Exchange Commission giving public notice of the Stockholder Approval.</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify; text-indent: 1.5in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify; text-indent: 1in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">(z)
&ldquo;<B>Standard Settlement Period</B>&rdquo; means the standard settlement period, expressed in a number of Trading Days or hours,
on the Company&rsquo;s primary Eligible Market with respect to the Common Stock as in effect on the date of delivery of the applicable
Exercise Notice. As of the date of the initial issuance of this Warrant, the Standard Settlement Period is one Trading Day.</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify; text-indent: 1.5in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify; text-indent: 1in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">(aa)
&ldquo;<B>Trading Day</B>&rdquo; means any day on which the Common Stock is traded on the Principal Market, or, if the Principal Market
is not the principal trading market for the Common Stock on such day, then on the principal securities exchange or securities market
on which the Common Stock is then traded.</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify; text-indent: 1.5in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>


<!-- Field: Page; Sequence: 12; Value: 2 -->
    <DIV STYLE="margin-bottom: 6pt; border-bottom: Black 1pt solid"><TABLE CELLPADDING="0" CELLSPACING="0" STYLE="border-collapse: collapse; width: 100%; font-size: 10pt"><TR STYLE="vertical-align: top; text-align: left"><TD STYLE="text-align: center; width: 100%"><!-- Field: Sequence; Type: Arabic; Name: PageNo -->12<!-- Field: /Sequence --></TD></TR></TABLE></DIV>
    <DIV STYLE="break-before: page; margin-top: 6pt"><P STYLE="margin: 0pt">&nbsp;</P></DIV>
    <!-- Field: /Page -->

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify; text-indent: 1in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">(bb)
&ldquo;<B>Transaction Documents</B>&rdquo; means the Securities Purchase Agreement, the Warrants, the Lock-Up Agreements and all exhibits
and schedules thereto and hereto and any other documents or agreements executed in connection with the transactions contemplated hereunder.</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify; text-indent: 1.5in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify; text-indent: 1in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">(cc)
&ldquo;<B>VWAP</B>&rdquo; means, for any date, the price determined by the first of the following clauses that applies: (a) if the Common
Stock is then listed or quoted on a Trading Market, the daily volume weighted average price of the Common Stock for such date (or the
nearest preceding date) on the Trading Market on which the Common Stock is then listed or quoted as reported by Bloomberg L.P. (based
on a Trading Day from 9:30 a.m. (New York City time) to 4:02 p.m. (New York City time)), (b)&#8239; if OTCQB or OTCQX is not a Trading
Market, the volume weighted average price of the Common Stock for such date (or the nearest preceding date) on OTCQB or OTCQX as applicable,
(c) if the Common Stock is not then listed or quoted for trading on OTCQB or OTCQX and if prices for the Common Stock are then reported
on The Pink Open Market (or a similar organization or agency succeeding to its functions of reporting prices), the most recent bid price
per share of the Common Stock so reported, or (d)&#8239;in all other cases, the fair market value of a share of Common Stock as determined
by an independent appraiser selected in good faith by the Holders of a majority in interest of the Warrants then outstanding and reasonably
acceptable to the Company, the reasonable fees and expenses of which shall be paid by the Company.</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify; text-indent: 1.5in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify; text-indent: 1in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">(dd)
&ldquo;<B>Weighted Average Price</B>&rdquo; means, for any security as of any date, the dollar volume-weighted average price for such
security on the Principal Market during the period beginning at 9:30:01 a.m., New York time (or such other time as the Principal Market
publicly announces is the official open of trading), and ending at 4:00:00 p.m., New York time (or such other time as the Principal Market
publicly announces is the official close of trading), as reported by Bloomberg through its &ldquo;Volume at Price&rdquo; function or,
if the foregoing does not apply, the dollar volume-weighted average price of such security in the over-the-counter market on the electronic
bulletin board for such security during the period beginning at 9:30:01 a.m., New York time (or such other time as such market publicly
announces is the official open of trading), and ending at 4:00:00 p.m., New York time (or such other time as such market publicly announces
is the official close of trading), as reported by Bloomberg, or, if no dollar volume-weighted average price is reported for such security
by Bloomberg for such hours, the average of the highest closing bid price and the lowest closing ask price of any of the market makers
for such security as reported on the Pink Open Market. If the Weighted Average Price cannot be calculated for a security on a particular
date on any of the foregoing bases, the Weighted Average Price of such security on such date shall be the fair market value as mutually
determined by the Company and the Holder. If the Company and the Holder are unable to agree upon the fair market value of such security,
then such dispute shall be resolved pursuant to Section 12 with the term &ldquo;Weighted Average Price&rdquo; being substituted for the
term &ldquo;Exercise Price.&rdquo; All such determinations shall be appropriately adjusted for any stock dividend, stock split, stock
combination, reclassification or other similar transaction during the applicable calculation period.</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: center"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: center"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt"><I>[IMNN
Warrant Signature Pages Follow]</I></FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: center"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt"><I>&nbsp;</I></FONT></P>


<!-- Field: Page; Sequence: 13; Value: 2 -->
    <DIV STYLE="margin-bottom: 6pt; border-bottom: Black 1pt solid"><TABLE CELLPADDING="0" CELLSPACING="0" STYLE="border-collapse: collapse; width: 100%; font-size: 10pt"><TR STYLE="vertical-align: top; text-align: left"><TD STYLE="text-align: center; width: 100%"><!-- Field: Sequence; Type: Arabic; Name: PageNo -->13<!-- Field: /Sequence --></TD></TR></TABLE></DIV>
    <DIV STYLE="break-before: page; margin-top: 6pt"><P STYLE="margin: 0pt">&nbsp;</P></DIV>
    <!-- Field: /Page -->

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt"><I>&nbsp;</I></FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: center"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt"><I>[IMNN
Warrant &ndash; Company Signature Page]</I></FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt"><B>&nbsp;</B></FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify; text-indent: 0.5in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt"><B>IN
WITNESS WHEREOF,</B> the Company has caused this Warrant to Purchase Common Stock to be duly executed as of the Issuance Date set out
above.</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>

<TABLE CELLSPACING="0" CELLPADDING="0" STYLE="font: 10pt Times New Roman, Times, Serif; width: 100%; border-collapse: collapse">
  <TR STYLE="font: 10pt Times New Roman, Times, Serif; vertical-align: bottom">
    <TD STYLE="font: 10pt Times New Roman, Times, Serif"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></TD>
    <TD COLSPAN="2" STYLE="font: 10pt Times New Roman, Times, Serif"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt"><B>IMUNON,
    INC.</B></FONT></TD></TR>
  <TR STYLE="font: 10pt Times New Roman, Times, Serif; vertical-align: bottom">
    <TD STYLE="font: 10pt Times New Roman, Times, Serif"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></TD>
    <TD COLSPAN="2" STYLE="font: 10pt Times New Roman, Times, Serif"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></TD></TR>
  <TR STYLE="font: 10pt Times New Roman, Times, Serif; vertical-align: bottom">
    <TD STYLE="font: 10pt Times New Roman, Times, Serif; width: 50%"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></TD>
    <TD STYLE="font: 10pt Times New Roman, Times, Serif; width: 5%"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">By:</FONT></TD>
    <TD STYLE="border-bottom: Black 1pt solid; font: 10pt Times New Roman, Times, Serif; width: 45%"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;&nbsp;&nbsp;</FONT></TD></TR>
  <TR STYLE="font: 10pt Times New Roman, Times, Serif; vertical-align: bottom">
    <TD STYLE="font: 10pt Times New Roman, Times, Serif"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></TD>
    <TD STYLE="font: 10pt Times New Roman, Times, Serif"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">Name:</FONT></TD>
    <TD STYLE="font: 10pt Times New Roman, Times, Serif"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">Stacy
    R. Lindborg</FONT></TD></TR>
  <TR STYLE="font: 10pt Times New Roman, Times, Serif; vertical-align: bottom">
    <TD STYLE="font: 10pt Times New Roman, Times, Serif"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></TD>
    <TD STYLE="font: 10pt Times New Roman, Times, Serif"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">Title:</FONT></TD>
    <TD STYLE="font: 10pt Times New Roman, Times, Serif"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">President
    and Chief Executive Officer</FONT></TD></TR>
  </TABLE>
<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: center"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt"><B>&nbsp;</B></FONT></P>


<!-- Field: Page; Sequence: 14; Value: 2 -->
    <DIV STYLE="margin-bottom: 6pt; border-bottom: Black 1pt solid"><TABLE CELLPADDING="0" CELLSPACING="0" STYLE="border-collapse: collapse; width: 100%; font-size: 10pt"><TR STYLE="vertical-align: top; text-align: left"><TD STYLE="text-align: center; width: 100%"><!-- Field: Sequence; Type: Arabic; Name: PageNo -->14<!-- Field: /Sequence --></TD></TR></TABLE></DIV>
    <DIV STYLE="break-before: page; margin-top: 6pt"><P STYLE="margin: 0pt">&nbsp;</P></DIV>
    <!-- Field: /Page -->

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt"><B>&nbsp;</B></FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: right"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt"><B>EXHIBIT
A</B></FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: center"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt"><B>EXERCISE
NOTICE</B></FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: center"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: center"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt"><B>TO
BE EXECUTED BY THE REGISTERED HOLDER TO EXERCISE THIS </B></FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: center"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt"><B>WARRANT
TO PURCHASE COMMON STOCK</B></FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: center"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: center"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt"><B>IMUNON,
INC.</B></FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: center"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt"><B>&nbsp;</B></FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify; text-indent: 0.5in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">The
undersigned holder hereby exercises the right to purchase _________________ Common Stock (&ldquo;<B>Warrant Shares</B>&rdquo;) of Imunon,
Inc., a Delaware corporation (the &ldquo;<B>Company</B>&rdquo;), evidenced by the attached Warrant to Purchase Common Stock (the &ldquo;<B>Warrant</B>&rdquo;).
Capitalized terms used herein and not otherwise defined shall have the respective meanings set forth in the Warrant.</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify; text-indent: 0.5in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">1.
<U>Form of Exercise Price</U>. The Holder intends that payment of the Exercise Price shall be made as:</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>

<TABLE CELLSPACING="0" CELLPADDING="0" STYLE="font: 10pt Times New Roman, Times, Serif; width: 100%; border-collapse: collapse">
  <TR STYLE="font: 10pt Times New Roman, Times, Serif; vertical-align: top">
    <TD STYLE="font: 10pt Times New Roman, Times, Serif; width: 1in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">____________</FONT></TD>
    <TD STYLE="font: 10pt Times New Roman, Times, Serif; text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">a
    &ldquo;<U>Cash Exercise</U>&rdquo; with respect to _________________ Warrant Shares; and/or</FONT></TD></TR>
  <TR STYLE="font: 10pt Times New Roman, Times, Serif; vertical-align: top">
    <TD STYLE="font: 10pt Times New Roman, Times, Serif"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></TD>
    <TD STYLE="font: 10pt Times New Roman, Times, Serif; text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></TD></TR>
  <TR STYLE="font: 10pt Times New Roman, Times, Serif; vertical-align: top">
    <TD STYLE="font: 10pt Times New Roman, Times, Serif"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">____________</FONT></TD>
    <TD STYLE="font: 10pt Times New Roman, Times, Serif; text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">a
    &ldquo;<U>Cashless Exercise</U>&rdquo; with respect to _______________ Warrant Shares, resulting in a delivery obligation of the
    Company to the Holder of __________ Common Stock representing the applicable Net Number.</FONT></TD></TR>
  <TR STYLE="font: 10pt Times New Roman, Times, Serif; vertical-align: top">
    <TD STYLE="font: 10pt Times New Roman, Times, Serif"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></TD>
    <TD STYLE="font: 10pt Times New Roman, Times, Serif; text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></TD></TR>
  <TR STYLE="font: 10pt Times New Roman, Times, Serif; vertical-align: top">
    <TD STYLE="font: 10pt Times New Roman, Times, Serif"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">____________</FONT></TD>
    <TD STYLE="font: 10pt Times New Roman, Times, Serif; text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">the
    cancellation of such number of Warrant Shares as is necessary, in accordance with the provisions of subsection 1(e), to exercise
    this Warrant pursuant to the &ldquo;alternative cashless exercise&rdquo; procedure set forth in subsection 1(e).</FONT></TD></TR>
  </TABLE>
<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify; text-indent: 0.5in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">2.
Payment of Exercise Price. In the event that the holder has elected a Cash Exercise with respect to some or all of the Warrant Shares
to be issued pursuant hereto, the holder shall pay the Aggregate Exercise Price in the sum of $___________________ to the Company in
accordance with the terms of the Warrant.</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify; text-indent: 0.5in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">3.
Delivery of Warrant Shares. The Company shall deliver to the holder __________ Warrant Shares in accordance with the terms of the Warrant.</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">Date:
_______________ __, ______</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">_____________________________</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">Name
of Registered Holder</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>

<TABLE CELLSPACING="0" CELLPADDING="0" STYLE="font: 10pt Times New Roman, Times, Serif; width: 100%; border-collapse: collapse">
  <TR STYLE="font: 10pt Times New Roman, Times, Serif; vertical-align: top">
    <TD STYLE="font: 10pt Times New Roman, Times, Serif; width: 5%"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">By:</FONT></TD>
    <TD STYLE="border-bottom: Black 1pt solid; font: 10pt Times New Roman, Times, Serif; width: 45%"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></TD>
    <TD STYLE="padding-bottom: 1.5pt; font: 10pt Times New Roman, Times, Serif; width: 50%"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></TD></TR>
  <TR STYLE="font: 10pt Times New Roman, Times, Serif; vertical-align: top">
    <TD STYLE="font: 10pt Times New Roman, Times, Serif"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">Name:</FONT></TD>
    <TD STYLE="font: 10pt Times New Roman, Times, Serif"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></TD>
    <TD STYLE="font: 10pt Times New Roman, Times, Serif"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></TD></TR>
  <TR STYLE="font: 10pt Times New Roman, Times, Serif; vertical-align: top">
    <TD STYLE="font: 10pt Times New Roman, Times, Serif"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">Title:</FONT></TD>
    <TD STYLE="font: 10pt Times New Roman, Times, Serif"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></TD>
    <TD STYLE="font: 10pt Times New Roman, Times, Serif"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></TD></TR>
  </TABLE>
<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>


<!-- Field: Page; Sequence: 15; Value: 2 -->
    <DIV STYLE="margin-bottom: 6pt; border-bottom: Black 1pt solid"><TABLE CELLPADDING="0" CELLSPACING="0" STYLE="border-collapse: collapse; width: 100%; font-size: 10pt"><TR STYLE="vertical-align: top; text-align: left"><TD STYLE="text-align: center; width: 100%"><!-- Field: Sequence; Type: Arabic; Name: PageNo -->15<!-- Field: /Sequence --></TD></TR></TABLE></DIV>
    <DIV STYLE="break-before: page; margin-top: 6pt"><P STYLE="margin: 0pt">&nbsp;</P></DIV>
    <!-- Field: /Page -->

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: center"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt"><B>ACKNOWLEDGMENT</B></FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify; text-indent: 0.5in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">The
Company hereby acknowledges this Exercise Notice and hereby directs Equiniti Trust Company, LLC to issue the above indicated number of
shares of Common Stock in accordance with the Transfer Agent Instructions dated _________________________ from the Company and acknowledged
and agreed to by Equiniti Trust Company, LLC.</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>

<TABLE CELLSPACING="0" CELLPADDING="0" STYLE="font: 10pt Times New Roman, Times, Serif; width: 100%; border-collapse: collapse">
  <TR STYLE="font: 10pt Times New Roman, Times, Serif; vertical-align: top">
    <TD COLSPAN="2" STYLE="font: 10pt Times New Roman, Times, Serif"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt"><B>Imunon,
    Inc.</B></FONT></TD>
    <TD STYLE="font: 10pt Times New Roman, Times, Serif"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></TD></TR>
  <TR STYLE="font: 10pt Times New Roman, Times, Serif; vertical-align: top">
    <TD STYLE="font: 10pt Times New Roman, Times, Serif; width: 5%"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></TD>
    <TD STYLE="font: 10pt Times New Roman, Times, Serif; width: 45%"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></TD>
    <TD STYLE="font: 10pt Times New Roman, Times, Serif; width: 50%"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></TD></TR>
  <TR STYLE="font: 10pt Times New Roman, Times, Serif; vertical-align: top">
    <TD STYLE="font: 10pt Times New Roman, Times, Serif"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">By:</FONT></TD>
    <TD STYLE="border-bottom: Black 1pt solid; font: 10pt Times New Roman, Times, Serif"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></TD>
    <TD STYLE="font: 10pt Times New Roman, Times, Serif"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></TD></TR>
  <TR STYLE="font: 10pt Times New Roman, Times, Serif; vertical-align: top">
    <TD STYLE="font: 10pt Times New Roman, Times, Serif"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">Name:</FONT></TD>
    <TD STYLE="font: 10pt Times New Roman, Times, Serif"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></TD>
    <TD STYLE="font: 10pt Times New Roman, Times, Serif"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></TD></TR>
  <TR STYLE="font: 10pt Times New Roman, Times, Serif; vertical-align: top">
    <TD STYLE="font: 10pt Times New Roman, Times, Serif"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">Title:</FONT></TD>
    <TD STYLE="font: 10pt Times New Roman, Times, Serif"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></TD>
    <TD STYLE="font: 10pt Times New Roman, Times, Serif"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></TD></TR>
  </TABLE>
<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>


<!-- Field: Page; Sequence: 16; Options: Last -->
    <DIV STYLE="margin-bottom: 6pt; border-bottom: Black 1pt solid"><TABLE CELLPADDING="0" CELLSPACING="0" STYLE="border-collapse: collapse; width: 100%; font-size: 10pt"><TR STYLE="vertical-align: top; text-align: left"><TD STYLE="text-align: center; width: 100%"><!-- Field: Sequence; Type: Arabic; Name: PageNo -->16<!-- Field: /Sequence --></TD></TR></TABLE></DIV>
    <!-- Field: /Page -->

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>

</BODY>
</HTML>
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>EX-5.1
<SEQUENCE>4
<FILENAME>ex5-1.htm
<DESCRIPTION>EX-5.1
<TEXT>
<HTML>
<HEAD>
     <TITLE></TITLE>
</HEAD>
<BODY STYLE="font: 10pt Times New Roman, Times, Serif">

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt">&nbsp;</P>

<P STYLE="text-align: right; font: 10pt Times New Roman, Times, Serif; margin: 0pt"><B>Exhibit 5.1</B></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; text-align: center; margin-top: 0pt; margin-bottom: 0pt">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; text-align: center; margin-top: 0pt; margin-bottom: 0pt"><IMG SRC="ex5-1_001.jpg" ALT="" STYLE="width: 720px"></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">May
12, 2025</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">Imunon,
Inc.</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">997
Lenox Drive, Suite 100</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">Lawrenceville,
New Jersey 08648</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>

<TABLE CELLPADDING="0" CELLSPACING="0" BORDER="0" STYLE="width: 100%; margin-top: 0pt; margin-bottom: 0pt; font: 10pt Times New Roman, Times, Serif">
<TR STYLE="vertical-align: top">
  <TD STYLE="width: 0.5in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt"><B>Re:</B></FONT></TD>
  <TD><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt"><B>Registration Statement on Form S-1, as amended (File
  No. 333-286403)</B></FONT></TD></TR>
</TABLE>


<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">Ladies
and Gentlemen:</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt; text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">We
have acted as counsel for Imunon, Inc., a Delaware corporation (the &ldquo;<U>Company</U>&rdquo;), in connection with the preparation
and filing of a Registration Statement on Form S-1 (File No. 333-286403) (the &ldquo;<U>Registration Statement</U>&rdquo;), including
a related prospectus filed with the Registration Statement (the <U>&ldquo;Prospectus</U>&rdquo;), with the U.S. Securities and Exchange
Commission (the &ldquo;<U>Commission</U>&rdquo;) pursuant to the Securities Act of 1933, as amended (the &ldquo;<U>Securities Act</U>&rdquo;),
covering a proposed offering of $12,000,000 in securities, consisting of (i) shares (the &ldquo;<U>Shares</U>&rdquo;)
of the Company&rsquo;s common stock, par value $0.01 per share (the &ldquo;<U>Common Stock</U>&rdquo;), or pre-funded warrants
(the &ldquo;<U>Pre-Funded Warrants </U> &rdquo;), each having the right to purchase one share of Common Stock (&ldquo;<U>Pre-Funded
</U> <U>Warrant Shares </U> &rdquo;), in lieu of Shares, and (ii) common warrants (the &ldquo;<U>Common
Warrants</U>&rdquo; and, together with the Pre-Funded Warrants, the &ldquo;<U>Warrants</U>&rdquo;) to purchase shares of Common
Stock (&ldquo;<U>Common Warrant Shares</U>&rdquo; and, together with the Pre-Funded Warrant Shares, the &ldquo;<U>Warrant Shares</U>&rdquo;).
As noted in the Registration Statement, for each Pre-Funded Warrant sold, the number of Shares sold will be decreased on a one-for-one
basis. </FONT><P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt; text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt; text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">In
connection with this opinion, we have examined originals or copies (certified or otherwise identified to our satisfaction) of (i) the
Company&rsquo;s Amended and Restated Certificate of Incorporation, (ii) the Company&rsquo;s Amended and Restated Bylaws, (iii) the Registration
Statement and the Prospectus, (iv) the form of Common Warrant, (v) the form of Pre-Funded Warrant, and (vi) such corporate records, agreements,
documents, and other instruments, and such certificates or comparable documents of public officials or of officers and representatives
of the Company, as we have deemed relevant and necessary as a basis for the opinion hereinafter set forth.</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt; text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt; text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">In
such examination, we have assumed the genuineness of all signatures, the legal capacity of all natural persons, the authenticity of all
documents submitted to us as originals, the conformity to original documents of all documents submitted to us as certified, conformed
or photostatic copies, and the authenticity of the originals of such latter documents. As to certain questions of fact material to this
opinion, we have relied upon certificates or comparable documents of officers and representatives of the Company and have not sought
to independently verify such facts. For purposes of the opinion set forth in subsection (iii) in the following paragraph, we have assumed
that upon issuance of any of the Shares or Warrant Shares, the total number of shares of Common Stock issued and outstanding
will not exceed the total number of shares of Common Stock that the Company is then authorized to issue under the Amended
and Restated Certificate of Incorporation. With respect to the Warrants and the Warrant Shares, we express no opinion to the extent that,
notwithstanding the Company&rsquo;s current reservation of shares of Common Stock, future issuances of securities of the Company,
including the Warrant Shares and/or antidilution adjustments to outstanding securities of the Company, including the Warrants, may cause
the Warrants to be exercisable for more shares of Common Stock than the number that then remain authorized but unissued. Please note
that the Common Warrant Shares are not issuable upon exercise of the Common Warrants until the Company has filed an amendment to its
Amended and Restated Certificate of Incorporation with the Secretary of State of the State of Delaware following receipt of stockholder
approval of, among other things, an increase in the number of authorized shares of Common Stock, as described in  the
Common Warrants.</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt; text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt; text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">Based
on the foregoing, and subject to the assumptions, limitations and qualifications stated herein, we are of the opinion that (i) the Shares,
when duly issued and sold by the Company as contemplated in the Registration Statement and the Prospectus, will be validly issued, fully
paid, and non-assessable, (ii) the Warrants, when duly issued and sold by Company as contemplated in the Registration Statement and the
Prospectus, will constitute the legal, valid, and binding obligations of the Company, enforceable against the Company in accordance with
their terms, and (iii) the Warrant Shares have been duly authorized and, when issued upon the due exercise of the Warrants, will be validly
issued, fully paid, and non-assessable.</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; text-align: center"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; text-align: center"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt"><IMG SRC="ex5-1_002.jpg" ALT="" STYLE="width: 720px">&nbsp;</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt; text-align: justify"></P>

<!-- Field: Page; Sequence: 1 -->
    <DIV STYLE="margin-bottom: 6pt"><TABLE CELLPADDING="0" CELLSPACING="0" STYLE="border-bottom: Black 1pt solid; border-collapse: collapse; width: 100%; font-size: 10pt"><TR STYLE="vertical-align: top; text-align: left"><TD STYLE="width: 100%">&nbsp;</TD></TR></TABLE></DIV>
    <DIV STYLE="break-before: page; margin-top: 6pt"><P STYLE="margin: 0pt">&nbsp;</P></DIV>
    <!-- Field: /Page -->

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; text-align: center"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; text-align: center"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt"><IMG SRC="ex5-1_003.jpg" ALT="" STYLE="width: 720px">&nbsp;</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt; text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">The
opinion expressed herein is limited to the General Corporation Law of the State of Delaware and, with respect to the enforceability of
the Warrants, the laws of the State of New York, and we express no opinion as to the effect on the matters covered by this opinion of
the laws of any other jurisdiction. We express no opinion as to (a) any provision for liquidated damages, default interest, late charges,
monetary penalties, make-whole premiums or other economic remedies to the extent such provisions are deemed to constitute a penalty,
(b) consents to, or restrictions upon, governing law, jurisdiction, venue, arbitration, remedies or judicial relief, (c) waivers of rights
or defenses, (d) any provision requiring the payment of attorneys&rsquo; fees, where such payment is contrary to law or public policy,
(e) the creation, validity, attachment, perfection or priority of any lien or security interest, (f) advance waivers of claims, defenses,
rights granted by law or notice, opportunity for hearing, evidentiary requirements, statutes of limitation, trial by jury or at law or
other procedural rights, (g) waivers of broadly or vaguely stated rights, (h) provisions for exclusivity, election or cumulation of rights
or remedies, (i) provisions authorizing or validating conclusive or discretionary determinations, (j) grants of setoff rights, (k) proxies,
powers and trusts, (l) provisions prohibiting, restricting or requiring consent to assignment or transfer of any right or property and
(m) the severability, if invalid, of provisions to the foregoing effect. Our opinions set forth above are subject to bankruptcy, insolvency,
fraudulent transfer, reorganization, moratorium and other similar laws of general application affecting the rights and remedies of creditors
and to general principles of equity.</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt; text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt; text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">This
opinion letter is expressly limited to the matters set forth above, and we render no opinion, whether by implication or otherwise, as
to any other matters relating to the Company, the Registration Statement or the Prospectus.</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt; text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>

<P STYLE="text-align: justify; font: 10pt Times New Roman, Times, Serif; margin: 0pt"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">We
hereby consent to being named in the Registration Statement and in the Prospectus under the caption &ldquo;Legal Matters&rdquo; and to
the use of this opinion for filing with said Registration Statement as Exhibit 5.1 thereto. In giving this consent, we do not hereby
admit that we are within the category of persons whose consent is required under Section 7 of the Securities Act of 1933, as amended,
or the rules and regulations of the Commission promulgated thereunder.</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">Very
truly yours,</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt"><I>/s/
Thompson Hine LLP</I></FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt"><I>&nbsp;</I></FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">Thompson
Hine LLP</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt"></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt"></P>

<!-- Field: Page; Sequence: 2; Options: Last -->
    <DIV STYLE="margin-bottom: 6pt"><TABLE CELLPADDING="0" CELLSPACING="0" STYLE="border-bottom: Black 1pt solid; border-collapse: collapse; width: 100%; font-size: 10pt"><TR STYLE="vertical-align: top; text-align: left"><TD STYLE="width: 100%">&nbsp;</TD></TR></TABLE></DIV>
    <!-- Field: /Page -->

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>

</BODY>
</HTML>
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>EX-10.30
<SEQUENCE>5
<FILENAME>ex10-30.htm
<DESCRIPTION>EX-10.30
<TEXT>
<HTML>
<HEAD>
     <TITLE></TITLE>
</HEAD>
<BODY STYLE="font: 10pt Times New Roman, Times, Serif">

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: right"><B>&nbsp;</B></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: right"><B>Exhibit 10.30</B></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: right"><B>&nbsp;</B></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: center"><B>SECURITIES PURCHASE AGREEMENT</B></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify; text-indent: 0.5in">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify; text-indent: 0.5in">This Securities Purchase Agreement
(this &ldquo;<U>Agreement</U>&rdquo;) is dated as of [&#9679;], 2025, between Imunon, Inc., a Delaware corporation (the &ldquo;<U>Company</U>&rdquo;),
and each purchaser identified on the signature pages hereto (each, including its successors and assigns, a &ldquo;<U>Purchaser</U>&rdquo;
and collectively the &ldquo;<U>Purchasers</U>&rdquo;).</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify; text-indent: 0.5in">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify; text-indent: 0.5in">WHEREAS, subject to the terms
and conditions set forth in this Agreement and pursuant to an effective registration statement under the Securities Act (as defined below),
the Company desires to issue and sell to each Purchaser, and each Purchaser, severally and not jointly, desires to purchase from the Company,
securities of the Company as more fully described in this Agreement.</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify; text-indent: 0.5in">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify; text-indent: 0.5in">NOW, THEREFORE, IN CONSIDERATION
of the mutual covenants contained in this Agreement, and for other good and valuable consideration the receipt and adequacy of which are
hereby acknowledged, the Company and each Purchaser agree as follows:</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: center"><B>&nbsp;</B></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: center"><B>ARTICLE I.</B></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: center"><B>DEFINITIONS</B></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: center"><B>&nbsp;</B></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify">1.1 <U>Definitions</U>. In addition to the terms defined
elsewhere in this Agreement, for all purposes of this Agreement, the following terms have the meanings set forth in this Section 1.1:</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify; text-indent: 0.5in">&ldquo;<U>Acquiring Person</U>&rdquo;
shall have the meaning ascribed to such term in Section 4.5.</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify; text-indent: 0.5in">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify; text-indent: 0.5in">&ldquo;<U>Action</U>&rdquo; shall
have the meaning ascribed to such term in Section 3.1(j).</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify; text-indent: 0.5in">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify; text-indent: 0.5in">&ldquo;<U>Affiliate</U>&rdquo;
means any Person that, directly or indirectly through one or more intermediaries, controls or is controlled by or is under common control
with a Person as such terms are used in and construed under Rule 405 under the Securities Act.</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify; text-indent: 0.5in">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify; text-indent: 0.5in">&ldquo;<U>Board of Directors</U>&rdquo;
means the board of directors of the Company.</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify; text-indent: 0.5in">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify; text-indent: 0.5in">&ldquo;<U>Business
Day</U>&rdquo; means any day other than Saturday, Sunday, or other day on which banking institutions in the State of New York are authorized
or required by law to remain closed.</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify; text-indent: 0.5in">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify; text-indent: 0.5in">&ldquo;<U>Closing</U>&rdquo; means
the closing of the purchase and sale of the Shares and Warrants pursuant to Section 2.1.</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify; text-indent: 0.5in">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify; text-indent: 0.5in">&ldquo;<U>Closing Date</U>&rdquo;
means the Trading Day on which all of the Transaction Documents have been executed and delivered by the applicable parties thereto, and
all conditions precedent to (i) the Purchasers&rsquo; obligations to pay the Subscription Amount at the Closing and (ii) the Company&rsquo;s
obligations to deliver the Shares and Warrants, in each case, at the Closing have been satisfied or waived, but in no event later than
the first (1st) Trading Day following the date hereof if this Agreement is entered into before 4:00 p.m. Eastern time on a Trading Day,
or not later than the second (2<SUP>nd</SUP>)Trading Day following the date hereof, if this Agreement is entered at or after 4:00 p.m.
Eastern time on a Trading day or on a day that is not a Trading Day.</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify; text-indent: 0.5in">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify; text-indent: 0.5in">&ldquo;<U>Commission</U>&rdquo;
means the United States Securities and Exchange Commission.</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify; text-indent: 0.5in">&nbsp;</P>


<!-- Field: Page; Sequence: 1 -->
    <DIV STYLE="margin-bottom: 6pt; border-bottom: Black 1pt solid"><TABLE CELLPADDING="0" CELLSPACING="0" STYLE="border-collapse: collapse; width: 100%; font-size: 10pt"><TR STYLE="vertical-align: top; text-align: left"><TD STYLE="text-align: center; width: 100%"><!-- Field: Sequence; Type: Arabic; Name: PageNo -->1<!-- Field: /Sequence --></TD></TR></TABLE></DIV>
    <DIV STYLE="break-before: page; margin-top: 6pt"><P STYLE="margin: 0pt">&nbsp;</P></DIV>
    <!-- Field: /Page -->

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify; text-indent: 0.5in">&ldquo;<U>Common Stock</U>&rdquo;
means common stock of the Company, par value $0.01 per share.</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify; text-indent: 0.5in">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify; text-indent: 0.5in">&ldquo;<U>Common Stock Equivalents</U>&rdquo;
means any securities of the Company or the Subsidiaries which would entitle the holder thereof to acquire at any time Common Stock, including,
without limitation, any debt, preferred stock, right, option, warrant or other instrument that is at any time convertible into or exercisable
or exchangeable for, or otherwise entitles the holder thereof to receive, Common Stock.</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify; text-indent: 0.5in">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify; text-indent: 0.5in">&ldquo;<U>Common Warrants</U>&rdquo;
means, collectively, the Common Stock purchase warrants delivered to the Purchasers at the Closing in accordance with Section 2.2(a) hereof,
in substantially the form of Exhibit A attached hereto.</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify; text-indent: 0.5in">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify; text-indent: 0.5in">&ldquo;<U>Company Counsel</U>&rdquo;
means Thompson Hine LLP, with offices located at 3900 Key Center, 127 Public Square, Cleveland, Ohio 44114.</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify; text-indent: 0.5in">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify; text-indent: 0.5in">&ldquo;<U>Disclosure Schedules</U>&rdquo;
means the Disclosure Schedules of the Company delivered concurrently herewith.</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify; text-indent: 0.5in">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify; text-indent: 0.5in">&ldquo;<U>Disclosure Time</U>&rdquo;
means, (i) if this Agreement is signed on a day that is not a Trading Day or after 9:00 a.m. (New York City time) and before midnight
(New York City time) on any Trading Day, 9:01 a.m. (New York City time) on the Trading Day immediately following the date hereof, unless
otherwise instructed as to an earlier time by the Placement Agent, and (ii) if this Agreement is signed between midnight (New York City
time) and 9:00 a.m. (New York City time) on any Trading Day, no later than 9:01 a.m. (New York City time) on the date hereof, unless otherwise
instructed as to an earlier time by the Placement Agent.</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify; text-indent: 0.5in">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify; text-indent: 0.5in">&ldquo;<U>DVP</U>&rdquo; shall
have the meaning ascribed to such term in Section 2.1.</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify; text-indent: 0.5in">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify; text-indent: 0.5in">&ldquo;<U>Evaluation Date</U>&rdquo;
shall have the meaning ascribed to such term in Section 3.1(s).</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify; text-indent: 0.5in">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify; text-indent: 0.5in">&ldquo;<U>Exchange Act</U>&rdquo;
means the Securities Exchange Act of 1934, as amended, and the rules and regulations promulgated thereunder.</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify; text-indent: 0.5in">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify; text-indent: 0.5in">&ldquo;<U>Exempt Issuance</U>&rdquo;
means the issuance of (a) shares of Common Stock, restricted stock units, options or other equity awards to employees, consultants, officers,
or directors of the Company pursuant to any share or option plan in existence as of the date hereof or subsequently approved by a vote
of the stockholders of the Company, (b) shares of Common Stock upon the exercise or exchange of or conversion of any Securities issued
hereunder and other securities exercisable or exchangeable for or convertible into shares of Common Stock issued and outstanding on the
date of this Agreement, provided that such securities have not been amended since the date of this Agreement to increase the number of
such securities or to decrease the exercise price, exchange price or conversion price of such securities (other than in connection with
stock splits or combinations) or to extend the term (but not, for purposes of clarity, the exercise period of stock options) of such securities,
(c) securities issued pursuant to acquisitions or strategic transactions approved by a majority of the disinterested directors of the
Company, provided that such securities are issued as &ldquo;restricted securities&rdquo; (as defined in Rule 144) and carry no registration
rights that require or permit the filing of any registration statement in connection therewith during the prohibition period in Section
4.10(a) herein, and provided that any such issuance shall only be to a Person (or to the equity holders of a Person) which is, itself
or through its subsidiaries, an operating company or an owner of an asset in a business synergistic with the business of the Company and
shall provide to the Company additional benefits in addition to the investment of funds, but shall not include a transaction in which
the Company is issuing securities primarily for the purpose of raising capital or to an entity whose primary business is investing in
securities (for avoidance of doubt, securities issued to a venture arm of a strategic investor shall be deemed an &ldquo;Exempt Issuance&rdquo;),
(d) issuances of shares of Common Stock to consultants or vendors of the Company, provided that such securities are issued as &ldquo;restricted
securities&rdquo; (as defined in Rule 144) and carry no registration rights during the prohibition period in Section 4.10(a) herein; and
(e) issuances of shares of Common Stock to existing holders of the Company&rsquo;s securities in compliance with the terms of agreements
entered into with, or instruments issued to, such holders as of or prior to the date hereof, provided that such agreements regarding such
securities have not been amended since the date of this Agreement to increase the number of such securities or to decrease the exercise
price, exchange price or conversion price of such securities (other than in connection with stock splits or combinations) or to extend
the term of such securities, and provided further that such securities are issued as &ldquo;restricted securities&rdquo; (as defined in
Rule 144) and carry no registration rights during the prohibition period in Section 4.10(a) herein.</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify; text-indent: 0.5in">&nbsp;</P>


<!-- Field: Page; Sequence: 2 -->
    <DIV STYLE="margin-bottom: 6pt; border-bottom: Black 1pt solid"><TABLE CELLPADDING="0" CELLSPACING="0" STYLE="border-collapse: collapse; width: 100%; font-size: 10pt"><TR STYLE="vertical-align: top; text-align: left"><TD STYLE="text-align: center; width: 100%"><!-- Field: Sequence; Type: Arabic; Name: PageNo -->2<!-- Field: /Sequence --></TD></TR></TABLE></DIV>
    <DIV STYLE="break-before: page; margin-top: 6pt"><P STYLE="margin: 0pt">&nbsp;</P></DIV>
    <!-- Field: /Page -->

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify; text-indent: 0.5in">&ldquo;<U>FCPA</U>&rdquo; means
the Foreign Corrupt Practices Act of 1977, as amended.</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify; text-indent: 0.5in">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify; text-indent: 0.5in">&ldquo;<U>GAAP</U>&rdquo; means
generally accepted accounting principles in the United States.</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify; text-indent: 0.5in">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify; text-indent: 0.5in">&ldquo;<U>Indebtedness</U>&rdquo;
shall have the meaning ascribed to such term in Section 3.1(aa).</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify; text-indent: 0.5in">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify; text-indent: 0.5in">&ldquo;<U>Intellectual Property
Rights</U>&rdquo; shall have the meaning ascribed to such term in Section 3.1(p).</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify; text-indent: 0.5in">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify; text-indent: 0.5in">&ldquo;<U>Liens</U>&rdquo; means
a lien, charge, pledge, security interest, encumbrance, right of first refusal, preemptive right or other restriction.</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify; text-indent: 0.5in">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify; text-indent: 0.5in">&ldquo;<U>Lock-Up Agreement</U>&rdquo;
means the Lock-Up Agreement, dated as of the date hereof, signed by the directors and officers of the Company, in the form of <U>Exhibit
C</U> attached hereto.</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify; text-indent: 0.5in">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify; text-indent: 0.5in">&ldquo;<U>Material Adverse Effect</U>&rdquo;
shall have the meaning assigned to such term in Section 3.1(b).</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify; text-indent: 0.5in">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify; text-indent: 0.5in">&ldquo;<U>Material Permits</U>&rdquo;
shall have the meaning ascribed to such term in Section 3.1(n).</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify; text-indent: 0.5in">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify; text-indent: 0.5in">&ldquo;<U>Per Share Purchase Price</U>&rdquo;
equals $[___], subject to adjustment for reverse and forward stock splits, stock dividends, stock combinations and other similar transactions
of shares of Common Stock that occur between the date hereof and the Closing Date.</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify; text-indent: 0.5in">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify; text-indent: 0.5in">&ldquo;<U>Per Pre-Funded Warrant
Purchase Price</U>&rdquo; equals $[___], subject to adjustment for reverse and forward stock splits, stock dividends, stock combinations
and other similar transactions relating to shares of Common Stock that occur after the date of this Agreement.</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify; text-indent: 0.5in">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify; text-indent: 0.5in">&ldquo;<U>Person</U>&rdquo; means
an individual or corporation, partnership, trust, incorporated or unincorporated association, joint venture, limited liability company,
joint stock company, government (or an agency or subdivision thereof) or other entity of any kind.</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify; text-indent: 0.5in">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify; text-indent: 0.5in">&ldquo;<U>Placement Agent</U>&rdquo;
means Brookline Capital Markets, LLC.</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify; text-indent: 0.5in">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify; text-indent: 0.5in">&ldquo;<U>Placement Agent Counsel</U>&rdquo;
means Sullivan &amp; Worcester LLP, with offices located at 1251 Avenue of the Americas, 19<SUP>th</SUP> Floor, New York, New York 10020.</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify; text-indent: 0.5in">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify; text-indent: 0.5in">&ldquo;<U>Pre-Funded Warrants</U>&rdquo;
means, collectively, the pre-funded warrants delivered to the Purchasers at Closing in accordance with Section 2.2(a) hereof, which Pre-Funded
Warrants shall be exercisable immediately upon issuance and shall expire in accordance with the terms thereof, in the form of <U>Exhibit
B</U> attached hereto.</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify; text-indent: 0.5in">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify; text-indent: 0.5in">&ldquo;<U>Preliminary Prospectus</U>&rdquo;
means any preliminary prospectus included in the Registration Statement, as originally filed or as part of any amendment thereto, or filed
with the Commission pursuant to Rule 424(a) of the rules and regulations of the Commission under the Securities Act.</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify; text-indent: 0.5in">&nbsp;</P>


<!-- Field: Page; Sequence: 3 -->
    <DIV STYLE="margin-bottom: 6pt; border-bottom: Black 1pt solid"><TABLE CELLPADDING="0" CELLSPACING="0" STYLE="border-collapse: collapse; width: 100%; font-size: 10pt"><TR STYLE="vertical-align: top; text-align: left"><TD STYLE="text-align: center; width: 100%"><!-- Field: Sequence; Type: Arabic; Name: PageNo -->3<!-- Field: /Sequence --></TD></TR></TABLE></DIV>
    <DIV STYLE="break-before: page; margin-top: 6pt"><P STYLE="margin: 0pt">&nbsp;</P></DIV>
    <!-- Field: /Page -->

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify; text-indent: 0.5in">&ldquo;<U>Proceeding</U>&rdquo;
means an action, claim, suit, investigation or proceeding (including, without limitation, an informal investigation or partial proceeding,
such as a deposition), whether commenced or threatened.</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify; text-indent: 0.5in">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify; text-indent: 0.5in">&ldquo;<U>Prospectus</U>&rdquo;
means the final prospectus filed pursuant to Rule 424(b) under the Securities Act.</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify; text-indent: 0.5in">&ldquo;<U>Purchaser Party</U>&rdquo;
shall have the meaning ascribed to such term in Section 4.8.</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify; text-indent: 0.5in">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify; text-indent: 0.5in">&ldquo;<U>Registration Statement</U>&rdquo;
means the effective registration statement filed with the Commission on Form S-1 (File No. 333-286403), including all information, documents
and exhibits filed with or incorporated by reference into such registration statement, which registers the sale of the Securities and
includes any Rule 462(b) Registration Statement.</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify; text-indent: 0.5in">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify; text-indent: 0.5in">&ldquo;<U>Required Approvals</U>&rdquo;
shall have the meaning ascribed to such term in Section 3.1(e).</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify; text-indent: 0.5in">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify; text-indent: 0.5in">&ldquo;<U>Rule 144</U>&rdquo;
means Rule 144 promulgated by the Commission pursuant to the Securities Act, as such Rule may be amended or interpreted from time to time,
or any similar rule or regulation hereafter adopted by the Commission having substantially the same purpose and effect as such Rule.</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify; text-indent: 0.5in">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify; text-indent: 0.5in">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify; text-indent: 0.5in">&ldquo;<U>Rule 462(b) Registration
Statement</U>&rdquo; means any registration statement prepared by the Company registering additional Securities, which was filed with
the Commission on or prior to the date hereof and became automatically effective pursuant to Rule 462(b) promulgated by the Commission
pursuant to the Securities Act.</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify; text-indent: 0.5in">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify; text-indent: 0.5in">&ldquo;<U>SEC Reports</U>&rdquo;
shall have the meaning ascribed to such term in Section 3.1(h).</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify; text-indent: 0.5in">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify; text-indent: 0.5in">&ldquo;<U>Securities</U>&rdquo;
means the Shares, the Warrants, and the Warrant Shares.</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify; text-indent: 0.5in">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify; text-indent: 0.5in">&ldquo;<U>Securities Act</U>&rdquo;
means the Securities Act of 1933, as amended, and the rules and regulations promulgated thereunder.</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify; text-indent: 0.5in">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify; text-indent: 0.5in">&ldquo;<U>Shares</U>&rdquo; means
the shares of Common Stock issued and issuable to each Purchaser pursuant to this Agreement.</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify; text-indent: 0.5in">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify; text-indent: 0.5in">&ldquo;<U>Short Sales</U>&rdquo;
means all &ldquo;short sales&rdquo; as defined in Rule 200 of Regulation SHO under the Exchange Act (but shall not be deemed to include
locating and/or borrowing shares of Common Stock).</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify; text-indent: 0.5in">&nbsp;</P>

<P STYLE="font: 11pt Times New Roman, Times, Serif; margin: 0; text-align: justify; text-indent: 0.5in">&ldquo;<U>Stockholder Approval</U>&rdquo;
shall have the meaning ascribed to such term in the Common Warrant.</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify; text-indent: 0.5in">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify; text-indent: 0.5in">&ldquo;<U>Stockholder Approval Notice</U>&rdquo; shall have the meaning ascribed to such term in the Common Warrant.</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify; text-indent: 0.5in">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify; text-indent: 0.5in">&ldquo;<U>Stockholder Approval Notice Date</U>&rdquo; shall have the meaning ascribed to such term in the Common
Warrant.</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify; text-indent: 0.5in">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify; text-indent: 0.5in">&ldquo;<U>Subscription Amount</U>&rdquo;
means, as to each Purchaser, the aggregate amount to be paid for Shares and Warrants, purchased hereunder as specified below such Purchaser&rsquo;s
name on the signature page of this Agreement and next to the heading &ldquo;Subscription Amount,&rdquo; in United States dollars and in
immediately available funds.</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify; text-indent: 0.5in">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify; text-indent: 0.5in">&ldquo;<U>Subsidiary</U>&rdquo;
means any subsidiary of the Company as set forth on Schedule 3.1(a), and shall, where applicable, also include any direct or indirect
subsidiary of the Company formed or acquired after the date hereof.</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify; text-indent: 0.5in">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify; text-indent: 0.5in">&ldquo;<U>Trading Day</U>&rdquo;
means a day on which the principal Trading Market is open for trading.</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify; text-indent: 0.5in">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify; text-indent: 0.5in">&ldquo;<U>Trading Market</U>&rdquo;
means any of the following markets or exchanges on which the shares of Common Stock are listed or quoted for trading on the date in question:
the NYSE American, the Nasdaq Capital Market, the Nasdaq Global Market, the Nasdaq Global Select Market, or the New York Stock Exchange
(or any successors to any of the foregoing).</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify; text-indent: 0.5in">&nbsp;</P>


<!-- Field: Page; Sequence: 4 -->
    <DIV STYLE="margin-bottom: 6pt; border-bottom: Black 1pt solid"><TABLE CELLPADDING="0" CELLSPACING="0" STYLE="border-collapse: collapse; width: 100%; font-size: 10pt"><TR STYLE="vertical-align: top; text-align: left"><TD STYLE="text-align: center; width: 100%"><!-- Field: Sequence; Type: Arabic; Name: PageNo -->4<!-- Field: /Sequence --></TD></TR></TABLE></DIV>
    <DIV STYLE="break-before: page; margin-top: 6pt"><P STYLE="margin: 0pt">&nbsp;</P></DIV>
    <!-- Field: /Page -->

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify; text-indent: 0.5in">&ldquo;<U>Transaction Documents</U>&rdquo;
means this Agreement, the Warrants, the Lock-Up Agreements and all exhibits and schedules thereto and hereto and any other documents or
agreements executed in connection with the transactions contemplated hereunder.</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify; text-indent: 0.5in">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify; text-indent: 0.5in">&ldquo;<U>Transfer Agent</U>&rdquo;
means <FONT STYLE="background-color: white">Equiniti Trust Company, LLC. Equiniti Trust Company, LLC is located at 6201 15th Avenue, Brooklyn,
NY 11219. </FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify; text-indent: 0.5in">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify; text-indent: 0.5in">&ldquo;<U>Variable Rate Transaction</U>&rdquo;
shall have the meaning ascribed to such term in Section 4.10(b).</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify; text-indent: 0.5in">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify; text-indent: 0.5in">&ldquo;<U>Warrants</U>&rdquo;
means, collectively, the Common Warrants and the Pre-Funded Warrants.</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify; text-indent: 0.5in">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify; text-indent: 0.5in">&ldquo;<U>Warrant Shares</U>&rdquo;
means the shares of Common Stock issuable upon exercise of the Warrants.</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: center"><B>&nbsp;</B></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: center"><B>ARTICLE II.</B></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: center"><B>PURCHASE AND SALE</B></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: center"><B>&nbsp;</B></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify">2.1 <U>Closing</U>. On the Closing Date, upon the
terms and subject to the conditions set forth herein, substantially concurrent with the execution and delivery of this Agreement by the
parties hereto, the Company agrees to sell, and the Purchasers, severally and not jointly, agree to purchase, (i) the number of shares
of Common Stock set forth under the heading &ldquo;Subscription Amount&rdquo; on the Purchaser&rsquo;s signature page hereto, at the Per
Share Purchase Price, and (ii) Common Warrants exercisable for shares of Common Stock as calculated pursuant to Section 2.2(a); provided,
however, that, to the extent that a Purchaser determines, in its sole discretion, that such Purchaser (together with such Purchaser&rsquo;s
Affiliates, and any Person acting as a group together with such Purchaser or any of such Purchaser&rsquo;s Affiliates) would beneficially
own in excess of the Beneficial Ownership Limitation, or as such Purchaser may otherwise choose, in lieu of purchasing shares of Common
Stock, such Purchaser may elect to purchase Pre-Funded Warrants in lieu of shares of Common Stock in such manner to result in the full
Subscription Amount being paid by such Purchaser to the Company. The &ldquo;<U>Beneficial Ownership Limitation</U>&rdquo; shall be 4.99%
(or, at the election of the Purchaser, 9.99%) of the number of shares of Common Stock, in each case, outstanding immediately after giving
effect to the issuance of the Securities on the Closing Date.</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify; text-indent: 0.5in">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify; text-indent: 0.5in">Each Purchaser&rsquo;s Subscription
Amount as set forth on the signature page hereto executed by such Purchaser shall be made available for Delivery Versus Payment (&ldquo;<U>DVP</U>&rdquo;)
settlement with the Company or its designees. The Company shall deliver to each Purchaser its respective Shares and Warrants as determined
pursuant to Section 2.2(a), and the Company and each Purchaser shall deliver the other items set forth in Section 2.2 at the Closing.
Upon satisfaction of the covenants and conditions set forth in Sections 2.2 and 2.3, the Closing shall occur at the offices of the Placement Agent
or such other location as the parties shall mutually agree. Unless otherwise directed by the Placement Agent, settlement of the Shares
shall occur via DVP (i.e., on the Closing Date, the Company shall issue the Shares registered in the Purchasers&rsquo; names and addresses
and released by the Transfer Agent directly to the account(s) at the Placement Agent identified by each Purchaser; upon receipt of such
Shares, the Placement Agent shall promptly electronically deliver such Shares to the applicable Purchaser, and payment therefor shall
be made by the Placement Agent (or one of their clearing firms) by wire transfer to the Company). Notwithstanding anything herein to
the contrary, if at any time on or after the time of execution of this Agreement by the Company and an applicable Purchaser through the
Closing (the &ldquo;<U>Pre-Settlement Period</U>&rdquo;), such Purchaser sells to any Person all, or any portion, of any Shares to be
issued hereunder to such Purchaser at the Closing (collectively, the &ldquo;<U>Pre-Settlement Shares</U>&rdquo;), such Person shall, automatically
hereunder (without any additional required actions by such Purchaser or the Company), be deemed to be a Purchaser under this Agreement
unconditionally bound to purchase, and the Company shall be deemed unconditionally bound to sell, such Pre-Settlement Shares to such Person
at the Closing; provided, that the Company shall not be required to deliver any Pre-Settlement Shares to such Purchaser prior to the Company&rsquo;s
receipt of the Subscription Amount for such Pre-Settlement Shares hereunder; provided, further, that the Company hereby acknowledges and
agrees that the forgoing shall not constitute a representation or covenant by such Purchaser as to whether or not such Purchaser will
elect to sell any Pre-Settlement Shares during the Pre-Settlement Period. The decision to sell any Shares will be made in the sole discretion
of such Purchaser from time to time, including during the Pre-Settlement Period. Notwithstanding the foregoing, with respect to any Notice(s)
of Exercise (as defined in the Warrants) delivered on or prior to 12:00 p.m. (New York City time) on the Closing Date, which may be delivered
at any time after the time of execution of this Agreement, the Company agrees to deliver the Warrant Shares subject to such notice(s)
by 4:00 p.m. (New York City time) on the Closing Date and the Closing Date shall be the Warrant Share Delivery Date (as defined in the
Warrants) for purposes hereunder.</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify; text-indent: 0.5in">&nbsp;</P>


<!-- Field: Page; Sequence: 5 -->
    <DIV STYLE="margin-bottom: 6pt; border-bottom: Black 1pt solid"><TABLE CELLPADDING="0" CELLSPACING="0" STYLE="border-collapse: collapse; width: 100%; font-size: 10pt"><TR STYLE="vertical-align: top; text-align: left"><TD STYLE="text-align: center; width: 100%"><!-- Field: Sequence; Type: Arabic; Name: PageNo -->5<!-- Field: /Sequence --></TD></TR></TABLE></DIV>
    <DIV STYLE="break-before: page; margin-top: 6pt"><P STYLE="margin: 0pt">&nbsp;</P></DIV>
    <!-- Field: /Page -->

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify">2.2 <U>Deliveries</U>.</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify">&nbsp;</P>

<TABLE CELLPADDING="0" CELLSPACING="0" STYLE="border-collapse: collapse; font: 10pt Times New Roman, Times, Serif; width: 100%">
<TR STYLE="vertical-align: top; text-align: left">
  <TD STYLE="width: 0.25in">&nbsp;</TD>
  <TD STYLE="text-align: left; width: 0.25in">(a)</TD>
  <TD STYLE="text-align: justify">On or prior to
the Closing Date, the Company shall deliver or cause to be delivered to each Purchaser the following:</TD></TR>
</TABLE>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify"></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0.75in; text-align: justify; text-indent: -0.25in"> </P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify">&nbsp;</P>

<TABLE CELLSPACING="0" CELLPADDING="0" STYLE="font: 10pt Times New Roman, Times, Serif; width: 100%; border-collapse: collapse">
  <TR STYLE="font: 10pt Times New Roman, Times, Serif; vertical-align: top">
    <TD STYLE="font: 10pt Times New Roman, Times, Serif; width: 0.5in">&nbsp;</TD>
    <TD STYLE="font: 10pt Times New Roman, Times, Serif; text-align: left; width: 0.5in">(i)</TD>
    <TD STYLE="font: 10pt Times New Roman, Times, Serif; text-align: justify">this Agreement duly executed by the Company;</TD></TR>
  <TR STYLE="font: 10pt Times New Roman, Times, Serif; vertical-align: top">
    <TD STYLE="font: 10pt Times New Roman, Times, Serif">&nbsp;</TD>
    <TD STYLE="font: 10pt Times New Roman, Times, Serif; text-align: left">&nbsp;</TD>
    <TD STYLE="font: 10pt Times New Roman, Times, Serif; text-align: justify">&nbsp;</TD></TR>
  <TR STYLE="font: 10pt Times New Roman, Times, Serif; vertical-align: top">
    <TD STYLE="font: 10pt Times New Roman, Times, Serif">&nbsp;</TD>
    <TD STYLE="font: 10pt Times New Roman, Times, Serif; text-align: left">(ii)</TD>
    <TD STYLE="font: 10pt Times New Roman, Times, Serif; text-align: justify">a legal opinion of Company Counsel, in form and substance reasonably satisfactory to the Placement Agent;</TD></TR>
  <TR STYLE="font: 10pt Times New Roman, Times, Serif; vertical-align: top">
    <TD STYLE="font: 10pt Times New Roman, Times, Serif">&nbsp;</TD>
    <TD STYLE="font: 10pt Times New Roman, Times, Serif; text-align: left">&nbsp;</TD>
    <TD STYLE="font: 10pt Times New Roman, Times, Serif; text-align: justify">&nbsp;</TD></TR>
  <TR STYLE="font: 10pt Times New Roman, Times, Serif; vertical-align: top">
    <TD STYLE="font: 10pt Times New Roman, Times, Serif">&nbsp;</TD>
    <TD STYLE="font: 10pt Times New Roman, Times, Serif; text-align: left">(iii)</TD>
    <TD STYLE="font: 10pt Times New Roman, Times, Serif; text-align: justify">the Company&rsquo;s wire instructions, on Company letterhead and executed by the Company&rsquo;s Chief Executive Officer or Chief Financial Officer;</TD></TR>
  <TR STYLE="font: 10pt Times New Roman, Times, Serif; vertical-align: top">
    <TD STYLE="font: 10pt Times New Roman, Times, Serif">&nbsp;</TD>
    <TD STYLE="font: 10pt Times New Roman, Times, Serif; text-align: left">&nbsp;</TD>
    <TD STYLE="font: 10pt Times New Roman, Times, Serif; text-align: justify">&nbsp;</TD></TR>
  <TR STYLE="font: 10pt Times New Roman, Times, Serif; vertical-align: top">
    <TD STYLE="font: 10pt Times New Roman, Times, Serif">&nbsp;</TD>
    <TD STYLE="font: 10pt Times New Roman, Times, Serif; text-align: left">(iv)</TD>
    <TD STYLE="font: 10pt Times New Roman, Times, Serif; text-align: justify">subject to the last sentence in Section 2.1, a copy of the irrevocable instructions to the Transfer Agent instructing the Transfer Agent to deliver on an expedited basis via The Depository Trust Company Deposit or Withdrawal at Custodian system shares of Common Stock equal to the portion of such Purchaser&rsquo;s Subscription Amount divided by the Per Share Purchase Price, registered in the name of such Purchaser;</TD></TR>
  <TR STYLE="font: 10pt Times New Roman, Times, Serif; vertical-align: top">
    <TD STYLE="font: 10pt Times New Roman, Times, Serif">&nbsp;</TD>
    <TD STYLE="font: 10pt Times New Roman, Times, Serif; text-align: left">&nbsp;</TD>
    <TD STYLE="font: 10pt Times New Roman, Times, Serif; text-align: justify">&nbsp;</TD></TR>
  <TR STYLE="font: 10pt Times New Roman, Times, Serif; vertical-align: top">
    <TD STYLE="font: 10pt Times New Roman, Times, Serif">&nbsp;</TD>
    <TD STYLE="font: 10pt Times New Roman, Times, Serif; text-align: left">(v)</TD>
    <TD STYLE="font: 10pt Times New Roman, Times, Serif; text-align: justify">for each Purchaser of Pre-Funded Warrants pursuant to Section 2.1, a Pre-Funded Warrant registered in the name of such Purchaser to purchase up to a number of shares of Common Stock equal to the portion of such Purchaser&rsquo;s Subscription Amount applicable to Pre-Funded Warrants divided by the sum of the Per Pre-Funded Warrant Purchase Price plus the exercise price per Warrant Share underlying such Pre-Funded Warrants, subject to adjustment therein;</TD></TR>
  <TR STYLE="font: 10pt Times New Roman, Times, Serif; vertical-align: top">
    <TD STYLE="font: 10pt Times New Roman, Times, Serif">&nbsp;</TD>
    <TD STYLE="font: 10pt Times New Roman, Times, Serif; text-align: left">&nbsp;</TD>
    <TD STYLE="font: 10pt Times New Roman, Times, Serif; text-align: justify">&nbsp;</TD></TR>
  <TR STYLE="font: 10pt Times New Roman, Times, Serif; vertical-align: top">
    <TD STYLE="font: 10pt Times New Roman, Times, Serif">&nbsp;</TD>
    <TD STYLE="font: 10pt Times New Roman, Times, Serif; text-align: left">(vi)</TD>
    <TD STYLE="font: 10pt Times New Roman, Times, Serif; text-align: justify">the Preliminary Prospectus and the Prospectus (which may be delivered in accordance with Rule 172 under the Securities Act);</TD></TR>
  <TR STYLE="font: 10pt Times New Roman, Times, Serif; vertical-align: top">
    <TD STYLE="font: 10pt Times New Roman, Times, Serif">&nbsp;</TD>
    <TD STYLE="font: 10pt Times New Roman, Times, Serif; text-align: left">&nbsp;</TD>
    <TD STYLE="font: 10pt Times New Roman, Times, Serif; text-align: justify">&nbsp;</TD></TR>
  <TR STYLE="font: 10pt Times New Roman, Times, Serif; vertical-align: top">
    <TD STYLE="font: 10pt Times New Roman, Times, Serif">&nbsp;</TD>
    <TD STYLE="font: 10pt Times New Roman, Times, Serif; text-align: left">(vii)</TD>
    <TD STYLE="font: 10pt Times New Roman, Times, Serif; text-align: justify">an originally signed Common Warrant registered in the name of such Purchaser to purchase up to a number of shares of Common Stock equal to 100% of such Purchaser&rsquo;s Shares or Pre-Funded Warrants, as applicable, with an exercise price equal to $[___] per share, subject to adjustment therein;</TD></TR>
  <TR STYLE="font: 10pt Times New Roman, Times, Serif; vertical-align: top">
    <TD STYLE="font: 10pt Times New Roman, Times, Serif">&nbsp;</TD>
    <TD STYLE="font: 10pt Times New Roman, Times, Serif; text-align: left">&nbsp;</TD>
    <TD STYLE="font: 10pt Times New Roman, Times, Serif; text-align: justify">&nbsp;</TD></TR>
  <TR STYLE="font: 10pt Times New Roman, Times, Serif; vertical-align: top">
    <TD STYLE="font: 10pt Times New Roman, Times, Serif">&nbsp;</TD>
    <TD STYLE="font: 10pt Times New Roman, Times, Serif; text-align: left">(viii)</TD>
    <TD STYLE="font: 10pt Times New Roman, Times, Serif; text-align: justify">the duly executed Lock-Up Agreements;</TD></TR>
  <TR STYLE="font: 10pt Times New Roman, Times, Serif; vertical-align: top">
    <TD STYLE="font: 10pt Times New Roman, Times, Serif">&nbsp;</TD>
    <TD STYLE="font: 10pt Times New Roman, Times, Serif; text-align: left">&nbsp;</TD>
    <TD STYLE="font: 10pt Times New Roman, Times, Serif; text-align: justify">&nbsp;</TD></TR>
  <TR STYLE="font: 10pt Times New Roman, Times, Serif; vertical-align: top">
    <TD STYLE="font: 10pt Times New Roman, Times, Serif">&nbsp;</TD>
    <TD STYLE="font: 10pt Times New Roman, Times, Serif; text-align: left">(ix)</TD>
    <TD STYLE="font: 10pt Times New Roman, Times, Serif; text-align: justify">a certificate executed by the Chief Executive Officer and Chief Financial Officer of the Company, dated as of the date of the Closing Date, in form and substance reasonably acceptable to the Purchasers and Placement Agent; and</TD></TR>
  <TR STYLE="font: 10pt Times New Roman, Times, Serif; vertical-align: top">
    <TD STYLE="font: 10pt Times New Roman, Times, Serif">&nbsp;</TD>
    <TD STYLE="font: 10pt Times New Roman, Times, Serif; text-align: left">&nbsp;</TD>
    <TD STYLE="font: 10pt Times New Roman, Times, Serif; text-align: justify">&nbsp;</TD></TR>
  <TR STYLE="font: 10pt Times New Roman, Times, Serif; vertical-align: top">
    <TD STYLE="font: 10pt Times New Roman, Times, Serif">&nbsp;</TD>
    <TD STYLE="font: 10pt Times New Roman, Times, Serif; text-align: left">(x)</TD>
    <TD STYLE="font: 10pt Times New Roman, Times, Serif; text-align: justify">a certificate executed by the Secretary of the Company, dated as of the Closing Date, in form and substance reasonable acceptable to the Purchasers and Placement Agent.</TD></TR>
  </TABLE>
<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 1in">&nbsp;</P>


<!-- Field: Page; Sequence: 6 -->
    <DIV STYLE="margin-bottom: 6pt; border-bottom: Black 1pt solid"><TABLE CELLPADDING="0" CELLSPACING="0" STYLE="border-collapse: collapse; width: 100%; font-size: 10pt"><TR STYLE="vertical-align: top; text-align: left"><TD STYLE="text-align: center; width: 100%"><!-- Field: Sequence; Type: Arabic; Name: PageNo -->6<!-- Field: /Sequence --></TD></TR></TABLE></DIV>
    <DIV STYLE="break-before: page; margin-top: 6pt"><P STYLE="margin: 0pt">&nbsp;</P></DIV>
    <!-- Field: /Page -->

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0"></P>

<TABLE CELLPADDING="0" CELLSPACING="0" STYLE="border-collapse: collapse; font: 10pt Times New Roman, Times, Serif; width: 100%">
<TR STYLE="vertical-align: top; text-align: left">
  <TD STYLE="width: 0.25in">&nbsp;</TD>
  <TD STYLE="text-align: left; width: 0.25in">(b)</TD>
  <TD STYLE="text-align: justify">At the time this
Agreement is executed, the Placement Agent shall have received from WithumSmith+Brown, PC a cold comfort letter containing statements
and information of the type customarily included in accountants&rsquo; comfort letters with respect to the financial statements and certain
financial information contained in the Registration Statement, the Preliminary Prospectus and any issuer free writing prospectus, as defined
in Rule 433 under the Securities Act, addressed to the Placement Agent and in form and substance satisfactory in all respects to the
Placement Agent, dated as of the date of this Agreement.</TD></TR>
<TR STYLE="vertical-align: top; text-align: left">
  <TD>&nbsp;</TD>
  <TD STYLE="text-align: left">&nbsp;</TD>
  <TD STYLE="text-align: justify">&nbsp;</TD></TR>
<TR STYLE="vertical-align: top; text-align: left">
  <TD>&nbsp;</TD>
  <TD STYLE="text-align: left">(c)</TD>
  <TD STYLE="text-align: justify">On or prior to
the Closing Date, the Placement Agent shall have received from WithumSmith+Brown, PC a bringdown comfort letter containing statements
and information of the type customarily included in accountants&rsquo; comfort letters, (i) reaffirming the statements made in the letter
furnished by them pursuant to &lrm;Section 2.2(b), except that the specified date referred to therein for the carrying out of procedures
shall be no more than three business days prior to the Closing Date; and (ii) covering certain financial information contained in the
Prospectus, addressed to the Placement Agent and in form and substance satisfactory in all respects to the Placement Agent, dated as
of the Closing Date.</TD></TR>
<TR STYLE="vertical-align: top; text-align: left">
  <TD>&nbsp;</TD>
  <TD STYLE="text-align: left">&nbsp;</TD>
  <TD STYLE="text-align: justify">&nbsp;</TD></TR>
<TR STYLE="vertical-align: top; text-align: left">
  <TD>&nbsp;</TD>
  <TD STYLE="text-align: left">(d)</TD>
  <TD STYLE="text-align: justify">On or prior to
the Closing Date, each Purchaser shall deliver or cause to be delivered to the Company the following:</TD></TR>
</TABLE>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0.75in; text-align: justify; text-indent: -0.25in"> </P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0.75in; text-align: justify"></P>

<TABLE CELLSPACING="0" CELLPADDING="0" STYLE="font: 10pt Times New Roman, Times, Serif; width: 100%; border-collapse: collapse">
  <TR STYLE="font: 10pt Times New Roman, Times, Serif; vertical-align: top">
    <TD STYLE="font: 10pt Times New Roman, Times, Serif; width: 0.5in">&nbsp;</TD>
    <TD STYLE="text-align: left; font: 10pt Times New Roman, Times, Serif; width: 0.5in">(i)</TD>
    <TD STYLE="text-align: justify; font: 10pt Times New Roman, Times, Serif">this Agreement duly executed by such Purchaser; and </TD></TR>
  <TR STYLE="font: 10pt Times New Roman, Times, Serif; vertical-align: top">
    <TD STYLE="font: 10pt Times New Roman, Times, Serif">&nbsp;</TD>
    <TD STYLE="text-align: left; font: 10pt Times New Roman, Times, Serif">&nbsp;</TD>
    <TD STYLE="text-align: justify; font: 10pt Times New Roman, Times, Serif">&nbsp;</TD></TR>
  <TR STYLE="font: 10pt Times New Roman, Times, Serif; vertical-align: top">
    <TD STYLE="font: 10pt Times New Roman, Times, Serif">&nbsp;</TD>
    <TD STYLE="text-align: left; font: 10pt Times New Roman, Times, Serif">(ii)</TD>
    <TD STYLE="text-align: justify; font: 10pt Times New Roman, Times, Serif">such Purchaser&rsquo;s Subscription Amount with respect to the Securities purchased by such Purchaser, which shall be made available for DVP settlement with the Company or its designees.</TD></TR>
  </TABLE>
<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify">2.3 <U>Closing Conditions</U>.</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify"></P>

<TABLE CELLPADDING="0" CELLSPACING="0" STYLE="border-collapse: collapse; font: 10pt Times New Roman, Times, Serif; width: 100%">
<TR STYLE="vertical-align: top; text-align: left">
  <TD STYLE="width: 0.25in">&nbsp;</TD>
  <TD STYLE="text-align: left; width: 0.25in">(a)</TD>
  <TD STYLE="text-align: justify">The obligations
of the Company hereunder in connection with the Closing are subject to the following conditions being met:</TD></TR>
</TABLE>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify">&nbsp;</P>

<TABLE CELLSPACING="0" CELLPADDING="0" STYLE="font: 10pt Times New Roman, Times, Serif; width: 100%; border-collapse: collapse">
  <TR STYLE="font: 10pt Times New Roman, Times, Serif; vertical-align: top">
    <TD STYLE="font: 10pt Times New Roman, Times, Serif; width: 0.5in">&nbsp;</TD>
    <TD STYLE="font: 10pt Times New Roman, Times, Serif; text-align: left; width: 0.5in">(i)</TD>
    <TD STYLE="font: 10pt Times New Roman, Times, Serif; text-align: justify">the accuracy in all material respects (or, to the extent representations or warranties are qualified by materiality or Material Adverse Effect, in all respects) when made and on the Closing Date of the representations and warranties of the Purchasers contained herein (unless such representation or warranty is as of a specific date therein in which case they shall be accurate as of such date);</TD></TR>
  <TR STYLE="font: 10pt Times New Roman, Times, Serif; vertical-align: top">
    <TD STYLE="font: 10pt Times New Roman, Times, Serif">&nbsp;</TD>
    <TD STYLE="font: 10pt Times New Roman, Times, Serif; text-align: left">&nbsp;</TD>
    <TD STYLE="font: 10pt Times New Roman, Times, Serif; text-align: justify">&nbsp;</TD></TR>
  <TR STYLE="font: 10pt Times New Roman, Times, Serif; vertical-align: top">
    <TD STYLE="font: 10pt Times New Roman, Times, Serif">&nbsp;</TD>
    <TD STYLE="font: 10pt Times New Roman, Times, Serif; text-align: left">(ii)</TD>
    <TD STYLE="font: 10pt Times New Roman, Times, Serif; text-align: justify">all obligations, covenants and agreements of each Purchaser required to be performed at or prior to the Closing Date shall have been performed; and</TD></TR>
  <TR STYLE="font: 10pt Times New Roman, Times, Serif; vertical-align: top">
    <TD STYLE="font: 10pt Times New Roman, Times, Serif">&nbsp;</TD>
    <TD STYLE="font: 10pt Times New Roman, Times, Serif; text-align: left">&nbsp;</TD>
    <TD STYLE="font: 10pt Times New Roman, Times, Serif; text-align: justify">&nbsp;</TD></TR>
  <TR STYLE="font: 10pt Times New Roman, Times, Serif; vertical-align: top">
    <TD STYLE="font: 10pt Times New Roman, Times, Serif">&nbsp;</TD>
    <TD STYLE="font: 10pt Times New Roman, Times, Serif; text-align: left">(iii)</TD>
    <TD STYLE="font: 10pt Times New Roman, Times, Serif; text-align: justify">
    <P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt; text-align: justify; text-indent: 0pt">the delivery by each Purchaser
of the items set forth in Section 2.2(d) of this Agreement.</P></TD></TR>
  </TABLE>
<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify">&nbsp;</P>


<!-- Field: Page; Sequence: 7 -->
    <DIV STYLE="margin-bottom: 6pt; border-bottom: Black 1pt solid"><TABLE CELLPADDING="0" CELLSPACING="0" STYLE="border-collapse: collapse; width: 100%; font-size: 10pt"><TR STYLE="vertical-align: top; text-align: left"><TD STYLE="text-align: center; width: 100%"><!-- Field: Sequence; Type: Arabic; Name: PageNo -->7<!-- Field: /Sequence --></TD></TR></TABLE></DIV>
    <DIV STYLE="break-before: page; margin-top: 6pt"><P STYLE="margin: 0pt">&nbsp;</P></DIV>
    <!-- Field: /Page -->

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0"></P>

<TABLE CELLPADDING="0" CELLSPACING="0" STYLE="border-collapse: collapse; font: 10pt Times New Roman, Times, Serif; width: 100%">
<TR STYLE="vertical-align: top; text-align: left">
  <TD STYLE="width: 0.25in">&nbsp;</TD>
  <TD STYLE="width: 0.25in">(b)</TD>
  <TD><P STYLE="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-right: 0pt; margin-bottom: 0pt; text-align: justify">The respective
obligations of the Purchasers hereunder in connection with the Closing are subject to the following conditions being met:</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify"></P>

</TD></TR>
</TABLE>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0.5in; text-align: justify; text-indent: -0.25in"></P>

<TABLE CELLSPACING="0" CELLPADDING="0" STYLE="font: 10pt Times New Roman, Times, Serif; width: 100%; border-collapse: collapse">
  <TR STYLE="font: 10pt Times New Roman, Times, Serif; vertical-align: top">
    <TD STYLE="text-align: justify; font: 10pt Times New Roman, Times, Serif; width: 0.5in">&nbsp;</TD>
    <TD STYLE="font: 10pt Times New Roman, Times, Serif; text-align: left; width: 0.5in">(i)</TD>
    <TD STYLE="text-align: justify; font: 10pt Times New Roman, Times, Serif">the accuracy in all material respects (or, to the extent representations or warranties are qualified by materiality or Material Adverse Effect, in all respects) when made and on the Closing Date of the representations and warranties of the Company contained herein (unless such representation or warranty is as of a specific date therein in which case they shall be accurate as of such date);</TD></TR>
  <TR STYLE="font: 10pt Times New Roman, Times, Serif; vertical-align: top">
    <TD STYLE="text-align: justify; font: 10pt Times New Roman, Times, Serif">&nbsp;</TD>
    <TD STYLE="font: 10pt Times New Roman, Times, Serif; text-align: left">&nbsp;</TD>
    <TD STYLE="text-align: justify; font: 10pt Times New Roman, Times, Serif">&nbsp;</TD></TR>
  <TR STYLE="font: 10pt Times New Roman, Times, Serif; vertical-align: top">
    <TD STYLE="text-align: justify; font: 10pt Times New Roman, Times, Serif">&nbsp;</TD>
    <TD STYLE="font: 10pt Times New Roman, Times, Serif; text-align: left">(ii)</TD>
    <TD STYLE="text-align: justify; font: 10pt Times New Roman, Times, Serif">all obligations, covenants and agreements of the Company required to be performed at or prior to the Closing Date shall have been performed;</TD></TR>
  <TR STYLE="font: 10pt Times New Roman, Times, Serif; vertical-align: top">
    <TD STYLE="text-align: justify; font: 10pt Times New Roman, Times, Serif">&nbsp;</TD>
    <TD STYLE="font: 10pt Times New Roman, Times, Serif; text-align: left">&nbsp;</TD>
    <TD STYLE="text-align: justify; font: 10pt Times New Roman, Times, Serif">&nbsp;</TD></TR>
  <TR STYLE="font: 10pt Times New Roman, Times, Serif; vertical-align: top">
    <TD STYLE="text-align: justify; font: 10pt Times New Roman, Times, Serif">&nbsp;</TD>
    <TD STYLE="font: 10pt Times New Roman, Times, Serif; text-align: left">(iii)</TD>
    <TD STYLE="text-align: justify; font: 10pt Times New Roman, Times, Serif">the delivery by the Company of the items set forth in Section 2.2 of this Agreement and if the Company files a Rule 462(b) Registration Statement, then the Rule 462(b) Registration Statement having been filed with the Commission;</TD></TR>
  <TR STYLE="font: 10pt Times New Roman, Times, Serif; vertical-align: top">
    <TD STYLE="text-align: justify; font: 10pt Times New Roman, Times, Serif">&nbsp;</TD>
    <TD STYLE="font: 10pt Times New Roman, Times, Serif; text-align: left">&nbsp;</TD>
    <TD STYLE="text-align: justify; font: 10pt Times New Roman, Times, Serif">&nbsp;</TD></TR>
  <TR STYLE="font: 10pt Times New Roman, Times, Serif; vertical-align: top">
    <TD STYLE="text-align: justify; font: 10pt Times New Roman, Times, Serif">&nbsp;</TD>
    <TD STYLE="font: 10pt Times New Roman, Times, Serif; text-align: left">(iv)</TD>
    <TD STYLE="text-align: justify; font: 10pt Times New Roman, Times, Serif">there shall have been no Material Adverse Effect with respect to the Company since the date hereof; and</TD></TR>
  <TR STYLE="font: 10pt Times New Roman, Times, Serif; vertical-align: top">
    <TD STYLE="text-align: justify; font: 10pt Times New Roman, Times, Serif">&nbsp;</TD>
    <TD STYLE="font: 10pt Times New Roman, Times, Serif; text-align: left">&nbsp;</TD>
    <TD STYLE="text-align: justify; font: 10pt Times New Roman, Times, Serif">&nbsp;</TD></TR>
  <TR STYLE="font: 10pt Times New Roman, Times, Serif; vertical-align: top">
    <TD STYLE="text-align: justify; font: 10pt Times New Roman, Times, Serif">&nbsp;</TD>
    <TD STYLE="font: 10pt Times New Roman, Times, Serif; text-align: left">(v)</TD>
    <TD STYLE="text-align: justify; font: 10pt Times New Roman, Times, Serif">from the date hereof to the Closing Date, trading in the Common Stock shall not have been suspended by the Commission or the Company&rsquo;s principal Trading Market, and, at any time prior to the Closing Date, trading in securities generally as reported by Bloomberg L.P. shall not have been suspended or limited, or minimum prices shall not have been established on securities whose trades are reported by such service, or on any Trading Market, nor shall a banking moratorium have been declared either by the United States or New York State authorities nor shall there have occurred after the date of this Agreement any material outbreak or escalation of hostilities or other national or international calamity of such magnitude in its effect on, or any material adverse change in, any financial market which, in each case, in the reasonable judgment of such Purchaser, makes it impracticable or inadvisable to purchase the Shares and the Warrants at the Closing.</TD></TR>
  </TABLE>
<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: center"><B>&nbsp;</B></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: center"><B>ARTICLE III.</B></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: center"><B>REPRESENTATIONS AND WARRANTIES</B></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: center"><B>&nbsp;</B></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify">3.1 <U>Representations and Warranties of the Company</U>.
Except as set forth in the Disclosure Schedules, which Disclosure Schedules shall be deemed a part hereof and shall qualify any representation
made herein to the extent of the disclosures contained in the corresponding section of the Disclosure Schedules, the Company hereby makes
the following representations and warranties to each Purchaser:</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify">&nbsp;</P>

<TABLE CELLPADDING="0" CELLSPACING="0" STYLE="border-collapse: collapse; font: 10pt Times New Roman, Times, Serif; width: 100%">
  <TR STYLE="font: 10pt Times New Roman, Times, Serif; vertical-align: top">
    <TD STYLE="font: 10pt Times New Roman, Times, Serif; width: 0.25in">&nbsp;</TD>
    <TD STYLE="text-align: left; font: 10pt Times New Roman, Times, Serif; width: 0.25in">(a)</TD>
    <TD STYLE="font: 10pt Times New Roman, Times, Serif; text-align: justify">&nbsp;<U>Subsidiaries</U>. All of the direct and indirect subsidiaries of the Company are set forth on <U>Schedule 3.1(a)</U>. The Company owns, directly or indirectly, all of the capital stock or other equity interests of each Subsidiary, free and clear of any Liens, and all of the issued and outstanding shares of capital stock of each Subsidiary are validly issued and are fully paid, non-assessable and free of preemptive and similar rights to subscribe for or purchase securities. There are no outstanding options, warrants, scrip rights to subscribe to, calls or commitments of any character whatsoever relating to, or securities, rights or obligations convertible into or exercisable or exchangeable for, or giving any Person any right to subscribe for or acquire, any capital stock of any Subsidiary, or contracts, commitments, understandings or arrangements by which any Subsidiary is or may become bound to issue capital stock. If the Company has no subsidiaries, all other references to the Subsidiaries or any of them in the Transaction Documents shall be disregarded. </TD></TR>
  </TABLE>
<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0">&nbsp;</P>


<!-- Field: Page; Sequence: 8 -->
    <DIV STYLE="margin-bottom: 6pt; border-bottom: Black 1pt solid"><TABLE CELLPADDING="0" CELLSPACING="0" STYLE="border-collapse: collapse; width: 100%; font-size: 10pt"><TR STYLE="vertical-align: top; text-align: left"><TD STYLE="text-align: center; width: 100%"><!-- Field: Sequence; Type: Arabic; Name: PageNo -->8<!-- Field: /Sequence --></TD></TR></TABLE></DIV>
    <DIV STYLE="break-before: page; margin-top: 6pt"><P STYLE="margin: 0pt">&nbsp;</P></DIV>
    <!-- Field: /Page -->

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0">&nbsp;</P>

<TABLE CELLPADDING="0" CELLSPACING="0" STYLE="border-collapse: collapse; font: 10pt Times New Roman, Times, Serif; width: 100%">
  <TR STYLE="font: 10pt Times New Roman, Times, Serif; vertical-align: top">
    <TD STYLE="font: 10pt Times New Roman, Times, Serif; width: 0.25in">&nbsp;</TD>
    <TD STYLE="text-align: left; font: 10pt Times New Roman, Times, Serif; width: 0.25in">(b)</TD>
    <TD STYLE="font: 10pt Times New Roman, Times, Serif; text-align: justify"><U>Organization and Qualification</U>. The Company and each of the Subsidiaries is an entity duly incorporated or otherwise organized, validly existing, and, if applicable under the laws of the jurisdiction in which it was formed, in good standing under the laws of the jurisdiction of its incorporation or organization, with the requisite power and authority to own and use its properties and assets and to carry on its business as currently conducted. Neither the Company nor any Subsidiary is in violation nor default of any of the provisions of its respective articles of association, certificate or articles of incorporation, bylaws, operating agreement, or other organizational or charter documents. Each of the Company and the Subsidiaries is duly qualified to conduct business and is in good standing as a foreign corporation or other entity in each jurisdiction in which the nature of the business conducted or property owned by it makes such qualification necessary, except where the failure to be so qualified or in good standing, as the case may be, would not have or reasonably be expected to result in: (i) a material adverse effect on the legality, validity or enforceability of any Transaction Document, (ii) a material adverse effect on the results of operations, assets, business, prospects or condition (financial or otherwise) of the Company and the Subsidiaries, taken as a whole, or (iii) a material adverse effect on the Company&rsquo;s ability to perform in any material respect on a timely basis its obligations under any Transaction Document (any of (i), (ii) or (iii), a &ldquo;<U>Material Adverse Effect</U>&rdquo;) and no Proceeding has been instituted in any such jurisdiction revoking, limiting or curtailing or seeking to revoke, limit or curtail such power and authority or qualification.</TD></TR>
  <TR STYLE="font: 10pt Times New Roman, Times, Serif; vertical-align: top">
    <TD STYLE="font: 10pt Times New Roman, Times, Serif">&nbsp;</TD>
    <TD STYLE="text-align: left; font: 10pt Times New Roman, Times, Serif">&nbsp;</TD>
    <TD STYLE="font: 10pt Times New Roman, Times, Serif; text-align: justify">&nbsp;</TD></TR>
  <TR STYLE="font: 10pt Times New Roman, Times, Serif; vertical-align: top">
    <TD STYLE="font: 10pt Times New Roman, Times, Serif">&nbsp;</TD>
    <TD STYLE="text-align: left; font: 10pt Times New Roman, Times, Serif">(c)</TD>
    <TD STYLE="font: 10pt Times New Roman, Times, Serif; text-align: justify"><U>Authorization; Enforcement</U>. The Company has the requisite corporate power and authority to enter into and to consummate the transactions contemplated by this Agreement and each of the other Transaction Documents and otherwise to carry out its obligations hereunder and thereunder. The execution and delivery of this Agreement and each of the other Transaction Documents by the Company and the consummation by it of the transactions contemplated hereby and thereby have been duly authorized by all necessary action on the part of the Company and no further action is required by the Company, the Board of Directors, a committee of the Board of Directors, or the Company&rsquo;s stockholders in connection herewith or therewith other than in connection with the Required Approvals. This Agreement and each other Transaction Document to which the Company is a party has been (or upon delivery will have been) duly executed by the Company and, when delivered in accordance with the terms hereof and thereof, will constitute the valid and binding obligation of the Company enforceable against the Company in accordance with its terms, except (i) as limited by general equitable principles and applicable bankruptcy, insolvency, reorganization, moratorium and other laws of general application affecting enforcement of creditors&rsquo; rights generally, (ii) as limited by laws relating to the availability of specific performance, injunctive relief or other equitable remedies and (iii) insofar as indemnification and contribution provisions may be limited by applicable law.</TD></TR>
  <TR STYLE="font: 10pt Times New Roman, Times, Serif; vertical-align: top">
    <TD STYLE="font: 10pt Times New Roman, Times, Serif">&nbsp;</TD>
    <TD STYLE="text-align: left; font: 10pt Times New Roman, Times, Serif">&nbsp;</TD>
    <TD STYLE="font: 10pt Times New Roman, Times, Serif; text-align: justify">&nbsp;</TD></TR>
  <TR STYLE="font: 10pt Times New Roman, Times, Serif; vertical-align: top">
    <TD STYLE="font: 10pt Times New Roman, Times, Serif">&nbsp;</TD>
    <TD STYLE="text-align: left; font: 10pt Times New Roman, Times, Serif">(d)</TD>
    <TD STYLE="font: 10pt Times New Roman, Times, Serif; text-align: justify"><U>No Conflicts</U>. Except as set forth in <U>Schedule 3.1(d)</U>, the execution, delivery and performance by the Company of this Agreement and the other Transaction Documents to which it is a party, the issuance and sale of the Securities and the consummation by it of the transactions contemplated hereby and thereby do not and will not (i) conflict with or violate any provision of the Company&rsquo;s or any Subsidiary&rsquo;s certificate or articles of incorporation, bylaws, or other organizational or charter documents, or (ii) conflict with, or constitute a default (or an event that with notice or lapse of time or both would become a default) under, result in the creation of any Lien upon any of the properties or assets of the Company or any Subsidiary, or give to others any rights of termination, amendment, anti-dilution or similar adjustments, acceleration or cancellation (with or without notice, lapse of time or both) of, any agreement, credit facility, debt or other instrument (evidencing a Company or Subsidiary debt or otherwise) or other understanding to which the Company or any Subsidiary is a party or by which any property or asset of the Company or any Subsidiary is bound or affected, or (iii) subject to the Required Approvals, conflict with or result in a violation of any law, rule, regulation, order, judgment, injunction, decree or other restriction of any court or governmental authority to which the Company or a Subsidiary is subject (including federal and state securities laws and regulations), or by which any property or asset of the Company or a Subsidiary is bound or affected; except in the case of each of clauses (ii) and (iii), such as would not have or reasonably be expected to result in a Material Adverse Effect.</TD></TR>
  </TABLE>
<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0">&nbsp;</P>


<!-- Field: Page; Sequence: 9 -->
    <DIV STYLE="margin-bottom: 6pt; border-bottom: Black 1pt solid"><TABLE CELLPADDING="0" CELLSPACING="0" STYLE="border-collapse: collapse; width: 100%; font-size: 10pt"><TR STYLE="vertical-align: top; text-align: left"><TD STYLE="text-align: center; width: 100%"><!-- Field: Sequence; Type: Arabic; Name: PageNo -->9<!-- Field: /Sequence --></TD></TR></TABLE></DIV>
    <DIV STYLE="break-before: page; margin-top: 6pt"><P STYLE="margin: 0pt">&nbsp;</P></DIV>
    <!-- Field: /Page -->

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0">&nbsp;</P>

<TABLE CELLPADDING="0" CELLSPACING="0" STYLE="border-collapse: collapse; font: 10pt Times New Roman, Times, Serif; width: 100%">
  <TR STYLE="font: 10pt Times New Roman, Times, Serif; vertical-align: top">
    <TD STYLE="font: 10pt Times New Roman, Times, Serif; width: 0.25in">&nbsp;</TD>
    <TD STYLE="text-align: left; font: 10pt Times New Roman, Times, Serif; width: 0.25in">(e)</TD>
    <TD STYLE="font: 10pt Times New Roman, Times, Serif; text-align: justify"><U>Filings, Consents and Approvals</U>. The Company is not
    required to obtain any consent, waiver, authorization or order of, give any notice to, or make any filing or registration with, any
    court or other federal, state, local or other governmental authority or other Person in connection with the execution, delivery and
    performance by the Company of the Transaction Documents, other than: (i) the filings required pursuant to Section 4.4 of this
    Agreement, (ii) the filing with the Commission of the Prospectus, (iii) notices and/or application(s) to and approvals by each
    applicable Trading Market for the listing of the applicable Securities for trading thereon in the time and manner required thereby,
    (iv) filings required by the Financial Industry Regulatory Authority (&ldquo;<U>FINRA</U>&rdquo;), and (v) the Stockholder Approval
    (collectively, the &ldquo;<U>Required Approvals</U>&rdquo;).</TD></TR>
  <TR STYLE="font: 10pt Times New Roman, Times, Serif; vertical-align: top">
    <TD STYLE="font: 10pt Times New Roman, Times, Serif">&nbsp;</TD>
    <TD STYLE="text-align: left; font: 10pt Times New Roman, Times, Serif">&nbsp;</TD>
    <TD STYLE="font: 10pt Times New Roman, Times, Serif; text-align: justify">&nbsp;</TD></TR>
  <TR STYLE="font: 10pt Times New Roman, Times, Serif; vertical-align: top">
    <TD STYLE="font: 10pt Times New Roman, Times, Serif">&nbsp;</TD>
    <TD STYLE="text-align: left; font: 10pt Times New Roman, Times, Serif">(f)</TD>
    <TD STYLE="font: 10pt Times New Roman, Times, Serif; text-align: justify"><U>Issuance of the Securities; Registration</U>. The Shares
    and Pre-Funded Warrant Shares are duly authorized and, when issued and paid for in accordance with the applicable Transaction Documents,
    will be duly and validly issued, fully paid and non-assessable, free and clear of all Liens imposed by the Company. Upon receipt
    of Stockholder Approval, the Common Warrant Shares will be duly authorized and, when issued and paid for in accordance with the applicable
    Transaction Documents, will be duly and validly issued, fully paid and non-assessable, free and clear of all Liens imposed by the
    Company. The Warrants are duly authorized and, when issued in accordance with this Agreement, will be duly and validly issued, fully
    paid and non-assessable, and free and clear of all Liens imposed by the Company. Upon receipt of Stockholder Approval, the Company
    will have reserved from its duly authorized capital stock the maximum number of shares of Common Stock issuable pursuant to this
    Agreement and the Common Warrants. The Company has prepared and filed the Registration Statement in conformity with the requirements
    of the Securities Act, which Registration Statement became effective on [&bull;], 2025, including the Prospectus, and such amendments
    and supplements thereto as may have been required to the date of this Agreement. The Registration Statement is effective under the
    Securities Act and no stop order preventing or suspending the effectiveness of the Registration Statement or suspending or preventing
    the use of the Preliminary Prospectus or the Prospectus has been issued by the Commission and no proceedings for that purpose have
    been instituted or, to the knowledge of the Company, are threatened by the Commission. The Company, if required by the rules and
    regulations of the Commission, shall file the Prospectus with the Commission pursuant to Rule 424(b) under the Securities Act. At
    the time the Registration Statement and any amendments thereto became effective as determined under the Securities Act, at the date
    of this Agreement and at the Closing Date, the Registration Statement and any amendments thereto conformed and will conform in all
    material respects to the requirements of the Securities Act and did not and will not contain any untrue statement of a material fact
    or omit to state any material fact required to be stated therein or necessary to make the statements therein not misleading; and
    the Prospectus and any amendments or supplements thereto, at the time the Preliminary Prospectus, the Prospectus or any amendment
    or supplement thereto was issued and at the Closing Date, conformed and will conform in all material respects to the requirements
    of the Securities Act and did not and will not contain an untrue statement of a material fact or omit to state a material fact necessary
    in order to make the statements therein, in the light of the circumstances under which they were made, not misleading.</TD></TR>
  </TABLE>
<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0">&nbsp;</P>


<!-- Field: Page; Sequence: 10 -->
    <DIV STYLE="margin-bottom: 6pt; border-bottom: Black 1pt solid"><TABLE CELLPADDING="0" CELLSPACING="0" STYLE="border-collapse: collapse; width: 100%; font-size: 10pt"><TR STYLE="vertical-align: top; text-align: left"><TD STYLE="text-align: center; width: 100%"><!-- Field: Sequence; Type: Arabic; Name: PageNo -->10<!-- Field: /Sequence --></TD></TR></TABLE></DIV>
    <DIV STYLE="break-before: page; margin-top: 6pt"><P STYLE="margin: 0pt">&nbsp;</P></DIV>
    <!-- Field: /Page -->

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0">&nbsp;</P>

<TABLE CELLPADDING="0" CELLSPACING="0" STYLE="border-collapse: collapse; font: 10pt Times New Roman, Times, Serif; width: 100%">
  <TR STYLE="font: 10pt Times New Roman, Times, Serif; vertical-align: top">
    <TD STYLE="font: 10pt Times New Roman, Times, Serif; width: 0.25in">&nbsp;</TD>
    <TD STYLE="text-align: left; font: 10pt Times New Roman, Times, Serif; width: 0.25in">(g)</TD>
    <TD STYLE="font: 10pt Times New Roman, Times, Serif; text-align: justify"><U>Capitalization</U>. The capitalization of the Company
    as of the date hereof is as set forth on <U>Schedule 3.1(g)</U>, which <U>Schedule 3.1(g)</U> shall also include the number of shares
    of Common Stock owned beneficially, and of record, by Affiliates of the Company as of the date hereof. Except as set forth on <U>Schedule
    3.1(g)</U>, the Company has not issued any capital stock since its most recently filed periodic report under the Exchange Act, other
    than pursuant to the exercise of employee stock options under the Company&rsquo;s stock option plans, the issuance of shares of Common
    Stock to employees pursuant to the Company&rsquo;s employee stock purchase plans and pursuant to the conversion and/or exercise of
    Common Stock Equivalents outstanding as of the date of the most recently filed periodic report under the Exchange Act. No Person
    has any right of first refusal, preemptive right, right of participation, or any similar right to participate in the transactions
    contemplated by the Transaction Documents. Except as set forth on <U>Schedule 3.1(g)</U> and as a result of the purchase and sale
    of the Securities, there are no outstanding options, warrants, scrip rights to subscribe to, calls or commitments of any character
    whatsoever relating to, or securities, rights or obligations convertible into or exercisable or exchangeable for, or giving any Person
    any right to subscribe for or acquire, any shares of Common Stock, or contracts, commitments, understandings or arrangements by which
    the Company or any Subsidiary is or may become bound to issue additional shares of Common Stock or Common Stock Equivalents. The
    issuance and sale of the Securities will not obligate the Company or any Subsidiary to issue shares of Common Stock or other securities
    to any Person (other than the Purchasers). Except as set forth on <U>Schedule 3.1(g)</U>, here are no outstanding securities or instruments
    of the Company or any Subsidiary with any provision that adjusts the exercise, conversion, exchange or reset price under any of such
    securities. Except as set forth on <U>Schedule 3.1(g)</U>, there are no outstanding securities or instruments of the Company
    or any Subsidiary that contain any redemption or similar provisions, and there are no contracts, commitments, understandings or arrangements
    by which the Company or any Subsidiary is or may become bound to redeem a security of the Company or such Subsidiary. The Company
    does not have any share appreciation rights or &ldquo;phantom share&rdquo; plans or agreements or any similar plan or agreement.
    All of the outstanding shares of capital stock of the Company are duly authorized, validly issued, fully paid and non-assessable,
    have been issued in compliance with all federal and state securities laws where applicable, and none of such outstanding shares was
    issued in violation of any preemptive rights or similar rights to subscribe for or purchase securities. Except for the Required Approvals,
    no further approval or authorization of any shareholder, the Board of Directors or others is required for the issuance and sale of
    the Securities. There are no shareholder agreements, voting agreements or other similar agreements with respect to the Company&rsquo;s
    share capital to which the Company is a party or, to the knowledge of the Company, between or among any of the Company&rsquo;s shareholders.</TD></TR>
  <TR STYLE="font: 10pt Times New Roman, Times, Serif; vertical-align: top">
    <TD STYLE="font: 10pt Times New Roman, Times, Serif">&nbsp;</TD>
    <TD STYLE="text-align: left; font: 10pt Times New Roman, Times, Serif">&nbsp;</TD>
    <TD STYLE="font: 10pt Times New Roman, Times, Serif; text-align: justify">&nbsp;</TD></TR>
  <TR STYLE="font: 10pt Times New Roman, Times, Serif; vertical-align: top">
    <TD STYLE="font: 10pt Times New Roman, Times, Serif">&nbsp;</TD>
    <TD STYLE="text-align: left; font: 10pt Times New Roman, Times, Serif">(h)</TD>
    <TD STYLE="font: 10pt Times New Roman, Times, Serif; text-align: justify"><U>SEC Reports; Financial Statements</U>. The Company has filed all reports, schedules, forms, statements and other documents required to be filed by the Company under the Securities Act and the Exchange Act, including pursuant to Section 13(a) or 15(d) thereof, for the one year preceding the date hereof (or such shorter period as the Company was required by law or regulation to file such materials) (the foregoing materials, including the exhibits thereto and documents incorporated by reference therein, together with the Preliminary Prospectus and the Prospectus, being collectively referred to herein as the &ldquo;<U>SEC Reports</U>&rdquo;) and on a timely basis or has received a valid extension of such time of filing and has filed any such SEC Reports prior to the expiration of any such extension. The Company has never been an issuer subject to Rule 144(i) under the Securities Act. As of their respective dates, the SEC Reports complied in all material respects with the requirements of the Securities Act and the Exchange Act, as applicable, and none of the SEC Reports, when filed, contained any untrue statement of a material fact or omitted to state a material fact required to be stated therein or necessary in order to make the statements therein, in the light of the circumstances under which they were made, not misleading. The financial statements of the Company included in the SEC Reports comply in all material respects with applicable accounting requirements and the rules and regulations of the Commission with respect thereto as in effect at the time of filing. Such financial statements have been prepared in accordance with GAAP, except as may be otherwise specified in such financial statements or the notes thereto and except that unaudited financial statements may not contain all footnotes required by GAAP, and fairly present in all material respects the financial position of the Company and its consolidated Subsidiaries as of and for the dates thereof and the results of operations and cash flows for the periods then ended, subject, in the case of unaudited statements, to normal, immaterial, year-end audit adjustments.</TD></TR>
  </TABLE>
<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0">&nbsp;</P>


<!-- Field: Page; Sequence: 11 -->
    <DIV STYLE="margin-bottom: 6pt; border-bottom: Black 1pt solid"><TABLE CELLPADDING="0" CELLSPACING="0" STYLE="border-collapse: collapse; width: 100%; font-size: 10pt"><TR STYLE="vertical-align: top; text-align: left"><TD STYLE="text-align: center; width: 100%"><!-- Field: Sequence; Type: Arabic; Name: PageNo -->11<!-- Field: /Sequence --></TD></TR></TABLE></DIV>
    <DIV STYLE="break-before: page; margin-top: 6pt"><P STYLE="margin: 0pt">&nbsp;</P></DIV>
    <!-- Field: /Page -->

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0">&nbsp;</P>

<TABLE CELLPADDING="0" CELLSPACING="0" STYLE="border-collapse: collapse; font: 10pt Times New Roman, Times, Serif; width: 100%">
  <TR STYLE="font: 10pt Times New Roman, Times, Serif; vertical-align: top">
    <TD STYLE="font: 10pt Times New Roman, Times, Serif; width: 0.25in">&nbsp;</TD>
    <TD STYLE="text-align: left; font: 10pt Times New Roman, Times, Serif; width: 0.25in">(i)</TD>
    <TD STYLE="font: 10pt Times New Roman, Times, Serif; text-align: justify"><U>Material Changes; Undisclosed Events, Liabilities or Developments</U>. Since the date of the latest audited financial statements included within the SEC Reports, except as set forth on <U>Schedule 3.1(i)</U>, (i) there has been no event, occurrence or development that has had or that would reasonably be expected to result in a Material Adverse Effect, (ii) the Company has not incurred any material liabilities (contingent or otherwise) other than (A) trade payables and accrued expenses incurred in the ordinary course of business consistent with past practice and strategic acquisitions and (B) liabilities not required to be reflected in the Company&rsquo;s financial statements pursuant to GAAP or disclosed in filings made with the Commission, (iii) the Company has not altered its method of accounting, (iv) the Company has not declared or made any dividend or distribution of cash or other property to its shareholders or purchased, redeemed or made any agreements to purchase or redeem any of its shares of capital stock other than the repurchase of Common Stock pursuant to a stock buyback program and (v) the Company has not issued any equity securities to any officer, director or Affiliate, except pursuant to existing Company share option plans. Except for the issuance of the Securities contemplated by this Agreement or as set forth on <U>Schedule 3.1(i)</U>, no event, liability, fact, circumstance, occurrence or development has occurred or exists or is reasonably expected to occur or exist with respect to the Company or its Subsidiaries or their respective businesses, prospects, properties, operations, assets or financial condition that would be required to be disclosed by the Company under applicable securities laws at the time this representation is made or deemed made that has not been publicly disclosed at least one (1) Trading Day prior to the date that this representation is made.</TD></TR>
  <TR STYLE="font: 10pt Times New Roman, Times, Serif; vertical-align: top">
    <TD STYLE="font: 10pt Times New Roman, Times, Serif">&nbsp;</TD>
    <TD STYLE="text-align: left; font: 10pt Times New Roman, Times, Serif">&nbsp;</TD>
    <TD STYLE="font: 10pt Times New Roman, Times, Serif; text-align: justify">&nbsp;</TD></TR>
  <TR STYLE="font: 10pt Times New Roman, Times, Serif; vertical-align: top">
    <TD STYLE="font: 10pt Times New Roman, Times, Serif">&nbsp;</TD>
    <TD STYLE="text-align: left; font: 10pt Times New Roman, Times, Serif">(j)</TD>
    <TD STYLE="font: 10pt Times New Roman, Times, Serif; text-align: justify"><U>Litigation</U>. Except as set forth on <U>Schedule 3.1(j)</U>, there is no action, suit, inquiry, notice of violation, proceeding or investigation pending or, to the knowledge of the Company, threatened against or affecting the Company, any Subsidiary or any of their respective properties before or by any court, arbitrator, governmental or administrative agency or regulatory authority (federal, state, county, local or foreign) (collectively, an &ldquo;<U>Action</U>&rdquo;) which (i) adversely affects or challenges the legality, validity or enforceability of any of the Transaction Documents, the Shares, the Warrants or the Warrant Shares or (ii) could, if there were an unfavorable decision, have or reasonably be expected to result in a Material Adverse Effect. Except as set forth on <U>Schedule 3.1(j)</U>, neither the Company nor any Subsidiary, nor any director or officer thereof, is or has been the subject of any Action involving a claim of violation of or liability under federal or state securities laws or a claim of breach of fiduciary duty, which could reasonably be expected to result in a Material Adverse Effect. There has not been, and to the knowledge of the Company, there is not pending or contemplated, any investigation by the Commission involving the Company or any current or former director or officer of the Company. The Commission has not issued any stop order or other order suspending the effectiveness of any registration statement filed by the Company or any Subsidiary under the Exchange Act or the Securities Act.</TD></TR>
  <TR STYLE="font: 10pt Times New Roman, Times, Serif; vertical-align: top">
    <TD STYLE="font: 10pt Times New Roman, Times, Serif">&nbsp;</TD>
    <TD STYLE="text-align: left; font: 10pt Times New Roman, Times, Serif">&nbsp;</TD>
    <TD STYLE="font: 10pt Times New Roman, Times, Serif; text-align: justify">&nbsp;</TD></TR>
  <TR STYLE="font: 10pt Times New Roman, Times, Serif; vertical-align: top">
    <TD STYLE="font: 10pt Times New Roman, Times, Serif">&nbsp;</TD>
    <TD STYLE="text-align: left; font: 10pt Times New Roman, Times, Serif">(k)</TD>
    <TD STYLE="font: 10pt Times New Roman, Times, Serif; text-align: justify"><U>Labor Relations</U>. No labor dispute exists or, to the knowledge of the Company, is imminent with respect to any of the employees of the Company, which would reasonably be expected to result in a Material Adverse Effect. None of the Company&rsquo;s or its Subsidiaries&rsquo; employees is a member of a union that relates to such employee&rsquo;s relationship with the Company or such Subsidiary, and neither the Company nor any of its Subsidiaries is a party to a collective bargaining agreement, and the Company and its Subsidiaries believe that their relationships with their employees are good. To the knowledge of the Company, no executive officer of the Company or any Subsidiary, is, or is now expected to be, in violation of any material term of any employment contract, confidentiality, disclosure or proprietary information agreement or non-competition agreement, or any other contract or agreement or any restrictive covenant in favor of any third party, and the continued employment of each such executive officer does not subject the Company or any of its Subsidiaries to any liability with respect to any of the foregoing matters. The Company and its Subsidiaries are in compliance with all applicable U.S. federal, state, local and foreign laws and regulations relating to employment and employment practices, terms and conditions of employment and wages and hours, except where the failure to be in compliance would not, individually or in the aggregate, reasonably be expected to have a Material Adverse Effect.</TD></TR>
  </TABLE>
<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0">&nbsp;</P>


<!-- Field: Page; Sequence: 12 -->
    <DIV STYLE="margin-bottom: 6pt; border-bottom: Black 1pt solid"><TABLE CELLPADDING="0" CELLSPACING="0" STYLE="border-collapse: collapse; width: 100%; font-size: 10pt"><TR STYLE="vertical-align: top; text-align: left"><TD STYLE="text-align: center; width: 100%"><!-- Field: Sequence; Type: Arabic; Name: PageNo -->12<!-- Field: /Sequence --></TD></TR></TABLE></DIV>
    <DIV STYLE="break-before: page; margin-top: 6pt"><P STYLE="margin: 0pt">&nbsp;</P></DIV>
    <!-- Field: /Page -->

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0">&nbsp;</P>

<TABLE CELLPADDING="0" CELLSPACING="0" STYLE="border-collapse: collapse; font: 10pt Times New Roman, Times, Serif; width: 100%">
  <TR STYLE="font: 10pt Times New Roman, Times, Serif; vertical-align: top">
    <TD STYLE="font: 10pt Times New Roman, Times, Serif; width: 0.25in">&nbsp;</TD>
    <TD STYLE="text-align: left; font: 10pt Times New Roman, Times, Serif; width: 0.25in">(l)</TD>
    <TD STYLE="font: 10pt Times New Roman, Times, Serif; text-align: justify"><U>Compliance</U>. Neither the Company nor any Subsidiary: (i) is in default under or in violation of (and no event has occurred that has not been waived that, with notice or lapse of time or both, would result in a default by the Company or any Subsidiary under), nor has the Company or any Subsidiary received notice of a claim that it is in default under or that it is in violation of, any indenture, loan or credit agreement or any other agreement or instrument to which it is a party or by which it or any of its properties is bound (whether or not such default or violation has been waived), (ii) is in violation of any judgment, decree or order of any court, arbitrator or other governmental authority or (iii) is or has been in violation of any statute, rule, ordinance or regulation of any governmental authority, including without limitation all foreign, federal, state and local laws relating to taxes, environmental protection, occupational health and safety, product quality and safety and employment and labor matters, except in each case of (i), (ii) and (iii) as would not have or reasonably be expected to result in a Material Adverse Effect.</TD></TR>
  <TR STYLE="font: 10pt Times New Roman, Times, Serif; vertical-align: top">
    <TD STYLE="font: 10pt Times New Roman, Times, Serif">&nbsp;</TD>
    <TD STYLE="text-align: left; font: 10pt Times New Roman, Times, Serif">&nbsp;</TD>
    <TD STYLE="font: 10pt Times New Roman, Times, Serif; text-align: justify">&nbsp;</TD></TR>
  <TR STYLE="font: 10pt Times New Roman, Times, Serif; vertical-align: top">
    <TD STYLE="font: 10pt Times New Roman, Times, Serif">&nbsp;</TD>
    <TD STYLE="text-align: left; font: 10pt Times New Roman, Times, Serif">(m)</TD>
    <TD STYLE="font: 10pt Times New Roman, Times, Serif; text-align: justify"><U>Environmental Laws</U>. The Company and its Subsidiaries (i) are in compliance with all applicable federal, state, local and foreign laws relating to pollution or protection of human health or the environment (including ambient air, surface water, groundwater, land surface or subsurface strata), including laws relating to emissions, discharges, releases or threatened releases of chemicals, pollutants, contaminants, or toxic or hazardous substances or wastes (collectively, &ldquo;<U>Hazardous Materials</U>&rdquo;) into the environment, or otherwise relating to the manufacture, processing, distribution, use, treatment, storage, disposal, transport or handling of Hazardous Materials, as well as all authorizations, codes, decrees, demands, or demand letters, injunctions, judgments, licenses, notices or notice letters, orders, permits, plans or regulations, issued, entered, promulgated or approved thereunder (&ldquo;<U>Environmental Laws</U>&rdquo;); (ii) have received all permits licenses or other approvals required of them under applicable Environmental Laws to conduct their respective businesses; and (iii) are in compliance with all terms and conditions of any such permit, license or approval where in each clause (i), (ii) and (iii), the failure to so comply would be reasonably expected to have, individually or in the aggregate, a Material Adverse Effect.</TD></TR>
  <TR STYLE="font: 10pt Times New Roman, Times, Serif; vertical-align: top">
    <TD STYLE="font: 10pt Times New Roman, Times, Serif">&nbsp;</TD>
    <TD STYLE="text-align: left; font: 10pt Times New Roman, Times, Serif">&nbsp;</TD>
    <TD STYLE="font: 10pt Times New Roman, Times, Serif; text-align: justify">&nbsp;</TD></TR>
  <TR STYLE="font: 10pt Times New Roman, Times, Serif; vertical-align: top">
    <TD STYLE="font: 10pt Times New Roman, Times, Serif">&nbsp;</TD>
    <TD STYLE="text-align: left; font: 10pt Times New Roman, Times, Serif">(n)</TD>
    <TD STYLE="font: 10pt Times New Roman, Times, Serif; text-align: justify"><U>Regulatory Permits</U>. The Company and the Subsidiaries possess all certificates, authorizations and permits issued by the appropriate federal, state, local or foreign regulatory authorities necessary to conduct their respective businesses as described in the SEC Reports, except where the failure to possess such certificates, authorizations or permits would not reasonably be expected to result in a Material Adverse Effect (&ldquo;<U>Material Permits</U>&rdquo;), and neither the Company nor any Subsidiary has received any notice of proceedings relating to the revocation or modification of any Material Permit.</TD></TR>
  <TR STYLE="font: 10pt Times New Roman, Times, Serif; vertical-align: top">
    <TD STYLE="font: 10pt Times New Roman, Times, Serif">&nbsp;</TD>
    <TD STYLE="text-align: left; font: 10pt Times New Roman, Times, Serif">&nbsp;</TD>
    <TD STYLE="font: 10pt Times New Roman, Times, Serif; text-align: justify">&nbsp;</TD></TR>
  <TR STYLE="font: 10pt Times New Roman, Times, Serif; vertical-align: top">
    <TD STYLE="font: 10pt Times New Roman, Times, Serif">&nbsp;</TD>
    <TD STYLE="text-align: left; font: 10pt Times New Roman, Times, Serif">(o)</TD>
    <TD STYLE="font: 10pt Times New Roman, Times, Serif; text-align: justify"><U>Title to Assets</U>. The Company and the Subsidiaries have good and marketable title in fee simple to all real property owned by them and good and marketable title in all personal property owned by them that is material to the business of the Company and the Subsidiaries, in each case free and clear of all Liens, except for (i) Liens as do not materially affect the value of such property and do not materially interfere with the use made and proposed to be made of such property by the Company and the Subsidiaries and (ii) Liens for the payment of federal, state or other taxes, for which appropriate reserves have been made therefor in accordance with GAAP and, the payment of which is neither delinquent nor subject to penalties. Any real property and facilities held under lease by the Company and the Subsidiaries are held by them under valid, subsisting and enforceable leases with which the Company and the Subsidiaries are in compliance in all material respects.</TD></TR>
  </TABLE>
<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0">&nbsp;</P>


<!-- Field: Page; Sequence: 13 -->
    <DIV STYLE="margin-bottom: 6pt; border-bottom: Black 1pt solid"><TABLE CELLPADDING="0" CELLSPACING="0" STYLE="border-collapse: collapse; width: 100%; font-size: 10pt"><TR STYLE="vertical-align: top; text-align: left"><TD STYLE="text-align: center; width: 100%"><!-- Field: Sequence; Type: Arabic; Name: PageNo -->13<!-- Field: /Sequence --></TD></TR></TABLE></DIV>
    <DIV STYLE="break-before: page; margin-top: 6pt"><P STYLE="margin: 0pt">&nbsp;</P></DIV>
    <!-- Field: /Page -->

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0">&nbsp;</P>

<TABLE CELLPADDING="0" CELLSPACING="0" STYLE="border-collapse: collapse; font: 10pt Times New Roman, Times, Serif; width: 100%">
  <TR STYLE="font: 10pt Times New Roman, Times, Serif; vertical-align: top">
    <TD STYLE="font: 10pt Times New Roman, Times, Serif; width: 0.25in">&nbsp;</TD>
    <TD STYLE="text-align: left; font: 10pt Times New Roman, Times, Serif; width: 0.25in">(p)</TD>
    <TD STYLE="font: 10pt Times New Roman, Times, Serif; text-align: justify"><U>Intellectual Property</U>. The Company and the Subsidiaries have, or have rights to use, all patents, patent applications, trademarks, trademark applications, service marks, trade names, trade secrets, inventions, copyrights, licenses and other intellectual property rights and similar rights necessary or required for use in connection with their respective businesses as described in the SEC Reports and which the failure to so have would reasonably be expected to have a Material Adverse Effect (collectively, the &ldquo;<U>Intellectual Property Rights</U>&rdquo;). None of, and neither the Company nor any Subsidiary has received a notice (written or otherwise) that any of, the Intellectual Property Rights has expired, terminated or been abandoned, or is expected to expire or terminate or be abandoned, within two (2) years from the date of this Agreement except as would not reasonably be expected to have a Material Adverse Effect. Neither the Company nor any Subsidiary has received, since the date of the latest audited financial statements included within the SEC Reports, a written notice of a claim or otherwise has any knowledge that the Intellectual Property Rights violate or infringe upon the rights of any Person, except as would not have or reasonably be expected to not have a Material Adverse Effect. To the knowledge of the Company, all such Intellectual Property Rights are enforceable and there is no existing infringement by another Person of any of the Intellectual Property Rights. The Company and its Subsidiaries have taken reasonable security measures to protect the secrecy, confidentiality and value of all of their intellectual properties, except where failure to do so would not, individually or in the aggregate, reasonably be expected to have a Material Adverse Effect. The Company has no knowledge of any facts that would preclude it from having valid license rights or clear title to the Intellectual Property Rights. The Company has no knowledge that it lacks or will be unable to obtain any rights or licenses to use all Intellectual Property Rights that are necessary to conduct its business.</TD></TR>
  <TR STYLE="font: 10pt Times New Roman, Times, Serif; vertical-align: top">
    <TD STYLE="font: 10pt Times New Roman, Times, Serif">&nbsp;</TD>
    <TD STYLE="text-align: left; font: 10pt Times New Roman, Times, Serif">&nbsp;</TD>
    <TD STYLE="font: 10pt Times New Roman, Times, Serif; text-align: justify">&nbsp;</TD></TR>
  <TR STYLE="font: 10pt Times New Roman, Times, Serif; vertical-align: top">
    <TD STYLE="font: 10pt Times New Roman, Times, Serif">&nbsp;</TD>
    <TD STYLE="text-align: left; font: 10pt Times New Roman, Times, Serif">(q)</TD>
    <TD STYLE="font: 10pt Times New Roman, Times, Serif; text-align: justify"><U>Insurance</U>. The Company and the Subsidiaries are insured by insurers of recognized financial responsibility against such losses and risks and in such amounts as are prudent and customary in the businesses in which the Company and the Subsidiaries are engaged, including, but not limited to, directors and officers insurance coverage at least equal to the aggregate Subscription Amount. Neither the Company nor any Subsidiary has any reason to believe that it will not be able to renew its existing insurance coverage as and when such coverage expires or to obtain similar coverage from similar insurers as may be necessary to continue its business without a significant increase in cost.</TD></TR>
  <TR STYLE="font: 10pt Times New Roman, Times, Serif; vertical-align: top">
    <TD STYLE="font: 10pt Times New Roman, Times, Serif">&nbsp;</TD>
    <TD STYLE="text-align: left; font: 10pt Times New Roman, Times, Serif">&nbsp;</TD>
    <TD STYLE="font: 10pt Times New Roman, Times, Serif; text-align: justify">&nbsp;</TD></TR>
  <TR STYLE="font: 10pt Times New Roman, Times, Serif; vertical-align: top">
    <TD STYLE="font: 10pt Times New Roman, Times, Serif">&nbsp;</TD>
    <TD STYLE="text-align: left; font: 10pt Times New Roman, Times, Serif">(r)</TD>
    <TD STYLE="font: 10pt Times New Roman, Times, Serif; text-align: justify"><U>Transactions with Affiliates and Employees</U>. Except as set forth on Schedule 3.1(r), none of the officers or directors of the Company or any Subsidiary and, to the knowledge of the Company, none of the employees of the Company or any Subsidiary is presently a party to any transaction with the Company or any Subsidiary (other than for services as employees, officers and directors), including any contract, agreement or other arrangement providing for the furnishing of services to or by, providing for rental of real or personal property to or from, providing for the borrowing of money from or lending of money to or otherwise requiring payments to or from any officer, director or such employee or, to the knowledge of the Company, any entity in which any officer, director, or any such employee has a substantial interest or is an officer, director, trustee, shareholder, member or partner, in each case in excess of $120,000 other than for (i) payment of salary or consulting fees for services rendered, (ii) reimbursement for expenses incurred on behalf of the Company or a Subsidiary and (iii) other employee benefits, including share option agreements under any share option plan of the Company.</TD></TR>
  </TABLE>
<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0">&nbsp;</P>


<!-- Field: Page; Sequence: 14 -->
    <DIV STYLE="margin-bottom: 6pt; border-bottom: Black 1pt solid"><TABLE CELLPADDING="0" CELLSPACING="0" STYLE="border-collapse: collapse; width: 100%; font-size: 10pt"><TR STYLE="vertical-align: top; text-align: left"><TD STYLE="text-align: center; width: 100%"><!-- Field: Sequence; Type: Arabic; Name: PageNo -->14<!-- Field: /Sequence --></TD></TR></TABLE></DIV>
    <DIV STYLE="break-before: page; margin-top: 6pt"><P STYLE="margin: 0pt">&nbsp;</P></DIV>
    <!-- Field: /Page -->

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0">&nbsp;</P>

<TABLE CELLPADDING="0" CELLSPACING="0" STYLE="border-collapse: collapse; font: 10pt Times New Roman, Times, Serif; width: 100%">
  <TR STYLE="font: 10pt Times New Roman, Times, Serif; vertical-align: top">
    <TD STYLE="font: 10pt Times New Roman, Times, Serif; width: 0.25in">&nbsp;</TD>
    <TD STYLE="font: 10pt Times New Roman, Times, Serif; text-align: left; width: 0.25in">(s)</TD>
    <TD STYLE="font: 10pt Times New Roman, Times, Serif; text-align: justify"><U>Sarbanes-Oxley; Internal Accounting Controls</U>. The Company and the Subsidiaries are in material compliance with any and all applicable requirements of the Sarbanes-Oxley Act of 2002 that are effective as of the date hereof, and any and all applicable rules and regulations promulgated by the Commission thereunder that are effective as of the date hereof and as of the Closing Date. The Company and the Subsidiaries maintain a system of internal accounting controls sufficient to provide reasonable assurance that: (i) transactions are executed in accordance with management&rsquo;s general or specific authorizations, (ii) transactions are recorded as necessary to permit preparation of financial statements in conformity with GAAP and to maintain asset accountability, (iii) access to assets is permitted only in accordance with management&rsquo;s general or specific authorization, and (iv) the recorded accountability for assets is compared with the existing assets at reasonable intervals and appropriate action is taken with respect to any differences. The Company and the Subsidiaries have established disclosure controls and procedures (as defined in Exchange Act Rules 13a-15(e) and 15d-15(e)) for the Company and the Subsidiaries and designed such disclosure controls and procedures to ensure that information required to be disclosed by the Company in the reports it files or submits under the Exchange Act is recorded, processed, summarized and reported, within the time periods specified in the Commission&rsquo;s rules and forms. The Company&rsquo;s certifying officers have evaluated the effectiveness of the disclosure controls and procedures of the Company and the Subsidiaries as of the end of the period covered by the most recently filed Form 10-K under the Exchange Act (such date, the &ldquo;<U>Evaluation Date</U>&rdquo;). The Company presented in its most recently filed Form 10-K under the Exchange Act the conclusions of the certifying officers about the effectiveness of the disclosure controls and procedures based on their evaluations as of the Evaluation Date. Since the Evaluation Date, there have been no changes in the internal control over financial reporting (as such term is defined in the Exchange Act) that have materially affected, or is reasonably likely to materially affect, the internal control over financial reporting of the Company and its Subsidiaries.</TD></TR>
  <TR STYLE="font: 10pt Times New Roman, Times, Serif; vertical-align: top">
    <TD STYLE="font: 10pt Times New Roman, Times, Serif">&nbsp;</TD>
    <TD STYLE="font: 10pt Times New Roman, Times, Serif; text-align: left">&nbsp;</TD>
    <TD STYLE="font: 10pt Times New Roman, Times, Serif; text-align: justify">&nbsp;</TD></TR>
  <TR STYLE="font: 10pt Times New Roman, Times, Serif; vertical-align: top">
    <TD STYLE="font: 10pt Times New Roman, Times, Serif">&nbsp;</TD>
    <TD STYLE="font: 10pt Times New Roman, Times, Serif; text-align: left">(t)</TD>
    <TD STYLE="font: 10pt Times New Roman, Times, Serif; text-align: justify"><U>Certain Fees</U>. Except as set forth in the Preliminary Prospectus and the Prospectus, no brokerage or finder&rsquo;s fees or commissions are or will be payable by the Company or any Subsidiary to any broker, financial advisor or consultant, finder, placement agent, investment banker, bank or other Person with respect to the transactions contemplated by the Transaction Documents (for the avoidance of doubt, the foregoing shall not include any fees and/or commissions owed to the Transfer Agent). Other than for Persons engaged by any Purchaser, if any, the Purchasers shall have no obligation with respect to any fees or with respect to any claims made by or on behalf of other Persons for fees of a type contemplated in this Section 3.1(t) that may be due in connection with the transactions contemplated by the Transaction Documents.</TD></TR>
  <TR STYLE="font: 10pt Times New Roman, Times, Serif; vertical-align: top">
    <TD STYLE="font: 10pt Times New Roman, Times, Serif">&nbsp;</TD>
    <TD STYLE="font: 10pt Times New Roman, Times, Serif; text-align: left">&nbsp;</TD>
    <TD STYLE="font: 10pt Times New Roman, Times, Serif; text-align: justify">&nbsp;</TD></TR>
  <TR STYLE="font: 10pt Times New Roman, Times, Serif; vertical-align: top">
    <TD STYLE="font: 10pt Times New Roman, Times, Serif">&nbsp;</TD>
    <TD STYLE="font: 10pt Times New Roman, Times, Serif; text-align: left">(u)</TD>
    <TD STYLE="font: 10pt Times New Roman, Times, Serif; text-align: justify"><U>Investment Company</U>. The Company is not, and is not an Affiliate of, and immediately after receipt of payment for the Securities, will not be or be an Affiliate of, an &ldquo;investment company&rdquo; within the meaning of the Investment Company Act of 1940, as amended. The Company shall conduct its business in a manner so that it will not become an &ldquo;investment company&rdquo; subject to registration under the Investment Company Act of 1940, as amended.</TD></TR>
  <TR STYLE="font: 10pt Times New Roman, Times, Serif; vertical-align: top">
    <TD STYLE="font: 10pt Times New Roman, Times, Serif">&nbsp;</TD>
    <TD STYLE="font: 10pt Times New Roman, Times, Serif; text-align: left">&nbsp;</TD>
    <TD STYLE="font: 10pt Times New Roman, Times, Serif; text-align: justify">&nbsp;</TD></TR>
  <TR STYLE="font: 10pt Times New Roman, Times, Serif; vertical-align: top">
    <TD STYLE="font: 10pt Times New Roman, Times, Serif">&nbsp;</TD>
    <TD STYLE="font: 10pt Times New Roman, Times, Serif; text-align: left">(v)</TD>
    <TD STYLE="font: 10pt Times New Roman, Times, Serif; text-align: justify"><U>Registration Rights</U>. Except as set forth on <U>Schedule 3.1(v)</U>, no Person has any right to cause the Company to effect the registration under the Securities Act of any securities of the Company or any Subsidiary.</TD></TR>
  </TABLE>
<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0">&nbsp;</P>


<!-- Field: Page; Sequence: 15 -->
    <DIV STYLE="margin-bottom: 6pt; border-bottom: Black 1pt solid"><TABLE CELLPADDING="0" CELLSPACING="0" STYLE="border-collapse: collapse; width: 100%; font-size: 10pt"><TR STYLE="vertical-align: top; text-align: left"><TD STYLE="text-align: center; width: 100%"><!-- Field: Sequence; Type: Arabic; Name: PageNo -->15<!-- Field: /Sequence --></TD></TR></TABLE></DIV>
    <DIV STYLE="break-before: page; margin-top: 6pt"><P STYLE="margin: 0pt">&nbsp;</P></DIV>
    <!-- Field: /Page -->

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0">&nbsp;</P>

<TABLE CELLPADDING="0" CELLSPACING="0" STYLE="border-collapse: collapse; font: 10pt Times New Roman, Times, Serif; width: 100%">
  <TR STYLE="font: 10pt Times New Roman, Times, Serif; vertical-align: top">
    <TD STYLE="font: 10pt Times New Roman, Times, Serif; width: 0.25in">&nbsp;</TD>
    <TD STYLE="text-align: left; font: 10pt Times New Roman, Times, Serif; width: 0.25in">(w)</TD>
    <TD STYLE="font: 10pt Times New Roman, Times, Serif; text-align: justify"><U>Listing and Maintenance Requirements</U>. The shares
    of Common Stock are registered pursuant to Section 12(b) or 12(g) of the Exchange Act, and the Company has taken no action designed
    to, or which to its knowledge is likely to have the effect of, terminating the registration of the Common Stock under the Exchange
    Act nor has the Company received any notification that the Commission is contemplating terminating such registration. Except as set
    forth in <U>Schedule 3.1(w)</U>, the Company has not, in the 12 months preceding the date hereof, received notice from any Trading
    Market on which the Common Stock is or has been listed or quoted to the effect that the Company is not in compliance with the listing
    or maintenance requirements of such Trading Market. Except as set forth in <U>Schedule 3.1(w)</U>, the Company is, and has
    no reason to believe, that it will not in the foreseeable future continue to be, in compliance with all such listing and maintenance
    requirements. The Common Stock is currently eligible for electronic transfer through The Depository Trust Company or another established
    clearing corporation and the Company is current in payment of the fees to The Depository Trust Company (or such other established
    clearing corporation) in connection with such electronic transfer.</TD></TR>
  <TR STYLE="font: 10pt Times New Roman, Times, Serif; vertical-align: top">
    <TD STYLE="font: 10pt Times New Roman, Times, Serif">&nbsp;</TD>
    <TD STYLE="text-align: left; font: 10pt Times New Roman, Times, Serif">&nbsp;</TD>
    <TD STYLE="font: 10pt Times New Roman, Times, Serif; text-align: justify">&nbsp;</TD></TR>
  <TR STYLE="font: 10pt Times New Roman, Times, Serif; vertical-align: top">
    <TD STYLE="font: 10pt Times New Roman, Times, Serif">&nbsp;</TD>
    <TD STYLE="text-align: left; font: 10pt Times New Roman, Times, Serif">(x)</TD>
    <TD STYLE="font: 10pt Times New Roman, Times, Serif; text-align: justify"><U>Application of Takeover Protections</U>. The Company and the Board of Directors have taken all necessary action, if any, in order to render inapplicable any control share acquisition, business combination, poison pill (including any distribution under a rights agreement) or other similar anti-takeover provision under the Company&rsquo;s certificate of incorporation (or similar charter documents) or the laws of its state of incorporation that is or could become applicable to the Purchasers as a result of the Purchasers and the Company fulfilling their obligations or exercising their rights under the Transaction Documents, including without limitation as a result of the Company&rsquo;s issuance of the Securities and the Purchasers&rsquo; ownership of the Securities.</TD></TR>
  <TR STYLE="font: 10pt Times New Roman, Times, Serif; vertical-align: top">
    <TD STYLE="font: 10pt Times New Roman, Times, Serif">&nbsp;</TD>
    <TD STYLE="text-align: left; font: 10pt Times New Roman, Times, Serif">&nbsp;</TD>
    <TD STYLE="font: 10pt Times New Roman, Times, Serif; text-align: justify">&nbsp;</TD></TR>
  <TR STYLE="font: 10pt Times New Roman, Times, Serif; vertical-align: top">
    <TD STYLE="font: 10pt Times New Roman, Times, Serif">&nbsp;</TD>
    <TD STYLE="text-align: left; font: 10pt Times New Roman, Times, Serif">(y)</TD>
    <TD STYLE="font: 10pt Times New Roman, Times, Serif; text-align: justify"><U>Disclosure</U>. Except with respect to the material terms and conditions of the transactions contemplated by the Transaction Documents, the Company confirms that neither it nor any other Person acting on its behalf has provided any of the Purchasers or their agents or counsel with any information that it believes constitutes or might constitute material, non-public information which is not otherwise disclosed in the Preliminary Prospectus or the Prospectus. The Company understands and confirms that the Purchasers will rely on the foregoing representation in effecting transactions in securities of the Company. All of the disclosure furnished by or on behalf of the Company to the Purchasers regarding the Company and its Subsidiaries, their respective businesses and the transactions contemplated hereby, including the Disclosure Schedules to this Agreement, is true and correct in all material respects and does not contain any untrue statement of a material fact or omit to state any material fact necessary in order to make the statements made therein, in the light of the circumstances under which they were made, not misleading. The press releases disseminated by the Company during the twelve (12) months preceding the date of this Agreement taken as a whole do not contain any untrue statement of a material fact or omit to state a material fact required to be stated therein or necessary in order to make the statements therein, in light of the circumstances under which they were made and when made, not misleading. The Company acknowledges that no Purchaser makes or has made any representations or warranties with respect to the transactions contemplated hereby other than those specifically set forth in Section 3.2 hereof.</TD></TR>
  <TR STYLE="font: 10pt Times New Roman, Times, Serif; vertical-align: top">
    <TD STYLE="font: 10pt Times New Roman, Times, Serif">&nbsp;</TD>
    <TD STYLE="text-align: left; font: 10pt Times New Roman, Times, Serif">&nbsp;</TD>
    <TD STYLE="font: 10pt Times New Roman, Times, Serif; text-align: justify">&nbsp;</TD></TR>
  <TR STYLE="font: 10pt Times New Roman, Times, Serif; vertical-align: top">
    <TD STYLE="font: 10pt Times New Roman, Times, Serif">&nbsp;</TD>
    <TD STYLE="text-align: left; font: 10pt Times New Roman, Times, Serif">(z)</TD>
    <TD STYLE="font: 10pt Times New Roman, Times, Serif; text-align: justify"><U>No Integrated Offering</U>. Assuming the accuracy of
    the Purchasers&rsquo; representations and warranties set forth in Section 3.2, except as set forth on Schedule 3.1(z), neither
    the Company, nor any of its Affiliates, nor any Person acting on its or their behalf has, directly or indirectly, made any offers
    or sales of any security or solicited any offers to buy any security, under circumstances that would cause this offering of the Securities
    to be integrated with prior offerings by the Company for purposes of any applicable shareholder approval provisions of any Trading
    Market on which any of the securities of the Company are listed or designated.</TD></TR>
  </TABLE>
<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0">&nbsp;</P>


<!-- Field: Page; Sequence: 16 -->
    <DIV STYLE="margin-bottom: 6pt; border-bottom: Black 1pt solid"><TABLE CELLPADDING="0" CELLSPACING="0" STYLE="border-collapse: collapse; width: 100%; font-size: 10pt"><TR STYLE="vertical-align: top; text-align: left"><TD STYLE="text-align: center; width: 100%"><!-- Field: Sequence; Type: Arabic; Name: PageNo -->16<!-- Field: /Sequence --></TD></TR></TABLE></DIV>
    <DIV STYLE="break-before: page; margin-top: 6pt"><P STYLE="margin: 0pt">&nbsp;</P></DIV>
    <!-- Field: /Page -->

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0">&nbsp;</P>

<TABLE CELLPADDING="0" CELLSPACING="0" STYLE="border-collapse: collapse; font: 10pt Times New Roman, Times, Serif; width: 100%">
  <TR STYLE="font: 10pt Times New Roman, Times, Serif; vertical-align: top">
    <TD STYLE="font: 10pt Times New Roman, Times, Serif; width: 0.25in">&nbsp;</TD>
    <TD STYLE="text-align: left; font: 10pt Times New Roman, Times, Serif; width: 0.25in">(aa)</TD>
    <TD STYLE="font: 10pt Times New Roman, Times, Serif; text-align: justify"><U>Solvency</U>. Except as set forth in Schedule 3.1(aa),
    based on the consolidated financial condition of the Company as of the Closing Date, after giving effect to the receipt by the
    Company of the proceeds from the sale of the Securities hereunder, (i) the fair saleable value of the Company&rsquo;s assets exceeds
    the amount that will be required to be paid on or in respect of the Company&rsquo;s existing debts and other liabilities (including
    known contingent liabilities) as they mature, (ii) the Company&rsquo;s assets do not constitute unreasonably small capital to carry
    on its business as now conducted and as proposed to be conducted including its capital needs taking into account the particular
    capital requirements of the business conducted by the Company, consolidated and projected capital requirements and capital
    availability thereof, and (iii) the current cash flow of the Company, together with the proceeds the Company would receive, were it
    to liquidate all of its assets, after taking into account all anticipated uses of the cash, would be sufficient to pay all amounts
    on or in respect of its liabilities when such amounts are required to be paid. Except as set forth in Schedule 3.1(aa), (i) the
    Company does not intend to incur debts beyond its ability to pay such debts as they mature (taking into account the timing and
    amounts of cash to be payable on or in respect of its debt) and (ii) the Company has no knowledge of any facts or circumstances,
    which lead it to believe that it will file for reorganization or liquidation under the bankruptcy or reorganization laws of any
    jurisdiction within one year from the Closing Date. <U>Schedule 3.1(aa)</U> sets forth, as of the last date of the
    month preceding the date of this Agreement, all outstanding secured and unsecured Indebtedness of the Company or any Subsidiary,
    or for which the Company or any Subsidiary has commitments. For the purposes of this Agreement, &ldquo;<U>Indebtedness</U>&rdquo;
    means (x) any liabilities for borrowed money or amounts owed by the Company in excess of $50,000 (other than trade accounts payable
    incurred in the ordinary course of business), (y) all guaranties, endorsements and other contingent obligations in respect of
    indebtedness of others to third parties, whether or not the same are or should be reflected in the Company&rsquo;s consolidated
    balance sheet (or the notes thereto), except guaranties by endorsement of negotiable instruments for deposit or collection or
    similar transactions in the ordinary course of business; and (z) the present value of any lease payments in excess of $50,000 due
    under leases required to be capitalized in accordance with GAAP. Neither the Company nor any Subsidiary is in default with respect
    to any Indebtedness.</TD></TR>
  <TR STYLE="font: 10pt Times New Roman, Times, Serif; vertical-align: top">
    <TD STYLE="font: 10pt Times New Roman, Times, Serif">&nbsp;</TD>
    <TD STYLE="text-align: left; font: 10pt Times New Roman, Times, Serif">&nbsp;</TD>
    <TD STYLE="font: 10pt Times New Roman, Times, Serif; text-align: justify">&nbsp;</TD></TR>
  <TR STYLE="font: 10pt Times New Roman, Times, Serif; vertical-align: top">
    <TD STYLE="font: 10pt Times New Roman, Times, Serif">&nbsp;</TD>
    <TD STYLE="text-align: left; font: 10pt Times New Roman, Times, Serif">(bb)</TD>
    <TD STYLE="font: 10pt Times New Roman, Times, Serif; text-align: justify"><U>Tax Compliance</U>. Except for matters that would not, individually or in the aggregate, have or reasonably be expected to result in a Material Adverse Effect, the Company and its Subsidiaries each (i) has made or filed all federal, state and local income and all foreign income and franchise tax returns, reports and declarations required by any jurisdiction to which it is subject, (ii) has paid all taxes and other governmental assessments and charges, fines or penalties that are material in amount, shown or determined to be due on such returns, reports and declarations and (iii) has set aside on its financial statements provision reasonably adequate for the payment of all material tax liability of which has not been finally determined and all material taxes for periods subsequent to the periods to which such returns, reports or declarations apply. There are no unpaid taxes in any material amount claimed to be due by the taxing authority of any jurisdiction, and the officers of the Company or of any Subsidiary know of no basis for any such claim.</TD></TR>
  <TR STYLE="font: 10pt Times New Roman, Times, Serif; vertical-align: top">
    <TD STYLE="font: 10pt Times New Roman, Times, Serif">&nbsp;</TD>
    <TD STYLE="text-align: left; font: 10pt Times New Roman, Times, Serif">&nbsp;</TD>
    <TD STYLE="font: 10pt Times New Roman, Times, Serif; text-align: justify">&nbsp;</TD></TR>
  <TR STYLE="font: 10pt Times New Roman, Times, Serif; vertical-align: top">
    <TD STYLE="font: 10pt Times New Roman, Times, Serif">&nbsp;</TD>
    <TD STYLE="text-align: left; font: 10pt Times New Roman, Times, Serif">(cc)</TD>
    <TD STYLE="font: 10pt Times New Roman, Times, Serif; text-align: justify"><U>Foreign Corrupt Practices</U>. Neither the Company nor any Subsidiary, nor to the knowledge of the Company or any Subsidiary, any agent or other person acting on behalf of the Company or any Subsidiary, has (i) directly or indirectly, used any funds for unlawful contributions, gifts, entertainment or other unlawful expenses related to foreign or domestic political activity, (ii) made any unlawful payment to foreign or domestic government officials or employees or to any foreign or domestic political parties or campaigns from corporate funds, (iii) failed to disclose fully any contribution made by the Company or any Subsidiary (or made by any person acting on its behalf of which the Company is aware) which is in violation of law, or (iv) violated in any material respect any provision of FCPA.</TD></TR>
  </TABLE>
<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0">&nbsp;</P>


<!-- Field: Page; Sequence: 17 -->
    <DIV STYLE="margin-bottom: 6pt; border-bottom: Black 1pt solid"><TABLE CELLPADDING="0" CELLSPACING="0" STYLE="border-collapse: collapse; width: 100%; font-size: 10pt"><TR STYLE="vertical-align: top; text-align: left"><TD STYLE="text-align: center; width: 100%"><!-- Field: Sequence; Type: Arabic; Name: PageNo -->17<!-- Field: /Sequence --></TD></TR></TABLE></DIV>
    <DIV STYLE="break-before: page; margin-top: 6pt"><P STYLE="margin: 0pt">&nbsp;</P></DIV>
    <!-- Field: /Page -->

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0">&nbsp;</P>

<TABLE CELLPADDING="0" CELLSPACING="0" STYLE="border-collapse: collapse; font: 10pt Times New Roman, Times, Serif; width: 100%">
  <TR STYLE="font: 10pt Times New Roman, Times, Serif; vertical-align: top">
    <TD STYLE="font: 10pt Times New Roman, Times, Serif; width: 0.25in">&nbsp;</TD>
    <TD STYLE="font: 10pt Times New Roman, Times, Serif; text-align: left; width: 0.25in">(dd)</TD>
    <TD STYLE="font: 10pt Times New Roman, Times, Serif; text-align: justify"><U>Accountants</U>. The Company&rsquo;s independent registered
    public accounting firm is WithumSmith+Brown, PC. To the knowledge and belief of the Company, such accounting firm (i) is a registered
    public accounting firm as required by the Exchange Act and (ii) has expressed its opinion with respect to the financial
    statements included in the Company&rsquo;s Annual Report for the fiscal year ended December 31, 2024.</TD></TR>
  <TR STYLE="font: 10pt Times New Roman, Times, Serif; vertical-align: top">
    <TD STYLE="font: 10pt Times New Roman, Times, Serif">&nbsp;</TD>
    <TD STYLE="text-align: left; font: 10pt Times New Roman, Times, Serif">&nbsp;</TD>
    <TD STYLE="font: 10pt Times New Roman, Times, Serif; text-align: justify">&nbsp;</TD></TR>
  <TR STYLE="font: 10pt Times New Roman, Times, Serif; vertical-align: top">
    <TD STYLE="font: 10pt Times New Roman, Times, Serif">&nbsp;</TD>
    <TD STYLE="text-align: left; font: 10pt Times New Roman, Times, Serif">(ee)</TD>
    <TD STYLE="font: 10pt Times New Roman, Times, Serif; text-align: justify"><U>Acknowledgment Regarding Purchasers&rsquo; Purchase of Securities</U>. The Company acknowledges and agrees that each of the Purchasers is acting solely in the capacity of an arm&rsquo;s length purchaser with respect to the Transaction Documents and the transactions contemplated thereby. The Company further acknowledges that no Purchaser is acting as a financial advisor or fiduciary of the Company (or in any similar capacity) with respect to the Transaction Documents and the transactions contemplated thereby and any advice given by any Purchaser or any of their respective representatives or agents in connection with the Transaction Documents and the transactions contemplated thereby is merely incidental to the Purchasers&rsquo; purchase of the Securities. The Company further represents to each Purchaser that the Company&rsquo;s decision to enter into this Agreement and the other Transaction Documents has been based solely on the independent evaluation of the transactions contemplated hereby by the Company and its representatives.</TD></TR>
  <TR STYLE="font: 10pt Times New Roman, Times, Serif; vertical-align: top">
    <TD STYLE="font: 10pt Times New Roman, Times, Serif">&nbsp;</TD>
    <TD STYLE="text-align: left; font: 10pt Times New Roman, Times, Serif">&nbsp;</TD>
    <TD STYLE="font: 10pt Times New Roman, Times, Serif; text-align: justify">&nbsp;</TD></TR>
  <TR STYLE="font: 10pt Times New Roman, Times, Serif; vertical-align: top">
    <TD STYLE="font: 10pt Times New Roman, Times, Serif">&nbsp;</TD>
    <TD STYLE="text-align: left; font: 10pt Times New Roman, Times, Serif">(ff)</TD>
    <TD STYLE="font: 10pt Times New Roman, Times, Serif; text-align: justify"><U>Acknowledgment Regarding Purchasers&rsquo; Trading Activity</U>. Anything in this Agreement or elsewhere herein to the contrary notwithstanding (except for Sections 3.2(f) and 4.12 hereof), it is understood and acknowledged by the Company that: (i) none of the Purchasers has been asked by the Company to agree, nor has any Purchaser agreed, to desist from purchasing or selling, long and/or short, securities of the Company, or &ldquo;derivative&rdquo; securities based on securities issued by the Company or to hold the Securities for any specified term; (ii) past or future open market or other transactions by any Purchaser, specifically including, without limitation, Short Sales or &ldquo;derivative&rdquo; transactions, before or after the closing of this or future private placement transactions, may negatively impact the market price of the Company&rsquo;s publicly-traded securities; (iii) any Purchaser, and counter-parties in &ldquo;derivative&rdquo; transactions to which any such Purchaser is a party, directly or indirectly, presently may have a &ldquo;short&rdquo; position in the shares of Common Stock, and (iv) each Purchaser shall not be deemed to have any affiliation with or control over any arm&rsquo;s length counter-party in any &ldquo;derivative&rdquo; transaction. The Company further understands and acknowledges that (y) one or more Purchasers may engage in hedging activities (in material compliance with applicable laws) at various times during the period that the shares of Common Stock are outstanding, and (z) such hedging activities (if any) could reduce the value of the existing stockholders&rsquo; equity interests in the Company at and after the time that the hedging activities are being conducted. The Company acknowledges that such aforementioned hedging activities do not constitute a breach of any of the Transaction Documents.</TD></TR>
  <TR STYLE="font: 10pt Times New Roman, Times, Serif; vertical-align: top">
    <TD STYLE="font: 10pt Times New Roman, Times, Serif">&nbsp;</TD>
    <TD STYLE="text-align: left; font: 10pt Times New Roman, Times, Serif">&nbsp;</TD>
    <TD STYLE="font: 10pt Times New Roman, Times, Serif; text-align: justify">&nbsp;</TD></TR>
  <TR STYLE="font: 10pt Times New Roman, Times, Serif; vertical-align: top">
    <TD STYLE="font: 10pt Times New Roman, Times, Serif">&nbsp;</TD>
    <TD STYLE="text-align: left; font: 10pt Times New Roman, Times, Serif">(gg)</TD>
    <TD STYLE="font: 10pt Times New Roman, Times, Serif; text-align: justify"><U>Regulation M Compliance</U>. The Company has not, and to its knowledge no one acting on its behalf has, (i) taken, directly or indirectly, any action designed to cause or to result in the stabilization or manipulation of the price of any security of the Company to facilitate the sale or resale of any of the shares of Common Stock, (ii) except as previously disclosed in the SEC Reports and pursuant to the Company&rsquo;s stock buyback program, sold, bid for, purchased, or, paid any compensation for soliciting purchases of, any of the shares of Common Stock, or (iii) except as previously disclosed in the SEC Reports and pursuant to the Company&rsquo;s stock buyback program, paid or agreed to pay to any Person any compensation for soliciting another to purchase any other securities of the Company, other than, in the case of clauses (ii) and (iii), compensation paid to the Placement Agent in connection with the placement of the shares of Common Stock.</TD></TR>
  </TABLE>
<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0">&nbsp;</P>


<!-- Field: Page; Sequence: 18 -->
    <DIV STYLE="margin-bottom: 6pt; border-bottom: Black 1pt solid"><TABLE CELLPADDING="0" CELLSPACING="0" STYLE="border-collapse: collapse; width: 100%; font-size: 10pt"><TR STYLE="vertical-align: top; text-align: left"><TD STYLE="text-align: center; width: 100%"><!-- Field: Sequence; Type: Arabic; Name: PageNo -->18<!-- Field: /Sequence --></TD></TR></TABLE></DIV>
    <DIV STYLE="break-before: page; margin-top: 6pt"><P STYLE="margin: 0pt">&nbsp;</P></DIV>
    <!-- Field: /Page -->

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0">&nbsp;</P>

<TABLE CELLSPACING="0" CELLPADDING="0" STYLE="font: 10pt Times New Roman, Times, Serif; width: 100%; border-collapse: collapse">
  <TR STYLE="font: 10pt Times New Roman, Times, Serif; vertical-align: top">
    <TD STYLE="font: 10pt Times New Roman, Times, Serif; width: 0.25in">&nbsp;</TD>
    <TD STYLE="text-align: left; font: 10pt Times New Roman, Times, Serif; width: 0.25in">(hh)</TD>
    <TD STYLE="font: 10pt Times New Roman, Times, Serif; text-align: justify"><U>Non-Contravention of Existing Instruments; No Further Authorizations or Approvals Required</U>. The Company&rsquo;s execution, delivery and performance of this Agreement and consummation of the transactions contemplated hereby will not (A) result in a material violation of any existing applicable law, rule, regulation, judgment, order or decree of any governmental entity as of the date hereof (including, without limitation, those promulgated by the Food and Drug Administration of the U.S. Department of Health and Human Services (the &ldquo;<U>FDA</U>&rdquo;) or by any foreign, federal, state or local regulatory authority performing functions similar to those performed by the FDA), (B) conflict with, result in any violation or breach of, or constitute a default (or an event that with notice or lapse of time or both would become a default) under, or give to others any right of termination, amendment, acceleration or cancellation (with or without notice, lapse of time or both) (a &ldquo;<U>Default Acceleration Event</U>&rdquo;) of, any agreement, lease, credit facility, debt, note, bond, mortgage, indenture or other instrument (&ldquo;<U>Contract</U>&rdquo;) or obligation or other understanding to which the Company is a party or by which any property or asset of the Company is bound or affected, except to the extent that such conflict, default, or Default Acceleration Event is not reasonably likely to result in a Material Adverse Effect, or (C) result in a breach or violation of any of the terms and provisions of, or constitute a default under, the Company&rsquo;s articles of incorporation (as the same may be amended or restated from time to time) or bylaws (as the same may be amended or restated from time to time). The Company is not in violation, breach or default under its certificate of incorporation (as the same may be amended or restated from time to time) or bylaws (as the same may be amended or restated from time to time). Neither the Company nor, to its knowledge, any other party is in violation, breach or default of any Contract that has resulted in or could reasonably be expected to result in a Material Adverse Effect. Each approval, consent, order, authorization, designation, declaration or filing by or with any regulatory, administrative or other governmental body necessary in connection with the execution and delivery by the Company of this Agreement and the performance of the Company of the transactions herein contemplated has been obtained or made and is in full force and effect, except filings with the Commission required under the Securities Act or the Exchange Act, or filings with the Exchange pursuant to the rules and regulations of the Exchange, in each case that are contemplated by this Agreement to be made after the date of this Agreement. </TD></TR>
  <TR STYLE="font: 10pt Times New Roman, Times, Serif; vertical-align: top">
    <TD STYLE="font: 10pt Times New Roman, Times, Serif">&nbsp;</TD>
    <TD STYLE="text-align: left; font: 10pt Times New Roman, Times, Serif">&nbsp;</TD>
    <TD STYLE="font: 10pt Times New Roman, Times, Serif; text-align: justify">&nbsp;</TD></TR>
  <TR STYLE="font: 10pt Times New Roman, Times, Serif; vertical-align: top">
    <TD STYLE="font: 10pt Times New Roman, Times, Serif">&nbsp;</TD>
    <TD STYLE="text-align: left; font: 10pt Times New Roman, Times, Serif">(ii)</TD>
    <TD STYLE="font: 10pt Times New Roman, Times, Serif; text-align: justify"><U>Stock Option Plans</U>. Each stock option granted by
    the Company under the Company&rsquo;s stock option plan or pursuant to an inducement option grant was granted (i) in accordance
    with the terms of the Company&rsquo;s stock option plan or inducement option agreements and (ii) with an exercise price at least equal to the fair market
    value of the Common Stock on the date such stock option would be considered granted under GAAP and applicable law. No stock option
    granted under the Company&rsquo;s stock option plan has been backdated. The Company has not knowingly granted, and there is no and
    has been no Company policy or practice to knowingly grant, stock options prior to, or otherwise knowingly coordinate the grant of
    stock options with, the release or other public announcement of material information regarding the Company or its Subsidiaries or
    their financial results or prospects.</TD></TR>
  <TR STYLE="font: 10pt Times New Roman, Times, Serif; vertical-align: top">
    <TD STYLE="font: 10pt Times New Roman, Times, Serif">&nbsp;</TD>
    <TD STYLE="text-align: left; font: 10pt Times New Roman, Times, Serif">&nbsp;</TD>
    <TD STYLE="font: 10pt Times New Roman, Times, Serif; text-align: justify">&nbsp;</TD></TR>
  <TR STYLE="font: 10pt Times New Roman, Times, Serif; vertical-align: top">
    <TD STYLE="font: 10pt Times New Roman, Times, Serif">&nbsp;</TD>
    <TD STYLE="text-align: left; font: 10pt Times New Roman, Times, Serif">(jj)</TD>
    <TD STYLE="font: 10pt Times New Roman, Times, Serif; text-align: justify"><U>Cybersecurity</U>. (i)(x)To the knowledge of the Company, there has been no material security breach or other compromise of or relating to any of the Company&rsquo;s or any Subsidiary&rsquo;s information technology and computer systems, networks, hardware, software, data (including the data of its respective customers, employees, suppliers, vendors and any third-party data maintained by or on behalf of it), equipment or technology (collectively, &ldquo;<U>IT Systems and Data</U>&rdquo;) and (y) the Company and the Subsidiaries have not been notified of, and has no knowledge of any event or condition that would reasonably be expected to result in, any security breach or other compromise to its IT Systems and Data that would require notification to any third party under applicable law; (ii) the Company and the Subsidiaries are presently in compliance with all applicable laws or statutes and all judgments, orders, rules and regulations of any court or arbitrator or governmental or regulatory authority, internal policies and contractual obligations relating to the privacy and security of IT Systems and Data and to the protection of such IT Systems and Data from unauthorized use, access, misappropriation or modification, except as would not, individually or in the aggregate, have a Material Adverse Effect; (iii) the Company and the Subsidiaries have implemented and maintained commercially reasonable safeguards to maintain and protect its material confidential information and the integrity, continuous operation, redundancy and security of all IT Systems and Data; and (iv) the Company and the Subsidiaries have implemented backup and disaster recovery technology consistent with commercially reasonable industry standards and practices.</TD></TR>
  </TABLE>
<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0">&nbsp;</P>


<!-- Field: Page; Sequence: 19 -->
    <DIV STYLE="margin-bottom: 6pt; border-bottom: Black 1pt solid"><TABLE CELLPADDING="0" CELLSPACING="0" STYLE="border-collapse: collapse; width: 100%; font-size: 10pt"><TR STYLE="vertical-align: top; text-align: left"><TD STYLE="text-align: center; width: 100%"><!-- Field: Sequence; Type: Arabic; Name: PageNo -->19<!-- Field: /Sequence --></TD></TR></TABLE></DIV>
    <DIV STYLE="break-before: page; margin-top: 6pt"><P STYLE="margin: 0pt">&nbsp;</P></DIV>
    <!-- Field: /Page -->

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0">&nbsp;</P>

<TABLE CELLSPACING="0" CELLPADDING="0" STYLE="font: 10pt Times New Roman, Times, Serif; width: 100%; border-collapse: collapse">
  <TR STYLE="font: 10pt Times New Roman, Times, Serif; vertical-align: top">
    <TD STYLE="font: 10pt Times New Roman, Times, Serif; width: 0.25in">&nbsp;</TD>
    <TD STYLE="font: 10pt Times New Roman, Times, Serif; width: 0.25in">(kk)</TD>
    <TD STYLE="font: 10pt Times New Roman, Times, Serif; text-align: justify"><U>Office of Foreign Assets Control</U>. Neither the Company nor any Subsidiary nor, to the Company&rsquo;s knowledge, any director, officer, agent, employee or affiliate of the Company or any Subsidiary is currently subject to any U.S. sanctions administered by the Office of Foreign Assets Control of the U.S. Treasury Department.</TD></TR>
  <TR STYLE="font: 10pt Times New Roman, Times, Serif; vertical-align: top">
    <TD STYLE="font: 10pt Times New Roman, Times, Serif">&nbsp;</TD>
    <TD STYLE="font: 10pt Times New Roman, Times, Serif">&nbsp;</TD>
    <TD STYLE="font: 10pt Times New Roman, Times, Serif; text-align: justify">&nbsp;</TD></TR>
  <TR STYLE="font: 10pt Times New Roman, Times, Serif; vertical-align: top">
    <TD STYLE="font: 10pt Times New Roman, Times, Serif">&nbsp;</TD>
    <TD STYLE="font: 10pt Times New Roman, Times, Serif">(ll)</TD>
    <TD STYLE="font: 10pt Times New Roman, Times, Serif; text-align: justify"><U>U.S. Real Property Holding Corporation</U>. The Company is not and has never been a U.S. real property holding corporation within the meaning of Section 897 of the Internal Revenue Code of 1986, as amended, and the Company shall so certify upon the Purchasers&rsquo; request.</TD></TR>
  <TR STYLE="font: 10pt Times New Roman, Times, Serif; vertical-align: top">
    <TD STYLE="font: 10pt Times New Roman, Times, Serif">&nbsp;</TD>
    <TD STYLE="font: 10pt Times New Roman, Times, Serif">&nbsp;</TD>
    <TD STYLE="font: 10pt Times New Roman, Times, Serif; text-align: justify">&nbsp;</TD></TR>
  <TR STYLE="font: 10pt Times New Roman, Times, Serif; vertical-align: top">
    <TD STYLE="font: 10pt Times New Roman, Times, Serif">&nbsp;</TD>
    <TD STYLE="font: 10pt Times New Roman, Times, Serif">(mm)</TD>
    <TD STYLE="font: 10pt Times New Roman, Times, Serif; text-align: justify"><U>Bank Holding Company Act</U>. Neither the Company nor any of its Subsidiaries or Affiliates is subject to the Bank Holding Company Act of 1956, as amended (the &ldquo;<U>BHCA</U>&rdquo;) and to regulation by the Board of Governors of the Federal Reserve System (the &ldquo;<U>Federal Reserve</U>&rdquo;). Neither the Company nor any of its Subsidiaries or Affiliates owns or controls, directly or indirectly, five percent (5%) or more of the outstanding shares of any class of voting securities or twenty-five percent (25%) or more of the total equity of a bank or any entity that is subject to the BHCA and to regulation by the Federal Reserve. Neither the Company nor any of its Subsidiaries or Affiliates exercises a controlling influence over the management or policies of a bank or any entity that is subject to the BHCA and to regulation by the Federal Reserve.</TD></TR>
  <TR STYLE="font: 10pt Times New Roman, Times, Serif; vertical-align: top">
    <TD STYLE="font: 10pt Times New Roman, Times, Serif">&nbsp;</TD>
    <TD STYLE="font: 10pt Times New Roman, Times, Serif">&nbsp;</TD>
    <TD STYLE="font: 10pt Times New Roman, Times, Serif; text-align: justify">&nbsp;</TD></TR>
  <TR STYLE="font: 10pt Times New Roman, Times, Serif; vertical-align: top">
    <TD STYLE="font: 10pt Times New Roman, Times, Serif">&nbsp;</TD>
    <TD STYLE="font: 10pt Times New Roman, Times, Serif">(nn)</TD>
    <TD STYLE="font: 10pt Times New Roman, Times, Serif; text-align: justify"><U>Money Laundering</U>. The operations of the Company and its Subsidiaries are and have been conducted at all times in compliance with applicable financial record-keeping and reporting requirements of the Currency and Foreign Transactions Reporting Act of 1970, as amended, applicable money laundering statutes and applicable rules and regulations thereunder (collectively, the &ldquo;<U>Money Laundering Laws</U>&rdquo;), and no action, suit or proceeding by or before any court or governmental agency, authority or body or any arbitrator involving the Company or any Subsidiary with respect to the Money Laundering Laws is pending or, to the knowledge of the Company or any Subsidiary, threatened.</TD></TR>
  <TR STYLE="font: 10pt Times New Roman, Times, Serif; vertical-align: top">
    <TD STYLE="font: 10pt Times New Roman, Times, Serif">&nbsp;</TD>
    <TD STYLE="font: 10pt Times New Roman, Times, Serif">&nbsp;</TD>
    <TD STYLE="font: 10pt Times New Roman, Times, Serif; text-align: justify">&nbsp;</TD></TR>
  <TR STYLE="font: 10pt Times New Roman, Times, Serif; vertical-align: top">
    <TD STYLE="font: 10pt Times New Roman, Times, Serif">&nbsp;</TD>
    <TD STYLE="font: 10pt Times New Roman, Times, Serif">(oo)</TD>
    <TD STYLE="font: 10pt Times New Roman, Times, Serif; text-align: justify"><U>Promotional Stock Activities</U>. Neither the Company nor any Subsidiary of the Company and none of their respective officers, directors, managers, affiliates or agents have engaged in any stock promotional activity that could give rise to a complaint, inquiry, or trading suspension by the Commission alleging (i) a violation of the anti-fraud provisions of the federal securities laws, (ii) violations of the anti-touting provisions, (iii) improper &ldquo;gun-jumping&rdquo;; or (iv) promotion without proper disclosure of compensation.</TD></TR>
  <TR STYLE="font: 10pt Times New Roman, Times, Serif; vertical-align: top">
    <TD STYLE="font: 10pt Times New Roman, Times, Serif">&nbsp;</TD>
    <TD STYLE="font: 10pt Times New Roman, Times, Serif">&nbsp;</TD>
    <TD STYLE="font: 10pt Times New Roman, Times, Serif; text-align: justify">&nbsp;</TD></TR>
  <TR STYLE="font: 10pt Times New Roman, Times, Serif; vertical-align: top">
    <TD STYLE="font: 10pt Times New Roman, Times, Serif">&nbsp;</TD>
    <TD STYLE="font: 10pt Times New Roman, Times, Serif">(pp)</TD>
    <TD STYLE="font: 10pt Times New Roman, Times, Serif; text-align: justify"><U>Regulatory Matters; Compliance</U>. All preclinical and other nonclinical studies and clinical trials conducted by or on behalf of the Company that are material to the Company have been adequately described in the Registration Statement, in all material respects. The clinical trials and nonclinical studies conducted by or on behalf of the Company that are described in the Registration Statement or the results of such trials and studies which are referred to in the Registration Statement were and, if still ongoing, are being conducted in material compliance with all laws and regulations applicable thereto in the jurisdictions in which they are being conducted. The descriptions in the Registration Statement of the results of such trials and studies are accurate and complete in all material respects and fairly present the data derived from such trials and studies, and the Company has no knowledge of any clinical trials the aggregate results of which are inconsistent with or otherwise call into question the results of any clinical trial conducted by or on behalf of the Company that are described in the Registration Statement or the results of which are referred to in the Registration Statement. Except as disclosed in the Registration Statement, the Company has not received any written notices or other communications from the FDA, the European Medicines Agency (&ldquo;<U>EMA</U>&rdquo;) or any other governmental agency or authority imposing, requiring, requesting or suggesting a clinical hold, termination, suspension or material modification of any clinical trial that is described in the Registration Statement or the results of which are referred to in the Registration Statement. Except as disclosed in the Registration Statement, the Company has not received any written notices or other communications from the FDA, the EMA or any other governmental agency, and otherwise has no knowledge of, or reason to believe that, (i) any investigational new drug application for a potential product of the Company is or has been rejected or determined to be non-approvable or conditionally approvable; and (ii) any license, approval, permit or authorization to conduct any clinical trial of any potential product of the Company has been, will be or may be suspended, revoked, modified or limited.</TD></TR>
  </TABLE>
<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0">&nbsp;</P>


<!-- Field: Page; Sequence: 20 -->
    <DIV STYLE="margin-bottom: 6pt; border-bottom: Black 1pt solid"><TABLE CELLPADDING="0" CELLSPACING="0" STYLE="border-collapse: collapse; width: 100%; font-size: 10pt"><TR STYLE="vertical-align: top; text-align: left"><TD STYLE="text-align: center; width: 100%"><!-- Field: Sequence; Type: Arabic; Name: PageNo -->20<!-- Field: /Sequence --></TD></TR></TABLE></DIV>
    <DIV STYLE="break-before: page; margin-top: 6pt"><P STYLE="margin: 0pt">&nbsp;</P></DIV>
    <!-- Field: /Page -->

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0">&nbsp;</P>

<TABLE CELLSPACING="0" CELLPADDING="0" STYLE="font: 10pt Times New Roman, Times, Serif; width: 100%; border-collapse: collapse">
  <TR STYLE="font: 10pt Times New Roman, Times, Serif; vertical-align: top">
    <TD STYLE="font: 10pt Times New Roman, Times, Serif; width: 0.25in">&nbsp;</TD>
    <TD STYLE="text-align: left; font: 10pt Times New Roman, Times, Serif; width: 0.25in">(qq)</TD>
    <TD STYLE="font: 10pt Times New Roman, Times, Serif; text-align: justify"><U>Compliance with Data Privacy Laws</U>. (i) The Company and the Subsidiaries are, and at all times during the last three (3) years were, in compliance with all applicable state, federal and foreign data privacy and security laws and regulations, (collectively, &ldquo;<U>Privacy Laws</U>&rdquo;); (ii) the Company and the Subsidiaries have in place, comply with, and take commercially reasonable steps designed to comply with their policies and procedures relating to data privacy and security and the collection, storage, use, disclosure, handling and analysis of Personal Data (as defined below) (the &ldquo;<U>Policies</U>&rdquo;); &ldquo;Personal Data&rdquo; means (i) a natural person&rsquo;s name, street address, telephone number, email address, photograph, social security number, bank information, or customer or account number; and (ii) any other piece of information that allows the identification of such natural person, or his or her family, or permits the collection or analysis of any identifiable data related to an identified person&rsquo;s health or sexual orientation. (i) None of such disclosures made or contained in any of the Policies have been inaccurate, misleading, or deceptive in violation of any Privacy Laws and (ii) the execution, delivery and performance of the Transaction Documents will not result in a breach of any Privacy Laws or Policies. Neither the Company nor the Subsidiaries (is a party to any order, decree, or agreement by or with any court or arbitrator or governmental or regulatory authority that imposed any obligation or liability under any Privacy Law.</TD></TR>
  </TABLE>
<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify">3.2 <U>Representations and Warranties of the Purchasers</U>.
Each Purchaser, for itself and for no other Purchaser, hereby represents and warrants as of the date hereof and as of the Closing Date
to the Company as follows (unless as of a specific date therein, in which case they shall be accurate as of such date):</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify">&nbsp;</P>

<TABLE CELLSPACING="0" CELLPADDING="0" STYLE="font: 10pt Times New Roman, Times, Serif; width: 100%; border-collapse: collapse">
  <TR STYLE="font: 10pt Times New Roman, Times, Serif; vertical-align: top">
    <TD STYLE="font: 10pt Times New Roman, Times, Serif; width: 0.25in">&nbsp;</TD>
    <TD STYLE="text-align: left; font: 10pt Times New Roman, Times, Serif; width: 0.25in">(a)</TD>
    <TD STYLE="font: 10pt Times New Roman, Times, Serif; text-align: justify"><U>Organization; Authority</U>. Such Purchaser is either an individual or an entity duly incorporated or formed, validly existing and in good standing under the laws of the jurisdiction of its incorporation or formation with full right, corporate, partnership limited liability company or similar power and authority to enter into and to consummate the transactions contemplated by the Transaction Documents and otherwise to carry out its obligations hereunder and thereunder. The execution and delivery of the Transaction Documents and performance by such Purchaser of the transactions contemplated by the Transaction Documents have been duly authorized by all necessary corporate, partnership, limited liability company or similar action, as applicable, on the part of such Purchaser. Each Transaction Document to which it is a party has been duly executed by such Purchaser, and when delivered by such Purchaser in accordance with the terms hereof, will constitute the valid and legally binding obligation of such Purchaser, enforceable against it in accordance with its terms, except: (i) as limited by general equitable principles and applicable bankruptcy, insolvency, reorganization, moratorium and other laws of general application affecting enforcement of creditors&rsquo; rights generally, (ii) as limited by laws relating to the availability of specific performance, injunctive relief or other equitable remedies and (iii) insofar as indemnification and contribution provisions may be limited by applicable law.</TD></TR>
  <TR STYLE="font: 10pt Times New Roman, Times, Serif; vertical-align: top">
    <TD STYLE="font: 10pt Times New Roman, Times, Serif">&nbsp;</TD>
    <TD STYLE="text-align: left; font: 10pt Times New Roman, Times, Serif">&nbsp;</TD>
    <TD STYLE="font: 10pt Times New Roman, Times, Serif; text-align: justify">&nbsp;</TD></TR>
  <TR STYLE="font: 10pt Times New Roman, Times, Serif; vertical-align: top">
    <TD STYLE="font: 10pt Times New Roman, Times, Serif">&nbsp;</TD>
    <TD STYLE="text-align: left; font: 10pt Times New Roman, Times, Serif">(b)</TD>
    <TD STYLE="font: 10pt Times New Roman, Times, Serif; text-align: justify"><U>Understandings or Arrangements</U>. Such Purchaser is
    acquiring the Securities as principal for its own account and has no direct or indirect arrangement or understandings with any other
    persons to distribute or regarding the distribution of such Securities (this representation and warranty not limiting such Purchaser&rsquo;s
    right to sell the Securities pursuant to the Registration Statement or otherwise in compliance with applicable federal and state
    securities laws). Such Purchaser acknowledges and understands that the Company has not sought or obtained approval from the Trading
    Market any national securities exchange or quotation system with respect to the issuance and sale of the Securities contemplated
    by this Agreement. Such Purchaser further acknowledges and understands that there is a risk that the issuance of the Securities in
    the transaction contemplated by this Agreement may not comply with the applicable listing standards or rules of such Trading Market
    or exchange or quotation system, which could result in the delisting or suspension of trading of the Company&rsquo;s Securities.
    The Purchaser hereby assumes all risks associated with any such consequences. </TD></TR>
  </TABLE>
<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0">&nbsp;</P>


<!-- Field: Page; Sequence: 21 -->
    <DIV STYLE="margin-bottom: 6pt; border-bottom: Black 1pt solid"><TABLE CELLPADDING="0" CELLSPACING="0" STYLE="border-collapse: collapse; width: 100%; font-size: 10pt"><TR STYLE="vertical-align: top; text-align: left"><TD STYLE="text-align: center; width: 100%"><!-- Field: Sequence; Type: Arabic; Name: PageNo -->21<!-- Field: /Sequence --></TD></TR></TABLE></DIV>
    <DIV STYLE="break-before: page; margin-top: 6pt"><P STYLE="margin: 0pt">&nbsp;</P></DIV>
    <!-- Field: /Page -->

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0">&nbsp;</P>

<TABLE CELLSPACING="0" CELLPADDING="0" STYLE="font: 10pt Times New Roman, Times, Serif; width: 100%; border-collapse: collapse">
  <TR STYLE="font: 10pt Times New Roman, Times, Serif; vertical-align: top">
    <TD STYLE="font: 10pt Times New Roman, Times, Serif; width: 0.25in">&nbsp;</TD>
    <TD STYLE="text-align: left; font: 10pt Times New Roman, Times, Serif; width: 0.25in">(c)</TD>
    <TD STYLE="font: 10pt Times New Roman, Times, Serif; text-align: justify"><U>Reserved</U>.</TD></TR>
  <TR STYLE="font: 10pt Times New Roman, Times, Serif; vertical-align: top">
    <TD STYLE="font: 10pt Times New Roman, Times, Serif">&nbsp;</TD>
    <TD STYLE="text-align: left; font: 10pt Times New Roman, Times, Serif">&nbsp;</TD>
    <TD STYLE="font: 10pt Times New Roman, Times, Serif; text-align: justify">&nbsp;</TD></TR>
  <TR STYLE="font: 10pt Times New Roman, Times, Serif; vertical-align: top">
    <TD STYLE="font: 10pt Times New Roman, Times, Serif">&nbsp;</TD>
    <TD STYLE="text-align: left; font: 10pt Times New Roman, Times, Serif">(d)</TD>
    <TD STYLE="font: 10pt Times New Roman, Times, Serif; text-align: justify"><U>Experience of Such Purchaser</U>. Such Purchaser, either alone or together with its representatives, has such knowledge, sophistication and experience in business and financial matters so as to be capable of evaluating the merits and risks of the prospective investment in the Securities, and has so evaluated the merits and risks of such investment. Such Purchaser is able to bear the economic risk of an investment in the Securities and, at the present time, is able to afford a complete loss of such investment.</TD></TR>
  <TR STYLE="font: 10pt Times New Roman, Times, Serif; vertical-align: top">
    <TD STYLE="font: 10pt Times New Roman, Times, Serif">&nbsp;</TD>
    <TD STYLE="text-align: left; font: 10pt Times New Roman, Times, Serif">&nbsp;</TD>
    <TD STYLE="font: 10pt Times New Roman, Times, Serif; text-align: justify">&nbsp;</TD></TR>
  <TR STYLE="font: 10pt Times New Roman, Times, Serif; vertical-align: top">
    <TD STYLE="font: 10pt Times New Roman, Times, Serif">&nbsp;</TD>
    <TD STYLE="text-align: left; font: 10pt Times New Roman, Times, Serif">(e)</TD>
    <TD STYLE="font: 10pt Times New Roman, Times, Serif; text-align: justify"><P STYLE="margin-top: 0; margin-bottom: 0"><U>Access to
Information</U>. Such Purchaser acknowledges that it has had the opportunity to review the Transaction Documents (including all exhibits
and schedules thereto) and the SEC Reports and has been afforded (i) the opportunity to ask such questions as it has deemed necessary
of, and to receive answers from, representatives of the Company concerning the terms and conditions of the offering of the Securities
and the merits and risks of investing in the Securities; (ii) access to information about the Company and its financial condition, results
of operations, business, properties, management and prospects sufficient to enable it to evaluate its investment; and (iii) the opportunity
to obtain such additional information that the Company possesses or can acquire without unreasonable effort or expense that is necessary
to make an informed investment decision with respect to the investment. Such Purchaser acknowledges and agrees that neither the Placement
Agent nor any Affiliate of the Placement Agent has provided such Purchaser with any information or advice with respect to the Securities
nor is such information or advice necessary or desired. Neither the Placement Agent nor any Affiliate has made or makes any representation
as to the Company or the quality of the Securities and the Placement Agent and any Affiliate may have acquired non-public information
with respect to the Company which such Purchaser agrees need not be provided to it. In connection with the issuance of the Securities
to such Purchaser, neither the Placement Agent nor any of its Affiliates has acted as a financial advisor or fiduciary to such Purchaser.</P>
                                                                              <P STYLE="margin-top: 0; margin-bottom: 0"></P></TD></TR>
  <TR STYLE="font: 10pt Times New Roman, Times, Serif; vertical-align: top">
    <TD STYLE="font: 10pt Times New Roman, Times, Serif">&nbsp;</TD>
    <TD STYLE="text-align: left; font: 10pt Times New Roman, Times, Serif">&nbsp;</TD>
    <TD STYLE="font: 10pt Times New Roman, Times, Serif; text-align: justify">&nbsp;</TD></TR>
  <TR STYLE="font: 10pt Times New Roman, Times, Serif; vertical-align: top">
    <TD STYLE="font: 10pt Times New Roman, Times, Serif">&nbsp;</TD>
    <TD STYLE="text-align: left; font: 10pt Times New Roman, Times, Serif">(f)</TD>
    <TD STYLE="font: 10pt Times New Roman, Times, Serif; text-align: justify"><U>Certain Transactions and Confidentiality</U>. Other than consummating the transactions contemplated hereunder, such Purchaser has not, nor has any Person acting on behalf of or pursuant to any understanding with such Purchaser, directly or indirectly executed any purchases or sales, including Short Sales, of the securities of the Company during the period commencing as of the time that the Preliminary Prospectus was filed with the Commission from the Company or any other Person representing the Company setting forth the material terms, which terms include definitive pricing terms, of the transactions contemplated hereunder and ending immediately prior to the execution hereof. Notwithstanding the foregoing, in the case of a Purchaser that is a multi-managed investment vehicle whereby separate portfolio managers manage separate portions of such Purchaser&rsquo;s assets and the portfolio managers have no direct knowledge of the investment decisions made by the portfolio managers managing other portions of such Purchaser&rsquo;s assets, the representation set forth above shall only apply with respect to the portion of assets managed by the portfolio manager that made the investment decision to purchase the Securities covered by this Agreement. Other than to other Persons party to this Agreement or to such Purchaser&rsquo;s representatives, including, without limitation, its officers, directors, partners, legal and other advisors, employees, agents and Affiliates, such Purchaser has maintained the confidentiality of all disclosures made to it in connection with this transaction (including the existence and terms of this transaction). Notwithstanding the foregoing, for the avoidance of doubt, nothing contained herein shall constitute a representation or warranty, or preclude any actions, with respect to locating or borrowing shares in order to effect Short Sales or similar transactions in the future.</TD></TR>
  </TABLE>
<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0">&nbsp;</P>


<!-- Field: Page; Sequence: 22 -->
    <DIV STYLE="margin-bottom: 6pt; border-bottom: Black 1pt solid"><TABLE CELLPADDING="0" CELLSPACING="0" STYLE="border-collapse: collapse; width: 100%; font-size: 10pt"><TR STYLE="vertical-align: top; text-align: left"><TD STYLE="text-align: center; width: 100%"><!-- Field: Sequence; Type: Arabic; Name: PageNo -->22<!-- Field: /Sequence --></TD></TR></TABLE></DIV>
    <DIV STYLE="break-before: page; margin-top: 6pt"><P STYLE="margin: 0pt">&nbsp;</P></DIV>
    <!-- Field: /Page -->

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0">&nbsp;</P>

<TABLE CELLSPACING="0" CELLPADDING="0" STYLE="font: 10pt Times New Roman, Times, Serif; width: 100%; border-collapse: collapse">
  <TR STYLE="font: 10pt Times New Roman, Times, Serif; vertical-align: top">
    <TD STYLE="font: 10pt Times New Roman, Times, Serif; width: 0.25in">&nbsp;</TD>
    <TD STYLE="text-align: left; font: 10pt Times New Roman, Times, Serif; width: 0.25in">(g)</TD>
    <TD STYLE="font: 10pt Times New Roman, Times, Serif; text-align: justify"><U>No Voting Agreements</U>. The Purchaser is not a party to any agreement or arrangement, whether written or oral, between the Purchaser and any other Purchaser and any of the Company&rsquo;s shareholders as of the date hereof, regulating the management of the Company, the shareholders&rsquo; rights in the Company, the transfer of shares in the Company, including any voting agreements, shareholder agreements or any other similar agreement even if its title is different or has any other relations or agreements with any of the Company&rsquo;s shareholders, directors or officers.</TD></TR>
  <TR STYLE="font: 10pt Times New Roman, Times, Serif; vertical-align: top">
    <TD STYLE="font: 10pt Times New Roman, Times, Serif">&nbsp;</TD>
    <TD STYLE="text-align: left; font: 10pt Times New Roman, Times, Serif">&nbsp;</TD>
    <TD STYLE="font: 10pt Times New Roman, Times, Serif; text-align: justify">&nbsp;</TD></TR>
  <TR STYLE="font: 10pt Times New Roman, Times, Serif; vertical-align: top">
    <TD STYLE="font: 10pt Times New Roman, Times, Serif">&nbsp;</TD>
    <TD STYLE="text-align: left; font: 10pt Times New Roman, Times, Serif">(h)</TD>
    <TD STYLE="font: 10pt Times New Roman, Times, Serif; text-align: justify"><U>Brokers</U>. Except as set forth in the Preliminary Prospectus or the Prospectus, no agent, broker, investment banker, person or firm acting in a similar capacity on behalf of or under the authority of the Purchaser is or will be entitled to any broker&rsquo;s or finder&rsquo;s fee or any other commission or similar fee, directly or indirectly, for which the Company or any of its Affiliates after the Closing could have any liabilities in connection with this Agreement, any of the transactions contemplated by this Agreement, or on account of any action taken by the Purchaser in connection with the transactions contemplated by this Agreement.</TD></TR>
  <TR STYLE="font: 10pt Times New Roman, Times, Serif; vertical-align: top">
    <TD STYLE="font: 10pt Times New Roman, Times, Serif">&nbsp;</TD>
    <TD STYLE="text-align: left; font: 10pt Times New Roman, Times, Serif">&nbsp;</TD>
    <TD STYLE="font: 10pt Times New Roman, Times, Serif; text-align: justify">&nbsp;</TD></TR>
  <TR STYLE="font: 10pt Times New Roman, Times, Serif; vertical-align: top">
    <TD STYLE="font: 10pt Times New Roman, Times, Serif">&nbsp;</TD>
    <TD STYLE="text-align: left; font: 10pt Times New Roman, Times, Serif">(i)</TD>
    <TD STYLE="font: 10pt Times New Roman, Times, Serif; text-align: justify"><U>Independent Advice</U>. Each Purchaser understands that nothing in this Agreement or any other materials presented by or on behalf of the Company to the Purchaser in connection with the purchase of the Securities constitutes legal, tax or investment advice.</TD></TR>
  </TABLE>
<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify; text-indent: 0.5in">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify; text-indent: 0.5in">The Company acknowledges and agrees
that the representations contained in this Section 3.2 shall not modify, amend or affect such Purchaser&rsquo;s right to rely on the Company&rsquo;s
representations and warranties contained in this Agreement or any representations and warranties contained in any other Transaction Document
or any other document or instrument executed and/or delivered in connection with this Agreement or the consummation of the transactions
contemplated hereby. Notwithstanding the foregoing, for the avoidance of doubt, nothing contained herein shall constitute a representation
or warranty, or preclude any actions, except as set forth in this Agreement, with respect to locating or borrowing shares in order to
effect Short Sales or similar transactions in the future.</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify; text-indent: 0.5in">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: center"><B>ARTICLE IV.<BR>
OTHER AGREEMENTS OF THE PARTIES</B></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: center"><B>&nbsp;</B></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify">4.1 <U>Legends</U>. The shares of Common Stock, the
Warrants, and, if all or any portion of a Warrant is exercised at a time when there is an effective registration statement to cover the
issuance or resale of the Warrant Shares or if the Warrant is exercised via cashless exercise, the Warrant Shares, shall be issued free
of legends. If at any time following the date hereof the Registration Statement is not effective or is not otherwise available for the
sale of the shares of Common Stock, the Warrants or the Warrant Shares, the Company shall immediately notify the holders of the Warrants
in writing that such Registration Statement is not then effective and thereafter shall promptly notify such holders when the Registration
Statement is effective again and available for the sale of the Shares, the Warrants or the Warrant Shares (it being understood and agreed
that the foregoing shall not limit the ability of the Company to issue, or any Purchaser to sell, any of the Shares, the Warrants or the
Warrant Shares in compliance with applicable federal and state securities laws). The Company shall use commercially reasonable best efforts
to keep a registration statement (including the Registration Statement) registering the issuance of the Warrant Shares effective during
the term of the Warrants.</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify">&nbsp;</P>


<!-- Field: Page; Sequence: 23 -->
    <DIV STYLE="margin-bottom: 6pt; border-bottom: Black 1pt solid"><TABLE CELLPADDING="0" CELLSPACING="0" STYLE="border-collapse: collapse; width: 100%; font-size: 10pt"><TR STYLE="vertical-align: top; text-align: left"><TD STYLE="text-align: center; width: 100%"><!-- Field: Sequence; Type: Arabic; Name: PageNo -->23<!-- Field: /Sequence --></TD></TR></TABLE></DIV>
    <DIV STYLE="break-before: page; margin-top: 6pt"><P STYLE="margin: 0pt">&nbsp;</P></DIV>
    <!-- Field: /Page -->

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify">4.2 <U>Furnishing of Information; Public Information</U>.
Until the earliest of the time that (i) no Purchaser owns Securities, or (ii) the Common Warrants have expired, the Company covenants
to maintain the registration of the Common Stock under Section 12(b) or 12(g) of the Exchange Act and to timely file (or obtain extensions
in respect thereof and file within the applicable grace period) all reports required to be filed by the Company after the date hereof
pursuant to the Exchange Act except in the case of a sale of all of substantially all of the assets of the Company, a merger or reorganization
of the Company with one or more other entities in which the Company is not the surviving entity or any transaction or series of related
transactions as a result of which any Person (together with its Affiliates) acquires then outstanding securities of the Company.</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify">4.3 <U>Integration</U>. The Company shall not sell,
offer for sale or solicit offers to buy or otherwise negotiate in respect of any security (as defined in Section 2 of the Securities Act)
that would be integrated with the offer or sale of the Securities for purposes of the rules and regulations of any Trading Market such
that it would require shareholder approval prior to the closing of such other transaction unless shareholder approval is obtained before
the closing of such subsequent transaction.</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify">4.4 <U>Securities Laws Disclosure; Publicity</U>.
The Company shall (a) by the Disclosure Time, issue a press release disclosing the material terms of the transactions contemplated hereby,
and (b) file a Current Report on Form 8-K, including the Transaction Documents as exhibits thereto, with the Commission within the time
required by the Exchange Act. From and after the issuance of such press release, the Company represents to the Purchasers that it shall
have publicly disclosed all material, non-public information delivered to any of the Purchasers by the Company or any of its Subsidiaries
or Affiliates, or any of their respective officers, directors, employees or agents, including, without limitation, the Placement Agent,
in connection with the transactions contemplated by the Transaction Documents. In addition, effective upon the issuance of such press
release, the Company acknowledges and agrees that any and all confidentiality or similar obligations under any agreement, whether written
or oral, between the Company, any of its Subsidiaries or any of their respective officers, directors, agents, employees or Affiliates,
including, without limitation, the Placement Agent, on the one hand, and any of the Purchasers or any of their Affiliates on the other
hand, with respect to the transactions contemplated hereby shall terminate and be of no further force or effect. The Company and each
Purchaser shall consult with each other in issuing any other press releases with respect to the transactions contemplated hereby, and
neither the Company nor any Purchaser shall issue any such press release nor otherwise make any such public statement without the prior
consent of the Company, with respect to any press release of any Purchaser, or without the prior consent of each Purchaser, with respect
to any press release of the Company, which consent shall not unreasonably be withheld or delayed, except if such disclosure is required
by law, in which case the disclosing party shall promptly provide the other party with prior notice of such public statement or communication.
Notwithstanding the foregoing, the Company shall not publicly disclose the name of any Purchaser, or include the name of any Purchaser
in any filing with the Commission or any regulatory agency or Trading Market, without the prior written consent of such Purchaser, except
(a) as required by federal securities law in connection with the filing of final Transaction Documents with the Commission, and (b) to
the extent such disclosure is required by law or Trading Market regulations, in which case the Company shall provide the Purchasers with
prior notice of such disclosure permitted under this clause (b).</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify">4.5 <U>Shareholder Rights Plan</U>. No claim will
be made or enforced by the Company or, with the consent of the Company, any other Person, that any Purchaser is an &ldquo;Acquiring Person&rdquo;
under any control share acquisition, business combination, poison pill (including any distribution under a rights agreement) or similar
anti-takeover plan or arrangement in effect or hereafter adopted by the Company, or that any Purchaser could be deemed to trigger the
provisions of any such plan or arrangement, by virtue of receiving Securities under the Transaction Documents or under any other agreement
between the Company and the Purchasers.</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify">&nbsp;</P>


<!-- Field: Page; Sequence: 24 -->
    <DIV STYLE="margin-bottom: 6pt; border-bottom: Black 1pt solid"><TABLE CELLPADDING="0" CELLSPACING="0" STYLE="border-collapse: collapse; width: 100%; font-size: 10pt"><TR STYLE="vertical-align: top; text-align: left"><TD STYLE="text-align: center; width: 100%"><!-- Field: Sequence; Type: Arabic; Name: PageNo -->24<!-- Field: /Sequence --></TD></TR></TABLE></DIV>
    <DIV STYLE="break-before: page; margin-top: 6pt"><P STYLE="margin: 0pt">&nbsp;</P></DIV>
    <!-- Field: /Page -->

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify">4.6 <U>Non-Public Information</U>. Except with respect
to the material terms and conditions of the transactions contemplated by the Transaction Documents, which shall be disclosed pursuant
to Section 4.4, the Company covenants and agrees that neither it, nor any other Person acting on its behalf will provide any Purchaser
or its agents or counsel with any information that the Company believes constitutes material non-public information, unless prior thereto
such Purchaser shall have entered into a written agreement with the Company regarding the confidentiality and use of such information.
The Company understands and confirms that each Purchaser shall be relying on the foregoing covenant in effecting transactions in securities
of the Company. To the extent that the Company delivers any material, non-public information to a Purchaser without such Purchaser&rsquo;s
consent, the Company hereby covenants and agrees that such Purchaser shall not have any duty of confidentiality to the Company, any of
its Subsidiaries, or any of their respective officers, directors, agents, employees or Affiliates, or a duty to the Company, any of its
Subsidiaries or any of their respective officers, directors, agents, employees or Affiliates not to trade on the basis of, such material,
non-public information, provided that the Purchaser shall remain subject to applicable law. To the extent that any notice provided pursuant
to any Transaction Document constitutes, or contains, material, non-public information regarding the Company or any Subsidiaries, the
Company shall simultaneously file such notice with the Commission pursuant to a Current Report on Form 8-K. The Company understands and
confirms that each Purchaser shall be relying on the foregoing covenant in effecting transactions in securities of the Company.</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify">4.7 <U>Use of Proceeds</U>. The Company shall use
the net proceeds from the sale of the Securities hereunder as disclosed in the Preliminary Prospectus and the Prospectus.</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify">4.8 <U>Indemnification of Purchasers</U>. Subject
to the provisions of this Section 4.8, the Company will indemnify and hold each Purchaser and its directors, officers, shareholders, members,
partners, employees and agents (and any other Persons with a functionally equivalent role of a Person holding such titles notwithstanding
a lack of such title or any other title), each Person who controls such Purchaser (within the meaning of Section 15 of the Securities
Act and Section 20 of the Exchange Act), and the directors, officers, shareholders, agents, members, partners or employees (and any other
Persons with a functionally equivalent role of a Person holding such titles notwithstanding a lack of such title or any other title) of
such controlling persons (each, a &ldquo;<U>Purchaser Party</U>&rdquo;) harmless from any and all losses, liabilities, obligations, claims,
contingencies, damages, costs and reasonable expenses, including all judgments, amounts paid in settlements, court costs and reasonable
attorneys&rsquo; fees and costs of investigation that any such Purchaser Party may suffer or incur as a result of or relating to (a) any
breach of any of the representations, warranties, covenants or agreements made by the Company in this Agreement or in the other Transaction
Documents or (b) any action instituted against a Purchaser Party in any capacity, or any of them or their respective Affiliates, by any
shareholder of the Company who is not an Affiliate of such Purchaser Party, with respect to any of the transactions contemplated by the
Transaction Documents (unless such action is based upon a breach of such Purchaser Party&rsquo;s representations, warranties or covenants
under the Transaction Documents or any agreements or understandings such Purchaser Party may have with any such shareholder or any violations
by such Purchaser Party of state or federal securities laws or any conduct by such Purchaser Party which is finally judicially determined
to constitute fraud, gross negligence or willful misconduct). If any action shall be brought against any Purchaser Party in respect of
which indemnity may be sought pursuant to this Agreement, such Purchaser Party shall promptly notify the Company in writing, and the Company
shall have the right to assume the defense thereof with counsel of its own choosing reasonably acceptable to the Purchaser Party. Any
Purchaser Party shall have the right to employ separate counsel in any such action and participate in the defense thereof, but the fees
and expenses of such counsel shall be at the expense of such Purchaser Party except to the extent that (i) the employment thereof has
been specifically authorized by the Company in writing, (ii) the Company has failed after a reasonable period of time to assume such defense
and to employ counsel or (iii) in such action there is, in the reasonable opinion of counsel, a material conflict on any material issue
between the position of the Company and the position of such Purchaser Party, in which case the Company shall be responsible for the reasonable
fees and expenses of no more than one such separate counsel. The Company will not be liable to any Purchaser Party under this Agreement
(y) for any settlement or compromise of, or consent to the entry of judgement in, any action, claim or proceeding by a Purchaser Party
effected without the Company&rsquo;s prior written consent, which shall not be unreasonably withheld or delayed; or (z) to the extent,
but only to the extent that a loss, claim, damage or liability is attributable to any Purchaser Party&rsquo;s breach of any of the representations,
warranties, covenants or agreements made by such Purchaser Party in this Agreement or in the other Transaction Documents. The indemnification
required by this Section 4.8 shall be made by periodic payments of the amount thereof during the course of the investigation or defense,
as and when bills are received or are incurred. The indemnity agreements contained herein shall be in addition to any cause of action
or similar right of any Purchaser Party against the Company or others and any liabilities the Company may be subject to pursuant to law.</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify">&nbsp;</P>


<!-- Field: Page; Sequence: 25 -->
    <DIV STYLE="margin-bottom: 6pt; border-bottom: Black 1pt solid"><TABLE CELLPADDING="0" CELLSPACING="0" STYLE="border-collapse: collapse; width: 100%; font-size: 10pt"><TR STYLE="vertical-align: top; text-align: left"><TD STYLE="text-align: center; width: 100%"><!-- Field: Sequence; Type: Arabic; Name: PageNo -->25<!-- Field: /Sequence --></TD></TR></TABLE></DIV>
    <DIV STYLE="break-before: page; margin-top: 6pt"><P STYLE="margin: 0pt">&nbsp;</P></DIV>
    <!-- Field: /Page -->

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify">4.9 <U>Listing of Common Stock</U>. The
Company hereby agrees to use commercially reasonable best efforts to maintain the listing or quotation of the shares of Common Stock
on each Trading Market on which it is currently listed, and concurrently with the Closing, the Company shall apply to list or quote all
of the Shares and Warrant Shares on such Trading Market and shall use its commercially reasonable best efforts to promptly secure
the listing of all of the Shares and Warrant Shares on such Trading Market except in the case of a sale of all of substantially all of
the assets of the Company, a merger or reorganization of the Company with one or more other entities in which the Company is not the
surviving entity or any transaction or series of related transactions as a result of which any Person (together with its Affiliates)
acquires then outstanding securities of the Company representing more than fifty percent (50%) of the voting control of the Company.
The Company further agrees, if the Company applies to have the Common Stock traded on any other Trading Market, it will then include
in such application all of the Shares and Warrant Shares, and will use its commercially reasonable best efforts to cause all of
the Shares and Warrant Shares to be listed or quoted on such other Trading Market as promptly as possible. The Company will use its
commercially reasonable best efforts to continue the listing and trading of the Common Stock on a Trading Market and will comply
in all material respects with the Company&rsquo;s reporting, filing and other obligations under the bylaws or rules of the Trading Market.
The Company agrees to use commercially reasonable efforts to maintain the eligibility of the Common Stock for electronic transfer through
the Depository Trust Company or another established clearing corporation, including, without limitation, by timely payment of fees to
the Depository Trust Company or such other established clearing corporation in connection with such electronic transfer.</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify">4.10 <U>Subsequent Equity Sales</U>.</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify">&nbsp;</P>

<TABLE CELLSPACING="0" CELLPADDING="0" STYLE="font: 10pt Times New Roman, Times, Serif; width: 100%; border-collapse: collapse">
  <TR STYLE="font: 10pt Times New Roman, Times, Serif; vertical-align: top">
    <TD STYLE="font: 10pt Times New Roman, Times, Serif; width: 0.5in">&nbsp;</TD>
    <TD STYLE="text-align: left; font: 10pt Times New Roman, Times, Serif; width: 0.5in">(a)</TD>
    <TD STYLE="text-align: justify; font: 10pt Times New Roman, Times, Serif">
    <P STYLE="text-align: justify; font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0">From the date hereof until forty-five
    (45) days after the Closing Date, neither the Company nor any Subsidiary shall (i) issue, enter into any agreement to issue or announce
    the issuance or proposed issuance of any shares of Common Stock or Common Stock Equivalents or (ii) file any registration statement
    or amendment or supplement thereto, other than the Prospectus, filing a registration statement on Form S-8 in connection with any
    employee benefit plan or the filing of a registration statement or post-effective registration statement registering the Securities
    issued pursuant to this Agreement, provided, however, the Company may enter into a new at-the-market sales agreement to implement
    a new at-the-market sales facility (the &ldquo;<U>Exempt ATM Facility</U>&rdquo;), and file any registration statement
    or any amendment or supplement thereto, with respect to the Exempt ATM Facility, and provided further that only beginning
    on the date that is thirty (30) days after the Stockholder Approval Notice Date, the Company may make sales of common stock
    pursuant to the Exempt ATM Facility.</P></TD></TR>
  </TABLE>
<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0">&nbsp;</P>


<!-- Field: Page; Sequence: 26 -->
    <DIV STYLE="margin-bottom: 6pt; border-bottom: Black 1pt solid"><TABLE CELLPADDING="0" CELLSPACING="0" STYLE="border-collapse: collapse; width: 100%; font-size: 10pt"><TR STYLE="vertical-align: top; text-align: left"><TD STYLE="text-align: center; width: 100%"><!-- Field: Sequence; Type: Arabic; Name: PageNo -->26<!-- Field: /Sequence --></TD></TR></TABLE></DIV>
    <DIV STYLE="break-before: page; margin-top: 6pt"><P STYLE="margin: 0pt">&nbsp;</P></DIV>
    <!-- Field: /Page -->

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0">&nbsp;</P>

<TABLE CELLSPACING="0" CELLPADDING="0" STYLE="font: 10pt Times New Roman, Times, Serif; width: 100%; border-collapse: collapse">
  <TR STYLE="font: 10pt Times New Roman, Times, Serif; vertical-align: top">
    <TD STYLE="font: 10pt Times New Roman, Times, Serif; width: 0.5in">&nbsp;</TD>
    <TD STYLE="text-align: left; font: 10pt Times New Roman, Times, Serif; width: 0.5in">(b)</TD>
    <TD STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify">From the date hereof until ninety
    (90) days after the Closing Date, the Company shall be prohibited from effecting or entering into an agreement to effect any issuance
    by the Company or any of its Subsidiaries of shares of Common Stock or Common Stock Equivalents (or a combination of units thereof)
    involving a Variable Rate Transaction. &ldquo;<U>Variable Rate Transaction</U>&rdquo; means a transaction in which the Company issues
    or sells any debt or equity securities that are convertible into, exchangeable or exercisable for, or include the right to receive
    additional shares of Common Stock either (A) at a conversion price, exercise price or exchange rate or other price that is based
    upon and/or varies with the trading prices of or quotations for the Common Stock at any time after the initial issuance of such debt
    or equity securities, or (B) with a conversion, exercise or exchange price that is subject to being reset at some future date after
    the initial issuance of such debt or equity security or upon the occurrence of specified or contingent events directly or indirectly
    related to the business of the Company or the market for shares of Common Stock, provided, however, that a Variable Rate Transaction
    shall not include the Exempt ATM Facility, and that sales under the Exempt ATM Facility may commence on the date that is thirty
    (30) days after the Stockholder Approval Notice Date. </TD></TR>
  </TABLE>
<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0">&nbsp;</P>

<TABLE CELLSPACING="0" CELLPADDING="0" STYLE="font: 10pt Times New Roman, Times, Serif; width: 100%; border-collapse: collapse">
  <TR STYLE="font: 10pt Times New Roman, Times, Serif; vertical-align: top">
    <TD STYLE="font: 10pt Times New Roman, Times, Serif; width: 0.5in">&nbsp;</TD>
    <TD STYLE="text-align: left; font: 10pt Times New Roman, Times, Serif; width: 0.5in">(c)</TD>
    <TD STYLE="font: 10pt Times New Roman, Times, Serif">
    <P STYLE="text-align: justify; font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0">Notwithstanding the foregoing, this Section 4.10 shall not apply in respect
    of an Exempt Issuance, except that no Variable Rate Transaction shall be an Exempt Issuance.</P>
    <P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify"></P></TD></TR>
  </TABLE>
<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify">4.11 <U>Equal Treatment of Purchasers</U>. No consideration
(including any modification of the Transaction Documents) shall be offered or paid to any Person to amend or consent to a waiver or modification
of any provision of the Transaction Documents unless the same consideration is also offered to all of the parties to the Transaction Documents.
For clarification purposes, this provision constitutes a separate right granted to each Purchaser by the Company and negotiated separately
by each Purchaser, and is intended for the Company to treat the Purchasers as a class and shall not in any way be construed as the Purchasers
acting in concert or as a group with respect to the purchase, disposition or voting of the shares of Common Stock or otherwise.</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify">4.12 <U>Certain Transactions and Confidentiality</U>.
Each Purchaser, severally and not jointly with the other Purchasers, covenants that neither it nor any Affiliate acting on its behalf
or pursuant to any understanding with it will execute any purchases or sales, including Short Sales of any of the Company&rsquo;s securities
during the period commencing with the execution of this Agreement and ending at such time that the transactions contemplated by this Agreement
are first publicly announced pursuant to the initial press release as described in Section 4.4 hereof. Each Purchaser, severally and not
jointly with the other Purchasers, covenants that until such time as the transactions contemplated by this Agreement are publicly disclosed
by the Company pursuant to the initial press release as described in Section 4.4 hereof, such Purchaser will maintain the confidentiality
of the existence and terms of this transaction and the information included in the Disclosure Schedules. Notwithstanding the foregoing,
and notwithstanding anything contained in this Agreement to the contrary, the Company expressly acknowledges and agrees that (i) no Purchaser
makes any representation, warranty or covenant hereby that it will not engage in effecting transactions in any securities of the Company
after the time that the transactions contemplated by this Agreement are first publicly announced pursuant to the initial press release
as described in Section 4.4 hereof, (ii) no Purchaser shall be restricted or prohibited from effecting any transactions in any securities
of the Company in accordance with applicable securities laws from and after the time that the transactions contemplated by this Agreement
are first publicly announced pursuant to the initial press release as described in Section 4.4 hereof and (iii) no Purchaser shall have
any duty of confidentiality or duty not to trade in the securities of the Company to the Company or its Subsidiaries after the issuance
of the initial press release as described in Section 4.4 hereof. Notwithstanding the foregoing, in the case of a Purchaser that is a multi-managed
investment vehicle whereby separate portfolio managers manage separate portions of such Purchaser&rsquo;s assets and the portfolio managers
have no direct knowledge of the investment decisions made by the portfolio managers managing other portions of such Purchaser&rsquo;s
assets, the covenant set forth above shall only apply with respect to the portion of assets managed by the portfolio manager that made
the investment decision to purchase the Securities covered by this Agreement.</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify">&nbsp;</P>


<!-- Field: Page; Sequence: 27 -->
    <DIV STYLE="margin-bottom: 6pt; border-bottom: Black 1pt solid"><TABLE CELLPADDING="0" CELLSPACING="0" STYLE="border-collapse: collapse; width: 100%; font-size: 10pt"><TR STYLE="vertical-align: top; text-align: left"><TD STYLE="text-align: center; width: 100%"><!-- Field: Sequence; Type: Arabic; Name: PageNo -->27<!-- Field: /Sequence --></TD></TR></TABLE></DIV>
    <DIV STYLE="break-before: page; margin-top: 6pt"><P STYLE="margin: 0pt">&nbsp;</P></DIV>
    <!-- Field: /Page -->

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify">4.13 <U>Exercise Procedures</U>. The form of Notice
of Exercise included in the Warrants set forth the totality of the procedures required of the Purchasers in order to exercise the Warrants.
No additional legal opinion, other information or instructions shall be required of the Purchasers to exercise their Warrants. Without
limiting the preceding sentences, no ink-original Notice of Exercise shall be required, nor shall any medallion guarantee (or other type
of guarantee or notarization) of any Notice of Exercise form be required in order to exercise the Warrants. The Company shall honor exercises
of the Warrants and shall deliver Warrant Shares in accordance with the terms, conditions and time periods set forth in the Transaction
Documents.</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify">4.14 <U>Reservations of Shares</U>.
As of the date hereof, the Company has reserved and the Company shall continue to reserve and keep available at all times, free of
preemptive rights, a sufficient number of shares of Common Stock for the purpose of enabling the Company to issue shares of Common
Stock pursuant to this Agreement and Pre-Funded Warrant Shares pursuant to any exercise of the Pre-Funded Warrants. Upon receipt of
Stockholder Approval, the Company shall reserve and the Company shall continue to reserve and keep available at all times, free of
preemptive rights, a sufficient number of shares of Common Stock for the purpose of enabling the Company to issue Common Warrant
Shares pursuant to any exercise of the Common Warrants.</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify">4.15. <U>Lock-Up Agreements</U>. The Company shall
not amend, modify, waive or terminate any provision of any of the Lock-Up Agreements except to extend the term of the lock-up period specified
therein and shall enforce the provisions of each Lock-Up Agreement in accordance with its terms. If any party to a Lock-Up Agreement breaches
any provision of a Lock-Up Agreement, the Company shall promptly use its best efforts to seek specific performance of the terms of such
Lock-Up Agreement.</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: center">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify">4.16 <U>Nasdaq Listing Standard Rule 5635 Compliance</U>.
Notwithstanding anything in this Agreement to the contrary, each Purchaser, severally but not jointly, acknowledges and agrees that, in
order to ensure the Company&rsquo;s compliance with Nasdaq Listing Standard Rule 5635 and applicable interpretations thereunder in connection
with the transactions contemplated by this Agreement, until such time as Stockholder Approval is obtained: (a)&nbsp;such Purchaser shall
not be entitled to vote any of the Shares nor Warrant Shares on any proposal at any special meeting or annual meeting of the stockholders
of the Company seeking approval from the stockholders of the Company with respect to the resolutions contemplated by clause (w)(i) of
the definition of &ldquo;Stockholder Approval&rdquo; in the Common Warrants, however, such Purchaser may attend such meetings and be present
and vote on any proposal at such special or annual meeting of the stockholders of the Company seeking approval of the resolution contemplated
by clause (w)(ii) of the definition of &ldquo;Stockholder Approval&rdquo; in the Common Warrants; (b)&nbsp;such Purchaser understands
and agrees that the Company shall be entitled to enforce the voting restriction in clause&nbsp;(a) hereof at any such special meeting
or annual meeting of the stockholders of the Company; (c)&nbsp;in addition to any other requirements under this Agreement, as a condition
of transfer of the Shares (and any Warrant Shares issued upon the exercise of Warrants) or any interest therein, any transferee shall
agree in writing to be bound by the terms of this Section&nbsp;4.16; and (d)&nbsp;such Purchaser understands and confirms that the Company
shall be relying on the foregoing covenants in entering into this Agreement and issuing the Securities.</P>

<P STYLE="font: 11pt Times New Roman, Times, Serif; margin: 0; text-align: justify">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify">4.17 <U>Proxy Statement</U>. The Company also agrees to file a proxy statement for Stockholder Approval (as defined
in the Common Warrants) promptly following the date of this Agreement.</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: center"><B>&nbsp;</B></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: center"><B>ARTICLE V.<BR>
MISCELLANEOUS</B></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: center"><B>&nbsp;</B></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify">5.1 <U>Termination</U>. This Agreement may be terminated
by any Purchaser, as to such Purchaser&rsquo;s obligations hereunder only and without any effect whatsoever on the obligations between
the Company and the other Purchasers, by written notice to the other parties, if the Closing has not been consummated on or before the
fifth (5th) Trading Day following the date hereof; <U>provided</U>, <U>however</U>, that no such termination will affect the right of
any party to sue for any breach by any other party (or parties).</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify">5.2 <U>Fees and Expenses</U>. Except as expressly
set forth in the Transaction Documents to the contrary, each party shall pay the fees and expenses of its advisers, counsel, accountants
and other experts, if any, and all other expenses incurred by such party incident to the negotiation, preparation, execution, delivery
and performance of this Agreement. The Company shall pay all Transfer Agent fees (including, without limitation, any fees required for
same-day processing of any instruction letter delivered by the Company and any exercise notice delivered by a Purchaser), stamp taxes
and other taxes and duties levied in connection with the delivery of any Securities to the Purchasers.</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify">5.3 <U>Entire Agreement</U>. The Transaction Documents,
together with the exhibits and schedules thereto, the Preliminary Prospectus and the Prospectus, contain the entire understanding of the
parties with respect to the subject matter hereof and thereof and supersede all prior agreements and understandings, oral or written,
with respect to such matters, which the parties acknowledge have been merged into such documents, exhibits and schedules.</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify">5.4 <U>Notices</U>. Any and all notices or other communications
or deliveries required or permitted to be provided hereunder shall be in writing and shall be deemed given and effective on the earliest
of: (a) the time of transmission, if such notice or communication is delivered via facsimile at the facsimile number or email attachment
at the email address as set forth on the signature pages attached hereto at or prior to 5:30 p.m. (New York City time) on a Trading Day,
(b) the next Trading Day after the time of transmission, if such notice or communication is delivered via facsimile at the facsimile number
or email attachment at the email address as set forth on the signature pages attached hereto on a day that is not a Trading Day or later
than 5:30 p.m. (New York City time) on any Trading Day, (c) the second (2nd) Trading Day following the date of mailing, if sent by U.S.
nationally recognized overnight courier service or (d) upon actual receipt by the party to whom such notice is required to be given. The
address for such notices and communications shall be as set forth on the signature pages attached hereto. To the extent that any notice
provided pursuant to any Transaction Document constitutes, or contains, material, non-public information regarding the Company or any
Subsidiaries, the Company shall simultaneously file such notice with the Commission pursuant to a Current Report on Form 8-K.</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify">&nbsp;</P>


<!-- Field: Page; Sequence: 28 -->
    <DIV STYLE="margin-bottom: 6pt; border-bottom: Black 1pt solid"><TABLE CELLPADDING="0" CELLSPACING="0" STYLE="border-collapse: collapse; width: 100%; font-size: 10pt"><TR STYLE="vertical-align: top; text-align: left"><TD STYLE="text-align: center; width: 100%"><!-- Field: Sequence; Type: Arabic; Name: PageNo -->28<!-- Field: /Sequence --></TD></TR></TABLE></DIV>
    <DIV STYLE="break-before: page; margin-top: 6pt"><P STYLE="margin: 0pt">&nbsp;</P></DIV>
    <!-- Field: /Page -->

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify">5.5 <U>Amendments; Waivers</U>. No provision of this
Agreement may be waived, modified, supplemented or amended except in a written instrument signed, in the case of an amendment, by the
Company and the Purchasers who, in the aggregate, hold at least 50.1% in interest of the sum of (i) the Shares and (ii) the Pre-Funded
Warrant Shares initially issuable upon exercise of the Pre-Funded Warrants based on the initial Subscription Amounts hereunder (or, if
prior to Closing, the Company and each Purchaser), or, in the case of a waiver, by the party against whom enforcement of any such waived
provision is sought; provided, that if any amendment, modification or waiver disproportionately and adversely impacts a Purchaser (or
group of Purchasers) relative to the comparable rights and obligations of the other Purchasers, the consent of such disproportionately
impacted Purchaser (or group of Purchasers) shall also be required. No waiver of any default with respect to any provision, condition
or requirement of this Agreement shall be deemed to be a continuing waiver in the future or a waiver of any subsequent default or a waiver
of any other provision, condition or requirement hereof, nor shall any delay or omission of any party to exercise any right hereunder
in any manner impair the exercise of any such right. Any amendment effected in accordance with this Section 5.5 shall be binding upon
each Purchaser and holder of Securities and the Company.</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify">5.6 <U>Headings</U>. The headings herein are for convenience
only, do not constitute a part of this Agreement and shall not be deemed to limit or affect any of the provisions hereof.</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify">5.7 <U>Successors and Assigns</U>. This Agreement
shall be binding upon and inure to the benefit of the parties and their successors and permitted assigns. The Company may not assign this
Agreement or any rights or obligations hereunder without the prior written consent of each Purchaser (other than by merger). Any Purchaser
may assign any or all of its rights under this Agreement to any Person to whom such Purchaser assigns or transfers any Securities, provided
that such transferee agrees in writing to be bound, with respect to the transferred Securities, by the provisions of the Transaction Documents
that apply to the &ldquo;Purchasers.&rdquo;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify">5.8 <U>No Third-Party Beneficiaries</U>. The Placement
Agents shall be third-party beneficiaries of the representations and warranties of the Company in Section 3.1 and the representations
and warranties of the Purchasers in Section 3.2. This Agreement is intended for the benefit of the parties hereto and their respective
successors and permitted assigns and is not for the benefit of, nor may any provision hereof be enforced by, any other Person, except
as otherwise set forth in Section 4.8 and this Section 5.8.</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify">5.9 <U>Governing Law</U>. All questions concerning
the construction, validity, enforcement and interpretation of the Transaction Documents shall be governed by and construed and enforced
in accordance with the internal laws of the State of New York, without regard to the principles of conflicts of law thereof. Each party
agrees that all legal proceedings concerning the interpretations, enforcement and defense of the transactions contemplated by this Agreement
and any other Transaction Documents (whether brought against a party hereto or its respective affiliates, directors, officers, shareholders,
partners, members, employees or agents) shall be commenced exclusively in the state and federal courts sitting in the City of New York.
Each party hereby irrevocably submits to the exclusive jurisdiction of the state and federal courts sitting in the City of New York, Borough
of Manhattan for the adjudication of any dispute hereunder or in connection herewith or with any transaction contemplated hereby or discussed
herein (including with respect to the enforcement of any of the Transaction Documents), and hereby irrevocably waives, and agrees not
to assert in any suit, action or proceeding, any claim that it is not personally subject to the jurisdiction of any such court, that such
suit, action or proceeding is improper or is an inconvenient venue for such proceeding. Each party hereby irrevocably waives personal
service of process and consents to process being served in any such suit, action or proceeding by mailing a copy thereof via registered
or certified mail or overnight delivery (with evidence of delivery) to such party at the address in effect for notices to it under this
Agreement and agrees that such service shall constitute good and sufficient service of process and notice thereof. Nothing contained herein
shall be deemed to limit in any way any right to serve process in any other manner permitted by law. If either party shall commence an
action, suit or proceeding to enforce any provisions of the Transaction Documents, then, in addition to the obligations of the Company
under Section 4.8, the prevailing party in such action, suit or proceeding shall be reimbursed by the other party for its reasonable attorneys&rsquo;
fees and other costs and expenses incurred with the investigation, preparation and prosecution of such action or proceeding.</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify">&nbsp;</P>


<!-- Field: Page; Sequence: 29 -->
    <DIV STYLE="margin-bottom: 6pt; border-bottom: Black 1pt solid"><TABLE CELLPADDING="0" CELLSPACING="0" STYLE="border-collapse: collapse; width: 100%; font-size: 10pt"><TR STYLE="vertical-align: top; text-align: left"><TD STYLE="text-align: center; width: 100%"><!-- Field: Sequence; Type: Arabic; Name: PageNo -->29<!-- Field: /Sequence --></TD></TR></TABLE></DIV>
    <DIV STYLE="break-before: page; margin-top: 6pt"><P STYLE="margin: 0pt">&nbsp;</P></DIV>
    <!-- Field: /Page -->

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify">5.10 <U>Survival</U>. The representations and warranties
contained herein shall survive the Closing and the delivery of the Securities for the applicable statutes of limitations.</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify">5.11 <U>Execution</U>. This Agreement may be executed
in two or more counterparts, all of which when taken together shall be considered one and the same agreement and shall become effective
when counterparts have been signed by each party and delivered to each other party, it being understood that the parties need not sign
the same counterpart. In the event that any signature is delivered by facsimile transmission or by e-mail delivery of a &ldquo;.pdf&rdquo;
format data file, such signature shall create a valid and binding obligation of the party executing (or on whose behalf such signature
is executed) with the same force and effect as if such facsimile or &ldquo;.pdf&rdquo; signature page were an original thereof.</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify">5.12 <U>Severability</U>. If any term, provision,
covenant or restriction of this Agreement is held by a court of competent jurisdiction to be invalid, illegal, void or unenforceable,
the remainder of the terms, provisions, covenants and restrictions set forth herein shall remain in full force and effect and shall in
no way be affected, impaired or invalidated, and the parties hereto shall use their commercially reasonable efforts to find and employ
an alternative means to achieve the same or substantially the same result as that contemplated by such term, provision, covenant or restriction.
It is hereby stipulated and declared to be the intention of the parties that they would have executed the remaining terms, provisions,
covenants and restrictions without including any of such that may be hereafter declared invalid, illegal, void or unenforceable.</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify">5.13 <U>Rescission and Withdrawal Right</U>. Notwithstanding
anything to the contrary contained in (and without limiting any similar provisions of) any of the other Transaction Documents, whenever
any Purchaser exercises a right, election, demand or option under a Transaction Document and the Company does not timely perform its related
obligations within the periods therein provided, then such Purchaser may rescind or withdraw, in its sole discretion from time to time
upon written notice to the Company, any relevant notice, demand or election in whole or in part without prejudice to its future actions
and rights; provided, however, that, in the case of a rescission of an exercise of a Warrant, the applicable Purchaser shall be required
to return any shares of Common Stock subject to any such rescinded exercise notice concurrently with the return to such Purchaser of the
aggregate exercise price paid to the Company for such shares and the restoration of such Purchaser&rsquo;s right to acquire such shares
pursuant to such Purchaser&rsquo;s Warrant (including, issuance of a replacement warrant certificate evidencing such restored right).</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify">5.14 <U>Replacement of Securities</U>. If any certificate
or instrument evidencing any Securities is mutilated, lost, stolen or destroyed, the Company shall issue or cause to be issued in exchange
and substitution for and upon cancellation thereof (in the case of mutilation), or in lieu of and substitution therefor, a new certificate
or instrument, but only upon receipt of evidence reasonably satisfactory to the Company of such loss, theft or destruction. The applicant
for a new certificate or instrument under such circumstances shall also pay any reasonable third-party costs (including customary indemnity)
associated with the issuance of such replacement Securities.</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify">5.15 <U>Remedies</U>. In addition to being entitled
to exercise all rights provided herein or granted by law, including recovery of damages, each of the Purchasers and the Company will be
entitled to seek specific performance under the Transaction Documents. The parties agree that monetary damages may not be adequate compensation
for any loss incurred by reason of any breach of obligations contained in the Transaction Documents and hereby agree to waive and not
to assert in any action for specific performance of any such obligation the defense that a remedy at law would be adequate.</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify">5.16 <U>Payment Set Aside</U>. To the extent that
the Company makes a payment or payments to any Purchaser pursuant to any Transaction Document or a Purchaser enforces or exercises its
rights thereunder, and such payment or payments or the proceeds of such enforcement or exercise or any part thereof are subsequently invalidated,
declared to be fraudulent or preferential, set aside, recovered from, disgorged by or are required to be refunded, repaid or otherwise
restored to the Company, a trustee, receiver or any other Person under any law (including, without limitation, any bankruptcy law, state
or federal law, common law or equitable cause of action), then to the extent of any such restoration the obligation or part thereof originally
intended to be satisfied shall be revived and continued in full force and effect as if such payment had not been made or such enforcement
or setoff had not occurred.</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify">&nbsp;</P>


<!-- Field: Page; Sequence: 30 -->
    <DIV STYLE="margin-bottom: 6pt; border-bottom: Black 1pt solid"><TABLE CELLPADDING="0" CELLSPACING="0" STYLE="border-collapse: collapse; width: 100%; font-size: 10pt"><TR STYLE="vertical-align: top; text-align: left"><TD STYLE="text-align: center; width: 100%"><!-- Field: Sequence; Type: Arabic; Name: PageNo -->30<!-- Field: /Sequence --></TD></TR></TABLE></DIV>
    <DIV STYLE="break-before: page; margin-top: 6pt"><P STYLE="margin: 0pt">&nbsp;</P></DIV>
    <!-- Field: /Page -->

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify">5.17 <U>Independent Nature of Purchasers&rsquo; Obligations
and Rights</U>. The obligations of each Purchaser under any Transaction Document are several and not joint with the obligations of any
other Purchaser, and no Purchaser shall be responsible in any way for the performance or non-performance of the obligations of any other
Purchaser under any Transaction Document. Nothing contained herein or in any other Transaction Document, and no action taken by any Purchaser
pursuant hereto or thereto, shall be deemed to constitute the Purchasers as a partnership, an association, a joint venture or any other
kind of entity, or create a presumption that the Purchasers are in any way acting in concert or as a group with respect to such obligations
or the transactions contemplated by the Transaction Documents. Each Purchaser shall be entitled to independently protect and enforce its
rights including, without limitation, the rights arising out of this Agreement or out of the other Transaction Documents, and it shall
not be necessary for any other Purchaser to be joined as an additional party in any proceeding for such purpose. Each Purchaser has been
represented by its own separate legal counsel in its review and negotiation of the Transaction Documents. For reasons of administrative
convenience only, each Purchaser and its respective counsel have chosen to communicate with the Company through Placement Agent Counsel.
Placement Agent Counsel does not represent any of the Purchasers and only represents the Placement Agent. The Company has elected to
provide all Purchasers with the same terms and Transaction Documents for the convenience of the Company and not because it was required
or requested to do so by any of the Purchasers. It is expressly understood and agreed that each provision contained in this Agreement
and in each other Transaction Document is between the Company and a Purchaser, solely, and not between the Company and the Purchasers
collectively and not between and among the Purchasers.</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify">5.18 <U>Saturdays, Sundays, Holidays, etc</U>. If
the last or appointed day for the taking of any action or the expiration of any right required or granted herein shall not be a Business
Day, then such action may be taken or such right may be exercised on the next succeeding Business Day.</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify">5.19 <U>Liquidated Damages</U>. The Company&rsquo;s
obligations to pay any partial liquidated damages or other amounts owing under the Transaction Documents is a continuing obligation of
the Company and shall not terminate until all unpaid partial liquidated damages and other amounts have been paid notwithstanding the fact
that the instrument or security pursuant to which such partial liquidated damages or other amounts are due and payable shall have been
canceled.</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify">5.20 <U>Construction</U>. The parties agree that each
of them and/or their respective counsel have reviewed and had an opportunity to revise the Transaction Documents and, therefore, the normal
rule of construction to the effect that any ambiguities are to be resolved against the drafting party shall not be employed in the interpretation
of the Transaction Documents or any amendments thereto. In addition, each and every reference to share prices and shares of Common Stock
in any Transaction Document shall be subject to adjustment for reverse and forward stock splits, stock dividends, stock combinations and
other similar transactions relating to shares of Common Stock that occur after the date of this Agreement.</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify">5.21 <B>WAIVER OF JURY TRIAL. IN ANY ACTION, SUIT,
OR PROCEEDING IN ANY JURISDICTION BROUGHT BY ANY PARTY AGAINST ANY OTHER PARTY, THE PARTIES EACH KNOWINGLY AND INTENTIONALLY, TO THE GREATEST
EXTENT PERMITTED BY APPLICABLE LAW, HEREBY ABSOLUTELY, UNCONDITIONALLY, IRREVOCABLY AND EXPRESSLY WAIVES FOREVER TRIAL BY JURY.</B></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: center"><I>(Signature Pages Follow)</I></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: center"><I>&nbsp;</I></P>


<!-- Field: Page; Sequence: 31 -->
    <DIV STYLE="margin-bottom: 6pt; border-bottom: Black 1pt solid"><TABLE CELLPADDING="0" CELLSPACING="0" STYLE="border-collapse: collapse; width: 100%; font-size: 10pt"><TR STYLE="vertical-align: top; text-align: left"><TD STYLE="text-align: center; width: 100%"><!-- Field: Sequence; Type: Arabic; Name: PageNo -->31<!-- Field: /Sequence --></TD></TR></TABLE></DIV>
    <DIV STYLE="break-before: page; margin-top: 6pt"><P STYLE="margin: 0pt">&nbsp;</P></DIV>
    <!-- Field: /Page -->

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify; text-indent: 0.5in">IN WITNESS WHEREOF, the parties
hereto have caused this Securities Purchase Agreement to be duly executed by their respective authorized signatories as of the date first
indicated above.</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify; text-indent: 0.5in">&nbsp;</P>

<TABLE CELLSPACING="0" CELLPADDING="0" STYLE="font: 10pt Times New Roman, Times, Serif; width: 100%; border-collapse: collapse">
  <TR STYLE="font: 10pt Times New Roman, Times, Serif; vertical-align: top">
    <TD COLSPAN="2" STYLE="font: 10pt Times New Roman, Times, Serif">IMUNON, INC.</TD>
    <TD STYLE="font: 10pt Times New Roman, Times, Serif">
    <P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0">&nbsp;</P></TD>
    <TD STYLE="font: 10pt Times New Roman, Times, Serif"><U>Address for Notice</U>:</TD></TR>
  <TR STYLE="font: 10pt Times New Roman, Times, Serif; vertical-align: top">
    <TD COLSPAN="2" STYLE="font: 10pt Times New Roman, Times, Serif"></TD>
    <TD STYLE="font: 10pt Times New Roman, Times, Serif"></TD>
    <TD STYLE="font: 10pt Times New Roman, Times, Serif">
    <P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0">997 Lenox Drive, Suite 100,</P>
    <P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0">Lawrenceville, NJ 08648</P></TD></TR>
  <TR STYLE="font: 10pt Times New Roman, Times, Serif; vertical-align: top">
    <TD STYLE="font: 10pt Times New Roman, Times, Serif; width: 5%">By:</TD>
    <TD STYLE="border-bottom: Black 1pt solid; font: 10pt Times New Roman, Times, Serif; width: 44%">&nbsp;</TD>
    <TD STYLE="font: 10pt Times New Roman, Times, Serif; width: 2%">&nbsp;</TD>
    <TD STYLE="font: 10pt Times New Roman, Times, Serif; width: 49%">&nbsp;</TD></TR>
  <TR STYLE="font: 10pt Times New Roman, Times, Serif; vertical-align: top">
    <TD STYLE="font: 10pt Times New Roman, Times, Serif">Name: </TD>
    <TD STYLE="font: 10pt Times New Roman, Times, Serif">Stacy R. Lindborg</TD>
    <TD STYLE="font: 10pt Times New Roman, Times, Serif">&nbsp;</TD>
    <TD STYLE="font: 10pt Times New Roman, Times, Serif">Email: [***]</TD></TR>
  <TR STYLE="font: 10pt Times New Roman, Times, Serif; vertical-align: top">
    <TD STYLE="font: 10pt Times New Roman, Times, Serif">Title:</TD>
    <TD STYLE="font: 10pt Times New Roman, Times, Serif">President and Chief Executive Officer</TD>
    <TD STYLE="font: 10pt Times New Roman, Times, Serif">&nbsp;</TD>
    <TD STYLE="font: 10pt Times New Roman, Times, Serif">&nbsp;</TD></TR>
  <TR STYLE="font: 10pt Times New Roman, Times, Serif; vertical-align: top">
    <TD COLSPAN="2" STYLE="font: 10pt Times New Roman, Times, Serif">&nbsp;</TD>
    <TD STYLE="font: 10pt Times New Roman, Times, Serif">&nbsp;</TD>
    <TD STYLE="font: 10pt Times New Roman, Times, Serif">&nbsp;</TD></TR>
  <TR STYLE="font: 10pt Times New Roman, Times, Serif; vertical-align: top">
    <TD COLSPAN="2" STYLE="font: 10pt Times New Roman, Times, Serif">With a copy to (which shall not constitute notice):</TD>
    <TD STYLE="font: 10pt Times New Roman, Times, Serif">&nbsp;</TD>
    <TD STYLE="font: 10pt Times New Roman, Times, Serif">&nbsp;</TD></TR>
  <TR STYLE="font: 10pt Times New Roman, Times, Serif; vertical-align: top">
    <TD COLSPAN="2" STYLE="font: 10pt Times New Roman, Times, Serif">&nbsp;</TD>
    <TD STYLE="font: 10pt Times New Roman, Times, Serif">&nbsp;</TD>
    <TD STYLE="font: 10pt Times New Roman, Times, Serif">&nbsp;</TD></TR>
  <TR STYLE="font: 10pt Times New Roman, Times, Serif; vertical-align: top">
    <TD COLSPAN="2" STYLE="font: 10pt Times New Roman, Times, Serif"><P STYLE="margin-top: 0; margin-bottom: 0">Imunon, Inc.</P>
                                                                     <P STYLE="margin-top: 0; margin-bottom: 0">997 Lenox Drive, Suite
                                            100</P>
                                                                     <P STYLE="margin-top: 0; margin-bottom: 0">Lawrenceville, NJ
                                            08648</P>
                                                                     <P STYLE="margin-top: 0; margin-bottom: 0">Attention: Susan Eylward</P></TD>
    <TD STYLE="font: 10pt Times New Roman, Times, Serif">&nbsp;</TD>
    <TD STYLE="font: 10pt Times New Roman, Times, Serif">Email: [***]</TD></TR>
  <TR STYLE="font: 10pt Times New Roman, Times, Serif; vertical-align: top">
    <TD COLSPAN="2" STYLE="font: 10pt Times New Roman, Times, Serif">&nbsp;</TD>
    <TD STYLE="font: 10pt Times New Roman, Times, Serif">&nbsp;</TD>
    <TD STYLE="font: 10pt Times New Roman, Times, Serif">&nbsp;</TD></TR>
  <TR STYLE="font: 10pt Times New Roman, Times, Serif; vertical-align: top">
    <TD COLSPAN="2" STYLE="font: 10pt Times New Roman, Times, Serif"><P STYLE="margin-top: 0; margin-bottom: 0">Thompson Hine LLP</P>
                                                                     <P STYLE="margin-top: 0; margin-bottom: 0">3900 Key Center</P>
                                                                     <P STYLE="margin-top: 0; margin-bottom: 0">127 Public Square</P>
                                                                     <P STYLE="margin-top: 0; margin-bottom: 0">Cleveland, OH 44114</P>
                                                                     <P STYLE="margin-top: 0; margin-bottom: 0">Attention: Jurgita
                                            Ashley</P></TD>
    <TD STYLE="font: 10pt Times New Roman, Times, Serif">&nbsp;</TD>
    <TD STYLE="font: 10pt Times New Roman, Times, Serif">Email: Jurgita.Ashley@thompsonhine.com</TD></TR>
  </TABLE>
<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: center">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: center">[REMAINDER OF PAGE INTENTIONALLY LEFT BLANK</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: center">SIGNATURE PAGE FOR PURCHASER FOLLOWS]</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: center">&nbsp;</P>


<!-- Field: Page; Sequence: 32 -->
    <DIV STYLE="margin-bottom: 6pt; border-bottom: Black 1pt solid"><TABLE CELLPADDING="0" CELLSPACING="0" STYLE="border-collapse: collapse; width: 100%; font-size: 10pt"><TR STYLE="vertical-align: top; text-align: left"><TD STYLE="text-align: center; width: 100%"><!-- Field: Sequence; Type: Arabic; Name: PageNo -->32<!-- Field: /Sequence --></TD></TR></TABLE></DIV>
    <DIV STYLE="break-before: page; margin-top: 6pt"><P STYLE="margin: 0pt">&nbsp;</P></DIV>
    <!-- Field: /Page -->

<P STYLE="text-align: center; font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: center">[PURCHASER SIGNATURE PAGES TO IMNN SECURITIES PURCHASE
AGREEMENT]</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: center">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify; text-indent: 0.5in">IN WITNESS WHEREOF, the undersigned
have caused this Securities Purchase Agreement to be duly executed by their respective authorized signatories as of the date first indicated
above.</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify; text-indent: 0.5in">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0">Name of Purchaser: __________________________________________________</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0"></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0"><I>Signature of Authorized Signatory of Purchaser</I>:___________________________</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0">Name of Authorized Signatory:___________________________________________</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0">Title of Authorized Signatory: </P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0">Email Address of Authorized Signatory: ____________________________________</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0">Facsimile Number of Authorized Signatory: ___________________________________</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0">Address for Notice to Purchaser:___________________________________________</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0">Address for Delivery of Warrant Shares to the Purchaser (if not same address
for notice):</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0">DWAC for Common Stock:</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0">Subscription Amount: $___________________</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0">Shares of Common Stock: ___________________</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0">Common Warrants:___________________</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0">Shares of Common Stock underlying the Pre-Funded Warrants: ________</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify; text-indent: 0.5in">Beneficial Ownership Blocker <FONT STYLE="font-family: Segoe UI Symbol,sans-serif">&#9744;</FONT>
4.99% or <FONT STYLE="font-family: Segoe UI Symbol,sans-serif">&#9744;</FONT> 9.99%</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify; text-indent: 0.5in">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0">Common Warrant Shares: __________ Beneficial Ownership Blocker <FONT STYLE="font-family: Segoe UI Symbol,sans-serif">&#9744;</FONT>
4.99% or <FONT STYLE="font-family: Segoe UI Symbol,sans-serif">&#9744;</FONT> 9.99%</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify">EIN Number: ___________________</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify"><FONT STYLE="font-family: Segoe UI Symbol,sans-serif">&#9744;</FONT>
Notwithstanding anything contained in this Agreement to the contrary, by checking this box (i) the obligations of the above-signed to
purchase the securities set forth in this Agreement to be purchased from the Company by the above-signed, and the obligations of the
Company to sell such securities to the above-signed, shall be unconditional and all conditions to Closing shall be disregarded, (ii)
the Closing shall occur on the first (1st) Trading Day following the date of this Agreement and (iii) any condition to Closing contemplated
by this Agreement (but prior to being disregarded by clause (i) above) that required delivery by the Company or the above-signed of any
agreement, instrument, certificate or the like or purchase price (as applicable) shall no longer be a condition and shall instead be
an unconditional obligation of the Company or the above-signed (as applicable) to deliver such agreement, instrument, certificate or
the like or purchase price (as applicable) to such other party on the Closing Date.</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: center">[SIGNATURE PAGES CONTINUE]</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: center">&nbsp;</P>


<!-- Field: Page; Sequence: 33 -->
    <DIV STYLE="margin-bottom: 6pt; border-bottom: Black 1pt solid"><TABLE CELLPADDING="0" CELLSPACING="0" STYLE="border-collapse: collapse; width: 100%; font-size: 10pt"><TR STYLE="vertical-align: top; text-align: left"><TD STYLE="text-align: center; width: 100%"><!-- Field: Sequence; Type: Arabic; Name: PageNo -->33<!-- Field: /Sequence --></TD></TR></TABLE></DIV>
    <DIV STYLE="break-before: page; margin-top: 6pt"><P STYLE="margin: 0pt">&nbsp;</P></DIV>
    <!-- Field: /Page -->

<P STYLE="text-align: center; font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; text-align: center"><B>Exhibit A</B></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; text-align: center"><B>&nbsp;</B></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; text-align: center"><B>Form of Common Warrant</B></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; text-align: center">(See Attached)</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: center">&nbsp;</P>


<!-- Field: Page; Sequence: 34 -->
    <DIV STYLE="margin-bottom: 6pt; border-bottom: Black 1pt solid"><TABLE CELLPADDING="0" CELLSPACING="0" STYLE="border-collapse: collapse; width: 100%; font-size: 10pt"><TR STYLE="vertical-align: top; text-align: left"><TD STYLE="text-align: center; width: 100%"><!-- Field: Sequence; Type: Arabic; Name: PageNo -->34<!-- Field: /Sequence --></TD></TR></TABLE></DIV>
    <DIV STYLE="break-before: page; margin-top: 6pt"><P STYLE="margin: 0pt">&nbsp;</P></DIV>
    <!-- Field: /Page -->

<P STYLE="text-align: center; font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; text-align: center"><B>Exhibit B</B></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; text-align: center"><B>&nbsp;</B></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; text-align: center"><B>Form of Pre-Funded Warrant</B></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; text-align: center">(See Attached)</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: center"><B>&nbsp;</B></P>


<!-- Field: Page; Sequence: 35 -->
    <DIV STYLE="margin-bottom: 6pt; border-bottom: Black 1pt solid"><TABLE CELLPADDING="0" CELLSPACING="0" STYLE="border-collapse: collapse; width: 100%; font-size: 10pt"><TR STYLE="vertical-align: top; text-align: left"><TD STYLE="text-align: center; width: 100%"><!-- Field: Sequence; Type: Arabic; Name: PageNo -->35<!-- Field: /Sequence --></TD></TR></TABLE></DIV>
    <DIV STYLE="break-before: page; margin-top: 6pt"><P STYLE="margin: 0pt">&nbsp;</P></DIV>
    <!-- Field: /Page -->

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0"><B>&nbsp;</B></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: center"><B>Exhibit C</B></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: center"><B>&nbsp;</B></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: center"><B>Form of Lock-Up Agreement</B></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: center">(See Attached)</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: center">&nbsp;</P>


<!-- Field: Page; Sequence: 36; Options: Last -->
    <DIV STYLE="margin-bottom: 6pt; border-bottom: Black 1pt solid"><TABLE CELLPADDING="0" CELLSPACING="0" STYLE="border-collapse: collapse; width: 100%; font-size: 10pt"><TR STYLE="vertical-align: top; text-align: left"><TD STYLE="text-align: center; width: 100%"><!-- Field: Sequence; Type: Arabic; Name: PageNo -->36<!-- Field: /Sequence --></TD></TR></TABLE></DIV>
    <!-- Field: /Page -->

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0">&nbsp;</P>

</BODY>
</HTML>
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>EX-10.31
<SEQUENCE>6
<FILENAME>ex10-31.htm
<DESCRIPTION>EX-10.31
<TEXT>
<HTML>
<HEAD>
     <TITLE></TITLE>
</HEAD>
<BODY STYLE="font: 10pt Times New Roman, Times, Serif">

<P STYLE="text-align: center; font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: right"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt"><B>Exhibit
10.31</B></FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; text-align: center"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt; font-variant: small-caps"><B>&nbsp;</B></FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; text-align: center"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt; font-variant: small-caps"><B>Exchange
Agreement</B></FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; text-align: center"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt"><B>&nbsp;</B></FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify; text-indent: 0.5in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">THIS
EXCHANGE AGREEMENT (the &ldquo;<B>Agreement</B>&rdquo;) is dated as of May 12, 2025 (the <B>&ldquo;Effective Date&rdquo;</B>),
by and among Imunon, Inc., a Delaware corporation (the &ldquo;<B>Company</B>&rdquo;), and each Holder identified on the signature pages
hereto (each, a &ldquo;<B>Holder</B>&rdquo; and collectively, the <B>&ldquo;Holders&rdquo;</B>).</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify; text-indent: 0.5in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify; text-indent: 0.5in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">WHEREAS,
prior to the execution of this Agreement, the Company entered into that certain Securities Purchase Agreement, dated as of July 30, 2024
(the &ldquo;<B>Purchase Agreement</B>&rdquo;), by and between the Company and the purchasers signatory thereto, including the Holders
(the <B>&ldquo;Purchasers&rdquo;</B>), pursuant to which the Purchasers purchased, and the Company issued and sold an aggregate of, (i)
5,000,000 shares of the Company&rsquo;s common stock, par value $0.01 per share (the &ldquo;<B>Common Stock</B>&rdquo;), and (ii) warrants
to purchase up to 5,000,000 shares of Common Stock in the form attached to the Purchase Agreement as <U>Exhibit C</U> (the &ldquo;<B>Warrants</B>&rdquo;);</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify; text-indent: 0.5in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">WHEREAS,
each Holder desires to exchange its Warrants for shares of the Company&rsquo;s Common Stock (the &ldquo;<B>Exchange Shares</B>&rdquo;),
and the Company desires to issue the Exchange Shares in exchange for the Warrants, on a one-for-one basis, with the number of Exchange
Shares issued not to exceed 19.99% of the Company&rsquo;s outstanding shares of Common Stock as of the date of this Agreement, all in
the amounts set forth on the Holder signature pages hereto, provided, that if such amounts exceed the limitation set forth above, the
Exchange Shares shall be allocated pro rata among the Holders, and on the terms and conditions set forth in this Agreement in reliance
on the exemption from registration provided by Section 3(a)(9) of the Securities Act of 1933, as amended (the &ldquo;<B>Securities Act</B>&rdquo;);
and</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify; text-indent: 0.5in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify; text-indent: 0.5in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">NOW,
THEREFORE, in consideration of the terms and conditions contained herein, and other good and valuable consideration, the receipt and
sufficiency of which is hereby acknowledged, the Company and each of the Holders hereby agree as follows:</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify; text-indent: 0.5in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>

<TABLE CELLPADDING="0" CELLSPACING="0" STYLE="width: 100%; font: 10pt Times New Roman, Times, Serif; margin-top: 0; margin-bottom: 0"><TR STYLE="font: 10pt Times New Roman, Times, Serif; vertical-align: top">
<TD STYLE="font: 10pt Times New Roman, Times, Serif; width: 0.5in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">1.</FONT></TD><TD STYLE="font: 10pt Times New Roman, Times, Serif; text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt"><U>Definitions</U>.
                                            The following terms have the meanings set forth below:</FONT></TD></TR></TABLE>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify; text-indent: 0.5in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0.5in; text-align: justify; text-indent: 0.5in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt"><B>&ldquo;Affiliate&rdquo;
</B>means any Person that, directly or indirectly through one or more intermediaries, controls or is controlled by or is under common
control with a Person, as such terms are used in and construed under Rule 405 under the Securities Act.</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0.5in; text-align: justify; text-indent: 0.5in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0.5in; text-align: justify; text-indent: 0.5in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt"><B>&ldquo;Commission&rdquo;
</B>means the United States Securities and Exchange Commission.</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0.5in; text-align: justify; text-indent: 0.5in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0.5in; text-align: justify; text-indent: 0.5in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt"><B>&ldquo;Exchange
Act&rdquo;</B> means the Securities Exchange Act of 1934, as amended, and the rules and regulations promulgated thereunder.</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0.5in; text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0.5in; text-align: justify; text-indent: 0.5in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt"><B>&ldquo;Person&rdquo;
</B>means an individual or corporation, partnership, trust, incorporated or unincorporated association, joint venture, limited liability
company, joint stock company, government (or an agency or subdivision thereof) or other entity of any kind.</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0.5in; text-align: justify; text-indent: 0.5in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0.5in; text-align: justify; text-indent: 0.5in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt"><B>&ldquo;Trading
Day&rdquo;</B> means a day on which the principal Trading Market is open for trading.</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0.5in; text-align: justify; text-indent: 0.5in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>


<!-- Field: Page; Sequence: 1 -->
    <DIV STYLE="margin-top: 0pt; margin-bottom: 6pt; border-bottom: Black 1pt solid"><TABLE CELLPADDING="0" CELLSPACING="0" STYLE="border-collapse: collapse; width: 100%; font-size: 10pt"><TR STYLE="vertical-align: top; text-align: left"><TD STYLE="width: 100%; text-align: right">&nbsp;</TD></TR></TABLE></DIV>
    <DIV STYLE="break-before: page; margin-top: 6pt; margin-bottom: 0pt"><P STYLE="margin: 0pt">&nbsp;</P></DIV>
    <!-- Field: /Page -->

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0.5in; text-align: justify; text-indent: 0.5in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt"><B>&ldquo;Trading
Market&rdquo;</B> means any of the following markets or exchanges on which the Ordinary Shares is listed or quoted for trading on the
date in question: the NYSE American, the Nasdaq Capital Market, the Nasdaq Global Market, the Nasdaq Global Select Market, or the New
York Stock Exchange (or any successors to any of the foregoing).</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0.5in; text-align: justify; text-indent: 0.5in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">2. <U>Exchange
and Waiver</U>. Subject to and upon the terms and conditions set forth in this Agreement, each Holder hereby agrees that the Warrants
listed below such Holder&rsquo;s name on the Holder signature pages hereto are deemed surrendered and, in exchange therefore, the Company
shall issue to such Holder the Exchange Shares, in such amounts and to such Holders as set forth on the respective Holder signature pages
hereto (each, an <B>&ldquo;Exchange&rdquo;</B>).</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify; text-indent: 0.5in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0.5in; text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">2.1. <U>Closing</U>.
On the Trading Day immediately following the date hereof (the &ldquo;<B>Closing Date</B>&rdquo;), the Company will issue and deliver
(or cause to be issued and delivered) the applicable number of Exchange Shares to each applicable Holder, or in the name of a custodian
or nominee of such Holder, or as otherwise requested by such Holder in writing, by book entry to the account or accounts specified by
the Holder at the Company&rsquo;s transfer agent, and such Holder will be deemed to have surrendered to the Company the applicable Warrants
set forth on the Holder signature pages hereto (such terms, the <B>&ldquo;Closing&rdquo;</B>). Notwithstanding anything to the contrary
herein, in no event shall any Holder&rsquo;s voting rights in the Company or ownership of the Company&rsquo;s issued and outstanding
share capital exceed 4.99% of the number of Ordinary Shares issued and outstanding immediately after giving effect to the issuance of
the Exchange Shares on the Closing Date.</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0.5in; text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">2.2.
<FONT STYLE="background-color: white"><U>Exchange Shares Delivery</U>. At the Closing, the Company shall deliver the Exchange Shares
applicable to each Holder, by instructing the Company&rsquo;s Transfer Agent to deliver on an expedited basis via The Depository Trust
Company Deposit or Withdrawal at Custodian system (&ldquo;<B>DWAC</B>&rdquo;), a number of Exchange Shares equal to the number of Exchange
Shares set forth in each of the Holder&rsquo;s signature pages hereto, to the accounts directed by each such Holder</FONT>.</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0.5in; text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0.5in; text-align: justify"></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 0.5in; text-align: justify">2.3. <U>Section 3(a)(9)</U>. Assuming
the accuracy of the representations and warranties of each of the Company and the Holders set forth in Sections 3 and 4 of this Agreement,
the parties acknowledge and agree that the purpose of such representations and warranties is, among other things, to ensure that the
Exchange qualifies as an exchange of securities under Section 3(a)(9) of the Securities Act, on which basis the Exchange Shares shall
be issued to the Holders free of all restrictive legends.<FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>
<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0.5in; text-align: justify"></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">3. <U>Representations
and Warranties of the Company</U>. The Company, represents and warrants to each Holder that:</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify; text-indent: 0.5in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0.5in; text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">3.1. <U>Issuance
of the Exchange Shares</U>. The Exchange Shares have been duly authorized and validly issued in accordance with the terms of this Agreement,
will be fully paid and nonassessable. The Exchange Shares are free and clear of all liens imposed by the Company, other than restrictions
set forth in this Agreement and applicable law.</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0.5in; text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">3.2. <U>Private
Placement</U>. Assuming the accuracy of the Holders&rsquo; representations and warranties set forth in Section 4, no registration under
the Securities Act is required for the issuance of the Exchange Shares by the Company to the Holders as contemplated hereby.</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0.5in; text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">3.3. <U>No
Integrated Offering</U>. Assuming the accuracy of the Holders&rsquo; representations and warranties set forth in this Section 4, neither
the Company, nor any of its Affiliates, nor any Person acting on its or their behalf has, directly or indirectly, made any offers or
sales of any security or solicited any offers to buy any security, under circumstances that would cause this Exchange to be integrated
with prior offerings by the Company for purposes of (i) the Securities Act which would require the registration of any such securities
under the Securities Act, or (ii) any applicable shareholder approval provisions of any Trading Market on which any of the securities
of the Company are listed or designated.</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>


<!-- Field: Page; Sequence: 2; Options: NewSection; Value: 2 -->
    <DIV STYLE="margin-top: 0pt; margin-bottom: 6pt; border-bottom: Black 1pt solid"><TABLE CELLPADDING="0" CELLSPACING="0" STYLE="border-collapse: collapse; width: 100%; font-size: 10pt"><TR STYLE="vertical-align: top; text-align: left"><TD STYLE="width: 100%; text-align: center"><!-- Field: Sequence; Type: Arabic; Name: PageNo -->2<!-- Field: /Sequence --></TD></TR></TABLE></DIV>
    <DIV STYLE="break-before: page; margin-top: 6pt; margin-bottom: 0pt"><P STYLE="margin: 0pt">&nbsp;</P></DIV>
    <!-- Field: /Page -->

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0.5in; text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">3.4. <U>No
General Solicitation</U>. Neither the Company nor any person acting on behalf of the Company has offered or issued any of the Exchange
Shares by any form of general solicitation or general advertising. The Company has offered the Exchange Shares only to the Holders and
certain other <B>&ldquo;accredited investors&rdquo;</B> within the meaning of Rule 501 under the Securities Act.</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0.5in; text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">3.5. <U>Acknowledgment
Regarding the Exchange</U>. The Company acknowledges and agrees that the Holders are acting solely in the capacity of an arm&rsquo;s
length party with respect to this Agreement and the transactions contemplated thereby. The Company further acknowledges that no Holder
is acting as a financial advisor or fiduciary of the Company (or in any similar capacity) with respect to this Agreement and the transactions
contemplated thereby and any advice given by any Holder or any of their respective representatives or agents in connection with this
Agreement and the transactions contemplated thereby is merely incidental to the Holders&rsquo; agreement to participate in the Exchange.
The Company further represents to the Holders that the Company&rsquo;s decision to enter into this Agreement has been based solely on
the independent evaluation of the transactions contemplated hereby by the Company and its representatives.</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0.5in; text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">3.6. <U>Non-Shell
Representation</U>. The Company hereby represents that it is not, and has never been, an issuer subject to Rule 144(i) under the Securities
Act<FONT STYLE="background-color: white">.</FONT></FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0.5in; text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt"><FONT STYLE="background-color: white">&nbsp;</FONT></FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0.5in; text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt"><FONT STYLE="background-color: white"></FONT></FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 0.5in; text-align: justify">3.7. <U>Resale; Restrictive Legends</U>.
The Exchange Shares shall be issued free of all restrictive legends and shall be freely tradeable. Other than pursuant to the terms of
this Agreement, the Company shall not undertake any actions to prohibit or restrict the resale by the Holders of any Exchange Shares
issued hereunder following the period contained in Section 7 herein.<FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt; background-color: white">&nbsp;</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 33pt; text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">4. <U>Representations
and Warranties of the Holders</U>. Each Holder represents and warrants to the Company, with respect to itself only, that:</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify; text-indent: 0.5in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0.5in; text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">4.1. <U>No
Public Sale or Distribution</U>. Such Holder is acquiring the Exchange Shares in the ordinary course of business for its own account
and not with a view toward, or for resale in connection with, the public sale or distribution thereof; provided, however, that by making
the representations herein, such Holder does not agree to hold any of the Exchange Shares for any minimum or other specific term and
reserves the right to dispose of the Exchange Shares at any time pursuant to an exemption from the registration requirements of the Securities
Act and applicable state securities laws. Such Holder does not presently have any agreement or understanding, directly or indirectly,
with any person to distribute, or transfer any interest or grant participation rights in, the Warrants or the Exchange Shares.</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0.5in; text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">4.2. <U>Accredited
Investor and Affiliate Status</U>. At the time such Holder was offered the Exchange Shares, it was, as of the date hereof, it is, and
it will be, an <B>&ldquo;accredited investor&rdquo;</B> as that term is defined in Rule 501 of Regulation D under the Securities Act.
Such Holder is not, and has not been, for a period of at least three (3) months prior to the date of this Agreement (a) an officer or
director of the Company, (b) an <B>&ldquo;affiliate&rdquo;</B> of the Company (as defined in Rule 144) or (c) a <B>&ldquo;beneficial
owner&rdquo;</B> of more than 10% of the Company&rsquo;s common stock (as defined for purposes of Rule 13d-3 of the Exchange Act).</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0.5in; text-align: justify; text-indent: 0.5in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>


<!-- Field: Page; Sequence: 3; Value: 2 -->
    <DIV STYLE="margin-top: 0pt; margin-bottom: 6pt; border-bottom: Black 1pt solid"><TABLE CELLPADDING="0" CELLSPACING="0" STYLE="border-collapse: collapse; width: 100%; font-size: 10pt"><TR STYLE="vertical-align: top; text-align: left"><TD STYLE="width: 100%; text-align: center"><!-- Field: Sequence; Type: Arabic; Name: PageNo -->3<!-- Field: /Sequence --></TD></TR></TABLE></DIV>
    <DIV STYLE="break-before: page; margin-top: 6pt; margin-bottom: 0pt"><P STYLE="margin: 0pt">&nbsp;</P></DIV>
    <!-- Field: /Page -->

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0.5in; text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">4.3. <U>Reliance
on Exemptions</U>. Such Holder understands that the Exchange is being made in reliance on specific exemptions from the registration requirements
of United States federal and state securities laws and that the Company is relying in part upon the truth and accuracy of, and such Holder&rsquo;s
compliance with, the representations, warranties, agreements, acknowledgments and understandings of such Holder set forth herein in order
to determine the availability of such exemptions and the eligibility of such Holder to complete the Exchange and to acquire its applicable
portion of the Exchange Shares. Neither the Holder, nor any agents, will receive any cash from the Company in connection with the Exchange.</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0.5in; text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">4.4. <U>Exchanged
Warrants</U>. Such Holder understands and acknowledges that not all of the Warrants purchased pursuant to the Purchase Agreement will
be exchanged for Exchange Shares pursuant to this Agreement, and that certain Warrants will remain outstanding following completion of
the Exchange.</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0.5in; text-align: justify; text-indent: 0.5in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt"></FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify">5. <U>Waiver; Acknowledgment</U>. Subject
to Section 6.2 herein, the Holder hereby grants to the Company a one-time waiver from (a) compliance with the provisions of
Section 4.12(b) of the Purchase Agreement with respect to any Company Variable Rate Transaction (as defined in the Purchase Agreement)
for a period of forty-five (45) days from the date of this Agreement, and (b) any other applicable provisions of the Purchase
Agreement that would restrict or prohibit the Exchange or any offering by the Company in the next six (6) months in which any of the
Holders may participate. The foregoing waiver shall be limited precisely as written to permit the Company to conduct a Variable Rate
Transaction without complying with the provisions of Section 4.12(b) of the Purchase Agreement and nothing herein shall be deemed a continuing
waiver of Section 4.12(b) of the Purchase Agreement. The Holder also agrees that the issuance by the Company of any common stock purchase
warrants including an &ldquo;alternative cashless exercise&rdquo; feature shall not constitute a Fundamental Transaction (as defined
in the Warrants). For the avoidance of doubt, nothing in the foregoing shall constitute a waiver of any provisions included in Section
3(e) of the Warrants.</P>
<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt"></FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt">6. <U>Subsequent Equity Sales.</U></P>


<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify"></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 0.5in; text-align: justify">6.1. From the date hereof until
five (5) days after the Closing Date, neither the Company nor any Subsidiary (as defined in the Purchase Agreement) shall (i) issue,
enter into any agreement to issue or announce the issuance or proposed issuance of any shares of Common Stock or Common Stock Equivalents
(as defined in the Purchase Agreement) or (ii) file any registration statement or amendment or supplement thereto, other than an amendment
to the Company&rsquo;s Registration Statement on Form S-1 (File No. 333-286403) or filing a registration statement on Form S-8 in connection
with any employee benefit plan.</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 0.5in; text-align: justify">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 0.5in; text-align: justify">6.2. From the date hereof until
five (5) days after the Closing Date, the Company shall be prohibited from effecting or entering into an agreement to effect any issuance
by the Company or any of its Subsidiaries of Common Stock or Common Stock Equivalents (or a combination of units thereof) involving a
Variable Rate Transaction. &ldquo;<B>Variable Rate Transaction</B>&rdquo; means a transaction in which the Company (i) issues or sells
any debt or equity securities that are convertible into, exchangeable or exercisable for, or include the right to receive additional
shares of Common Stock either (A) at a conversion price, exercise price or exchange rate or other price that is based upon and/or varies
with the trading prices of or quotations for the shares of Common Stock at any time after the initial issuance of such debt or equity
securities, or (B) with a conversion, exercise or exchange price that is subject to being reset at some future date after the initial
issuance of such debt or equity security or upon the occurrence of specified or contingent events directly or indirectly related to the
business of the Company or the market for the Common Stock or (ii) enters into, or effects a transaction under, any agreement, including,
but not limited to, an equity line of credit or an &ldquo;at-the-market offering&rdquo;, whereby the Company may issue securities at
a future determined price regardless of whether shares pursuant to such agreement have actually been issued and regardless of whether
such agreement is subsequently canceled. Any Purchaser shall be entitled to obtain injunctive relief against the Company to preclude
any such issuance, which remedy shall be in addition to any right to collect damages.<FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">7.
<U>Standstill</U>. For good and valuable consideration, the receipt and sufficiency of which are hereby acknowledged, the undersigned
Holder agrees with the Company that, during the period beginning on the date hereof until the opening of trading on the Trading Market
on May 14, 2025 (the &ldquo;<U>Lock-Up Period</U>&rdquo;), the undersigned Holder will not, and will not cause or direct any of its
affiliates to, without the prior written consent of the Company, directly or indirectly,&nbsp;offer, sell, assign, transfer, contract
to sell or otherwise dispose of, or announce the intention to otherwise dispose of, any Exchange Shares.</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify">8<FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">.
<U>Governing Law; Jurisdiction; Waiver of Jury Trial</U>. This Agreement shall be construed under the laws of the state of New York,
without regard to principles of conflicts of law or choice of law that would permit or require the application of the laws of another
jurisdiction. The Company and the Holders each hereby agree that all actions or proceedings arising directly or indirectly from or in
connection with this Agreement shall be litigated only in the Supreme Court of the State of New York or the United States District Court
for the Southern District of New York located in New York County, New York. The Company and the Holders each consents to the exclusive
jurisdiction and venue of the foregoing courts and consents that any process or notice of motion or other application to either of said
courts or a judge thereof may be served inside or outside the State of New York or the Southern District of New York by generally recognized
overnight courier or certified or registered mail, return receipt requested, directed to such party at its or his address set forth below
(and service so made shall be deemed <B>&ldquo;personal service&rdquo;</B>) or by personal service or in such other manner as may be
permissible under the rules of said courts. THE COMPANY AND THE HOLDERS EACH HEREBY WAIVE ANY RIGHT TO A JURY TRIAL IN CONNECTION WITH
ANY LITIGATION PURSUANT TO THIS AGREEMENT.</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>


<!-- Field: Page; Sequence: 4; Value: 2 -->
    <DIV STYLE="margin-top: 0pt; margin-bottom: 6pt; border-bottom: Black 1pt solid"><TABLE CELLPADDING="0" CELLSPACING="0" STYLE="border-collapse: collapse; width: 100%; font-size: 10pt"><TR STYLE="vertical-align: top; text-align: left"><TD STYLE="width: 100%; text-align: center"><!-- Field: Sequence; Type: Arabic; Name: PageNo -->4<!-- Field: /Sequence --></TD></TR></TABLE></DIV>
    <DIV STYLE="break-before: page; margin-top: 6pt; margin-bottom: 0pt"><P STYLE="margin: 0pt">&nbsp;</P></DIV>
    <!-- Field: /Page -->

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">9. <U>Counterparts</U>.
This Agreement may be executed in two or more identical counterparts, all of which shall be considered one and the same agreement and
shall become effective when counterparts have been signed by each party and delivered to the other party; provided that a facsimile signature
shall be considered due execution and shall be binding upon the signatory thereto with the same force and effect as if the signature
were an original, not a facsimile signature.</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify; text-indent: 0.5in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify">10<FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">.
<U>Headings</U>. The headings of this Agreement are for convenience of reference and shall not form part of, or affect the interpretation
of, this Agreement.</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify; text-indent: 0.5in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">11. <U>Severability</U>.
If any provision of this Agreement shall be invalid or unenforceable in any jurisdiction, such invalidity or unenforceability shall not
affect the validity or enforceability of the remainder of this Agreement in that jurisdiction or the validity or enforceability of any
provision of this Agreement in any other jurisdiction.</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify; text-indent: 0.5in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">12. <U>Entire
Agreement; Amendments</U>. This Agreement supersedes all other prior oral or written agreements between the Holders, the Company, its
affiliates and persons acting on their behalf with respect to the matters discussed herein, and this Agreement and the instruments referenced
herein contain the entire understanding of the parties with respect to the matters covered herein and therein and, except as specifically
set forth herein or therein, neither the Company nor the Holders make any representation, warranty, covenant or undertaking with respect
to such matters. No provision of this Agreement may be amended other than by an instrument in writing signed by each of the Company and
the Holders. No provision hereof may be waived other than by an instrument in writing signed by the party against whom enforcement is
sought.</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify; text-indent: 0.5in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">13. <U>Successors
and Assigns; No Third-Party Beneficiaries</U>. This Agreement shall be binding upon and inure to the benefit of the parties and their
respective successors and assigns, including any purchasers of the Exchange Shares. The Holder may assign some or all of their rights
hereunder without the consent of the Company, in which event such assignee shall be deemed to be the Holder hereunder with respect to
such assigned rights. This Agreement is intended for the benefit of the parties hereto and their respective permitted successors and
assigns, and is not for the benefit of, nor may any provision hereof be enforced by, any other person.</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify; text-indent: 0.5in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">14. <U>Survival
of Representations</U>. The representations and warranties of the Company and the Holder contained in Sections 3 and 4, respectively,
will survive the closing of the transactions contemplated by this Agreement.</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">15. <U>Further
Assurances</U>. Each party shall do and perform, or cause to be done and performed, all such further acts and things, and shall execute
and deliver all such other agreements, certificates, instruments and documents, as any other party may reasonably request in order to
carry out the intent and accomplish the purposes of this Agreement and the consummation of the transactions contemplated hereby.</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify; text-indent: 0.5in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">16.
<U>Securities Laws Disclosure; Publicity</U>. The Company shall by 10:00 P.M. (New York City time) on May 12, 2025, file
a Current Report on Form 8-K, including this Agreement as an exhibit thereto with the Commission. From and after the filing of such Form
8-K, the Company represents to the Holder that it shall have publicly disclosed all material, non-public information delivered to any
of the Holder by the Company or any of its Subsidiaries, or any of their respective officers, directors, employees or agents. In addition,
effective upon the filing of such Form 8-K, the Company acknowledges and agrees that any and all confidentiality or similar obligations
under any agreement, whether written or oral, between the Company, any of its Subsidiaries or any of their respective officers, directors,
agents, employees or Affiliates on the one hand, and the Holder or any of its Affiliates on the other hand, shall terminate. Notwithstanding
the foregoing, the Company shall not publicly disclose the name of the Holder, or include the name of the Holder in any filing with the
Commission or any regulatory agency or Trading Market, without the prior written consent of the Holder, except (a) as required by federal
securities law in connection with the filing of this Agreement with the Commission and (b) to the extent such disclosure is required
by law or Trading Market regulations, in which case the Company shall provide the Holder with prior notice of such disclosure permitted
under this clause (b).</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; text-align: center">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; text-align: center"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">[Signature
pages follow]</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: center"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>


<!-- Field: Page; Sequence: 5; Value: 2 -->
    <DIV STYLE="margin-top: 0pt; margin-bottom: 6pt; border-bottom: Black 1pt solid"><TABLE CELLPADDING="0" CELLSPACING="0" STYLE="border-collapse: collapse; width: 100%; font-size: 10pt"><TR STYLE="vertical-align: top; text-align: left"><TD STYLE="width: 100%; text-align: center"><!-- Field: Sequence; Type: Arabic; Name: PageNo -->5<!-- Field: /Sequence --></TD></TR></TABLE></DIV>
    <DIV STYLE="break-before: page; margin-top: 6pt; margin-bottom: 0pt"><P STYLE="margin: 0pt">&nbsp;</P></DIV>
    <!-- Field: /Page -->

<P STYLE="text-align: center; font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt"><B>&nbsp;</B></FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; text-align: center"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">[IMNN
Exchange Agreement &ndash; Company Signature Page]</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; text-align: center"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify; text-indent: 0.5in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">IN
WITNESS WHEREOF, the parties have executed this Exchange Agreement as of the date first written above.</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-indent: 0.5in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>

<TABLE CELLSPACING="0" CELLPADDING="0" STYLE="font: 10pt Times New Roman, Times, Serif; width: 100%; border-collapse: collapse">
  <TR STYLE="font: 10pt Times New Roman, Times, Serif; vertical-align: top">
    <TD COLSPAN="2" STYLE="font: 10pt Times New Roman, Times, Serif; text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt"><B><U>IMUNON,
    INC.</U></B></FONT></TD>
    <TD STYLE="font: 10pt Times New Roman, Times, Serif"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt"><B>&nbsp;</B></FONT></TD>
    <TD COLSPAN="2" STYLE="font: 10pt Times New Roman, Times, Serif"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt"><B><U>Address for Notice:</U></B></FONT></TD></TR>
  <TR STYLE="font: 10pt Times New Roman, Times, Serif; vertical-align: top">
    <TD STYLE="font: 10pt Times New Roman, Times, Serif; width: 5%"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></TD>
    <TD STYLE="font: 10pt Times New Roman, Times, Serif; width: 44%"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></TD>
    <TD STYLE="font: 10pt Times New Roman, Times, Serif; width: 2%"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></TD>
    <TD STYLE="font: 10pt Times New Roman, Times, Serif; width: 5%"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></TD>
    <TD STYLE="width: 44%">&nbsp;</TD></TR>
  <TR STYLE="font: 10pt Times New Roman, Times, Serif; vertical-align: top">
    <TD STYLE="font: 10pt Times New Roman, Times, Serif"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">By:</FONT></TD>
    <TD STYLE="border-bottom: black 1pt solid; font: 10pt Times New Roman, Times, Serif"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;</FONT></TD>
    <TD STYLE="font: 10pt Times New Roman, Times, Serif"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></TD>
    <TD STYLE="font: 10pt Times New Roman, Times, Serif"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">Email:
    </FONT></TD>
    <TD>&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;</TD></TR>
  <TR STYLE="font: 10pt Times New Roman, Times, Serif; vertical-align: top">
    <TD STYLE="font: 10pt Times New Roman, Times, Serif"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">Name:</FONT></TD>
    <TD STYLE="font: 10pt Times New Roman, Times, Serif"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></TD>
    <TD STYLE="font: 10pt Times New Roman, Times, Serif"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></TD>
    <TD STYLE="font: 10pt Times New Roman, Times, Serif"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></TD>
    <TD>&nbsp;</TD></TR>
  <TR STYLE="font: 10pt Times New Roman, Times, Serif; vertical-align: top">
    <TD STYLE="font: 10pt Times New Roman, Times, Serif"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">Title:</FONT></TD>
    <TD STYLE="font: 10pt Times New Roman, Times, Serif"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></TD>
    <TD STYLE="font: 10pt Times New Roman, Times, Serif"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></TD>
    <TD STYLE="font: 10pt Times New Roman, Times, Serif"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></TD>
    <TD>&nbsp;</TD></TR>
  </TABLE>
<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: center"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>


<!-- Field: Page; Sequence: 6; Value: 2 -->
    <DIV STYLE="margin-top: 0pt; margin-bottom: 6pt; border-bottom: Black 1pt solid"><TABLE CELLPADDING="0" CELLSPACING="0" STYLE="border-collapse: collapse; width: 100%; font-size: 10pt"><TR STYLE="vertical-align: top; text-align: left"><TD STYLE="width: 100%; text-align: center"><!-- Field: Sequence; Type: Arabic; Name: PageNo -->6<!-- Field: /Sequence --></TD></TR></TABLE></DIV>
    <DIV STYLE="break-before: page; margin-top: 6pt; margin-bottom: 0pt"><P STYLE="margin: 0pt">&nbsp;</P></DIV>
    <!-- Field: /Page -->

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; text-align: center"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; text-align: center"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">[IMNN
Exchange Agreement &ndash; Holder Signature Page]</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; text-align: center"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>

<TABLE CELLSPACING="0" CELLPADDING="0" STYLE="font: 10pt Times New Roman, Times, Serif; width: 100%; border-collapse: collapse">
  <TR STYLE="font: 10pt Times New Roman, Times, Serif; vertical-align: bottom">
    <TD STYLE="font: 10pt Times New Roman, Times, Serif; width: 60%"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">Name
    of Holder:</FONT></TD>
    <TD STYLE="border-bottom: black 1pt solid; font: 10pt Times New Roman, Times, Serif; width: 40%"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></TD></TR>
  <TR STYLE="font: 10pt Times New Roman, Times, Serif; vertical-align: bottom">
    <TD STYLE="font: 10pt Times New Roman, Times, Serif"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">Signature
    of Authorized Signatory of Holder:</FONT></TD>
    <TD STYLE="border-bottom: black 1pt solid; font: 10pt Times New Roman, Times, Serif"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></TD></TR>
  <TR STYLE="font: 10pt Times New Roman, Times, Serif; vertical-align: bottom">
    <TD STYLE="font: 10pt Times New Roman, Times, Serif"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">Name
    of Authorized Signatory:</FONT></TD>
    <TD STYLE="border-bottom: black 1pt solid; font: 10pt Times New Roman, Times, Serif"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></TD></TR>
  <TR STYLE="font: 10pt Times New Roman, Times, Serif; vertical-align: bottom">
    <TD STYLE="font: 10pt Times New Roman, Times, Serif"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">Title
    of Authorized Signatory:</FONT></TD>
    <TD STYLE="border-bottom: black 1pt solid; font: 10pt Times New Roman, Times, Serif"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></TD></TR>
  <TR STYLE="font: 10pt Times New Roman, Times, Serif; vertical-align: bottom">
    <TD STYLE="font: 10pt Times New Roman, Times, Serif"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">Email
    Address of Authorized Signatory:</FONT></TD>
    <TD STYLE="border-bottom: black 1pt solid; font: 10pt Times New Roman, Times, Serif"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></TD></TR>
  <TR STYLE="font: 10pt Times New Roman, Times, Serif; vertical-align: bottom">
    <TD STYLE="font: 10pt Times New Roman, Times, Serif"><P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt"></FONT></P>
    <P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">Address
    for Notice to Holder:</FONT></P></TD>
    <TD STYLE="border-bottom: black 1pt solid; font: 10pt Times New Roman, Times, Serif"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></TD></TR>
  <TR STYLE="font: 10pt Times New Roman, Times, Serif; vertical-align: bottom">
    <TD STYLE="font: 10pt Times New Roman, Times, Serif"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">Address
    for Delivery of Exchange Shares to Holder (if not same as address for notice):</FONT></TD>
    <TD STYLE="border-bottom: black 1pt solid; font: 10pt Times New Roman, Times, Serif"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></TD></TR>
  <TR STYLE="font: 10pt Times New Roman, Times, Serif; vertical-align: bottom">
    <TD STYLE="font: 10pt Times New Roman, Times, Serif"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">Number
    of Shares subject to Warrants:</FONT></TD>
    <TD STYLE="border-bottom: black 1pt solid; font: 10pt Times New Roman, Times, Serif"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></TD></TR>
  <TR STYLE="font: 10pt Times New Roman, Times, Serif; vertical-align: bottom">
    <TD STYLE="font: 10pt Times New Roman, Times, Serif"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">Number
    of Exchange Shares:</FONT></TD>
    <TD STYLE="border-bottom: black 1pt solid; font: 10pt Times New Roman, Times, Serif"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></TD></TR>
  </TABLE>
<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>


<!-- Field: Page; Sequence: 7; Options: Last -->
    <DIV STYLE="margin-top: 0pt; margin-bottom: 6pt; border-bottom: Black 1pt solid"><TABLE CELLPADDING="0" CELLSPACING="0" STYLE="border-collapse: collapse; width: 100%; font-size: 10pt"><TR STYLE="vertical-align: top; text-align: left"><TD STYLE="width: 100%; text-align: center"><!-- Field: Sequence; Type: Arabic; Name: PageNo -->7<!-- Field: /Sequence --></TD></TR></TABLE></DIV>
    <!-- Field: /Page -->

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>

</BODY>
</HTML>
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>EX-23.1
<SEQUENCE>7
<FILENAME>ex23-1.htm
<DESCRIPTION>EX-23.1
<TEXT>
<HTML>
<HEAD>
     <TITLE></TITLE>
</HEAD>
<BODY STYLE="font: 10pt Times New Roman, Times, Serif">

<P STYLE="text-align: center; font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: right"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt"><B>Exhibit
23.1</B></FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: right"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: center"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt; text-transform: uppercase"><B>CONSENT
OF INDEPENDENT REGISTERED PUBLIC ACCOUNTING FIRM</B></FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">We
hereby consent to the incorporation by reference in the Prospectus constituting a part of this Registration Statement on Amendment
No. 1 to Form S-1 of our report dated February 26, 2025 (which includes explanatory paragraphs relating to the Company&rsquo;s ability
to continue as a going concern), relating to the consolidated financial statements of Imunon, Inc. as of December 31, 2024 and 2023 appearing
in the entity&rsquo;s Annual Report on Form 10-K for the year ended December 31, 2024. We also consent to the reference to us under the
caption &ldquo;Experts&rdquo; in the Prospectus.</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">/s/
WithumSmith+Brown, PC</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">East
Brunswick, New Jersey</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">May
12, 2025</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>


<!-- Field: Page; Sequence: 1; Options: Last -->
    <DIV STYLE="margin-top: 0pt; margin-bottom: 6pt; border-bottom: Black 1pt solid"><TABLE CELLPADDING="0" CELLSPACING="0" STYLE="border-collapse: collapse; width: 100%; font-size: 10pt"><TR STYLE="vertical-align: top; text-align: left"><TD STYLE="width: 100%">&nbsp;</TD></TR></TABLE></DIV>
    <!-- Field: /Page -->

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>

</BODY>
</HTML>
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>EX-FILING FEES
<SEQUENCE>8
<FILENAME>ex107.htm
<DESCRIPTION>CALCULATION OF FILING FEE TABLES
<TEXT>
<HTML>
<HEAD>
     <TITLE></TITLE>
</HEAD>
<BODY STYLE="font: 10pt Times New Roman, Times, Serif">

<P STYLE="text-align: center; font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: right"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt"><B>Exhibit
107</B></FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: center"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: center"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt"><B>Calculation
of Filing Fee Tables</B></FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: center"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: center"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt"><B>Form
S-1</B></FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: center"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">(Form
Type)</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: center"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: center"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt"><B>Imunon,
Inc.</B></FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: center"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">(Exact
Name of Registrant as Specified in its Charter)</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: center"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: center"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt"><B><U>Table
1: Newly Registered Securities</U></B></FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: center"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: center"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt"></FONT></P>

<TABLE CELLSPACING="0" CELLPADDING="0" STYLE="font: 11pt Calibri, Helvetica, Sans-Serif; width: 100%; border-collapse: collapse">
  <TR STYLE="vertical-align: bottom">
    <TD STYLE="padding-bottom: 1pt; text-align: center; line-height: 106%"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt; line-height: 106%"><B>&nbsp;</B></FONT></TD>
    <TD STYLE="padding-bottom: 1pt; line-height: 106%"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt; line-height: 106%"><B>&nbsp;</B></FONT></TD>
    <TD STYLE="border-bottom: Black 1pt solid"><P STYLE="font: 11pt/106% Calibri, Helvetica, Sans-Serif; margin: 0; text-align: center"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt"><B>Security
                                            Type</B></FONT></P></TD>
    <TD STYLE="padding-bottom: 1pt; line-height: 106%"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt; line-height: 106%"><B>&nbsp;</B></FONT></TD>
    <TD STYLE="border-bottom: Black 1pt solid"><P STYLE="font: 11pt/106% Calibri, Helvetica, Sans-Serif; margin: 0; text-align: center"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt"><B>Security</B></FONT></P>
    <P STYLE="font: 9pt/106% Times New Roman, Times, Serif; margin: 0; text-align: center"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt"><B>Class</B></FONT></P>
    <P STYLE="font: 9pt/106% Times New Roman, Times, Serif; margin: 0; text-align: center"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt"><B>Title</B></FONT></P></TD>
    <TD STYLE="padding-bottom: 1pt; line-height: 106%"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt; line-height: 106%"><B>&nbsp;</B></FONT></TD>
    <TD STYLE="border-bottom: Black 1pt solid"><P STYLE="font: 11pt/106% Calibri, Helvetica, Sans-Serif; margin: 0; text-align: center"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt"><B>Fee
                                            Calculation</B></FONT></P>
    <P STYLE="font: 9pt/106% Times New Roman, Times, Serif; margin: 0; text-align: center"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt"><B>Rule</B></FONT></P></TD>
    <TD STYLE="padding-bottom: 1pt; line-height: 106%"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt; line-height: 106%"><B>&nbsp;</B></FONT></TD>
    <TD STYLE="border-bottom: Black 1pt solid"><P STYLE="font: 11pt/106% Calibri, Helvetica, Sans-Serif; margin: 0; text-align: center"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt"><B>Amount<BR>
                                            Registered </B></FONT></P></TD>
    <TD STYLE="padding-bottom: 1pt; line-height: 106%"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt; line-height: 106%"><B>&nbsp;</B></FONT></TD>
    <TD STYLE="border-bottom: Black 1pt solid"><P STYLE="font: 11pt/106% Calibri, Helvetica, Sans-Serif; margin: 0; text-align: center"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt"><B>Proposed<BR>
                                            Maximum<BR>
                                            Offering</B></FONT></P>
    <P STYLE="font: 9pt/106% Times New Roman, Times, Serif; margin: 0; text-align: center"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt"><B>Price
    Per Unit</B></FONT></P></TD>
    <TD STYLE="padding-bottom: 1pt; line-height: 106%"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt; line-height: 106%"><B>&nbsp;</B></FONT></TD>
    <TD COLSPAN="2" STYLE="border-bottom: Black 1pt solid"><P STYLE="font: 11pt/106% Calibri, Helvetica, Sans-Serif; margin: 0; text-align: center"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt"><B>Maximum<BR>
                                            Aggregate<BR>
                                            Offering Price<SUP>(1)(2)</SUP></B></FONT></P></TD>
    <TD STYLE="padding-bottom: 1pt; line-height: 106%"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt; line-height: 106%"><B>&nbsp;</B></FONT></TD>
    <TD STYLE="padding-bottom: 1pt; line-height: 106%"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt; line-height: 106%"><B>&nbsp;</B></FONT></TD>
    <TD COLSPAN="2" STYLE="border-bottom: Black 1pt solid"><P STYLE="font: 11pt/106% Calibri, Helvetica, Sans-Serif; margin: 0; text-align: center"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt"><B>Fee
                                            Rate</B></FONT></P></TD>
    <TD STYLE="padding-bottom: 1pt; line-height: 106%"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt; line-height: 106%"><B>&nbsp;</B></FONT></TD>
    <TD STYLE="padding-bottom: 1pt; line-height: 106%"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt; line-height: 106%"><B>&nbsp;</B></FONT></TD>
    <TD COLSPAN="2" STYLE="border-bottom: Black 1pt solid"><P STYLE="font: 11pt/106% Calibri, Helvetica, Sans-Serif; margin: 0; text-align: center"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt"><B>Amount
                                            of<BR>
                                            Registration<BR>
                                            Fee<SUP>(3)</SUP></B></FONT></P></TD>
    <TD STYLE="padding-bottom: 1pt; line-height: 106%"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt; line-height: 106%"><B>&nbsp;</B></FONT></TD></TR>
  <TR STYLE="vertical-align: bottom; background-color: #CCEEFF">
    <TD STYLE="width: 12%; text-align: center; line-height: 106%"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt; line-height: 106%"><B>Fees
    to be Paid</B></FONT></TD>
    <TD STYLE="width: 1%; line-height: 106%"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt; line-height: 106%">&nbsp;</FONT></TD>
    <TD STYLE="width: 6%; text-align: center; line-height: 106%"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt; line-height: 106%">Equity</FONT></TD>
    <TD STYLE="width: 1%; line-height: 106%"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt; line-height: 106%">&nbsp;</FONT></TD>
    <TD STYLE="width: 9%; text-align: center; line-height: 106%"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt; line-height: 106%">Common
    stock, par value $0.01 per share (&ldquo;Common Stock&rdquo;)</FONT></TD>
    <TD STYLE="width: 1%; line-height: 106%"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt; line-height: 106%">&nbsp;</FONT></TD>
    <TD STYLE="width: 10%; text-align: center; line-height: 106%"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt; line-height: 106%">457(o)</FONT></TD>
    <TD STYLE="width: 1%; line-height: 106%"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt; line-height: 106%">&nbsp;</FONT></TD>
    <TD STYLE="width: 9%; text-align: center; line-height: 106%"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt; line-height: 106%">&nbsp;</FONT></TD>
    <TD STYLE="width: 1%; line-height: 106%"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt; line-height: 106%">&nbsp;</FONT></TD>
    <TD STYLE="width: 9%; text-align: center; line-height: 106%"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt; line-height: 106%">&nbsp;</FONT></TD>
    <TD STYLE="width: 1%; line-height: 106%"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt; line-height: 106%">&nbsp;</FONT></TD>
    <TD STYLE="width: 1%; line-height: 106%"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt; line-height: 106%">$</FONT></TD>
    <TD STYLE="width: 10%; text-align: right; line-height: 106%"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt; line-height: 106%">12,000,000</FONT></TD>
    <TD STYLE="width: 2%; line-height: 106%"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt; line-height: 106%"><SUP>(3)</SUP></FONT></TD>
    <TD STYLE="width: 1%; line-height: 106%"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt; line-height: 106%">&nbsp;</FONT></TD>
    <TD STYLE="width: 1%; line-height: 106%"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt; line-height: 106%">&nbsp;</FONT></TD>
    <TD STYLE="width: 9%; text-align: right; line-height: 106%"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt; line-height: 106%">0.00015310</FONT></TD>
    <TD STYLE="width: 1%; line-height: 106%"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt; line-height: 106%">&nbsp;</FONT></TD>
    <TD STYLE="width: 1%; line-height: 106%"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt; line-height: 106%">&nbsp;</FONT></TD>
    <TD STYLE="width: 1%; line-height: 106%"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt; line-height: 106%">$</FONT></TD>
    <TD STYLE="width: 11%; text-align: right; line-height: 106%"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt; line-height: 106%">1,837.20</FONT></TD>
    <TD STYLE="width: 1%; line-height: 106%"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt; line-height: 106%">&nbsp;</FONT></TD></TR>
  <TR STYLE="vertical-align: bottom; background-color: white">
    <TD STYLE="text-align: center; line-height: 106%"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt; line-height: 106%">&nbsp;</FONT></TD>
    <TD STYLE="line-height: 106%"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt; line-height: 106%">&nbsp;</FONT></TD>
    <TD STYLE="text-align: center; line-height: 106%"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt; line-height: 106%">Equity</FONT></TD>
    <TD STYLE="line-height: 106%"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt; line-height: 106%">&nbsp;</FONT></TD>
    <TD STYLE="text-align: center; line-height: 106%"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt; line-height: 106%">Warrants
    to purchase Common Stock</FONT></TD>
    <TD STYLE="line-height: 106%"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt; line-height: 106%">&nbsp;</FONT></TD>
    <TD STYLE="text-align: center; line-height: 106%"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt; line-height: 106%">Other<SUP>(4)</SUP></FONT></TD>
    <TD STYLE="line-height: 106%"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt; line-height: 106%">&nbsp;</FONT></TD>
    <TD STYLE="text-align: center; line-height: 106%"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt; line-height: 106%">&nbsp;</FONT></TD>
    <TD STYLE="line-height: 106%"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt; line-height: 106%">&nbsp;</FONT></TD>
    <TD STYLE="text-align: center; line-height: 106%"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt; line-height: 106%">&nbsp;</FONT></TD>
    <TD STYLE="line-height: 106%"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt; line-height: 106%">&nbsp;</FONT></TD>
    <TD STYLE="line-height: 106%"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt; line-height: 106%">&nbsp;</FONT></TD>
    <TD><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></TD>
    <TD STYLE="line-height: 106%"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt; line-height: 106%"><SUP>(4)</SUP></FONT></TD>
    <TD STYLE="line-height: 106%"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt; line-height: 106%">&nbsp;</FONT></TD>
    <TD STYLE="line-height: 106%"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt; line-height: 106%">&nbsp;</FONT></TD>
    <TD STYLE="text-align: right; line-height: 106%"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt; line-height: 106%">&nbsp;</FONT></TD>
    <TD STYLE="line-height: 106%"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt; line-height: 106%">&nbsp;</FONT></TD>
    <TD STYLE="line-height: 106%"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt; line-height: 106%">&nbsp;</FONT></TD>
    <TD STYLE="line-height: 106%"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt; line-height: 106%">&nbsp;</FONT></TD>
    <TD STYLE="text-align: right; line-height: 106%"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt; line-height: 106%">&nbsp;</FONT></TD>
    <TD STYLE="line-height: 106%"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt; line-height: 106%">&nbsp;</FONT></TD></TR>
  <TR STYLE="vertical-align: bottom; background-color: #CCEEFF">
    <TD STYLE="text-align: center; line-height: 106%"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt; line-height: 106%">&nbsp;</FONT></TD>
    <TD STYLE="line-height: 106%"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt; line-height: 106%">&nbsp;</FONT></TD>
    <TD STYLE="text-align: center; line-height: 106%"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt; line-height: 106%">Equity</FONT></TD>
    <TD STYLE="line-height: 106%"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt; line-height: 106%">&nbsp;</FONT></TD>
    <TD STYLE="text-align: center; line-height: 106%"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt; line-height: 106%">Pre-funded
    warrants to purchase Common Stock</FONT></TD>
    <TD STYLE="line-height: 106%"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt; line-height: 106%">&nbsp;</FONT></TD>
    <TD STYLE="text-align: center; line-height: 106%"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt; line-height: 106%">Other<SUP>(4)</SUP></FONT></TD>
    <TD STYLE="line-height: 106%"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt; line-height: 106%">&nbsp;</FONT></TD>
    <TD STYLE="text-align: center; line-height: 106%"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt; line-height: 106%">&nbsp;</FONT></TD>
    <TD STYLE="line-height: 106%"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt; line-height: 106%">&nbsp;</FONT></TD>
    <TD STYLE="text-align: center; line-height: 106%"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt; line-height: 106%">&nbsp;</FONT></TD>
    <TD STYLE="line-height: 106%"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt; line-height: 106%">&nbsp;</FONT></TD>
    <TD STYLE="line-height: 106%"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt; line-height: 106%">&nbsp;</FONT></TD>
    <TD><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></TD>
    <TD STYLE="line-height: 106%"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt; line-height: 106%"><SUP>(4)</SUP></FONT></TD>
    <TD STYLE="line-height: 106%"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt; line-height: 106%">&nbsp;</FONT></TD>
    <TD STYLE="line-height: 106%"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt; line-height: 106%">&nbsp;</FONT></TD>
    <TD STYLE="text-align: right; line-height: 106%"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt; line-height: 106%">&nbsp;</FONT></TD>
    <TD STYLE="line-height: 106%"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt; line-height: 106%">&nbsp;</FONT></TD>
    <TD STYLE="line-height: 106%"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt; line-height: 106%">&nbsp;</FONT></TD>
    <TD STYLE="line-height: 106%"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt; line-height: 106%">&nbsp;</FONT></TD>
    <TD STYLE="text-align: right; line-height: 106%"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt; line-height: 106%">&nbsp;</FONT></TD>
    <TD STYLE="line-height: 106%"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt; line-height: 106%">&nbsp;</FONT></TD></TR>
  <TR STYLE="vertical-align: bottom; background-color: white">
    <TD STYLE="text-align: center; line-height: 106%"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt; line-height: 106%">&nbsp;</FONT></TD>
    <TD STYLE="line-height: 106%"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt; line-height: 106%">&nbsp;</FONT></TD>
    <TD STYLE="text-align: center; line-height: 106%"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt; line-height: 106%">Equity</FONT></TD>
    <TD STYLE="line-height: 106%"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt; line-height: 106%">&nbsp;</FONT></TD>
    <TD STYLE="text-align: center; line-height: 106%"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt; line-height: 106%">Common
    Stock issuable upon exercise of warrants</FONT></TD>
    <TD STYLE="line-height: 106%"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt; line-height: 106%">&nbsp;</FONT></TD>
    <TD STYLE="text-align: center; line-height: 106%"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt; line-height: 106%">457(o)</FONT></TD>
    <TD STYLE="line-height: 106%"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt; line-height: 106%">&nbsp;</FONT></TD>
    <TD STYLE="text-align: center; line-height: 106%"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt; line-height: 106%">&nbsp;</FONT></TD>
    <TD STYLE="line-height: 106%"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt; line-height: 106%">&nbsp;</FONT></TD>
    <TD STYLE="text-align: center; line-height: 106%"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt; line-height: 106%">&nbsp;</FONT></TD>
    <TD STYLE="line-height: 106%"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt; line-height: 106%">&nbsp;</FONT></TD>
    <TD STYLE="line-height: 106%"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt; line-height: 106%">$</FONT></TD>
    <TD STYLE="text-align: right; line-height: 106%"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt; line-height: 106%">36,000,000</FONT></TD>
    <TD STYLE="font: 10pt/normal Times New Roman, Times, Serif"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt"><SUP>(5)<FONT STYLE="line-height: 106%">&nbsp;</FONT></SUP></FONT></TD>
    <TD STYLE="line-height: 106%"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt; line-height: 106%">&nbsp;</FONT></TD>
    <TD STYLE="line-height: 106%"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt; line-height: 106%">&nbsp;</FONT></TD>
    <TD STYLE="text-align: right; line-height: 106%"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt; line-height: 106%">0.00015310</FONT></TD>
    <TD STYLE="line-height: 106%"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt; line-height: 106%">&nbsp;</FONT></TD>
    <TD STYLE="line-height: 106%"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt; line-height: 106%">&nbsp;</FONT></TD>
    <TD STYLE="line-height: 106%"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt; line-height: 106%">$</FONT></TD>
    <TD STYLE="text-align: right; line-height: 106%"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt; line-height: 106%">5,511.60</FONT></TD>
    <TD STYLE="line-height: 106%"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt; line-height: 106%">&nbsp;</FONT></TD></TR>
  <TR STYLE="vertical-align: bottom; background-color: #CCEEFF">
    <TD STYLE="text-align: center; line-height: 106%"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt; line-height: 106%">&nbsp;</FONT></TD>
    <TD STYLE="line-height: 106%"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt; line-height: 106%">&nbsp;</FONT></TD>
    <TD STYLE="text-align: center; line-height: 106%"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt; line-height: 106%">Equity</FONT></TD>
    <TD STYLE="line-height: 106%"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt; line-height: 106%">&nbsp;</FONT></TD>
    <TD STYLE="text-align: center; line-height: 106%"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt; line-height: 106%">Common
    Stock issuable upon exercise of pre-funded warrants<SUP>(3)</SUP></FONT></TD>
    <TD STYLE="line-height: 106%"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt; line-height: 106%">&nbsp;</FONT></TD>
    <TD STYLE="text-align: center; line-height: 106%"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt; line-height: 106%">457(o)</FONT></TD>
    <TD STYLE="line-height: 106%"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt; line-height: 106%">&nbsp;</FONT></TD>
    <TD STYLE="text-align: center; line-height: 106%"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt; line-height: 106%">&nbsp;</FONT></TD>
    <TD STYLE="line-height: 106%"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt; line-height: 106%">&nbsp;</FONT></TD>
    <TD STYLE="text-align: center; line-height: 106%"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt; line-height: 106%">&nbsp;</FONT></TD>
    <TD STYLE="line-height: 106%"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt; line-height: 106%">&nbsp;</FONT></TD>
    <TD STYLE="line-height: 106%"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt; line-height: 106%">&nbsp;</FONT></TD>
    <TD><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></TD>
    <TD STYLE="line-height: 106%"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt; line-height: 106%"><SUP>(3)</SUP></FONT></TD>
    <TD STYLE="line-height: 106%"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt; line-height: 106%">&nbsp;</FONT></TD>
    <TD STYLE="line-height: 106%"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt; line-height: 106%">&nbsp;</FONT></TD>
    <TD STYLE="text-align: right; line-height: 106%"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt; line-height: 106%">&nbsp;</FONT></TD>
    <TD STYLE="line-height: 106%"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt; line-height: 106%">&nbsp;</FONT></TD>
    <TD STYLE="line-height: 106%"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt; line-height: 106%">&nbsp;</FONT></TD>
    <TD STYLE="line-height: 106%"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt; line-height: 106%">&nbsp;</FONT></TD>
    <TD STYLE="text-align: right; line-height: 106%"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt; line-height: 106%">&nbsp;</FONT></TD>
    <TD STYLE="line-height: 106%"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt; line-height: 106%">&nbsp;</FONT></TD></TR>
  <TR STYLE="vertical-align: bottom">
    <TD COLSPAN="9" STYLE="text-align: right; line-height: 106%"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt; line-height: 106%"><B>Total Offering Amount</B></FONT></TD>
    <TD STYLE="line-height: 106%"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt; line-height: 106%">&nbsp;</FONT></TD>
    <TD STYLE="text-align: center; line-height: 106%"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt; line-height: 106%">&nbsp;</FONT></TD>
    <TD STYLE="line-height: 106%"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt; line-height: 106%">&nbsp;</FONT></TD>
    <TD STYLE="line-height: 106%"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt; line-height: 106%">$</FONT></TD>
    <TD STYLE="text-align: right; line-height: 106%"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt; line-height: 106%">48,000,000</FONT></TD>
    <TD STYLE="line-height: 106%"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt; line-height: 106%">&nbsp;</FONT></TD>
    <TD STYLE="line-height: 106%"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt; line-height: 106%">&nbsp;</FONT></TD>
    <TD STYLE="line-height: 106%"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt; line-height: 106%">&nbsp;</FONT></TD>
    <TD STYLE="text-align: center; line-height: 106%"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></TD>
    <TD STYLE="line-height: 106%"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt; line-height: 106%">&nbsp;</FONT></TD>
    <TD STYLE="line-height: 106%"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt; line-height: 106%">&nbsp;</FONT></TD>
    <TD STYLE="line-height: 106%"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt; line-height: 106%">$</FONT></TD>
    <TD STYLE="text-align: right; line-height: 106%"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt; line-height: 106%">7,348.80</FONT></TD>
    <TD STYLE="line-height: 106%"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt; line-height: 106%">&nbsp;</FONT></TD></TR>
  <TR STYLE="vertical-align: bottom">
    <TD COLSPAN="9" STYLE="background-color: #CCEEFF; text-align: right; line-height: 106%"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt; line-height: 106%"><B>Total Fees Previously Paid</B></FONT></TD>
    <TD STYLE="background-color: #CCEEFF; line-height: 106%"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt; line-height: 106%">&nbsp;</FONT></TD>
    <TD STYLE="background-color: #CCEEFF; text-align: center; line-height: 106%"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt; line-height: 106%">&nbsp;</FONT></TD>
    <TD STYLE="background-color: #CCEEFF; line-height: 106%"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt; line-height: 106%">&nbsp;</FONT></TD>
    <TD STYLE="background-color: #CCEEFF; line-height: 106%"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt; line-height: 106%">&nbsp;</FONT></TD>
    <TD STYLE="background-color: #CCEEFF; text-align: right; line-height: 106%"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt; line-height: 106%">&nbsp;</FONT></TD>
    <TD STYLE="background-color: #CCEEFF; line-height: 106%"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt; line-height: 106%">&nbsp;</FONT></TD>
    <TD STYLE="background-color: #CCEEFF; line-height: 106%"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt; line-height: 106%">&nbsp;</FONT></TD>
    <TD STYLE="background-color: #CCEEFF; line-height: 106%"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt; line-height: 106%">&nbsp;</FONT></TD>
    <TD STYLE="background-color: #CCEEFF; text-align: right; line-height: 106%"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt; line-height: 106%">&nbsp;</FONT></TD>
    <TD STYLE="background-color: #CCEEFF; line-height: 106%"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt; line-height: 106%">&nbsp;</FONT></TD>
    <TD STYLE="background-color: #CCEEFF; line-height: 106%"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt; line-height: 106%">&nbsp;</FONT></TD>
    <TD STYLE="background-color: #CCEEFF; line-height: 106%"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt; line-height: 106%">&nbsp;</FONT></TD>
    <TD STYLE="background-color: #CCECFF; text-align: right; line-height: 106%"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt; line-height: 106%">3,062.00</FONT></TD>
    <TD STYLE="background-color: #CCECFF; line-height: 106%"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt; line-height: 106%">&nbsp;</FONT></TD></TR>
  <TR STYLE="vertical-align: bottom">
    <TD COLSPAN="9" STYLE="text-align: right; line-height: 106%"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt; line-height: 106%"><B>Total Fee Offsets</B></FONT></TD>
    <TD STYLE="line-height: 106%"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt; line-height: 106%">&nbsp;</FONT></TD>
    <TD STYLE="text-align: center; line-height: 106%"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt; line-height: 106%">&nbsp;</FONT></TD>
    <TD STYLE="line-height: 106%"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt; line-height: 106%">&nbsp;</FONT></TD>
    <TD STYLE="line-height: 106%"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt; line-height: 106%">&nbsp;</FONT></TD>
    <TD STYLE="text-align: right; line-height: 106%"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt; line-height: 106%">&nbsp;</FONT></TD>
    <TD STYLE="line-height: 106%"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt; line-height: 106%">&nbsp;</FONT></TD>
    <TD STYLE="line-height: 106%"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt; line-height: 106%">&nbsp;</FONT></TD>
    <TD STYLE="line-height: 106%"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt; line-height: 106%">&nbsp;</FONT></TD>
    <TD STYLE="text-align: right; line-height: 106%"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt; line-height: 106%">&nbsp;</FONT></TD>
    <TD STYLE="line-height: 106%"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt; line-height: 106%">&nbsp;</FONT></TD>
    <TD STYLE="line-height: 106%"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt; line-height: 106%">&nbsp;</FONT></TD>
    <TD STYLE="line-height: 106%"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt; line-height: 106%">&nbsp;</FONT></TD>
    <TD STYLE="text-align: right; line-height: 106%"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt; line-height: 106%">&mdash;</FONT></TD>
    <TD STYLE="line-height: 106%"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt; line-height: 106%">&nbsp;</FONT></TD></TR>
  <TR STYLE="vertical-align: bottom; background-color: #CCEEFF">
    <TD COLSPAN="9" STYLE="text-align: right; line-height: 106%"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt; line-height: 106%"><B>Net Fee Due</B></FONT></TD>
    <TD STYLE="line-height: 106%"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt; line-height: 106%">&nbsp;</FONT></TD>
    <TD STYLE="text-align: center; line-height: 106%"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt; line-height: 106%">&nbsp;</FONT></TD>
    <TD STYLE="line-height: 106%"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt; line-height: 106%">&nbsp;</FONT></TD>
    <TD STYLE="line-height: 106%"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt; line-height: 106%">&nbsp;</FONT></TD>
    <TD STYLE="text-align: right; line-height: 106%"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt; line-height: 106%">&nbsp;</FONT></TD>
    <TD STYLE="line-height: 106%"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt; line-height: 106%">&nbsp;</FONT></TD>
    <TD STYLE="line-height: 106%"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt; line-height: 106%">&nbsp;</FONT></TD>
    <TD STYLE="line-height: 106%"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt; line-height: 106%">&nbsp;</FONT></TD>
    <TD STYLE="text-align: right; line-height: 106%"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt; line-height: 106%">&nbsp;</FONT></TD>
    <TD STYLE="line-height: 106%"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt; line-height: 106%">&nbsp;</FONT></TD>
    <TD STYLE="line-height: 106%"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt; line-height: 106%">&nbsp;</FONT></TD>
    <TD STYLE="line-height: 106%"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt; line-height: 106%">$</FONT></TD>
    <TD STYLE="text-align: right; line-height: 106%"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt; line-height: 106%">4,286.80</FONT></TD>
    <TD STYLE="line-height: 106%"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt; line-height: 106%">&nbsp;</FONT></TD></TR>
  </TABLE>
<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: center"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt"></FONT>(1)
Pursuant to Rule 416 under the Securities Act of 1933, as amended (the &ldquo;Securities Act&rdquo;), this Registration Statement also
covers (i) such additional number of shares of Common Stock issuable upon stock splits, stock dividends, reclassifications, recapitalizations,
combinations or similar events or (ii) such reduced number of shares of Common Stock in respect of any reverse stock splits, stock dividends,
reclassifications, recapitalizations, combinations or similar events, in each case with respect to the shares of Common Stock being registered
pursuant to this Registration Statement.</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">(2)
Estimated solely for the purpose of calculating the amount of the registration fee pursuant to Rule 457(o) under the Securities Act.</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">(3)
The proposed maximum aggregate offering price of the Common Stock proposed to be sold in the offering will be reduced on a dollar-for-dollar
basis based on the offering price of any pre-funded warrants sold in the offering, and, as such, the proposed maximum aggregate offering
price of the Common Stock and pre-funded warrants (including the Common Stock issuable upon exercise of the pre-funded warrants), if
any, is $12,000,000.</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">(4)
Pursuant to Rule 457(g) of the Securities Act, no separate registration fee is required for the warrants because the warrants are being
registered in the same registration statement as the Common Stock issuable upon exercise of the warrants.</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">(5) Estimated solely for the purposes of calculating the amount of the registration fee pursuant to Rule 457(o) under
the Securities Act. The proposed maximum offering price of the shares of Common Stock issuable upon exercise of the warrants to purchase
Common Stock proposed to be sold in the offering is $36,000,000, which is equal to 300% of the $12,000,000, as each share of Common Stock
to be sold in this offering (and each pre-funded warrant to be sold in this offering) will receive a warrant to purchase one share of
Common Stock, and each warrant may be exercised using the alternative cashless exercise provision contained therein, assuming receipt
of Stockholder Approval (as defined in the Registration Statement), whereby the holder thereof may not pay a cash purchase price upon
such exercise, but instead would receive upon such exercise three shares of Common Stock for every warrant exercised.</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>


<!-- Field: Page; Sequence: 1; Options: Last -->
    <DIV STYLE="margin-top: 0pt; margin-bottom: 6pt; border-bottom: Black 1pt solid"><TABLE CELLPADDING="0" CELLSPACING="0" STYLE="border-collapse: collapse; width: 100%; font-size: 10pt"><TR STYLE="vertical-align: top; text-align: left"><TD STYLE="width: 100%">&nbsp;</TD></TR></TABLE></DIV>
    <!-- Field: /Page -->

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>

</BODY>
</HTML>
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>GRAPHIC
<SEQUENCE>9
<FILENAME>ex5-1_001.jpg
<DESCRIPTION>GRAPHIC
<TEXT>
begin 644 ex5-1_001.jpg
M_]C_X  02D9)1@ ! 0$ 8 !@  #_VP!#  @&!@<&!0@'!P<)"0@*#!0-# L+
M#!D2$P\4'1H?'AT:'!P@)"XG("(L(QP<*#<I+# Q-#0T'R<Y/3@R/"XS-#+_
MVP!# 0@)"0P+#!@-#1@R(1PA,C(R,C(R,C(R,C(R,C(R,C(R,C(R,C(R,C(R
M,C(R,C(R,C(R,C(R,C(R,C(R,C(R,C+_P  1" !V!0L# 2(  A$! Q$!_\0
M'P   04! 0$! 0$           $" P0%!@<("0H+_\0 M1   @$# P($ P4%
M! 0   %] 0(#  01!1(A,4$&$U%A!R)Q%#*!D:$((T*QP152T? D,V)R@@D*
M%A<8&1HE)B<H*2HT-38W.#DZ0T1%1D=(24I35%565UA96F-D969G:&EJ<W1U
M=G=X>7J#A(6&AXB)BI*3E)66EYB9FJ*CI*6FIZBIJK*SM+6VM[BYNL+#Q,7&
MQ\C)RM+3U-76U]C9VN'BX^3EYN?HZ>KQ\O/T]?;W^/GZ_\0 'P$  P$! 0$!
M 0$! 0        $" P0%!@<("0H+_\0 M1$  @$"! 0#! <%! 0  0)W  $"
M Q$$!2$Q!A)!40=A<1,B,H$(%$*1H;'!"2,S4O 58G+1"A8D-.$E\1<8&1HF
M)R@I*C4V-S@Y.D-$149'2$E*4U155E=865IC9&5F9VAI:G-T=79W>'EZ@H.$
MA8:'B(F*DI.4E9:7F)F:HJ.DI::GJ*FJLK.TM;:WN+FZPL/$Q<;'R,G*TM/4
MU=;7V-G:XN/DY>;GZ.GJ\O/T]?;W^/GZ_]H # ,!  (1 Q$ /P"6;POXL\=>
M.==UG2=4?3+%;DVR3&5EWB/Y<*%Z@8_,FMU?ACXX50!\0KD8[8?_ .*KU>TM
M+>QMUM[6%(85)(1!@ DDG\R2:FIW%8^>?'NE>,? NE6M[+XVOKLSS&+8I9-O
M&<YW'-3>!]"\9>-M ;5(O'%[:[9VB\MRS= #G.X>OI70?M!_\BOI?_7X?_0#
M5_X"_P#(@S?]?LG\EHZ"ZE*3X9^/ A,?Q!G9NP;S /SR:R?#VB>,_#WQ3T:'
MQ!J5Q>6T_F^7*+AGC?"'((/0_45[I5:XL+:ZN[6ZFCW36K,\+9/RDJ5/Z&BX
M[%FBBBD,**** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH ****
M "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH
M**** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ H
MHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BB
MB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH ****
M "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH
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M@4444AA1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110
M4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1
M110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%
M% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444
M %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110
M4444 %%%% !1110 4444 %%%% !1110 4444 >/_ +0?_(KZ7_U^'_T U?\
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M[@(<].3Q0FKZ=+IIU&.]@:R S]H#@ICUSTK \>@'X8:T,?\ ,/;^5-\-@?\
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MT+Q>2DE[ DNG:@[?+.C#(5F_O#./\C.[H-NT@\90RW-VZQ7CQQ9N9"8T$:L
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M_09MOS/^%+VD.X?4\1_S[E]S_P CRWXZ74FMOIFF:9:7EU+:O(\_EVSD*2
M,XYZ'I7HO@'7[74/#.E6.V:*]M[2..6&6!T*E%"GDC';UK=MM<TR]TZ;4+:\
MCEM(<^9*N<+@9/Z&LG_A8GA '#>(+%&]'?:?R-6G=:'/*+A)J2LR#Q]X$LO'
M&CBWE807L.6MK@#.P]P?537GGA[Q)XN^&2#1_$VBW=]I$1Q#=VRF3RQZ!NA'
ML<$5Z5_PL/P@6VKX@L7;.,1R;C^E=(C++&KJ0R,,@^H-,DX6/XP>$)8@PNKK
M>1_JOLDA;/I@"LC5[SQ/\283I>DZ=<Z)H4IQ<WU\FR69/[J)UP?U]17IRVT"
MMN6",-ZA!FJNJZUIVAP)/J5TEO$[;59@3D_A2 A\.^'M/\+Z+!I>FQ[((ARQ
M^\[=V8]R:\J^-.JQ:K_9.F6,5Q=&VNC+=&&%F$8'&#QUZUZ(/B)X..?^*CTX
M8]9@*LZ?XS\.:M>)::?J]M<SO]U(F+9_'I3 T-+U.RU:S%Q82^9"#M^X5P<=
M,$"O-OC9X-FUK2;;6]-A>34+$A76-26>(GMCG*GGZ$UW.I^,_#NC7;6NI:K!
M:S+U67(]^#C!J?2/$^BZ_(Z:5J$5V4&YC'DC'UQCN* ,_P  >&AX6\(6=@X_
MTIQY]TW=I6P6^N.!^%'Q#MFO/A]KD"1O([6K;$1"[,PY  '/4"MO4]2M-'TV
M?4+Z7RK6!=TCXSM&<?UJ>">&ZMX[BWE26&10R2(<JP/0@TAGBWP9\21:!HUU
MHVMPW5D3.9H7EMW"L& !&<<=/UKMOB9K$47@34+6W6>:ZO[;9;QPP.Y<,0">
M!@<$]:[>H;JZALK62YN'V0QC+-@G ^@YIB/'?@IJB:'H][I6K6]Y:7$ER)(A
M+:R ," .N.N1WKVBN8/Q$\(K+Y1UVU$N<>7\V[/IC&<UOB^MC8?;O,_T;9YF
M_:?N]<XZT ANII)+I5Y'"I:5H'5 .Y*G%>5>"_BE::-H=MHGBJSO=.OK)!"'
M>W;;(J\#W!Q[8KMW^(_@^-V237[2-U."KDJ1^!%12?$/P/+CS->TY\=-QS_2
M@#EO%/BBY^(&FMX;\(6-U-'=D+=:A-"T<,4><GD]2<5Z%X<T2#PWX>LM(MCN
MCM8PFXCECU)_$DFET37-)UZT>?1[J.YMXG\LO$"%#8!P./>H[[Q3H>FW;6MY
MJ4,,Z8W(Q.1FI;2W-*=*=1V@FWY:G%?$OX7_ /"4R+K.C2+;:U$!G)VK,!TY
M'1AV-9FA?%#5_#D2:9XZT34(98AL6^CA+!P.,MV/U7/TKO\ _A./#/\ T&;;
M\S_A2-XU\+NI5]7M64]CDC^5+VD>YM]3Q'_/N7W/_(Q6^+GA9H_]$>_O9C]V
M"WLW9V/I@@"L6YT#Q%\3M2MYM?M9-&\-V[^9'8,V)YSZN.W'Y<_6NQC\8^$X
MB3'JEFA/=1C^E2?\)QX9_P"@S;?F?\*/:0[A]3Q'_/N7W/\ R-A4MM,L D:"
M&UMX\*B+PJJ.@ ]J\1U#6U'QTMO$,=C?R:3%&('N%M),<QD9'&< FO5O^$X\
M,_\ 09MOS/\ A1_PG'AG_H,VWYG_  H]I#N'U/$?\^Y?<_\ (V+*^M]1M5N;
M5R\+9PQ0KG'L0#5BN?\ ^$X\,_\ 09MOS/\ A1_PG'AG_H,VWYG_  I<\>X?
M4\1_S[E]S_R.-^*/PNC\2Q/K.C1K%K$8RZ#@7('K_M>A[]*V/@_:W%G\-["&
MYADAE$DV4D7:P_>,.0?I6U_PG'AG_H,VWYG_  H_X3CPS_T&;;\S_A3]I'N'
MU/$?\^Y?<_\ (Z"BN?\ ^$X\,_\ 09MOS/\ A1_PG'AG_H,VWYG_  I<\>X_
MJ>(_Y]R^Y_Y'045S_P#PG'AG_H,VWYG_  H_X3CPS_T&;;\S_A1SQ[A]3Q'_
M #[E]S_R.@HKG_\ A./#/_09MOS/^%'_  G'AG_H,VWYG_"CGCW#ZGB/^?<O
MN?\ D=!17/\ _"<>&?\ H,VWYG_"C_A./#/_ $&;;\S_ (4<\>X?4\1_S[E]
MS_R.@HKG_P#A./#/_09MOS/^%'_"<>&?^@S;?F?\*.>/</J>(_Y]R^Y_Y'04
M5S__  G'AG_H,VWYG_"C_A./#/\ T&;;\S_A1SQ[A]3Q'_/N7W/_ ".@HKG_
M /A./#/_ $&;;\S_ (4?\)QX9_Z#-M^9_P *.>/</J>(_P"?<ON?^1T%%<__
M ,)QX9_Z#-M^9_PH_P"$X\,_]!FV_,_X4<\>X?4\1_S[E]S_ ,@UO0;O6=8T
MFX:ZA6QL+@7!MFC),K@$ DY[9)''6JGB3PA)J^NZ-K6GWB65[IKL=QBW"5#C
M*'!''7\ZM_\ "<>&?^@S;?F?\*/^$X\,_P#09MOS/^%'M(]Q?4\1_P ^Y?<_
M\BC/X3OIOB!:^*?M]N#!;?9OL_DG!4Y).=W7)H\9^$;SQ1=Z1/:ZC%9MIL_V
MB,M"9"S\8SR..*O?\)QX9_Z#-M^9_P */^$X\,_]!FV_,_X4>TCW#ZGB/^?<
MON?^1EZGX6\1:T\2:EK=G):)+%(]M':,JR;&W8/SGJ<?E5OQAX//B6/3I;2Z
M6QOM/N1<07 CW8]1C(X.!^56?^$X\,_]!FV_,_X4?\)QX9_Z#-M^9_PH]I'N
M'U/$?\^Y?<_\AFD:!J%AXHU/6;B\MI!J,<*211Q,NTQ@A2"6/7<<U4/P_P!,
MB\>6OBJR)MIT\SSX4'R3,R%0V.Q^8_6KW_"<>&?^@S;?F?\ "C_A./#/_09M
MOS/^%'M(]P^IXC_GW+[G_D5/&OA.Z\5C3%AOHK5;&Y6Z&Z(N7=>@ZCBK/]@7
MMQXNMM:OKJWEBMK9X(K98B-A8@LX)/4XQTZ4[_A./#/_ $&;;\S_ (4?\)QX
M9_Z#-M^9_P */:1[A]3Q'_/N7W/_ "*=QX0F3Q['XHTV]CMBUL+>YMVB)689
MSG((P>GY5UE<_P#\)QX9_P"@S;?F?\*/^$X\,_\ 09MOS/\ A1[2/</J>(_Y
M]R^Y_P"1T%%<_P#\)QX9_P"@S;?F?\*/^$X\,_\ 09MOS/\ A1SQ[C^IXC_G
MW+[G_D:>KZ18Z[I<^FZC L]K,N'0_H1Z$>M<[8^$-9TFQ_L_3O%MTEDHVQ+<
M6R321+Z!^.G;(-7_ /A./#/_ $&;;\S_ (4?\)QX9_Z#-M^9_P */:1[B^IX
MC_GW+[G_ )%#4O S7VJ:#?QZM)$^BIM@#1!S(< ,7.1G..V*T8O#T\?B^77_
M .T,F6W%LUOY/R[ <C!SG.3U_2F_\)QX9_Z#-M^9_P */^$X\,_]!FV_,_X4
M>TCW#ZGB/^?<ON?^1%J?@?2=2\4Z=XB"&#4;.3>7C _?#& ']<>M1:MX(M[W
M7EU_3;^XTK5]NQY[<!EF7TD0\-T'ITJU_P )QX9_Z#-M^9_PH_X3CPS_ -!F
MV_,_X4>TCW#ZGB/^?<ON?^0MKH>JK<RW-]KS74I@:&%1;+'''NQEBH/S'@=Z
MR=)\ -I'@R^\,Q:LTEK=AQYCVXWH'&&Q@X^GI6K_ ,)QX9_Z#-M^9_PH_P"$
MX\,_]!FV_,_X4>TCW#ZGB/\ GW+[G_D6H="@?PW'HFI^7?VZPB!M\>-Z@8&1
MD\^XK&M? -MI_@F]\+6-[+%:W32YD= [*C]5'([<9J__ ,)QX9_Z#-M^9_PH
M_P"$X\,_]!FV_,_X4>TCW#ZGB/\ GW+[G_D6SH5O=^'ET;51'?0>4(G+Q[=P
M P#C)P?<=ZYZV^'<=CHVF:/:ZI(-/L+S[8(Y(0QE;>6"N<C*C/IVK6_X3CPS
M_P!!FV_,_P"%'_"<>&?^@S;?F?\ "CVD>X?4\1_S[E]S_P AGBWPE%XI33V^
MV265U87(N(+B) S*1VY['C\JK:GX.N-3\4:3K[ZMY=UIB%8D6V&Q]P(;=\V>
M<GH>*N?\)QX9_P"@S;?F?\*/^$X\,_\ 09MOS/\ A1[2/</J>(_Y]R^Y_P"1
M%XR\(_\ "7V=I:OJ#VB6\XN 8X@S%QTZGI710K(L*+*ZO(!AF5=H)]<9.*PO
M^$X\,_\ 09MOS/\ A1_PG'AG_H,VWYG_  H]I'N'U/$?\^Y?<_\ (Z"BN?\
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M%+VD>X?4\1_S[E]S_P CH**Y_P#X3CPS_P!!FV_,_P"%'_"<>&?^@S;?F?\
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M /PG'AG_ *#-M^9_PH_X3CPS_P!!FV_,_P"%'/'N'U/$?\^Y?<_\CH**Y_\
MX3CPS_T&;;\S_A4B^,?#KJ&75K<@]\G_  HYX]Q/"8A;TW]S_P C<J.>%+BW
MD@D&8Y%*,,XR",&I**LYT[.Z./\ ^%8^%_\ GSF_[_O_ (T?\*Q\+_\ /G-_
MW_?_ !KL**S]E#LCM_M'&?\ /V7WG'_\*Q\+_P#/G-_W_?\ QH_X5CX7_P"?
M.;_O^_\ C7844>RAV0?VCC/^?LOO./\ ^%8^%_\ GSF_[_O_ (T?\*Q\+_\
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M @Y!I F>0:M:0+^TEHKB),R69D;CJPCD /UX'Y5Z_7E.LI_QD5H##_GP?/\
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MUN+.XBN(6^[)$X93^(J>CV4.R#^T<9_S]E]YQ_\ PK'PO_SYS?\ ?]_\:/\
MA6/A?_GSF_[_ +_XUV%%'LH=D']HXS_G[+[SC_\ A6/A?_GSF_[_ +_XT?\
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MXR.GK6EH_B"RUW0H]9L?,>TD5F0LNTL%)!XSZ@T>RAV0?VEB_P#G[+[V8?\
MPK'PO_SYS?\ ?]_\:/\ A6/A?_GSF_[_ +_XTI^)&B+9Z==M#J(M]2<I:/\
M96/FL.P Y^GK5^7QA80:9?W\UKJ,4-ACSUDM65P",Y"GDCWH]E#^4/[2Q?\
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M-)\-+"VJSR0).VR-A"[AF],J#S[56C\<>'7O8[.6_P#LMQ*<1QW<+P%S[%P
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MS_0=ZLC4+0ZB=/%S']L$8E,.[YMA.-V/3(H]E#L']I8S_G[+[SF/^%8^%_\
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MVR.X ;/3'KGVH]E#L']I8O\ Y^R^\YO_ (5CX7_Y\YO^_P"_^-'_  K'PO\
M\^<W_?\ ?_&M>Q\6:#J5Z+*UU.!KHC(@8E'8>RL 3^%32>(='BU9=*DU&!=0
M;[ML6^<_04>RAV#^TL7_ ,_9?>87_"L?"_\ SYS?]_W_ ,:/^%8^%_\ GSF_
M[_O_ (UT&JZYI>AQI)JE_!9QR':K3-M!/IFEO=:TW3;6*YO+R*&*4@1ECRY]
M%'4GV%'LH=@_M+&?\_9?><]_PK'PO_SYS?\ ?]_\:/\ A6/A?_GSF_[_ +_X
MUTFFZM8ZQ;M/87"SQJY1B 058=00>0:N4>RAV0?VCC/^?LOO./\ ^%8^%_\
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M4/\ DFFN_P#7N/\ T(58^';%OAWH!/\ SYH/TJM\4F"_#/723C]P!_X\M/\
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M,5;;1=/?78]::W4ZA' 8%E[A"<XH X#XEV8L1X*L=.\N#R=3CC@WKN5,+@9
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M_P 4X;.;X<:Q]L5"$AW0ENHDR-N/?/%:FO>$-'\206L.IQ321VK!H0D[Q[6
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MV=%T_5HK*$J?EE9AF1\^G1?P->B0>#K46FM6E[<R7D.KNTEPLBJ,,1CY<=
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M !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444
M%%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4
M444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !11
M10 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%%
4 !1110 4444 %%%% !1110!__]D!

end
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>GRAPHIC
<SEQUENCE>10
<FILENAME>ex5-1_002.jpg
<DESCRIPTION>GRAPHIC
<TEXT>
begin 644 ex5-1_002.jpg
M_]C_X  02D9)1@ ! 0$ 9 !D  #_VP!#  $! 0$! 0$! 0$! 0$! 0$! 0$!
M 0$! 0$! 0$! 0$! 0$! 0$! 0$! 0$! 0$! 0$! 0$! 0$! 0$! 0$! 0'_
MVP!# 0$! 0$! 0$! 0$! 0$! 0$! 0$! 0$! 0$! 0$! 0$! 0$! 0$! 0$!
M 0$! 0$! 0$! 0$! 0$! 0$! 0$! 0'_P  1" !G!1,# 2(  A$! Q$!_\0
M'P   04! 0$! 0$           $" P0%!@<("0H+_\0 M1   @$# P($ P4%
M! 0   %] 0(#  01!1(A,4$&$U%A!R)Q%#*!D:$((T*QP152T? D,V)R@@D*
M%A<8&1HE)B<H*2HT-38W.#DZ0T1%1D=(24I35%565UA96F-D969G:&EJ<W1U
M=G=X>7J#A(6&AXB)BI*3E)66EYB9FJ*CI*6FIZBIJK*SM+6VM[BYNL+#Q,7&
MQ\C)RM+3U-76U]C9VN'BX^3EYN?HZ>KQ\O/T]?;W^/GZ_\0 'P$  P$! 0$!
M 0$! 0        $" P0%!@<("0H+_\0 M1$  @$"! 0#! <%! 0  0)W  $"
M Q$$!2$Q!A)!40=A<1,B,H$(%$*1H;'!"2,S4O 58G+1"A8D-.$E\1<8&1HF
M)R@I*C4V-S@Y.D-$149'2$E*4U155E=865IC9&5F9VAI:G-T=79W>'EZ@H.$
MA8:'B(F*DI.4E9:7F)F:HJ.DI::GJ*FJLK.TM;:WN+FZPL/$Q<;'R,G*TM/4
MU=;7V-G:XN/DY>;GZ.GJ\O/T]?;W^/GZ_]H # ,!  (1 Q$ /P#^P?\ X=L?
ML(_]&G?!3_PA='_^)H_X=L?L(_\ 1IWP4_\ "%T?_P")J/XU?%S]M3P]\46\
M%_L[_LI?"_XM^#-+\':/KGB/XG_%[]I?6?@!IQ\3ZWJWB.(>#_!.AZ%^SO\
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M?B3XD+_FXO&C].,>+M?2^)7XV.)_X=L_L'?]&G_!'_PAM)_^)H_X=L_L'?\
M1I_P1_\ "&TG_P")KZ<\,?$?X=^-?$_Q"\(>%?%GAOQ)XE^%.O:3X:^)&@Z5
MJ<&HZMX&\3:QH&A^,]%TGQ!I(=VTBYNO#&NZ'X@@$C1DP72,J^9%+LX+XO\
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M-/\ @C_X0VD__$T?\.V?V#O^C3_@C_X0VD__ !-?<FQ?3_R''_\ %4;%]/\
MR''_ /%4?4<#_P!"JG_X!3_^2#_B)7B1_P!'#XV_\3#BS_YK/AO_ (=L_L'?
M]&G_  1_\(;2?_B:/^';/[!W_1I_P1_\(;2?_B:^Y-B^G_D./_XJC8OI_P"0
MX_\ XJCZC@?^A53_ / *?_R0?\1*\2/^CA\;?^)AQ9_\UGPW_P .V?V#O^C3
M_@C_ .$-I/\ \31_P[9_8._Z-/\ @C_X0VD__$U]R;%]/_(<?_Q5&Q?3_P A
MQ_\ Q5'U' _]"JG_ . 4_P#Y(/\ B)7B1_T</C;_ ,3#BS_YK/AO_AVS^P=_
MT:?\$?\ PAM)_P#B:/\ AVS^P=_T:?\ !'_PAM)_^)K[DV+Z?^0X_P#XJC8O
MI_Y#C_\ BJ/J.!_Z%5/_ , I_P#R0?\ $2O$C_HX?&W_ (F'%G_S6?#?_#MG
M]@[_ *-/^"/_ (0VD_\ Q-'_  [9_8._Z-/^"/\ X0VD_P#Q-?<FQ?3_ ,AQ
M_P#Q5&Q?3_R''_\ %4?4<#_T*J?_ (!3_P#D@_XB5XD?]'#XV_\ $PXL_P#F
ML^&_^';/[!W_ $:?\$?_  AM)_\ B:/^';/[!W_1I_P1_P#"&TG_ .)K[DV+
MZ?\ D./_ .*HV+Z?^0X__BJ/J.!_Z%5/_P  I_\ R0?\1*\2/^CA\;?^)AQ9
M_P#-9\-_\.V?V#O^C3_@C_X0VD__ !-'_#MG]@[_ *-/^"/_ (0VD_\ Q-?<
MFQ?3_P AQ_\ Q5&Q?3_R''_\51]1P/\ T*J?_@%/_P"2#_B)7B1_T</C;_Q,
M.+/_ )K/AO\ X=L_L'?]&G_!'_PAM)_^)H_X=L_L'?\ 1I_P1_\ "&TG_P")
MK[DV+Z?^0X__ (JC8OI_Y#C_ /BJ/J.!_P"A53_\ I__ "0?\1*\2/\ HX?&
MW_B8<6?_ #6?#?\ P[9_8._Z-/\ @C_X0VD__$T?\.V?V#O^C3_@C_X0VD__
M !-?<FQ?3_R''_\ %4;%]/\ R''_ /%4?4<#_P!"JG_X!3_^2#_B)7B1_P!'
M#XV_\3#BS_YK/AO_ (=L_L'?]&G_  1_\(;2?_B:/^';/[!W_1I_P1_\(;2?
M_B:\:_:$_;C^/W@J_P#BG/\ LM?L5>(?VJ_!7P#FU:R^+?C:;XS^%?A!;+XD
M\+:3%K_C?P3\*M#UOPUXMUGXM>*_"GAR==\;CP9X0O\ Q<D_@:/QFWC"UGA@
M],T#_@H)\ M6_8)T/_@H7=7.LZ-\%]7^%J?$Y-&N]/3_ (3:#5'8:*WPU315
MW-JOCX>/_-\%1V:D"7Q9LAWK&6E4^H8/_H44_P#P"/KW_I:A_P 1)\2/^CB\
M:?\ B8<7_P#S1TZ_@;/_  [9_80_Z-,^"?\ X0ND_P"%'_#MG]A#_HTSX)_^
M$+I/^%>0^(/VZ?'OP=U_]GN]_:R^ >E_ [X9?M3^/O"_PD^'_C+0_B^_Q(O_
M  -\6_'FB2:Y\+O WQM\/+\+_"D/@1_%)TC6] ?Q1X2\5>-?"GACQHD%E?7#
M6%T/&0]4\7_M1>--8^-'Q)_9]_9T^$NC_&/XB_!OP3X9\7?%Z[\7?$UOA)X%
M\*:C\0)-8N/ GPWA\11_#SXKZAK?Q&\4^']!UOQ0^AR>%K3PSX7\+/X=N;WQ
M?$/%%BD:^H8/?^R:=O\ #'T[]Q?\10X__P"CC<9]+_\ &7<7Z7Z6^LW??33S
M+7_#MG]@[_HT_P""/_A#:3_\31_P[9_8._Z-/^"/_A#:3_\ $U4^"_[=_P $
M/BK^S!\1OVJ=6DO_ (8>&_@//\4?#'[1?A?QNJQ>)_@KX]^!;S#XL>"?$K*Y
M$VN>%3ILNU8H,^)HY=$>%D-U%$/(M:_X*">-OAC8?L__ !0^/7[/5Q\*?V<O
MVD_&_@+X?>%?B2?B _B7QI\,_%'Q::9OA;_PT%\,)_AWX57X<Z!XPFDT+PP=
M=\-^-O'4'@?Q5K,%IXYBM(V-U3^H8/\ Z%%/>WP1_P ]_P! 7B5XD?\ 1Q>-
M%_W>'%WG_P!1/>V^FM^Y[1_P[9_8._Z-/^"/_A#:3_\ $T?\.V?V#O\ HT_X
M(_\ A#:3_P#$U]R;%]/_ "''_P#%5^*WB7]M+]L#2?\ @K;X8_X)WVD/[.*_
M#WQ3^SE+^UK;^/+SP!\2#XXL_A_'\3_$7P^/PO\ )3XR#PW+\0'?06NHO& 1
M?#$@=2?!@B?[.#ZC@NF4TWZ0AHO_  (:\2?$A[^(O&D?\7&'%OX<N)E^GXGV
M+_P[9_8._P"C3_@C_P"$-I/_ ,31_P .V?V#O^C3_@C_ .$-I/\ \37F7QI^
M/O[3?B+]JSPA^S?^QU:_!G6+/P5X4UGQ=^U-\0_BKX3\:>)?#?P>77(0OPE\
M(:=_P@GQ$\(-K_Q'\4PIJGB-OAI=,;E?!4:>++F_\+PW?A=;_P#2*S6<VT/V
MQ[>2\%N!<FV1?L9?NR;R&">F0&QGC%'U#!]<IIKUA#_Y(;\2?$BU_P#B(W&C
M=[67&'%]_G?$I?<V?%7_  [9_8._Z-/^"/\ X0VD_P#Q-'_#MG]@[_HT_P""
M/_A#:3_\37W)L7T_\AQ__%4;%]/_ "''_P#%4?4<#_T*J?\ X!3_ /DA?\1*
M\2/^CA\;?^)AQ9_\UGPW_P .V?V#O^C3_@C_ .$-I/\ \31_P[9_8._Z-/\
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M'?\ 1I_P1_\ "&TG_P")H_X=L_L'?]&G_!'_ ,(;2?\ XFON38OI_P"0X_\
MXJC8OI_Y#C_^*H^HX'_H54__  "G_P#)!_Q$KQ(_Z.'QM_XF'%G_ ,UGPW_P
M[9_8._Z-/^"/_A#:3_\ $T?\.V?V#O\ HT_X(_\ A#:3_P#$U]R;%]/_ "''
M_P#%4;%]/_(<?_Q5'U' _P#0JI_^ 4__ )(/^(E>)'_1P^-O_$PXL_\ FL^&
M_P#AVS^P=_T:?\$?_"&TG_XFC_AVS^P=_P!&G_!'_P (;2?_ (FON38OI_Y#
MC_\ BJ-B^G_D./\ ^*H^HX'_ *%5/_P"G_\ )!_Q$KQ(_P"CA\;?^)AQ9_\
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M8OI_Y#C_ /BJ-B^G_D./_P"*H^HX'_H54_\ P"G_ /)!_P 1*\2/^CA\;?\
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MG_!'_P (;2?_ (FON38OI_Y#C_\ BJ-B^G_D./\ ^*H^HX'_ *%5/_P"G_\
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M;/[!W_1I_P $?_"&TG_XFON38OI_Y#C_ /BJ-B^G_D./_P"*H^HX'_H54_\
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M_P"2,/\ B)7B1_T</C;_ ,3#BS_YK/AO_AVS^P=_T:?\$?\ PAM)_P#B:/\
MAVS^P=_T:?\ !'_PAM)_^)K[DV+Z?^0X_P#XJC8OI_Y#C_\ BJ/J.!_Z%5/_
M , I_P#R0?\ $2O$C_HX?&W_ (F'%G_S6?#?_#MG]@[_ *-/^"/_ (0VD_\
MQ-'_  [9_8._Z-/^"/\ X0VD_P#Q-?<FQ?3_ ,AQ_P#Q5&Q?3_R''_\ %4?4
M<#_T*J?_ (!3_P#D@_XB5XD?]'#XV_\ $PXL_P#FL^&_^';/[!W_ $:?\$?_
M  AM)_\ B:/^';/[!W_1I_P1_P#"&TG_ .)K[DV+Z?\ D./_ .*HV+Z?^0X_
M_BJ/J.!_Z%5/_P  I_\ R0?\1*\2/^CA\;?^)AQ9_P#-9\-_\.V?V#O^C3_@
MC_X0VD__ !-'_#MG]@[_ *-/^"/_ (0VD_\ Q-?<FQ?3_P AQ_\ Q5&Q?3_R
M''_\51]1P/\ T*J?_@%/_P"2#_B)7B1_T</C;_Q,.+/_ )K/AK_AVQ^PC_T:
M=\%/_"%T?_XFC_AVQ^PC_P!&G?!3_P (71__ (FOASXD_ME?MU>$?^"G_P *
M_P#@GWHA_95N?#WQA^!WC3X_Z+\2]6^&_P 6EU;PGX6\,ZYX@T2+PCK6B67Q
MI5/$GB&4:&LG_"0QR>$+-@=JVB2%XS^F7[3'B#XR^#_@GXX\;_!36/AS:>-/
M GA;Q1XNGL_B/X1\3>)/#6MV'AOPGKNMIH;_ /"-^.?!^M:%<ZE<0:>%U];Z
M[%N$D,EI,TD8C7U#!_\ 0HA_X#'_ #_X'FSH_P"(D^(^G_&Q^,M;Z_ZX\7Z=
MO^7_ %_,\Q_X=L_L'?\ 1I_P1_\ "&TG_P")H_X=L_L'?]&G_!'_ ,(;2?\
MXFOD']@K_@H?\4OC%_P3;E_X*1_M0:%X*T[P3=>#OB%X]M_AG^S_ . /%>H^
M-="T3X4>-_'W@G68 _B'XB>+9/'VO>(#X-S8K"GA**,!XI!N9I$_3C]GKXT^
M%OVD/@E\,_CMX*TSQ/H_A/XK>$=*\9>'M*\:>'F\.^*++3=9B\Z&/6M$EF+V
ML^UE<H6<&-EE#D/P_J&#ZY137K"'^?\ P?(YWXD^)'_1Q>-'I?3C#BZWWO$K
M;KIZ'@O_  [9_8._Z-/^"/\ X0VD_P#Q-'_#MG]@[_HT_P""/_A#:3_\37W)
ML7T_\AQ__%4;%]/_ "''_P#%4?4<#_T*J?\ X!3_ /D@_P"(E>)'_1P^-O\
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M!_Q$KQ(_Z.'QM_XF'%G_ ,UGPW_P[9_8._Z-/^"/_A#:3_\ $T?\.V?V#O\
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MX=L_L'?]&G_!'_PAM)_^)K[DV+Z?^0X__BJ-B^G_ )#C_P#BJ/J.!_Z%5/\
M\ I__)!_Q$KQ(_Z.'QM_XF'%G_S6?#?_  [9_8._Z-/^"/\ X0VD_P#Q-'_#
MMG]@[_HT_P""/_A#:3_\37W)L7T_\AQ__%4;%]/_ "''_P#%4?4<#_T*J?\
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M1L7T_P#(<?\ \51]1P/_ $*J?_@%/_Y(/^(E>)'_ $</C;_Q,.+/_FL^&_\
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MP2,JZ];_ /"<:)XE$L2*5E\ O*96/B[Q<TW"_P#!?+XR_M'_  =_X*'? /\
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M_;7TKXF_!KQO^RQHWP;^(7P]TGP[\3?#GQH^%?Q9^(GB[X37^N7^N:M\/I_
M?C+P5XX\/?#7XO6[:WX1AT3QS:S>&O$OA1HGBU]EBN4G+>6 ?EY^R'_P5_\
M@1^UE^S7^W1^U#\+/@IXI^$/[9W[-WP(U7_AHK]G_P"(=E,?'>G:G\*M#^,/
MB'X7:/K12U5M9\.KXEU3Q[!!<+X8M?%ENUQ):^,XXC%91,?\&TVE6'C7_@FY
MX/\ VQ/%^J'QS^TA^V!\0_C'\2?VB_BMK,BZAXV\6>+/#OQF\?>!-!T76-;
MEG&A>'?"^AZ0_A/PV7\JU35G-M;P1R.U?4?[)/[ _BWP_P#M9_ME_MU?M%Z5
M\+=/^*?[7WAKP+\)[WX/_"ZXUGQ)X%\'?##P-H*Z%)'XC\;ZYX<\'7'Q&\?>
M+H$B_P"$M\2OX-\+6\(TJ#PO:6[1;YA\V_LB_P#!._\ ;7_X)3^*_B;\//V(
M=<^"?[0/[#?Q"\;:M\0/!W[/_P =?'/C+X2_$[X ^)/$ )UO2?!'Q1\.?#KX
MO>'?$'AR0B)BGB3PC;SL\$1<^8TCS 'PI_P6)\!P?L/?\%:?^"3?[;O[,^G?
M\(!\3?VH?VAU_9H_:.T#P;:)8:=\:/ NO:[X T;^T_&.B6Q2+Q!KUOX=\0ZY
M$LT\*SDV/A9]Q?PH9I_"_CO\*/VVO /_  4L_P""J_\ P4R_X)Q>)M2\??%?
M]F_]H?X$?#[X\?LH79N=0\$_M&_ 9/V-O@%K>NZ+I6D^2MRWQ)\(^(&\:S*\
M;23JKQGP%(L\;P>+OWLD_8)^*'[3G[8_P0_;'_;=U#P-:?\ #)]EXH'[,7[-
M?PGU_6_&'@OPAXX\:"+_ (2#XR?$_P >^)/#OA&7Q_\ $!XM&T%?!7AZV\%^
M$O"'@?8[K<>*[K,C[O[#_P"S;^TO\%?VN?\ @HY\6OBKH'PMTCX<_M;?&CX>
M_%WX;/X0^(VK^)_$VB#P=\'O#_PHU;2?&>B7'PW\+6^9QH&D:[')%XJE_P!:
MXC"S;RX!^:OQ2_X*)?L_?\%//V>_^"7/QT^!5\]KKFE?\%6OV2M%^)_PTUAP
M_COX->.I/!GQ<FU[P;XAW)&T6QY)$M_$,(-MXNMMIB91*((/ZDZ_GC_:#_X(
M=>#;O_@HQ^S7_P %#?V6M8T[X.:SX<^./AKX@_M5?"*T.JZ3X(^,NE:$=9*>
M-M*T?P\(T3XC^'FUFYD"-$MCXI$TC2"&4AIOZ'* /Y#/^#H+_A(?^%R?\$4?
M^$,_L'_A,?\ AX+X:_X1;_A*_P"T?^$=_P"$J_X2GX=_\(]_;W]A_P#%1?V%
M_;WD>;]C_P"6._R>-U?L+\6/^'MW_"K/BA_:?_#NC^S_ /A!/'GVS[)_PTO_
M &C_ &;_ &#K>W9GY<^7MV[>V[ONKY4_X+5_\$\/VO/VZ_B[_P $[_&'[.>F
M?!5?#_['/[2.F?M >+;SXG?$/7?#6H^*QH>N^ ];@T/1](T'X<^,%9W_ + U
MI'DDERSNK+&&DC1OVC^+5A\1_$'P/^(6G>&/#'AJ\^(_B;P#XFT72O#>J^*Y
MK#PR?$FKZ-<Z-"FK>,1X=D<:.HDC:65?!\KS")56WC+H8@#^>[_@T,_Y0Z>%
M_P#LXOXZ?^G;P_7._P#!!/\ Y2??\'(O_9]O@;_U-OVGZ^S/^""'["'[4/\
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M\*?#W_@X7\'>%A<#X8:]_P %!_V-AK/V,'^RO[5^*_\ P@/_  MC'_@CT/\
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M\3M%^(4W@KP/H7AWX=>,KBXTHK&?#O@Z3Q?Y@ECT-9O&TDS/<.=3]K#]G?\
M:V^+G[97_!._]H/P!\./@U+X3_9/N/BIXH\<:9XB^-&KZ9XEOM>^-?PU7P%K
M6B:+*GP2\6Q;/"!TP-!XD9HW\9QS, G@YUF>@#XJ^'7A']OKQY_P66_;T\/>
M'_VXO"OANT^%_P (_P!G._T?1_$?[,7_  FOAK3?A;\5=:^('B#0/AKX*T _
M&[PE_8'B'PD="5_&OQ.<>,'\8GQ F(_!DR+&/HS4OV\_CG\;O&/[8FB?L]6?
MBC1--_98^('BGX'^!+W1OV6_B?\ &K3_ (R_'WP+H6C:YXYT?QCXB\/X\/>
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M]XQTKQ)\3].^.NA_#_0#(R>'_@?XGC\!MX8?P3YK*/\ A+_-+-LPBX7(!?\
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MPU\')HG@#PC)JVL:R(X(KF]\9N;1)X?!R8D !Y5\0?VI/VV-0_X*AZQ^P?\
M#V+X"^#O &N?LDI^T3X0^*NN:9XO\9^)] TP?$Y? 6M:SK_@6/Q#X.35M=?7
MSJWASP;X5C\31>$GMEB\=3^+GF0> QQO[/W[0'_!1/X^_$W]LG]D8_$_]GGP
M'\2/V*?'WA3P9K?[2MO\)=9\9Q_%A?BEX)T/XB?"Q_\ A1[_ !*\)V_PZ8>&
M=9D;QPQ\8>+8II_+3P3,BMYT?M=_^S9^U!-_P5LTK]L^/P5\*F^ NG_LFR?L
MJ8_X6IKJ_$U!)\43\5O^%E)X,3X9Q^'2H;/A@>'F\8F4C-QY@0J5R_V3/V>O
MVM_@M^UU_P %&/CUXX^'OP?/A?\ :X\6?#SXA_#W3/#WQHUF^UC1-5^$WP8\
M/?";0/!OC.9O@O;QA/%SZ(OB2Z\3P)<'P=%++:>5XP,O <Y[5_P33_:K\:?M
M>?LPP_$?XJ:)X:T7XG^#_BG\8?@?\2/^$*&J?\(5KOB;X/>.-=\":QXM\.1Z
MTB76D^'O%<FBIXCAA=CM,^Q7=I(X:_16ORH_X)5_LV_M"?LH?![XJ?#;]H70
M/AII5_XE_:'^,GQH\.:M\./B#KGCG3;[3?BQXVUWQLNC:H->^'?@N30F\,&<
M0@QI,CLZ!=K K+^J]!T!1110 4444 %%%% !1110 4444 %%%% !1110 444
M4 %%%% !1110 4444 %%%>'_ ! ^/7PC^&/Q$^#'PH\<>--'\._$#]H77?$_
MASX0>'KMT2]\;ZMX*\)3>-O$VFZ-N;:3;>&]+EN)%)'F$(L9,A3 ![A1110
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MD?E3WJ:5_P (=8DW?B>TG/Y"ZY^U=_P4$_8E_;1_9.^%7[8GBCX!_'O]G/\
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MU]/-C\M-X!^BE%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444
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MQ,\6R:)J?B?Q8/%TWB[P4ZZYX<6+P-#':C/YEW/Q>_:)UK_@WP^-G[1'B/\
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M: [CQ=:>&66WAEE#*B%5(^T_VK/V5/A)^V7\)V^#?QG7Q:?"3^)/#/C*VN_
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M@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH ****
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M\)Z3\5_B3X:70_@SX(U?2"7B^(WBWP^O_"4^.U''@WX-$W#A;GQOX3+>U_\
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MIZY\!KB-8_%[CPT/AIJ.L>$[7X:^=B:-O#,<L2^3;D^Z6'B3X;_M@Z1\1/\
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M72+G^U-!;1?A/\1/B3XH^&D(\(R$-X%V^$F/A1<FV;)7'UW\3OA?\/\ XS^
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M0 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%%
M!1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %
M%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 44
M44 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !111
M0 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%%
M!1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %
F%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 ?_]D!

end
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>GRAPHIC
<SEQUENCE>11
<FILENAME>ex5-1_003.jpg
<DESCRIPTION>GRAPHIC
<TEXT>
begin 644 ex5-1_003.jpg
M_]C_X  02D9)1@ ! 0$ 8 !@  #_VP!#  @&!@<&!0@'!P<)"0@*#!0-# L+
M#!D2$P\4'1H?'AT:'!P@)"XG("(L(QP<*#<I+# Q-#0T'R<Y/3@R/"XS-#+_
MVP!# 0@)"0P+#!@-#1@R(1PA,C(R,C(R,C(R,C(R,C(R,C(R,C(R,C(R,C(R
M,C(R,C(R,C(R,C(R,C(R,C(R,C(R,C+_P  1" "%!:T# 2(  A$! Q$!_\0
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M@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH ****
M"BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH *
M*** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HH
MHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB
M@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH ****
M"BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH *
M*** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@#"\
M9Z\WACPCJ.L1HCRV\8\M7Z,Y8*H./<BN"T_XI^,;FT68_#B_G##B2)Y$5O<
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M %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110
M4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1
M110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%
M% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444
M %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110
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MQS^:NU\KE?F]^* /:****0PHHHH **** "BBB@ HHHH **** "BBB@ HHHH
M**** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ H
MHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BB
MB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH ****
M "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH
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MT3##))<QLI'N":YB7PU\+)IS,T6@JQ.2([I47_OE6 _2M/\ X5IX5_Z![_\
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M%Q_XUC_\*T\*_P#0/?\ \")/\:/^%:>%?^@>_P#X$2?XT7J]E^(<F7?SS_\
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M&/\ F;'_  D^@?\ 0<TS_P "X_\ &C_A)] _Z#FF?^!<?^-8_P#PK3PK_P!
M]_\ P(D_QH_X5IX5_P"@>_\ X$2?XT7J]E^(<F7?SS_\!C_F;'_"3Z!_T'-,
M_P# N/\ QH_X2?0/^@YIG_@7'_C6/_PK3PK_ - ]_P#P(D_QH_X5IX5_Z![_
M /@1)_C1>KV7XAR9=_//_P !C_F;'_"3Z!_T'-,_\"X_\:/^$GT#_H.:9_X%
MQ_XUC_\ "M/"O_0/?_P(D_QH_P"%:>%?^@>__@1)_C1>KV7XAR9=_//_ ,!C
M_F;'_"3Z!_T'-,_\"X_\:/\ A)] _P"@YIG_ (%Q_P"-8_\ PK3PK_T#W_\
M B3_ !H_X5IX5_Z![_\ @1)_C1>KV7XAR9=_//\ \!C_ )FQ_P )/H'_ $'-
M,_\  N/_ !H_X2?0/^@YIG_@7'_C6/\ \*T\*_\ 0/?_ ,")/\:/^%:>%?\
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M9=_//_P&/^9L?\)/H'_0<TS_ ,"X_P#&C_A)] _Z#FF?^!<?^-8__"M/"O\
MT#W_ / B3_&C_A6GA7_H'O\ ^!$G^-%ZO9?B')EW\\__  &/^9L?\)/H'_0<
MTS_P+C_QH_X2?0/^@YIG_@7'_C6/_P *T\*_] ]__ B3_&C_ (5IX5_Z![_^
M!$G^-%ZO9?B')EW\\_\ P&/^9L?\)/H'_0<TS_P+C_QH_P"$GT#_ *#FF?\
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MAR9=_//_ ,!C_F;'_"3Z!_T'-,_\"X_\:/\ A)] _P"@YIG_ (%Q_P"-8_\
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M ,")/\:/^%:>%?\ H'O_ .!$G^-%ZO9?B')EW\\__ 8_YFQ_PD^@?]!S3/\
MP+C_ ,:/^$GT#_H.:9_X%Q_XUC_\*T\*_P#0/?\ \")/\:/^%:>%?^@>_P#X
M$2?XT7J]E^(<F7?SS_\  8_YFQ_PD^@?]!S3/_ N/_&C_A)] _Z#FF?^!<?^
M-8__  K3PK_T#W_\")/\:/\ A6GA7_H'O_X$2?XT7J]E^(<F7?SS_P# 8_YF
MQ_PD^@?]!S3/_ N/_&C_ (2?0/\ H.:9_P"!<?\ C6/_ ,*T\*_] ]__  (D
M_P :/^%:>%?^@>__ ($2?XT7J]E^(<F7?SS_ / 8_P"9L?\ "3Z!_P!!S3/_
M  +C_P :/^$GT#_H.:9_X%Q_XUC_ /"M/"O_ $#W_P# B3_&C_A6GA7_ *![
M_P#@1)_C1>KV7XAR9=_//_P&/^9L?\)/H'_0<TS_ ,"X_P#&C_A)] _Z#FF?
M^!<?^-8__"M/"O\ T#W_ / B3_&C_A6GA7_H'O\ ^!$G^-%ZO9?B')EW\\__
M  &/^9L?\)/H'_0<TS_P+C_QH_X2?0/^@YIG_@7'_C6/_P *T\*_] ]__ B3
M_&C_ (5IX5_Z![_^!$G^-%ZO9?B')EW\\_\ P&/^9L?\)/H'_0<TS_P+C_QH
M_P"$GT#_ *#FF?\ @7'_ (UC_P#"M/"O_0/?_P ")/\ &C_A6GA7_H'O_P"!
M$G^-%ZO9?B')EW\\_P#P&/\ F;'_  D^@?\ 0<TS_P "X_\ &C_A)] _Z#FF
M?^!<?^-8_P#PK3PK_P! ]_\ P(D_QH_X5IX5_P"@>_\ X$2?XT7J]E^(<F7?
MSS_\!C_F;'_"3Z!_T'-,_P# N/\ QH_X2?0/^@YIG_@7'_C6/_PK3PK_ - ]
M_P#P(D_QH_X5IX5_Z![_ /@1)_C1>KV7XAR9=_//_P !C_F;'_"3Z!_T'-,_
M\"X_\:/^$GT#_H.:9_X%Q_XUC_\ "M/"O_0/?_P(D_QH_P"%:>%?^@>__@1)
M_C1>KV7XAR9=_//_ ,!C_F;'_"3Z!_T'-,_\"X_\:/\ A)] _P"@YIG_ (%Q
M_P"-8_\ PK3PK_T#W_\  B3_ !H_X5IX5_Z![_\ @1)_C1>KV7XAR9=_//\
M\!C_ )FQ_P )/H'_ $'-,_\  N/_ !H_X2?0/^@YIG_@7'_C6/\ \*T\*_\
M0/?_ ,")/\:/^%:>%?\ H'O_ .!$G^-%ZO9?B')EW\\__ 8_YFQ_PD^@?]!S
M3/\ P+C_ ,:/^$GT#_H.:9_X%Q_XUC_\*T\*_P#0/?\ \")/\:/^%:>%?^@>
M_P#X$2?XT7J]E^(<F7?SS_\  8_YFQ_PD^@?]!S3/_ N/_&C_A)] _Z#FF?^
M!<?^-8__  K3PK_T#W_\")/\:/\ A6GA7_H'O_X$2?XT7J]E^(<F7?SS_P#
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M "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH
M**** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ H
MHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BB
MB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH ****
M "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH
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%** /_]D!

end
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>GRAPHIC
<SEQUENCE>12
<FILENAME>form_001.jpg
<DESCRIPTION>GRAPHIC
<TEXT>
begin 644 form_001.jpg
M_]C_X  02D9)1@ ! 0$ 9 !D  #_VP!#  $! 0$! 0$! 0$! 0$! 0$! 0$!
M 0$! 0$! 0$! 0$! 0$! 0$! 0$! 0$! 0$! 0$! 0$! 0$! 0$! 0$! 0'_
MVP!# 0$! 0$! 0$! 0$! 0$! 0$! 0$! 0$! 0$! 0$! 0$! 0$! 0$! 0$!
M 0$! 0$! 0$! 0$! 0$! 0$! 0$! 0'_P  1" !^ 9 # 2(  A$! Q$!_\0
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M?A]=+L=3B9)+/Q!!9+>:U8?H%X3EUZ"UM[#Q#K4/B#5$1&O=3M]-AT>":>6
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M? V\D<,S6][I.II#'+>:'K^E7$,>I:'KMBKC[1I6H6R3PX4Q/+8B.\/X[?\
M!<#]M^U^$OP+N?V7? M])+\6?CO86VG>+4TEFN+WP5\)[V_M8[ZWNK6#;.-8
M^*217G@W0])^S27]_I#^)+L6T!73);C\9?A=^TS\6OV5]7A\??"'78-,O392
M6FLZ)JMJ-2\*^*-):&:.WL->T=V@@NHK&4I>Z7=0W,6H:=>1PR6L\%H^HV.L
M_77[%NG_  T^+7Q*\,?M:^,?$%G^TO\ M8_$[QEXJ/P/_9\35UGOO!OC'P[(
M=+\7?&G]H75$T][#P1X+\ Z5#::KH%S<Z%%IPTR31;;P]I?BCQI?>#= T?\
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M&LSQZ=KJV^P-_9&KW-J[MXMT:&XBCD7POI5AXCU>WN\/:-:(TLX^6?AO\?\
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M1)R=K1?+M*=.+2<D/+<BQV:TIU<.Z,(PJNBE5ER<[4'/FN]DU%JZTO9:/?\
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M8<$0:_XV\2>*?$=Y;M$&/DNNC_\ "/7.&4321WJ2.[JL17^[V<KET. ".PZ
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MNM#]7/\ @A;\.!\1?^"GG[/4LUK]JL/AQ:_$;XI7RM&7BA/ASP#KVEZ/<2.
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MU2<I*"6EY5*D>2/K[RCY^1\*XJ5XPCI+11TU<FE;MJV?YGG_  52^)*_%O\
MX*,_MA^-HITN+:3XQZEX/L)HG1XY-,^%FB:)\*M,:,H2JA[#P7;2J!R4=9&^
M9VS_ %#_ /!L?\/?^$<_8P^,7Q)NK=!>_$W]HW6;&SN@K;KKPWX!^'_@?2+$
M2%\DFV\4:CXWMU=7.Z(6ZG]X)WE_B;\6^)M5\:^+/%GC;796EUGQGXH\1>+=
M5G<AI9=2\2:O>:M?RR$$_,UW<RX!)*_ZLLQ4FO\ 10_X(I?#P?#C_@F7^RY9
MRP?9[WQKX2UCXH7B&(1-(GQ$\3:MXETR608#2.^A7FD+%.<B2VBC=3AP:_JS
MQD4,B\-<BR6C/DOBLFPE*FTDVL)DTLRK1?FZO/)M)6E6YMDT_P!%XHHK#9'A
M<(IJG-SPF&U5^:U!5N:UT]+I6;O>[OJT?(?_  <J_$"/PY^P=X8\ ).B7'Q3
M^.?@>QD@,C)+<:=X0MM3\6W;*@=1-%#J=IH+%-K 3^23R5*_PE'.",@[AC&U
M6#<\%E(96"L Q4Y5]JK(I7*M_6+_ ,'27Q%,WBC]COX16UTP73-"^+OQ.UVR
MW B0ZKJG@/POX4N"N=R^2OA_QFB'G?\ :967'DL:_F/^&GP7^(/Q=TOXP:MX
M#TAM7M_@7\(]8^.'CZ.)CY]I\/\ PUXM\'^$_$&IVBBVN4N)]$/C*U\17<$B
M1H-!T36[PR!;0J_TG@U2PV4>&^79C7E&@LSQ&-S6I4FU3C06)S3"Y9A>><M)
M*M5<9J2Y$U"5*SE-271PPX8?)8SKVINI6]JJC>EG-P3M_>4>^G,M._\ 1M_P
M;9_MGMX-^)GC3]B?QIJBQ>'OBG]N^*'P=:ZN%C6V^)'A_3T7Q[X;MBX >7QC
MX0L[;7+.U2:(0WG@O5YEAN+C6'8?VHU_DN?#3XE>,_@Y\1?!'Q9^'>K/H?CO
MX;^*-)\9^$]3A48LM>T"\M[RS:>W25H[JQO#;_8-6L&E6*]TN:ZLPR1W!K_4
M$_9'_:$\(?M6?L^?"[]H/P*?)T'XG>%[;6Y]*>Y%U=>&O$D$\^F>+O"E[,H3
M?>^%/$EEJ?A^X?:!+_9\;1YM_LS/^1^._"ZRCB*'$F$PUL%GE6.&QTJ$&J%/
M-:-*-J\8QO%0Q]*7MI-6<)TY<TJC=UX?%N6+#8J&-HPY:&)BW-<NE.JG'E3E
MM)UHMS6D;<K^*]SZ/D!D>6+@!F(![Y*QGZ<=?_KC-?YJ_P#P6 ^("?$S_@I?
M^U_XCAN([FTT[XD:;X!LY(O]6L/PP\">#_ATZJH)4%KKPS-<.8PJR33RS!5,
MFT?Z3UU/;V$-SJ-U*D%G9037EU-(P6.&WMHVGGE=FX"I%$S,Q( 53G !K_*
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MQ<W=JW,I0C.*V?OJ3VL_].R](<Q1G&YQ(%7H2!L=MH.!DJI4<$"1U!X.UO\
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M=B9J2:3HT?:*BVDG>*:CR+?JT?@9_P $Z_AO_P +9_;U_9!\!M#]JL]2^/\
M\.M:U*)(P\4FB^!_$47C368)T8C%C=Z3X3O897W$BWO54*S)N?[7_P""[/[(
M@_9F_;C\3^-?#>F36GPP_::M;GXQ>';F*V:.QTSQQJ-[>1_%?PVSF3R3>0>)
MHG\=21 0A]/\<6UE:1%=,9WW/^#>;X?R^-?^"EO@GQ'):/-:_"GX9_%GQ[+/
M\NRVO=5T'_A7]HTW&/+9O&\8A8$,);>U\Q5?<@_IY_X+C?LAG]JS]A[Q=?\
MA_2UU#XI?L_-=?&OX?16L+3:GJUGX?TG4%\?^#[1(D-S=GQ!X+_M"_LM*MB9
M-0\2>'/#V8]UO$Z?L/%7'$^'_%;A[ 5:Z>65N&XY3CH<[4:#SC,'BL/C:VEH
MT\JQF&HTI73G&EC))*I&3E#Z#'YE+ \08."O[*6%IRK:VA&O7JN47+_IY:47
MHK<LE>ST7\X__!N]^UU#\"?VM]>^!OB?58-/^'_[2OAF?3+>YU*YM[72="^*
M/PVL-?\ %/AJ_GN;E8A:PZ]X?O\ Q9X;-U)/;)<:A-HEM<OB"!5\>_X+.?\
M!3&\_;L^.$/@;X;ZQ(?V8_@GK6H6OP^2V=_[-^)?BR,7.G:M\7KZ%H8)Y[:[
MLYKK1/!%G<&2VM/#-Q>ZCY,LWB6=H_Q?A>1%BEBD>.55C*3*Q22(E5'F*8V
M#KDL%!"L<J2$)S])?LB?LJ_%#]LCX\^"O@-\)K&1M<\1W,5SK.O7,-S<>&_
M7@O3[NV3Q3XX\530HSPZ7H%E?1M;6^4N=8U:73-'LC-=W<<2_H.)X4X=P?%F
M9^(^9SC1Q>%RZGB*CJQA# TJN%II2S*E-WC>IA'AG&\)3DG>G2JU).$?7GEV
M!IX^MG6)]V5.E&I&R22J:R=9.[3FTU&]G=15HW>OW'_P2%_X)L7W[?/QL;6?
M'NE7:?LR_":]L[WXHWPN+G3H_'.K26T]UIGP>T?4H)[&9;W78'M[KQ3JEA.Q
M\/\ A87,L<UKK6L^&;FO&_\ @K1XRL/''_!1G]JO4]%M[2ST+P]\0=.^'/A_
M3].M$L-.T[1?A+X-\,_#+3]-L+***WCM+6SC\)&!+-((19N)++8AM\5_H2?L
MQ_LT?"S]C3X$>"?@O\,+"UT7P1\/=%\S4-3O'A2_U[5&6UN_%?C;Q+>I;VXN
M=9UZ>VN=6U*?;%:VJF'3;*WMM*TS3;>S_P P#XG>/;WXI_$GXC?$_4)&>_\
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M]:!&%Q#.B'+JJ'\/O^"EGQ"'Q2_;_P#VO?&4=RMW;3?''Q?X;LKF.3S!+8^
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M;)(PVX"'Y&W'(6(C#G$9Z[J_T$O^#A'X@/X(_P"":'Q+T19H(;WXL_$/X1^
MX=DC1W+V]GX[TSXAZK':NJ*SO)I?@)[*4,OS64LY(##*_P -?[+OP^/Q8_:?
M_9V^%B(L\7Q ^/'PE\%7*,QB2?3M=\=Z!INIC>(W,<?]ESW32N8R$3>Q  )K
M#P$4<MX1XCS^3C"#S"KCX7=HSADN5XBO4DFTURX7ZT^:^B6(T4VVH8<+I8?*
M\9B^9)^WJRFE=-4*>$J-N6B7LU53^&_O=.B_L _X*F?\$Y%\=_\ !*3X 1^#
M=%>Z^+?["GP-^&MSI*6T0DUCQ%\/O"WPR\,^%OBUX7\SS!(UW!:>'],^(ENS
MS27DVL^#%BM)&GU.[,W\4GA/Q5XB\"^*?"_COP9JMQH'BSP3X@T7QCX5US3W
M,=SI&O\ AC4K;7=&U"T7"(9[;4K&VFB#0[I700O"\;/"W^LS>Z<FHP/;^3:S
M6T\-S;S17D2W%O-9W,;1RV;PO&Z7%I< 0FY@G5K>Y@0121OY@>+_ #7_ /@J
M=^QD_P"PY^V1\0_A7I&G7=I\*O$3K\1?@A>2>;*'^'7BEEG;18;B53]K?P/X
MB;5?!5WY\\T[0Z!H>J-/%-K]U')YG@3Q:\S6=<(9A^\K5%C\UP$,7)3H5(8B
M&,GG.6N$W>:FJE'$2I<UG5E>,HJ\5'"V8^W^M8"LZLY5*U>M1@I)RJQKIQG#
M5V<:5^=)R6[2O8_OZ_83_:NT#]L[]E;X3?M!Z$+*SOO&'A^WMO'&@VC>8OA7
MXBZ$D6E^./#C,2)/)L-<M[B72Y)E22ZT6[TN[V[+F-F_EE_X.@/B$NK_ +1'
M[,?PLBF0IX'^$7C#QM=0K-EUO/B5XMM-)B\VW"@(MO8_#F)H) 27&H,IX45Q
M_P#P;E?MHGX2?'?Q5^R'XTU=;3P#^T*9_$GPXAN+D16NG?'/0M)M+:ZTZW^U
M2I;P'XB^"],6R8-*S3ZUX+\*Z;;V[S:B6C^./^"\'Q$;XA?\%/?CU%'=?:M/
M^&NB?"[X6Z6^_)MTT+P#I.O:]9*@++&L'B_Q/KY;:Y+,R[U23S$7AX-X*K<,
M^,U7"N%2IEV%RK,LYRNI.%_:4,QK87#X>G?9?4,7B:V'IQNI0=&GS<UXR>.6
MY;+!<2U**C+V,<-4Q-"4DESWFHQAN[MRJ2BM$KQ6O5_0O_!ME\-_^$M_;_\
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MA>(=)N+FSO#!=07%L_DW5GY6HQ6&IZ9_9O\ !?\ X.0_V$_%?A'2;CXP:/\
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M9I$#%OTFC7E@5. !C.><YS[?E_A3DC*J%+!L#' (''IEF(_%C[FG@8S[G/\
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=E*[;;?A22YI24N:524IRNMG)MV]$V[):*^A__]D!

end
</TEXT>
</DOCUMENT>
</SEC-DOCUMENT>
